Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
Breast Carcinoma,277/4963,4.476353091672883E-64,3.006318736367508E-60,0,0,5.231785917525354,763.1430187516985,CYFIP2;CBLC;UBE2L6;ENO2;MKI67;ANTXR2;MYLK;AQP1;EPS8;CDC20;C4B;RPS6KA3;C4A;DPYSL2;STMN1;CHEK1;KDR;RCC1;TNFSF11;TNS1;PRKCA;KRT5;SOX10;RUNX2;BIN1;FEZ1;TXNIP;COL8A1;PRKD1;EZR;ZFPM2;ATF3;EPAS1;USHBP1;PDGFA;GATA4;GATA3;C3;PPP4C;TERT;RACGAP1;FADD;A2M;PPARGC1A;BARD1;PLK4;STAT5A;NGFR;NFE2;STAT5B;EGR1;JUN;SIAH2;SH2D1A;CDC7;FLI1;GADD45G;COL1A1;GIPC2;SDC1;PAEP;CALR;TDGF1;EZH2;RET;NRP1;FEN1;BRCA1;BRCA2;AKAP12;CHAF1A;MECOM;CTLA4;RAC3;SOSTDC1;ELOB;TK1;TIMP1;CD36;IKBKE;TEAD1;NEFH;CEP55;VAV3;ANXA1;PARP1;DUSP1;ANXA3;BGN;IL18;NME3;FOS;PROX1;KIF22;TUBG1;PAX2;SYN1;VAV2;MMP14;NR5A2;TAL1;KIT;RARB;PPARG;PPARA;SGK1;ALDOA;CRYAB;CCL14;PRKN;YAP1;SATB1;CXCR4;ASCL1;PTGS2;HOXD10;CXCR2;CCL19;CCL16;PAK5;RUNX1T1;RIBC2;PAK4;CA12;ARNT2;CDKN2C;CCL21;STAT1;CDKN2A;AGT;PPP1CA;PER2;CENPF;KRT19;WT1;KRT15;CAMK1;CDKN3;MAD2L1;RAB3A;CTNND2;PROS1;IRS2;CIB1;FGF1;FGF2;ETS2;RIMS2;HOXA10;CDH5;ZFP36;FGF7;CCND2;CCND1;CFL1;RUVBL1;LEPR;SIRPA;NEK2;KPNA2;PITX1;TLE4;CISH;HGF;LMO2;LIFR;CDC25B;MELK;MYCN;CCNE2;FANCD2;ADAM12;S100A4;PRTN3;ERG;FKBP4;UTRN;FBN2;BLM;SHC3;ADRB1;ADRB2;PKMYT1;PLD1;FBLN2;FOXO1;SOCS3;VTN;CCNB2;GRK3;NDN;PMAIP1;OTX1;ZNF423;CBX4;CAV2;CAV1;LSM1;FANCA;HMGA1;HMGA2;BMX;ESR1;SELE;NDC80;GFAP;CXCL10;NR4A1;BMP2;EFNA3;IL6;CXCL12;BCL3;BMPR1B;FGFR4;FGFR3;ALK;GPSM2;FLT4;SIX1;SLC2A4;PKD2;ADRA1A;SYNE1;RND1;ALDH2;MDK;SIX2;CR1;DST;VWF;PLAUR;PLA2G4A;SSTR2;DCN;TGFBR2;CCNA2;ACTA2;DNAJC1;VCAN;ELF5;PECAM1;IRF7;LTA;EVL;MET;LRP1;SEMA3F;IL2RG;DEPP1;AURKA;MUC1;ERBB2;E2F1;S1PR1;REPS2;E2F2;CCL2;SNCG;BAK1;E2F5;MEST;BUB1;PDLIM4;TCF7L2;CMA1;TRAT1;PLA2G2A;GZMB;KLF4;MAPK15;RAD51;PRC1;SPRY2;VIM;TEK;NECTIN3
Neoplasm Metastasis,245/3920,3.366493875183709E-63,1.1304686432866896E-59,0,0,5.293333333333333,761.440648699192,MAML2;ENO2;MKI67;ANTXR2;MYLK;AQP1;CDC20;RPS6KA3;STMN1;CHEK1;KDR;TNFSF11;SOX5;TNS1;PRKCA;KRT5;SOX10;RUNX2;BIN1;TXNIP;PRKD1;EZR;ATF3;SKAP2;MAGED1;EPAS1;PDGFA;GATA4;GATA3;PPP4C;TERT;RACGAP1;FADD;A2M;PPARGC1A;PLK4;STAT5A;NGFR;STAT5B;EGR1;JUN;SIAH2;SH2D1A;FLI1;GADD45G;COL1A1;COL1A2;SDC1;PAEP;CALR;TDGF1;EZH2;RET;NRP1;FEN1;BRCA1;BRCA2;AKAP12;CHAF1A;CTLA4;RAC3;SOSTDC1;TIMP1;CD36;IKBKE;TEAD1;CEP55;VAV3;ANXA1;PARP1;DUSP1;BGN;IL18;PAX3;NME3;FOS;PROX1;KIF22;SYP;PAX2;VAV2;MMP14;NR5A2;TAL1;KIT;RARB;PPARG;PPARA;ALDOA;CRYAB;CCL14;PRKN;YAP1;SATB1;CXCR4;PTGS2;HOXD10;CXCR2;DMD;FLNC;CCL19;RXRG;PAK5;RUNX1T1;PAK4;CA12;CDKN2C;CCL21;STAT1;CDKN2A;AGT;PPP1CA;PER2;COL3A1;CENPF;KRT19;WT1;SAA1;F2RL2;CDKN3;MAD2L1;CTNND2;PROS1;IRS2;CIB1;FGF1;FGF2;ETS2;RIMS2;HOXA10;CDH5;ZFP36;FGF7;CCND2;CCND1;CFL1;LEPR;SIRPA;CAPN3;KPNA2;CISH;HGF;LMO2;TAP1;MITF;LIFR;CDC25B;MYCN;CCNE2;FANCD2;ADAM12;S100A4;ERG;FKBP4;UTRN;FBN2;BLM;ADRB2;PLD1;FBLN2;FOXO1;SOCS3;VTN;CCNB2;GRK3;GRK5;NDN;ECT2;CBX4;CAV2;CAV1;CCDC136;CBX2;HMGA1;HMGA2;INHBA;BMX;ESR1;SELE;GFAP;CXCL10;RCAN1;NR4A1;BMP2;EFNA3;IL6;CXCL12;BCL3;CNTN1;FGFR4;FGFR3;ALK;GPSM2;FLT4;SIX1;PKD2;ADRA1A;SYNE1;RND1;MDK;SIX2;SIX3;KLF11;CR1;VWF;PLAUR;PLA2G4A;SSTR2;DCN;TGFBR2;CCNA2;ACTA2;VCAN;ELF5;PECAM1;IRF7;LTA;EVL;MET;LRP1;SEMA3F;IL2RG;AURKA;ACAN;CLEC3B;MUC1;SH3BP1;ERBB2;E2F1;S1PR1;E2F2;CCL2;SNCG;BAK1;BUB1;PPP1R14A;TCF7L2;CMA1;PLA2G2A;GZMB;KLF4;RAD51;VIM;TEK;NECTIN3
Malignant neoplasm of breast,268/5054,4.566318259191937E-56,1.022246447624435E-52,0,0,4.672399016906656,595.3853879406819,CYFIP2;CBLC;UBE2L6;MKI67;ANTXR2;MYLK;AQP1;EPS8;CDC20;C4B;RPS6KA3;C4A;STMN1;CHEK1;KDR;RCC1;TNFSF11;TNS1;RFX2;PRKCA;KRT5;SOX10;RUNX2;BIN1;FEZ1;TXNIP;PRKD1;EZR;ATF3;EPAS1;PDGFA;GATA4;GATA3;C3;DSN1;PPP4C;TERT;RACGAP1;FADD;A2M;PPARGC1A;BARD1;PLK4;STAT5A;NGFR;STAT5B;EGR1;JUN;SIAH2;SH2D1A;CDC7;FLI1;GRIN2D;GADD45G;COL1A1;GIPC2;SDC1;PAEP;CALR;TDGF1;EZH2;RET;NRP1;FEN1;BRCA1;BRCA2;AKAP12;CHAF1A;MECOM;CTLA4;RAC3;SOSTDC1;TK1;TIMP1;CD36;IKBKE;NEFH;VAV3;ANXA1;PARP1;DUSP1;ANXA3;BGN;IL18;FOS;PROX1;KIF22;TUBG1;PAX2;SYN1;VAV2;MMP14;NR5A2;TAL1;KIT;RARB;PPARG;PPARA;SGK1;ALDOA;CRYAB;CCL14;PRKN;YAP1;SATB1;CXCR4;ASCL1;PTGS2;HOXD10;CXCR2;DMD;CCL19;CCL16;PAK5;RUNX1T1;RIBC2;PAK4;CA12;ARNT2;CDKN2C;CCL21;STAT1;CDKN2A;AGT;PPP1CA;PER2;CENPF;KRT19;WT1;CAMK1;F2RL2;CDKN3;MAD2L1;RAB3A;CTNND2;PROS1;IRS2;CIB1;FGF1;FGF2;ETS2;RIMS2;HOXA10;CDH5;ZFP36;FGF7;CCND2;CCND1;CFL1;RUVBL1;LEPR;SIRPA;NEK2;KPNA2;PITX1;TLE4;CISH;HGF;LMO2;LIFR;CDC25B;MELK;MYCN;CCNE2;FANCD2;ADAM12;S100A4;PRTN3;ERG;FKBP4;UTRN;BLM;SHC3;ADRB1;ADRB2;PKMYT1;PLD1;FBLN2;FOXO1;SOCS3;VTN;CCNB2;GRK3;NDN;PMAIP1;OTX1;ZNF423;ECT2;CAV2;CAV1;LSM1;FANCA;HMGA1;HMGA2;BMX;ESR1;SELE;NDC80;GFAP;CXCL10;NR4A1;BMP2;EFNA3;IL6;CXCL12;BCL3;BMPR1B;FGFR4;FGFR3;ALK;GPSM2;FLT4;SIX1;SLC2A4;ADRA1A;SYNE1;RND1;ALDH2;MDK;SIX2;CR1;RFC4;DST;VWF;PLAUR;PLA2G4A;SSTR2;DCN;TGFBR2;CCNA2;ACTA2;VCAN;ELF5;PECAM1;IRF7;LTA;EVL;MET;LRP1;SEMA3F;IL2RG;DEPP1;AURKA;MUC1;ERBB2;E2F1;S1PR1;REPS2;E2F2;CCL2;SNCG;BAK1;E2F5;BUB1;PDLIM4;TCF7L2;CMA1;TRAT1;PLA2G2A;GZMB;KLF4;MAPK15;RAD51;PRC1;SPRY2;VIM;TEK;NECTIN3
Mammary Neoplasms,180/2387,3.720225565257309E-54,6.246258724067021E-51,0,0,5.339169537748672,656.855660949907,IRS2;CIB1;FGF1;MKI67;ANTXR2;FGF2;ETS2;MYLK;AQP1;EPS8;RIMS2;CDH5;RPS6KA3;ZFP36;FGF7;CCND2;CCND1;STMN1;CFL1;CHEK1;LEPR;KDR;TNFSF11;KPNA2;CISH;HGF;PRKCA;LIFR;KRT5;RUNX2;CDC25B;SIGIRR;MELK;CCNE2;BIN1;FANCD2;MAPKAPK2;ADAM12;S100A4;PRKD1;UTRN;EZR;ATF3;BLM;EPAS1;PDGFA;GATA4;GATA3;PLD1;FOXO1;SOCS3;VTN;TERT;RACGAP1;NDN;FADD;APOB;PPARGC1A;BARD1;STAT5A;NGFR;STAT5B;EGR1;CDT1;JUN;CAV2;SIAH2;CAV1;LSM1;HMGA1;HMGA2;BMX;ESR1;SELE;NDC80;COL1A1;CXCL10;NR4A1;PYY;PTPRB;BMP2;IL6;COL1A2;CXCL12;BCL3;SDC1;PAEP;FGFR4;TDGF1;FGFR3;EZH2;RET;ALK;NRP1;FEN1;SIX1;BRCA1;BRCA2;SYNE1;RND1;AKAP12;CHAF1A;MECOM;MDK;CTLA4;RAC3;TIMP1;CD36;IKBKE;VAV3;ANXA1;RFC4;VWF;PARP1;DUSP1;PLAUR;PLA2G4A;FOS;PROX1;PAX2;DCN;TGFBR2;CCNA2;ACTA2;MMP14;VCAN;NR5A2;KIT;LTA;RARB;PPARG;EVL;PPARA;SGK1;ALDOA;CRYAB;MET;PRKN;YAP1;LRP1;SATB1;CXCR4;SEMA3F;PTGS2;HOXD10;DEPP1;RAD54B;AURKA;MUC1;CXCR2;ERBB2;E2F1;REPS2;E2F2;CCL2;SNCG;E2F5;MEST;RIBC2;CA12;ARNT2;TCF7L2;CCL21;STAT1;CDKN2A;CMA1;GZMB;KLF4;MAPK15;AGT;PPP1CA;PER2;CENPF;KRT19;RAD51;WT1;PRC1;VIM;TEK;MAD2L1
Tumor Progression,161/2090,1.1523287802459346E-48,1.5478080176263393E-45,0,0,5.179991822370198,571.7794089652937,CYFIP2;PROS1;IRS2;CIB1;FGF1;FGF2;ETS2;EPS8;RIMS2;CDC20;HOXA10;RPS6KA3;ZFP36;CCND2;CCND1;STMN1;CFL1;CHEK1;LEPR;KDR;TNFSF11;NEK2;KPNA2;SOX5;CISH;TPM3;HGF;LMO2;MITF;RUNX2;MYCN;BIN1;ADAM12;S100A4;PRTN3;ERG;EZR;ATF3;EPAS1;PDGFA;GATA4;GATA3;PLD1;PPL;SOCS3;VTN;PPP4C;TERT;RACGAP1;PMAIP1;ECT2;BARD1;PLK4;STAT5A;NGFR;STAT5B;EGR1;JUN;CAV2;SIAH2;CAV1;HMGA1;HMGA2;CDC7;INHBA;ESR1;SELE;FLI1;GFAP;GADD45G;CXCL10;NR4A1;BMP2;IL6;CXCL12;SDC1;CALR;FGFR4;TDGF1;FGFR3;EZH2;RET;ALK;NRP1;FEN1;FLT4;SIX1;BRCA1;LAMC1;BRCA2;ADRA1A;AKAP12;CHAF1A;MDK;CTLA4;RAC3;SOSTDC1;TIMP1;IKBKE;NEFH;CEP55;VAV3;ANXA1;VWF;PARP1;DUSP1;ANXA3;BGN;IL18;PLAUR;PLA2G4A;FOS;PROX1;SSTR2;DCN;TGFBR2;MMP14;VCAN;NR5A2;ELF5;KIT;IRF7;RARB;PPARG;PPARA;SGK1;MET;PRKN;YAP1;LRP1;SATB1;CXCR4;SEMA3F;PTGS2;HOXD10;AURKA;MUC1;CXCR2;ERBB2;E2F1;CCL2;SNCG;DMD;BUB1;PDLIM4;PAK4;CA12;STAT1;CDKN2A;CMA1;GZMB;KLF4;AGT;CENPF;KRT19;RAD51;WT1;SAA1;VIM;CDKN3;MAD2L1
Liver carcinoma,212/3593,1.0368911699824575E-47,1.1606268496003641E-44,0,0,4.352634578742861,470.89095753266304,MKI67;CDC20;C4B;RPS6KA3;STMN1;CHEK1;KDR;TNFSF11;TNS1;MEF2C;PRKCA;KRT5;SOX10;RUNX2;BIN1;SERPING1;TXNIP;PRKD1;EZR;ATF3;EPAS1;PDGFA;C3;TERT;RACGAP1;FADD;A2M;APOB;PPARGC1A;PLK4;STAT5A;NGFR;STAT5B;EGR1;JUN;EGR2;SIAH2;GADD45G;COL1A1;COL1A2;SDC1;PAEP;CALR;EZH2;RET;NRP1;FEN1;BRCA1;BRCA2;AKAP12;MECOM;CTLA4;SOSTDC1;ELOB;TIMP1;CD36;IKBKE;TEAD1;NEFH;CEP55;CCT3;ANXA1;PARP1;DUSP1;ANXA3;BGN;IL18;FOS;PROX1;KIF22;MMP14;KIT;RARB;PPARG;PPARA;SGK1;CRYAB;MATN2;CCL14;PRKN;YAP1;SERPINC1;SATB1;CXCR4;PTGS2;HOXD10;CXCR2;CCL19;CCL16;PAK5;PAK4;ARNT2;CDKN2C;CCL21;STAT1;CDKN2A;AGT;PPP1CA;PER2;KRT19;WT1;SAA1;F2RL2;CDKN3;MAD2L1;CHPF;IRS2;CIB1;FGF1;FGF2;ETS2;RIMS2;ZFP36;FGF7;CCND2;CCND1;LEPR;NEK2;KPNA2;PITX1;CISH;TPM3;HGF;TAP1;MITF;LIFR;CDC25B;MELK;MYCN;CCNE2;FANCD2;ADAM12;S100A4;FKBP4;ADRB2;PKMYT1;FOXO1;SOCS3;VTN;PMAIP1;ECT2;CBX4;CAV1;HMGA1;HMGA2;INHBA;BMX;ESR1;SELE;NDC80;GFAP;VIL1;CXCL10;NR4A1;BMP2;EFNA3;IL6;CXCL12;PROC;FGFR4;FGFR3;ALK;GPSM2;FLT4;SIX1;FHL5;SLC2A4;LAMC1;PKD2;ADRA1A;SYNE1;LMNB1;RND1;ALDH2;MDK;RFC4;TRIM63;PLAUR;PLA2G4A;SSTR2;DCN;TGFBR2;CCNA2;VCAN;PECAM1;LTA;MET;HLF;LRP1;AURKA;CLEC3B;MUC1;SH3BP1;ERBB2;E2F1;S1PR1;E2F2;CCL2;SNCG;BAK1;E2F5;MEST;BUB1;PDLIM4;TCF7L2;TRAT1;PLA2G2A;KLF4;RAD51;SPRY2;VIM;TEK
Ovarian Carcinoma,162/2203,2.614178571352859E-46,2.5081176121722574E-43,0,0,4.912142076824393,515.5684329883928,CYFIP2;CTNND2;PROS1;IRS2;CIB1;FGF1;MKI67;FGF2;ETS2;AQP1;EPS8;RIMS2;HOXA10;RPS6KA3;FGF7;CCND2;CCND1;STMN1;RUVBL1;CHEK1;LEPR;KDR;SIRPA;NEK2;HGF;PRKCA;LIFR;KRT5;MAPK8IP2;RUNX2;MYCN;CCNE2;FANCD2;ADAM12;S100A4;ATF3;SKAP1;FBN2;BLM;EPAS1;PDGFA;GATA4;ADRB1;FOXO1;C3;VTN;TERT;NDN;PMAIP1;FADD;BARD1;STAT5A;NGFR;STAT5B;EGR1;CDT1;JUN;CAV1;FANCA;HMGA1;HMGA2;CDC7;INHBA;ESR1;SELE;NDC80;BMP2;IL6;CXCL12;GIPC2;BCL3;SDC1;PAEP;CALR;BMPR1B;FGFR4;TDGF1;EZH2;ALK;NRP1;FEN1;FLT4;SIX1;FHL5;BRCA1;SLC2A4;BRCA2;SYNE1;AKAP12;CHAF1A;MECOM;ALDH2;MDK;CTLA4;TIMP1;IKBKE;TEAD1;NEFH;CEP55;VAV3;KLF11;DST;PARP1;DUSP1;ANXA3;IL18;PLAUR;PLA2G4A;FOS;KIF22;PAX2;DCN;TGFBR2;CCNA2;MMP14;VCAN;COL2A1;ELF5;KIT;PECAM1;RARB;PPARG;PPARA;SGK1;CRYAB;MET;PRKN;YAP1;LRP1;CXCR4;PTGS2;IL2RG;HOXD10;AURKA;MUC1;CXCR2;ERBB2;E2F1;E2F2;CCL2;SNCG;CCL19;BAK1;E2F5;MEST;RUNX1T1;PAK4;TCF7L2;STAT1;CDKN2A;PLA2G2A;GZMB;SNCAIP;KLF4;AGT;RAD51;WT1;VIM;TEK;NECTIN2;CDKN3;MAD2L1
Glioblastoma,149/1937,2.0468826727035493E-44,1.7183580037346297E-41,0,0,5.0019707207207205,503.18537994910895,CTNND2;ITSN1;FAM107A;IRS2;CIB1;ENO2;MKI67;FGF2;ETS2;AQP1;EPS8;CDC20;HOXA10;CDH5;ZFP36;FGF7;CCND2;CCND1;LEPR;KDR;SIRPA;KPNA2;TNS2;TNS1;TPM3;HGF;LMO2;TAP1;PRKCA;LIFR;RUNX2;CDC25B;MELK;MYCN;MAPKAPK2;ADAM12;S100A4;PRKD1;EZR;ATF3;GRIA2;SHC3;EPAS1;PDGFA;DTX1;GATA3;PKMYT1;FOXO1;SOCS3;VTN;GRK3;TERT;NDN;FADD;ECT2;GRIA4;STAT5A;STAT5B;EGR1;JUN;CAV2;CAV1;HMGA1;HMGA2;BMX;ESR1;SYT7;GFAP;CXCL10;RCAN1;NR4A1;BMP2;IL6;CXCL12;PAEP;AMOTL2;CALR;BMPR1B;FGFR4;TDGF1;FGFR3;EZH2;ALK;NRP1;FLT4;FHL5;BRCA1;LAMC1;BRCA2;PKD2;ADRA1A;CHAF1A;MDK;SIX3;CTLA4;TK1;TIMP1;CD36;IKBKE;TEAD1;VAV3;ANXA1;RFC4;PARP1;DUSP1;PLAUR;NME3;FOS;SYP;DCN;TGFBR2;CCNA2;MMP14;KIT;PECAM1;IRF7;PPARG;PPARA;SGK1;CRYAB;MET;PRKN;YAP1;LRP1;LAMA1;CXCR4;ASCL1;PTGS2;DEPP1;AURKA;CXCR2;ERBB2;E2F1;S1PR1;CCL2;BAK1;BUB1;PAK4;CDKN2C;STAT1;CDKN2A;CMA1;KLF4;AGT;PPP1CA;RAD51;WT1;VIM;CDKN3
Malignant tumor of colon,151/2001,4.620411041589487E-44,3.4478533950349993E-41,0,0,4.915342893914323,490.46894003980657,CYFIP2;IRS2;CIB1;FGF1;MKI67;FGF2;ETS2;AQP1;EPS8;RIMS2;RPS6KA3;ZFP36;FGF7;CCND2;CCND1;CFL1;RUVBL1;CHEK1;LEPR;KDR;KPNA2;CISH;TPM3;HGF;TAP1;PRKCA;MITF;LIFR;RUNX2;SIGIRR;MYCN;CCNE2;BIN1;S100A4;PRKD1;EZR;ATF3;FBN2;EPAS1;GATA4;PLD1;FOXO1;C3;SOCS3;TERT;GRK5;A2M;PPARGC1A;BARD1;PLK4;STAT5A;EGR1;JUN;CAV1;HMGA1;HMGA2;ESR1;SELE;FLI1;CXCL10;NR4A1;BMP2;IL6;CXCL12;SDC1;PAEP;AMOTL2;CALR;FGFR4;TDGF1;FGFR3;EZH2;RET;ALK;NRP1;FLT4;BRCA1;SLC2A4;BRCA2;PKD2;LMNB1;CHAF1A;MECOM;MDK;TIMP1;CD36;PARP1;BGN;IL18;PLAUR;PLA2G4A;FOS;PROX1;KIF22;SSTR2;PAX2;DCN;TGFBR2;CCNA2;ACTA2;MMP14;COL2A1;NR5A2;KIT;RHOJ;RARB;PPARG;PPARA;CRYAB;MET;PRKN;YAP1;LAMA1;CXCR4;SEMA3F;PTGS2;IL2RG;RAD54B;AURKA;ACAN;CLEC3B;MUC1;CXCR2;ERBB2;E2F1;CCL2;BAK1;MEST;RXRG;BUB1;PDLIM4;PAK5;RUNX1T1;PAK4;TCF7L2;CCL21;STAT1;CDKN2A;PLA2G2A;KLF4;PER2;KRT19;RAD51;NPHS1;WT1;PRC1;SAA1;SPRY2;VIM;TEK;CDKN3
Carcinogenesis,220/4065,1.1474276709024847E-43,7.706124237781087E-41,0,0,3.9950296199971103,395.0031059336602,MAML2;ITSN1;MKI67;AQP1;EPS8;CDC20;RPS6KA3;DPYSL2;STMN1;CHEK1;KDR;TNFSF11;TNS1;PRKCA;KRT5;SOX10;RUNX2;TXNIP;COL8A1;PRKD1;EZR;ATF3;MAGED1;EPAS1;PDGFA;GATA4;GATA3;PPL;TERT;PRKAR2B;FADD;PPARGC1A;BARD1;STAT5A;NGFR;STAT5B;EGR1;CDT1;JUN;SIAH2;CDC7;FLI1;GADD45G;COL1A2;SDC1;PAEP;CALR;TDGF1;EZH2;RET;NRP1;FEN1;BRCA1;BRCA2;AKAP12;CHAF1A;MECOM;CTLA4;RAC3;SOSTDC1;ELOB;TIMP1;CD36;IKBKE;TEAD1;CEP55;ANXA1;PARP1;DUSP1;ANXA3;BGN;IL18;PAX3;FOS;PROX1;PAX2;VAV2;MMP14;COL2A1;NR5A2;TAL1;KIT;RARB;PPARG;PPARA;SGK1;CRYAB;PRKN;YAP1;SATB1;CXCR4;ASCL1;PTGS2;CXCR2;CCL19;RXRG;PAK5;RUNX1T1;RIBC2;CDKN2C;CCL21;STAT1;CDKN2A;SORBS2;AGT;PER2;KRT19;WT1;RAMP1;F2RL2;CDKN3;MAD2L1;CTNND2;IRS2;CIB1;FGF1;FGF2;ETS2;RIMS2;HOXA10;ZFP36;FGF7;CCND2;CCND1;RUVBL1;LEPR;NEK2;KPNA2;PITX1;CISH;HGF;LMO2;TAP1;MITF;LIFR;CDC25B;MELK;MYCN;CCNE2;FANCD2;MAPKAPK2;S100A4;ERG;FKBP4;COL17A1;FBN2;BLM;ADRB2;PLD1;FOXO1;SPTA1;SOCS3;VTN;CCNB2;CAV2;CAV1;FANCA;HMGA1;HMGA2;ESR1;QKI;NDC80;GFAP;CXCL10;RCAN1;NR4A1;PTPRB;BMP2;EFNA3;IL6;CXCL12;BCL3;FGFR4;FGFR3;ALK;GPSM2;FLT4;SIX1;SLC2A4;ADRA1A;ALDH2;MDK;SIX2;SIX3;KLF11;PLAUR;PLA2G4A;DCN;TGFBR2;CCNA2;VCAN;DBF4;ELF5;PECAM1;IRF7;LTA;MCM4;MET;LRP1;SEMA3F;AURKA;MUC1;ERBB2;E2F1;E2F2;CCL2;SNCG;E2F5;BUB1;PDLIM4;TCF7L2;CMA1;TRAT1;PLA2G2A;KLF4;RAD51;PRC1;SPRY2;VIM;TEK
Prostate carcinoma,191/3145,1.4412923289496375E-43,8.799744801114332E-41,0,0,4.22594080360808,416.8705457402987,CTNND2;PROS1;F13A1;IRS2;CIB1;ENO2;FGF1;MKI67;ANTXR2;FGF2;ETS2;MYLK;AQP1;RIMS2;RPS6KA3;ZFP36;FGF7;CCND2;CCND1;STMN1;CFL1;CHEK1;LEPR;KDR;RCC1;TNFSF11;KPNA2;PITX1;SOX5;TNS1;CISH;HGF;LMO2;TAP1;PRKCA;MAPK8IP2;RUNX2;CDC25B;MELK;MYCN;CCNE2;BIN1;MAPKAPK2;TXNIP;S100A4;PRKD1;ERG;FKBP4;EZR;ATF3;BLM;MAGED1;EPAS1;GATA3;ADRB2;FOXO1;SOCS3;VTN;GRK3;TERT;GRK5;PMAIP1;FADD;NKX2-5;A2M;PPARGC1A;PLK4;STAT5A;NGFR;STAT5B;EGR1;JUN;CBX4;SIAH2;CAV1;CBX2;LSM1;HMGA1;HMGA2;INHBA;BMX;ESR1;SELE;FLI1;QKI;GADD45G;NR4A1;BMP2;IL6;CXCL12;BCL3;CNTN1;SDC1;PAEP;CALR;FGFR4;TDGF1;FGFR3;EZH2;RET;ALK;NRP1;FEN1;FLT4;BRCA1;SLC2A4;LAMC1;BRCA2;AKAP12;CHAF1A;MECOM;MDK;CTLA4;RAC3;SOSTDC1;TIMP1;TEAD1;NEFH;CEP55;VAV3;ANXA1;DST;PARP1;DUSP1;ANXA3;BGN;IL18;PLAUR;PLA2G4A;FOS;KIF22;SYP;SSTR2;PAX2;DCN;TGFBR2;CCNA2;MMP14;VCAN;NR5A2;KIT;PECAM1;LTA;RARB;PPARG;PPARA;SGK1;MET;PRKN;YAP1;LRP1;SATB1;CXCR4;SEMA3F;PTGS2;AURKA;MUC1;CXCR2;ERBB2;E2F1;REPS2;E2F2;CCL2;FLNC;CCL19;BAK1;BUB1;PDLIM4;PAK4;TCF7L2;STAT1;CDKN2A;CMA1;GAD1;MX1;PLA2G2A;GZMB;KLF4;AGT;PER2;CENPF;KRT19;RAD51;ACTC1;WT1;SPRY2;VIM;TEK;RAMP1;F2RL2;CDKN3
Malignant neoplasm of prostate,194/3239,1.614790628762191E-43,9.037444885639062E-41,0,0,4.190711701633531,412.91901132232545,ITSN1;ENO2;MKI67;ANTXR2;MYLK;AQP1;RPS6KA3;STMN1;CHEK1;KDR;RCC1;TNFSF11;SOX5;TNS1;PRKCA;MAPK8IP2;RUNX2;BIN1;TXNIP;PRKD1;EZR;ATF3;EPAS1;GATA3;PPL;TERT;FADD;NKX2-5;A2M;PPARGC1A;PLK4;STAT5A;NGFR;STAT5B;EGR1;JUN;SIAH2;FLI1;GADD45G;SDC1;PAEP;CALR;TDGF1;EZH2;RET;NRP1;FEN1;BRCA1;BRCA2;AKAP12;MECOM;CTLA4;RAC3;SOSTDC1;TIMP1;TEAD1;CEP55;VAV3;ANXA1;PARP1;DUSP1;ANXA3;BGN;IL18;FOS;KIF22;SYP;PAX2;MMP14;NR5A2;KIT;RARB;PPARG;PPARA;SGK1;CRYAB;PRKN;YAP1;SATB1;CXCR4;PTGS2;CXCR2;FLNC;CCL19;PAK4;STAT1;CDKN2A;GAD1;AGT;PER2;CENPF;KRT19;WT1;RAMP1;F2RL2;CDKN3;CTNND2;PROS1;F13A1;IRS2;CIB1;FGF1;FGF2;ETS2;RIMS2;ZFP36;FGF7;CCND2;CCND1;CFL1;LEPR;KPNA2;PITX1;CISH;HGF;LMO2;TAP1;LIFR;CDC25B;MELK;MYCN;CCNE2;MAPKAPK2;S100A4;ERG;FKBP4;BLM;ADRB2;FOXO1;SOCS3;VTN;GRK3;GRK5;PMAIP1;CBX4;CAV2;CAV1;CBX2;LSM1;HMGA1;HMGA2;INHBA;BMX;ESR1;SELE;QKI;NR4A1;BMP2;IL6;CXCL12;BCL3;CNTN1;BMPR1B;FGFR4;FGFR3;ALK;FLT4;SLC2A4;LAMC1;MDK;DST;PLAUR;PLA2G4A;SSTR2;DCN;TGFBR2;CCNA2;VCAN;PECAM1;LTA;MET;LRP1;SEMA3F;AURKA;MUC1;ERBB2;E2F1;REPS2;E2F2;CCL2;BAK1;BUB1;PDLIM4;TCF7L2;CMA1;MX1;PLA2G2A;GZMB;KLF4;RAD51;ACTC1;SPRY2;VIM;TEK
Malignant neoplasm of pancreas,142/1846,4.785957913700693E-42,2.3950917827972685E-39,0,0,4.90951595159516,467.10552489272595,IRS2;CIB1;FGF2;ETS2;EPS8;CDC20;CDH5;ZFP36;FGF7;CCND2;CCND1;STMN1;CFL1;RUVBL1;CHEK1;KDR;RCC1;NEK2;HGF;LMO2;PRKCA;MITF;RUNX2;CDC25B;MYCN;CCNE2;FANCD2;MAPKAPK2;TXNIP;HOXB2;S100A4;PRKD1;FKBP4;UTRN;EZR;ATF3;FBN2;MAGED1;EPAS1;PDGFA;GATA4;ADRB2;FBLN2;FOXO1;C3;SOCS3;VTN;TERT;PMAIP1;FADD;PPARGC1A;NGFR;NFE2;STAT5B;EGR1;JUN;CAV1;HMGA1;HMGA2;CDC7;SYT9;ESR1;SELE;GADD45G;CXCL10;NR4A1;BMP2;IL6;CXCL12;SDC1;PAEP;CALR;FGFR4;TDGF1;FGFR3;EZH2;RET;ALK;NRP1;FLT4;SIX1;BRCA1;SLC2A4;BRCA2;PKD2;LMNB1;ALDH2;MDK;CTLA4;TK1;TIMP1;TEAD1;VAV3;KLF11;PARP1;DUSP1;BGN;PLAUR;FOS;PROX1;SSTR2;DCN;TGFBR2;CCNA2;MMP14;NR5A2;PECAM1;LTA;PPARG;MET;PRKN;YAP1;LRP1;SATB1;CXCR4;PTGS2;AURKA;MUC1;CXCR2;ERBB2;E2F1;CCL2;SNCG;DMD;BAK1;PAK3;BUB1;PAK4;TCF7L2;CCL21;STAT1;CDKN2A;GAD1;SORBS2;KLF4;AGT;PER2;KRT19;RAD51;WT1;VIM;CDKN3
Malignant neoplasm of ovary,149/2026,4.992746420363573E-42,2.3950917827972685E-39,0,0,4.740928595084163,450.8650959327856,CYFIP2;CTNND2;PROS1;FAM107A;IRS2;CIB1;FGF1;MKI67;FGF2;ETS2;AQP1;EPS8;RIMS2;HOXA10;RPS6KA3;FGF7;CCND2;CCND1;STMN1;RUVBL1;CHEK1;LEPR;KDR;NEK2;CISH;HGF;PRKCA;KRT5;MAPK8IP2;RUNX2;MYCN;CCNE2;FANCD2;ADAM12;ATF3;SKAP1;FBN2;BLM;EPAS1;GATA4;ADRB1;FOXO1;C3;VTN;TERT;NDN;PMAIP1;BARD1;STAT5B;EGR1;CDT1;JUN;CAV1;FANCA;HMGA1;HMGA2;CDC7;INHBA;ESR1;SELE;NDC80;BMP2;IL6;CXCL12;GIPC2;BCL3;PAEP;BMPR1B;FGFR4;EZH2;ALK;NRP1;FEN1;FLT4;SIX1;FHL5;BRCA1;SLC2A4;BRCA2;SYNE1;AKAP12;CHAF1A;MECOM;ALDH2;MDK;CTLA4;SOSTDC1;TIMP1;IKBKE;TEAD1;NEFH;CEP55;VAV3;KLF11;DST;PARP1;DUSP1;ANXA3;IL18;PLAUR;FOS;KIF22;PAX2;DCN;TGFBR2;CCNA2;MMP14;VCAN;COL2A1;KIT;PECAM1;RARB;PPARG;PPARA;SGK1;CRYAB;MET;PRKN;YAP1;LRP1;CXCR4;PTGS2;IL2RG;HOXD10;AURKA;MUC1;CXCR2;ERBB2;E2F1;E2F2;CCL2;SNCG;E2F5;MEST;RUNX1T1;PAK4;TCF7L2;CCL21;STAT1;CDKN2A;KLF4;AGT;RAD51;WT1;VIM;TEK;NECTIN2;CDKN3;MAD2L1
Pancreatic carcinoma,142/1869,2.0304142549573888E-41,9.090841424195882E-39,0,0,4.837890158442596,453.2994176297302,IRS2;CIB1;FGF2;ETS2;EPS8;RIMS2;CDC20;CDH5;ZFP36;FGF7;CCND2;CCND1;STMN1;CFL1;RUVBL1;CHEK1;KDR;RCC1;NEK2;HGF;LMO2;PRKCA;MITF;RUNX2;CDC25B;MYCN;CCNE2;FANCD2;MAPKAPK2;TXNIP;HOXB2;S100A4;PRKD1;FKBP4;UTRN;EZR;ATF3;FBN2;MAGED1;EPAS1;PDGFA;GATA4;ADRB2;FBLN2;FOXO1;C3;SOCS3;VTN;TERT;PMAIP1;FADD;PPARGC1A;NGFR;NFE2;STAT5B;EGR1;JUN;CAV1;HMGA1;HMGA2;CDC7;SYT9;ESR1;SELE;CXCL10;NR4A1;BMP2;IL6;CXCL12;SDC1;PAEP;CALR;FGFR4;TDGF1;FGFR3;EZH2;RET;ALK;NRP1;FLT4;SIX1;BRCA1;SLC2A4;BRCA2;PKD2;LMNB1;ALDH2;MDK;CTLA4;TK1;TIMP1;TEAD1;VAV3;KLF11;PARP1;DUSP1;BGN;PLAUR;FOS;PROX1;SSTR2;DCN;TGFBR2;CCNA2;MMP14;NR5A2;PECAM1;LTA;PPARG;MET;PRKN;YAP1;SATB1;CXCR4;PTGS2;AURKA;MUC1;CXCR2;ERBB2;E2F1;CCL2;SNCG;DMD;BAK1;PAK3;BUB1;PAK4;TCF7L2;CCL21;STAT1;CDKN2A;GAD1;GZMB;SORBS2;KLF4;AGT;PER2;KRT19;RAD51;WT1;VIM;CDKN3
Glioma,155/2211,2.2656853015820777E-41,9.510214053390772E-39,0,0,4.549082584194284,425.74004828595974,MAML2;CTNND2;ITSN1;FAM107A;CIB1;ENO2;FGF1;MKI67;FGF2;MYLK;AQP1;CDC20;HOXA10;CDH5;ZFP36;FGF7;CCND2;CCND1;STMN1;CHEK1;LEPR;KDR;TNFRSF4;SOX5;CISH;TPM3;HGF;LMO2;TAP1;PRKCA;MITF;SOX10;RUNX2;CDC25B;MELK;MYCN;FANCD2;MAPKAPK2;SERPING1;S100A4;EZR;ZFPM2;GRIA2;FKBP2;SHC3;MAGED1;EPAS1;PDGFA;DTX1;GATA4;ADRB2;PLD1;FOXO1;SOCS3;VTN;CCNB2;PPP4C;TERT;FADD;ECT2;GRIA4;NGFR;EGR1;JUN;CAV2;CAV1;HMGA1;HMGA2;ESR1;QKI;NDC80;GFAP;COL1A1;CXCL10;IL6;CXCL12;CNTN1;SDC1;PAEP;CALR;TDGF1;FGFR3;EZH2;ALK;CNTNAP2;NRP1;FEN1;SIX1;BRCA2;PKD2;ADRA1A;AKAP12;CHAF1A;MECOM;MDK;RAC3;SOSTDC1;TIMP1;IKBKE;TEAD1;ANXA1;PARP1;DUSP1;PLAUR;PAX3;PLA2G4A;FOS;PROX1;SSTR2;DCN;TGFBR2;MMP14;VCAN;KIT;PECAM1;IRF7;RARB;PPARG;SGK1;CRYAB;MET;ARHGEF6;PRKN;YAP1;LRP1;SATB1;CXCR4;SEMA3F;ASCL1;PTGS2;HOXD10;AURKA;ERBB2;E2F1;E2F2;CCL2;DMD;FLNC;BAK1;PAK5;PAK4;TCF7L2;CDKN2C;STAT1;CDKN2A;CMA1;TRAT1;GAD1;KLF4;RAD51;WT1;SPRY2;VIM;TEK;CDKN3
Colon Carcinoma,150/2091,4.900737871062123E-41,1.9360797377678362E-38,0,0,4.614256149634558,428.27958133341826,CYFIP2;PROS1;IRS2;CIB1;FGF1;FGF2;ETS2;AQP1;EPS8;RIMS2;RPS6KA3;ZFP36;FGF7;CCND1;DPYSL2;CFL1;RUVBL1;CHEK1;LEPR;KDR;KPNA2;CISH;TPM3;HGF;TAP1;PRKCA;MITF;LIFR;RUNX2;SIGIRR;CCNE2;BIN1;S100A4;PRKD1;FKBP4;EZR;ATF3;FBN2;EPAS1;GATA4;PLD1;FOXO1;SOCS3;TERT;GRK5;PPARGC1A;BARD1;PLK4;STAT5A;EGR1;JUN;CAV1;HMGA1;HMGA2;ESR1;SELE;FLI1;NDC80;CXCL10;NR4A1;BMP2;IL6;CXCL12;SDC1;PAEP;AMOTL2;CALR;FGFR4;TDGF1;FGFR3;EZH2;RET;NRP1;FLT4;BRCA1;SLC2A4;BRCA2;PKD2;LMNB1;CHAF1A;MECOM;MDK;SOSTDC1;TIMP1;CD36;VWF;PARP1;BGN;IL18;PLAUR;PLA2G4A;FOS;PROX1;KIF22;PAX2;DCN;TGFBR2;CCNA2;MMP14;COL2A1;NR5A2;KIT;PECAM1;RARB;PPARG;PPARA;SGK1;MET;PRKN;YAP1;LRP1;SATB1;LAMA1;CXCR4;SEMA3F;PTGS2;IL2RG;RAD54B;AURKA;CLEC3B;MUC1;CXCR2;ERBB2;E2F1;CCL2;MEST;RXRG;BUB1;PDLIM4;PAK5;RUNX1T1;PAK4;TCF7L2;CCL21;STAT1;CDKN2A;PLA2G2A;KLF4;PER2;KRT19;RAD51;NPHS1;WT1;PRC1;SAA1;SPRY2;VIM;TEK;CDKN3;MAD2L1
Colorectal Cancer,190/3298,6.525733540005118E-40,2.434823691926354E-37,0,0,3.9429303252832666,355.7613387556924,CTNND2;PROS1;IRS2;CIB1;MKI67;ANTXR2;FGF2;ETS2;EPS8;RIMS2;CDH5;RPS6KA3;FGF7;CCND2;CCND1;DPYSL2;STMN1;CFL1;CHEK1;LEPR;KDR;NEK2;KPNA2;PITX1;TNFRSF4;SOX5;TNS1;TLE4;CISH;TPM3;HGF;TAP1;LIFR;RUNX2;MYCN;BIN1;FANCD2;S100A4;KCNQ5;PRKD1;ERG;EZR;ATF3;FBN2;BLM;EPAS1;GATA4;GATA3;ADRB2;PLD1;FBLN2;SOCS3;TERT;RACGAP1;NDN;PMAIP1;FADD;APOB;ECT2;PPARGC1A;PLK4;STAT5A;NGFR;STAT5B;EGR1;JUN;CBX4;CAV2;CAV1;FANCA;HMGA1;HMGA2;CDC7;INHBA;SYT9;ESR1;SELE;QKI;GADD45G;CXCL10;RCAN1;NR4A1;BMP2;IL6;CXCL12;MRGBP;CNTN1;SDC1;PAEP;CALR;FGFR4;TDGF1;FGFR3;EZH2;RET;ALK;NRP1;FEN1;FLT4;SIX1;BRCA1;SLC2A4;LAMC1;BRCA2;PKD2;SYNE1;AKAP12;CHAF1A;MECOM;ALDH2;MDK;CTLA4;SOSTDC1;TK1;TIMP1;CD36;IKBKE;CEP55;VAV3;CCT3;ANXA1;PARP1;DUSP1;BGN;IL18;PLAUR;PLA2G4A;FOS;PROX1;KIF22;DCN;TGFBR2;CCNA2;MMP14;VCAN;COL2A1;NR5A2;KIT;PECAM1;IRF7;LTA;RARB;PPARG;EVL;PPARA;SGK1;CRYAB;MET;PRKN;YAP1;LRP1;SATB1;LAMA1;CXCR4;SEMA3F;PTGS2;HOXD10;RAD54B;AURKA;MUC1;CXCR2;ERBB2;E2F1;E2F2;CCL2;SNCG;DMD;FLNC;CCL19;BAK1;E2F5;BUB1;RUNX1T1;PAK4;PPP1R14A;TCF7L2;STAT1;CDKN2A;CMA1;PLA2G2A;GZMB;KLF4;PER2;COL3A1;KRT19;WT1;VIM;TEK;CDKN3;MAD2L1
Squamous cell carcinoma,139/1876,3.382951502177969E-39,1.1957843309803811E-36,0,0,4.6596415576401355,412.76069497308396,MAML2;IRS2;CIB1;MKI67;FGF2;ETS2;AQP1;EPS8;HOXA10;RPS6KA3;FGF7;CCND2;CCND1;STMN1;CHEK1;LEPR;KDR;PITX1;CISH;HGF;KRT5;CDC25B;BIN1;FANCD2;FEZ1;ADAM12;S100A4;ERG;EZR;ATF3;COL17A1;BLM;EPAS1;GATA4;GATA3;ADRB2;PPL;SOCS3;CCNB2;TERT;RACGAP1;NDN;OTX1;STAT5A;NGFR;EGR1;JUN;CAV2;CAV1;FANCA;HMGA1;HMGA2;CDC7;INHBA;ESR1;SELE;GFAP;VIL1;CXCL10;NR4A1;BMP2;IL6;CXCL12;SDC1;CALR;FGFR4;TDGF1;FGFR3;EZH2;ALK;NRP1;SIX1;BRCA1;SLC2A4;BRCA2;PKD2;AKAP12;MECOM;ALDH2;MDK;CTLA4;TIMP1;CD36;IKBKE;ANXA1;DST;PARP1;DUSP1;IL18;PLAUR;FOS;PROX1;SYP;DCN;VAV2;TGFBR2;MMP14;TAL1;ITPKA;KIT;IRF7;LTA;RARB;PPARG;PPARA;SGK1;CRYAB;MET;YAP1;SATB1;CXCR4;SEMA3F;ASCL1;PTGS2;AURKA;MUC1;ERBB2;E2F1;CCL2;SNCG;BAK1;PAK5;PAK4;CCL21;STAT1;CDKN2A;CMA1;GZMB;KLF4;AGT;PPP1CA;PER2;CENPF;KRT19;RAD51;WT1;VIM;CDKN3;MAD2L1
Endometriosis,88/749,6.25616820400916E-39,2.100821282906276E-36,0,0,7.045907016361764,619.8090691782782,NRP1;FEN1;IRS2;CIB1;BRCA1;SLC2A4;FGF1;BRCA2;FGF2;SYNE1;HOXA10;CCND1;MDK;CFL1;LEPR;KDR;CTLA4;TIMP1;CD36;KLF11;ANXA1;DUSP1;HGF;IL18;FOS;SYP;PAX2;DCN;CCNA2;ACTA2;MMP14;VCAN;CCNE2;RHOJ;LTA;TXNIP;RARB;HOXB2;PPARG;S100A4;PPARA;FKBP4;UTRN;EZR;MET;CCL14;YAP1;PDGFA;CXCR4;PTGS2;FOXO1;DEPP1;C3;VTN;MUC1;TERT;CXCR2;ERBB2;S1PR1;CCL2;SNCG;PPARGC1A;PAK4;EGR1;JUN;CCL21;CDKN2A;SH2D1A;PLA2G2A;HMGA1;HMGA2;INHBA;ESR1;AGT;GRIN2D;COL1A1;CXCL10;NR4A1;IL6;CXCL12;WT1;SDC1;PAEP;TEK;BMPR1B;NECTIN3;TDGF1;CDKN3
Colorectal Carcinoma,176/2931,1.064384146424062E-38,3.404001870182857E-36,0,0,3.9897718915928455,348.849045451339,CTNND2;IRS2;CIB1;MKI67;ANTXR2;FGF2;ETS2;AQP1;EPS8;RIMS2;CDH5;RPS6KA3;ZFP36;FGF7;CCND2;CCND1;STMN1;CFL1;CHEK1;LEPR;KDR;RCC1;NEK2;KPNA2;PITX1;TNFRSF4;SOX5;TNS1;TLE4;CISH;TPM3;HGF;TAP1;LIFR;RUNX2;MYCN;BIN1;FANCD2;S100A4;PRKD1;ERG;EZR;ATF3;FBN2;BLM;EPAS1;GATA4;ADRB2;PLD1;PPL;FBLN2;SOCS3;PPP4C;TERT;RACGAP1;NDN;PMAIP1;FADD;ECT2;PPARGC1A;PLK4;STAT5A;NGFR;STAT5B;EGR1;JUN;CBX4;CAV1;FANCA;HMGA1;HMGA2;CDC7;ESR1;SELE;GADD45G;CXCL10;RCAN1;NR4A1;BMP2;IL6;CXCL12;MRGBP;SDC1;PAEP;CALR;FGFR4;TDGF1;FGFR3;EZH2;RET;ALK;NRP1;FEN1;FLT4;SIX1;BRCA1;SLC2A4;BRCA2;PKD2;SYNE1;AKAP12;MECOM;ALDH2;MDK;TK1;TIMP1;IKBKE;VAV3;CCT3;ANXA1;PARP1;DUSP1;BGN;IL18;PLAUR;PLA2G4A;FOS;PROX1;KIF22;DCN;TGFBR2;CCNA2;MMP14;VCAN;COL2A1;NR5A2;KIT;PECAM1;IRF7;LTA;RARB;PPARG;EVL;PPARA;SGK1;CRYAB;MET;PRKN;YAP1;LRP1;SATB1;LAMA1;CXCR4;SEMA3F;PTGS2;HOXD10;RAD54B;AURKA;MUC1;CXCR2;ERBB2;E2F1;E2F2;CCL2;SNCG;FLNC;CCL19;E2F5;BUB1;PAK5;PAK4;PPP1R14A;TCF7L2;STAT1;CDKN2A;CMA1;PLA2G2A;GZMB;KLF4;PER2;COL3A1;KRT19;WT1;VIM;TEK;MAD2L1
melanoma,159/2454,2.693837270905828E-38,8.223550505183427E-36,0,0,4.18108688696924,361.69439910374075,MAML2;CIB1;FGF1;MKI67;FGF2;AQP1;RIMS2;CDH5;ZFP36;CCND1;STMN1;CHEK1;LEPR;KDR;TNFSF11;CAPN3;PITX1;TNFRSF4;SOX5;TNS1;CISH;HGF;TAP1;PRKCA;MITF;LIFR;SOX10;RUNX2;MYCN;BIN1;TXNIP;S100A4;PRTN3;FKBP4;UTRN;ATF3;SKAP2;BLM;MAGED1;EPAS1;PDGFA;GATA4;ADRB2;PKMYT1;PLD1;FOXO1;SOCS3;VTN;TERT;NDN;PMAIP1;FADD;A2M;PPARGC1A;NGFR;STAT5B;EGR1;JUN;SIAH2;CAV1;FANCA;HMGA2;CDC7;ESR1;SELE;FLI1;CXCL10;RCAN1;NR4A1;IL6;CXCL12;DLG2;GIPC2;BCL3;SDC1;PAEP;CALR;FGFR4;NFKBIE;TDGF1;FGFR3;EZH2;RET;ALK;NRP1;FLT4;BRCA1;BRCA2;ADRA1A;SYNE1;CTLA4;TIMP1;CD36;TEAD1;ANXA1;CR1;TRIM63;DST;VWF;PARP1;DUSP1;BGN;IL18;PLAUR;PAX3;PLA2G4A;FOS;PROX1;KIF22;PAX2;SYN1;DCN;TGFBR2;MMP14;DNAJC1;VCAN;COL2A1;DBF4;NR5A2;TAL1;KIT;PECAM1;LTA;RARB;PPARG;PPARA;MET;PRKN;YAP1;LRP1;CXCR4;ASCL1;PTGS2;IL2RG;AURKA;MUC1;GNG2;CXCR2;ERBB2;E2F1;CCL2;DMD;BAK1;CCL16;RUNX1T1;TCF7L2;CDKN2C;CCL21;STAT1;CDKN2A;PLA2G2A;GZMB;KLF4;AGT;WT1;SPRY2;VIM;TEK;CDKN3
Malignant neoplasm of lung,158/2449,8.754232403771375E-38,2.556235861901242E-35,0,0,4.148504145139974,353.9864500803297,CTNND2;F13A1;IRS2;CIB1;ENO2;FGF2;ETS2;MYLK;AQP1;CDC20;RPS6KA3;ZFP36;CCND2;CCND1;DPYSL2;STMN1;CFL1;CHEK1;LEPR;KDR;TNFSF11;NEK2;KPNA2;PITX1;HGF;TAP1;PRKCA;KRT5;CDC25B;MYCN;FEZ1;MAPKAPK2;SERPING1;TXNIP;S100A4;ERG;EZR;ATF3;SKAP2;FBN2;SHC3;MAGED1;EPAS1;GATA3;ADRB2;FOXO1;SOCS3;CCNB2;TERT;RACGAP1;PMAIP1;FADD;A2M;APOB;PPARGC1A;BARD1;STAT5A;STAT5B;EGR1;JUN;SIAH2;CAV1;LSM1;HMGA1;HMGA2;ESR1;QKI;NDC80;GADD45G;NR4A1;BMP2;EFNA3;IL6;CXCL12;CNTN1;SDC1;PAEP;FGFR4;FGFR3;EZH2;RET;ALK;NRP1;FEN1;FLT4;BRCA1;BRCA2;ADRA1A;ALDH2;MDK;SIX3;CTLA4;TIMP1;TEAD1;ANXA1;DST;PARP1;DUSP1;IL18;PLAUR;PLA2G4A;FOS;KIF22;SSTR2;VAV2;TGFBR2;CCNA2;MMP14;KIT;PECAM1;IRF7;LTA;RARB;PPARG;PPARA;ALDOA;MET;PRKN;YAP1;LRP1;SATB1;CXCR4;SEMA3F;ASCL1;PTGS2;AURKA;MUC1;CXCR2;ERBB2;E2F1;E2F2;CCL2;SNCG;CCL19;BAK1;BUB1;PDLIM4;PAK5;PAK4;CA12;TCF7L2;CDKN2C;CCL21;STAT1;CDKN2A;CMA1;TRAT1;PLA2G2A;GZMB;KLF4;AGT;PPP1CA;KRT19;RAD51;WT1;SPRY2;VIM;MAD2L1
Non-Small Cell Lung Carcinoma,149/2243,9.194533166330881E-37,2.5729368643782583E-34,0,0,4.19746411884664,348.2931453781986,CTNND2;CIB1;ENO2;MKI67;FGF2;ETS2;MYLK;AQP1;RIMS2;CCND2;CCND1;DPYSL2;STMN1;CFL1;CHEK1;LEPR;KDR;TNFSF11;NEK2;KPNA2;TNS1;HGF;TAP1;PRKCA;KRT5;RUNX2;CDC25B;MYCN;CCNE2;BIN1;MAPKAPK2;ADAM12;S100A4;PRKD1;UTRN;EZR;ATF3;FBN2;MAGED1;EPAS1;GATA4;GATA3;FOXO1;SOCS3;VTN;CCNB2;TERT;RACGAP1;PMAIP1;ECT2;BARD1;STAT5A;NFE2;STAT5B;EGR1;JUN;SIAH2;CAV1;HMGA1;HMGA2;INHBA;BMX;ESR1;SELE;NDC80;CXCL10;BMP2;IL6;CXCL12;BCL3;SDC1;PAEP;FGFR4;TDGF1;FGFR3;EZH2;RET;ALK;NRP1;FEN1;FLT4;SIX1;BRCA1;BRCA2;MECOM;MDK;CTLA4;TIMP1;IKBKE;TEAD1;PARP1;DUSP1;PLA2G4A;FOS;KIF22;SYP;SSTR2;SPTB;DCN;CIT;VAV2;TGFBR2;CCNA2;MMP14;KIT;PECAM1;RARB;MCM4;PPARG;PPARA;SGK1;MET;PRKN;YAP1;LRP1;SATB1;CXCR4;ASCL1;PTGS2;AURKA;MUC1;CXCR2;ERBB2;E2F1;REPS2;CCL2;CCL19;BAK1;BUB1;PAK4;ARNT2;CDKN2C;CCL21;STAT1;CDKN2A;CMA1;TRAT1;PLA2G2A;KLF4;HNRNPAB;KRT19;RAD51;WT1;SPRY2;CAMK1;VIM;TEK;CDKN3;MAD2L1
leukemia,137/1941,3.043864720633084E-36,8.177038185508717E-34,0,0,4.376794353097014,357.93395923691315,PROS1;UBE2L6;CIB1;FGF1;FGF2;ETS2;RIMS2;HOXA10;RPS6KA3;ZFP36;CCND2;CCND1;STMN1;CHEK1;LEPR;KDR;RCC1;TNS1;MEF2C;TPM3;HGF;LMO2;LIFR;SOX10;RUNX2;MYCN;CCNE2;FANCD2;FEZ1;TXNIP;S100A4;PRTN3;ERG;EZR;COL17A1;BLM;EPAS1;GATA4;GATA3;ADRB2;C3;SOCS3;VTN;TERT;PMAIP1;PLK4;STAT5A;NGFR;STAT5B;EGR1;JUN;SIAH2;CAV1;SH2D1A;FANCA;HMGA1;HMGA2;BMX;ESR1;SELE;FLI1;NDC80;CXCL10;RCAN1;NR4A1;IL6;CXCL12;BCL3;SDC1;PAEP;CALR;FGFR4;FGFR3;EZH2;RET;ALK;NRP1;FLT4;BRCA1;BRCA2;ADRA1A;SYNE1;MECOM;CTSG;CD36;TEAD1;ANXA1;CR1;PARP1;DUSP1;IL18;PAX3;FOS;PAX2;TGFBR2;CCNA2;NR5A2;TAL1;KIT;PECAM1;LTA;RARB;MCM4;PPARG;SCN4A;PPARA;MET;PRKN;YAP1;HLF;LRP1;SERPINC1;CXCR4;PTGS2;IL2RG;AURKA;MUC1;ERBB2;CCL2;PAK3;BUB1;RUNX1T1;TCF7L2;STAT1;CDKN2A;GZMB;KLF4;KLF1;KRT19;RAD51;WT1;PRC1;CD5;VIM;TEK;NECTIN2;CDKN3
Rheumatoid Arthritis,132/1833,1.1141411531630221E-35,2.8779123017857143E-33,0,0,4.426503485076435,356.2555993560356,FAM107A;F13A1;CIB1;FGF1;FGF2;ETS2;RIMS2;C4B;RPS6KA3;C4A;ZFP36;FGF7;CCND1;KDR;TNFSF11;KPNA2;CISH;HGF;TAP1;MITF;RUNX2;SIGIRR;DDX39A;MYCN;TXNIP;HOXB2;S100A4;PRTN3;ERG;EPAS1;GATA3;ADRB2;FOXO1;C3;SOCS3;VTN;TERT;GRK5;FADD;ZNF423;A2M;APOB;STAT5A;STAT5B;EGR1;JUN;EGR2;CAV2;SH2D1A;INHBA;BMX;ESR1;SELE;GFAP;VIL1;CXCL10;RCAN1;NR4A1;BMP2;IL6;CXCL12;PROC;BCL3;SDC1;PAEP;CALR;NFKBIE;TDGF1;EZH2;RET;NRP1;FLT4;ADRA1A;MDK;CTLA4;TIMP1;IKBKE;CCT3;ANXA1;CR1;VWF;PARP1;DUSP1;ANXA3;BGN;IL18;PLA2G4A;FOS;CCNA2;MMP14;COL2A1;TAL1;PECAM1;LTA;RARB;PPARG;PPARA;MET;PRKN;CCL13;LRP1;SERPINC1;CXCR4;PTGS2;IL2RG;HOXD10;AURKA;ACAN;MUC1;CXCR2;ERBB2;E2F1;S1PR1;E2F2;CCL2;BAK1;PAK3;PDLIM4;RUNX1T1;CDKN2C;CCL21;STAT1;CDKN2A;PLA2G2A;GZMB;PER2;CD5;SAA1;SPRY2;VIM;TEK;CDKN3
Adenocarcinoma,127/1712,1.7134414295002167E-35,4.262026903897576E-33,0,0,4.527885244925897,362.46615359900056,MAML2;CTNND2;PROS1;CIB1;FGF1;MKI67;FGF2;ETS2;AQP1;HOXA10;FGF7;CCND2;CCND1;STMN1;CFL1;CHEK1;KDR;TNFSF11;PITX1;TPM3;HGF;KRT5;RUNX2;MYCN;ADAM12;HOXB2;S100A4;PRKD1;ERG;SKAP2;COL17A1;GRIA2;EPAS1;PDGFA;GATA4;ADRB2;FBLN2;SOCS3;VTN;CCNB2;TERT;FADD;ECT2;STAT5A;STAT5B;EGR1;JUN;CAV1;HMGA1;HMGA2;INHBA;ESR1;SELE;BMP2;IL6;CXCL12;CNTN1;SDC1;PAEP;CALR;FGFR4;FGFR3;EZH2;RET;ALK;NRP1;FLT4;SIX1;BRCA1;SLC2A4;BRCA2;SYNE1;ALDH2;SIX3;CTLA4;TIMP1;ANXA1;DST;DUSP1;IL18;PLAUR;PLA2G4A;FOS;SYP;SSTR2;PAX2;TGFBR2;CCNA2;ACTA2;MMP14;NR5A2;KIT;PECAM1;LTA;RARB;MCM4;PPARG;MET;PRKN;YAP1;LRP1;CXCR4;ASCL1;PTGS2;AURKA;CLEC3B;MUC1;CXCR2;ERBB2;E2F1;CCL2;BAK1;MEST;BUB1;CCL16;TCF7L2;STAT1;CDKN2A;CMA1;PLA2G2A;AGT;KRT19;RAD51;WT1;VIM;CDKN3;MAD2L1
Renal Cell Carcinoma,112/1348,1.958943524535773E-35,4.6986659681365186E-33,0,0,4.984907237334422,398.3841802171795,FAM107A;IRS2;CIB1;MKI67;FGF2;AQP1;CDC20;CCND1;CHEK1;KDR;RCC1;TNFSF11;CISH;HGF;TAP1;PRKCA;MITF;TXNIP;S100A4;EZR;FBN2;MAGED1;EPAS1;PDGFA;GATA3;FOXO1;C3;SOCS3;VTN;TERT;FADD;PPARGC1A;AP1M2;EGR1;JUN;CAV2;CAV1;HMGA1;HMGA2;INHBA;BMX;ESR1;SELE;CXCL10;NR4A1;PYY;BMP2;IL6;CXCL12;FGFR4;FGFR3;EZH2;ALK;NRP1;GPSM2;BRCA1;SLC2A4;CHAF1A;SIX2;CTLA4;SOSTDC1;TIMP1;CD36;ANXA1;VWF;PARP1;DUSP1;IL18;PLAUR;KIF22;PAX2;DCN;TGFBR2;CCNA2;ACTA2;MMP14;VCAN;KIT;PECAM1;RARB;PPARG;PPARA;CRYAB;MET;PRKN;SATB1;CXCR4;PTGS2;AURKA;MUC1;CXCR2;ERBB2;E2F1;CCL2;RXRG;PAK5;CA12;TCF7L2;STAT1;CDKN2A;F12;GAD1;GZMB;KLF4;AGT;PER2;COL3A1;KRT19;WT1;VIM;TEK;F2RL2
Neuroblastoma,126/1698,3.3782264368317146E-35,7.823506465435102E-33,0,0,4.5184498312953165,358.64349413631174,ITSN1;FAM107A;CIB1;ENO2;FGF2;RIMS2;CDH5;RPS6KA3;CCND2;CCND1;DPYSL2;STMN1;CFL1;CHEK1;LEPR;KDR;TPM3;HGF;PRKCA;LIFR;RUNX2;MYCN;BIN1;SERPING1;FKBP4;UTRN;ZFPM2;ATF3;GRIA2;SHC3;EPAS1;PDGFA;GATA4;GATA3;ADRB2;PKMYT1;FOXO1;SOCS3;VTN;TERT;NDN;PMAIP1;ZNF423;BARD1;STAT5A;NGFR;STAT5B;EGR1;JUN;EGR2;CAV2;CAV1;HMGA1;HMGA2;ESR1;FLI1;GFAP;RCAN1;BMP2;IL6;CXCL12;SDC1;PAEP;CALR;FGFR4;EZH2;RET;ALK;NRP1;FLT4;SIX1;BRCA1;CHAF1A;MDK;NEFH;PARP1;IL18;PAX3;NME3;FOS;PROX1;SYP;SSTR2;SYN1;MMP14;KIT;PECAM1;LTA;RARB;PPARG;PPARA;SGK1;MET;PRKN;YAP1;LRP1;CXCR4;ASCL1;PTGS2;DEPP1;AURKA;MUC1;ERBB2;E2F1;E2F2;CCL2;BAK1;PAK5;ARNT2;CDKN2C;CCL21;STAT1;CDKN2A;CMA1;TRAT1;PLA2G2A;SNCAIP;KLF4;PER2;KRT19;SAA1;SPRY2;VIM;TEK;RAMP1;CDKN3
"Leukemia, Myelocytic, Acute",125/1703,2.048285908711099E-34,4.58542938763458E-32,0,0,4.450104958808619,345.19860162741344,MAML2;CBLC;CIB1;ENO2;FGF1;FGF2;ETS2;RIMS2;HOXA10;CCND2;CCND1;STMN1;CHEK1;LEPR;KDR;SIRPA;TLE4;MEF2C;HGF;LMO2;PRKCA;LIFR;RUNX2;CDC25B;MYCN;CCNE2;FANCD2;TXNIP;HOXB2;S100A4;PRTN3;ERG;FKBP4;FBN2;BLM;EPAS1;GATA4;FOXO1;SOCS3;TERT;PMAIP1;BARD1;STAT5A;STAT5B;EGR1;JUN;CAV1;FANCA;HMGA2;CDC7;ESR1;SELE;FLI1;NR4A1;IL6;CXCL12;PAEP;FXYD6;CALR;FGFR4;EZH2;RET;NRP1;FLT4;BRCA1;BRCA2;AKAP12;MECOM;CTLA4;CTSG;TK1;TIMP1;CD36;CR1;VWF;PARP1;DUSP1;IL18;PLAUR;RHOH;PLA2G4A;FOS;MMP14;NR5A2;TAL1;ELF5;KIT;IRF7;LTA;PPARG;SCN4A;SGK1;MET;PRKN;LRP1;SATB1;CXCR4;PTGS2;STX11;AURKA;MUC1;CXCR2;ERBB2;E2F1;CCL2;BAK1;PAK3;BUB1;PDLIM4;RUNX1T1;STAT1;CDKN2A;MX1;GZMB;KLF4;KLF1;PER2;RAD51;WT1;PRC1;CAMK1;VIM;TEK;RHEBL1;CDKN3
Prostatic Neoplasms,119/1554,2.270627778122786E-34,4.8292885200183383E-32,0,0,4.609307197366452,357.07305779255915,CTNND2;PROS1;ITSN1;CIB1;MKI67;ANTXR2;FGF2;RIMS2;RPS6KA3;ZFP36;FGF7;CCND2;CCND1;STMN1;RUVBL1;CHEK1;LEPR;KDR;TNFSF11;PITX1;SOX5;TPM3;HGF;TAP1;PRKCA;LIFR;RUNX2;CDC25B;BIN1;MAPKAPK2;TXNIP;PRKD1;ERG;FKBP4;EZR;ATF3;EPAS1;GATA3;ADRB2;PPL;FOXO1;SOCS3;GRK3;TERT;A2M;STAT5A;NGFR;STAT5B;EGR1;JUN;CAV2;SIAH2;CAV1;LSM1;BMX;ESR1;CXCL10;NR4A1;BMP2;IL6;CXCL12;SDC1;CALR;BMPR1B;FGFR4;FGFR3;EZH2;NRP1;FLT4;BRCA1;LAMC1;BRCA2;ADRA1A;AKAP12;CHAF1A;CTLA4;TIMP1;TEAD1;VAV3;ANXA1;PARP1;ANXA3;IL18;PLAUR;FOS;KIF22;SSTR2;PAX2;DCN;TGFBR2;MMP14;VCAN;PECAM1;RARB;PPARG;PPARA;CRYAB;MET;YAP1;SERPINC1;SATB1;CXCR4;ASCL1;PTGS2;AURKA;MUC1;ERBB2;E2F1;REPS2;CCL2;CCL16;TCF7L2;STAT1;CDKN2A;PLA2G2A;RAD51;SPRY2;VIM;TEK
Primary malignant neoplasm of lung,146/2268,2.3010308612356585E-34,4.8292885200183383E-32,0,0,4.01151497766668,310.7100310064659,CTNND2;F13A1;IRS2;CIB1;ENO2;FGF2;ETS2;MYLK;AQP1;CDC20;RPS6KA3;ZFP36;CCND1;DPYSL2;STMN1;CFL1;CHEK1;LEPR;KDR;TNFSF11;NEK2;KPNA2;PITX1;HGF;TAP1;PRKCA;KRT5;CDC25B;MYCN;FEZ1;MAPKAPK2;TXNIP;ERG;EZR;ATF3;SKAP2;FBN2;SHC3;MAGED1;EPAS1;GATA3;ADRB2;FOXO1;SOCS3;CCNB2;TERT;RACGAP1;PMAIP1;APOB;PPARGC1A;BARD1;STAT5B;EGR1;JUN;SIAH2;CAV1;LSM1;HMGA1;HMGA2;ESR1;QKI;NDC80;GADD45G;NR4A1;BMP2;EFNA3;IL6;CXCL12;CNTN1;SDC1;PAEP;FGFR4;FGFR3;EZH2;RET;ALK;NRP1;FEN1;FLT4;BRCA1;BRCA2;ALDH2;MDK;SIX3;CTLA4;SOSTDC1;TIMP1;TEAD1;ANXA1;DST;PARP1;DUSP1;IL18;PLAUR;PLA2G4A;KIF22;SSTR2;VAV2;TGFBR2;MMP14;KIT;PECAM1;IRF7;LTA;RARB;PPARG;PPARA;ALDOA;MET;PRKN;YAP1;LRP1;SATB1;CXCR4;SEMA3F;ASCL1;PTGS2;AURKA;MUC1;CXCR2;ERBB2;E2F1;E2F2;CCL2;SNCG;CCL19;BAK1;BUB1;PAK5;PAK4;TCF7L2;CCL21;STAT1;CDKN2A;CMA1;TRAT1;PLA2G2A;KLF4;AGT;PPP1CA;KRT19;RAD51;WT1;SPRY2;VIM;MAD2L1
Central neuroblastoma,123/1655,2.412941082434161E-34,4.9107006998872196E-32,0,0,4.493839498564779,347.8548443419561,ITSN1;FAM107A;CIB1;ENO2;FGF2;RIMS2;CDH5;RPS6KA3;CCND2;CCND1;DPYSL2;STMN1;CFL1;CHEK1;LEPR;KDR;TPM3;HGF;PRKCA;LIFR;RUNX2;MYCN;BIN1;SERPING1;FKBP4;UTRN;ZFPM2;ATF3;GRIA2;SHC3;EPAS1;PDGFA;GATA4;GATA3;ADRB2;PKMYT1;FOXO1;SOCS3;VTN;TERT;NDN;PMAIP1;ZNF423;BARD1;STAT5A;NGFR;STAT5B;EGR1;JUN;EGR2;CAV2;CAV1;HMGA1;HMGA2;ESR1;FLI1;GFAP;RCAN1;BMP2;IL6;CXCL12;SDC1;PAEP;CALR;FGFR4;EZH2;RET;ALK;NRP1;FLT4;SIX1;BRCA1;CHAF1A;MDK;NEFH;PARP1;IL18;PAX3;NME3;FOS;PROX1;SYP;SSTR2;SYN1;MMP14;KIT;PECAM1;LTA;RARB;PPARG;PPARA;SGK1;PRKN;LRP1;CXCR4;ASCL1;PTGS2;DEPP1;AURKA;MUC1;ERBB2;E2F1;E2F2;CCL2;BAK1;PAK5;ARNT2;CDKN2C;CCL21;STAT1;CDKN2A;CMA1;TRAT1;PLA2G2A;SNCAIP;KLF4;PER2;KRT19;SAA1;VIM;TEK;RAMP1;CDKN3
Secondary malignant neoplasm of lymph node,107/1271,2.98986744393065E-34,5.90586757454066E-32,0,0,5.001720754793713,386.0961501893605,CTNND2;PROS1;F13A1;ENO2;MKI67;FGF2;EPS8;HOXA10;FGF7;CCND1;STMN1;CHEK1;LEPR;KDR;NEK2;KPNA2;PRKCA;MITF;KRT5;RUNX2;CDC25B;MYCN;BIN1;S100A4;PRKD1;ERG;EZR;ATF3;EPAS1;PDGFA;GATA3;ADRB2;SOCS3;TERT;RACGAP1;FADD;EGR1;JUN;SIAH2;CAV1;HMGA1;HMGA2;ESR1;FLI1;NR4A1;BMP2;IL6;CXCL12;SDC1;CALR;FGFR4;TDGF1;FGFR3;EZH2;RET;ALK;NRP1;FLT4;SIX1;BRCA1;BRCA2;AKAP12;CHAF1A;MDK;TIMP1;CEP55;PARP1;ANXA3;BGN;IL18;FOS;PROX1;PAX2;TGFBR2;MMP14;NR5A2;KIT;PECAM1;RARB;PPARG;MET;PRKN;SATB1;CXCR4;SEMA3F;PTGS2;AURKA;MUC1;CXCR2;ERBB2;E2F1;CCL2;SNCG;CCL19;BUB1;PAK4;CCL21;CDKN2A;GZMB;KLF4;AGT;PER2;CENPF;KRT19;RAD51;VIM;MAD2L1
Carcinoma of lung,153/2476,3.490553691882228E-34,6.697873884194584E-32,0,0,3.8868256093030387,299.4326213624858,CTNND2;F13A1;IRS2;CIB1;ENO2;FGF2;ETS2;MYLK;AQP1;RIMS2;CDC20;RPS6KA3;ZFP36;CCND2;CCND1;DPYSL2;STMN1;CFL1;CHEK1;LEPR;KDR;TNFSF11;NEK2;KPNA2;PITX1;HGF;TAP1;PRKCA;KRT5;CDC25B;MYCN;FEZ1;MAPKAPK2;TXNIP;S100A4;ERG;EZR;ATF3;SKAP2;FBN2;SHC3;MAGED1;EPAS1;PDGFA;GATA3;ADRB2;FOXO1;SOCS3;CCNB2;TERT;RACGAP1;PMAIP1;APOB;PPARGC1A;BARD1;STAT5B;EGR1;JUN;SIAH2;CAV1;LSM1;HMGA1;HMGA2;ESR1;QKI;NDC80;GADD45G;NR4A1;BMP2;EFNA3;IL6;CXCL12;CNTN1;SDC1;PAEP;FGFR4;FGFR3;EZH2;RET;ALK;NRP1;FEN1;FLT4;BRCA1;BRCA2;ADRA1A;ALDH2;MDK;SIX3;CTLA4;SOSTDC1;TIMP1;TEAD1;ANXA1;DST;VWF;PARP1;DUSP1;IL18;PLAUR;PLA2G4A;KIF22;SSTR2;VAV2;TGFBR2;MMP14;KIT;PECAM1;IRF7;LTA;RARB;PPARG;PPARA;ALDOA;MET;PRKN;YAP1;LRP1;SATB1;CXCR4;SEMA3F;ASCL1;PTGS2;AURKA;MUC1;CXCR2;ERBB2;E2F1;E2F2;CCL2;SNCG;CCL19;BAK1;BUB1;PAK5;PAK4;TCF7L2;CCL21;STAT1;CDKN2A;CMA1;TRAT1;PLA2G2A;KLF4;AGT;PPP1CA;KRT19;RAD51;WT1;SPRY2;VIM;CDKN3;MAD2L1
Malignant neoplasm of urinary bladder,100/1144,3.049210297753036E-33,5.688471211030385E-31,0,0,5.139374757065911,384.7871745081891,CIB1;ENO2;FGF1;MKI67;FGF2;ETS2;MYLK;RIMS2;CDC20;CCND1;STMN1;CHEK1;KDR;KPNA2;HGF;PRKCA;KRT5;SOX10;DDX39A;MYCN;CCNE2;FEZ1;MAPKAPK2;ADAM12;TXNIP;HOXB2;S100A4;PRTN3;ATF3;BLM;EPAS1;GATA4;GATA3;FOXO1;CCNB2;TERT;NGFR;EGR1;JUN;CAV2;CAV1;FANCA;HMGA1;HMGA2;ESR1;CXCL10;IL6;COL1A2;CXCL12;SDC1;CALR;FGFR4;TDGF1;FGFR3;EZH2;NRP1;BRCA1;BRCA2;CHAF1A;ALDH2;MDK;TIMP1;TEAD1;CEP55;ANXA1;PARP1;BGN;FOS;PAX2;DCN;MMP14;VCAN;RARB;PPARG;PPARA;MET;YAP1;SATB1;CXCR4;PTGS2;AURKA;MUC1;CXCR2;ERBB2;E2F1;CCL2;PAK5;STAT1;CDKN2A;CMA1;GZMB;KLF4;MAPK15;AGT;KRT19;RAD51;PRC1;KRT15;VIM;MAD2L1
Osteosarcoma,97/1103,2.0787527952742697E-32,3.7732172359627014E-30,0,0,5.139430657434702,374.92637399732826,CIB1;FGF1;MKI67;FGF2;ETS2;AQP1;CDC20;RPS6KA3;CCND1;STMN1;CHEK1;KDR;TNFSF11;CISH;HGF;RUNX2;MYCN;S100A4;EZR;EPAS1;PDGFA;DTX1;ADRB2;FOXO1;SOCS3;TERT;FADD;ECT2;PPARGC1A;EGR1;JUN;EGR2;CAV2;CAV1;HMGA1;HMGA2;ESR1;NDC80;GFAP;COL1A1;BMP2;IL6;COL1A2;CXCL12;SDC1;PAEP;FXYD6;FGFR4;FGFR3;EZH2;FLT4;SIX1;SLC2A4;BRCA2;MDK;CTLA4;TIMP1;CD36;TEAD1;ANXA1;VWF;PARP1;DUSP1;BGN;PLAUR;PAX3;FOS;KIF22;DCN;CCNA2;ACTA2;MMP14;VCAN;KIT;PPARG;ALDOA;CRYAB;MET;PRKN;YAP1;LRP1;SATB1;CXCR4;PTGS2;AURKA;ERBB2;E2F1;E2F2;CCL2;CDKN2A;CMA1;KLF4;KRT19;RAD51;WT1;SPRY2;CDKN3
Bladder Neoplasm,102/1217,2.1576242383948516E-32,3.813316943436796E-30,0,0,4.9180405025559235,358.5926047867454,CIB1;ENO2;FGF1;MKI67;FGF2;ETS2;MYLK;RIMS2;CDC20;CCND1;STMN1;CHEK1;LEPR;KDR;KPNA2;CISH;HGF;PRKCA;KRT5;SOX10;DDX39A;MYCN;CCNE2;FEZ1;MAPKAPK2;TXNIP;HOXB2;S100A4;PRTN3;ATF3;BLM;EPAS1;GATA4;GATA3;FOXO1;CCNB2;TERT;NGFR;EGR1;JUN;CAV2;CAV1;FANCA;HMGA1;HMGA2;ESR1;CXCL10;IL6;COL1A2;CXCL12;SDC1;CALR;FGFR4;TDGF1;FGFR3;EZH2;NRP1;BRCA1;ALDH2;MDK;TIMP1;TEAD1;CEP55;ANXA1;PARP1;BGN;PLAUR;FOS;PAX2;DCN;MMP14;VCAN;LTA;RARB;PPARG;PPARA;MET;YAP1;SATB1;CXCR4;PTGS2;AURKA;MUC1;CXCR2;ERBB2;E2F1;CCL2;SNCG;BUB1;PAK5;STAT1;CDKN2A;CMA1;GZMB;KLF4;MAPK15;AGT;KRT19;RAD51;PRC1;VIM;MAD2L1
Carcinoma of bladder,99/1162,5.669029407510911E-32,9.762359359190584E-30,0,0,4.977482204905954,358.1184215854084,CIB1;FGF1;MKI67;FGF2;ETS2;MYLK;RIMS2;CDC20;FGF7;CCND1;STMN1;CHEK1;KDR;KPNA2;CISH;HGF;PRKCA;KRT5;SOX10;DDX39A;MYCN;CCNE2;FEZ1;MAPKAPK2;TXNIP;HOXB2;S100A4;PRTN3;ATF3;BLM;EPAS1;GATA4;GATA3;FOXO1;CCNB2;TERT;NGFR;EGR1;JUN;CAV2;CAV1;FANCA;HMGA1;HMGA2;ESR1;CXCL10;IL6;COL1A2;CXCL12;SDC1;CALR;FGFR4;TDGF1;FGFR3;EZH2;RET;NRP1;BRCA1;CHAF1A;ALDH2;MDK;CTLA4;TIMP1;TEAD1;CEP55;ANXA1;PARP1;BGN;FOS;PAX2;DCN;MMP14;VCAN;RARB;PPARG;PPARA;MET;YAP1;SATB1;CXCR4;PTGS2;AURKA;MUC1;CXCR2;ERBB2;E2F1;CCL2;PAK5;STAT1;CDKN2A;CMA1;GZMB;KLF4;AGT;KRT19;RAD51;PRC1;VIM;MAD2L1
Solid Neoplasm,84/840,6.669677663291411E-32,1.1198388796666278E-29,0,0,5.786088027085257,415.35520528911707,RET;ALK;NRP1;FLT4;CIB1;BRCA1;BRCA2;FGF2;MECOM;CCND1;MDK;STMN1;CHEK1;KDR;CTLA4;SIRPA;TEAD1;VWF;PARP1;DUSP1;TPM3;HGF;IL18;PAX3;NME3;KIF22;RUNX2;MMP14;MYCN;CCNE2;BIN1;FANCD2;KIT;PECAM1;RARB;PPARG;S100A4;ERG;EZR;CRYAB;MET;EPAS1;CXCR4;PTGS2;IL2RG;FOXO1;AURKA;SOCS3;CLEC3B;MUC1;TERT;ERBB2;S1PR1;SNCG;BUB1;STAT5A;STAT5B;EGR1;CCL21;CDKN2A;TRAT1;FANCA;GZMB;HMGA2;SNCAIP;BMX;ESR1;FLI1;AGT;GFAP;KRT19;IL6;CXCL12;WT1;BCL3;SDC1;PAEP;VIM;TEK;FGFR4;FGFR3;NECTIN2;EZH2;CDKN3
Epithelial ovarian cancer,106/1329,7.272026234650368E-32,1.1911933705344359E-29,0,0,4.6869417771956865,336.04757621035463,CIB1;MKI67;FGF2;ETS2;AQP1;HOXA10;CDH5;CCND2;CCND1;STMN1;CHEK1;KDR;SIRPA;KPNA2;CISH;HGF;KRT5;RUNX2;CCNE2;ADAM12;S100A4;FKBP4;EZR;SKAP1;FOXO1;VTN;TERT;FADD;PPARGC1A;BARD1;STAT5A;NGFR;STAT5B;EGR1;JUN;CAV1;FANCA;HMGA1;HMGA2;CDC7;ESR1;NDC80;BMP2;IL6;CXCL12;SDC1;PAEP;CALR;FGFR4;TDGF1;EZH2;ALK;NRP1;FEN1;FLT4;SIX1;FHL5;BRCA1;SLC2A4;BRCA2;SYNE1;CHAF1A;MECOM;ALDH2;NEFH;CEP55;VAV3;PARP1;DUSP1;IL18;PLA2G4A;FOS;PAX2;TGFBR2;MMP14;ELF5;KIT;PECAM1;RARB;PPARG;MET;YAP1;CXCR4;PTGS2;IL2RG;HOXD10;AURKA;MUC1;CXCR2;ERBB2;E2F1;CCL2;SNCG;DMD;BAK1;STAT1;CDKN2A;PLA2G2A;SNCAIP;WT1;SPRY2;VIM;TEK;NECTIN2;CDKN3;MAD2L1
Lymphoma,104/1307,3.856887291769124E-31,6.167346440838437E-29,0,0,4.652610896999924,325.823631870977,MAML2;CIB1;ENO2;MKI67;ANTXR2;FGF2;RIMS2;ZFP36;CCND2;CCND1;STMN1;CHEK1;KDR;TNFSF11;CISH;TPM3;HGF;LMO2;RUNX2;CDC25B;MYCN;S100A4;BLM;EPAS1;PDGFA;GATA3;FOXO1;SPTA1;TERT;PLK4;STAT5A;STAT5B;EGR1;JUN;SH2D1A;HMGA1;HMGA2;ESR1;FLI1;CXCL10;RCAN1;NR4A1;IL6;CXCL12;BCL3;SDC1;FGFR4;FGFR3;EZH2;RET;ALK;NRP1;FLT4;BRCA1;BRCA2;ADRA1A;MDK;CTLA4;TIMP1;ANXA1;PARP1;DUSP1;IL18;PAX3;RHOH;FOS;TGFBR2;TAL1;KIT;RHOJ;IRF7;LTA;PPARG;MET;PRKN;SERPINC1;SATB1;CXCR4;SEMA3F;ASCL1;PTGS2;IL2RG;HOXD10;RAD54B;AURKA;MUC1;ERBB2;E2F1;CCL2;BUB1;CA12;PPP1R14A;CCL21;STAT1;CDKN2A;CMA1;GZMB;KLF4;PER2;RAD51;WT1;CD5;SPRY2;VIM
Malignant neoplasm of stomach,145/2398,4.279832008537443E-31,6.684500411473829E-29,0,0,3.711776890072496,259.5505427147319,IRS2;CIB1;FGF2;ETS2;CDC20;HOXA10;FGF7;CCND2;CCND1;STMN1;CHEK1;LEPR;KDR;KPNA2;PITX1;TNS1;CISH;TPM3;HGF;PRKCA;LIFR;MAPK8IP2;RUNX2;MELK;MYCN;ADAM12;TXNIP;S100A4;PRKD1;ERG;EZR;FKBP2;EPAS1;GATA4;ADRB1;GATA3;ADRB2;PLD1;FOXO1;SOCS3;VTN;TERT;RACGAP1;STAT5A;NGFR;STAT5B;EGR1;JUN;EGR2;CAV1;CCDC136;HMGA2;INHBA;ESR1;SELE;FLI1;GADD45G;COL1A1;CXCL10;NR4A1;BMP2;IL6;COL1A2;CXCL12;GIPC2;CNTN1;PAEP;CALR;FGFR4;EZH2;NRP1;FLT4;SIX1;BRCA1;SLC2A4;BRCA2;AKAP12;CHAF1A;ALDH2;MDK;CTLA4;SOSTDC1;TIMP1;CEP55;VAV3;ANXA1;VWF;PARP1;BGN;IL18;PLAUR;PAX3;FOS;KIF22;VAV2;TGFBR2;CCNA2;MMP14;VCAN;NR5A2;KIT;IRF7;LTA;RARB;PPARG;ALDOA;MET;PRKN;YAP1;OPRD1;SATB1;CXCR4;PTGS2;HOXD10;AURKA;MUC1;CXCR2;ERBB2;E2F1;CCL2;SNCG;FLNC;BAK1;BUB1;PAK5;PAK4;TCF7L2;STAT1;CDKN2A;CMA1;MX1;PLA2G2A;SORBS2;KLF4;MAPK15;AGT;PPP1CA;KRT19;RAD51;ACTC1;WT1;VIM;TEK;CDKN3;MAD2L1
Myocardial Infarction,88/966,2.0291413503919662E-30,3.097207570280101E-28,0,0,5.243569865303752,358.5025574245442,NRP1;PROS1;F13A1;BRCA1;FGF2;MYLK;C4B;CCND1;ALDH2;MDK;CFL1;TNFSF11;SIRPA;CTSG;TIMP1;CD36;TEAD1;TNFRSF4;MEF2C;VWF;PARP1;HGF;BGN;IL18;PLAUR;PLA2G4A;LIFR;DCN;TGFBR2;CCNA2;ACTA2;MMP14;VCAN;DDX39A;BIN1;KIT;PECAM1;LTA;SLC27A6;PPARG;PPARA;MET;YAP1;OPRD1;LRP1;SERPINC1;EPAS1;PDGFA;CXCR4;GATA4;ADRB1;SEMA3F;ADRB2;PTGS2;FOXO1;C3;SOCS3;CXCR2;E2F1;CCL2;A2M;APOB;PPARGC1A;RUNX1T1;EGR1;CDKN2A;CMA1;SIAH2;CAV1;PLA2G2A;INHBA;KLF4;ESR1;SELE;AGT;QKI;GFAP;COL1A1;CXCL10;RCAN1;COL3A1;IL6;CXCL12;SDC1;CALR;TEK;RAMP1;FGFR3
Alzheimer's Disease,129/1982,2.371558554323891E-30,3.539419389075389E-28,0,0,3.899864742087754,266.02539470455207,RAB3A;CTNND2;ITSN1;F13A1;IRS2;CIB1;ENO2;FGF1;FGF2;ETS2;AQP1;RIMS2;C4B;C4A;CCND1;DPYSL2;STMN1;CHEK1;MEF2C;CISH;HGF;LIFR;CDC25B;DDX39A;BIN1;FANCD2;MAPKAPK2;SERPING1;ERG;FKBP4;UTRN;GRIA2;BLM;ADRB1;ADRB2;PLD1;FOXO1;C3;SOCS3;TERT;GRK5;A2M;APOB;PPARGC1A;NGFR;EGR1;JUN;EGR2;CAV1;HMGA1;ESR1;GFAP;RCAN1;PYY;IL6;CXCL12;BCL3;FXYD6;CALR;FGFR3;EZH2;RET;FLT4;BRCA1;SLC2A4;LAMC1;BRCA2;SYNE1;LMNB1;RND1;ALDH2;MDK;TIMP1;CD36;NEFH;ANXA1;CR1;DST;VWF;PARP1;ARHGEF15;IL18;PLAUR;PLA2G4A;FOS;SYP;SSTR2;SYN1;DCN;TGFBR2;MMP14;VCAN;PECAM1;IRF7;PPARG;PPARA;CRYAB;MET;PRKN;OPRD1;LRP1;SERPINC1;LAMA1;CXCR4;PTGS2;ACAN;CXCR2;ERBB2;E2F1;CCL2;SNCG;DMD;CCL19;RUNX1T1;CCL21;STAT1;CDKN2A;GAD1;MX1;PLA2G2A;GZMB;SNCAIP;AGT;PPP1CA;PER2;COL3A1;WT1;VIM;NECTIN2
Stomach Neoplasms,81/835,8.122561140909743E-30,1.1858939265728226E-27,0,0,5.548725478765267,371.66976423266794,FLT4;IRS2;BRCA1;MKI67;CDC20;AKAP12;FGF7;CCND2;CCND1;ALDH2;MDK;CHEK1;LEPR;KDR;TNFSF11;TIMP1;PITX1;ANXA1;DUSP1;TPM3;HGF;IL18;PLAUR;PRKCA;FOS;TGFBR2;CCNA2;MMP14;NR5A2;KIT;LTA;TXNIP;RARB;PPARG;S100A4;MET;FKBP2;CXCR4;GATA4;ADRB1;GATA3;ADRB2;PTGS2;HOXD10;AURKA;SOCS3;MUC1;TERT;ERBB2;E2F1;CCL2;BAK1;FADD;NGFR;TCF7L2;JUN;CDKN2A;CMA1;CAV1;MX1;PLA2G2A;HMGA2;KLF4;ESR1;SELE;AGT;NR4A1;KRT19;BMP2;IL6;CXCL12;ACTC1;SDC1;CALR;VIM;TEK;NFKBIE;TDGF1;FGFR3;EZH2;MAD2L1
Stomach Carcinoma,142/2378,8.774288929573134E-30,1.2537898819364503E-27,0,0,3.6299172851095487,242.86225511854948,CIB1;ANTXR2;FGF2;ETS2;CDC20;HOXA10;FGF7;CCND2;CCND1;STMN1;CHEK1;LEPR;KDR;KPNA2;PITX1;TNS1;CISH;HGF;TAP1;PRKCA;LIFR;MAPK8IP2;MELK;MYCN;FEZ1;ADAM12;TXNIP;S100A4;PRKD1;ERG;EZR;EPAS1;PDGFA;GATA4;GATA3;ADRB2;PLD1;FOXO1;SOCS3;VTN;TERT;RACGAP1;STAT5A;NGFR;STAT5B;EGR1;JUN;EGR2;CAV1;CCDC136;HMGA2;INHBA;ESR1;SELE;FLI1;COL1A1;CXCL10;NR4A1;BMP2;IL6;COL1A2;CXCL12;GIPC2;CNTN1;PAEP;CALR;FGFR4;EZH2;ALK;NRP1;FLT4;SIX1;BRCA1;SLC2A4;BRCA2;AKAP12;CHAF1A;ALDH2;MDK;CTLA4;SOSTDC1;TIMP1;CEP55;VAV3;ANXA1;VWF;PARP1;BGN;IL18;PLAUR;PAX3;FOS;KIF22;VAV2;TGFBR2;CCNA2;MMP14;VCAN;NR5A2;KIT;IRF7;LTA;RARB;PPARG;ALDOA;MET;PRKN;YAP1;OPRD1;SATB1;CXCR4;PTGS2;HOXD10;AURKA;MUC1;CXCR2;ERBB2;E2F1;CCL2;SNCG;FLNC;BAK1;BUB1;PAK5;PAK4;STAT1;CDKN2A;CMA1;PLA2G2A;SORBS2;KLF4;MAPK15;AGT;PPP1CA;KRT19;RAD51;WT1;PRC1;VIM;TEK;CDKN3;MAD2L1
Secondary malignant neoplasm of lung,73/683,1.694251193407528E-29,2.3705397947760325E-27,0,0,6.094592808038075,403.7529194711832,RET;ALK;FLT4;SIX1;BRCA1;FGF1;BRCA2;FGF2;ETS2;AKAP12;MDK;STMN1;KDR;CTLA4;TNFSF11;TIMP1;VAV3;ANXA1;VWF;HGF;PAX3;PRKCA;PROX1;KIF22;DCN;TGFBR2;MMP14;VCAN;MYCN;ELF5;ADAM12;PECAM1;S100A4;PRTN3;EZR;CRYAB;MET;ATF3;SKAP2;YAP1;LRP1;SATB1;CXCR4;GATA3;FOXO1;MUC1;PPP4C;TERT;ERBB2;E2F2;CCL2;CCL19;NGFR;CCL21;CAV1;HMGA2;INHBA;ESR1;SELE;RCAN1;KRT19;IL6;CXCL12;RAD51;WT1;CNTN1;SDC1;PAEP;CALR;VIM;TEK;FGFR4;EZH2
Lung Neoplasms,96/1177,1.834691595025661E-29,2.5146507657535384E-27,0,0,4.700900418534255,311.0496080742737,RET;ALK;NRP1;FEN1;FLT4;ENO2;FGF1;MKI67;BRCA2;ADRA1A;CCND2;CCND1;ALDH2;STMN1;CHEK1;CTLA4;TK1;ANXA1;VWF;PARP1;DUSP1;HGF;LMO2;PLAUR;FOS;KIF22;SSTR2;RUNX2;TGFBR2;MMP14;KIT;ADAM12;LTA;SERPING1;RARB;PPARG;ERG;PPARA;EZR;MET;PRKN;YAP1;BLM;LRP1;CXCR4;GATA4;SEMA3F;ADRB2;ASCL1;PTGS2;AURKA;SOCS3;CCNB2;MUC1;TERT;CXCR2;ERBB2;E2F1;CCL2;SNCG;BAK1;FADD;A2M;BUB1;PDLIM4;STAT5A;CA12;STAT5B;EGR1;TCF7L2;JUN;CCL21;CDKN2A;CAV1;CBX2;PLA2G2A;HMGA1;HMGA2;KLF4;ESR1;SELE;GADD45G;RCAN1;NR4A1;KRT19;IL6;CXCL12;RAD51;WT1;SDC1;SPRY2;CALR;VIM;FGFR4;EZH2;MAD2L1
Myocardial Ischemia,59/448,1.1307866572473895E-28,1.514618585941003E-26,0,0,7.530894947853537,484.60909141433496,FGF1;FGF2;ZFP36;CCND2;CCND1;ALDH2;KDR;CD36;TLE4;TRIM63;VWF;PARP1;DUSP1;HGF;IL18;TAP1;DCN;CCNA2;MMP14;KIT;PECAM1;LTA;TXNIP;PPARG;PPARA;ALDOA;ATF3;YAP1;ADRB1;ADRB2;PTGS2;PLD1;FOXO1;SOCS3;GRK5;ERBB2;CCL2;DMD;APOB;RXRG;STAT5A;EGR1;TCF7L2;EGR2;MX1;PLA2G2A;KLF4;ESR1;SELE;AGT;PER2;CXCL10;RCAN1;NR4A1;BMP2;IL6;CXCL12;CALR;TDGF1
Degenerative polyarthritis,86/976,1.1501719458456097E-28,1.514618585941003E-26,0,0,5.023911614659948,323.20064903290995,FLT4;FGF1;FGF2;LMNB1;C4B;ZFP36;DPYSL2;STMN1;LEPR;KDR;TNFSF11;SOSTDC1;TIMP1;CD36;KPNA2;IKBKE;PITX1;CISH;PARP1;DUSP1;HGF;IL18;PLA2G4A;FOS;KRT5;KIF22;RUNX2;TGFBR2;MMP14;COL2A1;ADAM12;PECAM1;RARB;PPARG;S100A4;PPARA;EZR;ALDOA;CRYAB;MET;CCL13;LRP1;SERPINC1;EPAS1;CXCR4;PTGS2;IL2RG;AURKA;C3;SOCS3;VTN;ACAN;CLEC3B;PRKAR2B;CXCR2;ERBB2;CCL2;ZNF423;A2M;PPARGC1A;NFE2;EGR1;JUN;CCL21;CDKN2A;CAV1;HMGA2;SORBS2;INHBA;ESR1;SELE;COL1A1;CXCL10;COL3A1;BMP2;IL6;COL1A2;CXCL12;SAA1;SDC1;SPRY2;CALR;VIM;FGFR4;FGFR3;EZH2
Brain Neoplasms,70/646,1.2039029055967593E-28,1.5548869065361222E-26,0,0,6.150601851851852,395.40259664384934,RET;ALK;NRP1;BRCA1;LAMC1;MKI67;CDC20;CCND2;CCND1;MDK;KDR;RAC3;SIRPA;TK1;TIMP1;VAV3;PARP1;HGF;IL18;KRT5;SOX10;DCN;TGFBR2;MMP14;VCAN;MELK;MYCN;KIT;PECAM1;IRF7;TXNIP;PPARG;S100A4;CRYAB;MET;CCL14;YAP1;MAGED1;EPAS1;CXCR4;GATA4;SEMA3F;IL2RG;FOXO1;AURKA;SOCS3;TERT;ERBB2;E2F1;CCL2;DMD;FADD;STAT5A;STAT5B;EGR1;TCF7L2;STAT1;CDKN2A;CAV1;HMGA2;ESR1;GFAP;NR4A1;IL6;CXCL12;RAD51;PAEP;VIM;TEK;EZH2
Sarcoma,70/658,3.73101376455535E-28,4.727828008066742E-26,0,0,6.0212698412698415,380.2775274921853,CYFIP2;RET;ALK;FLT4;IRS2;CIB1;BRCA1;FGF1;MKI67;FGF2;RIMS2;CCND1;MDK;STMN1;KDR;PARP1;HGF;PLAUR;PAX3;MITF;FOS;KIF22;MAPK8IP2;SYN1;MELK;MYCN;KIT;PPARG;S100A4;ERG;EZR;MET;YAP1;EPAS1;PDGFA;CXCR4;PTGS2;IL2RG;FOXO1;AURKA;ACAN;TERT;CXCR2;ERBB2;E2F1;CCL2;DMD;BUB1;NGFR;JUN;STAT1;CDKN2A;CAV1;HMGA2;KLF4;ESR1;FLI1;COL1A1;BMP2;IL6;RAD51;WT1;VIM;TEK;BMPR1B;FGFR4;FGFR3;EZH2;CDKN3;MAD2L1
Neoplasms,96/1236,8.205990228680088E-28,1.0205820439965827E-25,0,0,4.443372040416227,277.12208660255,RET;ALK;FAM107A;SIX1;FHL5;BRCA1;BRCA2;FGF2;RIMS2;RPS6KA3;ZFP36;MDK;STMN1;CHEK1;SIX3;KDR;CTLA4;SOSTDC1;TIMP1;IKBKE;TNS1;ANXA1;PARP1;TPM3;HGF;IL18;PLAUR;PAX3;PRKCA;MITF;MAPK8IP2;SOX10;RUNX2;VAV2;SIGIRR;MMP14;MYCN;BIN1;ITPKA;KIT;ADAM12;TXNIP;RARB;PPARG;PPARA;EZR;CRYAB;MET;PRKN;YAP1;LRP1;EPAS1;SATB1;CXCR4;DTX1;PTGS2;FOXO1;RAD54B;SOCS3;MUC1;TERT;ERBB2;E2F1;CCL2;SNCG;ECT2;STAT5A;CA12;STAT5B;STAT1;CDKN2A;CMA1;TRAT1;CAV1;HMGA1;HMGA2;BMX;KLF4;ESR1;FLI1;NDC80;GFAP;COL1A1;PER2;CXCL10;NR4A1;BMP2;IL6;CXCL12;WT1;SDC1;VIM;FGFR4;TDGF1;FGFR3;EZH2
Malignant Neoplasms,103/1438,4.5096015339861034E-27,5.50663343677285E-25,0,0,4.110344525483496,249.34824976222603,FGF1;ETS2;AQP1;RPS6KA3;ZFP36;CCND2;CCND1;STMN1;CHEK1;KDR;TNFSF11;TNS1;CISH;TPM3;HGF;MITF;KRT5;SOX10;RUNX2;BIN1;FANCD2;ADAM12;TXNIP;PRKD1;UTRN;BLM;FKBP2;MAGED1;EPAS1;GATA3;SOCS3;TERT;PMAIP1;APOB;BARD1;PLK4;STAT5A;STAT5B;CAV1;HMGA1;HMGA2;ESR1;SELE;FLI1;BMP2;IL6;CXCL12;SDC1;FGFR4;TDGF1;FGFR3;EZH2;RET;ALK;NRP1;FEN1;SIX1;BRCA1;LAMC1;BRCA2;ADRA1A;CHAF1A;ALDH2;CTLA4;IKBKE;ANXA1;PARP1;IL18;PLAUR;PLA2G4A;FOS;VCAN;KIT;IRF7;PPARG;PPARA;SGK1;CRYAB;MET;PRKN;YAP1;SATB1;CXCR4;PTGS2;RAD54B;AURKA;MUC1;ERBB2;E2F1;CA12;TCF7L2;CDKN2C;STAT1;CDKN2A;GAD1;PER2;KRT19;RAD51;WT1;PRC1;VIM;TEK;CDKN3
"Myeloid Leukemia, Chronic",79/876,5.984311430271462E-27,7.176899208161275E-25,0,0,5.080122865115769,306.74115231299555,RET;CIB1;BRCA1;SLC2A4;PKD2;FGF2;ETS2;RIMS2;AKAP12;HOXA10;CCND2;MECOM;CCND1;LEPR;KDR;CTLA4;RAC3;TIMP1;CR1;TRIM63;PARP1;HGF;IL18;NME3;FOS;TGFBR2;MMP14;NR5A2;BIN1;TAL1;FANCD2;KIT;PECAM1;LTA;PPARG;PRTN3;PRKD1;ERG;MET;ATF3;YAP1;FBN2;EPAS1;LAMA1;CXCR4;PTGS2;FOXO1;AURKA;SOCS3;MUC1;TERT;ERBB2;CCL19;FADD;ZNF423;PAK3;PDLIM4;RUNX1T1;STAT5A;STAT5B;EGR1;CCL21;STAT1;CDKN2A;CAV1;GZMB;HMGA2;KLF4;ESR1;PER2;IL6;CXCL12;RAD51;WT1;VIM;TEK;FGFR4;FGFR3;EZH2
Atherosclerosis,90/1134,1.0949357917313423E-26,1.2901032942574903E-24,0,0,4.495143273433706,268.7040069262609,NRP1;PROS1;FLT4;F13A1;IRS2;BRCA1;FGF1;FGF2;PCSK5;MYLK;AQP1;LMNB1;ZFP36;ALDH2;LEPR;KDR;TNFSF11;SOSTDC1;TIMP1;CD36;TNFRSF4;MEF2C;CR1;VWF;PARP1;DUSP1;HGF;BGN;IL18;PLAUR;PLA2G4A;FOS;PROX1;SSTR2;DCN;CCNA2;MMP14;VCAN;NR5A2;KIT;PECAM1;LTA;PPARG;PPARA;FBN2;BLM;LRP1;PDE1A;PDGFA;CXCR4;ADRB2;PTGS2;FOXO1;C3;SOCS3;VTN;ACAN;TERT;CXCR2;S1PR1;CCL2;DMD;CCL19;APOB;PPARGC1A;NFE2;EGR1;TCF7L2;CCL21;STAT1;CDKN2A;CAV1;PLA2G2A;HMGA1;GZMB;KLF4;ESR1;SELE;AGT;RCAN1;NR4A1;COL3A1;BMP2;IL6;CXCL12;BCL3;SAA1;SDC1;PAEP;VIM
Adenocarcinoma of lung (disorder),92/1187,1.5345532140305385E-26,1.7769067905912235E-24,0,0,4.393703028186322,261.1571962992613,RET;ALK;FEN1;CTNND2;SIX1;CIB1;ENO2;MKI67;BRCA2;FGF2;LMNB1;CDC20;FGF7;CCND1;MDK;STMN1;CFL1;CHEK1;SIX3;KDR;RAC3;NEK2;TK1;TIMP1;KPNA2;ANXA1;RFC4;PARP1;HGF;PRKCA;FOS;RUNX2;TGFBR2;ACTA2;MMP14;KIT;LTA;PPARG;S100A4;PRTN3;EZR;ALDOA;MET;PRKN;YAP1;LRP1;EPAS1;SATB1;LAMA1;GATA4;ADRB1;ADRB2;ASCL1;PTGS2;FBLN2;FOXO1;RAD54B;CCNB2;MUC1;TERT;CXCR2;ERBB2;E2F1;CCL2;CCL19;ECT2;PPARGC1A;MEST;PAK5;STAT5A;STAT5B;EGR1;JUN;CDKN2A;CMA1;SIAH2;CAV1;INHBA;BMX;ESR1;SELE;KRT19;BMP2;IL6;CXCL12;WT1;CNTN1;VIM;FGFR4;FGFR3;EZH2;CDKN3
Astrocytoma,72/741,1.6419316644400287E-26,1.869019162437158E-24,0,0,5.449260029574773,323.5298646510069,ALK;NRP1;CIB1;MKI67;FGF2;AQP1;RIMS2;AKAP12;CCND1;MDK;STMN1;KDR;SIRPA;TIMP1;KPNA2;PITX1;ANXA1;TPM3;HGF;PLA2G4A;PRKCA;SOX10;VAV2;MMP14;VCAN;MELK;MYCN;PECAM1;IRF7;LTA;S100A4;MET;MATN2;CCL14;YAP1;SHC3;EPAS1;PDGFA;CXCR4;GATA4;ASCL1;PTGS2;PLD1;C3;VTN;MUC1;TERT;CXCR2;ERBB2;CCL2;A2M;CA12;NGFR;EGR1;TCF7L2;CDKN2A;CAV1;PLA2G2A;KLF4;LSM4;ESR1;FLI1;GFAP;IL6;CXCL12;CALR;VIM;TEK;FGFR4;F2RL2;EZH2;CDKN3
ovarian neoplasm,81/938,2.2505290658128062E-26,2.5190922009998014E-24,0,0,4.855097644479208,286.72287511361424,ALK;NRP1;PROS1;FLT4;CIB1;BRCA1;FGF1;MKI67;BRCA2;FGF2;ETS2;AQP1;FGF7;CCND2;MECOM;CCND1;MDK;KDR;TK1;TIMP1;DUSP1;ANXA3;HGF;IL18;PLAUR;PRKCA;PAX2;DCN;VAV2;TGFBR2;CCNA2;MMP14;VCAN;FANCD2;KIT;PECAM1;PPARG;S100A4;UTRN;ZFPM2;SGK1;MET;ATF3;SKAP1;PRKN;YAP1;SATB1;GATA4;GATA3;PTGS2;FOXO1;AURKA;VTN;MUC1;TERT;ERBB2;E2F1;E2F2;CCL2;SNCG;RUNX1T1;BARD1;STAT5A;STAT5B;JUN;CDKN2A;CAV1;FANCA;HMGA1;HMGA2;ESR1;QKI;IL6;CXCL12;RAD51;WT1;SDC1;PAEP;FGFR4;TDGF1;EZH2
Triple Negative Breast Neoplasms,66/632,4.380234711875569E-26,4.822566610648578E-24,0,0,5.842387909413838,341.1376733226064,RET;CIB1;BRCA1;BRCA2;FGF2;RND1;CDC20;RPS6KA3;CCND1;CHEK1;LEPR;KDR;NEK2;IKBKE;TEAD1;PARP1;HGF;IL18;PLAUR;PRKCA;KRT5;CDC25B;MMP14;MELK;FANCD2;KIT;ADAM12;TXNIP;PPARG;S100A4;PPARA;CRYAB;MET;PRKN;EPAS1;CXCR4;GATA3;IL2RG;PPL;SOCS3;GRK3;MUC1;TERT;ERBB2;E2F1;PMAIP1;PDLIM4;BARD1;STAT1;CDKN2A;CAV1;FANCA;HMGA1;GZMB;HMGA2;CDC7;KLF4;ESR1;NR4A1;IL6;RAD51;WT1;SDC1;PAEP;VIM;EZH2
Arteriosclerosis,87/1087,4.995182883257536E-26,5.4109110070899374E-24,0,0,4.509175977653631,262.69890365079993,PROS1;FLT4;F13A1;IRS2;BRCA1;FGF1;FGF2;PCSK5;MYLK;AQP1;LMNB1;ZFP36;ALDH2;LEPR;KDR;TNFSF11;TIMP1;CD36;TNFRSF4;MEF2C;CR1;VWF;PARP1;DUSP1;HGF;BGN;IL18;PLA2G4A;FOS;PROX1;SSTR2;DCN;CCNA2;MMP14;VCAN;NR5A2;KIT;PECAM1;LTA;PPARG;PPARA;FBN2;BLM;LRP1;PDGFA;CXCR4;ADRB2;PTGS2;FOXO1;C3;SOCS3;VTN;ACAN;TERT;CXCR2;S1PR1;CCL2;DMD;CCL19;APOB;PPARGC1A;NFE2;EGR1;TCF7L2;CCL21;STAT1;CDKN2A;CAV1;PLA2G2A;HMGA1;GZMB;KLF4;ESR1;SELE;AGT;RCAN1;NR4A1;BMP2;IL6;CXCL12;BCL3;SAA1;SDC1;PAEP;VIM;TEK;RAMP1
Osteosarcoma of bone,85/1042,5.545616874016191E-26,5.911803639030594E-24,0,0,4.588499941948218,266.84056422252905,SIX1;CIB1;SLC2A4;FGF1;MKI67;FGF2;AQP1;CDC20;RPS6KA3;CCND1;MDK;STMN1;CHEK1;KDR;CTLA4;TNFSF11;TIMP1;TEAD1;ANXA1;CISH;VWF;PARP1;DUSP1;HGF;BGN;PLAUR;FOS;KIF22;RUNX2;DCN;CCNA2;MMP14;VCAN;PPARG;S100A4;EZR;ALDOA;CRYAB;MET;PRKN;YAP1;LRP1;EPAS1;SATB1;CXCR4;DTX1;ADRB2;PTGS2;FOXO1;AURKA;SOCS3;TERT;ERBB2;E2F1;E2F2;CCL2;FADD;ECT2;PPARGC1A;EGR1;EGR2;CDKN2A;CMA1;CAV2;CAV1;HMGA1;HMGA2;KLF4;ESR1;NDC80;COL1A1;KRT19;BMP2;IL6;COL1A2;CXCL12;RAD51;WT1;SDC1;PAEP;SPRY2;FXYD6;FGFR3;EZH2;CDKN3
Hypertensive disease,96/1310,6.884480630174494E-26,7.224401861289359E-24,0,0,4.155756857672899,240.77600279259582,RET;CNTNAP2;IRS2;BRCA1;SLC2A4;FGF1;PKD2;FGF2;ADRA1A;MYLK;AQP1;CCND1;ALDH2;LEPR;KDR;TNFSF11;TIMP1;CD36;NEFH;VAV3;ANXA1;VWF;PARP1;DUSP1;HGF;BGN;IL18;TAP1;PRKCA;FOS;PAX2;DCN;VAV2;TGFBR2;ACTA2;TXNIP;PPARG;S100A4;PRKD1;PPARA;SGK1;ATF3;YAP1;OPRD1;LRP1;EPAS1;CXCR4;GATA4;ADRB1;ADRB2;PTGS2;FBLN2;FOXO1;ADCY5;C3;VTN;MUC1;TERT;GRK5;CXCR2;CCL2;DMD;FADD;NKX2-5;APOB;PPARGC1A;STAT5A;NGFR;EGR1;TCF7L2;JUN;CCL21;CDKN2A;CMA1;F12;CAV1;KLHL3;KLF4;ESR1;SELE;AGT;COL1A1;PYY;COL3A1;BMP2;IL6;RAD51;PROC;ACTC1;NPHS1;WT1;PAEP;CALR;TEK;FGFR4;RAMP1
Colorectal Neoplasms,86/1073,9.188652876182788E-26,9.493998879452862E-24,0,0,4.506630768232143,259.80385262086395,RET;FEN1;FLT4;BRCA1;MKI67;FGF2;SYNE1;CDH5;FGF7;CCND2;CCND1;ALDH2;DPYSL2;STMN1;CHEK1;LEPR;KDR;CTLA4;TK1;TIMP1;TNFRSF4;PARP1;HGF;BGN;IL18;PLAUR;TAP1;FOS;SSTR2;PAX2;TGFBR2;CCNA2;MMP14;NR5A2;FANCD2;RARB;PPARG;S100A4;EVL;PRKD1;EZR;MET;ATF3;FBN2;BLM;LRP1;LAMA1;CXCR4;GATA4;PTGS2;PLD1;FBLN2;AURKA;MUC1;TERT;CXCR2;ERBB2;PMAIP1;SNCG;FLNC;BAK1;BUB1;CA12;PPP1R14A;TCF7L2;CCL21;CDKN2A;CAV1;PLA2G2A;KLF4;ESR1;SELE;PER2;CXCL10;KRT19;BMP2;IL6;COL1A2;CXCL12;GIPC2;SDC1;CALR;VIM;TDGF1;FGFR3;MAD2L1
Pancreatic Neoplasm,67/665,1.416361187954649E-25,1.439177516909549E-23,0,0,5.618901629771195,321.49408898652007,RET;ALK;NRP1;FLT4;IRS2;CIB1;BRCA1;BRCA2;FGF2;RIMS2;FGF7;CCND1;ALDH2;KDR;TIMP1;PARP1;DUSP1;HGF;BGN;PLAUR;PROX1;SSTR2;DCN;CDC25B;TGFBR2;MMP14;NR5A2;KIT;TXNIP;PPARG;S100A4;EZR;MET;MAGED1;PDGFA;CXCR4;GATA4;GATA3;PTGS2;FOXO1;AURKA;VTN;MUC1;TERT;CXCR2;ERBB2;CCL2;PMAIP1;ECT2;BUB1;PAK4;NGFR;JUN;CDKN2A;CAV1;LSM1;FANCA;HMGA2;SORBS2;KLF4;NR4A1;IL6;CXCL12;RAD51;WT1;SDC1;EZH2
Thyroid Neoplasm,57/476,1.4357488629085733E-25,1.439177516909549E-23,0,0,6.709347243067687,383.79439285712573,RET;FLT4;MKI67;FGF2;ADRA1A;RIMS2;CCND2;CCND1;KDR;TIMP1;ANXA1;TPM3;PLAUR;FOS;SSTR2;RUNX2;DCN;TGFBR2;MMP14;KIT;TXNIP;PPARG;S100A4;MET;YAP1;SHC3;LRP1;PDGFA;CXCR4;ASCL1;PTGS2;FOXO1;MUC1;TERT;ERBB2;E2F1;CCL2;BAK1;RXRG;BUB1;CA12;EGR1;JUN;CDKN2C;CCL21;CDKN2A;HMGA1;HMGA2;ESR1;FLI1;CXCL10;KRT19;IL6;WT1;SDC1;FGFR4;MAD2L1
Small cell carcinoma of lung,67/673,2.8196757424401635E-25,2.784844453857079E-23,0,0,5.542384794034959,313.2999577404644,RET;ALK;CNTNAP2;NRP1;FEN1;CIB1;BRCA1;ENO2;FGF1;MKI67;BRCA2;FGF2;RIMS2;CCND2;CCND1;CHEK1;KDR;CTLA4;ANXA1;PARP1;TPM3;HGF;PLAUR;PAX3;TAP1;PRKCA;SYP;SSTR2;TGFBR2;MMP14;MYCN;KIT;RARB;ERG;MET;YAP1;FBN2;BLM;LRP1;EPAS1;CXCR4;SEMA3F;ASCL1;PTGS2;AURKA;SPTA1;MUC1;TERT;CXCR2;ERBB2;E2F1;CCL2;PMAIP1;RUNX1T1;NGFR;CDKN2A;CAV1;BMX;VIL1;RCAN1;KRT19;IL6;CXCL12;RAD51;SDC1;VIM;EZH2
Nasopharyngeal carcinoma,72/782,4.372458538205663E-25,4.255859643853512E-23,0,0,5.12343767700034,287.37004252548996,MAML2;UBE2L6;BRCA1;BRCA2;FGF2;SYNE1;RIMS2;HOXA10;MECOM;CCND1;STMN1;CHEK1;CEP55;SOX5;ANXA1;DST;PARP1;HGF;IL18;TGFBR2;MMP14;MAPKAPK2;KIT;LTA;S100A4;EZR;CRYAB;MET;COL17A1;PRKN;BLM;SATB1;CXCR4;PTGS2;IL2RG;FBLN2;FOXO1;TERT;CXCR2;ERBB2;E2F1;CCL2;ZNF423;STAT5A;STAT5B;EGR1;JUN;STAT1;CDKN2A;CAV1;HMGA2;KLF4;ESR1;GADD45G;CXCL10;COL3A1;CENPF;KRT19;BMP2;IL6;CXCL12;RAD51;BCL3;SAA1;SDC1;CALR;VIM;TDGF1;FGFR3;EZH2;CDKN3;MAD2L1
Thyroid carcinoma,69/721,5.104936312781636E-25,4.897821753805924E-23,0,0,5.320401220467302,297.593552969333,RET;ALK;NRP1;CIB1;BRCA2;FGF2;CDH5;CCND2;CCND1;KDR;SOSTDC1;TIMP1;ANXA1;PARP1;TPM3;HGF;BGN;IL18;PRKCA;FOS;PROX1;RUNX2;MMP14;MYCN;CCNE2;KIT;PECAM1;TXNIP;RARB;PPARG;S100A4;MET;YAP1;SHC3;PDGFA;CXCR4;PTGS2;PPL;AURKA;SOCS3;VTN;MUC1;TERT;ERBB2;CCL2;BUB1;CCL16;JUN;CCL21;STAT1;CDKN2A;CAV1;HMGA1;HMGA2;ESR1;SELE;CXCL10;RCAN1;NR4A1;KRT19;IL6;RAD51;WT1;SPRY2;VIM;TEK;FGFR4;RAMP1;EZH2
Glioblastoma Multiforme,74/854,3.659352478674244E-24,3.4614382037712986E-22,0,0,4.801126546409566,259.09162269089126,NRP1;CTNND2;MKI67;FGF2;ADRA1A;SYNE1;AQP1;EPS8;CDC20;CDH5;RPS6KA3;FGF7;CCND1;KDR;CTLA4;ANXA1;CISH;PARP1;HGF;PLAUR;TAP1;PRKCA;FOS;TGFBR2;MELK;PECAM1;IRF7;PPARG;S100A4;PPARA;SGK1;MET;ATF3;ARHGEF6;PRKN;YAP1;EPAS1;SATB1;PDGFA;CXCR4;GATA4;ASCL1;PTGS2;DEPP1;SOCS3;VTN;GRK3;TERT;ERBB2;E2F1;CCL2;FADD;NGFR;JUN;CDKN2C;STAT1;CDKN2A;CMA1;HMGA1;HMGA2;AGT;GFAP;PPP1CA;BMP2;IL6;CXCL12;RAD51;WT1;SPRY2;VIM;TEK;FGFR4;FGFR3;EZH2
Vascular Diseases,51/401,3.7896612497748074E-24,3.534911799095501E-22,0,0,7.102646845540247,383.04407949658105,CIB1;BRCA1;PKD2;FGF2;MYLK;ALDH2;KDR;TIMP1;TRIM63;CISH;VWF;HGF;BGN;FOS;PROX1;TGFBR2;ACTA2;MMP14;VCAN;PECAM1;LTA;TXNIP;PPARG;S100A4;SGK1;PRKN;CXCR4;PTGS2;VTN;SOCS3;S1PR1;CCL2;DMD;APOB;STAT5A;EGR1;STAT5B;JUN;CDKN2A;STAT1;CAV1;PLA2G2A;GZMB;KLF4;ESR1;SELE;FLI1;AGT;NR4A1;IL6;CXCL12
Hodgkin Disease,61/592,8.034729613371226E-24,7.391951244301528E-22,0,0,5.691227244193346,302.6496126735885,RET;ALK;FLT4;SIX1;CIB1;BRCA1;MKI67;BRCA2;FGF2;RIMS2;CCND2;CCND1;MDK;STMN1;TIMP1;IKBKE;TNFRSF4;ANXA1;DUSP1;HGF;LMO2;IL18;TAP1;RHOH;MITF;FOS;KIT;PECAM1;LTA;ERG;FKBP4;MET;SATB1;GATA3;PTGS2;FOXO1;MUC1;ERBB2;CCL2;BAK1;STAT5A;NGFR;STAT5B;EGR1;JUN;CDKN2C;STAT1;CDKN2A;SH2D1A;GZMB;KLF4;CXCL10;KRT19;IL6;CXCL12;BCL3;SDC1;VIM;NFKBIE;EZH2;CDKN3
Colonic Neoplasms,70/778,8.368287274712409E-24,7.59478612661737E-22,0,0,4.9690772128060265,264.0448024946752,IRS2;MKI67;FGF2;EPS8;CCND2;MECOM;CCND1;MDK;CFL1;RUVBL1;CHEK1;KDR;CTLA4;TIMP1;KPNA2;CEP55;CISH;PARP1;TPM3;HGF;BGN;PLAUR;TAP1;PLA2G4A;KIF22;RUNX2;DCN;TGFBR2;ACTA2;MMP14;COL2A1;BIN1;KIT;RHOJ;RARB;PPARG;S100A4;EZR;CRYAB;MET;PRKN;EPAS1;PTGS2;AURKA;MUC1;ERBB2;E2F1;CCL2;BAK1;A2M;EGR1;TCF7L2;JUN;STAT1;CDKN2A;CAV2;CAV1;PLA2G2A;KLF4;ESR1;SELE;CXCL10;NR4A1;IL6;CXCL12;WT1;SAA1;CALR;FGFR4;TDGF1
Squamous cell carcinoma of the head and neck,77/934,8.694387219776944E-24,7.785533942402927E-22,0,0,4.565172999847801,242.40778540544315,BRCA1;BRCA2;FGF2;ADRA1A;RIMS2;RPS6KA3;ZFP36;CCND1;ALDH2;CHEK1;KDR;TNFSF11;CEP55;ANXA1;DST;PARP1;DUSP1;HGF;TAP1;PRKCA;FOS;KRT5;KIF22;TGFBR2;MMP14;ADAM12;TXNIP;RARB;S100A4;FKBP4;CRYAB;MET;PRKN;YAP1;PDGFA;CXCR4;DTX1;PTGS2;HOXD10;AURKA;SOCS3;VTN;MUC1;TERT;RACGAP1;GNG7;ERBB2;E2F1;NDN;E2F2;CCL2;PMAIP1;FADD;ECT2;BUB1;STAT5A;STAT5B;EGR1;JUN;STAT1;CDKN2A;CAV1;HMGA2;KLF4;ESR1;CENPF;KRT19;IL6;CXCL12;RAD51;WT1;SDC1;VIM;FGFR4;FGFR3;EZH2;CDKN3
Primary malignant neoplasm,81/1032,1.2035250557768384E-23,1.0635360887627957E-21,0,0,4.3532083058896935,229.73709597079676,RET;ALK;NRP1;FEN1;SIX1;BRCA1;LAMC1;FGF1;BRCA2;ADRA1A;RPS6KA3;ZFP36;CHAF1A;CHEK1;CTLA4;TNFSF11;SOSTDC1;IKBKE;ANXA1;CISH;PARP1;DUSP1;HGF;IL18;PLA2G4A;FOS;KRT5;SOX10;RUNX2;FANCD2;KIT;IRF7;TXNIP;PPARG;PRKD1;ERG;PPARA;UTRN;SGK1;CRYAB;MET;PRKN;YAP1;MAGED1;EPAS1;SATB1;CXCR4;PTGS2;RAD54B;AURKA;SOCS3;MUC1;TERT;ERBB2;PMAIP1;APOB;PLK4;STAT5A;CA12;STAT5B;TCF7L2;CDKN2A;GAD1;CAV1;HMGA1;ESR1;SELE;FLI1;PER2;KRT19;IL6;CXCL12;RAD51;PRC1;SDC1;VIM;FGFR4;TDGF1;FGFR3;EZH2;CDKN3
Kidney Diseases,63/639,1.4892490079330188E-23,1.2989345892569031E-21,0,0,5.434105039267016,285.623001188497,NRP1;IRS2;MKI67;PKD2;FGF2;ADRA1A;PCSK5;AQP1;ZFP36;CCND1;SIX2;LEPR;KDR;CTLA4;SOSTDC1;TIMP1;CD36;ANXA1;DST;VWF;PARP1;HGF;BGN;IL18;PLAUR;PAX2;DCN;TGFBR2;ACTA2;MMP14;VCAN;PPARG;PRKD1;PPARA;EZR;SGK1;GATA3;ADRB2;PTGS2;SOCS3;MUC1;TERT;CCL2;ZNF423;APOB;NGFR;EGR1;TCF7L2;CDKN2A;CMA1;GAD1;PLA2G2A;GZMB;HMGA2;ESR1;FLI1;AGT;GADD45G;NR4A1;IL6;NPHS1;WT1;SAA1
Noninfiltrating Intraductal Carcinoma,43/287,2.4845316351693677E-23,2.139245443820189E-21,0,0,8.46559212136041,440.6287617693556,NRP1;CXCR4;SIX1;GATA4;IRS2;BRCA1;MKI67;BRCA2;PTGS2;AURKA;MUC1;CCND2;TERT;CCND1;CHEK1;ERBB2;LEPR;CTLA4;SNCG;NEK2;KPNA2;STAT5A;STAT5B;PARP1;CISH;CDKN2A;STAT1;SIAH2;HGF;CAV1;KRT5;ESR1;AGT;KRT19;NR5A2;CXCL12;KRT15;KIT;PECAM1;SDC1;VIM;MET;EZH2
Endometrial Carcinoma,72/840,3.1376045025500115E-23,2.667360992294415E-21,0,0,4.721933646112601,244.67170213139542,FEN1;FLT4;SIX1;CIB1;BRCA1;LAMC1;FGF1;BRCA2;FGF2;AQP1;HOXA10;FGF7;MECOM;CCND1;STMN1;CHEK1;LEPR;KDR;TNFSF11;TIMP1;PARP1;HGF;BGN;PRKCA;FOS;PAX2;DCN;TGFBR2;CCNA2;MMP14;VCAN;FANCD2;KIT;LTA;RARB;PPARG;S100A4;EZR;SGK1;MET;PRKN;LRP1;CXCR4;GATA4;SEMA3F;PTGS2;FOXO1;AURKA;SOCS3;TERT;CXCR2;ERBB2;CCL2;SNCG;PAK4;BARD1;EGR1;TCF7L2;CDKN2A;CAV1;ESR1;AGT;NDC80;PER2;KRT19;IL6;CXCL12;SDC1;PAEP;VIM;FGFR4;EZH2
Cervix carcinoma,83/1105,5.52841186233265E-23,4.64110175842826E-21,0,0,4.1578072461104325,213.0857775852391,SIX1;CIB1;BRCA1;ANTXR2;BRCA2;FGF2;ETS2;AQP1;RIMS2;CDC20;ZFP36;FGF7;CCND1;MDK;STMN1;RUVBL1;CHEK1;CTLA4;TIMP1;TEAD1;CISH;PARP1;TPM3;HGF;IL18;TAP1;FOS;MAPK8IP2;MMP14;VCAN;MYCN;LTA;RARB;MCM4;PPARG;EVL;PPARA;EZR;SGK1;MET;ATF3;CXCR4;GATA3;PTGS2;FOXO1;AURKA;SOCS3;MUC1;TERT;ERBB2;E2F1;CCL2;BAK1;PAK3;PDLIM4;BARD1;STAT5A;CA12;STAT5B;EGR1;JUN;STAT1;CDKN2A;CAV1;FANCA;HMGA1;GZMB;HMGA2;KLF4;ESR1;AGT;NDC80;KLF1;KRT19;IL6;RAD51;SDC1;PAEP;CALR;VIM;FGFR3;EZH2;CDKN3
Pulmonary Fibrosis,51/432,1.1710030370540923E-22,9.709205428216399E-21,0,0,6.514209201007234,328.9611244932453,FGF1;FGF2;ETS2;FGF7;CTLA4;TIMP1;CD36;ANXA1;VWF;PARP1;HGF;BGN;PLAUR;PLA2G4A;FOS;DCN;TGFBR2;MAPKAPK2;PPARG;S100A4;PRTN3;UTRN;EZR;CRYAB;PRKN;BLM;HLF;PDGFA;CXCR4;PTGS2;VTN;MUC1;TERT;ERBB2;CCL2;NKX2-5;BARD1;EGR1;STAT1;CMA1;CAV1;SELE;AGT;COL1A1;COL3A1;IL6;COL1A2;CXCL12;WT1;SDC1;F2RL2
Adenoma,78/1000,1.3615060403053676E-22,1.1151066544744937E-20,0,0,4.2951704327164615,216.25444606917586,RET;NRP1;FLT4;CIB1;FHL5;BRCA1;ENO2;MKI67;FGF2;SYNE1;EPS8;ZFP36;CCND1;ALDH2;MDK;LEPR;TIMP1;PITX1;TLE4;PARP1;ANXA3;HGF;PRKCA;FOS;PROX1;SYP;SSTR2;PAX2;TGFBR2;KIT;LTA;PPARG;S100A4;SGK1;MET;PRKN;YAP1;FBN2;BLM;CXCR4;ASCL1;PTGS2;AURKA;C3;CCNB2;MUC1;TERT;PRKAR2B;ERBB2;CCL2;BAK1;BUB1;TCF7L2;CDKN2C;CDKN2A;CAV2;CAV1;PLA2G2A;HMGA1;HMGA2;KLF4;ESR1;MAPK15;AGT;GADD45G;KRT19;IL6;COL1A2;CXCL12;RAD51;MRGBP;WT1;CALR;VIM;FGFR4;F2RL2;EZH2;CDKN3
Hyperactive behavior,65/709,1.4731660135498549E-22,1.1920220418073285E-20,0,0,5.022944589735207,252.50070314665012,ALK;CNTNAP2;RAB3A;BRCA1;SLC2A4;BRCA2;FGF2;RPS6KA3;MECOM;KDR;CTLA4;RAC3;CD36;TNFRSF4;MEF2C;VWF;PARP1;DUSP1;HGF;IL18;MITF;FOS;PAX2;RUNX2;CCNA2;FEZ1;KIT;S100A4;PRKD1;PPARA;EZR;CRYAB;MET;YAP1;GRIA2;BLM;HLF;SERPINC1;PDGFA;ADRB2;PTGS2;ADCY5;MUC1;GRK5;ERBB2;E2F1;CCL2;SNCG;DMD;APOB;PAK3;STAT5B;STAT1;CDKN2A;CAV1;HMGA1;ESR1;IL6;CXCL12;RAD51;VIM;TEK;FGFR3;EZH2;CDKN3
Tumor Angiogenesis,55/511,1.9705272161935454E-22,1.5754834266614107E-20,0,0,5.9066857849752585,295.20771438581136,RET;ALK;NRP1;PKD2;FGF2;ETS2;AQP1;FGF7;MDK;KDR;TNFSF11;IKBKE;TEAD1;VWF;PARP1;HGF;BGN;FOS;SSTR2;RUNX2;DCN;TGFBR2;MMP14;COL2A1;ADAM12;PECAM1;TXNIP;PPARG;S100A4;PRKD1;PPARA;EZR;CRYAB;MET;EPAS1;CXCR4;SEMA3F;PTGS2;CLEC3B;ERBB2;CCL2;JUN;CMA1;CAV1;SELE;AGT;CXCL10;RCAN1;IL6;CXCL12;SDC1;TEK;TDGF1;FGFR3;EZH2
"Mammary Neoplasms, Human",53/476,2.528025356257024E-22,1.997437446190844E-20,0,0,6.115187919139287,304.1048312062054,BRCA1;MKI67;BRCA2;ETS2;SYNE1;AKAP12;CDH5;MECOM;CCND1;STMN1;CFL1;CHEK1;LEPR;KDR;PARP1;PLA2G4A;FOS;KRT5;ACTA2;MMP14;KIT;RARB;EVL;ALDOA;YAP1;PDGFA;CXCR4;PTGS2;DEPP1;AURKA;TERT;ERBB2;E2F1;REPS2;SNCG;RIBC2;BARD1;STAT5A;JUN;CDKN2A;CAV1;GZMB;ESR1;CENPF;BMP2;IL6;CXCL12;RAD51;WT1;PRC1;PAEP;VIM;EZH2
Esophageal Neoplasms,61/637,3.667946631134339E-22,2.8644104156625835E-20,0,0,5.234189633969907,258.34515418624335,FEN1;UBE2L6;CIB1;BRCA1;MKI67;BRCA2;FGF2;RIMS2;CDC20;AKAP12;FGF7;CCND1;ALDH2;MDK;KDR;RAC3;TIMP1;ANXA1;HGF;IL18;PROX1;PAX2;CDC25B;TGFBR2;CCNA2;MMP14;ADAM12;PECAM1;RARB;PPARG;S100A4;EZR;CRYAB;MET;YAP1;MAGED1;SATB1;CXCR4;GATA4;PTGS2;PPL;AURKA;MUC1;TERT;GNG7;CXCR2;ERBB2;E2F1;SNCG;EGR1;CDKN2A;KLF4;GADD45G;PER2;CXCL10;IL6;CXCL12;RAD51;CNTN1;CALR;CDKN3
Hematologic Neoplasms,57/557,3.831936700406336E-22,2.958078951715972E-20,0,0,5.598634020618556,276.0882483190924,RET;ALK;CIB1;BRCA1;BRCA2;FGF2;CDC20;FGF7;CCND2;MECOM;CCND1;STMN1;LEPR;KDR;CTLA4;SIRPA;CTSG;IL18;PROX1;MAPK8IP2;PAX2;FANCD2;KIT;PECAM1;S100A4;ERG;PRKN;YAP1;BLM;LRP1;CXCR4;PTGS2;MUC1;TERT;ERBB2;PMAIP1;RUNX1T1;PLK4;STAT5A;STAT5B;EGR1;CDKN2A;SH2D1A;FANCA;GZMB;KLF4;CXCL10;NR4A1;KRT19;IL6;WT1;BCL3;CALR;FGFR3;EZH2;CDKN3;MAD2L1
Precancerous Conditions,51/446,4.986140768908389E-22,3.805331977725993E-20,0,0,6.2787380325130115,307.9734179518952,RET;FLT4;CIB1;BRCA1;MKI67;FGF2;SYNE1;AKAP12;CCND1;ALDH2;STMN1;CFL1;CHEK1;SIX3;SIRPA;CISH;PARP1;HGF;LMO2;FOS;KRT5;DCN;CDC25B;VCAN;COL2A1;MYCN;KIT;RARB;S100A4;MET;GATA4;PTGS2;MUC1;TERT;ERBB2;E2F1;BARD1;STAT5A;STAT1;CDKN2A;CMA1;CAV1;ESR1;MAPK15;IL6;ACTC1;SDC1;VIM;FGFR4;FGFR3;EZH2
Chronic Lymphocytic Leukemia,82/1120,5.448434234998904E-22,4.111425204747488E-20,0,0,4.029772236288264,197.3038697495089,CYFIP2;NRP1;MAML2;FLT4;CIB1;BRCA1;SLC2A4;MKI67;BRCA2;FGF2;ETS2;AQP1;ZFP36;CCND2;MECOM;CCND1;KDR;CTLA4;TNFSF11;SOSTDC1;CTSG;CR1;TRIM63;PARP1;DUSP1;HGF;IL18;RHOH;PRKCA;FOS;SSTR2;ACTA2;PECAM1;LTA;PPARA;MET;CCL13;SHC3;CXCR4;ADRB2;PTGS2;IL2RG;AURKA;TERT;ERBB2;E2F1;S1PR1;CCL2;PMAIP1;DMD;CCL19;BAK1;FADD;RUNX1T1;STAT5A;NGFR;STAT5B;JUN;EGR2;CCL21;STAT1;CDKN2A;CAV1;GZMB;CDC7;ESR1;PER2;CXCL10;NR4A1;IL6;CXCL12;RAD51;CD5;BCL3;SDC1;PAEP;CALR;VIM;FGFR4;NFKBIE;FGFR3;CDKN3
Hyperglycemia,53/488,8.05211614528228E-22,6.008668003523977E-20,0,0,5.94276331222144,288.64558312006864,PTPRN;IRS2;SLC2A4;FGF2;MYLK;RIMS2;CDH5;CCND1;ALDH2;LEPR;KDR;CTLA4;TIMP1;CD36;KLF11;VWF;PARP1;HGF;PLA2G4A;PRKCA;FOS;PROX1;RUNX2;LTA;TXNIP;PPARG;PPARA;UTRN;SGK1;EPAS1;ADRB1;PTGS2;FOXO1;ADCY5;SOCS3;CCL2;APOB;PPARGC1A;NFE2;EGR1;TCF7L2;JUN;GAD1;PLA2G2A;HMGA1;ESR1;SELE;AGT;CXCL10;COL3A1;IL6;CXCL12;NPHS1
Asthma,89/1313,1.2812536344811878E-21,9.455933416676546E-20,0,0,3.744076797385621,180.11423558286847,F13A1;CIB1;FGF2;ADRA1A;ETS2;MYLK;RIMS2;C4A;ZFP36;ALDH2;FLAD1;CFL1;CHEK1;LEPR;KDR;CTLA4;RCC1;CTSG;TIMP1;TNFRSF4;SOX5;TNS1;TLE4;VAV3;ANXA1;CR1;PARP1;DUSP1;IL18;PLAUR;PLA2G4A;LIFR;FOS;DCN;TGFBR2;SIGIRR;VCAN;ELF5;KIT;ADAM12;PECAM1;IRF7;LTA;SERPING1;TXNIP;PPARG;PPARA;FKBP4;MET;ATF3;CCL13;PDGFA;GATA3;ADRB2;PTGS2;C3;SOCS3;VTN;MUC1;GRK5;CXCR2;ERBB2;S1PR1;CCL2;FLNC;CCL19;A2M;STAT5A;STAT5B;EGR1;JUN;CCL21;STAT1;CMA1;CAV1;PLA2G2A;GZMB;ESR1;SELE;AGT;COL1A1;CXCL10;COL3A1;KRT19;IL6;CXCL12;PROC;BMPR1B;RAMP1
Liver neoplasms,89/1321,1.92699890494245E-21,1.4067092006079885E-19,0,0,3.7181412337662336,177.34910201752987,ALK;NRP1;FLT4;IRS2;CIB1;SLC2A4;BRCA2;FGF2;RIMS2;C4B;CCND1;ALDH2;STMN1;SIX3;LEPR;KDR;TK1;TIMP1;CD36;TEAD1;PARP1;DUSP1;HGF;BGN;IL18;PLA2G4A;PRKCA;LIFR;FOS;KRT5;PROX1;CCNA2;MMP14;MYCN;BIN1;KIT;ADAM12;SERPING1;RARB;PPARG;PPARA;SGK1;MET;ATF3;HLF;SATB1;CXCR4;PTGS2;FOXO1;C3;SOCS3;VTN;MUC1;TERT;SH3BP1;ERBB2;E2F1;CCL2;SNCG;A2M;APOB;PPARGC1A;PDLIM4;CCL16;STAT5A;STAT5B;EGR1;TCF7L2;JUN;STAT1;CDKN2A;CAV1;PLA2G2A;ESR1;AGT;GADD45G;CXCL10;KRT19;IL6;CXCL12;PROC;WT1;SDC1;PAEP;VIM;FGFR4;EZH2;CDKN3;MAD2L1
Pancreatic Ductal Adenocarcinoma,63/701,2.0197328730015686E-21,1.4585511801159716E-19,0,0,4.889999015247255,233.01491614566177,ALK;NRP1;BRCA1;BRCA2;CDC20;AKAP12;FGF7;MECOM;CCND1;MDK;CTLA4;TEAD1;VAV3;PARP1;DUSP1;HGF;BGN;PLAUR;TAP1;RUNX2;CDC25B;TGFBR2;MMP14;VCAN;NR5A2;MAPKAPK2;PECAM1;PPARG;S100A4;SKAP2;YAP1;EPAS1;CXCR4;ADRB2;PTGS2;FOXO1;AURKA;SOCS3;MUC1;PPP4C;TERT;CXCR2;ERBB2;E2F1;CCL2;PMAIP1;ECT2;PAK4;CDKN2A;GAD1;CAV1;HMGA2;KLF4;CXCL10;KRT19;BMP2;IL6;CXCL12;WT1;VIM;FGFR4;FGFR3;EZH2
Obesity,112/1961,2.3310242341411366E-21,1.6654424209033907E-19,0,0,3.220752391114749,153.01143759389444,IRS2;ENO2;FGF1;FGF2;RPS6KA3;ZFP36;CCND2;CCND1;CFL1;CHEK1;LEPR;CAPN3;NEK2;TNFRSF4;CISH;HGF;ADAM12;SLC27A6;ZFPM2;ATF3;MAGED1;EPAS1;GATA4;ADRB1;ADRB2;PLD1;FOXO1;C3;SOCS3;PRKAR2B;NDN;FADD;A2M;APOB;ECT2;PPARGC1A;STAT5A;STAT5B;EGR1;JUN;CAV2;CAV1;HMGA2;ESR1;SELE;COL1A1;CXCL10;NR4A1;PYY;IL6;SDC1;CALR;FGFR4;FGFR3;BRCA1;SLC2A4;ADRA1A;CTLA4;TIMP1;CD36;IKBKE;NEFH;ANXA1;VWF;PARP1;DUSP1;BGN;IL18;PLA2G4A;FOS;PROX1;DCN;MMP14;NR5A2;TAL1;KIT;PECAM1;LTA;PPARG;PPARA;SGK1;PRKN;OPRD1;LRP1;LAMA1;CXCR4;ASCL1;PTGS2;IL2RG;DEPP1;ADCY5;ACAN;CXCR2;ERBB2;CCL2;SNCG;CCL19;MEST;ARNT2;TCF7L2;CDKN2C;STAT1;CDKN2A;CMA1;GAD1;SNCAIP;KLF4;AGT;PER2;WT1;SAA1;VIM
Kaposi Sarcoma,43/323,2.8601006856750746E-21,2.021940653157242E-19,0,0,7.36340618336887,348.3143698687454,YAP1;LRP1;FLT4;PDGFA;CXCR4;F13A1;CIB1;MKI67;PTGS2;FGF2;ADRA1A;RIMS2;RPS6KA3;MUC1;TERT;CCND1;CXCR2;KDR;IKBKE;TNFRSF4;BUB1;EGR1;CISH;CDKN2A;HGF;PROX1;SELE;PAX2;TGFBR2;RCAN1;CXCL10;MMP14;IL6;CXCL12;KRT15;KIT;IRF7;LTA;PECAM1;SDC1;TEK;EZH2;CDKN3
B-Cell Lymphomas,64/730,3.468930279911206E-21,2.4268058083212145E-19,0,0,4.764197268134276,224.4434328031501,ALK;FLT4;IRS2;CIB1;SLC2A4;MKI67;BRCA2;FGF2;RIMS2;CCND2;CCND1;STMN1;CHEK1;KDR;TIMP1;VAV3;ANXA1;PARP1;TPM3;HGF;LMO2;RHOH;TGFBR2;MYCN;TAL1;KIT;PPARG;PRTN3;PRKN;BLM;CXCR4;PTGS2;FOXO1;AURKA;SOCS3;MUC1;TERT;ERBB2;PMAIP1;BAK1;RUNX1T1;STAT5A;STAT5B;EGR1;CDT1;CDKN2A;SH2D1A;KLF4;ESR1;PER2;NR4A1;IL6;CXCL12;PRC1;CD5;BCL3;SDC1;SPRY2;VIM;TEK;FGFR4;NFKBIE;FGFR3;EZH2
Malignant Glioma,53/504,3.56911927483874E-21,2.471155159774946E-19,0,0,5.727136974523734,269.64488027726236,ITSN1;FAM107A;MKI67;BRCA2;FGF2;MYLK;ZFP36;CCND2;CCND1;MDK;STMN1;KDR;TK1;TIMP1;IKBKE;TNS1;PARP1;HGF;FOS;DCN;MMP14;MYCN;MET;GRIA2;EPAS1;CXCR4;PTGS2;VTN;TERT;ERBB2;E2F1;CCL2;BAK1;FADD;EGR1;STAT1;CDKN2A;CAV2;CAV1;HMGA1;HMGA2;QKI;GFAP;CXCL10;NR4A1;IL6;WT1;SDC1;CALR;VIM;TEK;FGFR4;EZH2
Malignant neoplasm of thyroid,53/505,3.909275653911956E-21,2.679050539966602E-19,0,0,5.714167193426043,268.51405831282443,RET;ALK;CIB1;BRCA2;FGF2;CDH5;CCND2;CCND1;KDR;SOSTDC1;TIMP1;ANXA1;PARP1;TPM3;HGF;IL18;PRKCA;FOS;PROX1;RUNX2;MMP14;MYCN;CCNE2;KIT;PECAM1;TXNIP;RARB;PPARG;S100A4;MET;YAP1;SHC3;CXCR4;PTGS2;AURKA;SOCS3;MUC1;TERT;ERBB2;BUB1;JUN;CDKN2A;CAV1;HMGA1;RCAN1;KRT19;RAD51;WT1;SPRY2;VIM;TEK;FGFR4;EZH2
Mesothelioma,46/383,8.022994551252346E-21,5.43918064912236E-19,0,0,6.574507485330537,304.21544741365466,YAP1;FLT4;PDGFA;BRCA1;MKI67;BRCA2;PTGS2;FGF1;FGF2;ADRA1A;ETS2;AQP1;AURKA;HOXA10;RIMS2;SOCS3;MUC1;TERT;MDK;CHEK1;KDR;E2F1;CCL2;BAK1;EGR1;PPP1R14A;CDKN2A;STAT1;HGF;LSM1;PLA2G4A;KRT5;KIF22;ESR1;CXCL10;MMP14;BMP2;IL6;WT1;FANCD2;KIT;SDC1;PPARG;S100A4;VIM;MET
Anaplasia,40/283,8.098839560932639E-21,5.43918064912236E-19,0,0,7.849209978153737,363.1245959615716,RET;NRP1;PROS1;BRCA1;ENO2;MKI67;FGF1;FGF2;FOXO1;SOCS3;MUC1;TERT;CCND1;ERBB2;CCL2;KPNA2;JUN;DUSP1;CDKN2A;CMA1;HGF;CAV1;MITF;PROX1;KLF4;ESR1;DCN;GFAP;BMP2;MYCN;RAD51;WT1;KIT;SDC1;PPARG;CALR;ERG;TEK;VIM;EZH2
Esophageal carcinoma,61/685,1.4888164730656636E-20,9.89989250802871E-19,0,0,4.819340110844017,220.02080578327133,FEN1;UBE2L6;CIB1;BRCA1;BRCA2;FGF2;RIMS2;CDC20;AKAP12;FGF7;CCND1;ALDH2;KDR;RAC3;TIMP1;ANXA1;HGF;IL18;PRKCA;PROX1;PAX2;CDC25B;TGFBR2;CCNA2;MMP14;PECAM1;RARB;PPARG;S100A4;EZR;MET;YAP1;MAGED1;SATB1;CXCR4;GATA4;PTGS2;PPL;AURKA;MUC1;TERT;CXCR2;ERBB2;E2F1;SNCG;EGR1;CCL21;CDKN2A;CAV1;HMGA2;KLF4;ESR1;GADD45G;PER2;CXCL10;IL6;CXCL12;RAD51;CNTN1;CALR;CDKN3
Polycystic Ovary Syndrome,53/526,2.5097896761284895E-20,1.6525242612626407E-18,0,0,5.454469948655995,246.16842633092662,FLT4;IRS2;SLC2A4;ANTXR2;ADRA1A;HOXA10;CCND2;FLAD1;LEPR;ZNF205;TIMP1;CD36;CEP55;PLAUR;LIFR;FOS;VCAN;CCNE2;PPARG;FKBP4;YAP1;SERPINC1;GATA4;ADRB2;FOXO1;RAD54B;C3;SOCS3;ACAN;MUC1;RACGAP1;PRKAR2B;RHPN1;CCL2;DMD;APOB;PPARGC1A;PDLIM4;NGFR;TCF7L2;CAV1;CBX2;HMGA2;INHBA;ESR1;AGT;NR4A1;IL6;WT1;PAEP;VIM;FGFR4;MAD2L1
Malignant neoplasm of esophagus,60/673,3.000309751684108E-20,1.956318474981599E-18,0,0,4.815660685154976,216.47832893033788,ALK;FEN1;UBE2L6;BRCA1;BRCA2;FGF2;RIMS2;CDC20;AKAP12;FGF7;CCND1;ALDH2;KDR;RAC3;TIMP1;ANXA1;HGF;IL18;PROX1;PAX2;CDC25B;TGFBR2;CCNA2;MMP14;PECAM1;RARB;S100A4;EZR;CRYAB;MET;YAP1;LRP1;MAGED1;SATB1;CXCR4;GATA4;PTGS2;PPL;AURKA;MUC1;TERT;GNG7;CXCR2;ERBB2;E2F1;SNCG;EGR1;CDKN2A;KLF4;GADD45G;PER2;CXCL10;IL6;CXCL12;RAD51;CNTN1;CALR;EZH2;CDKN3;MAD2L1
Fibroid Tumor,41/310,3.2224056227752094E-20,2.080930400245991E-18,0,0,7.275994699841731,326.5580922994546,BRCA1;MKI67;PTGS2;FGF1;FGF2;FOXO1;HOXA10;RIMS2;TERT;CCND1;ERBB2;CCL2;BAK1;EGR1;EGR2;PARP1;VWF;CDKN2A;CAV1;IL18;HMGA2;FOS;INHBA;ESR1;COL1A1;COL3A1;BMP2;IL6;VCAN;KIT;ADAM12;PECAM1;PAEP;PPARG;S100A4;TEK;PPARA;TDGF1;FGFR3;ATF3;EZH2
"Carcinoma, Transitional Cell",46/399,4.3037673381202784E-20,2.7527715659824563E-18,0,0,6.2712872833642175,279.6505663809965,ALK;CIB1;GATA3;BRCA1;PTGS2;MKI67;FGF2;PPL;AURKA;CDC20;FGF7;MUC1;CCND2;TERT;CCND1;STMN1;ERBB2;E2F1;KDR;NDN;KPNA2;CEP55;ANXA1;CISH;PARP1;DUSP1;CDKN2A;CAV1;BGN;PLAUR;GZMB;PLA2G4A;INHBA;ESR1;DCN;CCNA2;MMP14;KRT19;IL6;SDC1;S100A4;PPARA;MET;FGFR3;EZH2;MAD2L1
Malignant tumor of cervix,69/884,5.230365534512509E-20,3.3138806537533974E-18,0,0,4.219618848714267,187.33934926405243,SIX1;CIB1;BRCA1;FGF2;AQP1;RIMS2;CDC20;ZFP36;CCND1;MDK;STMN1;RUVBL1;CHEK1;CTLA4;CISH;PARP1;TPM3;HGF;IL18;TAP1;MAPK8IP2;MMP14;VCAN;LTA;RARB;MCM4;PPARG;EVL;PPARA;EZR;MET;ATF3;CXCR4;PTGS2;FOXO1;AURKA;SOCS3;MUC1;TERT;ERBB2;E2F1;CCL2;BAK1;PAK3;PDLIM4;BARD1;STAT5A;CA12;STAT5B;EGR1;JUN;CDKN2A;CAV1;FANCA;HMGA1;KLF4;ESR1;AGT;NDC80;KLF1;KRT19;IL6;RAD51;SDC1;CALR;VIM;FGFR3;EZH2;CDKN3
Endometrial Neoplasms,36/238,7.723925814361571E-20,4.848026707406758E-18,0,0,8.432883875184585,371.10911760087555,CXCR4;SIX1;BRCA1;SEMA3F;BRCA2;PTGS2;FOXO1;HOXA10;SOCS3;TERT;CCND1;MDK;ERBB2;LEPR;CCL2;TCF7L2;JUN;CDKN2A;CAV1;FOS;INHBA;ESR1;DCN;CDC25B;CXCL10;MMP14;IL6;VCAN;NR5A2;WT1;SDC1;RARB;PPARG;S100A4;MET;EZH2
Adult T-Cell Lymphoma/Leukemia,51/500,8.072597836010735E-20,5.019959913578527E-18,0,0,5.508043819881745,242.1513781170248,ALK;NRP1;CIB1;ENO2;ANTXR2;ETS2;CCND1;CTLA4;TNFSF11;TNFRSF4;CISH;HGF;LMO2;FOS;TAL1;KIT;IRF7;LTA;TXNIP;S100A4;FKBP4;MET;ATF3;LRP1;SATB1;CXCR4;GATA4;GATA3;IL2RG;C3;MUC1;TERT;CCL2;CCL19;BAK1;APOB;BUB1;STAT5A;STAT5B;EGR1;JUN;CCL21;STAT1;CDKN2A;HMGA1;KLF4;IL6;CD5;BCL3;VIM;EZH2
Diabetes Mellitus,93/1507,8.298784394183126E-20,5.113269357003108E-18,0,0,3.389628471775749,148.9253363278214,PTPRN;IRS2;BRCA1;SLC2A4;ENO2;BRCA2;FGF2;AQP1;RIMS2;ZFP36;ALDH2;FLAD1;LEPR;KDR;CTLA4;TNFSF11;SOSTDC1;CAPN3;TIMP1;CD36;KLF11;TRIM63;CISH;VWF;PARP1;HGF;IL18;PRKCA;FOS;PROX1;SYP;DCN;MMP14;DDX39A;NR5A2;LTA;TXNIP;PPARG;PPARA;EZR;SGK1;ATF3;PRKN;FBN2;GRIA2;SERPINC1;CXCR4;GATA4;ADRB1;GATA3;ADRB2;PTGS2;FOXO1;ADCY5;C3;SOCS3;TERT;SH3BP1;CCL2;DMD;FADD;A2M;APOB;PPARGC1A;MEST;RXRG;BUB1;STAT5A;NGFR;NFE2;STAT5B;EGR1;TCF7L2;STAT1;CDKN2A;GAD1;CAV1;PLA2G2A;HMGA1;HMGA2;ESR1;SELE;AGT;GFAP;COL1A1;CXCL10;IL6;CXCL12;PAEP;TEK;FGFR4;EZH2;CDKN3
Diabetic Nephropathy,54/561,8.725652472817241E-20,5.327407455221872E-18,0,0,5.18869837618608,227.7082833126371,IRS2;FGF2;AQP1;RIMS2;ZFP36;ALDH2;MDK;KDR;TIMP1;CD36;VWF;HGF;BGN;IL18;PRKCA;DCN;TGFBR2;VCAN;LTA;TXNIP;COL8A1;PPARG;PPARA;UTRN;SGK1;PDGFA;CXCR4;PTGS2;FOXO1;NCALD;MUC1;E2F1;CCL2;APOB;PPARGC1A;STAT5A;STAT5B;TCF7L2;JUN;STAT1;CDKN2A;CAV1;HMGA2;ESR1;AGT;CXCL10;BMP2;IL6;COL1A2;PROC;NPHS1;WT1;SAA1;EZH2
Desmoplastic,23/80,1.1764072326167984E-19,7.117793670499475E-18,0,0,18.6436351542363,812.6136317239228,RET;CDKN2A;HGF;CAV1;PDGFA;SYP;INHBA;MKI67;FGF2;RUNX2;GFAP;MMP14;MYCN;COL1A2;WT1;ADAM12;ERBB2;PECAM1;PPARG;DMD;CD36;TIMP1;OTX1
Hepatocarcinogenesis,52/527,1.4897033363876747E-19,8.932899649267522E-18,0,0,5.314905584572117,230.40402591698438,FLT4;CIB1;ETS2;AKAP12;RPS6KA3;CCND2;CCND1;ALDH2;STMN1;PITX1;DUSP1;TPM3;HGF;PRKCA;FOS;DCN;TGFBR2;CCNA2;BIN1;TXNIP;PPARG;PPARA;MET;PRKN;YAP1;PTGS2;AURKA;SOCS3;MUC1;TERT;ERBB2;E2F1;E2F2;SNCG;E2F5;CCL16;PAK4;PLK4;EGR1;JUN;CDKN2C;CDKN2A;CAV1;ESR1;AGT;NR4A1;IL6;SPRY2;FGFR4;FGFR3;EZH2;CDKN3
Medulloblastoma,55/590,1.6987478657250035E-19,1.0096274925848781E-17,0,0,5.013659237958303,216.6864683671693,IRS2;CIB1;BRCA2;FGF2;AKAP12;CCND2;CCND1;MDK;STMN1;KDR;PARP1;TPM3;HGF;PAX3;LIFR;SYP;SSTR2;VCAN;MELK;MYCN;KIT;MCM4;PPARG;S100A4;EZR;MET;CXCR4;ASCL1;AURKA;C3;TERT;GRK5;ERBB2;E2F1;CCL2;OTX1;NGFR;CDKN2C;CDKN2A;HMGA1;KLF4;ESR1;FLI1;GFAP;NR4A1;BMP2;IL6;COL1A2;CXCL12;RAD51;WT1;SDC1;CAMK1;VIM;EZH2
Amyloidosis,66/833,1.7188011983696941E-19,1.0125849866886724E-17,0,0,4.265696112393488,184.31002082573124,GPSM2;CTNND2;CIB1;BRCA1;ENO2;BRCA2;FGF2;ADRA1A;ETS2;LMNB1;RIMS2;TIMP1;CD36;CR1;CISH;VWF;PARP1;BGN;PLA2G4A;PRKCA;LIFR;SYP;DCN;MMP14;BIN1;FANCD2;RARB;PPARG;PPARA;FKBP4;UTRN;CRYAB;PRKN;LRP1;SERPINC1;PTGS2;PLD1;FOXO1;C3;SOCS3;VTN;ACAN;CXCR2;ERBB2;E2F1;CCL2;SNCG;DMD;A2M;APOB;PPARGC1A;NGFR;EGR1;GAD1;CAV1;SH2D1A;PLA2G2A;ESR1;AGT;GFAP;PPP1CA;RCAN1;IL6;CXCL12;SAA1;SDC1
"Diabetes Mellitus, Non-Insulin-Dependent",98/1672,2.468635042619571E-19,1.4416828648898295E-17,0,0,3.22630717458411,138.23258719629553,IRS2;CIB1;MKI67;FGF2;RIMS2;C4B;RPS6KA3;C4A;ZFP36;CCND2;FLAD1;STMN1;LEPR;KDR;CAPN3;CISH;HGF;RUNX2;FANCD2;SERPING1;TXNIP;SLC27A6;COL8A1;ATF3;FBN2;BLM;EPAS1;GATA4;ADRB2;PLD1;FOXO1;C3;SOCS3;VTN;GRK5;APOB;PPARGC1A;STAT5A;STAT5B;CAV2;CAV1;HMGA1;HMGA2;ESR1;SELE;CXCL10;PYY;IL6;CXCL12;BCL3;FGFR4;ALK;PTPRN;SLC2A4;BRCA2;ADRA1A;ALDH2;CTLA4;TIMP1;CD36;KLF11;ANXA1;DST;VWF;PARP1;BGN;IL18;PLA2G4A;PROX1;DCN;TGFBR2;MMP14;LTA;PPARG;PPARA;SGK1;PRKN;LRP1;LAMA1;CXCR4;PTGS2;ADCY5;CCL2;DMD;RXRG;TCF7L2;CDKN2A;CMA1;GAD1;PLA2G2A;AGT;PER2;COL3A1;PRC1;SPRY2;TEK;NECTIN2;CDKN3
Autoimmune Diseases,75/1060,3.010916746193663E-19,1.743216971330745E-17,0,0,3.821511867197146,162.9755280875348,NRP1;FEN1;PTPRN;ADRA1A;C4B;C4A;ZFP36;KDR;CTLA4;TNFSF11;SIRPA;TIMP1;CD36;TNFRSF4;VAV3;ANXA1;CR1;DST;PARP1;DUSP1;TPM3;HGF;IL18;SIGIRR;PECAM1;IRF7;LTA;SERPING1;PPARG;PRTN3;SGK1;COL17A1;PRKN;LRP1;CXCR4;ADRB2;PTGS2;IL2RG;PLD1;FOXO1;C3;ACAN;MUC1;TERT;CXCR2;ERBB2;S1PR1;E2F2;CCL2;BAK1;STAT5A;STAT5B;EGR1;EGR2;CCL21;STAT1;CDKN2A;GAD1;CAV1;SH2D1A;GZMB;ESR1;FLI1;GFAP;COL1A1;CXCL10;KRT19;BMP2;IL6;CXCL12;SAA1;CALR;VIM;FGFR3;EZH2
Benign Prostatic Hyperplasia,46/420,3.440851078837759E-19,1.9751073372200333E-17,0,0,5.912682776459866,251.36823564719157,SATB1;CTNND2;PROS1;FLT4;GATA3;ENO2;PTGS2;MKI67;FGF2;ADRA1A;AKAP12;FGF7;ERBB2;KDR;CCL2;CCL19;A2M;CEP55;PPP1R14A;EGR1;JUN;ANXA1;CBX4;DUSP1;CDKN2A;CAV1;IL18;KLF4;SSTR2;ESR1;FLI1;PAX2;BMP2;IL6;VCAN;KIT;TXNIP;SPRY2;PPARG;ERG;SGK1;FGFR4;MET;FGFR3;ATF3;EZH2
Leukemogenesis,61/730,3.5460080923488113E-19,2.018219521035137E-17,0,0,4.48448399352267,190.5156531779081,RET;ALK;SIX1;FGF2;ADRA1A;ETS2;RIMS2;HOXA10;ZFP36;MECOM;CCND1;LEPR;KDR;CTLA4;SOSTDC1;CTSG;TIMP1;LMO2;PAX3;PRKCA;FOS;RUNX2;BIN1;TAL1;FANCD2;KIT;ERG;PRKN;HLF;EPAS1;CXCR4;GATA3;IL2RG;FOXO1;TERT;CXCR2;E2F1;NKX2-5;BUB1;RUNX1T1;STAT5A;STAT5B;EGR1;JUN;CDKN2A;CMA1;FANCA;HMGA1;KLF4;SELE;FLI1;NR4A1;IL6;CXCL12;WT1;PRC1;CD5;BCL3;NFKBIE;EZH2;MAD2L1
cervical cancer,71/965,3.724145576780526E-19,2.101795100307396E-17,0,0,3.9626356338752706,168.1515873182781,SIX1;CIB1;BRCA1;FGF2;AQP1;RIMS2;CDC20;ZFP36;CCND1;MDK;STMN1;RUVBL1;CHEK1;CTLA4;CISH;PARP1;TPM3;HGF;IL18;TAP1;MAPK8IP2;MMP14;VCAN;LTA;RARB;MCM4;PPARG;S100A4;EVL;PPARA;EZR;MET;ATF3;CXCR4;PTGS2;FOXO1;AURKA;SOCS3;MUC1;TERT;ERBB2;E2F1;CCL2;BAK1;PAK3;PDLIM4;BARD1;STAT5A;CA12;STAT5B;EGR1;JUN;CDKN2A;CAV1;FANCA;HMGA1;KLF4;ESR1;AGT;NDC80;KLF1;CXCL10;KRT19;IL6;RAD51;SDC1;CALR;VIM;FGFR3;EZH2;CDKN3
Invasive carcinoma of breast,44/385,4.128283372392251E-19,2.3104625940821968E-17,0,0,6.182607996138685,261.7175562347746,CXCR4;CIB1;GATA3;BRCA1;PTGS2;BRCA2;HOXD10;EPS8;CDH5;ZFP36;MUC1;CHAF1A;CCND1;ERBB2;KDR;CCL2;SNCG;E2F5;MEST;JUN;PARP1;HGF;PLA2G2A;ESR1;RUNX2;TGFBR2;CCNA2;MMP14;KRT19;IL6;CXCL12;NR5A2;FANCD2;MAPKAPK2;RARB;S100A4;PRKD1;ERG;VIM;EZR;FGFR4;MET;F2RL2;EZH2
Invasive Carcinoma,29/154,6.897901167540189E-19,3.828620185223133E-17,0,0,10.835961538461538,453.1371514699984,CXCR4;BRCA1;MKI67;BRCA2;PTGS2;AURKA;FGF7;CCND2;CCND1;CFL1;CHEK1;ERBB2;STAT5A;STAT5B;CDKN2A;STAT1;HGF;LMO2;ESR1;AGT;TGFBR2;IL6;MMP14;SDC1;ERG;VIM;MET;EZH2;MAD2L1
Conventional (Clear Cell) Renal Cell Carcinoma,56/631,7.577370248671828E-19,4.1712802123016394E-17,0,0,4.751894489773108,198.26781075915318,ALK;FLT4;CIB1;CCND1;KDR;SOSTDC1;ELOB;HGF;MITF;PAX2;CCNA2;MMP14;VCAN;KIT;PECAM1;PPARG;SGK1;CRYAB;MET;PRKN;YAP1;FBN2;EPAS1;SATB1;CXCR4;GATA3;PTGS2;PKMYT1;FOXO1;SOCS3;MUC1;TERT;ERBB2;E2F1;ECT2;PPARGC1A;GRIA4;PAK4;EGR1;TCF7L2;STAT1;CDKN2A;CMA1;CAV1;KLF4;GADD45G;KRT19;IL6;CXCL12;WT1;VIM;TEK;RHEBL1;BMPR1B;EZH2;MAD2L1
Multiple Myeloma,84/1312,7.813810905490558E-19,4.266467808233706E-17,0,0,3.472682649534861,144.78733548378204,RET;FLT4;CIB1;BRCA1;SLC2A4;FGF1;FGF2;ADRA1A;RPS6KA3;CCND2;CCND1;STMN1;CFL1;CHEK1;LEPR;KDR;CTLA4;TNFSF11;NEK2;TIMP1;TEAD1;TRIM63;PARP1;HGF;RHOH;FOS;RUNX2;DCN;CCNA2;VCAN;FANCD2;MAPKAPK2;KIT;PECAM1;LTA;TXNIP;MCM4;PPARG;SGK1;MET;ATF3;PRKN;SHC3;LRP1;EPAS1;CXCR4;ADRB2;PTGS2;IL2RG;AURKA;SOCS3;MUC1;TERT;ERBB2;E2F1;S1PR1;CCL2;PMAIP1;BAK1;BUB1;PAK4;STAT5A;STAT5B;EGR1;JUN;CDKN2C;STAT1;CDKN2A;CMA1;CAV1;KLF4;ESR1;COL1A1;CXCL10;BMP2;IL6;CXCL12;RAD51;BCL3;SDC1;FGFR4;FGFR3;EZH2;CDKN3
"Carcinoma, Papillary",32/196,8.944049765545916E-19,4.844212760113417E-17,0,0,9.161282702415402,380.72576181462006,RET;FBN2;ALK;FLT4;CIB1;BRCA1;BRCA2;PTGS2;MUC1;TERT;CCND1;MDK;ERBB2;KDR;ANXA1;DUSP1;CDKN2A;TPM3;HGF;BGN;HMGA2;SSTR2;ESR1;RUNX2;KRT19;IL6;KIT;PPARG;S100A4;FGFR3;MET;MAD2L1
Fibrosis,30/169,9.768668876060038E-19,5.2485104137295376E-17,0,0,10.097599029210366,418.74679111097475,ADRB2;MKI67;PTGS2;FGF2;ADCY5;FGF7;CCND2;CCND1;LEPR;CCL2;TIMP1;EGR1;CMA1;STAT1;HGF;CAV1;PRKCA;DCN;AGT;TGFBR2;COL1A1;CCNA2;IL6;COL3A1;COL1A2;CXCL12;WT1;VIM;SGK1;MATN2
Urothelial Carcinoma,36/257,1.0364499544549739E-18,5.524442773110797E-17,0,0,7.700317516511965,318.8757719420145,ALK;CIB1;GATA3;MKI67;PTGS2;PPL;FGF2;AURKA;CDC20;FGF7;MUC1;TERT;CCND1;STMN1;ERBB2;KDR;NDN;KPNA2;PARP1;CISH;DUSP1;CDKN2A;BGN;PLA2G4A;GZMB;INHBA;DCN;KRT19;IL6;SDC1;S100A4;FGFR3;MET;EZH2;CDKN3;MAD2L1
Cirrhosis,46/433,1.1669039229023014E-18,6.170808461584139E-17,0,0,5.710192794648119,235.78629530522645,FBN2;CNTNAP2;CXCR4;ADRB2;SLC2A4;PTGS2;ADCY5;AQP1;SOCS3;FGF7;CCND2;TERT;ALDH2;ERBB2;LEPR;CCL2;TIMP1;APOB;TEAD1;NGFR;CDKN2C;TRIM63;VWF;CDKN2A;STAT1;HGF;CAV1;PLA2G2A;IL18;PROX1;ESR1;AGT;DCN;COL1A1;CXCL10;MMP14;COL3A1;KRT19;IL6;COL1A2;PECAM1;PAEP;SPRY2;CALR;VIM;MET
Diabetes,82/1268,1.2098469502234154E-18,6.347915716953483E-17,0,0,3.498710855295249,144.34294733127928,PTPRN;IRS2;BRCA1;SLC2A4;BRCA2;FGF2;RIMS2;ZFP36;ALDH2;FLAD1;LEPR;KDR;CTLA4;TNFSF11;SOSTDC1;CAPN3;TIMP1;CD36;KLF11;TRIM63;CISH;VWF;PARP1;HGF;IL18;PRKCA;PROX1;SYP;DCN;MMP14;DDX39A;NR5A2;LTA;TXNIP;PPARG;PPARA;EZR;SGK1;ATF3;PRKN;FBN2;GRIA2;SERPINC1;CXCR4;GATA4;GATA3;ADRB2;PTGS2;FOXO1;ADCY5;C3;SOCS3;CCL2;DMD;FADD;A2M;APOB;PPARGC1A;RXRG;STAT5A;NGFR;STAT5B;EGR1;TCF7L2;STAT1;CDKN2A;GAD1;CAV1;HMGA1;HMGA2;ESR1;SELE;AGT;GFAP;COL1A1;CXCL10;IL6;CXCL12;PAEP;FGFR4;EZH2;CDKN3
Liver Cirrhosis,58/683,1.3696664976899896E-18,7.130759843787574E-17,0,0,4.539286821705426,186.70978393375725,CNTNAP2;SLC2A4;FGF2;ADRA1A;AQP1;FGF7;ALDH2;STMN1;KDR;CTLA4;TIMP1;CD36;TEAD1;CR1;TRIM63;VWF;HGF;IL18;PROX1;ACTA2;MMP14;ADAM12;PECAM1;IRF7;SERPING1;PPARG;MET;PRKN;CXCR4;ADRB2;PTGS2;SOCS3;VTN;TERT;ERBB2;CCL2;SNCG;A2M;APOB;NGFR;EGR1;STAT1;CDKN2A;CAV1;PLA2G2A;ESR1;AGT;COL1A1;CXCL10;COL3A1;KRT19;IL6;COL1A2;PAEP;SPRY2;CALR;VIM;FGFR4
Aortic Valve Insufficiency,33/214,1.5303866962821117E-18,7.906213117100509E-17,0,0,8.573486026926997,351.69306657156847,PROS1;BRCA1;ADRB2;FOXO1;MYLK;MUC1;CCND1;ERBB2;CCL2;TIMP1;NKX2-5;PPARGC1A;TEAD1;STAT5A;VAV3;EGR2;JUN;CAV1;IL18;FOS;ESR1;AGT;TGFBR2;COL1A1;ACTA2;COL3A1;IL6;COL1A2;ERG;SGK1;FKBP4;MET;EZH2
Squamous cell carcinoma of esophagus,72/1023,2.3357740301347553E-18,1.19748537300649E-16,0,0,3.776152096142624,153.30493402717835,BRCA1;MKI67;BRCA2;FGF2;ETS2;RIMS2;AKAP12;CHAF1A;MECOM;CCND1;ALDH2;MDK;STMN1;CFL1;CAPN3;NEFH;ANXA1;PARP1;HGF;IL18;LIFR;PROX1;PAX2;CDC25B;TGFBR2;MMP14;BIN1;PECAM1;LTA;RARB;S100A4;EZR;MET;ATF3;YAP1;MAGED1;SATB1;CXCR4;PTGS2;PPL;AURKA;MUC1;TERT;CXCR2;ERBB2;E2F1;FADD;PDLIM4;PAK5;NGFR;EGR1;JUN;CCL21;STAT1;CDKN2A;CAV1;HMGA2;SORBS2;KLF4;ESR1;GADD45G;CXCL10;KRT19;IL6;CXCL12;CALR;VIM;TDGF1;F2RL2;EZH2;CDKN3;MAD2L1
Chronic Obstructive Airway Disease,57/669,2.3970407914727375E-18,1.219585299661432E-16,0,0,4.547162421669698,184.4888229190125,ALK;NRP1;SLC2A4;FGF2;AKAP12;C4A;FGF7;CCND1;ALDH2;MDK;LEPR;KDR;CTLA4;TIMP1;IKBKE;TNFRSF4;SOX5;TNS1;TRIM63;VWF;PARP1;HGF;IL18;PLAUR;KRT5;MMP14;VCAN;RARB;PPARG;S100A4;PRTN3;PPARA;CCL13;EPAS1;SATB1;AKAP5;ADRB2;PTGS2;FOXO1;SOCS3;VTN;MUC1;CXCR2;CCL2;A2M;PPARGC1A;EGR1;STAT1;CDKN2A;CAV1;PLA2G2A;GZMB;COL1A1;CXCL10;IL6;DLG2;VIM
Myeloid Leukemia,49/501,2.599693009734879E-18,1.312747237096199E-16,0,0,5.229546571913828,211.75029353680054,NRP1;PKD2;RIMS2;HOXA10;RPS6KA3;MECOM;CCND1;CHEK1;KDR;TIMP1;MEF2C;PARP1;DUSP1;LMO2;IL18;FOS;NR5A2;TAL1;FANCD2;KIT;PRTN3;ERG;MET;PRKN;EPAS1;GATA4;PTGS2;IL2RG;RUNX1T1;STAT5A;STAT5B;EGR1;JUN;EGR2;STAT1;CDKN2A;PLA2G2A;FANCA;CDC7;KLF4;ESR1;PER2;IL6;WT1;VIM;TEK;FGFR4;NECTIN2;EZH2
Experimental Organism Basal Cell Carcinoma,37/282,3.138262505040177E-18,1.5728784316305843E-16,0,0,7.1475590236094435,288.06708760617283,PRKN;COL17A1;ALK;SHC3;PDGFA;CXCR4;GATA3;PTGS2;FGF2;ADRA1A;TERT;CTLA4;CCL2;JUN;PARP1;DST;CDKN2A;STAT1;HGF;BGN;PLAUR;KRT5;FOS;KLF4;DCN;TGFBR2;CCNA2;CXCL10;BMP2;IL6;COL1A2;MYCN;CXCL12;RARB;TEK;FGFR4;FGFR3
"Diabetes Mellitus, Insulin-Dependent",69/956,3.5178087540151416E-18,1.750044710515977E-16,0,0,3.8622058576602942,155.2170070271614,NRP1;PTPRN;SLC2A4;FGF2;ADRA1A;C4B;C4A;ALDH2;CTLA4;TNFSF11;TIMP1;CD36;TNFRSF4;ANXA1;CR1;CISH;VWF;PARP1;DUSP1;HGF;IL18;TAP1;FOS;DCN;CIT;MMP14;VCAN;DDX39A;IRF7;LTA;TXNIP;PPARG;ERG;ATF3;SKAP2;SERPINC1;GATA4;ADRB1;GATA3;ADRB2;PTGS2;C3;SOCS3;ACAN;E2F1;CCL2;FADD;PPARGC1A;STAT5A;STAT5B;TCF7L2;STAT1;CDKN2A;GAD1;SH2D1A;GZMB;ESR1;SELE;AGT;GFAP;COL1A1;VIL1;CXCL10;BMP2;IL6;COL1A2;CXCL12;PAEP;EZH2
Nephroblastoma,42/370,3.545980105084282E-18,1.7510884107166205E-16,0,0,6.109166011014949,245.47067106367152,RET;PDGFA;SIX1;BRCA1;ENO2;BRCA2;PTGS2;HOXD10;RIMS2;CCND2;TERT;CCND1;MDK;SIX2;SIX3;ERBB2;SOSTDC1;TIMP1;RUNX1T1;EGR1;EGR2;CDKN2A;STAT1;HGF;PRKCA;ESR1;FLI1;PAX2;BMP2;MYCN;DLG2;NPHS1;WT1;KIT;PECAM1;PRTN3;VIM;ZFPM2;MET;ATF3;EZH2;CDKN3
Undifferentiated carcinoma,34/237,4.612958432006516E-18,2.261359768566114E-16,0,0,7.88618412378795,314.7980345345145,RET;FBN2;PDGFA;GATA3;BRCA1;PTGS2;AQP1;ADCY5;VTN;MUC1;TERT;CCND1;STMN1;ERBB2;S1PR1;NDN;SNCG;STAT5A;TLE4;EGR1;ANXA1;CDKN2A;TPM3;IL18;PLAUR;HMGA2;KRT5;ESR1;TGFBR2;PPARG;EZR;PPARA;SGK1;MET
Inflammation,45/429,4.6503058378306166E-18,2.263148841077567E-16,0,0,5.61650390625,224.15241691049803,RET;CCL13;PDGFA;GATA3;PTGS2;FGF1;FGF2;C3;C4B;VTN;SOCS3;C4A;FGF7;ZFP36;MUC1;CCL2;CTSG;TIMP1;CCL19;EGR1;ANXA1;CCL21;VWF;PARP1;HGF;IL18;PLAUR;SELE;AGT;CXCL10;IL6;COL2A1;CXCL12;PROC;BIN1;PECAM1;SAA1;IRF7;SERPING1;TXNIP;PPARG;PRTN3;PPARA;FKBP4;CRYAB
Rhabdomyosarcoma,43/397,8.097703914901866E-18,3.912530898739636E-16,0,0,5.801803131236473,228.32967863590446,ALK;YAP1;CXCR4;SIX1;BRCA1;MKI67;FGF2;FOXO1;CCND2;TERT;CXCR2;ERBB2;CCL2;DMD;FADD;PPARGC1A;PDLIM4;EGR1;MEF2C;CDKN2C;PARP1;CDKN2A;STAT1;HGF;CAV1;PAX3;HMGA2;LIFR;ESR1;MMP14;BMP2;CXCL12;MYCN;KIT;ERG;VIM;PPARA;EZR;FGFR4;MET;FGFR3;F2RL2;EZH2
Meningioma,45/438,1.0394659306073448E-17,4.9864665642563765E-16,0,0,5.485305343511451,214.50417934173146,PRKN;YAP1;PDGFA;F13A1;CXCR4;BRCA1;PTGS2;MKI67;BRCA2;FGF2;HOXA10;TERT;RACGAP1;CCND1;MDK;CFL1;ERBB2;LEPR;CCL2;SOSTDC1;TIMP1;CDKN2C;CDKN2A;HGF;CAV1;PLA2G2A;PLAUR;FOS;KLF4;SSTR2;ESR1;GFAP;IL6;VCAN;CXCL12;MYCN;WT1;MCM4;S100A4;PPARA;EZR;SGK1;FGFR4;CRYAB;FGFR3
Retinoblastoma,50/539,1.054726684458722E-17,5.023790363705515E-16,0,0,4.935414563433512,192.92863691281997,RET;ALK;CIB1;BRCA1;FGF1;MKI67;BRCA2;ADRA1A;RIMS2;AKAP12;CCND1;STMN1;CHEK1;KDR;KPNA2;TPM3;LMO2;BGN;FOS;RUNX2;DCN;CDC25B;TGFBR2;MYCN;KIT;PPARG;S100A4;CRYAB;SATB1;PTGS2;FOXO1;GRK3;TERT;ERBB2;E2F1;CCL2;SNCG;FADD;CDKN2C;CDKN2A;CAV1;HMGA2;ESR1;IL6;WT1;BCL3;FGFR3;EZH2;CDKN3;MAD2L1
Acute lymphocytic leukemia,66/907,1.383519860733373E-17,6.543464355412206E-16,0,0,3.875032550142907,150.42611193242706,ALK;NRP1;CIB1;ENO2;FGF2;RIMS2;HOXA10;CCND2;MECOM;CCND1;MDK;STMN1;CHEK1;KDR;CTLA4;TLE4;MEF2C;CR1;LMO2;FOS;TAL1;KIT;PECAM1;S100A4;ERG;PPARA;FKBP4;ATF3;HLF;LRP1;SERPINC1;PDE1A;CXCR4;GATA3;ADRB2;AURKA;C3;SOCS3;TERT;ERBB2;CCL2;PMAIP1;BUB1;RUNX1T1;PLK4;STAT5A;NGFR;STAT5B;TCF7L2;JUN;STAT1;CDKN2A;SIAH2;GZMB;HMGA2;KLF4;ESR1;FLI1;CXCL10;IL6;CXCL12;WT1;CD5;GIPC2;FGFR4;EZH2
Hemangiosarcoma,22/87,1.5696490499663762E-17,7.371862251450478E-16,0,0,15.594835424622659,603.4124411334011,RET;JUN;CDKN2C;VWF;CDKN2A;FLT4;HGF;PROX1;BRCA2;CXCL10;EFNA3;PTPRB;CCND1;TERT;WT1;KIT;ERBB2;KDR;PECAM1;ERG;TEK;MET
Secondary malignant neoplasm of liver,48/508,2.3799499460404985E-17,1.109982210944999E-15,0,0,5.01894644617238,192.10954622518176,RET;ALK;YAP1;NRP1;FLT4;CXCR4;SEMA3F;PTGS2;BRCA2;AURKA;FGF7;MUC1;CHAF1A;CCND1;CXCR2;ERBB2;E2F1;KDR;S1PR1;CCL2;SNCG;NEK2;TIMP1;RUNX1T1;CDKN2A;HGF;KIF22;SSTR2;ESR1;SELE;AGT;RUNX2;IL6;CXCL12;KIT;ADAM12;PECAM1;SPRY2;PPARG;S100A4;VIM;TEK;EZR;FGFR4;MET;TDGF1;ATF3;EZH2
Cutaneous Melanoma,37/301,2.805003931641813E-17,1.2992004417176839E-15,0,0,6.626624702911467,252.55750992415688,RET;YAP1;ALK;MAML2;CXCR4;BRCA1;ADRB2;MKI67;BRCA2;PTGS2;FGF2;SYNE1;SOCS3;CHAF1A;TERT;CCND1;ERBB2;E2F1;CCL19;TEAD1;CDKN2C;PARP1;CCL21;CDKN2A;HGF;FANCA;MITF;DBF4;KIT;RARB;MCM4;PRTN3;S100A4;VIM;FGFR4;TDGF1;EZH2
Mammary Tumorigenesis,29/176,3.074371372957745E-17,1.4142108315605627E-15,0,0,9.203819989534276,349.9370236496081,SIX1;IRS2;GATA3;BRCA1;BRCA2;PTGS2;FOXO1;RND1;MUC1;CCND1;CHEK1;ERBB2;NDN;SNCG;PAK4;STAT5A;PARP1;CDKN2A;CAV1;HMGA2;PLA2G4A;CDC7;KLF4;ESR1;MELK;S100A4;PPARG;TDGF1;MET
Infection,47/492,3.4042469945375024E-17,1.5447920821158019E-15,0,0,5.071255152165321,192.29653267862938,PROS1;CXCR4;ADRB2;PTGS2;SOCS3;C4A;MUC1;TERT;E2F1;CTLA4;CCL2;PMAIP1;TIMP1;CCL19;FADD;CD36;KPNA2;APOB;IKBKE;TNFRSF4;CCL21;PARP1;STAT1;CDKN2A;CAV2;CAV1;SH2D1A;MX1;IL18;PLAUR;TAP1;GZMB;PRKCA;FOS;ESR1;SELE;CXCL10;IL6;COL2A1;CXCL12;SAA1;IRF7;LTA;PPARG;VIM;PPARA;EZR
Malignant neoplasm of mouth,47/492,3.4042469945375024E-17,1.5447920821158019E-15,0,0,5.071255152165321,192.29653267862938,RET;NRP1;CXCR4;CIB1;PTGS2;HOXD10;FOXO1;CDC20;HOXA10;TERT;CCND1;ALDH2;ERBB2;LEPR;CCL2;TNFSF11;CD36;ZNF423;ECT2;CEP55;JUN;ANXA1;PARP1;STAT1;CDKN2A;HGF;CAV1;IL18;PLAUR;FOS;KRT5;KLF4;DCN;TGFBR2;PER2;MMP14;IL6;CXCL12;BCL3;RARB;PPARG;S100A4;ERG;VIM;PPARA;CRYAB;EZH2
Malignant neoplasm of endometrium,51/577,3.7165868619982626E-17,1.6752078768577405E-15,0,0,4.6827845438227405,177.15508161946147,FLT4;BRCA1;FGF1;BRCA2;FGF2;AQP1;FGF7;CCND1;STMN1;CHEK1;LEPR;KDR;TNFSF11;TIMP1;PARP1;PRKCA;FOS;PAX2;DCN;TGFBR2;VCAN;FANCD2;KIT;LTA;RARB;S100A4;EZR;SGK1;MET;CXCR4;GATA4;SEMA3F;PTGS2;FOXO1;TERT;ERBB2;CCL2;SNCG;PAK4;EGR1;CDKN2A;CAV1;ESR1;NDC80;KRT19;IL6;CXCL12;SDC1;PAEP;VIM;EZH2
Ataxia Telangiectasia,42/396,4.288870859495677E-17,1.910223904537731E-15,0,0,5.652815746309459,213.04288506351352,RET;ALK;BLM;SERPINC1;CXCR4;IRS2;BRCA1;ADRB2;IL2RG;BRCA2;RIMS2;RPS6KA3;CCNB2;MUC1;CHAF1A;TERT;CCND1;CHEK1;ERBB2;E2F1;CTLA4;CCL2;CCL16;GRIA4;STAT5B;CDKN2A;TRAT1;HGF;CAV1;SH2D1A;SYP;AGT;CXCL10;CXCL12;FANCD2;KIT;TXNIP;PPARG;VIM;CRYAB;EZH2;CDKN3
Uterine Corpus Cancer,51/579,4.294875068272742E-17,1.910223904537731E-15,0,0,4.664556414397785,175.7909177904431,FLT4;BRCA1;FGF1;BRCA2;FGF2;AQP1;FGF7;CCND1;STMN1;CHEK1;LEPR;KDR;TNFSF11;TIMP1;PARP1;PRKCA;FOS;PAX2;DCN;TGFBR2;VCAN;FANCD2;KIT;LTA;RARB;S100A4;EZR;SGK1;MET;CXCR4;GATA4;SEMA3F;PTGS2;FOXO1;TERT;ERBB2;CCL2;SNCG;PAK4;EGR1;CDKN2A;CAV1;ESR1;NDC80;KRT19;IL6;CXCL12;SDC1;PAEP;VIM;EZH2
"Aortic Aneurysm, Abdominal",36/288,4.453371935204627E-17,1.9676872313706757E-15,0,0,6.7422284317149845,253.84682221443734,LRP1;CXCR4;PTGS2;FBLN2;MYLK;C3;CXCR2;CTLA4;CCL2;TIMP1;BAK1;STAT5A;EGR1;STAT5B;JUN;CDKN2A;STAT1;BGN;GZMB;FOS;KLF4;ESR1;AGT;DCN;TGFBR2;MMP14;COL3A1;IL6;VCAN;COL1A2;PROC;CXCL12;PECAM1;PPARG;ERG;PPARA
"Lymphoma, Non-Hodgkin",49/539,5.213453652684784E-17,2.2884676295052946E-15,0,0,4.8143939393939394,180.50464717656206,ALK;FLT4;CIB1;BRCA1;MKI67;FGF2;CCND2;CCND1;MDK;CHEK1;LEPR;KDR;CTLA4;TIMP1;PARP1;HGF;LMO2;IL18;RHOH;TGFBR2;MYCN;KIT;ADAM12;LTA;S100A4;CXCR4;PTGS2;IL2RG;FOXO1;RAD54B;AURKA;MUC1;TERT;ERBB2;E2F1;CCL21;CDKN2A;SH2D1A;ESR1;SELE;IL6;CXCL12;WT1;CD5;BCL3;SDC1;SPRY2;FGFR4;EZH2
Congestive heart failure,64/884,5.863663813013331E-17,2.557166634298541E-15,0,0,3.8379105050893028,143.44256505111727,RET;BRCA1;SLC2A4;PKD2;MYLK;ALDH2;TIMP1;CD36;MEF2C;CISH;VWF;PARP1;HGF;IL18;NME3;PRKCA;MITF;LIFR;FOS;DCN;MMP14;BIN1;MAPKAPK2;PECAM1;LTA;SLC27A6;PPARG;PRKD1;PPARA;UTRN;ZFPM2;SGK1;ATF3;CXCR4;GATA4;ADRB1;ADRB2;PTGS2;HOXD10;ACAN;GRK3;GRK5;PRKAR2B;ERBB2;S1PR1;CCL2;DMD;FLNC;CCL19;PPARGC1A;NGFR;EGR1;CCL21;CMA1;ESR1;AGT;COL1A1;NR4A1;COL3A1;IL6;COL1A2;CXCL12;ACTC1;CALR
"Lupus Erythematosus, Systemic",73/1113,6.165359845268796E-17,2.671390756182273E-15,0,0,3.4935768196856904,130.397755063507,RET;FEN1;LAMC1;ETS2;RIMS2;C4B;C4A;STMN1;LEPR;KDR;CTLA4;TNFSF11;TIMP1;CD36;IKBKE;TNFRSF4;TNS1;ANXA1;CR1;TRIM63;VWF;PARP1;ANXA3;HGF;BGN;IL18;TAP1;FOS;SIGIRR;PECAM1;IRF7;LTA;SERPING1;PPARG;PRTN3;SGK1;CCL14;SERPINC1;LAMA1;CXCR4;GATA3;PTGS2;FOXO1;C3;SOCS3;TERT;PRKAR2B;CXCR2;ERBB2;S1PR1;CCL2;ZNF423;PAK3;JUN;EGR2;CDKN2C;STAT1;CDKN2A;SH2D1A;MX1;PLA2G2A;GZMB;ESR1;SELE;FLI1;AGT;CXCL10;IL6;CXCL12;SDC1;CALR;EZH2;CDKN3
Heart failure,61/815,7.229686029603932E-17,3.1124725240269233E-15,0,0,3.96103075265252,147.21468254444224,RET;BRCA1;SLC2A4;PKD2;FGF2;MYLK;ALDH2;TIMP1;CD36;MEF2C;CISH;VWF;PARP1;DUSP1;HGF;IL18;NME3;PRKCA;MITF;LIFR;FOS;DCN;MMP14;BIN1;MAPKAPK2;SLC27A6;PPARG;PRKD1;PPARA;UTRN;ZFPM2;SGK1;ATF3;CXCR4;GATA4;ADRB1;ADRB2;PTGS2;ACAN;GRK3;GRK5;PRKAR2B;ERBB2;S1PR1;CCL2;DMD;FLNC;CCL19;PPARGC1A;NGFR;TCF7L2;CCL21;CMA1;AGT;COL1A1;NR4A1;IL6;COL1A2;CXCL12;ACTC1;CALR
"Fibrosis, Liver",49/545,8.158494121936341E-17,3.489964746683087E-15,0,0,4.7546584799608995,176.13578598457553,FGF2;ADRA1A;FGF7;ALDH2;LEPR;KDR;SOSTDC1;TIMP1;TNS1;ANXA1;CISH;HGF;PLA2G4A;DCN;TGFBR2;CCNA2;ACTA2;MMP14;MYCN;SERPING1;PPARG;S100A4;PPARA;MET;PRKN;SATB1;ASCL1;PTGS2;SOCS3;VTN;TERT;CCL2;BAK1;FADD;A2M;APOB;NGFR;EGR1;STAT1;AGT;COL1A1;CXCL10;COL3A1;IL6;COL1A2;PAEP;SPRY2;VIM;EZH2
Recurrent tumor,39/347,8.363468671331217E-17,3.555003518775978E-15,0,0,6.002758940566823,222.22257614418487,CIB1;GATA3;BRCA1;MKI67;BRCA2;PTGS2;FGF2;ADRA1A;ETS2;RIMS2;TERT;STMN1;ERBB2;KDR;E2F1;CCL2;CEP55;PARP1;CISH;CDKN2A;HGF;CAV1;KRT5;KIF22;PROX1;ESR1;SELE;KRT19;IL6;COL2A1;FANCD2;KIT;S100A4;ERG;TDGF1;FGFR3;MET;EZH2;CDKN3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,42/408,1.2634447956010444E-16,5.336663677519883E-15,0,0,5.4640605296343,200.02570256623773,CXCR4;DTX1;GATA3;SEMA3F;BRCA1;IL2RG;BRCA2;HOXA10;RPS6KA3;ZFP36;CCND2;TERT;MECOM;CCND1;CHEK1;NKX2-5;PITX1;STAT5A;CA12;STAT5B;MEF2C;CDKN2C;PARP1;DUSP1;CDKN2A;STAT1;SIAH2;LMO2;HMGA1;HMGA2;KLF4;RUNX2;CXCL12;MYCN;TAL1;WT1;FANCD2;KIT;S100A4;ERG;FGFR4;EZH2
Immunologic Deficiency Syndromes,53/641,1.492922893919588E-16,6.2665438472274706E-15,0,0,4.361251388310426,158.92672905756936,ALK;NRP1;BRCA1;ANTXR2;FGF2;C4A;ZFP36;CCND1;STMN1;LEPR;KDR;CTLA4;CD36;TNFRSF4;PARP1;HGF;LMO2;IL18;RHOH;MITF;KRT5;KIF22;TGFBR2;IRF7;PPARG;PPARA;MET;CXCR4;ADRB2;PTGS2;IL2RG;PLD1;FOXO1;C3;SOCS3;MUC1;TERT;ERBB2;CCL2;DMD;PPARGC1A;NGFR;EGR1;STAT1;SH2D1A;SELE;KRT19;BMP2;IL6;CXCL12;SDC1;PAEP;CALR
Malignant mesothelioma,38/335,1.5547902718438744E-16,6.485696562548733E-15,0,0,6.054020963111872,220.36648913093936,YAP1;ALK;NRP1;PDGFA;CXCR4;CIB1;BRCA1;PTGS2;FGF2;MUC1;CCND2;CCND1;MDK;KDR;PDLIM4;TNS1;NGFR;JUN;PARP1;CDKN2A;HGF;IL18;ESR1;CXCL10;MMP14;BMP2;IL6;CXCL12;CCNE2;WT1;KIT;LTA;TXNIP;SDC1;VIM;MET;ATF3;CDKN3
Tumor Initiation,32/234,1.8903456995368085E-16,7.836766492647658E-15,0,0,7.423297293409728,268.75752229667876,ALK;BLM;SIX1;IRS2;GATA3;BRCA1;PTGS2;RPS6KA3;MUC1;CCND1;SIX2;ERBB2;KDR;IKBKE;BARD1;STAT5A;HGF;CAV1;HMGA1;HMGA2;PRKCA;KLF4;DCN;BMP2;VCAN;MYCN;MELK;RAD51;CNTN1;SDC1;ERG;MET
Congenital chromosomal disease,46/497,2.546337363212828E-16,1.0491534804501442E-14,0,0,4.883516996482337,175.35100654514272,RET;ALK;FBN2;BLM;MAML2;EPAS1;BRCA1;MKI67;BRCA2;AURKA;RPS6KA3;CCND2;TERT;MECOM;CCND1;STMN1;CHEK1;ERBB2;KDR;RUNX1T1;CDT1;PARP1;CDKN2A;CBX2;LMO2;HMGA1;HMGA2;FOS;KRT5;KLF4;PAX2;RUNX2;GADD45G;IL6;COL1A2;RAD51;MYCN;TAL1;FANCD2;ELF5;KIT;SDC1;S100A4;VIM;ZFPM2;EZH2
Well Differentiated Oligodendroglioma,28/176,2.818336145146653E-16,1.1541430213905439E-14,0,0,8.804783200466654,315.2571537296422,CNTNAP2;DTX1;PDGFA;CIB1;MKI67;ASCL1;PTGS2;FGF2;AURKA;RIMS2;CCND1;TERT;ERBB2;RCC1;ANXA1;CDKN2C;PARP1;CDKN2A;CAV1;PLA2G4A;SYP;SOX10;NDC80;SYN1;GFAP;MELK;MET;EZH2
MYELODYSPLASTIC SYNDROME,54/683,5.1451932583573E-16,2.0942495710986443E-14,0,0,4.155518238262333,146.28794920044646,MAML2;IRS2;CIB1;CDC20;AKAP12;MECOM;CCND1;STMN1;CFL1;CHEK1;CTLA4;TK1;TIMP1;CD36;KLF11;IL18;FOS;RUNX2;TGFBR2;MMP14;FANCD2;KIT;LTA;SCN4A;ERG;ZFPM2;MET;CXCR4;STX11;TERT;CXCR2;E2F1;FADD;PDLIM4;RUNX1T1;PLK4;EGR1;CDKN2C;CDKN2A;GZMB;HMGA2;SELE;FLI1;BMP2;IL6;CXCL12;RAD51;WT1;SAA1;CALR;TEK;EZH2;CDKN3;MAD2L1
"Cardiomyopathy, Familial Idiopathic",40/388,6.633969762239779E-16,2.6839602965784554E-14,0,0,5.45111394919824,190.5118432610179,CXCR4;GATA4;ADRB1;BRCA1;ADRB2;SLC2A4;PTGS2;MKI67;FOXO1;HOXA10;CDH5;MUC1;CCND1;ERBB2;KDR;CTLA4;CCL2;DMD;NEK2;TIMP1;CD36;NKX2-5;CDKN2A;HGF;ESR1;AGT;ACTA2;MMP14;IL6;CXCL12;ACTC1;RHOJ;PECAM1;S100A4;PRKD1;CALR;TEK;VIM;PPARA;CRYAB
Hepatitis B,60/839,1.0868166848280997E-15,4.3706951229374357E-14,0,0,3.756264274877882,129.4240517856879,ALK;CNTNAP2;FLT4;ETS2;ZFP36;CCND2;ALDH2;STMN1;LEPR;CTLA4;ANXA1;CISH;PARP1;IL18;TAP1;CCNA2;MMP14;NR5A2;KIT;LTA;RARB;PPARG;S100A4;ERG;PPARA;PRKN;CCL13;DTX1;PTGS2;SOCS3;VTN;TERT;ERBB2;E2F1;CCL2;APOB;PPARGC1A;PAK4;CA12;JUN;EGR2;STAT1;CDKN2A;CAV1;SH2D1A;MX1;GZMB;ESR1;SELE;AGT;GFAP;PER2;CXCL10;NR4A1;KRT19;IL6;PAEP;CALR;VIM;FGFR4
Carcinoma,30/216,1.102687520704655E-15,4.4081246363407516E-14,0,0,7.5277885736494365,259.26476194411276,ALK;PDGFA;GATA3;BRCA1;PTGS2;AQP1;ADCY5;MUC1;TERT;CCND1;MDK;STMN1;ERBB2;S1PR1;NDN;SNCG;STAT5A;TLE4;ANXA1;TPM3;PLAUR;KRT5;ESR1;FLI1;TGFBR2;EZR;PPARA;SGK1;FGFR3;MET
Cerebrovascular accident,57/768,1.2116466162340233E-15,4.815040635874379E-14,0,0,3.893557788507547,133.73123554541942,F13A1;ENO2;FGF1;C4B;ALDH2;KDR;HOMER3;TIMP1;CD36;TEAD1;ANXA1;VWF;PARP1;IL18;ACTA2;MMP14;LTA;PPARG;FBN2;GRIA2;LRP1;SERPINC1;LAMA1;CXCR4;GATA4;ADRB1;GATA3;ADRB2;ASCL1;PTGS2;C3;CCL2;NKX2-5;A2M;APOB;PPARGC1A;RUNX1T1;EGR1;TCF7L2;STAT1;CDKN2A;F12;CAV1;PLA2G2A;ESR1;SELE;AGT;GFAP;CXCL10;RCAN1;PTPRB;IL6;CXCL12;PAEP;TEK;RAMP1;EZH2
synovial sarcoma,30/217,1.2537450094340471E-15,4.953030284328859E-14,0,0,7.487146446749565,256.90377050121157,CXCR4;CIB1;ENO2;MKI67;FGF2;MUC1;TERT;CCND1;ERBB2;REPS2;EGR1;CDKN2A;HGF;CAV1;HMGA1;HMGA2;SYP;SOX10;PAX2;IL6;MYCN;KIT;PAEP;S100A4;ERG;VIM;EZR;MET;EZH2;CDKN3
Metastatic melanoma,41/417,1.4764124951453486E-15,5.798588489705358E-14,0,0,5.176552296187065,176.77491902730335,BLM;FLT4;ADRB2;PTGS2;FGF2;AURKA;AKAP12;MUC1;CCND1;ERBB2;E2F1;KDR;CTLA4;CCL2;PMAIP1;TIMP1;BAK1;PAK5;STAT5A;JUN;PARP1;CDKN2A;STAT1;HGF;CAV1;IL18;PAX3;TAP1;GZMB;MITF;FOS;IL6;KIT;PAEP;PRKD1;CALR;CAMK1;VIM;BMPR1B;FGFR4;EZH2
Anaplastic carcinoma,29/204,1.786768832841578E-15,6.976709000793043E-14,0,0,7.720054945054945,262.1604631572128,RET;ALK;PDGFA;GATA3;BRCA1;PTGS2;AQP1;ADCY5;TERT;CCND1;STMN1;ERBB2;S1PR1;NDN;SNCG;STAT5A;TLE4;ANXA1;TPM3;PLAUR;KRT5;ESR1;TGFBR2;PPARG;S100A4;EZR;PPARA;SGK1;MET
Anoxia,34/288,1.9538721935231498E-15,7.585089972081777E-14,0,0,6.28612755522348,212.90462315923156,EPAS1;CXCR4;BRCA1;PTGS2;AURKA;MUC1;TERT;CCND1;ERBB2;KDR;PMAIP1;CCL2;BAK1;BARD1;EGR1;STAT5B;JUN;DUSP1;STAT1;SIAH2;HGF;HMGA1;PLAUR;FOS;INHBA;ESR1;RUNX2;TGFBR2;EFNA3;IL6;CXCL12;TXNIP;TEK;SGK1
Papillary thyroid carcinoma,48/571,2.386445687012008E-15,9.21113174366244E-14,0,0,4.399805424045542,148.1369225307626,RET;ALK;SHC3;CXCR4;BRCA1;PTGS2;FGF2;MUC1;TERT;CCND1;MDK;CHEK1;LEPR;KDR;TK1;TIMP1;VAV3;CA12;NGFR;JUN;EGR2;ANXA1;CCL21;PARP1;CDKN2A;TPM3;HGF;PLA2G2A;FOS;PROX1;ESR1;SELE;FLI1;RUNX2;PER2;CXCL10;KRT19;CXCL12;KIT;RARB;SPRY2;PPARG;S100A4;VIM;TEK;MET;EZH2;CDKN3
Precursor Cell Lymphoblastic Leukemia Lymphoma,50/618,2.7552317543781596E-15,1.0573792264230696E-13,0,0,4.231369228026386,141.85781629571403,ALK;NRP1;FLT4;F13A1;CIB1;ENO2;CDC20;MECOM;CCND1;MDK;STMN1;CHEK1;LEPR;MEF2C;LMO2;CCNA2;TAL1;KIT;S100A4;ERG;PPARA;MET;ATF3;HLF;PDE1A;CXCR4;GATA3;ADRB2;AURKA;SOCS3;TERT;CCL2;PMAIP1;NKX2-5;BUB1;RUNX1T1;PLK4;STAT5A;STAT5B;CDT1;CDKN2A;SIAH2;GZMB;HMGA2;CXCL10;CXCL12;WT1;GIPC2;EZH2;CDKN3
Diffuse Large B-Cell Lymphoma,48/575,3.123878798303952E-15,1.1920437505346216E-13,0,0,4.365492617783279,145.80614797985885,ALK;CCL13;CXCR4;CIB1;BRCA1;MKI67;BRCA2;FOXO1;LMNB1;MUC1;CCND2;CCND1;LEPR;E2F1;KDR;CCL2;PMAIP1;NEK2;FADD;CD36;STAT5A;STAT5B;STAT1;CDKN2A;CMA1;HGF;SH2D1A;LMO2;RHOH;CDC7;FLI1;PER2;NR4A1;COL3A1;IL6;TAL1;BCL3;LTA;TXNIP;SDC1;CAMK1;VIM;FKBP4;EZR;SGK1;MET;ATF3;EZH2
Gastrointestinal Carcinoid Tumor,30/225,3.4120345786453818E-15,1.2946454367334679E-13,0,0,7.177015755329008,239.0769280201829,CXCR4;GATA4;BRCA1;MKI67;BRCA2;FGF2;FOXO1;CCND2;ERBB2;KDR;TNFSF11;CCL2;BAK1;TEAD1;STAT5A;CISH;CDKN2A;STAT1;FOS;ESR1;RUNX2;FLI1;TGFBR2;BMP2;CXCL12;TAL1;KIT;PPARG;BMPR1B;FGFR3
Adenomatous Polyposis Coli,39/392,5.086126696420336E-15,1.919012746806684E-13,0,0,5.2252892169860035,171.97607633051777,RET;ALK;PRKN;YAP1;GPSM2;BLM;FEN1;PDGFA;IRS2;BRCA1;PTGS2;MKI67;BRCA2;FOXO1;HOXA10;VTN;MUC1;TERT;CCND1;CHEK1;ERBB2;TCF7L2;CISH;PARP1;CDKN2A;CAV1;PLA2G2A;BGN;FOS;KLF4;ESR1;TGFBR2;PYY;KIT;PECAM1;RARB;PPARG;SGK1;MET
Aneurysm,25/152,5.1487504336129275E-15,1.931788151516448E-13,0,0,9.105736782902138,299.5789436153838,LRP1;PKD2;FGF2;CDH5;CCL2;FADD;TIMP1;NKX2-5;STAT1;BGN;GZMB;KLF4;SELE;DCN;AGT;TGFBR2;COL1A1;ACTA2;RCAN1;IL6;MMP14;COL3A1;COL1A2;PECAM1;VIM
Arthritis,50/630,5.896106512106309E-15,2.199902851961443E-13,0,0,4.141204714098647,135.6844363206857,FGF2;C4B;C4A;ZFP36;MDK;KDR;CTLA4;TNFSF11;TIMP1;HGF;IL18;PLA2G4A;LIFR;FOS;RUNX2;CDC25B;MMP14;COL2A1;PECAM1;PPARG;CXCR4;PTGS2;PLD1;HOXD10;FOXO1;C3;SOCS3;ACAN;GRK3;MUC1;CXCR2;S1PR1;CCL2;JUN;CDKN2A;CAV1;PLA2G2A;ESR1;VIL1;CXCL10;BMP2;IL6;CXCL12;SAA1;SPRY2;CALR;VIM;TEK;F2RL2;CDKN3
Ulcer,27/184,7.677249639951406E-15,2.848641358116776E-13,0,0,7.980769816840886,259.3791293966895,ADRB2;PTGS2;FGF2;SOCS3;FGF7;MUC1;CCND1;TERT;KDR;EGR1;PARP1;CDKN2A;HGF;MX1;PLA2G4A;FLI1;AGT;GFAP;TGFBR2;CCNA2;IL6;MMP14;CXCL12;KIT;PECAM1;SDC1;TEK
Cardiomyopathies,43/480,8.119379675523092E-15,2.996140324220499E-13,0,0,4.679542789485069,151.82553197032001,LRP1;SIX1;GATA4;ADRB1;ADRB2;PTGS2;ADCY5;SYNE1;GRK5;ALDH2;ERBB2;KDR;CCL2;DMD;TIMP1;FLNC;NKX2-5;APOB;PPARGC1A;MEF2C;TRIM63;PARP1;CMA1;HGF;SH2D1A;IL18;PRKCA;AGT;DCN;CCNA2;ACTA2;MMP14;COL3A1;IL6;RAD51;ACTC1;BIN1;RHOJ;PPARG;PPARA;UTRN;CRYAB;ATF3
Idiopathic Pulmonary Fibrosis,38/379,9.0091249981953E-15,3.306299644146428E-13,0,0,5.260809730017941,170.13741931245,FBN2;PDGFA;CXCR4;PTGS2;PKD2;FGF2;ETS2;FGF7;MUC1;TERT;CCND1;CXCR2;CCL2;CD36;EGR1;ANXA1;CCL21;CDKN2A;HGF;CAV1;IL18;AGT;DCN;TGFBR2;COL1A1;CCNA2;CXCL10;COL3A1;IL6;CXCL12;PRC1;SDC1;S100A4;PRKD1;VIM;UTRN;CRYAB;EZH2
Malignant neoplasm of liver,57/805,9.371590350042936E-15,3.4206304777656714E-13,0,0,3.693695214730691,119.31039480623276,FLT4;LMNB1;ZFP36;CCND1;ALDH2;SIX3;KDR;TK1;KPNA2;TEAD1;TNS1;ANXA3;TPM3;HGF;RUNX2;DCN;TGFBR2;CCNA2;VCAN;MAPKAPK2;ADAM12;PPARG;PPARA;MET;ATF3;PRKN;YAP1;HLF;SERPINC1;EPAS1;SATB1;CXCR4;GATA4;PTGS2;AURKA;MUC1;TERT;ERBB2;E2F1;SNCG;EGR1;TCF7L2;JUN;CDKN2A;CAV1;HMGA2;ESR1;AGT;NDC80;NR4A1;BMP2;IL6;SDC1;PAEP;SPRY2;EZH2;CDKN3
Chronic Kidney Diseases,38/380,9.80907429451281E-15,3.560959079024218E-13,0,0,5.245154245154245,169.18490747577763,CCL14;CXCR4;IRS2;GATA3;PTGS2;PKD2;C3;SOCS3;KDR;CCL2;CD36;TIMP1;APOB;EGR1;TCF7L2;VWF;CDKN2A;HGF;SH2D1A;IL18;GZMB;MITF;ESR1;AGT;BMP2;IL6;VCAN;CXCL12;NPHS1;WT1;SAA1;LTA;PECAM1;PPARG;S100A4;SGK1;FGFR4;ATF3
Sepsis,45/529,1.2314770201522832E-14,4.446558960936954E-13,0,0,4.43282541322314,141.97443048415985,PRKN;NRP1;CXCR4;BRCA1;ADRB2;ENO2;PTGS2;MYLK;AQP1;RIMS2;SOCS3;GRK5;CXCR2;CCL2;TIMP1;APOB;PPARGC1A;NFE2;JUN;VWF;PARP1;DUSP1;CAV1;PLA2G2A;IL18;HMGA1;PLAUR;GZMB;PLA2G4A;PRKCA;FOS;SELE;AGT;CCNA2;RCAN1;IL6;CXCL12;PROC;SAA1;LTA;SERPING1;SDC1;PPARG;TEK;ATF3
"Carcinoma, Spindle-Cell",27/188,1.3224366732872847E-14,4.724193988190108E-13,0,0,7.780885018871289,248.65152734882253,ALK;PDGFA;GATA3;BRCA1;PTGS2;AQP1;ADCY5;CCND1;STMN1;S1PR1;NDN;SNCG;TLE4;STAT5A;ANXA1;TPM3;CDKN2A;HGF;PLAUR;KRT5;ESR1;TGFBR2;VIM;EZR;PPARA;SGK1;MET
Malignant Peripheral Nerve Sheath Tumor,27/188,1.3224366732872847E-14,4.724193988190108E-13,0,0,7.780885018871289,248.65152734882253,PDGFA;CIB1;BRCA1;BRCA2;ASCL1;AURKA;CCND1;TERT;MDK;ERBB2;KDR;NGFR;PARP1;CDKN2A;HGF;HMGA1;HMGA2;SOX10;ESR1;SYN1;BMP2;EFNA3;MYCN;WT1;KIT;MET;EZH2
Anemia,43/490,1.6771051447198063E-14,5.959491085681597E-13,0,0,4.572462074415395,145.03448294088147,COL17A1;EPAS1;CIB1;FGF2;AQP1;SPTA1;MUC1;TERT;MECOM;CCND1;CHEK1;ERBB2;KDR;CTLA4;CCL2;TNFSF11;CD36;PPARGC1A;RUNX1T1;NFE2;EGR1;VWF;PARP1;STAT1;CDKN2A;CAV2;HGF;CAV1;SH2D1A;FANCA;IL18;AGT;KLF1;CXCL10;IL6;TAL1;FANCD2;KIT;LTA;PAEP;CALR;PPARA;MET
Malignant Head and Neck Neoplasm,42/470,1.8495597705183148E-14,6.537707062526843E-13,0,0,4.65744069015097,147.27406686278056,PRKN;YAP1;PROS1;CXCR4;CIB1;PTGS2;BRCA2;HOXD10;ADRA1A;SOCS3;ZFP36;CCND1;ALDH2;CHEK1;ERBB2;KDR;CTLA4;FADD;CEP55;TNS1;STAT5A;STAT5B;JUN;CISH;STAT1;CDKN2A;FANCA;IL18;FOS;MMP14;IL6;CXCL12;RAD51;FANCD2;MAPKAPK2;ADAM12;PECAM1;RARB;S100A4;VIM;FGFR4;MET
Secondary malignant neoplasm of bone,35/330,1.9912361175180235E-14,7.001644903272799E-13,0,0,5.5733774286895414,175.82576601571313,NRP1;SATB1;CXCR4;F13A1;ENO2;BRCA2;PTGS2;FOXO1;MUC1;ERBB2;KDR;TNFSF11;SOSTDC1;CCL2;A2M;VAV3;CDKN2A;HGF;KLF4;ESR1;SELE;RUNX2;DCN;MMP14;BMP2;IL6;VCAN;CXCL12;CNTN1;IRF7;PECAM1;VIM;EZR;MET;EZH2
Multiple malignancy,26/176,2.0738446808452696E-14,7.254135873206682E-13,0,0,8.02752585521082,252.9215479282954,YAP1;BLM;PDGFA;SIX1;CXCR4;AURKA;HOXA10;CCND2;TERT;ALDH2;ERBB2;E2F1;APOB;EGR1;CAV1;SOX10;QKI;CCNA2;MMP14;MYCN;RAD51;ELF5;RARB;ERG;MET;EZH2
Schizophrenia,96/1923,2.1064164189923566E-14,7.329892575105009E-13,0,0,2.669113253442865,84.05358776908808,ALK;CNTNAP2;CTNND2;BRCA1;ENO2;BRCA2;FGF2;ADRA1A;SYNE1;RIMS2;CCND2;CCND1;ALDH2;MDK;DPYSL2;CFL1;CHEK1;LEPR;KDR;CTLA4;SIRPA;SOX5;VAV3;CCT3;ANXA1;IL18;TAP1;PLA2G4A;PRKCA;LIFR;SYP;SOX10;SYN1;CIT;TGFBR2;CCNA2;TAL1;FEZ1;KIT;ADAM12;LTA;TXNIP;RARB;PPARG;KCNQ5;SCN4A;PRKD1;PPARA;ZFPM2;MET;ATF3;PRKN;OPRD1;GRIA2;LRP1;LAMA1;CXCR4;AKAP5;ASCL1;PTGS2;IL2RG;C3;ACAN;GRK3;TERT;GNG7;CCL2;DMD;PAK3;PPARGC1A;GRIA4;NGFR;EGR1;ARNT2;TCF7L2;JUN;EGR2;CCL21;GAD1;CAV1;PLA2G2A;LSM1;HMGA1;INHBA;GRIN2C;ESR1;QKI;GRIN2D;GFAP;COL3A1;IL6;CXCL12;DLG2;FXYD6;CALR;VIM
Acute Erythroblastic Leukemia,29/224,2.1747507785557603E-14,7.528673313804374E-13,0,0,6.9211045364891515,217.73294634093372,ALK;SATB1;FLT4;CIB1;PTGS2;ADRA1A;ETS2;AQP1;RIMS2;STMN1;ERBB2;STAT5A;NFE2;STAT5B;CR1;STAT1;HGF;INHBA;ESR1;FLI1;PAX2;IL6;TAL1;WT1;KIT;PPARG;ERG;FGFR4;EZH2
Chondrosarcoma,30/241,2.224168293013844E-14,7.660263720964603E-13,0,0,6.627305430251813,208.34133007187867,EPAS1;CXCR4;MKI67;PTGS2;FGF2;RIMS2;ACAN;TERT;CCND1;SIX3;ERBB2;TIMP1;CDKN2A;HGF;HMGA2;INHBA;RUNX2;DCN;GFAP;CCNA2;MMP14;BMP2;IL6;VCAN;COL2A1;CXCL12;KIT;PPARG;FGFR3;MET
Lip and Oral Cavity Carcinoma,42/473,2.302169450958494E-14,7.888454098284309E-13,0,0,4.6242968916421505,145.21374040374735,RET;CXCR4;CIB1;PTGS2;FOXO1;AURKA;CDC20;HOXA10;TERT;CCND1;ERBB2;LEPR;CCL2;TNFSF11;CD36;ZNF423;ECT2;CEP55;PARP1;STAT1;CDKN2A;HGF;CAV1;IL18;PLAUR;KRT5;KLF4;DCN;TGFBR2;PER2;MMP14;IL6;CXCL12;BCL3;RARB;PPARG;S100A4;ERG;VIM;PPARA;CRYAB;EZH2
Congenital Abnormality,48/607,2.464802973610734E-14,8.360412510489741E-13,0,0,4.108668321895432,128.74133953823534,RET;NRP1;SERPINC1;SIX1;GATA4;GATA3;PCSK5;FOXO1;RIMS2;RPS6KA3;ZFP36;FGF7;ALDH2;SIX3;ERBB2;NKX2-5;ZNF423;TEAD1;ARNT2;MEF2C;VWF;STAT1;TPM3;FANCA;PAX3;PRKCA;LIFR;KLF4;ESR1;FLI1;PAX2;RUNX2;RCAN1;MMP14;COL3A1;CENPF;BMP2;COL2A1;WT1;FANCD2;KIT;PECAM1;COL8A1;PPARG;PRKD1;TEK;FGFR3;ATF3
Liver and Intrahepatic Biliary Tract Carcinoma,48/607,2.464802973610734E-14,8.360412510489741E-13,0,0,4.108668321895432,128.74133953823534,PRKN;YAP1;SERPINC1;EPAS1;SATB1;FLT4;CXCR4;GATA4;PTGS2;LMNB1;AURKA;ZFP36;MUC1;TERT;CCND1;ALDH2;ERBB2;E2F1;SNCG;TK1;KPNA2;TEAD1;TNS1;EGR1;TCF7L2;ANXA3;CDKN2A;TPM3;HGF;CAV1;HMGA2;ESR1;AGT;RUNX2;DCN;CCNA2;NR4A1;BMP2;IL6;VCAN;MAPKAPK2;PAEP;SPRY2;PPARG;PPARA;MET;EZH2;CDKN3
Colitis,48/608,2.6227780979103726E-14,8.851546585711588E-13,0,0,4.101115509175963,128.24990868831412,NRP1;PROS1;BRCA1;PTGS2;PLD1;ETS2;SYNE1;RIMS2;SOCS3;FGF7;MUC1;CXCR2;KDR;CTLA4;CCL2;TIMP1;FADD;PPARGC1A;TNFRSF4;STAT5A;STAT5B;ANXA1;TRIM63;PARP1;STAT1;HGF;IL18;PLA2G4A;SELE;RUNX2;TGFBR2;CXCL10;NR4A1;IL6;COL2A1;BIN1;BCL3;LTA;SDC1;PAEP;PPARG;PRTN3;VIM;TEK;PPARA;EZR;SGK1;EZH2
Lung diseases,38/393,2.888147620510923E-14,9.698399709675678E-13,0,0,5.049659134166176,157.42603194494106,PRKN;CTNND2;PDGFA;CXCR4;ADRB2;PTGS2;ADRA1A;PCSK5;MYLK;FGF7;TERT;ALDH2;CXCR2;CCL2;CTSG;A2M;EGR1;STAT5B;JUN;ANXA1;CDKN2A;HGF;PLA2G2A;IL18;FOS;GADD45G;CXCL10;COL3A1;IL6;VCAN;WT1;KIT;LTA;SPRY2;PPARG;PRTN3;VIM;EZR
Cholangiocarcinoma,41/455,2.912361215985253E-14,9.731053694804458E-13,0,0,4.692094752953556,146.2395829057656,PRKN;YAP1;FLT4;CXCR4;CIB1;PTGS2;PPL;FOXO1;AQP1;EPS8;SOCS3;MUC1;TERT;CCND1;STMN1;CXCR2;ERBB2;KDR;NEK2;TIMP1;KPNA2;APOB;ANXA1;CISH;STAT1;CDKN2A;HGF;MITF;PROX1;SSTR2;ESR1;TGFBR2;KRT19;IL6;CXCL12;KIT;PECAM1;PPARG;MET;EZH2;CDKN3
Idiopathic pulmonary arterial hypertension,33/297,2.997855975120591E-14,9.967129073717766E-13,0,0,5.852851941747573,182.24782417115105,FLT4;ITSN1;PDGFA;CXCR4;FGF2;AQP1;TERT;CCL2;TIMP1;PPARGC1A;EGR1;PARP1;CAV1;BGN;HMGA1;GZMB;LIFR;KLF4;ESR1;TGFBR2;COL1A1;ACTA2;BMP2;IL6;COL1A2;CXCL12;PECAM1;PPARG;S100A4;TEK;UTRN;BMPR1B;EZH2
Metastatic Neoplasm,45/544,3.3822491615260976E-14,1.1189746487098164E-12,0,0,4.296192384769539,133.25779336166892,ALK;PRKN;GPSM2;EPAS1;SATB1;PROS1;CXCR4;GATA3;BRCA1;PTGS2;FOXO1;AURKA;RPS6KA3;MUC1;MDK;STMN1;CXCR2;ERBB2;RAC3;PPARGC1A;PAK4;HGF;CAV1;HMGA1;HMGA2;KLF4;ESR1;VAV2;KRT19;BMP2;IL6;VCAN;CXCL12;MYCN;KIT;S100A4;CALR;VIM;PPARA;EZR;FGFR4;MET;F2RL2;EZH2;MAD2L1
Coronary Arteriosclerosis,54/760,4.4219154787615825E-14,1.455763938988372E-12,0,0,3.6872332872057556,113.3810162880334,FEN1;F13A1;IRS2;FGF2;ALDH2;FLAD1;LEPR;KDR;CD36;ANXA1;VWF;PARP1;HGF;IL18;FOS;TGFBR2;CCNA2;ACTA2;MMP14;PECAM1;LTA;TXNIP;PPARG;PPARA;ATF3;LRP1;PDGFA;ADRB1;ADRB2;PTGS2;PLD1;C3;TERT;GRK5;CCL2;CCL19;APOB;EGR1;TCF7L2;CCL21;CDKN2A;F12;CAV1;PLA2G2A;GZMB;ESR1;SELE;AGT;PER2;RCAN1;COL3A1;BMP2;IL6;CXCL12
oligodendroglioma,26/183,5.357030612616116E-14,1.7550154924063333E-12,0,0,7.666844017451317,234.2817440538927,CNTNAP2;DTX1;PDGFA;CIB1;MKI67;ASCL1;PTGS2;FGF2;AURKA;RIMS2;CCND1;TERT;STMN1;ANXA1;CDKN2C;PARP1;CDKN2A;CAV1;SYP;SOX10;NDC80;SYN1;GFAP;MELK;MET;EZH2
Mental Depression,46/575,5.838609210722837E-14,1.9034999737482804E-12,0,0,4.146453089244852,126.34946913570833,ALK;NRP1;MAGED1;ADRB1;BRCA1;ADRB2;PTGS2;FGF2;ETS2;ADCY5;SYNE1;MUC1;ALDH2;DPYSL2;STMN1;SOSTDC1;SIRPA;SNCG;CD36;A2M;PPARGC1A;NGFR;JUN;CISH;DST;DUSP1;CDKN2A;GAD1;PLA2G2A;IL18;SYP;ESR1;AGT;SYN1;GRIN2D;CIT;GFAP;PER2;PYY;IL6;TAL1;KIT;SERPING1;FKBP4;MET;ATF3
Barrett Esophagus,34/323,5.942976945471895E-14,1.9281658534197705E-12,0,0,5.514813224559897,167.94801784762228,ADRB2;MKI67;PTGS2;FGF1;FGF2;AKAP12;MUC1;TERT;CCND1;ERBB2;LEPR;S1PR1;TIMP1;APOB;PITX1;BUB1;ANXA1;PARP1;CDKN2A;HGF;CAV1;IL18;GZMB;KRT5;INHBA;KLF4;ESR1;CCNA2;IL6;PPARG;S100A4;VIM;FGFR4;MAD2L1
Presenile dementia,36/362,6.03999081740034E-14,1.9502201120029176E-12,0,0,5.191804040979795,158.02703494364434,PRKN;ALK;RAB3A;LRP1;CXCR4;SLC2A4;BRCA2;PTGS2;ALDH2;DPYSL2;E2F1;SOSTDC1;CCL2;TIMP1;A2M;APOB;PPARGC1A;RUNX1T1;MEF2C;CR1;TRIM63;STAT1;IL18;SYP;SNCAIP;ESR1;SELE;GFAP;CXCL10;PYY;IL6;CXCL12;BIN1;FANCD2;PPARG;PPARA
Hamman-Rich syndrome,29/233,6.121938605766356E-14,1.9672219940826243E-12,0,0,6.612686180241328,201.1864307453315,PDGFA;CXCR4;PTGS2;FGF1;FGF2;ETS2;FGF7;TERT;CCND1;CXCR2;CCL2;TIMP1;ANXA1;PARP1;CCL21;CDKN2A;CMA1;HGF;CAV1;AGT;DCN;CXCL10;COL3A1;IL6;S100A4;PRKD1;VIM;UTRN;EZH2
Septicemia,41/468,7.492494622569599E-14,2.396171137389401E-12,0,0,4.546154381246087,137.39519381906058,PRKN;CXCR4;BRCA1;ADRB2;PTGS2;MYLK;AQP1;RIMS2;SOCS3;GRK5;CXCR2;CCL2;TIMP1;APOB;PPARGC1A;NFE2;JUN;VWF;PARP1;DUSP1;CAV1;PLA2G2A;IL18;HMGA1;PLAUR;GZMB;PLA2G4A;FOS;SELE;AGT;CCNA2;RCAN1;IL6;CXCL12;PROC;SAA1;LTA;SERPING1;PPARG;TEK;ATF3
Major Depressive Disorder,43/513,8.26640804479506E-14,2.631146750182162E-12,0,0,4.343468826082354,130.84261679344073,GRIA2;CNTNAP2;NRP1;HLF;LRP1;CTNND2;ADRB1;PTGS2;FGF2;ADRA1A;ADCY5;TERT;CCND1;GRK5;STMN1;KDR;CTLA4;CCL2;SOSTDC1;IKBKE;GRIA4;NGFR;EGR1;KLF11;JUN;DST;DUSP1;CDKN2A;GAD1;FOS;ESR1;QKI;CIT;GFAP;CXCL10;IL6;DLG2;TAL1;IRF7;LTA;FKBP4;SGK1;MET
Fanconi Anemia,32/290,9.042665433210363E-14,2.864648162709472E-12,0,0,5.795221202395029,174.0550489271774,PRKN;BLM;GATA3;BRCA1;BRCA2;PTGS2;RIMS2;MECOM;ALDH2;CHEK1;STMN1;RUVBL1;ERBB2;E2F1;EGR1;NGFR;PARP1;STAT1;MX1;FANCA;INHBA;ESR1;GADD45G;IL6;RAD51;WT1;FANCD2;KIT;SAA1;LTA;MCM4;PRTN3
Coronary Artery Disease,62/981,9.882965774980597E-14,3.1161501476417694E-12,0,0,3.2826917667915803,98.30144796602326,FEN1;F13A1;IRS2;FHL5;SLC2A4;BRCA2;MYLK;CDH5;CCND1;ALDH2;FLAD1;LEPR;KDR;CD36;TNS1;ANXA1;VWF;IL18;PLA2G4A;FOS;TGFBR2;ACTA2;PECAM1;LTA;PPARG;PPARA;ZFPM2;CCL13;LRP1;PDGFA;CXCR4;GATA4;ADRB1;ADRB2;PTGS2;C3;VTN;TERT;CCL2;CCL19;APOB;EGR1;TCF7L2;CCL21;STAT1;CDKN2A;F12;CAV1;SH2D1A;PLA2G2A;HMGA1;ESR1;SELE;AGT;COL3A1;IL6;CXCL12;BCL3;SAA1;TEK;BMPR1B;NECTIN2
Systemic Scleroderma,45/562,1.0823820079839295E-13,3.3968586755233975E-12,0,0,4.142698259187621,123.677945041289,BLM;PDGFA;CXCR4;GATA3;PTGS2;FGF2;CXCR2;KDR;CTLA4;NDN;CCL2;CTSG;TIMP1;CCL19;TNFRSF4;SOX5;EGR1;JUN;EGR2;VWF;HGF;CAV1;MX1;IL18;PLAUR;TAP1;LIFR;FOS;SELE;FLI1;AGT;TGFBR2;COL1A1;CCNA2;ACTA2;CXCL10;MMP14;COL3A1;IL6;COL1A2;CXCL12;IRF7;PPARG;MET;ATF3
Malignant neoplasm of salivary gland,17/69,1.2226091632140588E-13,3.819089832625869E-12,0,0,14.897151329978433,442.9313243143086,STAT5A;STAT5B;MAML2;FANCA;CXCR4;KRT5;AQP1;VCAN;CXCL12;CCND1;KRT15;ERBB2;HOMER3;PPARG;PRKD1;MET;CDKN3
Neuroendocrine Tumors,30/257,1.2468311261018396E-13,3.8767212235647935E-12,0,0,6.155087309590786,182.88611523435458,RET;YAP1;ALK;SEMA3F;ENO2;MKI67;ASCL1;PKD2;MUC1;TERT;CCND1;STMN1;ERBB2;PAK3;CDKN2A;HMGA1;HMGA2;SYP;SSTR2;ESR1;FLI1;KRT19;IL6;MYCN;CXCL12;KIT;RARB;CALR;TEK;MET
Pituitary Adenoma,32/294,1.3247643134198867E-13,4.100053976464498E-12,0,0,5.705561613958561,169.1834334032607,RET;PDGFA;CXCR4;CIB1;ENO2;MKI67;FGF2;CCNB2;CCND1;MDK;LEPR;E2F1;TIMP1;PITX1;CDKN2C;CDKN2A;HMGA1;HMGA2;PRKCA;SYP;SSTR2;ESR1;GADD45G;GFAP;IL6;CXCL12;KIT;PPARG;S100A4;FGFR4;EZH2;CDKN3
Rectal Carcinoma,31/276,1.3796644933161922E-13,4.2503792372071315E-12,0,0,5.901705609780144,174.75992469203356,YAP1;NRP1;BLM;SATB1;CXCR4;IRS2;MKI67;PTGS2;RIMS2;TERT;CCND1;ALDH2;CXCR2;ERBB2;KDR;BAK1;TCF7L2;ANXA1;CDKN2A;HGF;KLF4;BMP2;IL6;CXCL12;RAD51;KIT;PPARG;VIM;BMPR1B;TDGF1;MET
Metastatic Prostate Carcinoma,29/241,1.4737048720221136E-13,4.519361607534482E-12,0,0,6.360520228592162,187.9268281268509,SATB1;PROS1;CXCR4;CIB1;ADRB2;BRCA2;PTGS2;FGF2;MUC1;TERT;ERBB2;KDR;TIMP1;PAK4;CDKN2A;HGF;CAV1;KLF4;RUNX2;TGFBR2;MMP14;IL6;BIN1;S100A4;PRKD1;ERG;VIM;MET;EZH2
Anaplastic thyroid carcinoma,25/176,1.6605820020276747E-13,5.069303966189938E-12,0,0,7.6490066225165565,225.0830196314402,ALK;RET;CXCR4;SOCS3;MUC1;CCND1;TERT;ERBB2;KDR;CCL2;ANXA1;CDKN2A;HGF;CAV1;HMGA1;PROX1;KLF4;GADD45G;CXCL12;KIT;PAEP;S100A4;PPARG;MET;EZH2
Depressive disorder,52/741,2.2202225552505042E-13,6.747065466544066E-12,0,0,3.623025589322579,105.56046910675497,ALK;NRP1;BRCA1;FGF2;ETS2;SYNE1;LMNB1;ALDH2;DPYSL2;STMN1;KDR;SOSTDC1;SIRPA;CD36;NEFH;KLF11;CISH;DST;DUSP1;IL18;SYP;SYN1;CIT;TGFBR2;TAL1;KIT;SERPING1;FKBP4;MET;ATF3;MAGED1;ADRB1;GATA3;ADRB2;PTGS2;ADCY5;MUC1;A2M;PPARGC1A;NGFR;CDKN2A;GAD1;PLA2G2A;SNCAIP;ESR1;AGT;GRIN2D;GFAP;PER2;PYY;IL6;PAEP
"Lymphoma, Follicular",35/359,2.460007929025882E-13,7.442078041143164E-12,0,0,5.0668849744052995,147.1091091797197,ALK;CXCR4;BRCA1;MKI67;BRCA2;FOXO1;RIMS2;SOCS3;CCND1;CHEK1;STMN1;KDR;TNFSF11;PMAIP1;E2F2;CCL2;SOX5;RUNX1T1;STAT5A;STAT5B;CDKN2A;STAT1;LMO2;RHOH;ESR1;NR4A1;CXCL12;TAL1;KIT;BCL3;SDC1;VIM;FGFR4;EZH2;CDKN3
Virus Diseases,57/875,3.173170621137044E-13,9.55650847154995E-12,0,0,3.3650373049681144,96.84198771748098,CIB1;FGF2;RIMS2;RPS6KA3;ZFP36;CHEK1;LEPR;CTLA4;SIRPA;TNFRSF4;TRIM63;CISH;DUSP1;HGF;IL18;TAP1;FOS;KIF22;RUNX2;CCNE2;IRF7;SERPING1;PPARG;PPARA;FKBP4;UTRN;MET;PRKN;CXCR4;PTGS2;PLD1;FOXO1;C3;SOCS3;VTN;TERT;ERBB2;CCL2;DMD;APOB;PAK3;RUNX1T1;EGR1;JUN;STAT1;CDKN2A;TRAT1;SH2D1A;MX1;GZMB;ESR1;SELE;GFAP;CXCL10;IL6;PAEP;FGFR3
polyps,31/285,3.2879643169560875E-13,9.858021586016556E-12,0,0,5.689936855719122,163.54777587725573,PRKN;CXCR4;DTX1;SEMA3F;MKI67;PTGS2;ADRA1A;AURKA;C3;MUC1;CCND1;ALDH2;ERBB2;E2F1;EGR1;JUN;PARP1;CDKN2A;PLA2G2A;HMGA1;ESR1;PER2;COL3A1;IL6;KIT;PAEP;PPARG;CALR;VIM;FGFR4;EZH2
Reperfusion Injury,20/110,4.0302060961491856E-13,1.202971739632797E-11,0,0,10.177777777777777,290.4716271501086,EGR1;JUN;HGF;CAV1;PLA2G2A;FOS;PTGS2;FGF2;SELE;AGT;FGF7;IL6;TERT;KDR;CCL2;PPARG;CD36;VIM;PPARA;ATF3
Adenocarcinoma of prostate,27/216,4.131083169161175E-13,1.2276263081454182E-11,0,0,6.618591934381408,188.72958959381802,PRKN;CTNND2;PROS1;CXCR4;CIB1;BRCA1;ADRB2;BRCA2;PTGS2;AURKA;CCND1;ERBB2;KDR;CCL2;EGR1;NGFR;ANXA1;CDKN2A;SIAH2;GAD1;FANCA;ESR1;VCAN;MYCN;S100A4;ERG;PPARA
Invasive Ductal Breast Carcinoma,27/218,5.169243852142229E-13,1.529367476254943E-11,0,0,6.548610937147724,185.26596480082134,CXCR4;BRCA1;MKI67;PTGS2;PKD2;HOXD10;AURKA;MUC1;CCND2;CCND1;ERBB2;CCL2;SNCG;NEK2;STAT5A;CDKN2A;HGF;CAV1;LMO2;ESR1;NR5A2;CXCL12;RAD51;KIT;ADAM12;PECAM1;FGFR4
Coronary heart disease,58/913,5.501906608827602E-13,1.6206493326704463E-11,0,0,3.2778759992142286,92.52956040693367,FEN1;PROS1;F13A1;IRS2;ETS2;MECOM;ALDH2;FLAD1;LEPR;KDR;TIMP1;CD36;MEF2C;ANXA1;VWF;IL18;FOS;TGFBR2;ACTA2;MMP14;PECAM1;LTA;PPARG;PPARA;ZFPM2;YAP1;FBN2;SERPINC1;PDGFA;CXCR4;GATA4;ADRB1;ADRB2;PTGS2;FOXO1;C3;CCL2;CCL19;NKX2-5;APOB;EGR1;TCF7L2;CCL21;CDKN2A;F12;GAD1;CAV1;PLA2G2A;HMGA1;ESR1;SELE;AGT;QKI;COL3A1;IL6;CXCL12;PROC;ACTC1
Sarcoidosis,28/236,5.57004254384134E-13,1.633554835128316E-11,0,0,6.24557277255119,176.2263524304135,PDGFA;CXCR4;PTGS2;MUC1;TERT;KDR;CCL2;CCL19;PPARGC1A;CCL16;CR1;STAT1;CMA1;HGF;IL18;TAP1;FOS;SELE;AGT;COL1A1;CXCL10;MMP14;COL3A1;IL6;CXCL12;LTA;PPARG;ERG
"Kidney Failure, Acute",32/310,5.721412037427889E-13,1.6706523149289436E-11,0,0,5.372724580626056,151.45383165143983,YAP1;EPAS1;SERPINC1;CXCR4;ADRB2;PTGS2;PKD2;IL2RG;C3;MUC1;CCND1;SOSTDC1;CCL2;A2M;PPARGC1A;RUNX1T1;ANXA1;PARP1;CDKN2A;HGF;BGN;IL18;BMP2;IL6;VCAN;CXCL12;BCL3;RARB;PPARG;PPARA;MET;ATF3
Ulcerative Colitis,58/915,6.026694952154327E-13,1.7521767661761237E-11,0,0,3.2698765901121334,92.00584992474687,MAML2;ANTXR2;FGF2;FGF7;CCND1;CHEK1;LEPR;KDR;CTLA4;TIMP1;ANXA1;DUSP1;TPM3;HGF;IL18;FOS;CIT;TGFBR2;ACTA2;VCAN;DDX39A;NR5A2;BIN1;PECAM1;LTA;TXNIP;PPARG;PRTN3;PPARA;MET;SKAP2;ARHGEF6;PRKN;CXCR4;PTGS2;SOCS3;TERT;CXCR2;CCL2;STAT5A;EGR1;TCF7L2;CCL21;STAT1;CDKN2A;PLA2G2A;GZMB;ESR1;CXCL10;NR4A1;IL6;CXCL12;RAD51;BCL3;SAA1;SDC1;PAEP;MAD2L1
Multiple Sclerosis,65/1106,6.452687820724634E-13,1.8643290989114823E-11,0,0,3.042140654229233,85.39017898136979,CNTNAP2;PTPRN;FAM107A;BRCA2;LMNB1;CCND1;DPYSL2;STMN1;CTLA4;TNFSF11;TIMP1;TNFRSF4;ANXA1;CISH;DST;PARP1;IL18;TAP1;PLA2G4A;PRKCA;DCN;VAV2;PECAM1;LTA;PPARG;ERG;PPARA;CRYAB;ATF3;SKAP2;LRP1;CXCR4;GATA3;ADRB2;C3;SOCS3;CXCR2;S1PR1;CCL2;CCL19;A2M;PPARGC1A;EGR2;CCL21;STAT1;CDKN2A;GAD1;CAV1;MX1;GZMB;ESR1;SELE;AGT;GFAP;CXCL10;NR4A1;BMP2;IL6;CXCL12;NPHS1;WT1;SDC1;PAEP;NECTIN2;EZH2
Cardiovascular Diseases,53/787,6.467967243096715E-13,1.8643290989114823E-11,0,0,3.4668610632263803,97.30350309502018,RET;PROS1;BRCA1;SLC2A4;C4B;CCND1;ALDH2;FLAD1;LEPR;TNFSF11;CD36;ANXA1;VWF;DUSP1;HGF;BGN;IL18;PLA2G4A;FOS;TGFBR2;PECAM1;LTA;SLC27A6;PPARG;PPARA;GATA4;ADRB1;ADRB2;ASCL1;PTGS2;FOXO1;GRK5;CCL2;FLNC;APOB;PPARGC1A;TCF7L2;JUN;CCL21;CDKN2A;F12;CAV1;PLA2G2A;ESR1;SELE;FLI1;AGT;IL6;CXCL12;PROC;BCL3;SAA1;SPRY2
Ewings sarcoma,34/352,7.137818477451612E-13,2.0486149100241464E-11,0,0,5.004345896647233,139.96254197546415,YAP1;ALK;LRP1;SERPINC1;CXCR4;ENO2;FGF2;FOXO1;CCND2;TERT;CCND1;MDK;STMN1;ERBB2;PMAIP1;PAK3;EGR2;PARP1;CDKN2A;STAT1;CAV1;PAX3;FLI1;TGFBR2;IL6;MYCN;CXCL12;WT1;KIT;ERG;EZR;MET;NECTIN2;EZH2
Interstitial lung fibrosis,21/127,7.231428564298151E-13,2.0666499675670803E-11,0,0,9.0875088999644,254.04285257497352,YAP1;CDKN2A;HGF;BGN;CXCR4;ADRB1;GATA3;PKD2;FGF2;DCN;AGT;COL1A1;VCAN;MUC1;ALDH2;NPHS1;SDC1;CCL2;PPARG;TIMP1;VIM
Lymphatic Metastasis,22/142,8.030025257275398E-13,2.285154645248372E-11,0,0,8.423364854215919,234.59423666801504,VAV3;EGR1;ANXA1;CCL21;CDKN2A;HGF;FLT4;SIX1;CXCR4;FGF1;PTGS2;ESR1;IL6;MMP14;MUC1;CXCL12;ERBB2;KDR;TEK;EZR;CRYAB;MET
Pituitary Neoplasms,31/296,9.069359554873217E-13,2.5700345472796845E-11,0,0,5.450642603226688,151.13925839971145,RET;CXCR4;CIB1;PTGS2;FGF2;EPS8;RIMS2;CCNB2;CCND1;ERBB2;KDR;LEPR;E2F1;PITX1;SOX5;VWF;CDKN2A;HMGA1;HMGA2;SSTR2;ESR1;RUNX2;GADD45G;GFAP;IL6;CXCL12;PPARG;S100A4;FGFR4;EZH2;CDKN3
Prostatic Intraepithelial Neoplasias,24/174,9.841867957558036E-13,2.777226269031923E-11,0,0,7.374821852731592,203.89140980504556,ANXA1;DUSP1;CDKN2A;PROS1;CAV1;PLAUR;IRS2;MKI67;BMX;PTGS2;ESR1;AURKA;AKAP12;MMP14;KRT19;CCND1;ERBB2;SOSTDC1;ERG;TIMP1;VIM;EZR;SGK1;MET
"Cardiomyopathy, Dilated",37/419,1.0309736661691588E-12,2.8970791389088162E-11,0,0,4.551643825069295,125.62772483479313,YAP1;ADRB1;BRCA1;ADRB2;SLC2A4;PKD2;SYNE1;GRK3;GRK5;ALDH2;ERBB2;KDR;CTLA4;CCL2;DMD;TIMP1;FLNC;CD36;NKX2-5;PPARGC1A;TPM3;HGF;IL18;LIFR;PROX1;ESR1;AGT;GFAP;RCAN1;MMP14;CENPF;ACTC1;PPARG;CALR;PPARA;UTRN;CRYAB
Malignant neoplasm of kidney,37/421,1.1900899538014719E-12,3.3302683873877855E-11,0,0,4.52746502246732,124.31057189925856,PRKN;EPAS1;CXCR4;CIB1;GATA3;PTGS2;BRCA2;FGF2;MYLK;AURKA;MUC1;CCND1;ERBB2;LEPR;KDR;SOSTDC1;TNS1;EGR1;CDKN2A;HGF;CAV1;PRKCA;MITF;KLF4;PAX2;COL1A1;PER2;IL6;MELK;CXCL12;WT1;VIM;PPARA;SGK1;MET;EZH2;MAD2L1
Carcinomatosis,24/176,1.2677349727754061E-12,3.532824928282003E-11,0,0,7.277034629328666,199.34555331927058,TLE4;STAT5A;ANXA1;TPM3;PLAUR;PDGFA;KRT5;GATA3;BRCA1;IL2RG;PTGS2;ESR1;AQP1;TGFBR2;ADCY5;CCND1;STMN1;S1PR1;NDN;SNCG;EZR;PPARA;SGK1;MET
Prolactinoma,18/91,1.348966038506552E-12,3.737394122466856E-11,0,0,11.250072182477302,307.48340340477995,STAT5A;NGFR;STAT5B;CDKN2C;CXCR4;HMGA2;CIB1;LIFR;FOS;MKI67;SSTR2;FGF2;ESR1;IL6;CCND1;ERBB2;E2F1;PPARG
Neoplastic Cell Transformation,21/131,1.3522733349604616E-12,3.737394122466856E-11,0,0,8.755253001715266,239.2743579072524,ALK;JUN;EPAS1;CTNND2;CXCR4;MITF;KRT5;BRCA1;FOS;ENO2;ESR1;IL6;MMP14;MUC1;KRT19;CCND2;MYCN;CCND1;BIN1;KRT15;VIM
Glomerulonephritis,26/210,1.4181446948227005E-12,3.8874529675221454E-11,0,0,6.532712462384559,178.2233163927095,CCL13;CXCR4;C3;C4A;ERBB2;CTLA4;CCL2;TIMP1;JUN;CR1;STAT1;HGF;SH2D1A;IL18;FOS;ESR1;SELE;FLI1;AGT;DCN;CXCL10;IL6;NPHS1;WT1;KIT;PPARG
Neurofibromatosis 1,26/210,1.4181446948227005E-12,3.8874529675221454E-11,0,0,6.532712462384559,178.2233163927095,RET;ALK;EPAS1;CIB1;BRCA1;ENO2;BRCA2;AURKA;CCND1;MDK;DPYSL2;ERBB2;APOB;NGFR;CDKN2A;HGF;FANCA;ESR1;GFAP;CCNA2;BMP2;CXCL12;FANCD2;KIT;HOXB2;MATN2
Metastatic malignant neoplasm to brain,23/163,1.8148395809234256E-12,4.9546596038543604E-11,0,0,7.55831076506432,204.33911321477697,BARD1;ALK;RET;ANXA1;CDKN2A;CAV1;CXCR4;PRKCA;BRCA1;PROX1;PTGS2;KLF4;ESR1;ACTA2;MMP14;CXCL12;RAD51;KIT;ERBB2;KDR;CCL2;MET;EZH2
"Leukemia, T-Cell",34/364,1.8478990143056315E-12,5.024489789504705E-11,0,0,4.819361498193615,130.20455364318718,LRP1;SATB1;CXCR4;CIB1;IL2RG;CDC20;RPS6KA3;CCND2;TERT;CCND1;TNFSF11;CCL2;CCL19;BAK1;TNFRSF4;STAT5A;STAT5B;MEF2C;JUN;CDKN2A;STAT1;HGF;SH2D1A;LMO2;FOS;KLF4;IL6;TAL1;BCL3;TXNIP;MET;ATF3;EZH2;CDKN3
"FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)",28/249,2.097847395361792E-12,5.681106091632982E-11,0,0,5.874236357520319,157.95885798237438,PRKN;BLM;GATA3;BRCA1;BRCA2;PTGS2;RIMS2;SPTA1;MECOM;ALDH2;CHEK1;STMN1;ERBB2;E2F1;EGR1;NGFR;PARP1;STAT1;FANCA;INHBA;ESR1;GADD45G;IL6;RAD51;WT1;KIT;LTA;PRTN3
Thyroid Gland Follicular Adenoma,21/134,2.1296839412911114E-12,5.744159578197231E-11,0,0,8.521497745867423,229.01565696050386,RET;CDKN2C;TPM3;PDGFA;HMGA2;CXCR4;ADRB2;SSTR2;PTGS2;ESR1;DCN;NR4A1;CXCL10;IL6;CXCL12;CCND1;TERT;ERBB2;E2F1;CCL2;PPARG
Pneumonia,40/497,2.3287906623364293E-12,6.256063235300583E-11,0,0,4.12740092389983,110.5552074101568,CCL13;NRP1;CXCR4;GATA3;BRCA1;ADRB2;PTGS2;IL2RG;BRCA2;ETS2;MYLK;C3;SOCS3;FGF7;TERT;CXCR2;S1PR1;CCL2;CTSG;TIMP1;CCL19;JUN;PARP1;DUSP1;HGF;CAV1;IL18;GZMB;PLA2G4A;FOS;KLF4;AGT;CXCL10;IL6;CXCL12;IRF7;PPARG;VIM;TEK;ATF3
Acute Promyelocytic Leukemia,39/475,2.4010144930977584E-12,6.424387783125317E-11,0,0,4.212280245853482,112.70010457353902,RET;PRKN;BLM;FEN1;F13A1;CXCR4;CIB1;PTGS2;RIMS2;ZFP36;TERT;MECOM;STMN1;ERBB2;PMAIP1;CTSG;TIMP1;RUNX1T1;STAT5A;NGFR;STAT5B;EGR1;ANXA1;STAT1;CDKN2A;HGF;RUNX2;CCNA2;BMP2;IL6;WT1;KIT;PECAM1;TXNIP;RARB;HOXB2;PPARG;ERG;VIM
Renal carcinoma,40/500,2.8153983966176833E-12,7.503260171303318E-11,0,0,4.099838969404187,109.038978329472,PRKN;EPAS1;CXCR4;CIB1;GATA3;MYLK;C3;MUC1;CCND1;ERBB2;LEPR;KDR;RCC1;SOSTDC1;TNS1;EGR1;PARP1;CDKN2A;HGF;CAV1;IL18;MITF;KLF4;PAX2;COL1A1;PER2;KRT19;IL6;MELK;CXCL12;WT1;PPARG;VIM;TEK;PPARA;SGK1;FGFR4;MET;EZH2;MAD2L1
Uterine Fibroids,33/349,2.831797581700652E-12,7.517135398696277E-11,0,0,4.876543873663512,129.66783518258418,PDGFA;MKI67;PTGS2;FGF2;FOXO1;HOXA10;RIMS2;TERT;CCND1;CCL2;BAK1;EGR1;KLF11;EGR2;CDKN2A;CAV1;IL18;HMGA2;FOS;INHBA;ESR1;SPTB;COL1A1;BMP2;VCAN;KIT;ADAM12;PAEP;PPARG;PPARA;TDGF1;ATF3;EZH2
Pulmonary Hypertension,22/151,2.8748387119707053E-12,7.601345192754038E-11,0,0,7.832059669763777,208.13717794963554,EGR1;JUN;VWF;EPAS1;CAV1;PDGFA;GATA4;SLC2A4;PTGS2;FGF2;FOXO1;AGT;TGFBR2;COL1A1;BMP2;IL6;TERT;PECAM1;CCL2;PPARG;BMPR1B;ARHGEF6
Cystic Fibrosis,44/594,2.963407402853703E-12,7.804801614731556E-11,0,0,3.7915211970074814,100.64472204441816,OPRD1;NRP1;BRCA1;ADRB2;PTGS2;VTN;ZFP36;FGF7;MUC1;MDK;CXCR2;DMD;CTSG;TIMP1;FLNC;A2M;TCF7L2;JUN;ANXA1;CCL21;STAT1;CDKN2A;CAV2;HGF;CAV1;PLA2G2A;IL18;TAP1;PLA2G4A;FOS;ESR1;RCAN1;KRT19;IL6;COL1A2;RAD51;PECAM1;PAEP;PPARG;PRTN3;PPARA;EZR;SGK1;MET
Neoplasm Invasiveness,24/183,2.9915528757059928E-12,7.84815199735994E-11,0,0,6.954152287903913,184.53002003146068,ANXA1;CDKN2A;HGF;PLAUR;HMGA2;CXCR4;ESR1;MYLK;EPS8;RPS6KA3;ZFP36;IL6;MMP14;KRT19;CXCL12;CFL1;CCL2;S100A4;DMD;CALR;TIMP1;VIM;ALDOA;MET
Herpes Simplex Infections,40/503,3.398353523150404E-12,8.880677922754129E-11,0,0,4.072634189264859,107.54902430117298,PRKN;PROS1;CXCR4;ENO2;PTGS2;ANTXR2;BRCA2;FGF2;LMNB1;RIMS2;TERT;MDK;ERBB2;CCL2;TNFSF11;EGR1;VWF;STAT1;GAD1;MX1;IL18;HMGA1;TAP1;GZMB;FOS;ESR1;GRIN2D;GFAP;CCNA2;CXCL10;BMP2;IL6;RAD51;FANCD2;LTA;CALR;VIM;ATF3;NECTIN2;CDKN3
Uveal melanoma,27/236,3.4809687704846843E-12,9.061312504874085E-11,0,0,5.979052677365445,157.7495947756698,RET;YAP1;CXCR4;CIB1;BRCA1;BRCA2;FGF2;ADRA1A;CCND2;TERT;CCND1;E2F1;CCL2;CDKN2A;HGF;PRKCA;MITF;VCAN;CXCL12;RAD51;FANCD2;KIT;RARB;VIM;MET;ATF3;EZH2
Hyperplasia,20/123,3.5444212612607056E-12,9.19086223576328E-11,0,0,8.88726442033124,234.3184696074223,RET;TCF7L2;BLM;HGF;CAV1;PLAUR;CXCR4;IRS2;KRT5;PTGS2;FGF2;FOXO1;ZFP36;MYCN;COL2A1;CCND1;TERT;SAA1;RXRG;EZH2
Periodontitis,27/237,3.848962469012803E-12,9.942166131496149E-11,0,0,5.950273410799727,156.39233019598143,ADRB1;GATA3;PTGS2;C3;TERT;ALDH2;CXCR2;LEPR;TNFSF11;CTLA4;CCL2;CTSG;TIMP1;CDKN2A;CAV1;IL18;AGT;COL3A1;IL6;DDX39A;LTA;KCNQ5;PPARG;PRTN3;S100A4;PPARA;MET
Luminal A Breast Carcinoma,19/110,4.074055677724679E-12,1.0483278900995764E-10,0,0,9.539699736882836,250.1918107203872,CDKN2C;PARP1;CDKN2A;KRT5;GATA3;BRCA1;SYP;SOX10;ESR1;DEPP1;MUC1;MELK;CCND1;CCNE2;ELF5;ERBB2;LEPR;CCL2;VIM
"Neoplasm, Residual",26/220,4.18157754636001E-12,1.0682552392834644E-10,0,0,6.192776123809758,162.2527937719709,ALK;NRP1;HLF;GATA4;RPS6KA3;MECOM;CCND1;MDK;ERBB2;CTLA4;CCL19;RUNX1T1;TLE4;CDKN2A;GZMB;PRKCA;ESR1;KRT19;MYCN;TAL1;WT1;KIT;SDC1;S100A4;CALR;ERG
Adenocarcinoma of pancreas,33/354,4.183310421851566E-12,1.0682552392834644E-10,0,0,4.799337628164413,125.74225334831317,RET;CCL14;NRP1;PDGFA;CXCR4;IRS2;BRCA1;BRCA2;PTGS2;FGF1;FGF2;MUC1;CCND2;TERT;CCND1;ERBB2;KDR;CCL21;CDKN2A;HMGA1;CDC7;SSTR2;TGFBR2;NR4A1;IL6;MYCN;RAD51;SDC1;SPRY2;S100A4;PRKD1;FGFR4;EZH2
Overweight,27/238,4.253559960329849E-12,1.0820798747566388E-10,0,0,5.921766933490555,155.05119197521856,PRKN;CCL13;CXCR4;IRS2;ADRB2;ENO2;PTGS2;AURKA;RPS6KA3;LEPR;NDN;CCL2;CD36;A2M;APOB;EGR1;TCF7L2;GAD1;IL18;HMGA2;ESR1;SELE;AGT;NDC80;IL6;PPARG;PPARA
Medullary carcinoma of thyroid,27/239,4.698171478761235E-12,1.190676213258885E-10,0,0,5.893529385212602,153.72592307606618,RET;YAP1;ALK;SHC3;FLT4;CXCR4;ASCL1;PTGS2;TERT;ERBB2;KDR;TK1;JUN;ANXA1;CDKN2A;FOS;PROX1;SYP;SSTR2;ESR1;KRT19;MYCN;CXCL12;KIT;RAMP1;MET;EZH2
Peripheral Arterial Diseases,20/125,4.829350869940479E-12,1.2193203173879794E-10,0,0,8.717086834733893,227.13510860551423,TCF7L2;BLM;TRIM63;HGF;F12;FGF1;FGF2;FOXO1;AGT;BMP2;IL6;CXCL12;CCND1;PECAM1;CCL2;CD36;UTRN;APOB;PPARGC1A;ATF3
Hepatitis,31/317,5.527682262424228E-12,1.388867709274311E-10,0,0,5.044922468835512,130.77070920285604,BRCA1;PTGS2;VTN;SOCS3;TERT;LEPR;CTLA4;FADD;APOB;CCL16;JUN;CR1;PARP1;CDKN2A;STAT1;HGF;IL18;HMGA1;GZMB;ESR1;AGT;CXCL10;IL6;VCAN;MYCN;CXCL12;PECAM1;TXNIP;PAEP;PPARG;PPARA
HIV Infections,52/806,5.542235647491295E-12,1.388867709274311E-10,0,0,3.299289286654383,85.51303568393664,RET;ALK;CTNND2;F13A1;SLC2A4;FGF2;ADRA1A;MDK;LEPR;CTLA4;TK1;TIMP1;CD36;CCT3;CISH;PARP1;DUSP1;IL18;PLA2G4A;FOS;SYP;PECAM1;IRF7;PPARG;FKBP4;PRKN;PDGFA;CXCR4;DTX1;GATA4;GATA3;ADRB2;PTGS2;IL2RG;SOCS3;CXCR2;CCL2;CCL19;APOB;PAK3;JUN;STAT1;CDKN2A;GAD1;GZMB;GFAP;CXCL10;IL6;CXCL12;PAEP;FGFR4;EZH2
Liver diseases,44/606,5.7924693767647154E-12,1.4461793432844545E-10,0,0,3.7082205518232887,95.94821333296049,NRP1;CXCR4;PTGS2;SOCS3;FGF7;TERT;GRK5;ALDH2;LEPR;KDR;CCL2;TNFSF11;TIMP1;CCL19;CD36;TEAD1;CCL16;PAK4;NGFR;TCF7L2;JUN;ANXA1;CR1;CCL21;VWF;CDKN2A;HGF;IL18;TAP1;ESR1;SELE;CIT;ACTA2;CXCL10;COL3A1;IL6;COL1A2;CXCL12;NR5A2;WT1;LTA;PAEP;PPARG;PPARA
Epithelioma,30/298,5.881606207236188E-12,1.457596578885544E-10,0,0,5.202391656176947,134.52964067391687,ALK;BRCA1;PTGS2;FGF2;MUC1;TERT;MDK;ERBB2;KDR;TNFSF11;EGR1;NGFR;CDKN2A;HGF;HMGA1;ESR1;COL1A1;MMP14;KRT19;IL6;WT1;FEZ1;KIT;SDC1;RARB;PPARG;VIM;SGK1;MET;EZH2
Fibrosarcoma,30/298,5.881606207236188E-12,1.457596578885544E-10,0,0,5.202391656176947,134.52964067391687,RET;MKI67;FGF2;AKAP12;CCND1;ERBB2;E2F1;CCL2;FADD;CD36;EGR1;JUN;CDKN2A;STAT1;CMA1;HGF;CAV1;BGN;FOS;FLI1;SYN1;GFAP;COL1A1;MMP14;IL6;RAD51;SPRY2;SNRPE;TEK;MET
Malignant Pleural Mesothelioma,28/260,6.023090057363006E-12,1.487171795045954E-10,0,0,5.5925328702555195,144.48543942422353,RET;CXCR4;CIB1;PTGS2;AQP1;SOCS3;MUC1;TERT;STMN1;KDR;JUN;PARP1;CDKN2A;STAT1;CMA1;HGF;NDC80;CXCL10;MMP14;KRT19;IL6;COL1A2;CXCL12;RARB;VIM;MET;CDKN3;MAD2L1
Exanthema,26/225,7.016246471714389E-12,1.7197485877384613E-10,0,0,6.035619625574172,155.011567849963,BRCA2;PTGS2;IL2RG;VTN;FGF7;KDR;CTLA4;PMAIP1;DMD;RUNX1T1;CDKN2A;STAT1;RHOH;HMGA2;KRT5;SOX10;RUNX2;CCNA2;IL6;DLG2;SERPING1;PAEP;PRTN3;TEK;VIM;FGFR3
Pulmonary Emphysema,26/225,7.016246471714389E-12,1.7197485877384613E-10,0,0,6.035619625574172,155.011567849963,EPAS1;ADRB2;C3;FGF7;TERT;KDR;CCL2;A2M;SOX5;EGR1;CDT1;JUN;CDKN2A;HGF;CAV1;IL18;TAP1;GZMB;FOS;MMP14;IL6;VCAN;SERPING1;PPARG;PRTN3;S100A4
Intestinal Neoplasms,22/158,7.275144615456068E-12,1.7767225904510165E-10,0,0,7.426261994159366,190.4580546837438,TCF7L2;BLM;ANXA1;PLA2G2A;CIB1;PRKCA;PROX1;PTGS2;KLF4;FGF2;DCN;TGFBR2;MUC1;NR5A2;CCND1;TERT;KIT;ERBB2;CXCR2;KDR;PPARG;SGK1
Senile Plaques,30/301,7.588226135204855E-12,1.8464683595665148E-10,0,0,5.144000355666207,131.70916236950592,RAB3A;LRP1;BRCA1;ENO2;BRCA2;PTGS2;RIMS2;CCND1;FLAD1;CCL2;A2M;APOB;PPARGC1A;RUNX1T1;EGR1;VWF;CDKN2A;SH2D1A;MX1;BGN;SYP;SYN1;DCN;GFAP;RCAN1;MMP14;IL6;SERPING1;PPARG;VIM
Cerebral Infarction,29/283,8.631647776031698E-12,2.0927850708963497E-10,0,0,5.297253558449425,134.95063696715252,NRP1;SERPINC1;PTGS2;FGF2;ALDH2;MDK;KDR;CCL2;CTSG;JUN;ANXA1;PARP1;VWF;HGF;IL18;PLA2G4A;FOS;SYP;ESR1;AGT;GFAP;TGFBR2;IL6;CXCL12;LTA;PPARG;VIM;SGK1;RAMP1
Brain Ischemia,28/264,8.714348328007597E-12,2.105236092478382E-10,0,0,5.496606104946551,139.9768470842456,RET;FBN2;EPAS1;PTGS2;FGF1;C3;MDK;DPYSL2;KDR;CTLA4;CCL2;EGR1;JUN;ANXA1;PARP1;HGF;CAV1;IL18;PLA2G4A;PRKCA;SELE;GFAP;CXCL10;MMP14;IL6;CXCL12;PRTN3;TEK
Kidney Neoplasm,27/246,9.28582576851833E-12,2.2352546903716527E-10,0,0,5.703087107557187,144.8728526875991,EPAS1;CXCR4;MKI67;PTGS2;AURKA;MUC1;TERT;CCND1;SIX2;ERBB2;KDR;E2F1;SOSTDC1;PPARGC1A;TNS1;CDKN2A;PAX2;KRT19;DLG2;CXCL12;WT1;GIPC2;KIT;PPARG;S100A4;VIM;MET
T-Cell Lymphoma,31/324,9.754349441027527E-12,2.339650387355031E-10,0,0,4.9226063873637695,124.80435508383108,ALK;LRP1;CXCR4;GATA3;MKI67;IL2RG;SOCS3;MUC1;CCND2;TERT;KDR;CTLA4;CA12;EGR1;STAT5B;CDKN2A;CMA1;CAV1;GZMB;IL6;CXCL12;TAL1;KIT;RHOJ;BCL3;SAA1;LTA;PPARG;FKBP4;MET;EZH2
"Thrombocythemia, Essential",21/145,1.0172394069156504E-11,2.431238383219042E-10,0,0,7.76116479001826,196.44550818177171,STAT5A;NFE2;STAT5B;STAT1;PDGFA;HMGA2;CXCR4;IRS2;FGF2;SELE;FLI1;VTN;SOCS3;IL6;CXCL12;CCND1;TERT;CXCR2;PAEP;CALR;RUNX1T1
Acute myocardial infarction,27/247,1.0214289479657985E-11,2.432594615084504E-10,0,0,5.676870378425402,143.66588391316196,CXCR4;GATA4;ADRB1;C4B;AKAP12;C4A;VTN;CCND1;CTLA4;CCL2;DMD;APOB;PPARGC1A;CCL21;VWF;CMA1;HGF;PLA2G2A;IL18;KLF4;AGT;MMP14;IL6;CXCL12;LTA;PPARG;PRTN3
Refractory anemias,28/266,1.0453680289484523E-11,2.4808097817730763E-10,0,0,5.449851883199323,137.79442025683778,RET;F13A1;CIB1;RIMS2;TERT;CCND1;CCL2;FADD;RUNX1T1;JUN;PARP1;CDKN2A;STAT1;FOS;ESR1;GFAP;IL6;MYCN;KIT;LTA;RARB;HOXB2;PRTN3;S100A4;VIM;PPARA;TDGF1;CDKN3
Metabolic Syndrome X,41/548,1.2512288551971595E-11,2.9588918984169444E-10,0,0,3.8127990313824283,95.71768835728376,IRS2;BRCA1;ADRB2;PTGS2;ADRA1A;FOXO1;C3;SOCS3;VTN;ZFP36;CCND1;ALDH2;FLAD1;LEPR;CTLA4;CCL2;TIMP1;FADD;CD36;APOB;PPARGC1A;TCF7L2;VWF;HGF;CAV1;PLA2G2A;IL18;HMGA1;PLA2G4A;ESR1;SELE;AGT;PER2;PYY;IL6;LTA;SLC27A6;PPARG;PPARA;SGK1;ATF3
Encephalomyelitis,32/348,1.2843484805227975E-11,3.026555928137231E-10,0,0,4.717320011033807,118.3018213568229,CXCR4;GATA3;C3;DPYSL2;CXCR2;E2F1;S1PR1;CTLA4;SIRPA;CCL2;FADD;TIMP1;TNFRSF4;EGR1;EGR2;DUSP1;CDKN2A;STAT1;BGN;IL18;PLA2G4A;ESR1;GFAP;NR4A1;CXCL10;IL6;CXCL12;KIT;PECAM1;PPARG;PPARA;CRYAB
androgen independent prostate cancer,22/163,1.3692435594318415E-11,3.2153285822182684E-10,0,0,7.161075063293262,179.12840331113168,RET;EGR1;MEF2C;PROS1;PLA2G2A;PTGS2;ESR1;RUNX2;PAX2;CCNA2;IL6;MUC1;CCND1;ERBB2;CXCR2;KDR;PECAM1;PPARG;ERG;VIM;BUB1;EZH2
"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",32/349,1.3854142665143594E-11,3.24196592819179E-10,0,0,4.702194453143499,117.56631972359915,PRKN;CXCR4;CIB1;MKI67;FOXO1;RIMS2;SOCS3;CCND2;TERT;CCND1;CHEK1;E2F1;PMAIP1;FADD;CCL19;CDT1;CDKN2C;PARP1;CDKN2A;STAT1;CCNA2;IL6;MYCN;CXCL12;RAD51;TAL1;CD5;KIT;LTA;PECAM1;EZH2;CDKN3
Metastasis from malignant tumor of prostate,26/232,1.4134859981543343E-11,3.29617082069601E-10,0,0,5.828417174502398,145.60771534521925,SATB1;PROS1;CXCR4;ADRB2;BRCA2;PTGS2;FGF2;MUC1;TERT;ERBB2;KDR;TIMP1;CDKN2A;HGF;CAV1;KLF4;RUNX2;TGFBR2;MMP14;IL6;BIN1;S100A4;PRKD1;ERG;MET;EZH2
Carcinoma breast stage IV,34/392,1.4581447429204117E-11,3.3885467451396146E-10,0,0,4.4359580801696366,110.68279273214334,YAP1;CXCR4;BRCA1;PTGS2;BRCA2;RPS6KA3;MUC1;MECOM;CCND1;ERBB2;KDR;CCL2;TIMP1;PARP1;CDKN2A;HGF;HMGA1;HMGA2;PROX1;ESR1;RUNX2;DCN;TGFBR2;KRT19;BMP2;IL6;CXCL12;CCNE2;TXNIP;RARB;VIM;MET;ATF3;EZH2
"Kidney Failure, Chronic",36/437,1.5842448760893924E-11,3.6688926164883997E-10,0,0,4.204305861263711,104.55405779246502,RET;CCL14;CXCR4;ADRB2;PTGS2;PKD2;FGF2;ADRA1A;C3;ZFP36;MUC1;TERT;CXCR2;KDR;CCL2;TIMP1;APOB;VWF;HGF;CAV1;PLA2G2A;ESR1;SELE;PAX2;AGT;COL1A1;IL6;NPHS1;WT1;PPARG;S100A4;PRTN3;PRKD1;PPARA;SGK1;MET
Ischemic stroke,34/394,1.677150775438559E-11,3.8707026143798495E-10,0,0,4.410854284941876,109.43920374992354,GRIA2;LRP1;SERPINC1;PDGFA;F13A1;ADRB2;PTGS2;BRCA2;FGF2;ADRA1A;FLAD1;KDR;A2M;APOB;BARD1;EGR1;VWF;CDKN2A;F12;PLA2G2A;IL18;ESR1;SELE;AGT;ACTA2;IL6;PECAM1;SAA1;LTA;PPARG;PPARA;SGK1;EZH2;CDKN3
Epstein-Barr Virus Infections,26/234,1.7181115398240306E-11,3.9516565415952703E-10,0,0,5.771778042959427,143.06627602445982,ALK;CXCR4;PTGS2;FOXO1;RIMS2;MUC1;CCND1;STMN1;CXCR2;ERBB2;CTLA4;CCL2;TIMP1;EGR1;CDKN2A;SH2D1A;IL18;TAP1;SELE;DCN;CXCL10;IL6;CXCL12;MAPKAPK2;IRF7;VIM
Anaplastic astrocytoma,22/166,1.978166488119056E-11,4.5188320184379523E-10,0,0,7.010802469135802,172.7900998871403,CDKN2A;HGF;CAV1;HMGA2;MKI67;ASCL1;FGF2;ESR1;GFAP;VTN;CCND2;MYCN;MELK;CCND1;TERT;KIT;S100A4;TIMP1;VIM;FGFR4;CRYAB;MET
Classical Hodgkin's Lymphoma,22/166,1.978166488119056E-11,4.5188320184379523E-10,0,0,7.010802469135802,172.7900998871403,STAT5A;ALK;STAT5B;JUN;MAML2;PARP1;DUSP1;SATB1;CDKN2A;STAT1;HGF;GATA3;FOS;FOXO1;SOCS3;IL6;MUC1;GNG7;BCL3;MET;ATF3;SKAP1
Cyst,22/169,2.8344599870772156E-11,6.452960431596807E-10,0,0,6.866663450250076,166.76780269880473,RET;EPAS1;LAMA1;HGF;CAV1;GAD1;BRCA1;PKD2;FGF2;ESR1;PAX2;AGT;HOXA10;FGF7;KRT19;TERT;NPHS1;CXCR2;PECAM1;SDC1;SNCG;PRKD1
Acute leukemia,38/492,2.8857813389261592E-11,6.547603875752732E-10,0,0,3.9281624435809457,95.3311615073299,NRP1;LAMA1;CXCR4;BRCA1;BRCA2;ETS2;RIMS2;AKAP12;CDH5;VTN;MECOM;MDK;STMN1;CHEK1;LEPR;CTSG;ZNF423;RUNX1T1;STAT5A;NGFR;STAT5B;STAT1;CDKN2A;LMO2;IL18;SELE;FLI1;CCNA2;NR4A1;IL6;RAD51;TAL1;WT1;FANCD2;KIT;ERG;EZH2;CDKN3
"Respiratory Distress Syndrome, Adult",23/186,2.911906778508974E-11,6.584634991402783E-10,0,0,6.484110138691013,157.3020992660827,STAT5A;STAT5B;EPAS1;SERPINC1;PROS1;HGF;IL18;PLA2G4A;GZMB;AGT;AQP1;MYLK;CXCL10;FGF7;IL6;MUC1;LTA;CCL2;S100A4;TIMP1;TEK;FGFR4;PPARA
Psoriasis,51/818,3.143363575866779E-11,7.08417106561117E-10,0,0,3.170729124613664,76.67819454696422,PROS1;FLT4;F13A1;MKI67;ANTXR2;AQP1;C4B;C4A;FGF7;KDR;CTLA4;TIMP1;IKBKE;DUSP1;IL18;TAP1;FOS;KRT5;CCNA2;ACTA2;NR5A2;MAPKAPK2;PECAM1;LTA;PPARG;S100A4;PPARA;SKAP2;PRKN;EPAS1;CXCR4;GATA3;C3;SOCS3;CXCR2;CCL2;CCL19;APOB;EGR1;JUN;CCL21;CDKN2A;CAV1;PLA2G2A;SELE;CXCL10;IL6;CXCL12;SAA1;SDC1;TEK
Adenocarcinoma Of Esophagus,29/299,3.3291762941674654E-11,7.47784213766846E-10,0,0,4.979211182336182,120.127010533999,GATA4;ADRB2;PTGS2;FGF1;FGF2;AURKA;C3;AKAP12;MUC1;CCND1;STMN1;ERBB2;KDR;S1PR1;TIMP1;PITX1;PARP1;CDKN2A;HGF;IL18;ESR1;MMP14;IL6;PPARG;CALR;VIM;FKBP4;FGFR4;MET
"Meningioma, benign, no ICD-O subtype",26/241,3.346111139383157E-11,7.490827470699094E-10,0,0,5.581839373924627,134.6375224768389,YAP1;PDGFA;CXCR4;MKI67;BRCA2;PTGS2;TERT;CCND1;MDK;LEPR;SOSTDC1;CCL2;TIMP1;CDKN2A;PLAUR;FOS;ESR1;GFAP;IL6;MYCN;CXCL12;WT1;PPARA;SGK1;FGFR4;FGFR3
"Lymphoma, T-Cell, Cutaneous",27/260,3.375426512740585E-11,7.531350318792613E-10,0,0,5.356531203154199,129.15622148954503,PRKN;FLT4;CXCR4;CIB1;PTGS2;AURKA;RIMS2;SOCS3;MUC1;CCND2;CCND1;CTLA4;STAT5A;STAT5B;JUN;CDKN2A;STAT1;IL18;FOS;NR4A1;CXCL10;IL6;BIN1;CD5;KIT;LTA;FGFR3
Thymoma,24/205,3.4684200537727044E-11,7.713214927528968E-10,0,0,6.101967165785226,146.96427344660748,STAT5A;STAT5B;CDKN2A;STAT1;HGF;FLT4;LMO2;CXCR4;IRS2;PTGS2;ESR1;CCNA2;KRT19;BMP2;IL6;MECOM;CCND1;KIT;ERBB2;LTA;CTLA4;ERG;TNFRSF4;MET
Gastric Adenocarcinoma,33/383,3.5078655124825906E-11,7.775189696974614E-10,0,0,4.395041608876561,105.80371898763232,PRKN;YAP1;FLT4;GATA4;GATA3;ADRB2;PTGS2;FGF2;RPS6KA3;FGF7;MUC1;CCND1;MDK;STMN1;ERBB2;KDR;KPNA2;CDKN2A;STAT1;GAD1;PLA2G2A;TAP1;KLF4;ESR1;TGFBR2;IL6;KIT;LTA;PECAM1;PAEP;PPARG;BMPR1B;MET
Burkitt Lymphoma,34/407,4.070388416502231E-11,8.992344935930587E-10,0,0,4.254241599968689,101.78144377108052,RET;HLF;CXCR4;CIB1;GATA3;BRCA1;PTGS2;MKI67;BRCA2;RIMS2;CCND2;CCND1;ERBB2;E2F1;PMAIP1;TIMP1;EGR1;PARP1;CDKN2A;SH2D1A;IL18;HMGA1;TAP1;KLF4;TGFBR2;IL6;CXCL12;KIT;SDC1;CAMK1;VIM;MET;EZH2;CDKN3
Chronic kidney disease stage 5,33/388,4.951879129401182E-11,1.0903875486248636E-9,0,0,4.332011486394093,102.79286621557439,CCL14;FBN2;CXCR4;GATA3;ADRB2;PTGS2;PKD2;FGF2;C3;ZFP36;MUC1;CXCR2;CCL2;TIMP1;APOB;VWF;CAV1;PLA2G2A;ESR1;SELE;PAX2;AGT;COL1A1;IL6;NPHS1;WT1;PPARG;S100A4;PRTN3;PRKD1;PPARA;SGK1;MET
Malignant neoplasm of other specified sites of female breast,9/18,5.019425114242E-11,1.0980605559364583E-9,0,0,44.830275229357795,1063.1553842617689,BARD1;STAT1;CAV1;HGF;ERBB2;BRCA1;BRCA2;ESR1;MET
Myoma,9/18,5.019425114242E-11,1.0980605559364583E-9,0,0,44.830275229357795,1063.1553842617689,HOXA10;FGF7;TERT;CAV1;LEPR;PDGFA;HMGA2;ESR1;FGF2
Precursor B-cell lymphoblastic leukemia,32/367,5.163878537132181E-11,1.1259937745253157E-9,0,0,4.445376025441798,105.2965019968759,ALK;BLM;HLF;CXCR4;GATA4;GATA3;BRCA1;BRCA2;PTGS2;IL2RG;C3;HOXA10;MDK;STMN1;CCL19;STAT5A;STAT5B;PARP1;CDKN2A;LMO2;PLA2G4A;KLF4;SELE;IL6;MYCN;CXCL12;WT1;FANCD2;KIT;FGFR4;FGFR3;EZH2
Myxoid cyst,24/209,5.225187514306992E-11,1.1356750597438758E-9,0,0,5.968800154073313,141.31101738006885,RET;ALK;NGFR;GPSM2;PARP1;CAV2;GAD1;PDGFA;CXCR4;SYP;PTGS2;FGF1;SSTR2;SOX10;ESR1;AQP1;GFAP;MYCN;KDR;E2F1;TXNIP;APOB;UTRN;RAMP1
Crohn Disease,54/912,5.4867449762672837E-11,1.1886767503422928E-9,0,0,3.0095505517500403,71.10394482999736,FEN1;F13A1;ANTXR2;FGF2;FGF7;KDR;CTLA4;TIMP1;ANXA1;TPM3;HGF;IL18;TAP1;PLA2G4A;FOS;TGFBR2;ACTA2;DDX39A;NR5A2;LTA;PPARG;S100A4;PPARA;SGK1;SKAP2;ARHGEF6;CXCR4;PTGS2;C3;SOCS3;VTN;MUC1;GRK5;CCL2;CCL19;STAT5A;STAT5B;EGR1;TCF7L2;JUN;CCL21;PLA2G2A;GZMB;AGT;COL1A1;VIL1;NR4A1;IL6;CXCL12;BCL3;SAA1;SDC1;PAEP;VIM
Marfan Syndrome,15/73,5.7334267920001565E-11,1.2381252197772683E-9,0,0,11.726343223736968,276.53206386828924,FBN2;LRP1;BGN;LAMC1;DCN;AGT;MYLK;TGFBR2;ACTA2;COL1A1;MMP14;COL3A1;COL2A1;COL1A2;PPARG
Diabetic Retinopathy,26/247,5.8100597168006025E-11,1.2506525980138732E-9,0,0,5.428611540081427,127.94610489712508,NRP1;FLT4;PTGS2;FGF2;VTN;ALDH2;KDR;CCL2;CD36;TIMP1;PPARGC1A;TCF7L2;VWF;HGF;SELE;AGT;PER2;CXCL10;IL6;LTA;PECAM1;SERPING1;TXNIP;SDC1;PPARG;PPARA
Ependymoma,19/128,6.41131283697335E-11,1.3756669972240581E-9,0,0,7.956971184907611,186.75307340238845,YAP1;RAB3A;SHC3;ANXA1;CDKN2A;CAV1;SYP;MKI67;PTGS2;SOX10;GFAP;MYCN;MECOM;STMN1;KIT;ERBB2;SNCG;S100A4;FGFR3
"Mammary Neoplasms, Experimental",21/160,6.867330530443071E-11,1.46882139625655E-9,0,0,6.918284240532103,161.8993394634506,TLE4;STAT5A;ANXA1;TPM3;PDGFA;KRT5;GATA3;BRCA1;ESR1;HNRNPAB;AQP1;ADCY5;AURKA;CCND1;STMN1;ERBB2;S1PR1;SNCG;EZR;PPARA;SGK1
"Neuroectodermal Tumor, Primitive",18/114,7.151979583237527E-11,1.52484745654042E-9,0,0,8.544642857142858,199.6118020147359,NGFR;CDKN2C;TPM3;CDKN2A;ASCL1;PTGS2;SOX10;FLI1;MYCN;COL1A2;CCND1;MDK;STMN1;KIT;KDR;E2F1;ERG;FGFR4
"Lupus Erythematosus, Discoid",29/309,7.382467445232594E-11,1.5690079544994338E-9,0,0,4.798892513736264,111.95493796013119,CCL14;SERPINC1;CXCR4;GATA3;FOXO1;C4B;C3;C4A;ERBB2;CTLA4;CCL2;CD36;PAK3;ZNF423;TNS1;EGR2;VWF;STAT1;HGF;SH2D1A;BGN;IL18;ESR1;FLI1;IL6;IRF7;CALR;EZH2;CDKN3
"Mammary Carcinoma, Animal",20/145,7.877086223649458E-11,1.6636009772965332E-9,0,0,7.314823529411765,170.17555075216453,TLE4;STAT5A;ANXA1;TPM3;PDGFA;KRT5;GATA3;BRCA1;ESR1;AQP1;ADCY5;CCND1;STMN1;ERBB2;S1PR1;NDN;SNCG;EZR;PPARA;SGK1
Animal Mammary Neoplasms,20/145,7.877086223649458E-11,1.6636009772965332E-9,0,0,7.314823529411765,170.17555075216453,TLE4;STAT5A;ANXA1;TPM3;PDGFA;KRT5;GATA3;BRCA1;ESR1;AQP1;ADCY5;CCND1;STMN1;ERBB2;S1PR1;NDN;SNCG;EZR;PPARA;SGK1
Carcinomatosis of peritoneal cavity,13/52,7.939951619026725E-11,1.671621162175031E-9,0,0,15.058641975308642,350.2117414052935,HGF;CXCR4;BRCA1;BRCA2;IL2RG;CXCL12;TERT;KDR;CTLA4;PAEP;MET;ATF3;CDKN3
Osteoporosis,35/441,8.596214795142341E-11,1.8041305801304989E-9,0,0,4.026282590412111,93.31761082234551,LRP1;GATA4;IRS2;ADRB2;ANTXR2;FGF2;FOXO1;ADCY5;TERT;MECOM;CCND1;ALDH2;LEPR;TNFSF11;DMD;PDLIM4;STAT1;HGF;MITF;LIFR;ESR1;AGT;RUNX2;COL1A1;MMP14;BMP2;IL6;COL1A2;WT1;KIT;LTA;PPARG;PPARA;ZFPM2;BMPR1B
Retinal Diseases,31/355,1.0050081561127366E-10,2.102689961511881E-9,0,0,4.444451899564621,102.3150839473639,LAMA1;PROS1;ADRB2;ENO2;PTGS2;PKD2;FGF2;AQP1;CCND1;ALDH2;KDR;CCL2;PPARGC1A;MPDZ;TCF7L2;MEF2C;HGF;CAV1;AGT;GFAP;CCNA2;IL6;COL2A1;CXCL12;COL8A1;TXNIP;PPARG;ERG;TEK;VIM;CRYAB
Hyperinsulinism,32/377,1.0336123261275183E-10,2.1558199944945382E-9,0,0,4.314278696003088,99.19730902239023,IRS2;SLC2A4;FOXO1;MYLK;CCND1;ALDH2;ERBB2;LEPR;NDN;CCL2;NEK2;CD36;PPARGC1A;KLF11;TCF7L2;TRIM63;STAT1;CAV1;IL18;FANCA;FOS;ESR1;AGT;PYY;COL3A1;IL6;CXCL12;LTA;TXNIP;PPARG;PPARA;SGK1
precancerous lesions,19/132,1.1086974964284913E-10,2.3052669925739154E-9,0,0,7.673729693797,175.90233530367829,EGR1;PARP1;CDKN2A;IL18;CIB1;BRCA1;PTGS2;ESR1;IL6;MMP14;MYCN;CXCL12;CCND1;TERT;MDK;STMN1;PECAM1;TIMP1;VIM
Severe Combined Immunodeficiency,24/217,1.1516846353815779E-10,2.3872574108711967E-9,0,0,5.719025759048897,130.87776077137605,STAT5A;RET;CDKN2A;STAT1;HGF;CXCR4;PTGS2;IL2RG;KLF4;FGF2;VTN;IL6;MUC1;CCND2;CCND1;STMN1;ERBB2;PECAM1;E2F1;PAEP;CTLA4;PPARG;FADD;TEK
Primary Myelofibrosis,22/182,1.2336797277167377E-10,2.5493517081063417E-9,0,0,6.304521276595745,143.8430091086222,STAT5A;RET;NFE2;STAT5B;CDKN2A;HMGA2;CXCR4;BRCA2;FGF2;TGFBR2;SOCS3;IL6;MMP14;CXCL12;STMN1;KIT;CXCR2;PAEP;RARB;CALR;FKBP4;EZH2
Skin Neoplasms,26/256,1.287786047724989E-10,2.6529972688714803E-9,0,0,5.21375946871433,118.73256079469094,RET;PTGS2;AURKA;TERT;CCND1;ERBB2;E2F1;CTLA4;TIMP1;ANXA1;CDKN2A;HGF;KRT5;COL1A1;MMP14;KRT19;IL6;VCAN;FANCD2;KRT15;KIT;ADAM12;SDC1;S100A4;FGFR3;CDKN3
invasive cancer,21/166,1.3859162440822326E-10,2.8464261453383104E-9,0,0,6.629960962914769,150.49672900421893,CISH;CDKN2A;SIX1;CXCR4;BRCA1;BRCA2;PTGS2;FGF2;ESR1;MAPK15;AURKA;RPS6KA3;CCNB2;ZFP36;MMP14;CCND1;ERBB2;SOSTDC1;VIM;PPARGC1A;MET
Cardiac Hypertrophy,15/78,1.555633281933205E-10,3.18525400044616E-9,0,0,10.792912513842746,243.7467931270107,TRIM63;CAV1;IL18;PRKCA;GATA4;SLC2A4;AKAP5;FGF1;PLD1;FGF2;AGT;CCND2;DMD;PPARA;NKX2-5
Neurilemmoma,19/135,1.6497532404009595E-10,3.3677029673352112E-9,0,0,7.47411769467379,168.35618427734605,STAT5A;RET;PRKN;STAT5B;CDKN2A;FOS;SEMA3F;MKI67;SOX10;GFAP;BMP2;VCAN;CCND1;WT1;KIT;ERBB2;DMD;TEK;EZR
Hypercholesterolemia,25/240,1.7126547145703068E-10,3.4855118372891453E-9,0,0,5.35437430786268,120.40813228537559,CXCR4;FGF2;MYLK;C3;CXCR2;KDR;LEPR;CCL2;CD36;APOB;VWF;CAV1;PLA2G2A;BGN;ESR1;SELE;AGT;NR4A1;COL3A1;IL6;NR5A2;CXCL12;BIN1;CALR;ATF3
"Cardiomyopathies, Primary",16/92,1.8493906651631334E-10,3.752419246898974E-9,0,0,9.559072506440927,214.22832342488888,TRIM63;PARP1;LRP1;HGF;IL18;ADRB2;PTGS2;AGT;ADCY5;IL6;RAD51;RHOJ;CCL2;DMD;PPARGC1A;ATF3
"Hepatitis C, Chronic",32/386,1.8899760990214861E-10,3.823216711153103E-9,0,0,4.202623767116729,94.09374861160454,CXCR4;PTGS2;FGF2;FOXO1;C3;SOCS3;MUC1;CCND1;CTLA4;CCL2;TIMP1;CD36;APOB;PPARGC1A;CR1;CCL21;CDKN2A;STAT1;GAD1;SH2D1A;MX1;IL18;GZMB;FOS;CXCL10;IL6;CXCL12;IRF7;LTA;PAEP;ERG;PPARA
Papilloma,23/204,1.9202989475410803E-10,3.872891210716485E-9,0,0,5.8338613809536275,130.52313952084597,PRKN;CDKN2A;CAV1;HMGA1;PLA2G4A;KRT5;MKI67;PTGS2;ESR1;DCN;AURKA;MUC1;TERT;CCND1;KRT15;KIT;ERBB2;E2F1;SDC1;RARB;PPARG;FGFR3;CDKN3
"Adenocarcinoma, Oxyphilic",18/122,2.2707373243531833E-10,4.565949661783227E-9,0,0,7.884119978382273,175.07276834380934,STAT5A;RET;TCF7L2;TPM3;CDKN2A;HMGA2;MKI67;PTGS2;ESR1;HOXA10;MMP14;CCND1;ERBB2;KDR;RARB;PPARG;PRKD1;MET
Lupus Erythematosus,28/304,2.4427820262380507E-10,4.89723107110888E-9,0,0,4.690265179161019,103.80829481833649,CCL14;SERPINC1;CXCR4;GATA3;FOXO1;C4B;C3;C4A;ERBB2;CTLA4;CCL2;CD36;ZNF423;TNS1;EGR2;VWF;STAT1;HGF;SH2D1A;BGN;IL18;ESR1;FLI1;IL6;IRF7;CALR;EZH2;CDKN3
Lupus Vulgaris,27/284,2.531213183283834E-10,5.059413017539949E-9,0,0,4.850278331130267,107.17733860714178,CCL14;SERPINC1;CXCR4;GATA3;FOXO1;C4B;C3;C4A;ERBB2;CTLA4;CCL2;CD36;ZNF423;TNS1;EGR2;VWF;STAT1;HGF;SH2D1A;BGN;IL18;ESR1;FLI1;IL6;IRF7;CALR;EZH2
Peripheral T-Cell Lymphoma,18/123,2.606256433551961E-10,5.193951990425807E-9,0,0,7.808631649381064,172.32038391457056,ALK;EGR1;CAV1;CXCR4;GZMB;GATA3;STX11;IL6;CCND1;TERT;BCL3;RHOJ;LTA;TEK;FGFR4;FGFR3;SKAP1;NECTIN2
Malignant neoplasm of skin,28/307,3.063724205996478E-10,6.08756561167821E-9,0,0,4.639110217202582,101.62536759906007,BRCA1;PTGS2;ADRA1A;AURKA;TERT;CCND1;ERBB2;CTLA4;JUN;CDKN2A;PRKCA;LIFR;FOS;KLF4;AGT;COL1A1;CXCL10;MMP14;KRT19;VCAN;KIT;ADAM12;SDC1;FGFR4;FGFR3;ATF3;EZH2;CDKN3
Endometrioma,24/229,3.5221455340306076E-10,6.977796285117865E-9,0,0,5.38091651700365,117.12522924878502,NRP1;DUSP1;PLA2G2A;HMGA1;FOS;SYP;PTGS2;ESR1;PAX2;FOXO1;DEPP1;ACTA2;NR4A1;IL6;VCAN;CCNE2;ERBB2;LEPR;TXNIP;RARB;TIMP1;PPARGC1A;NECTIN3;PAK4
Ovarian adenocarcinoma,14/70,3.6904010992456694E-10,7.289627583098211E-9,0,0,11.31032482598608,245.66156471639795,GRIA2;HMGA1;CXCR4;BRCA1;INHBA;PTGS2;FGF2;ESR1;VTN;CXCL12;ERBB2;CCL2;TEAD1;MET
Sporadic Breast Carcinoma,20/159,4.2411617189357584E-10,8.352974224156174E-9,0,0,6.573338975878121,141.8593185451651,BARD1;PARP1;CDKN2A;CAV1;FANCA;HMGA1;CXCR4;GATA4;BRCA1;PROX1;BRCA2;ESR1;TGFBR2;CXCL12;RAD51;CCND1;FANCD2;ERBB2;LEPR;CTLA4
Lymphoid leukemia,23/213,4.5617559937025806E-10,8.958114986463897E-9,0,0,5.554938887503118,119.47642158295538,ALK;NRP1;CDKN2A;SIAH2;CXCR4;PTGS2;IL6;CCND2;MYCN;CXCL12;TERT;MECOM;TAL1;WT1;E2F1;CTLA4;CTSG;PRTN3;ERG;PPARA;BUB1;ATF3;RUNX1T1
Unipolar Depression,37/517,4.589444252926579E-10,8.986212129053908E-9,0,0,3.6038347630718954,77.48998659590778,GRIA2;CNTNAP2;HLF;LRP1;CTNND2;ADRB1;PTGS2;FGF2;ADRA1A;ADCY5;SYNE1;TERT;CCND1;KDR;CTLA4;CCL2;IKBKE;GRIA4;NGFR;DST;DUSP1;CDKN2A;GAD1;FOS;ESR1;QKI;CIT;GFAP;CXCL10;IL6;DLG2;TAL1;IRF7;LTA;FKBP4;SGK1;MET
Disseminated Malignant Neoplasm,22/195,4.727738193424656E-10,9.230084217162788E-9,0,0,5.826862897825879,125.11675434046357,CDKN2A;CMA1;HGF;CAV1;PAX3;PTGS2;ESR1;SELE;RUNX2;FOXO1;CDC25B;CDH5;IL6;CXCL12;ERBB2;TNFSF11;PAEP;SOSTDC1;S100A4;VIM;TNS1;EZH2
Inflammatory Bowel Diseases,52/911,4.742024088410746E-10,9.231140225439586E-9,0,0,2.8798265336046707,61.82810994688077,FEN1;MAML2;BRCA1;FGF2;MYLK;C4B;FGF7;CCND1;CTLA4;TIMP1;CD36;TNFRSF4;ANXA1;TRIM63;HGF;IL18;PLA2G4A;CIT;MMP14;NR5A2;LTA;PPARG;EZR;SKAP2;ARHGEF6;CCL14;CXCR4;PTGS2;FOXO1;C3;SOCS3;MUC1;TERT;CXCR2;CCL2;STAT5A;EGR1;TCF7L2;CMA1;GZMB;ESR1;AGT;CXCL10;NR4A1;IL6;CXCL12;PROC;BCL3;SAA1;SDC1;PAEP;TEK
"Liver Cirrhosis, Experimental",48/801,4.758076165805401E-10,9.235618361141351E-9,0,0,3.0189769887703592,64.80538271419282,PDGFA;PTGS2;IL2RG;MKI67;PKD2;FGF2;CDH5;CCNB2;ALDH2;EPB41L2;S1PR1;CCL2;TIMP1;CD36;A2M;ECT2;ANXA1;VWF;ANXA3;TPM3;HGF;CAV1;LMO2;BGN;IL18;PLA2G4A;FOS;FLI1;AGT;TGFBR2;COL1A1;CCNA2;ACTA2;CXCL10;COL3A1;KRT19;COL1A2;CXCL12;FXYD6;VIM;EZR;NFKBIE;CRYAB;RAMP1;ATF3;NECTIN2;SKAP2;CDKN3
Prostatic Hyperplasia,15/85,5.555972583337553E-10,1.0753288723255045E-8,0,0,9.710132890365449,206.93242296272723,EGR1;ADRA1A;FGF2;ESR1;FLI1;AKAP12;FGF7;VCAN;ERBB2;LEPR;RARB;CCL2;A2M;FGFR4;ATF3
Intellectual Disability,102/2503,5.87725071783957E-10,1.134241833937085E-8,0,0,2.1246103725002823,45.158087475313565,CTNND2;ETS2;EPS8;RIMS2;RPS6KA3;CCND2;FLAD1;LEPR;NEK2;SOX5;MEF2C;SOX10;RUNX2;MYCN;BIN1;FANCD2;KCNQ5;PRKD1;FBN2;GRIA2;BLM;MAGED1;GATA4;ADRB2;TERT;NDN;NKX2-5;ZNF423;MPDZ;GRIA4;PLK4;STAT5B;CDT1;JUN;EGR2;CAV1;FANCA;FLI1;QKI;GFAP;RCAN1;IL6;COL1A2;DLG2;BMPR1B;FGFR3;EZH2;RET;CNTNAP2;GPSM2;FLT4;SIX1;BRCA2;SYNE1;SIX3;GPRASP1;ANXA1;PARP1;BGN;PAX3;FOS;KIF22;SYP;PAX2;SYN1;CIT;TGFBR2;CCNA2;ACTA2;COL2A1;TAL1;KIT;RARB;PPARG;SCN4A;ALDOA;PAFAH1B3;MET;ARHGEF6;PRKN;YAP1;LRP1;LAMA1;ASCL1;HOXD10;STX11;ADCY5;ACAN;DMD;PAK3;BUB1;RUNX1T1;STAT1;GAD1;AGT;KLF1;COL3A1;CENPF;RAD51;NPHS1;WT1;TEK
leiomyosarcoma,17/114,6.085528895449048E-10,1.1710719788491634E-8,0,0,7.967675113209365,169.0735662444053,CDKN2A;HMGA1;BGN;HMGA2;IRS2;BRCA1;PTGS2;FGF2;ESR1;SOCS3;VCAN;CCND1;WT1;KIT;DMD;VIM;TDGF1
Pneumonitis,29/339,6.641909742418849E-10,1.2744875951452854E-8,0,0,4.327737282878412,91.45569778506089,CCL13;CXCR4;GATA3;PTGS2;ETS2;MYLK;SOCS3;ZFP36;CXCR2;S1PR1;CCL2;CTSG;TIMP1;CCL19;JUN;PARP1;CAV1;IL18;PLA2G4A;GZMB;FOS;KLF4;AGT;CXCL10;IL6;CXCL12;RAD51;PPARG;ATF3
Rash and Dermatitis Adverse Event Associated with Chemoradiation,16/100,6.707826996370713E-10,1.2834691198753761E-8,0,0,8.645132645132644,182.60747026315056,EGR1;PARP1;CDKN2A;MKI67;PTGS2;FGF2;ESR1;AURKA;CDC20;RIMS2;FANCD2;CHEK1;ERBB2;KDR;PECAM1;CCL2
"MYELOPROLIFERATIVE SYNDROME, TRANSIENT",13/61,6.844573974062311E-10,1.3059136025512067E-8,0,0,12.22950424382716,258.071825686964,PTGS2;ESR1;NDC80;MYCN;CCND1;CCNE2;WT1;KIT;CAPN3;CCL2;ERG;VIM;EZH2
Hepatitis C,47/783,6.937292071353929E-10,1.3198542082496598E-8,0,0,3.0194894308499016,63.67782969562398,FKBP2;CXCR4;CIB1;PTGS2;MKI67;FOXO1;C3;SOCS3;VTN;RACGAP1;LEPR;E2F1;CTLA4;CCL2;NEK2;APOB;PPARGC1A;PITX1;STAT5A;STAT5B;DUSP1;STAT1;CDKN2A;TRAT1;MX1;IL18;TAP1;GZMB;ESR1;PER2;CXCL10;MMP14;IL6;CXCL12;MYCN;KIT;SAA1;IRF7;LTA;SERPING1;PAEP;PPARG;VIM;PPARA;FKBP4;MET;CDKN3
Aplasia Cutis Congenita,22/199,6.986641730166486E-10,1.3237294036205936E-8,0,0,5.694007025417051,120.04020729463569,BARD1;COL17A1;JUN;CDKN2A;CXCR4;BRCA1;FOS;SOX10;ESR1;AGT;AQP1;GFAP;VCAN;TERT;CCND1;KRT15;KIT;ERBB2;PPARG;VIM;FGFR3;MET
Pancreatic intraepithelial neoplasia,17/115,6.997080677267878E-10,1.3237294036205936E-8,0,0,7.88596700362388,166.23900693420924,CISH;EPAS1;CDKN2A;LMO2;CXCR4;BRCA2;PTGS2;KLF4;RUNX2;SOCS3;IL6;MUC1;CCND1;ERBB2;HOXB2;S100A4;FGFR4
Atypical Ductal Breast Hyperplasia,12/50,7.172715078346471E-10,1.3531447883756994E-8,0,0,14.233864105992463,299.702074726503,STAT5A;CXCL12;CCND1;CDKN2A;KRT15;ERBB2;CXCR4;DMD;BRCA1;BRCA2;APOB;ESR1
Nephrotic Syndrome,21/182,7.785428458074067E-10,1.4646200987234016E-8,0,0,5.966160787530763,125.13185253067863,CCL13;SERPINC1;IL18;GATA3;PTGS2;FGF2;PAX2;AGT;C3;COL1A1;CCND1;NPHS1;WT1;CFL1;KDR;LEPR;SAA1;CCL2;A2M;APOB;PPARGC1A
Nevus,15/87,7.8080312427483E-10,1.464769213025072E-8,0,0,9.439437984496124,197.95160401266497,ALK;PARP1;CDKN2A;PAX3;MITF;FOS;FGF2;SOX10;CCND1;TERT;KIT;ERBB2;PPARG;FGFR3;EZH2
Ischemic cardiomyopathy,17/116,8.03316576589173E-10,1.502806163892169E-8,0,0,7.805909562918909,163.4734831267592,HGF;IL18;ADRB1;GATA4;ESR1;CCNA2;GRK3;IL6;MMP14;CXCL12;GRK5;BCL3;ERBB2;DMD;TIMP1;FLNC;TEK
Dementia,33/436,1.021437535943443E-9,1.9055484698322674E-8,0,0,3.806499795225132,78.80236755825075,ALK;PRKN;RAB3A;LRP1;CXCR4;ENO2;PTGS2;BRCA2;ALDH2;E2F1;CCL2;SOSTDC1;TIMP1;APOB;PPARGC1A;RUNX1T1;MEF2C;TRIM63;STAT1;IL18;PLAUR;SYP;SNCAIP;ESR1;SELE;GFAP;CXCL10;IL6;CXCL12;BIN1;FANCD2;PPARG;PPARA
"Myocardial Diseases, Secondary",15/89,1.0869657120080605E-9,2.022177762284248E-8,0,0,9.183375235700817,189.54372404166986,TRIM63;PARP1;LRP1;HGF;ADRB2;PTGS2;AGT;ADCY5;IL6;RAD51;RHOJ;CCL2;DMD;PPARGC1A;ATF3
Breast adenocarcinoma,20/168,1.1377528968439582E-9,2.1108144903878515E-8,0,0,6.170747217806041,127.08166815111656,BARD1;EGR1;CAV2;CAV1;KRT5;GATA3;BRCA1;BRCA2;PTGS2;KLF4;ESR1;RUNX2;TGFBR2;MMP14;KRT19;NR5A2;ERBB2;KDR;PAEP;CD36
Juvenile arthritis,28/326,1.2040988179288032E-9,2.2277486669999565E-8,0,0,4.33904688329873,89.11332471025696,MAML2;PROS1;CXCR4;C4A;CXCR2;TNFSF11;CTLA4;TIMP1;CCL19;EGR1;TCF7L2;JUN;CCL21;DUSP1;STAT1;IL18;PLAUR;TAP1;GZMB;FOS;KLF4;ESR1;SELE;VIL1;CXCL10;IL6;LTA;VIM
Middle Cerebral Artery Occlusion,18/135,1.2309262088994505E-9,2.2670975997366115E-8,0,0,7.003422806701495,143.6787131362347,EGR1;VWF;HGF;GAD1;FOS;SYP;PLD1;PTGS2;FGF2;GFAP;C3;RCAN1;IL6;CXCR2;KDR;CCL2;TEK;ATF3
Embryonal Carcinoma,22/205,1.2321182607264195E-9,2.2670975997366115E-8,0,0,5.505613042411089,112.94506935322472,CDKN2A;HMGA1;HMGA2;MKI67;FGF2;FOXO1;CCNA2;BMP2;IL6;NR5A2;CCND2;CXCL12;CCND1;MDK;KIT;RCC1;RARB;HOXB2;VIM;FGFR4;TDGF1;CDKN3
Vascular Neoplasms,11/42,1.3455159699148128E-9,2.4655558807283875E-8,0,0,15.962836331202617,326.0646891822187,CDH5;WT1;FLT4;CXCR4;PRKCA;PPARG;TIMP1;FOS;PROX1;TEK;PPARA
Malnutrition,23/225,1.3473183565028561E-9,2.4655558807283875E-8,0,0,5.22170475341373,106.65410087352085,STAT5A;STAT5B;TRIM63;CCL21;VWF;SERPINC1;STAT1;IL18;CXCR4;TAP1;MITF;BRCA1;SLC2A4;PYY;ZFP36;IL6;CXCL12;GRK5;SAA1;LEPR;CD36;APOB;UTRN
Polycythemia Vera,22/207,1.4815802096433889E-9,2.7038838825991848E-8,0,0,5.445530637019998,110.70849067270805,STAT5A;NFE2;STAT5B;DST;CDKN2A;STAT1;HGF;PLAUR;HMGA2;KLF4;TGFBR2;SOCS3;IL6;TERT;MECOM;TAL1;KIT;PAEP;CALR;CD36;MET;RUNX1T1
Embryonal Rhabdomyosarcoma,15/91,1.499625207545061E-9,2.729399158231065E-8,0,0,8.94078947368421,181.65941312423797,ALK;YAP1;HGF;PAX3;CXCR4;SLC2A4;FGF2;ESR1;FOXO1;MYCN;TERT;ERBB2;DMD;FGFR4;TEAD1
Keloid,20/171,1.5577211711024342E-9,2.8274744284118777E-8,0,0,6.047214647448383,122.6377662557807,BGN;PDGFA;INHBA;FGF1;FGF2;DCN;AGT;COL1A1;IL6;VCAN;COL3A1;COL1A2;ADAM12;ERBB2;CXCR2;CCL2;S100A4;PPARG;TIMP1;VIM
Periodontal Diseases,18/137,1.5679672694844338E-9,2.8384011271852983E-8,0,0,6.885009741601559,139.583147155478,STAT1;HGF;IL18;CXCR4;PTGS2;SELE;CXCL10;FGF7;IL6;COL3A1;CXCL12;TERT;ALDH2;PECAM1;TNFSF11;CTLA4;CCL2;PPARG
"Breast Cancer, Familial",19/154,1.6206944463526785E-9,2.9259634144367175E-8,0,0,6.415927664753956,129.86101358001488,BARD1;TCF7L2;BLM;ANXA1;PARP1;CAV1;HMGA1;BRCA1;BRCA2;ESR1;PER2;CXCL10;RAD51;CCND1;FANCD2;CHEK1;ERBB2;TEK;PPARGC1A
Ki-1+ Anaplastic Large Cell Lymphoma,23/228,1.745775821687537E-9,3.143332551864209E-8,0,0,5.144491966246677,103.74416855665952,ALK;NRP1;JUN;CDKN2A;TPM3;FLT4;GZMB;CIB1;FOXO1;RIMS2;SOCS3;IL6;MUC1;CCND1;MDK;KIT;BCL3;E2F2;TIMP1;FKBP4;FGFR4;SKAP1;EZH2
Thyroid associated opthalmopathies,15/92,1.755736656611139E-9,3.152814809037543E-8,0,0,8.824222289338568,177.89965091515927,STAT1;IL18;HMGA2;FOS;SSTR2;PTGS2;SOCS3;CXCL10;ZFP36;IL6;LTA;CTLA4;CCL2;PPARG;PPARA
Congenital heart disease,17/122,1.785396148398028E-9,3.1890214182556265E-8,0,0,7.357587894971073,148.208495246039,FBN2;EGR1;MEF2C;CDKN2A;FANCA;CXCR4;GATA4;KLHL3;CXCL12;ACTC1;ALDH2;FANCD2;S100A4;ZFPM2;NKX2-5;TDGF1;RUNX1T1
Pilocytic Astrocytoma,17/122,1.785396148398028E-9,3.1890214182556265E-8,0,0,7.357587894971073,148.208495246039,PARP1;CDKN2A;HGF;MKI67;SOX10;ESR1;COL1A1;AKAP12;SOCS3;COL2A1;KIT;ERBB2;KDR;TIMP1;FGFR3;MET;MATN2
Parkinson Disease,56/1064,1.9013774139472506E-9,3.387175255190911E-8,0,0,2.6488146243930304,53.19001807875416,RET;FGF2;SYNE1;AQP1;C4B;C4A;ALDH2;MEF2C;DST;PARP1;HGF;IL18;LIFR;SYP;CIT;DNAJC1;BIN1;FEZ1;PECAM1;PPARG;PRKD1;ERG;PPARA;FKBP4;UTRN;SGK1;PRKN;HLF;LRP1;CXCR4;ADRB2;ASCL1;PTGS2;FOXO1;ADCY5;GRK3;GRK5;E2F1;NDN;CCL2;SNCG;FADD;PPARGC1A;EGR1;CDKN2A;CMA1;GAD1;SNCAIP;ESR1;GFAP;IL6;CXCL12;DLG2;CNTN1;PAEP;FGFR4
"Encephalitis, St. Louis",17/124,2.3049948494151405E-9,4.0953294731936725E-8,0,0,7.219320464669403,143.57919826610103,FEN1;CR1;STAT1;IL18;CXCR4;GZMB;C3;CXCL10;IL6;STMN1;IRF7;CTLA4;CCL2;PPARG;CALR;CD36;IKBKE
Glaucoma,30/381,2.4006915419779002E-9,4.254101423726538E-8,0,0,3.9551024611265575,78.49893168762124,SIX1;ADRB2;MYLK;VTN;CCND2;SNCG;NEK2;BAK1;BUB1;PAK5;PLK4;VAV3;CA12;NGFR;ANXA3;CDKN2A;CAV2;CAV1;CDC7;AGT;VAV2;COL3A1;IL6;VCAN;COL2A1;WT1;SAA1;TXNIP;TEK;UTRN
Huntington Disease,40/627,2.5325571660296975E-9,4.475961559751433E-8,0,0,3.1914526678865123,63.17172998052759,RET;PRKN;FEN1;PROS1;F13A1;DTX1;GATA4;IRS2;CIB1;BRCA1;PTGS2;CHRDL2;FGF2;ADRA1A;FOXO1;C3;RIMS2;DPYSL2;E2F1;E2F2;CCL2;DMD;PPARGC1A;EGR1;VWF;DUSP1;ANXA3;CDKN2A;CAV1;PRKCA;SYN1;GFAP;RCAN1;IL6;CXCL12;TAL1;CNTN1;PPARG;SGK1;FGFR3
Carcinoid Tumor,22/213,2.541361747468763E-9,4.479733725984307E-8,0,0,5.272833042466551,104.35234916612397,RET;JUN;CDKN2A;PTPRN;PDGFA;CXCR4;CIB1;FOS;SYP;MKI67;BRCA2;ASCL1;SSTR2;FGF2;PYY;KRT19;TERT;WT1;KIT;ERBB2;PAK3;PITX1
"Adenocarcinoma, Tubular",17/125,2.6140009863838347E-9,4.595714823181632E-8,0,0,7.152107130494981,141.34268640909718,STAT5A;TCF7L2;TPM3;CDKN2A;MKI67;BRCA2;PTGS2;ESR1;HOXA10;MMP14;CCND1;ERBB2;KDR;RARB;PPARG;PRKD1;MET
Chronic myeloproliferative disorder,23/233,2.6625046454817473E-9,4.6687679370901865E-8,0,0,5.020706386820131,99.12881967723546,STAT5A;RET;EGR1;NFE2;STAT5B;NRP1;CISH;CXCR4;HMGA2;IRS2;FLI1;HOXA10;RPS6KA3;SOCS3;CXCL10;CXCL12;TERT;MECOM;KIT;CALR;TEK;EZH2;RUNX1T1
Cardiomegaly,19/159,2.7891732009404328E-9,4.878147712894777E-8,0,0,6.185194500335346,121.8329962633756,TRIM63;PARP1;CAV1;IL18;PRKCA;GATA4;SLC2A4;AKAP5;PLD1;FGF2;AGT;MYLK;TGFBR2;ACTA2;RCAN1;CCND2;DMD;NKX2-5;PPARA
Alveolar rhabdomyosarcoma,13/68,2.838655193426631E-9,4.95179435819565E-8,0,0,10.669191919191919,209.96900795714777,ALK;CDKN2A;CAV1;PAX3;SLC2A4;SYP;FOXO1;FLI1;MYCN;ERBB2;E2F1;FGFR4;MET
Malignant neoplasm of tongue,14/82,3.292328089059947E-9,5.728309701069069E-8,0,0,9.30865292752832,181.81354547082174,CDKN2A;PROS1;CAV1;HMGA2;BRCA1;FOS;PTGS2;FOXO1;CCND1;SGK1;EZR;CRYAB;FGFR3;EZH2
Dyslipidemias,22/216,3.3040823530876514E-9,5.73390622308441E-8,0,0,5.190490117228437,101.36044668405795,TCF7L2;LRP1;HGF;CAV1;ADRB2;PTGS2;ESR1;AGT;FOXO1;MYLK;C3;SOCS3;IL6;CXCL12;LEPR;LTA;TXNIP;PPARG;CD36;APOB;PPARA;RXRG
Adenoma of large intestine,24/258,3.932743822949507E-9,6.807295751270332E-8,0,0,4.706985809123577,91.09866671037327,FEN1;PARP1;CDKN2A;PLA2G2A;CXCR4;IRS2;SEMA3F;PTGS2;KLF4;ESR1;AURKA;EPS8;IL6;VCAN;COL2A1;CXCL12;CCND1;ALDH2;LEPR;CTLA4;PPARG;TIMP1;VIM;MET
insulinoma,20/181,4.228374892897448E-9,7.300196858791583E-8,0,0,5.668688344903178,109.30052013876937,STAT5A;RET;EGR1;STAT5B;RAB3A;CDKN2C;CDKN2A;CMA1;STAT1;PTPRN;GAD1;BRCA1;SSTR2;KRT19;CCND2;CXCL12;MDK;ERBB2;LEPR;MET
liposarcoma,17/129,4.2709108476320015E-9,7.354727500691415E-8,0,0,6.895256174899867,132.88150682770717,RET;JUN;CAV2;CDKN2A;CAV1;HMGA2;MKI67;CCND1;TAL1;CHEK1;LEPR;E2F1;CAPN3;SDC1;PPARG;CALR;A2M
Gastrointestinal Stromal Tumors,27/323,4.3080994838732445E-9,7.399794407594043E-8,0,0,4.202710784947627,80.95584696162524,RET;SLC2A4;MKI67;FGF2;AURKA;RIMS2;TERT;CCND1;ERBB2;KDR;E2F1;DMD;TK1;CDKN2A;MAPK8IP2;SSTR2;TGFBR2;VCAN;RAD51;WT1;KIT;MAPKAPK2;TEK;EZR;FGFR4;FGFR3;MET
Myelofibrosis,15/98,4.334712787217737E-9,7.407616050624508E-8,0,0,8.183804987391426,157.592344913478,STAT5A;NFE2;STAT5B;CDKN2A;HMGA2;CXCR4;FGF2;CXCL12;TAL1;KIT;CXCR2;PAEP;RARB;CALR;EZH2
Thrombosis,15/98,4.334712787217737E-9,7.407616050624508E-8,0,0,8.183804987391426,157.592344913478,EGR1;VWF;SERPINC1;PROS1;HGF;F13A1;PTGS2;KLF4;DCN;AGT;C4B;IL6;PROC;LEPR;PECAM1
Hepatitis A,24/261,4.945443986813717E-9,8.429848176507849E-8,0,0,4.64668210108542,88.86686162256042,JUN;CR1;PARP1;CDKN2A;HGF;IL18;GZMB;BRCA1;PTGS2;ESR1;AGT;VTN;SOCS3;CXCL10;BMP2;VCAN;MYCN;TERT;LEPR;PAEP;CTLA4;RARB;APOB;CCL16
Ischemia of kidney,15/99,5.006091325447024E-9,8.511622618152458E-8,0,0,8.085963455149502,154.54386923423348,EGR1;PARP1;EPAS1;SERPINC1;BGN;IL18;SELE;PAX2;AGT;IL6;PECAM1;SDC1;CCL2;SGK1;ATF3
Renal fibrosis,21/202,5.2235182680731234E-9,8.858875931408862E-8,0,0,5.3014437610757845,101.09903438155509,EGR1;CISH;EPAS1;STAT1;HGF;IL18;PKD2;AGT;DCN;SOCS3;NR4A1;IL6;CXCL12;CCL2;S100A4;CD36;TIMP1;VIM;EZR;PPARGC1A;MET
"Carcinoma, Cribriform",16/115,5.502284280151597E-9,9.273773275112443E-8,0,0,7.329613147794966,139.39533418337703,STAT5A;TCF7L2;TPM3;CDKN2A;MKI67;PTGS2;ESR1;HOXA10;MMP14;CCND1;ERBB2;KDR;RARB;PPARG;PRKD1;MET
"Carcinoma, Granular Cell",16/115,5.502284280151597E-9,9.273773275112443E-8,0,0,7.329613147794966,139.39533418337703,STAT5A;TCF7L2;TPM3;CDKN2A;MKI67;PTGS2;ESR1;HOXA10;MMP14;CCND1;ERBB2;KDR;RARB;PPARG;PRKD1;MET
Impaired cognition,41/671,5.5095823954286255E-9,9.273773275112443E-8,0,0,3.0485816438786735,57.9741973091436,GRIA2;CNTNAP2;LRP1;CTNND2;BRCA1;ENO2;PTGS2;LMNB1;C3;RPS6KA3;ALDH2;KDR;S1PR1;CCL2;SOSTDC1;CAPN3;DMD;CD36;PAK3;RUNX1T1;PLK4;EGR1;MEF2C;ARHGEF15;GAD1;HGF;MX1;IL18;PLA2G4A;PRKCA;SYP;MAPK8IP2;ESR1;GFAP;COL3A1;BMP2;IL6;BIN1;PPARG;UTRN;FGFR3
Melanocytic nevus,21/203,5.708282995377211E-9,9.584207149238336E-8,0,0,5.272042815674891,100.07047703464671,PARP1;CDKN2A;HGF;PAX3;MITF;FOS;ADRB2;MKI67;PTGS2;SOX10;FGF2;TGFBR2;COL3A1;VCAN;TERT;CCND1;KIT;ERBB2;PPARG;FGFR3;EZH2
Malignant neoplasm of gastrointestinal tract,24/263,5.750474396018443E-9,9.630969088194481E-8,0,0,4.607320684960097,87.41922657218002,YAP1;FEN1;SATB1;CDKN2A;IL18;CXCR4;BRCA2;PTGS2;PKD2;KLF4;SOX10;AURKA;RIMS2;IL6;NR5A2;TERT;ALDH2;GNG7;ERBB2;SDC1;PPARG;TIMP1;BAK1;EZH2
Anxiety Disorders,30/396,5.8871369520466995E-9,9.835326310931748E-8,0,0,3.7900454276120876,71.82324088141023,PRKN;GRIA2;MAGED1;CTNND2;PROS1;FLT4;BRCA1;ADRB2;PTGS2;BRCA2;CCND1;ALDH2;MDK;STMN1;SOSTDC1;PPARGC1A;IKBKE;EGR1;CISH;CDKN2A;GAD1;FOS;ESR1;AGT;QKI;SYN1;RCAN1;IL6;TAL1;FKBP4
Adrenocortical carcinoma,20/185,6.182277153739746E-9,1.0302290788301098E-7,0,0,5.530124777183601,104.528091250937,STAT5A;STAT5B;CDKN2A;LIFR;GATA4;KRT5;SYP;FGF2;ESR1;AGT;GFAP;TGFBR2;CXCL10;BMP2;TERT;PPARG;VIM;SGK1;MET;CDKN3
Myeloproliferative disease,24/264,6.197327990580172E-9,1.0302290788301098E-7,0,0,4.587885985748218,86.70713444897427,STAT5A;RET;NFE2;STAT5B;CISH;CDKN2A;CBLC;HMGA2;IRS2;FGF2;HOXA10;RPS6KA3;SOCS3;NR4A1;TERT;MECOM;KIT;BCL3;CALR;TEK;FGFR4;FGFR3;EZH2;RUNX1T1
Follicular thyroid carcinoma,19/167,6.3652110124716235E-9,1.0555248681422079E-7,0,0,5.84844880091359,110.37437307464064,RET;CAV2;CDKN2A;HGF;CAV1;HMGA2;MKI67;PTGS2;FGF2;PER2;NR4A1;IL6;CCND2;TERT;KDR;E2F1;PPARG;VIM;EZH2
PACHYONYCHIA CONGENITA 3,17/133,6.849002073173992E-9,1.13295315082356E-7,0,0,6.6561190783113116,125.12946668875963,PROS1;HGF;GZMB;BRCA2;ESR1;RUNX2;FOXO1;CCNA2;IL6;MDK;ERBB2;KDR;TNFSF11;CCL2;PPARG;VIM;ATF3
"Adenocarcinoma, Basal Cell",16/117,7.099004913426401E-9,1.1714230220779288E-7,0,0,7.183733757991184,134.79063219234993,STAT5A;TCF7L2;TPM3;CDKN2A;MKI67;PTGS2;ESR1;HOXA10;MMP14;CCND1;ERBB2;KDR;RARB;PPARG;PRKD1;MET
Malignant Childhood Neoplasm,14/87,7.3190847171078054E-9,1.2047787490219612E-7,0,0,8.668849124368306,162.39164831498928,ALK;CDKN2A;SIX1;PAX3;BRCA1;BRCA2;ESR1;FOXO1;AURKA;MMP14;MYCN;ERBB2;LEPR;EZR
Inflammatory Breast Carcinoma,15/102,7.63016490901849E-9,1.2529141205126693E-7,0,0,7.805934242181235,145.90193760202112,ALK;CAV1;IL18;CXCR4;BRCA1;BRCA2;PTGS2;ESR1;SELE;AGT;MUC1;ERBB2;PMAIP1;SDC1;EZH2
Adenocarcinoma of colon,24/267,7.739787357816709E-9,1.2647302164257181E-7,0,0,4.5305416263452685,84.61643494816293,NRP1;JUN;ANXA1;PARP1;CCL21;EPAS1;CAV1;PLA2G2A;PLAUR;FOS;PTGS2;KLF4;ESR1;SELE;FOXO1;CCNA2;PYY;ZFP36;COL2A1;CCND1;E2F1;COL8A1;PPARG;S100A4
Trichohepatoenteric Syndrome,24/267,7.739787357816709E-9,1.2647302164257181E-7,0,0,4.5305416263452685,84.61643494816293,RET;PRKN;STAT5B;VWF;SH2D1A;CXCR4;ADRB1;SOX10;COL1A1;RIMS2;CXCL10;COL3A1;ZFP36;IL6;COL1A2;COL2A1;CXCL12;RAD51;GRK5;KIT;CCL2;PPARG;SCN4A;CALR
Nervous System Neoplasms,11/49,7.960340123720672E-9,1.2976127250220396E-7,0,0,13.017644918748484,242.76337987240913,ALK;NGFR;RAB3A;MYCN;TERT;MDK;TPM3;CDKN2A;ERBB2;CCL2;SOX10
Familial Alzheimer Disease (FAD),20/188,8.163917462245602E-9,1.3275755369598415E-7,0,0,5.430532212885154,101.13574313080213,CR1;SLC2A4;FOS;ENO2;BRCA2;PTGS2;FGF2;ESR1;GFAP;PYY;CCND1;FLAD1;BIN1;FANCD2;DPYSL2;CCL2;SNCG;PPARG;VIM;A2M
Pre-Eclampsia,18/152,8.44828096907207E-9,1.3704989127605802E-7,0,0,6.1095809011150335,113.57284966892551,VWF;IL18;TAP1;ADRB2;INHBA;ESR1;SELE;AGT;C3;SOCS3;CXCL10;IL6;NPHS1;ADAM12;LEPR;PPARG;CALR;TEK
Trisomy,21/209,9.60931305564989E-9,1.555087867029992E-7,0,0,5.102205439582497,94.18943239409445,RET;CCL21;CDKN2A;HMGA2;ETS2;AURKA;RCAN1;IL6;VCAN;COL1A2;CCND2;MYCN;CXCL12;TERT;CCND1;TAL1;KIT;BCL3;ERBB2;ERG;MET
Proliferative diabetic retinopathy,13/75,9.946402881362525E-9,1.6057702344045846E-7,0,0,9.461208183990442,174.33274114038593,NRP1;TCF7L2;VWF;HGF;FGF2;GFAP;CCNA2;IL6;CXCL12;KDR;CCL2;SDC1;PPARG
Erythroblastosis,11/50,1.000328760578994E-8,1.6068713706760867E-7,0,0,12.683209263854424,233.62917960425312,JUN;CCND1;PROS1;CAV1;ERBB2;KDR;BGN;E2F1;FOS;ETS2;KLF1
Low grade glioma,12/62,1.0025001553205485E-8,1.6068713706760867E-7,0,0,10.81108545034642,199.12055791623757,CDC20;VAV3;TCF7L2;SATB1;CDKN2A;KDR;PLAUR;PAX3;FLNC;VIM;ECT2;SOX10
Phyllodes Tumor,12/62,1.0025001553205485E-8,1.6068713706760867E-7,0,0,10.81108545034642,199.12055791623757,CXCL12;CCND1;TERT;CDKN2A;KIT;ERBB2;CXCR4;HMGA2;S100A4;CCL19;ESR1;DCN
Eczema,32/454,1.0365203748918543E-8,1.657445437565165E-7,0,0,3.5129385033795026,64.58471196336096,CCL13;NRP1;SATB1;FLT4;CXCR4;GATA3;PTGS2;RIMS2;SOCS3;FLAD1;CXCR2;CTLA4;CCL2;CTSG;STAT5A;NGFR;STAT5B;JUN;DUSP1;STAT1;CMA1;IL18;TAP1;GZMB;FOS;SELE;CXCL10;IL6;BCL3;LTA;PPARG;PPARA
Germ cell tumor,21/210,1.0460882898926307E-8,1.668771723258648E-7,0,0,5.0749475890985325,93.25532351368096,RET;PARP1;CISH;CDKN2A;GATA4;ENO2;ESR1;AURKA;CCND2;TERT;CCND1;TAL1;WT1;MDK;KIT;ERBB2;KDR;TK1;TDGF1;TEAD1;FGFR3
Mixed Salivary Gland Tumor,15/105,1.1455996210735632E-8,1.8231865059549884E-7,0,0,7.544573643410852,137.95066222156572,MAML2;CDKN2A;PDGFA;HMGA2;LIFR;PTGS2;GFAP;CCNA2;BMP2;IL6;CENPF;CCND1;TERT;ERBB2;KDR
Inflammatory disorder,20/192,1.1724274921812764E-8,1.8614711672551895E-7,0,0,5.3031463748290015,96.84396098619278,PRKN;HGF;BGN;CXCR4;ADRB2;GATA3;PTGS2;ESR1;SELE;MYLK;CXCL10;IL6;MUC1;MAPKAPK2;BCL3;SAA1;CTLA4;CCL2;PRTN3;SGK1
Neurodegenerative Disorders,43/745,1.2301537974472156E-8,1.9485171942583725E-7,0,0,2.872670125157687,52.32149666622066,PRKN;OPRD1;CXCR4;PTGS2;FGF1;BRCA2;PKD2;FOXO1;AQP1;LMNB1;RIMS2;SOCS3;DPYSL2;STMN1;ERBB2;CCL2;SNCG;A2M;PAK3;PPARGC1A;TEAD1;NEFH;NGFR;JUN;ANXA1;PARP1;CAV2;GAD1;HGF;PLA2G2A;FOS;SNCAIP;KLF4;GFAP;MMP14;IL6;TXNIP;PPARG;VIM;SGK1;FGFR4;CRYAB;EZH2
Differentiated Thyroid Gland Carcinoma,17/139,1.3464665976721597E-8,2.1277340399920528E-7,0,0,6.3268155354680555,114.66212381169073,ALK;RET;VAV3;PARP1;CDKN2A;CAV1;BRCA1;FGF2;ADRA1A;GRK5;TERT;ERBB2;KDR;TXNIP;CTLA4;PPARG;MET
"Dermatitis, Atopic",33/484,1.3631836916983496E-8,2.1490942895413418E-7,0,0,3.3928486857684113,61.44740018726632,CCL13;NRP1;SATB1;FLT4;CXCR4;GATA3;ADRB2;PTGS2;C3;RIMS2;SOCS3;FLAD1;CXCR2;CTLA4;CCL2;TIMP1;STAT5A;NGFR;STAT5B;JUN;DUSP1;CMA1;IL18;PLAUR;TAP1;FOS;SELE;CXCL10;IL6;BCL3;LTA;PPARG;PPARA
Cerebral Ischemia,24/275,1.3777717737267083E-8,2.1670059092151226E-7,0,0,4.384324933046909,79.35721605457422,EGR1;NRP1;JUN;PARP1;VWF;IL18;PLA2G4A;FOS;PTGS2;SELE;AGT;GFAP;TGFBR2;CXCL10;IL6;CXCL12;ALDH2;KDR;CTLA4;CCL2;CTSG;PPARG;PRTN3;SGK1
High-Grade Prostatic Intraepithelial Neoplasia,13/77,1.3864912130159297E-8,2.1756249968726597E-7,0,0,9.164605034722221,165.82348823658094,ANXA1;DUSP1;CAV1;BRCA2;MKI67;PTGS2;DCN;AURKA;CHEK1;ERBB2;ERG;MET;CDKN3
Adenocarcinoma of large intestine,25/297,1.4173966391769205E-8,2.2137757741191158E-7,0,0,4.21984418767507,76.2604287720551,RET;ALK;FEN1;LAMC1;PTGS2;AURKA;VTN;CCND2;CCND1;ERBB2;E2F1;TIMP1;PAK3;PAK5;STAT5A;STAT5B;TCF7L2;PRKCA;RUNX2;WT1;KIT;PAEP;S100A4;FGFR3;MET
Kidney Failure,25/297,1.4173966391769205E-8,2.2137757741191158E-7,0,0,4.21984418767507,76.2604287720551,PRKN;ALK;HLF;SERPINC1;GATA3;PTGS2;PKD2;C3;MUC1;CCL2;TIMP1;PPARGC1A;PARP1;VWF;CAV1;IL18;RUNX2;PAX2;AGT;IL6;NPHS1;WT1;SDC1;PPARG;SGK1
Bronchiolitis Obliterans,12/64,1.4640784594431732E-8,2.276099753152859E-7,0,0,10.394208562799786,187.50585489903045,CXCL10;VCAN;MUC1;IL6;CXCL12;HGF;SIX1;CXCR4;CCL2;GZMB;TIMP1;SELE
Uterine Cancer,12/64,1.4640784594431732E-8,2.276099753152859E-7,0,0,10.394208562799786,187.50585489903045,RIMS2;BARD1;CCND1;CDKN2A;ERBB2;HMGA1;BRCA1;INHBA;BRCA2;PTGS2;ESR1;AURKA
Basal cell carcinoma,15/107,1.490270358632355E-8,2.3061418729435247E-7,0,0,7.379802831142568,132.99676383223647,STAT5B;CDKN2A;PRKCA;KRT5;PTGS2;TGFBR2;BMP2;IL6;MUC1;KRT19;MYCN;CXCL12;TERT;KRT15;ERBB2
Pleural effusion disorder,15/107,1.490270358632355E-8,2.3061418729435247E-7,0,0,7.379802831142568,132.99676383223647,ALK;CDKN2A;CTNND2;HGF;SIAH2;ENO2;FGF2;RIMS2;IL6;MUC1;TERT;CCL2;CALR;TIMP1;KPNA2
Acute Coronary Syndrome,23/255,1.4939447944168395E-8,2.3065133883456306E-7,0,0,4.539436590946233,81.79729095234562,STAT5A;STAT5B;VWF;SERPINC1;F12;HGF;PLA2G2A;IL18;ADRB1;ADRB2;PTGS2;SELE;COL3A1;IL6;CXCL12;ALDH2;CCL2;PPARG;TIMP1;VIM;APOB;PPARA;TNFRSF4
"Plaque, Amyloid",22/235,1.5698181630769793E-8,2.418096051198393E-7,0,0,4.7228493102032205,84.86828419795563,VWF;SERPINC1;SH2D1A;BGN;SYP;ENO2;BRCA2;PTGS2;DCN;GFAP;RIMS2;MMP14;IL6;FLAD1;FANCD2;SAA1;SERPING1;CCL2;PPARG;VIM;A2M;APOB
"Pleural Effusion, Malignant",13/78,1.6305457641410848E-8,2.505891384890509E-7,0,0,9.023148148148149,161.80098081994936,RET;CDKN2A;FGF2;ESR1;MUC1;IL6;CXCL12;TERT;MDK;CD5;KDR;RARB;CCL2
Tumor Promotion,15/108,1.6958695770297948E-8,2.6003333514456857E-7,0,0,7.300075018754689,130.61648357404488,STAT5A;STAT5B;JUN;STAT1;PRKCA;FOS;ASCL1;PTGS2;KLF4;ESR1;EPS8;ZFP36;IL6;MYCN;CXCL12
Essential Hypertension,24/278,1.7005182606540134E-8,2.6015217855472333E-7,0,0,4.331868255185442,77.49603006888488,SERPINC1;HGF;BGN;ADRB1;ADRB2;SELE;ADRA1A;AGT;MYLK;SYNE1;TGFBR2;IL6;ALDH2;LEPR;LTA;CCL2;PPARG;APOB;SGK1;PPARGC1A;NEFH;TEAD1;RAMP1;TNFRSF4
Mammary Ductal Carcinoma,12/65,1.7598249296600683E-8,2.6861327789993227E-7,0,0,10.197568521504206,182.08234221605457,IL6;NR5A2;CAV2;CAV1;ERBB2;E2F1;PAEP;GATA3;MKI67;PTGS2;ESR1;MAD2L1
Intraepithelial Neoplasia,14/93,1.7774911696562752E-8,2.706945735920985E-7,0,0,8.00798848718024,142.90638100377527,RET;STAT5A;STAT5B;CDKN2A;BRCA1;PTGS2;VTN;MUC1;CCND2;CFL1;ERBB2;S100A4;TDGF1;EZH2
IGA Glomerulonephritis,22/237,1.8318356440408134E-8,2.783395517053869E-7,0,0,4.678432019352356,83.34796093261237,VAV3;NGFR;CCL21;CHPF;VWF;STAT1;HGF;BGN;PDGFA;CIB1;SELE;AGT;DCN;C3;MMP14;IL6;PRC1;CCL2;SPRY2;PPARG;TIMP1;EZR
Vascular inflammations,17/142,1.8623327999030137E-8,2.823346971591115E-7,0,0,6.174018691588785,109.89043782790095,VWF;DUSP1;GZMB;PTGS2;KLF4;AGT;NR4A1;ZFP36;IL6;MMP14;PECAM1;S1PR1;CCL2;PPARG;CCL19;TEK;SGK1
Malignant neoplasm of large intestine,34/516,1.902770440021305E-8,2.8781545664826764E-7,0,0,3.2734752804111014,58.19378056970638,ALK;YAP1;CXCR4;IRS2;PTGS2;SOCS3;TERT;CCND1;CHEK1;CXCR2;ERBB2;E2F1;NDN;CCL2;TIMP1;ECT2;IKBKE;TNS1;PAK4;STAT1;CDKN2A;CAV1;HMGA2;KLF4;TGFBR2;IL6;CXCL12;S100A4;PPARA;SGK1;CRYAB;MET;ATF3;EZH2
Heart Diseases,26/325,2.0676207350142843E-8,3.12048109131594E-7,0,0,3.9962643976341186,70.71103000202889,GATA4;ADRB1;FGF1;FGF2;MYLK;SYNE1;GRK3;GRK5;ALDH2;DMD;CD36;TIMP1;APOB;NKX2-5;PPARGC1A;VWF;CMA1;HGF;IL18;RUNX2;AGT;CCNA2;IL6;PPARA;SGK1;MET
Childhood Acute Lymphoblastic Leukemia,31/443,2.0939796458461144E-8,3.146122438814878E-7,0,0,3.4791578725200507,61.51712777085044,FEN1;HLF;SERPINC1;GATA4;CIB1;GATA3;PTGS2;FBLN2;AURKA;C3;CCND2;TERT;MECOM;CCND1;LEPR;TIMP1;PARP1;CDKN2A;KLF4;ESR1;TGFBR2;COL1A1;MMP14;IL6;RAD51;TAL1;WT1;BCL3;S100A4;ERG;EZH2
Fatty Liver,31/443,2.0939796458461144E-8,3.146122438814878E-7,0,0,3.4791578725200507,61.51712777085044,EPAS1;CXCR4;ADRB2;ENO2;PTGS2;FOXO1;CCND1;ALDH2;CXCR2;LEPR;KDR;CCL2;CD36;APOB;PPARGC1A;EGR1;KLF11;TCF7L2;HGF;IL18;SELE;CXCL10;COL3A1;IL6;SAA1;TXNIP;PAEP;PPARG;PPARA;MET;ATF3
Impaired glucose tolerance,26/326,2.201268717060206E-8,3.299937657092934E-7,0,0,3.982736674622116,70.222206584251,PTPRN;CXCR4;IRS2;ADRB2;SLC2A4;FOXO1;MYLK;SOCS3;ALDH2;LEPR;CD36;APOB;PPARGC1A;KLF11;TCF7L2;CISH;GAD1;CAV1;ESR1;SELE;AGT;IL6;TXNIP;PPARG;PPARA;SGK1
Status Epilepticus,21/221,2.57398890023916E-8,3.8500911924289973E-7,0,0,4.793101415094339,83.76052062969165,RET;GRIA2;MEF2C;JUN;CDKN2A;IL18;PLAUR;FOS;PROX1;ASCL1;PTGS2;SSTR2;AQP1;SOCS3;ACAN;CXCL12;CCND1;DPYSL2;CFL1;CCL2;DMD
Dissection of aorta,10/43,2.672438796595161E-8,3.988466435096245E-7,0,0,13.599442702890979,237.14285625427652,ACTA2;COL1A1;COL3A1;IL6;MMP14;STAT1;CCL2;AGT;MYLK;TGFBR2
"Scoliosis, unspecified",11/55,2.8991925802174322E-8,4.3172898822040517E-7,0,0,11.23905529953917,195.0678363057465,FBN2;COL1A1;ACAN;EGR2;COL3A1;IL6;COL1A2;TNFSF11;FGF2;ESR1;RUNX2
Infection caused by Helicobacter pylori,25/308,2.918039302493595E-8,4.335741583085616E-7,0,0,4.053508329126704,70.3274324403944,GATA4;GATA3;PTGS2;MUC1;ALDH2;CXCR2;ERBB2;CCL2;TIMP1;TEAD1;JUN;PARP1;CDKN2A;HGF;CAV1;IL18;FOS;AGT;BMP2;IL6;RAD51;LTA;PPARG;CALR;ATF3
Endometrial adenocarcinoma,16/129,2.9442524340813975E-8,4.365032968496836E-7,0,0,6.416898735482806,111.27432315780518,CDKN2A;CAV1;CXCR4;PTGS2;FGF2;ESR1;FOXO1;NDC80;PAX2;HOXA10;RCAN1;FGF7;CXCL12;ERBB2;CXCR2;PAEP
Primary Lesion,9/33,2.9600974752802864E-8,4.378857851097446E-7,0,0,16.798451834862384,291.2088654088228,ALK;RET;RIMS2;COL1A2;CDKN2A;ERBB2;KIT;CXCR4;VIM
"Carcinoma, Large Cell",12/68,2.995437738268777E-8,4.421397769277606E-7,0,0,9.649785549323656,167.16893198312482,ALK;IL6;KRT19;RAD51;CDKN2A;ERBB2;HMGA1;PPARG;BRCA1;BRCA2;MET;TGFBR2
Down Syndrome,32/475,3.0152760454446876E-8,4.4409197195628337E-7,0,0,3.3427379904787413,57.88615821640353,RET;SERPINC1;EPAS1;ITSN1;GATA4;CIB1;ADRB2;ENO2;PTGS2;ETS2;RIMS2;CCND1;DPYSL2;STMN1;ERBB2;E2F1;CCL2;A2M;NEFH;PARP1;STAT1;MX1;SYP;ESR1;GFAP;RCAN1;IL6;WT1;KIT;ADAM12;ERG;EZH2
Aortic Valve Stenosis,16/130,3.289915061678912E-8,4.834807342283495E-7,0,0,6.360282991861939,109.58652471710786,JUN;VWF;CCL21;CMA1;BGN;GATA4;FOS;ESR1;RUNX2;AGT;MMP14;TNFSF11;PPARG;FLNC;APOB;NKX2-5
Oral Submucous Fibrosis,10/44,3.390341597769933E-8,4.971514011053029E-7,0,0,13.198782961460447,227.01576805089732,COL1A1;KRT19;COL1A2;ERBB2;CTLA4;S100A4;TIMP1;PTGS2;FGF2;FGFR3
Gingival Diseases,15/114,3.573629510186543E-8,5.228866185275125E-7,0,0,6.8555320648343905,117.55248697979226,STAT1;IL18;CXCR4;PTGS2;SELE;CXCL10;IL6;COL3A1;CXCL12;TERT;ALDH2;TNFSF11;CTLA4;CCL2;PPARG
Progressive Neoplastic Disease,18/167,3.732738554275877E-8,5.44979828924278E-7,0,0,5.490278672807004,93.90319311084603,ALK;RET;CDKN2A;HGF;IL18;BRCA1;PTGS2;ESR1;SELE;CXCL10;IL6;MUC1;MYCN;ERBB2;PECAM1;SDC1;CCL2;CCL19
Cholangitis,9/34,3.947042462342892E-8,5.750181600237498E-7,0,0,16.125688073394496,274.9061213793974,COL1A1;EGR1;KRT19;HGF;PLA2G2A;BCL3;PPARG;TIMP1;TGFBR2
Pancreatitis,23/269,4.051071096705822E-8,5.888959628890974E-7,0,0,4.277992910260856,72.81870947989418,EGR1;DUSP1;CDKN2A;HGF;CAV1;SH2D1A;PLA2G2A;IL18;PLAUR;PDGFA;PTGS2;SELE;CDC20;IL6;PROC;ALDH2;LEPR;LTA;CTLA4;CCL2;PPARG;A2M;MET
Mouth Neoplasms,16/132,4.094657341761589E-8,5.934548423774259E-7,0,0,6.249979905152319,106.31839383767944,ANXA1;CDKN2A;CAV1;IL18;PTGS2;HOXD10;DCN;CDC20;CXCL12;CCND1;CD5;E2F1;SDC1;CCL2;VIM;CRYAB
Soft Tissue Neoplasms,13/84,4.100104926490852E-8,5.934548423774259E-7,0,0,8.258085550339072,140.46729500293603,ALK;NGFR;CDKN2A;HGF;HMGA2;MKI67;FGF2;FLI1;TERT;KIT;ERBB2;S100A4;MET
Monoclonal Gammopathy of Undetermined Significance,17/150,4.245883097983314E-8,6.132333523882997E-7,0,0,5.800259995783852,98.45785265572499,CDKN2C;CDKN2A;HGF;FLT4;CXCR4;FGF2;RUNX2;AURKA;IL6;CCND1;KIT;LTA;TNFSF11;SDC1;CTLA4;FGFR3;MET
"Liposarcoma, Dedifferentiated",10/45,4.273178341377945E-8,6.158511961522377E-7,0,0,12.821018062397373,217.5511737658004,JUN;CCND1;EPAS1;CDKN2A;HGF;HMGA2;SDC1;CD36;CALR;MET
Progressive cGVHD,18/169,4.4920612159381105E-8,6.460103453156392E-7,0,0,5.4170014113559875,91.64682918095173,ALK;RET;CDKN2A;HGF;IL18;BRCA1;PTGS2;ESR1;SELE;CXCL10;IL6;MUC1;MYCN;ERBB2;PECAM1;SDC1;CCL2;CCL19
Adenoid Cystic Carcinoma,20/208,4.547022531985999E-8,6.511258704652019E-7,0,0,4.847809762202753,81.958080735764,CDKN2A;FANCA;CXCR4;KRT5;BRCA1;MKI67;SOX10;FGF2;AQP1;CDH5;CENPF;VCAN;MYCN;CCND1;KRT15;KIT;ERBB2;SDC1;HOMER3;FGFR4
Colorectal cancer metastatic,20/208,4.547022531985999E-8,6.511258704652019E-7,0,0,4.847809762202753,81.958080735764,RET;YAP1;EGR1;NRP1;DUSP1;HGF;IRS2;MAPK8IP2;PTGS2;AURKA;VIL1;KRT19;CCND1;CXCR2;ERBB2;KDR;PRKD1;TIMP1;MET;EZH2
"Cicatrix, Hypertrophic",13/85,4.743738479838496E-8,6.778499495871349E-7,0,0,8.142971965020577,137.32190019952552,TPM3;CXCR4;DCN;AGT;TGFBR2;COL3A1;IL6;COL1A2;CXCL12;CCND1;TIMP1;VIM;CDKN3
Rhabdoid Tumor,12/71,4.958220509139803E-8,7.06993820369064E-7,0,0,9.157709320076721,154.0293175393621,PLK4;CNTNAP2;CCND1;BIN1;CDKN2A;E2F1;PMAIP1;HMGA2;SYP;VIM;MKI67;EZH2
Tumor Immunity,16/134,5.0751773999249765E-8,7.221375300401726E-7,0,0,6.14341590612777,103.186774930767,JUN;CCL21;CDKN2A;PROS1;IL18;BRCA1;FOS;ADRA1A;MUC1;TERT;ERBB2;KDR;E2F1;CTLA4;CALR;TNFRSF4
"Carcinoma, Small Cell",15/117,5.094490438892498E-8,7.233530187653703E-7,0,0,6.652872777017784,111.71850644558461,ALK;CDKN2A;ASCL1;TGFBR2;AURKA;KRT19;CCND1;TERT;FEZ1;CHEK1;KIT;ERBB2;CXCR2;PPARG;ERG
Agenesis of corpus callosum,25/317,5.133856180256061E-8,7.274046014050571E-7,0,0,3.9267367906066535,65.90958464882522,CXCR4;BRCA1;AQP1;TERT;CCND1;SIX3;ERBB2;BARD1;ARNT2;JUN;CDKN2A;FOS;SOX10;ESR1;AGT;CIT;GFAP;CENPF;VCAN;KRT15;KIT;PPARG;VIM;FGFR3;MET
Congenital aneurysm of ascending aorta,11/58,5.195614108383327E-8,7.346051442505773E-7,0,0,10.520050985390725,176.45140459646709,ACTA2;FBN2;COL1A1;COL3A1;COL2A1;COL1A2;BGN;PPARG;PKD2;MYLK;TGFBR2
Hemangioma,14/101,5.228646847260557E-8,7.377225257605441E-7,0,0,7.268634824119263,121.86977096027204,RET;FLT4;HMGA1;ADRB1;ADRB2;FOS;FGF2;NDC80;CCND1;WT1;KDR;PECAM1;ERG;TEK
Lupus Nephritis,20/210,5.334975744658523E-8,7.511466897510826E-7,0,0,4.796284829721362,80.32048703299014,DUSP1;STAT1;HGF;MX1;BGN;IL18;GATA3;PTGS2;SELE;FLI1;CXCL10;IL6;ERBB2;SERPING1;CCL2;SNRPE;CALR;SGK1;PAK5;TNS1
Thrombocytopenia,26/341,5.4612366537008E-8,7.673151750262463E-7,0,0,3.790127666022654,63.38232575339251,CXCR4;BRCA2;CDC20;VTN;SOCS3;TERT;MECOM;E2F1;TNFSF11;CD36;NFE2;VWF;STAT1;HGF;SH2D1A;FANCA;FLI1;CXCL10;IL6;CXCL12;RAD51;FANCD2;IRF7;PECAM1;PAEP;MAD2L1
Herpes NOS,13/86,5.4769194864455066E-8,7.679121350932781E-7,0,0,8.031012176560122,134.27963137834755,COL17A1;DST;STAT1;IL18;PTGS2;ADRA1A;ESR1;MYLK;IL6;ERBB2;LTA;TK1;FKBP4
Familial lichen amyloidosis,17/153,5.701332333477344E-8,7.977114156590383E-7,0,0,5.671436915887851,94.59945917003407,RET;PRKN;PROS1;IL18;MITF;MKI67;PTGS2;KLF4;AURKA;IL6;MYCN;CCND1;BIN1;ERBB2;CCL2;ERG;A2M
Hematopoietic Neoplasms,19/192,6.244590174876131E-8,8.711761486248526E-7,0,0,4.996852017693832,82.89260436622583,STAT5A;RET;STAT5B;CDKN2A;HMGA1;CIB1;FGF2;ESR1;IL6;CCND2;CCND1;TERT;WT1;KIT;LEPR;SPRY2;S100A4;PPARG;MET
"Fibromatosis, Aggressive",11/59,6.259822251177868E-8,8.711761486248526E-7,0,0,10.300355222734256,170.8471401344941,RET;CCND1;MDK;WT1;KIT;KDR;PECAM1;PDGFA;PTGS2;ESR1;FOXO1
Follicular adenoma,16/136,6.265307918192433E-8,8.711761486248526E-7,0,0,6.040404040404041,100.18404544140974,RET;CDKN2A;HGF;SSTR2;PTGS2;RUNX2;NR4A1;MMP14;CCND2;CCND1;TERT;WT1;ERBB2;E2F1;S100A4;PPARG
Von Hippel-Lindau Syndrome,15/119,6.412720438469985E-8,8.898312079496782E-7,0,0,6.5242620751341684,108.05741964914031,RET;PRKN;CISH;EPAS1;CXCR4;PTGS2;PAX2;RIMS2;MMP14;CXCL12;CCND1;SIX2;RARB;ELOB;MET
Promyelocytic leukemia,21/233,6.44050410922979E-8,8.918438267543768E-7,0,0,4.518990299038804,74.82577545622988,PRKN;FEN1;BLM;ANXA1;CDKN2A;BRCA1;RIMS2;CXCL10;ZFP36;BMP2;TERT;MECOM;CCND1;TXNIP;RARB;PMAIP1;CTSG;PPARG;VIM;PPARGC1A;RUNX1T1
Steatohepatitis,35/569,6.463490021322819E-8,8.931851642634579E-7,0,0,3.0407189184251395,50.33761575923671,EPAS1;CXCR4;IRS2;ADRB2;PTGS2;FGF1;FOXO1;DEPP1;CCND1;ALDH2;CXCR2;LEPR;CCL2;CD36;APOB;PPARGC1A;EGR1;KLF11;TCF7L2;ANXA1;HGF;CAV1;SELE;AGT;DCN;COL1A1;CXCL10;COL3A1;IL6;TXNIP;PAEP;PPARG;PPARA;ATF3;EZH2
"Ichthyosis, X-Linked",14/103,6.735683737316569E-8,9.288881310024246E-7,0,0,7.104564769675956,117.31953531147894,PARP1;EPAS1;CDKN2A;BRCA1;MKI67;BMP2;KIT;ERBB2;KDR;PECAM1;CCL2;DMD;VIM;EZR
Bone neoplasms,12/73,6.839864369557496E-8,9.374801858356765E-7,0,0,8.856547912013024,146.11455552919497,IL6;CAV1;ERBB2;CTLA4;TNFSF11;CXCR4;VIM;PTGS2;MET;RUNX2;FLI1;TGFBR2
hypopigmented skin patch,12/73,6.839864369557496E-8,9.374801858356765E-7,0,0,8.856547912013024,146.11455552919497,RAD51;TERT;FANCD2;CAV1;KIT;FANCA;CTLA4;PAX3;MITF;KRT5;BRCA2;SOX10
mixed gliomas,12/73,6.839864369557496E-8,9.374801858356765E-7,0,0,8.856547912013024,146.11455552919497,TERT;MDK;CDKN2A;STMN1;ERBB2;FAM107A;BRCA2;MKI67;PTGS2;FGF2;QKI;MYLK
Acquired scoliosis,29/418,7.273936697878654E-8,9.94944172361569E-7,0,0,3.4346821237888077,56.45375121312274,RET;FBN2;CTNND2;BRCA2;RPS6KA3;SIX3;NDN;TNNI2;DMD;SOX5;PLK4;EGR2;TPM3;GAD1;FANCA;LIFR;KIF22;RUNX2;TGFBR2;COL1A1;COL3A1;COL1A2;COL2A1;RAD51;BIN1;FANCD2;PRKD1;FGFR3;EZH2
Ischemia,14/104,7.627587992692496E-8,1.0411967674577805E-6,0,0,7.025264243361691,115.13641687835276,EGR1;NGFR;ANXA1;IL18;PRKCA;PTGS2;SELE;ACTA2;IL6;MMP14;CXCL12;CCL2;S100A4;PPARG
Restenosis,20/215,7.886703133438331E-8,1.0743833315247835E-6,0,0,4.672096530920061,76.41448672638337,EGR1;JUN;ANXA1;PLA2G2A;IL18;CIB1;FOS;ESR1;SELE;AGT;C3;CCNA2;NR4A1;IL6;VCAN;PECAM1;SERPING1;CCL2;PPARG;TIMP1
Acoustic Neuroma,12/74,8.001335021881802E-8,1.087792834148951E-6,0,0,8.71325337107949,142.38390364013907,CCND1;PARP1;CDKN2A;HGF;CAV1;CHEK1;ERBB2;FGF1;PTGS2;FGF2;MET;AQP1
Bronchioloalveolar Adenocarcinoma,13/89,8.32810061128844E-8,1.1299297718265285E-6,0,0,7.71281067251462,125.72687640691092,ALK;PRKN;CDKN2A;HGF;CAV1;TGFBR2;MUC1;RAD51;CCND1;TERT;SIX3;ERBB2;MET
Pheochromocytoma,23/280,8.455070107074613E-8,1.1448437669176028E-6,0,0,4.0925553690965755,66.65100670422143,RET;NRP1;CDKN2C;CBX4;EPAS1;DUSP1;CDKN2A;GATA4;SYP;MKI67;PKD2;SSTR2;AGT;CXCL10;MYCN;CXCL12;TERT;CCND1;STMN1;KIT;ERBB2;KDR;ELOB
Carotid Atherosclerosis,14/105,8.624827793083205E-8,1.165087989547998E-6,0,0,6.94770658575763,113.0116436853629,STAT1;HGF;PLA2G2A;ESR1;SELE;AGT;LMNB1;IL6;CXCL12;CCL2;PPARG;CD36;APOB;PPARGC1A
Benign neoplasm of breast,8/27,8.639276634825833E-8,1.165087989547998E-6,0,0,18.823075996627725,306.145319844361,DUSP1;S100A4;BRCA1;TIMP1;BRCA2;ESR1;NDC80;AURKA
"Truncus Arteriosus, Persistent",9/37,8.823441576822317E-8,1.1875397521029796E-6,0,0,14.395724115334207,233.8336156359125,RET;NRP1;DDX39A;PAX3;GATA4;PRKD1;NKX2-5;ZFPM2;FGFR3
Intrahepatic Cholangiocarcinoma,18/177,9.167376406816209E-8,1.2313619989635531E-6,0,0,5.142326896734567,83.3315595988708,YAP1;CISH;CDKN2A;HGF;BGN;CXCR4;PTGS2;IL6;MUC1;CXCL12;RAD51;CCND1;TERT;ERBB2;KDR;SDC1;VIM;PPARA
Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,12/75,9.335959075900598E-8,1.2515030170408865E-6,0,0,8.574507863191466,138.79390589460903,ALK;IL6;MYCN;CCND1;PARP1;CDKN2A;CAV1;ERG;BRCA2;ENO2;FGF2;FLI1
Atrial Premature Complexes,14/106,9.738327216486145E-8,1.302840748723525E-6,0,0,6.871834964188439,110.94310499685541,RET;TCF7L2;BLM;CCL21;CDKN2A;CAV1;BRCA1;BRCA2;PTGS2;KLF4;FOXO1;ACTC1;CHEK1;SGK1
Cerebrovascular Disorders,18/178,9.992932092227114E-8,1.3342451676222127E-6,0,0,5.109923887587822,82.36585491327484,NRP1;MEF2C;HGF;FLT4;F13A1;PKD2;TUBG1;PTGS2;SELE;AGT;TGFBR2;ACTA2;COL3A1;CCND1;PECAM1;CTSG;TEK;APOB
Squamous cell carcinoma of lung,23/283,1.0263707305708046E-7,1.3676797274828421E-6,0,0,4.0447047028800585,65.08765759213014,RET;YAP1;COL17A1;ALK;CDKN2A;STAT1;SIAH2;GZMB;GATA4;BRCA2;FGF1;TGFBR2;IL6;TERT;CCND1;ERBB2;E2F1;SERPING1;RARB;VIM;FGFR4;FGFR3;MET
Varicosity,12/76,1.0865986675268324E-7,1.4448687817046728E-6,0,0,8.440098152424943,135.33733951692128,COL1A1;JUN;COL3A1;EPAS1;KDR;CCL2;TIMP1;FOS;CALR;ESR1;SELE;GFAP
Scleroderma,18/179,1.0885997670377672E-7,1.4448687817046728E-6,0,0,5.077923400293831,81.41537871608057,EGR1;BLM;EGR2;HGF;CAV1;PLAUR;PDGFA;PTGS2;FGF2;FLI1;TGFBR2;COL1A1;IL6;COL3A1;COL1A2;CTLA4;CCL2;TIMP1
"Dermatitis, Allergic Contact",14/107,1.0979983341816711E-7,1.451605671725217E-6,0,0,6.797594990394931,108.92878707674227,CISH;CCL21;IL18;F13A1;GZMB;SELE;ETS2;SOCS3;CXCL10;CCL2;PPARG;CD36;CCL19;PPARA
Head and Neck Neoplasms,14/107,1.0979983341816711E-7,1.451605671725217E-6,0,0,6.797594990394931,108.92878707674227,STAT5A;STAT5B;EPAS1;BRCA1;MKI67;PTGS2;IL6;RAD51;CCND1;ERBB2;KDR;RARB;VIM;FGFR4
Polycystic Kidney Diseases,15/124,1.1166906913560334E-7,1.4734174230151512E-6,0,0,6.223383827608278,99.62222359915754,JUN;HGF;IL18;SIX1;GATA3;FOS;PKD2;PAX2;AQP1;FGF7;ERBB2;RCC1;PAEP;PRKD1;ZNF423
"Polycystic Kidney, Autosomal Dominant",17/161,1.2083238421046751E-7,1.591196651681372E-6,0,0,5.35415044132918,85.28552086308098,STAT5A;STAT5B;JUN;CBX4;IL18;FOS;PKD2;ESR1;PAX2;AGT;FGF7;ERBB2;CXCR2;PPARG;PRKD1;TIMP1;PAK4
Arthropathy,15/125,1.2434978475350628E-7,1.6340882161278437E-6,0,0,6.166490486257928,98.0482309876498,PRKN;KRT5;FGF1;PTGS2;FGF2;DCN;COL1A1;ACAN;IL6;MMP14;COL2A1;KDR;LTA;CCL2;CALR
Carcinosarcoma,10/50,1.2457611177150924E-7,1.6340882161278437E-6,0,0,11.21551724137931,178.30820696347106,ALK;CCND1;CDKN2A;KIT;ERBB2;HMGA2;BRCA1;VIM;MKI67;MET
Nephritis,17/162,1.3227926854330068E-7,1.731749644321262E-6,0,0,5.3169513374154045,84.21173875888726,CDKN2A;CAV1;IL18;GATA3;PTGS2;FGF2;ESR1;FLI1;AGT;GADD45G;TGFBR2;C3;CXCL10;CCND2;CXCR2;CCL2;MET
Nodule,15/126,1.383209383289781E-7,1.8073218323296047E-6,0,0,6.1106222501571335,96.50926870993302,RET;FANCA;MITF;PTGS2;RUNX2;AQP1;AURKA;COL1A1;BMP2;VCAN;KRT19;MDK;KIT;ERG;VIM
Encephalitis,16/144,1.4012905920731745E-7,1.8273917701676582E-6,0,0,5.660547785547785,89.32741768973487,EGR1;CNTNAP2;STAT1;SH2D1A;IL18;CXCR4;ENO2;PTGS2;FGF2;GFAP;VTN;CXCL10;IL6;CCL2;PPARG;TIMP1
Non-alcoholic Fatty Liver Disease,25/334,1.4075950153003538E-7,1.8320558377436388E-6,0,0,3.7074279550007705,58.48917334410256,YAP1;LAMA1;IRS2;FGF1;TERT;ALDH2;CXCR2;LEPR;S1PR1;CCL2;CD36;APOB;PPARGC1A;TCF7L2;JUN;CAV1;FOS;AGT;COL1A1;IL6;TXNIP;PPARG;TEK;PPARA;EZH2
Cerebral arterial aneurysm,12/78,1.4613456904094044E-7,1.8946713623145867E-6,0,0,8.183497795507034,128.79792718685482,ACTA2;VCAN;COL3A1;IL6;COL1A2;CDKN2A;STAT1;CCL2;PKD2;PTGS2;AGT;TGFBR2
Pulmonary Edema,12/78,1.4613456904094044E-7,1.8946713623145867E-6,0,0,8.183497795507034,128.79792718685482,FGF7;IL6;VWF;EPAS1;PECAM1;CCL2;ADRB2;TEK;SGK1;PTGS2;KLF4;AQP1
Graves Disease,25/335,1.4902810924648108E-7,1.928463933910148E-6,0,0,3.6952764976958523,58.086534964683835,RET;CXCR4;ADRB1;GATA3;ADRB2;C4B;C4A;SOCS3;CTLA4;BAK1;VAV3;ANXA3;CDKN2A;GAD1;SH2D1A;PLA2G2A;IL18;TAP1;SSTR2;ESR1;CXCL10;IL6;LTA;PPARG;CALR
Cystadenoma,10/51,1.5191173457308778E-7,1.9619984796016493E-6,0,0,10.941407345107933,171.77972526192062,FGF7;PARP1;DUSP1;CDKN2A;SIX2;ERBB2;RARB;BRCA1;MKI67;EZH2
"Hepatitis, Chronic",18/183,1.5237261937697207E-7,1.9641737269400083E-6,0,0,4.9538002980625935,77.75949055872991,CR1;CDKN2A;STAT1;HGF;IL18;TAP1;MKI67;PTGS2;AGT;ACTA2;SOCS3;CXCL10;IL6;KRT19;PAEP;CCL2;CALR;MET
Curvature of spine,28/408,1.536089542817891E-7,1.976317503748076E-6,0,0,3.3882367789978542,53.15755797708379,RET;CTNND2;BRCA2;RPS6KA3;SIX3;NDN;TNNI2;DMD;SOX5;PLK4;TPM3;GAD1;FANCA;LIFR;KIF22;RUNX2;GFAP;TGFBR2;COL1A1;COL3A1;COL1A2;COL2A1;RAD51;BIN1;FANCD2;PRKD1;FGFR3;EZH2
Osteogenesis Imperfecta,19/204,1.6356326114501745E-7,2.100364936615559E-6,0,0,4.669838852937445,72.97121013995591,STAT5B;BLM;BGN;PAX3;CXCR4;LIFR;KIF22;ESR1;RUNX2;DCN;COL1A1;RPS6KA3;ACAN;COL3A1;COL1A2;COL2A1;DMD;BMPR1B;FGFR3
TARSAL-CARPAL COALITION SYNDROME,17/165,1.7280715582062227E-7,2.2148336994108765E-6,0,0,5.208370169234655,81.09999842113398,ANXA1;CDKN2A;PTGS2;FGF2;ESR1;IL6;CCND1;TERT;FEZ1;STMN1;ERBB2;E2F1;PRTN3;FGFR3;CEP55;EZH2;CDKN3
Hepatic methionine adenosyltransferase deficiency,11/65,1.7756870440840242E-7,2.2715265120130106E-6,0,0,9.153055128861581,142.27424900054035,ALK;NRP1;CDKN2A;HGF;CAV1;ERBB2;CXCR4;TIMP1;PTGS2;KLF4;MET
Invasive Lobular Breast Carcinoma,10/52,1.84381279953275E-7,2.3497242431996106E-6,0,0,10.680350301039956,165.6122891894846,CCND2;CCND1;KIT;ERBB2;CTLA4;BRCA1;TIMP1;GATA3;PTGS2;ESR1
Lymphocytic infiltration,10/52,1.84381279953275E-7,2.3497242431996106E-6,0,0,10.680350301039956,165.6122891894846,CXCL10;IL6;CXCL12;CCND1;ERBB2;LTA;CTLA4;CXCR4;BRCA1;ESR1
Luminal B Breast Carcinoma,12/80,1.947356658036192E-7,2.476978658214217E-6,0,0,7.941991577231354,122.71665779832767,MUC1;MELK;CCND1;CFL1;ERBB2;SIX1;CCL2;BRCA1;GATA3;BRCA2;UTRN;ESR1
Idiopathic pulmonary hypertension,13/96,2.076149767410476E-7,2.625879818818975E-6,0,0,7.059794734493529,108.63316011495564,STAT5A;STAT5B;CAV1;PDGFA;FGF2;DCN;TGFBR2;BMP2;IL6;CCL2;PPARG;BMPR1B;PPARGC1A
Steroid Sulfatase Deficiency Disease,13/96,2.076149767410476E-7,2.625879818818975E-6,0,0,7.059794734493529,108.63316011495564,PARP1;EPAS1;CDKN2A;BRCA1;MKI67;BMP2;KIT;ERBB2;KDR;PECAM1;CCL2;VIM;EZR
Werner Syndrome,13/96,2.076149767410476E-7,2.625879818818975E-6,0,0,7.059794734493529,108.63316011495564,FEN1;BLM;PARP1;CDKN2A;BRCA1;DCN;HOXA10;RIMS2;RPS6KA3;COL3A1;RAD51;FANCD2;TIMP1
High grade serous carcinoma,8/30,2.147995073001941E-7,2.711641900428766E-6,0,0,16.253796546702723,249.55365299172894,PARP1;CDKN2A;STMN1;HMGA2;BRCA1;BRCA2;ESR1;PAX2
"Adenocarcinoma, Clear Cell",14/113,2.1929059106510118E-7,2.747678376106753E-6,0,0,6.383650894091729,97.87967707156515,BARD1;MAML2;INHBA;SLC2A4;BRCA2;PTGS2;IL6;VCAN;MUC1;TERT;ERBB2;SDC1;CTLA4;MET
"Diabetes Mellitus, Experimental",14/113,2.1929059106510118E-7,2.747678376106753E-6,0,0,6.383650894091729,97.87967707156515,CAV1;IRS2;PRKCA;SLC2A4;PTGS2;ADRA1A;AGT;IL6;LEPR;PPARG;TIMP1;PPARA;PPARGC1A;ATF3
Alloxan Diabetes,14/113,2.1929059106510118E-7,2.747678376106753E-6,0,0,6.383650894091729,97.87967707156515,CAV1;IRS2;PRKCA;SLC2A4;PTGS2;ADRA1A;AGT;IL6;LEPR;PPARG;TIMP1;PPARA;PPARGC1A;ATF3
Streptozotocin Diabetes,14/113,2.1929059106510118E-7,2.747678376106753E-6,0,0,6.383650894091729,97.87967707156515,CAV1;IRS2;PRKCA;SLC2A4;PTGS2;ADRA1A;AGT;IL6;LEPR;PPARG;TIMP1;PPARA;PPARGC1A;ATF3
Tumor-Associated Vasculature,10/53,2.2279062642777135E-7,2.7863349107800976E-6,0,0,10.431435445068164,159.77864513735543,IL6;CXCL12;SERPINC1;KDR;PECAM1;FGF2;SELE;ATF3;FLI1;AQP1
Insulin Resistance,12/81,2.240589550286473E-7,2.7969887397256417E-6,0,0,7.826488603273421,119.83415814678675,C3;NR4A1;CAV1;LEPR;HMGA1;IRS2;PPARG;SLC2A4;CD36;FOS;ADRB2;PPARA
"Neoplasms, Intracranial",13/97,2.3496272722961073E-7,2.9222401408778993E-6,0,0,6.97539131393298,106.47124957968354,ALK;YAP1;CDKN2A;HGF;PLAUR;ESR1;TGFBR2;MELK;CCND1;MDK;KDR;LEPR;CCL2
Ovarian Serous Adenocarcinoma,13/97,2.3496272722961073E-7,2.9222401408778993E-6,0,0,6.97539131393298,106.47124957968354,ALK;HMGA2;BRCA1;BRCA2;PTGS2;PAX2;AURKA;TERT;CALR;TK1;TEK;BUB1;SKAP1
Ductal Carcinoma,20/230,2.378118051487146E-7,2.9522071781492924E-6,0,0,4.335014005602241,66.116706834008,STAT5A;CA12;CISH;CDKN2A;SIAH2;CAV1;HMGA1;BRCA1;BRCA2;PTGS2;KLF4;FGF2;ESR1;RPS6KA3;MUC1;CCND1;ERBB2;PECAM1;NEK2;S100A4
Gestational Diabetes,11/67,2.4495044910373975E-7,3.0245264487849613E-6,0,0,8.825255102040817,134.33988554382842,TCF7L2;IL6;CDKN2A;ELF5;KDR;LEPR;TXNIP;CCL2;PPARG;FGF2;MET
"Carcinoma, Endometrioid",14/114,2.449884437371976E-7,3.0245264487849613E-6,0,0,6.319489559164733,96.19561635193679,CDKN2A;LAMC1;ENO2;ESR1;AQP1;AURKA;IL6;TERT;WT1;KIT;ERBB2;CTLA4;S100A4;EZR
Intracranial Aneurysm,14/114,2.449884437371976E-7,3.0245264487849613E-6,0,0,6.319489559164733,96.19561635193679,FBN2;CDKN2A;STAT1;PKD2;FGF2;AGT;TGFBR2;ACTA2;IL6;VCAN;COL3A1;COL1A2;CCL2;TIMP1
Salivary Gland Neoplasms,12/82,2.5725265382679483E-7,3.1701079322949613E-6,0,0,7.714285714285714,117.05045512741447,VCAN;CCND1;HGF;KRT15;ERBB2;FANCA;HOMER3;PPARG;KRT5;PRKD1;PTGS2;AQP1
"Alzheimer Disease, Late Onset",21/253,2.6016145560297094E-7,3.2000812011530275E-6,0,0,4.125152488614184,62.54541111602713,EGR1;CR1;LRP1;IL18;GZMB;SLC2A4;ESR1;GFAP;PYY;IL6;ALDH2;BIN1;DPYSL2;ADAM12;LEPR;PPARG;A2M;PPARA;PPARGC1A;NECTIN2;CDKN3
Cerebral Aneurysm,10/54,2.680475893796088E-7,3.291055960280535E-6,0,0,10.193834900731453,154.25414235219878,ACTA2;COL3A1;IL6;SHC3;STAT1;KDR;CCL2;PTGS2;ESR1;AGT
Primary Sj??gren's syndrome,16/151,2.708100342860563E-7,3.3189054566882376E-6,0,0,5.365104031770699,81.1302889729246,STAT5A;STAT5B;STAT1;FLT4;IL18;PTGS2;RIMS2;C4A;IL6;KRT19;CXCL12;LTA;CTLA4;BAK1;IKBKE;RUNX1T1
Amyotrophic Lateral Sclerosis,37/660,2.7783420838687326E-7,3.398787875275484E-6,0,0,2.7558146854247316,41.60244339723433,RET;PRKN;GRIA2;PTPRN;BRCA1;LAMC1;PTGS2;FGF2;ETS2;LMNB1;C3;RIMS2;CHAF1A;STMN1;KDR;CCL2;TIMP1;PPARGC1A;TEAD1;NEFH;GRIA4;TNS1;STAT5A;NGFR;PARP1;CDKN2A;HGF;PLA2G4A;CDC7;SYP;GFAP;CXCL10;MMP14;PPARG;SGK1;CRYAB;MET
Transitional Cell Neoplasm,5/8,2.8256168470065637E-7,3.450335044453833E-6,0,0,74.06060606060606,1116.7872039871104,ANXA1;CCND2;CCND1;PLA2G4A;FGFR3
Bright Disease,8/31,2.839144959559151E-7,3.4542930341303004E-6,0,0,15.546313799621927,234.35434874412462,IL6;NPHS1;WT1;IL18;CCL2;PPARG;ESR1;AGT
Myelomonocytic leukemia,8/31,2.839144959559151E-7,3.4542930341303004E-6,0,0,15.546313799621927,234.35434874412462,NGFR;MEF2C;IL6;MECOM;CHEK1;E2F1;CCL2;SCN4A
Ewings sarcoma-primitive neuroectodermal tumor (PNET),9/42,2.8655759749401795E-7,3.4801461569074582E-6,0,0,12.211426188490409,183.96911990578252,CDKN2A;WT1;ERBB2;KIT;ERG;ENO2;FGF2;FLI1;EZH2
Choriocarcinoma,23/300,2.9250935240306973E-7,3.54601590386104E-6,0,0,3.7931288175612092,57.06674759378024,STAT1;CAV1;PDGFA;CXCR4;FGF2;ESR1;AGT;ETS2;RIMS2;RPS6KA3;KRT19;FGF7;IL6;MUC1;CCND2;TERT;KDR;PAEP;CCL2;PPARG;TIMP1;EZR;TEAD1
Skin Carcinogenesis,15/134,3.1249678455693714E-7,3.7814926217736756E-6,0,0,5.697478991596639,85.34066708915286,PRKN;PARP1;CDKN2A;STAT1;PRKCA;PTGS2;KLF4;AURKA;CCND1;FANCD2;KIT;ERBB2;SDC1;PPARG;FGFR3
Insulin Sensitivity,10/55,3.2117166969713133E-7,3.879476499435133E-6,0,0,9.966794380587483,149.0164337545831,C3;NR4A1;LEPR;HMGA1;IRS2;PPARG;SLC2A4;CD36;ADRB2;PPARA
Sezary Syndrome,16/153,3.2456494275695943E-7,3.906412465153655E-6,0,0,5.286236877477753,78.98050321371582,STAT5A;STAT5B;CCL21;SATB1;CDKN2A;GATA3;IL2RG;SOCS3;CXCL10;CCND1;BIN1;ERBB2;TNFSF11;CTLA4;CCL19;VIM
Squamous cell carcinoma of tongue,16/153,3.2456494275695943E-7,3.906412465153655E-6,0,0,5.286236877477753,78.98050321371582,CDT1;NRP1;EPAS1;SATB1;CDKN2A;CAV1;HMGA2;BRCA1;PTGS2;ESR1;MMP14;CCND1;SIX2;VIM;EZR;EZH2
Basal-Like Breast Carcinoma,7/22,3.289368892384538E-7,3.946533537205395E-6,0,0,20.818873668188736,310.77165334979355,IL6;MELK;HGF;ERBB2;ESR1;SOX10;MET
"Pancreatitis, Chronic",23/302,3.290736719528024E-7,3.946533537205395E-6,0,0,3.765547231989672,56.20826397729778,NGFR;DUSP1;CDKN2A;IL18;BRCA2;PTGS2;FGF1;FGF2;DCN;CDC20;COL1A1;NR4A1;CXCL10;IL6;MUC1;CCND1;ALDH2;ERBB2;LTA;SDC1;CCL2;S100A4;TK1
Thrombophilia,12/84,3.370485825898225E-7,4.032235971291141E-6,0,0,7.499230177059276,111.7613179613558,C3;IL6;PROC;VWF;SERPINC1;PROS1;F12;F13A1;BRCA2;A2M;FGFR4;ESR1
Polymyositis,13/100,3.374205800871979E-7,4.032235971291141E-6,0,0,6.733822903363134,100.34699573650147,CCL21;HGF;CXCR4;CXCL10;IL6;CXCL12;STMN1;SDC1;CCL2;DMD;TIMP1;CCL19;UTRN
Hyperhomocysteinemia,14/117,3.3915209619394905E-7,4.045729090654639E-6,0,0,6.13448066136553,91.38423683817939,MEF2C;F12;AGT;VAV2;IL6;KRT19;PROC;TERT;NPHS1;ERBB2;KDR;CCL2;TIMP1;ATF3
"Carcinoma of urinary bladder, superficial",9/43,3.5533779046653604E-7,4.231291845342652E-6,0,0,11.8516594711279,175.99947765579836,IL6;TERT;CDKN2A;CCL2;CIB1;S100A4;FGF2;FGFR3;EZH2
Lymphoproliferative Disorders,19/215,3.710148662013012E-7,4.4101519316954665E-6,0,0,4.405252946248922,65.228684799507,ALK;CCL21;SATB1;CDKN2A;SH2D1A;LMO2;IL18;CXCR4;IL6;CCND1;KIT;BCL3;ERBB2;PECAM1;CTLA4;MCM4;BAK1;NKX2-5;FGFR4
"Melanoma, B16",15/136,3.7944791821694615E-7,4.502424414743835E-6,0,0,5.602729194695368,82.83382144090614,HGF;CXCR4;PTGS2;FGF2;ESR1;VTN;IL6;MUC1;TERT;ERBB2;KDR;IRF7;CTLA4;PRTN3;CALR
Adult Cholangiocarcinoma,10/56,3.8330441351905895E-7,4.54016303561552E-6,0,0,9.749625187406297,144.04521676863638,PRKN;MUC1;HGF;STMN1;MITF;PPARG;KPNA2;MET;TGFBR2;EZH2
Aplastic Anemia,16/155,3.878137985981688E-7,4.577082208931934E-6,0,0,5.209639281581728,76.90855288049174,SERPINC1;SH2D1A;FANCA;IL18;CXCR4;GATA3;RIMS2;IL6;TERT;MECOM;FANCD2;TAL1;RUVBL1;KIT;CTLA4;EZH2
"Glaucoma, Open-Angle",11/70,3.884658813417514E-7,4.577082208931934E-6,0,0,8.375224556744513,123.62719632045597,VAV3;CAV2;CAV1;IL18;SIX1;TAP1;ADRB1;ADRB2;PTGS2;ESR1;AGT
Stromal Neoplasm,11/70,3.884658813417514E-7,4.577082208931934E-6,0,0,8.375224556744513,123.62719632045597,VCAN;IL6;HGF;CAV1;KIT;LEPR;CCL2;TIMP1;IL2RG;PAX2;ATF3
"Hepatitis B, Chronic",20/238,4.1214560353180104E-7,4.847582965533408E-6,0,0,4.174203993524015,61.36868437472645,STAT1;IL18;GZMB;PTGS2;ESR1;SELE;AGT;VTN;SOCS3;CXCL10;IL6;ALDH2;CXCR2;LEPR;PAEP;CTLA4;CCL2;PPARG;TIMP1;PAK3
Low density lipoprotein cholesterol measurement,22/283,4.1878769758964083E-7,4.917094715055993E-6,0,0,3.8447143646458883,56.46309735358193,TCF7L2;PARP1;LRP1;SERPINC1;CDKN2A;PDE1A;BRCA2;ESR1;SYN1;TGFBR2;ACAN;MMP14;MECOM;FANCD2;BCL3;KDR;LEPR;PPARG;CD36;APOB;PPARA;NECTIN2
Carotid Artery Diseases,10/57,4.557203967166593E-7,5.341392991883217E-6,0,0,9.541697236488139,139.32200807656795,IL6;LRP1;HGF;CCL2;PPARG;PTGS2;APOB;TNFRSF4;SELE;AGT
Pituitary Diseases,20/240,4.710427651512816E-7,5.511364478669002E-6,0,0,4.1358288770053475,60.252065933460315,RET;CDKN2C;CDKN2A;HMGA1;HMGA2;CIB1;ESR1;ADRA1A;AGT;EPS8;HOXA10;RIMS2;IL6;CCND1;SIX3;LEPR;E2F1;PPARG;APOB;PITX1
Refractory cancer,17/177,4.740388513058444E-7,5.536773783252263E-6,0,0,4.814763434579439,70.1124722465838,ALK;PARP1;SIX1;CXCR4;KIF22;BRCA2;FGF2;ESR1;AURKA;IL6;STMN1;KIT;ERBB2;RARB;FGFR3;MET;EZH2
Nasal Polyps,19/219,4.929029938597131E-7,5.747111990905959E-6,0,0,4.316255868544601,62.68478305407094,CCL13;JUN;ANXA1;PLA2G2A;TAP1;GATA3;FOS;PTGS2;SELE;SOCS3;IL6;MUC1;TERT;LEPR;SDC1;CCL2;VIM;A2M;MET
Renal Insufficiency,21/263,4.949004822773659E-7,5.760401454029098E-6,0,0,3.952645017932325,57.38809387998755,ALK;CLIC5;HLF;VWF;IL18;HMGA2;GATA3;ADRB2;PTGS2;PKD2;PAX2;AGT;TGFBR2;C3;IL6;VCAN;NPHS1;WT1;CTSG;PPARG;TIMP1
Multiple tumors,12/87,4.981602416846399E-7,5.7883117355606266E-6,0,0,7.198152424942263,104.46206445195945,RET;CDC20;MMP14;MELK;CDKN2A;CCL2;BRCA1;BRCA2;UTRN;PTGS2;MET;GADD45G
Pain,30/485,5.14613504980487E-7,5.9691611389446465E-6,0,0,3.034555805640143,43.939911953107206,COL17A1;OPRD1;ADRB2;PTGS2;ADRA1A;AQP1;ACAN;ERBB2;CCL2;CTSG;PPARGC1A;NEFH;NGFR;ANXA1;GAD1;HGF;BGN;PLA2G4A;ESR1;COL1A1;CXCL10;IL6;VCAN;COL2A1;CXCL12;TAL1;SERPING1;SCN4A;PPARA;RAMP1
Benign melanocytic nevus,11/72,5.213349682562383E-7,6.036699391049821E-6,0,0,8.099796026289944,117.17872099285702,CCND1;PARP1;CDKN2A;KIT;ERBB2;PAX3;MITF;PPARG;FOS;FGF2;SOX10
Atrial Fibrillation,22/288,5.641706737235997E-7,6.521463416054553E-6,0,0,3.771467676282906,54.26353379159646,TCF7L2;VWF;CAV2;CAV1;IL18;GATA4;ADRB1;SELE;AGT;COL1A1;IL6;CHAF1A;CXCL12;TERT;GRK5;KIT;CCL2;KCNQ5;CALR;TIMP1;NKX2-5;SOX5
"Leukoencephalopathy, Progressive Multifocal",13/105,5.990596601667857E-7,6.901002877667465E-6,0,0,6.366218800322061,91.21457591500057,PRKN;EGR1;STAT1;GFAP;CXCL10;RAD51;CCND1;TERT;RARB;CCL2;PPARG;PPARGC1A;RUNX1T1
Ehlers-Danlos Syndrome,13/105,5.990596601667857E-7,6.901002877667465E-6,0,0,6.366218800322061,91.21457591500057,FBN2;BGN;ADRB2;PKD2;PTGS2;DCN;MYLK;TGFBR2;COL1A1;ACTA2;COL3A1;COL1A2;COL2A1
Parathyroid Gland Adenocarcinoma,8/34,6.162799310319568E-7,7.0751043022403794E-6,0,0,13.750396057032212,196.6246759113123,RET;RIMS2;CDKN2C;CCND1;TERT;BRCA2;APOB;EZH2
Rhabdoid Tumor of the Kidney,8/34,6.162799310319568E-7,7.0751043022403794E-6,0,0,13.750396057032212,196.6246759113123,YAP1;CDKN2A;ERBB2;KIT;CXCR4;CIB1;PTGS2;MET
Squamous cell carcinoma of mouth,10/59,6.372359114939116E-7,7.290760445644141E-6,0,0,9.151301900070372,130.55362507564632,CCND1;TERT;CDKN2A;CXCR4;CCL2;GZMB;TIMP1;KLF4;FGFR4;CEP55
SVEINSSON CHORIORETINAL ATROPHY,10/59,6.372359114939116E-7,7.290760445644141E-6,0,0,9.151301900070372,130.55362507564632,IL6;CXCL12;TERT;CDKN2A;ERBB2;BRCA1;ERG;APOB;TEAD1;FOXO1
Anxiety,29/464,6.474083095981375E-7,7.394547971532468E-6,0,0,3.0641025641025643,43.66434602291485,PRKN;GRIA2;MAGED1;CTNND2;FLT4;BRCA1;ADRB2;PTGS2;BRCA2;ADCY5;CCND1;ALDH2;STMN1;PAK3;PPARGC1A;NEFH;SOX5;EGR1;CISH;CDKN2A;GAD1;ESR1;AGT;SYN1;TGFBR2;RCAN1;IL6;TAL1;FKBP4
Familial multiple trichoepitheliomata,16/161,6.5019841574297E-7,7.4062167228902975E-6,0,0,4.992524716662648,71.12344852953554,ANXA1;CDKN2A;IL18;INHBA;BRCA2;PTGS2;ESR1;AKAP12;CCND1;TERT;ERBB2;PPARG;DMD;FKBP4;APOB;MET
Gastritis,17/181,6.506354774427152E-7,7.4062167228902975E-6,0,0,4.696361408707545,66.9011536982021,JUN;CDKN2A;HGF;CAV1;IL18;FOS;PTGS2;SELE;AGT;CXCL10;IL6;MUC1;TERT;CCL2;PRTN3;PPARG;MET
Disseminated Intravascular Coagulation,9/46,6.543664367723663E-7,7.4360828923235395E-6,0,0,10.889040416563352,155.0555618564829,VTN;MUC1;ZFP36;IL6;PROC;SERPINC1;TAL1;PROS1;F13A1
CNS disorder,14/124,6.964623702677611E-7,7.901083241078182E-6,0,0,5.742037544821768,81.40631368029058,ALK;MEF2C;PARP1;DST;GFAP;SOCS3;ZFP36;IL6;CXCL12;ERBB2;CCL2;PPARG;TIMP1;VIM
Venous Thrombosis,12/90,7.243511241536842E-7,8.203612394293664E-6,0,0,6.9202344999111745,97.83820327866292,C4A;PROC;VWF;SERPINC1;PROS1;F12;KDR;SAA1;F13A1;CALR;ESR1;AGT
BREAST CANCER 3,6/16,7.775177233953043E-7,8.790924293472835E-6,0,0,26.712984054669704,375.7758046876372,ERBB2;HMGA1;BRCA1;GATA3;BRCA2;ESR1
Carcinoma in situ of uterine cervix,9/47,7.935627744531068E-7,8.942227505414539E-6,0,0,10.601943505552873,148.922671710184,CCND1;TERT;CISH;CDKN2A;TAP1;GATA3;VIM;KLF4;FGFR3
Hyperparathyroidism,9/47,7.935627744531068E-7,8.942227505414539E-6,0,0,10.601943505552873,148.922671710184,RET;IL6;CDKN2C;CCND1;WT1;LEPR;TNFSF11;CDKN3;EZH2
Malignant Fibrous Histiocytoma,11/75,7.958107098673957E-7,8.952537231942092E-6,0,0,7.7189300115207375,108.40391577774953,COL1A1;EPAS1;CDKN2A;STAT1;WT1;CCL2;MKI67;EZR;PTGS2;PPARGC1A;FGFR3
Malaria,29/469,8.052076391642316E-7,9.043101178305986E-6,0,0,3.0284910402097904,42.49628796374735,FBN2;ADRB2;PTGS2;BRCA2;C3;SPTA1;CTLA4;CCL2;SOSTDC1;NEK2;CD36;ANXA1;CR1;CISH;IL18;TAP1;KLHL3;FOS;SELE;AGT;CXCL10;IL6;FANCD2;PECAM1;LTA;SDC1;PPARG;ERG;FKBP4
Cervical Intraepithelial Neoplasia,18/205,8.264403185400786E-7,9.266065407871731E-6,0,0,4.366040902202908,61.15137196693821,ALK;CDKN2A;TAP1;SIX1;GATA3;MKI67;PTGS2;FGF2;ESR1;AGT;IL6;TERT;CHEK1;ERBB2;EZR;MET;BUB1;CDKN3
"Cholestasis, Extrahepatic",10/61,8.790333113586051E-7,9.822941296313464E-6,0,0,8.79152580572459,122.5929308598534,ACTA2;COL1A1;JUN;COL3A1;IL6;CDKN2A;BRCA1;TIMP1;FOS;BRCA2
Bile duct carcinoma,10/61,8.790333113586051E-7,9.822941296313464E-6,0,0,8.79152580572459,122.5929308598534,MUC1;ANXA1;CDKN2A;ERBB2;CXCR2;SSTR2;PTGS2;APOB;ESR1;DEPP1
Bone Diseases,16/165,9.05109384540073E-7,1.0097532602277626E-5,0,0,4.857495971589931,67.59307668230788,LRP1;HGF;CXCR4;ESR1;RUNX2;TGFBR2;COL1A1;BMP2;IL6;CXCL12;ERBB2;TNFSF11;SDC1;PPARG;DMD;FGFR3
Early-Stage Breast Carcinoma,11/76,9.120988874763966E-7,1.0158633711926169E-5,0,0,7.599787309464729,105.69417442127241,MUC1;KRT19;CCND1;ERBB2;BRCA1;BRCA2;FKBP4;PTGS2;PDLIM4;ESR1;EZH2
Renal glomerular disease,14/127,9.333568007021086E-7,1.0378185883303578E-5,0,0,5.588731700305936,77.5966239400602,EPAS1;BGN;CIB1;DCN;AGT;VTN;VCAN;MUC1;WT1;CFL1;PECAM1;CTLA4;CCL2;PRTN3
Malignant neoplasm of brain,16/166,9.815328034794134E-7,1.0895825302756596E-5,0,0,4.824864024864024,66.74789458919695,ALK;RET;YAP1;CDKN2A;FGF2;FLI1;GFAP;TGFBR2;MMP14;CCND1;TERT;CHEK1;ERBB2;E2F1;PPARG;EZH2
Peritonitis,14/128,1.0270285897259772E-6,1.1349711135771383E-5,0,0,5.539422802947043,76.38221909449891,DUSP1;IL18;GATA4;GATA3;BRCA1;FOS;PTGS2;SELE;VTN;SOCS3;IL6;SDC1;CCL2;PPARG
Hemolytic-Uremic Syndrome,10/62,1.0274902278959204E-6,1.1349711135771383E-5,0,0,8.622015915119363,118.88373010491055,C3;ZFP36;IL6;CXCL12;VWF;WT1;SAA1;CXCR4;CCL2;FGF2
Hereditary Malignant Neoplasm,10/62,1.0274902278959204E-6,1.1349711135771383E-5,0,0,8.622015915119363,118.88373010491055,RET;BARD1;BLM;MUC1;RAD51;CDKN2A;ERBB2;BRCA1;BRCA2;MET
"Osteoarthritis, Knee",12/93,1.0373639862254853E-6,1.1439961463859374E-5,0,0,6.6629030878453515,91.80699356958335,ACAN;SOCS3;IL6;COL2A1;EPAS1;ADAM12;IL18;TNFSF11;PPARA;PTGS2;PITX1;ESR1
Superficial ulcer,11/77,1.043089823332332E-6,1.1484247956557282E-5,0,0,7.484254992319508,103.08306341056304,VCAN;MMP14;IL6;BGN;CTLA4;TNFSF11;GZMB;PRTN3;TIMP1;PTGS2;DCN
Transitional cell carcinoma of bladder,16/167,1.0637308265821466E-6,1.1692334257488864E-5,0,0,4.792664289353031,65.91700190135504,RET;SATB1;CDKN2A;CAV1;ENO2;PTGS2;SELE;FGF7;CCND1;ERBB2;KDR;SDC1;VIM;FGFR3;CEP55;EZH2
Chronic liver disease,14/129,1.129028189963594E-6,1.2389793012737741E-5,0,0,5.490971451629174,75.19420484727486,NGFR;HGF;PLA2G2A;ANTXR2;PTGS2;ESR1;IL6;TERT;RACGAP1;ALDH2;CCL2;TIMP1;FGFR4;CDKN3
Female Breast Carcinoma,9/49,1.1502458175418234E-6,1.2602040637211885E-5,0,0,10.070814220183486,137.7237711788772,ALDH2;CCND1;CDKN2A;ERBB2;PECAM1;CXCR4;BRCA1;BRCA2;ESR1
Congenital Heart Defects,21/277,1.1528696945495772E-6,1.2610216398363128E-5,0,0,3.733776164504717,51.05287860349121,RET;MEF2C;FANCA;GATA4;PROX1;PKD2;KLF4;SYNE1;TGFBR2;ACTA2;RCAN1;ACTC1;ALDH2;FANCD2;TNFSF11;RARB;CAPN3;TEK;ZFPM2;NKX2-5;TDGF1
Hypopharyngeal Carcinoma,6/17,1.1790923420570735E-6,1.2876071819927326E-5,0,0,24.283288465520812,331.48547925575343,NGFR;CDKN2A;CAV1;HGF;PTGS2;ETS2
Hyperlipidemia,19/232,1.1846511060036644E-6,1.2915774071299693E-5,0,0,4.050100288743415,55.267920667206674,LRP1;SERPINC1;ADRB2;SLC2A4;MYLK;C3;MMP14;IL6;NPHS1;SAA1;LEPR;TXNIP;PAEP;SDC1;CCL2;PPARG;CD36;APOB;PPARA
Fibroadenoma,10/63,1.1973681321960167E-6,1.3033264790645784E-5,0,0,8.458902624159618,115.3403908533121,TERT;CDKN2A;KIT;ERBB2;HMGA2;CCL19;INHBA;FGF1;FGFR4;ESR1
Hereditary pyropoikilocytosis,8/37,1.236002744182705E-6,1.3410330258370028E-5,0,0,12.326047502564506,167.67896467290223,SPTA1;COL1A1;COL1A2;CDKN2A;GATA4;SCN4A;SPTB;SYNE1
Pelvic Organ Prolapse,8/37,1.236002744182705E-6,1.3410330258370028E-5,0,0,12.326047502564506,167.67896467290223,COL3A1;IL6;PARP1;LAMC1;PTGS2;ESR1;DCN;ATF3
Gallbladder Carcinoma,19/233,1.2638037807628688E-6,1.368984869613456E-5,0,0,4.030966170856917,54.74610151735525,YAP1;FEN1;CR1;CDKN2A;HGF;CXCR4;HMGA2;PTGS2;ESR1;DEPP1;TGFBR2;MUC1;CXCL12;ERBB2;FADD;TIMP1;VIM;APOB;EZH2
Cleft Palate,13/112,1.2662026170571098E-6,1.3693746821506522E-5,0,0,5.913954358398803,80.30847343692076,GAD1;F13A1;CIB1;FGF1;FGF2;RUNX2;TGFBR2;FGF7;BMP2;COL2A1;SPRY2;FGFR3;TNS1
"Muscular Dystrophy, Duchenne",17/190,1.2840710505917865E-6,1.3842409591933286E-5,0,0,4.449975690130193,60.3660340590648,PARP1;BGN;DCN;AGT;AQP1;SYNE1;TGFBR2;IL6;TERT;E2F1;CCL2;DMD;ERG;TIMP1;UTRN;EZH2;CDKN3
Dermatitis,17/190,1.2840710505917865E-6,1.3842409591933286E-5,0,0,4.449975690130193,60.3660340590648,STAT5A;STAT5B;PARP1;FLT4;IL18;PLAUR;PLA2G4A;GATA3;PTGS2;ZFP36;IL6;CXCL12;CXCR2;PAEP;CTLA4;CCL2;PPARA
Gastric ulcer,12/95,1.3076049927831155E-6,1.4073517838992634E-5,0,0,6.501683407996883,88.08034239047204,ANXA1;HGF;F13A1;PDGFA;CCL2;SDC1;TIMP1;TEK;PTGS2;FGF2;MET;AGT
Giant Cell Tumors,9/50,1.3753951050683449E-6,1.4755836302937707E-5,0,0,9.824681136719624,132.60145689979467,CCNA2;IL6;CCND1;TNFSF11;CCL2;FOS;VIM;MKI67;MET
Li-Fraumeni Syndrome,9/50,1.3753951050683449E-6,1.4755836302937707E-5,0,0,9.824681136719624,132.60145689979467,CDKN2A;CAV1;CHEK1;ERBB2;IRF7;BRCA1;BRCA2;ESR1;DCN
Transient Ischemic Attack,17/191,1.3811658947516659E-6,1.4794115070418164E-5,0,0,4.4241728434848,59.69351736906229,NGFR;PARP1;VWF;DUSP1;CAV1;GATA3;PTGS2;ESR1;HNRNPAB;AGT;C3;CXCL12;TERT;CCL2;PPARG;SGK1;NEFH
Diaphragmatic Hernia,10/64,1.3912350979202292E-6,1.4854586514518695E-5,0,0,8.301830566198383,111.95283052781608,FGF7;IL6;LRP1;WT1;PAX3;RARB;GATA4;ZFPM2;FGF2;AGT
Retinopathy of Prematurity,10/64,1.3912350979202292E-6,1.4854586514518695E-5,0,0,8.301830566198383,111.95283052781608,CCNA2;NRP1;HLF;CDKN2C;EPAS1;HGF;CFL1;KDR;PPARGC1A;AGT
Autistic Disorder,36/677,1.4015035171425052E-6,1.4925296955376972E-5,0,0,2.597194939142309,35.00490237570947,PRKN;GRIA2;CNTNAP2;RAB3A;MAGED1;LAMA1;CTNND2;ADRB2;PTGS2;EPS8;C4B;ACAN;ALDH2;DPYSL2;DMD;OTX1;PITX1;MPDZ;MEF2C;EGR2;GAD1;IL18;PLAUR;PAX3;GZMB;PLA2G4A;MAPK8IP2;AGT;SYN1;IL6;WT1;PECAM1;KCTD13;LTA;ERG;MET
"Obesity, Morbid",13/113,1.4023023196609395E-6,1.4925296955376972E-5,0,0,5.854513888888889,78.90359713874273,IL18;IRS2;ADRB2;ESR1;PYY;IL6;LEPR;SOSTDC1;PPARG;CD36;PPARA;PPARGC1A;MEST
Bladder neck obstruction,8/38,1.5353775911444728E-6,1.631581630083272E-5,0,0,11.914569031273837,159.4971689610583,COL1A1;PPP1R14A;COL3A1;HGF;PTGS2;ADRA1A;ESR1;MET
Craniosynostosis,18/214,1.5415416229249985E-6,1.635544003090725E-5,0,0,4.16362376332266,55.72064260518428,PLK4;CDT1;PLA2G2A;SIX1;PTGS2;FGF2;RUNX2;TGFBR2;BMP2;IL6;TNFSF11;SDC1;KCNQ5;SCN4A;VIM;FGFR4;FGFR3;EZH2
Achondroplasia,7/27,1.5555413317736332E-6,1.6477942561816593E-5,0,0,15.610159817351597,208.76539063028005,ACAN;COL2A1;FGF1;FGF2;FGFR3;AGT;DCN
Sjogren's Syndrome,20/260,1.655534730503796E-6,1.7509561023722038E-5,0,0,3.787254901960784,50.413613779013176,NRP1;CCL21;CDKN2A;STAT1;IL18;CXCR4;ESR1;C3;RIMS2;CCNA2;CXCL10;IL6;MUC1;CXCL12;CXCR2;LTA;E2F1;CTLA4;CALR;IKBKE
Age related macular degeneration,25/382,1.7021258695224818E-6,1.797402097439149E-5,0,0,3.2009470454848605,42.520204449555216,FBN2;NRP1;CCL13;FLT4;FGF2;C3;C4A;VTN;GRK5;KDR;CCL2;CD36;TIMP1;APOB;PPARGC1A;IL18;ESR1;SELE;MMP14;IL6;SERPING1;COL8A1;EZR;PPARA;CRYAB
Seizures,52/1174,1.7139254868494198E-6,1.8070209685527007E-5,0,0,2.1737718450785355,28.860569286882722,RET;CNTNAP2;BRCA2;FGF2;RPS6KA3;CCND2;CCND1;FLAD1;SIX3;TIMP1;TNS1;MEF2C;HGF;FOS;PROX1;TUBG1;SSTR2;SOX10;PAX2;SYN1;TGFBR2;ACTA2;UTRN;PRKN;GRIA2;GATA4;ADRB2;ASCL1;PTGS2;PLD1;ACAN;FADD;OTX1;PAK3;MPDZ;GRIA4;PLK4;NGFR;ARNT2;GAD1;GRIN2C;ESR1;AGT;GRIN2D;GFAP;CXCL10;COL3A1;IL6;RAD51;PROC;FGFR3;EZH2
Cachexia,15/153,1.7254236401954518E-6,1.8134499479738114E-5,0,0,4.908240647118301,65.1325396506426,STAT5A;PLK4;PRKN;EGR1;TRIM63;ADRB1;INHBA;PTGS2;SOCS3;PYY;ZFP36;IL6;MDK;PECAM1;CCL2
Primary Effusion Lymphoma,15/153,1.7254236401954518E-6,1.8134499479738114E-5,0,0,4.908240647118301,65.1325396506426,CDKN2A;HGF;CIB1;PTGS2;FGF2;ADRA1A;TGFBR2;IL6;CXCL12;PAEP;SDC1;FADD;FKBP4;MET;CDKN3
Smoldering myeloma,6/18,1.7354944256868886E-6,1.8211844629551788E-5,0,0,22.25854214123007,295.2421600775461,CDKN2C;CCND1;CDKN2A;KIT;SDC1;FGF2
Vascular lesions,11/81,1.74755339585489E-6,1.8309779417412545E-5,0,0,7.05513495720869,93.53199698095419,EGR1;IL6;ALDH2;VWF;FLT4;BGN;IRF7;CCL2;PAEP;PPARG;PRTN3
Skeletal dysplasia,10/66,1.8624484494735586E-6,1.9463696200572635E-5,0,0,8.004515599343186,105.60852561701327,COL1A1;ACAN;BMP2;COL2A1;COL1A2;STAT1;LIFR;KIF22;FGFR3;RUNX2
Endothelial dysfunction,20/262,1.8634837190244498E-6,1.9463696200572635E-5,0,0,3.755566358774915,49.547423026831645,VWF;STAT1;HGF;CAV1;PLA2G2A;BRCA1;PTGS2;FGF2;SELE;AGT;FOXO1;PER2;CDH5;CXCL10;IL6;PECAM1;TXNIP;PPARG;VIM;UTRN
"Condition, Preneoplastic",13/116,1.8920313341552135E-6,1.9670096656635315E-5,0,0,5.68311758360302,74.8913251869096,STAT5A;CISH;CDKN2A;PTGS2;IL6;MUC1;ACTC1;CCND1;ALDH2;CFL1;SIX3;SIRPA;CD36
Pancytopenia,13/116,1.8920313341552135E-6,1.9670096656635315E-5,0,0,5.68311758360302,74.8913251869096,SH2D1A;FANCA;BRCA1;FGF2;IL6;TERT;ALDH2;MECOM;FANCD2;RHOJ;TNFSF11;TNFRSF4;BUB1
Respiratory Syncytial Virus Infections,13/116,1.8920313341552135E-6,1.9670096656635315E-5,0,0,5.68311758360302,74.8913251869096,OPRD1;NGFR;STAT1;TAP1;CXCR4;ADRB2;PTGS2;CXCL10;IL6;MUC1;CXCR2;CCL2;PPARG
"Hyperlipidemia, Familial Combined",11/82,1.978447075366744E-6,2.0536708745228828E-5,0,0,6.9554098786265985,91.34677737710253,C3;EGR1;TCF7L2;IL6;LEPR;TXNIP;PPARG;CD36;PPARA;APOB;RXRG
Biliary cirrhosis,15/155,2.0324840669693424E-6,2.100025075964016E-5,0,0,4.837624584717608,63.4031260889707,COL17A1;CAV2;STAT1;HGF;CAV1;PAX3;ESR1;AGT;TGFBR2;COL1A1;CDH5;CXCL10;CTLA4;PPARG;PPARGC1A
Focal glomerulosclerosis,15/155,2.0324840669693424E-6,2.100025075964016E-5,0,0,4.837624584717608,63.4031260889707,CXCR4;PKD2;PAX2;AGT;TGFBR2;ACTA2;IL6;MMP14;NPHS1;WT1;COL8A1;CTLA4;CCL2;PPARG;TIMP1
Other specified transient cerebral ischemias,15/155,2.0324840669693424E-6,2.100025075964016E-5,0,0,4.837624584717608,63.4031260889707,NGFR;PARP1;VWF;DUSP1;CAV1;ESR1;HNRNPAB;AGT;C3;CXCL12;TERT;CCL2;PPARG;SGK1;NEFH
Tuberculosis,33/602,2.0368581886741763E-6,2.101311765765863E-5,0,0,2.6726244305287765,35.022343254592144,PRKN;LRP1;CXCR4;CIB1;GATA3;BRCA1;BRCA2;FOXO1;C3;RIMS2;SOCS3;CXCR2;CCL2;CTSG;TIMP1;ANXA1;CISH;STAT1;SH2D1A;IL18;TAP1;GZMB;LSM4;GFAP;TGFBR2;SIGIRR;CXCL10;MMP14;IL6;LTA;SDC1;VIM;FGFR3
"Aortic Aneurysm, Thoracic",12/99,2.041022659698372E-6,2.102378555603415E-5,0,0,6.2014812455204265,81.25217671310952,FBN2;COL1A1;ACTA2;VCAN;COL3A1;COL1A2;ERBB2;BGN;PKD2;AGT;MYLK;TGFBR2
Teratoma,13/117,2.0861427890406956E-6,2.145564314119037E-5,0,0,5.62818287037037,73.61772241954412,EGR1;CDKN2A;HMGA1;HMGA2;BRCA1;KLF4;FGF2;ESR1;GADD45G;TERT;KIT;FGFR3;EZH2
Arteriopathic disease,10/67,2.146222602236459E-6,2.1939164378417132E-5,0,0,7.863682193990724,102.63521661909726,ACTA2;TCF7L2;VWF;CDKN2A;CAV1;IL18;S100A4;TIMP1;ESR1;AGT
Cervical Adenocarcinoma,10/67,2.146222602236459E-6,2.1939164378417132E-5,0,0,7.863682193990724,102.63521661909726,VIL1;SOCS3;MUC1;IL6;CDKN2A;ERBB2;SDC1;PTGS2;NDC80;CDKN3
neurofibroma,10/67,2.146222602236459E-6,2.1939164378417132E-5,0,0,7.863682193990724,102.63521661909726,EFNA3;MDK;CDKN2A;HGF;KIT;PDGFA;CIB1;FGF2;AURKA;EZH2
Tongue Carcinoma,10/67,2.146222602236459E-6,2.1939164378417132E-5,0,0,7.863682193990724,102.63521661909726,CCND1;CDKN2A;PROS1;CAV1;HMGA2;BRCA1;FADD;SGK1;FOXO1;EZH2
Malignant tumor of parathyroid gland,5/11,2.2055308109550043E-6,2.2511162502087855E-5,0,0,37.02462121212121,482.2287468753678,RET;CDKN2C;CCND1;TERT;BRCA2
"Carcinoma, Neuroendocrine",11/83,2.2356799128246874E-6,2.2784258413551747E-5,0,0,6.858454941116231,89.23511832189021,RET;GRIA2;BMP2;MYCN;TERT;CDKN2A;CAV1;KIT;ERBB2;KDR;ASCL1
"Adenocarcinoma of lung, stage IV",6/19,2.488974945837798E-6,2.5327205660979776E-5,0,0,20.545295251445594,265.10908541225535,ALK;RET;ACTA2;ERBB2;FBLN2;MET
Venous Thromboembolism,11/84,2.5217774685666173E-6,2.562217470331831E-5,0,0,6.7641563032636824,87.19367176911325,ALK;PROC;LRP1;SERPINC1;PROS1;F13A1;ADRB2;CALR;ZFPM2;ESR1;SELE
"Infarction, Middle Cerebral Artery",13/119,2.5281720184598056E-6,2.5648343317184373E-5,0,0,5.521422955974843,71.1601765703026,EGR1;NGFR;EGR2;PARP1;FOS;PLD1;AGT;C3;IL6;CXCR2;CCL2;FADD;ATF3
Stage IV Breast Cancer AJCC v6 and v7,7/29,2.6307704907750425E-6,2.6648951155422602E-5,0,0,14.189601494396015,182.31131742109892,PARP1;ERBB2;CXCR4;BRCA2;ESR1;MET;RUNX2
Mucoepidermoid Carcinoma,10/69,2.8283806662977023E-6,2.860753698020387E-5,0,0,7.596337424508085,97.04933486256496,MUC1;CENPF;CXCL12;MAML2;CCND1;KIT;ERBB2;CXCR4;HMGA2;ASCL1
Hurthle Cell Tumor,11/85,2.839460282475223E-6,2.867641392045654E-5,0,0,6.672406277244987,85.21928281418619,PRKN;KRT19;CCND1;TERT;KIT;MITF;SLC2A4;VIM;PTGS2;ESR1;PAX2
Acute Myeloid Leukemia (AML-M2),13/121,3.0513901141409565E-6,3.0724341838936524E-5,0,0,5.4186171124828535,68.81596751302888,RET;HGF;MX1;ENO2;FOXO1;CCND2;WT1;KIT;FXYD6;ERG;SGK1;MET;RUNX1T1
Juvenile Myelomonocytic Leukemia,13/121,3.0513901141409565E-6,3.0724341838936524E-5,0,0,5.4186171124828535,68.81596751302888,STAT5A;PRKN;STAT5B;CDKN2A;CXCR4;IL2RG;KLF1;AKAP12;MECOM;KIT;CALR;TEK;EZH2
Atherogenesis,9/55,3.1635125256623517E-6,3.1758071931761366E-5,0,0,8.754537295572398,110.86595093203502,SOCS3;IL6;PARP1;PLA2G2A;CCL2;PPARG;PTGS2;ESR1;AGT
Ganglioneuroma,9/55,3.1635125256623517E-6,3.1758071931761366E-5,0,0,8.754537295572398,110.86595093203502,ALK;RET;VTN;MYCN;CCND1;FLT4;SYP;ASCL1;GFAP
Left Ventricular Hypertrophy,17/203,3.188504272152605E-6,3.191355393707436E-5,0,0,4.13617978092654,52.3473201991464,CMA1;ADRB1;ADRB2;ESR1;ADRA1A;AGT;COL1A1;COL3A1;IL6;COL1A2;TNFSF11;SLC27A6;DMD;TIMP1;PPARA;FGFR4;PPARGC1A
Muscular Dystrophy,17/203,3.188504272152605E-6,3.191355393707436E-5,0,0,4.13617978092654,52.3473201991464,STAT5A;PRKN;ANXA1;PARP1;TRAT1;BGN;AQP1;LMNB1;SYNE1;RIMS2;CAPN3;DMD;TIMP1;FLNC;UTRN;CRYAB;BUB1
Hereditary pancreatitis,10/70,3.235036634907817E-6,3.233111017863229E-5,0,0,7.469348659003831,94.42354927444029,NGFR;MUC1;CBX4;CDKN2A;ERBB2;BGN;F13A1;SYP;BRCA2;PTGS2
Gastrointestinal Neoplasms,13/122,3.3473283037037264E-6,3.340365065033318E-5,0,0,5.368628950050969,67.68417373318336,BLM;SATB1;CDKN2A;CXCR4;BRCA1;BRCA2;PTGS2;SOX10;CXCL12;ERBB2;FADD;CALR;FGFR4
Thymic Carcinoma,7/30,3.366073680365974E-6,3.3540876613260945E-5,0,0,13.571967440937065,171.03072490901792,EGR1;CCND1;CDKN2A;FLT4;ERBB2;KIT;PTGS2
Carcinoma ex pleomorphic adenoma,6/20,3.489092529265475E-6,3.471517840969916E-5,0,0,19.076797917344614,239.71654120003717,IL6;MAML2;CCND1;CDKN2A;ERBB2;HMGA2
Abnormal behavior,24/372,3.5125226061154767E-6,3.489660032939577E-5,0,0,3.146367433860267,39.51578263757602,EGR1;CNTNAP2;GAD1;CTNND2;PRKCA;BRCA1;ADRB2;ESR1;SYN1;QKI;COL1A1;IL6;DPYSL2;FEZ1;STMN1;CTLA4;NDN;CCL2;DMD;CALR;FKBP4;ATF3;SOX5;EZH2
Mycosis Fungoides,14/142,3.5695122244626513E-6,3.541040487369449E-5,0,0,4.929995649651972,61.837337737552325,ALK;MEF2C;CCL21;CDKN2A;FLT4;MKI67;PTGS2;FGF2;SOCS3;IL6;CCND1;LTA;E2F1;CTLA4
Lipoma,11/87,3.5815061351226252E-6,3.5476984075934446E-5,0,0,6.496149648314335,81.45994403675994,STAT5A;STAT5B;CDKN2A;CAV1;KIT;LEPR;HMGA1;HMGA2;SDC1;PPARG;DCN
Squamous cell carcinoma of skin,17/205,3.641904742728401E-6,3.602213881025618E-5,0,0,4.091755319148936,51.24106713299235,PRKN;YAP1;CDKN2A;STAT1;PTGS2;KLF4;IL6;CXCL12;MRGBP;TERT;CCND1;TAL1;ERBB2;PPARG;S100A4;VIM;ATF3
Duodenal Ulcer,10/71,3.6915063124268366E-6,3.639537837996706E-5,0,0,7.346523459581684,91.90115866935729,EGR1;MUC1;IL6;ALDH2;LTA;PLA2G4A;TIMP1;PTGS2;SELE;AGT
Adenoviral infections,9/56,3.6958975662801573E-6,3.639537837996706E-5,0,0,8.567831348819052,107.1688945009389,CDKN2A;HGF;ERBB2;IL18;IRS2;TEK;PTGS2;FGFR4;FGF2
Laryngeal Diseases,9/56,3.6958975662801573E-6,3.639537837996706E-5,0,0,8.567831348819052,107.1688945009389,MMP14;CCND1;TERT;CDKN2A;WT1;FANCA;SERPING1;BRCA1;BRCA2
Premature Obstetric Labor,12/105,3.821243175771032E-6,3.757462542968997E-5,0,0,5.799597705430977,72.34960294921586,HOXA10;PPP1R14A;BMP2;IL6;IL18;PECAM1;CCL2;ADRB2;PTGS2;SELE;FOXO1;F2RL2
Cytopenia,17/206,3.889673726375037E-6,3.8191591734407534E-5,0,0,4.069895663353607,50.699444343859795,CDKN2A;FANCA;CBLC;CXCR4;BRCA1;BRCA2;KLF1;SPTA1;SH3BP1;WT1;FANCD2;KIT;TXNIP;CALR;CD36;ALDOA;EZH2
Chordoma,11/88,4.012387578940279E-6,3.932176191659222E-5,0,0,6.411454904542462,79.66953422596185,ACAN;CDKN2A;KIT;ERBB2;MKI67;FGF2;MET;ESR1;ETS2;GFAP;EZH2
Hyperthyroidism,13/124,4.016487295232618E-6,3.932176191659222E-5,0,0,5.271354688021355,65.49712412840464,ANXA1;VWF;ADRB2;BRCA1;SLC2A4;AQP1;IL6;KRT19;CTLA4;PPARG;VIM;APOB;PPARGC1A
Seminoma,18/229,4.040750420840527E-6,3.9501717360065474E-5,0,0,3.8646347825121814,47.99520905848794,RET;EGR1;CISH;HMGA1;HMGA2;KLF4;ESR1;FOXO1;AURKA;BMP2;KIT;SPRY2;NEK2;FKBP4;TDGF1;TEAD1;FGFR3;SOX5
Non-small cell lung cancer metastatic,8/43,4.1301401814155396E-6,4.020003109911125E-5,0,0,10.209872507355344,126.57382337560695,ALK;CCND2;CXCL12;CDKN2A;CXCR4;BRCA1;ESR1;MET
Primary Carcinoma,8/43,4.1301401814155396E-6,4.020003109911125E-5,0,0,10.209872507355344,126.57382337560695,ALDH2;CCND1;CDKN2A;CD5;ERBB2;KIT;S100A4;EZH2
Yolk Sac Tumor,8/43,4.1301401814155396E-6,4.020003109911125E-5,0,0,10.209872507355344,126.57382337560695,MUC1;BMP2;HMGA2;SPRY2;NKX2-5;KPNA2;ESR1;FGFR3
Malignant neoplasm of colon stage IV,9/57,4.303436115332578E-6,4.1705450145127846E-5,0,0,8.388904816513762,103.65411960467989,MYCN;CCND1;CAV1;E2F1;HMGA1;KIF22;PROX1;SELE;EZH2
Sentinel node (disorder),9/57,4.303436115332578E-6,4.1705450145127846E-5,0,0,8.388904816513762,103.65411960467989,MUC1;KRT19;CDKN2A;FLT4;ERBB2;KDR;CXCR4;KRT5;ESR1
Spondylarthropathies,9/57,4.303436115332578E-6,4.1705450145127846E-5,0,0,8.388904816513762,103.65411960467989,ACAN;VCAN;COL2A1;CXCL12;LTA;CTLA4;CCL2;ALDOA;PTGS2
Dwarfism,20/277,4.3545079143075984E-6,4.213958955690177E-5,0,0,3.5336232547493704,43.620101823808284,PLK4;STAT5B;CDT1;STAT1;BGN;HMGA2;ANTXR2;BRCA2;FGF2;AGT;ACAN;MMP14;COL1A2;COL2A1;CCND1;MCM4;HOXB2;DMD;FGFR3;CDKN3
Familial M??ni??re disease,13/125,4.393474480746966E-6,4.245550303985126E-5,0,0,5.224020337301587,64.44032922339977,PARP1;CAV1;IL18;FOS;PTGS2;ESR1;AQP1;CXCL10;IL6;CCND1;IRF7;CTLA4;CCL2
Congenital anemia,17/208,4.431182018812682E-6,4.2758359825209735E-5,0,0,4.026863042520918,49.63851329195481,CDKN2A;FANCA;CBLC;CXCR4;BRCA1;BRCA2;KLF1;SPTA1;SH3BP1;WT1;FANCD2;KIT;TXNIP;CALR;CD36;ALDOA;EZH2
"Anemia, Sickle Cell",18/231,4.564758240283195E-6,4.398409805127968E-5,0,0,3.827951314444041,47.07287238477271,EGR1;JUN;VWF;EPAS1;BRCA1;FOS;ADRB2;SELE;RUNX2;AGT;QKI;KLF1;SPTA1;IL6;CXCR2;CCL2;CD36;APOB
Childhood Glioblastoma,16/187,4.700631391801682E-6,4.5228424681003005E-5,0,0,4.22775664880928,51.86533101934899,ALK;PARP1;CDKN2A;STAT1;CXCR4;GATA3;FHL5;ASCL1;SYT7;SIX3;KIT;S100A4;PPARA;IKBKE;MET;EZH2
Nonalcoholic Steatohepatitis,17/209,4.726560060157234E-6,4.5412843153098696E-5,0,0,4.005682924454828,49.11893731794409,TCF7L2;ANXA1;LAMA1;IRS2;FOXO1;DCN;COL1A1;CXCL10;IL6;MUC1;CXCR2;KDR;LEPR;IRF7;CCL2;CD36;PPARA
Chagas Cardiomyopathy,6/21,4.793287833690741E-6,4.598817298723859E-5,0,0,17.804100227790432,218.06985375794565,CXCL10;IL6;ACTC1;DDX39A;IL18;LTA
Laryngeal Squamous Cell Carcinoma,13/126,4.8014317876721966E-6,4.6000593275330196E-5,0,0,5.177523762700754,63.40704384955149,ANXA1;CDKN2A;BRCA2;PKD2;AURKA;CCNB2;VCAN;CCND1;WT1;ERBB2;TIMP1;EZR;CRYAB
Thyroiditis,8/44,4.95062479243729E-6,4.73623876153972E-5,0,0,9.925756420035595,121.25300835360585,RET;CXCL10;STAT1;ERBB2;CTLA4;CCL2;CALR;CDC25B
"Carcinoma, Lobular",9/58,4.994715029151085E-6,4.771622494420866E-5,0,0,8.217281407976035,100.30942402662093,STAT5A;MUC1;ERBB2;PLAUR;BRCA1;KRT5;BRCA2;PTGS2;ESR1
Secondary Neoplasm,12/108,5.1417363925796654E-6,4.89814207270426E-5,0,0,5.617494226327945,68.4105171920333,ALK;RET;PRKN;IL6;CXCL12;MDK;SATB1;PROS1;ERBB2;HMGA2;ESR1;AURKA
Severe myopia,12/108,5.1417363925796654E-6,4.89814207270426E-5,0,0,5.617494226327945,68.4105171920333,COL1A1;EGR1;ACAN;JUN;COL2A1;CTNND2;HGF;TIMP1;FOS;ESR1;CRYAB;DCN
Autism Spectrum Disorders,31/572,5.265121918791683E-6,5.008577734646592E-5,0,0,2.6317072517345763,31.986839084919072,PRKN;CNTNAP2;CTNND2;IRS2;MKI67;ADRA1A;PPL;SYNE1;ACAN;MDK;CCL2;SOSTDC1;OTX1;ZNF423;MPDZ;SOX5;NGFR;ARNT2;MEF2C;ARHGEF15;GAD1;HGF;IL18;PLAUR;GZMB;SYN1;GFAP;ACTC1;WT1;LTA;MET
Dermatofibrosarcoma Protuberans,7/32,5.355323667294457E-6,5.064818267792484E-5,0,0,12.484931506849316,151.53485005143733,COL1A1;VCAN;CDKN2A;PRKCA;VIM;MKI67;TGFBR2
Giant Cell Fibroblastoma,7/32,5.355323667294457E-6,5.064818267792484E-5,0,0,12.484931506849316,151.53485005143733,COL1A1;VCAN;CDKN2A;PRKCA;VIM;MKI67;TGFBR2
Papillary serous cystadenocarcinoma,7/32,5.355323667294457E-6,5.064818267792484E-5,0,0,12.484931506849316,151.53485005143733,CCND1;WT1;ERBB2;SNCG;HMGA2;BRCA1;BRCA2
"Glaucoma, Primary Open Angle",14/147,5.36195025074517E-6,5.064818267792484E-5,0,0,4.743436317010624,57.56721022589146,VAV3;EGR1;CAV2;CDKN2A;CAV1;SIX1;PLA2G4A;CDC7;ADRB2;PTGS2;VAV2;COL1A1;TIMP1;CCL16
Monosomy,14/147,5.36195025074517E-6,5.064818267792484E-5,0,0,4.743436317010624,57.56721022589146,STAT5A;EGR1;STAT5B;CDKN2A;STAT1;ESR1;PAX2;AQP1;CCND1;TERT;MECOM;KIT;VIM;TNFRSF4
Adult Glioblastoma,16/189,5.390113854175181E-6,5.084270315258499E-5,0,0,4.178449681339854,50.68853930025321,ALK;PARP1;STAT1;CXCR4;GATA3;FHL5;ASCL1;PTGS2;SYT7;SIX3;KIT;S100A4;PPARA;IKBKE;MET;EZH2
Hereditary gingival fibromatosis,10/74,5.412205841552251E-6,5.097948728171798E-5,0,0,7.001077586206897,84.90104442905889,RIMS2;IL6;CDKN2A;HGF;CAV1;CIB1;ANTXR2;EZR;MET;EZH2
Childhood Leukemia,15/168,5.529940356223312E-6,5.194276843691716E-5,0,0,4.423620611035112,53.549402897832316,STAT5A;STAT5B;FEN1;PARP1;DUSP1;CAV1;UBE2L6;CIB1;GATA3;FOS;PRC1;PAEP;SCN4A;ERG;RUNX1T1
Kyphosis deformity of spine,15/168,5.529940356223312E-6,5.194276843691716E-5,0,0,4.423620611035112,53.549402897832316,RET;PARP1;BGN;KIF22;RUNX2;COL1A1;RPS6KA3;COL1A2;COL2A1;BIN1;NDN;DMD;UTRN;FGFR3;EZH2
Mental Retardation,50/1158,5.605563339363569E-6,5.257955780330409E-5,0,0,2.107457843988484,25.482855492323704,RET;CNTNAP2;CTNND2;BRCA2;ETS2;RIMS2;RPS6KA3;SIX3;LEPR;NEK2;SOX5;ANXA1;PAX3;FOS;SYP;SOX10;PAX2;CIT;TGFBR2;ACTA2;MYCN;TAL1;FANCD2;RARB;PPARG;PAFAH1B3;ARHGEF6;PRKN;YAP1;ASCL1;TERT;DMD;ZNF423;PAK3;MPDZ;BUB1;RUNX1T1;GRIA4;PLK4;GAD1;CAV1;FANCA;FLI1;RCAN1;COL3A1;IL6;RAD51;WT1;FGFR3;EZH2
Anaplastic Oligodendroglioma,9/59,5.779067888226901E-6,5.3981324454753073E-5,0,0,8.052522935779816,97.12363843901664,CDKN2C;CCND1;TERT;CDKN2A;STMN1;KIT;PLA2G4A;DTX1;MKI67
Progeria,9/59,5.779067888226901E-6,5.3981324454753073E-5,0,0,8.052522935779816,97.12363843901664,RIMS2;ACAN;RAD51;RARB;PDGFA;TIMP1;FOS;LMNB1;GFAP
nervous system disorder,26/436,5.779120351841493E-6,5.3981324454753073E-5,0,0,2.897549333488562,34.9480931941599,RET;GRIA2;CNTNAP2;CXCR4;ADRB2;ASCL1;PTGS2;ADRA1A;LMNB1;CCL2;PPARGC1A;NEFH;MEF2C;PARP1;GAD1;SH2D1A;PLA2G2A;PLA2G4A;FOS;SOX10;GRIN2D;GFAP;CXCL10;IL6;PPARG;ATF3
Hepatoblastoma,18/235,5.800256612424924E-6,5.410350473478582E-5,0,0,3.756612957187105,45.295767940123035,YAP1;CDKN2C;HLF;CDKN2A;HGF;GATA4;CIB1;ESR1;AGT;KRT19;IL6;TERT;CCND1;ERBB2;PPARG;APOB;MET;CDKN3
"Leukemia, Plasma Cell",8/45,5.9049717179651E-6,5.477595311858234E-5,0,0,9.656997959057456,116.26751185300249,SOCS3;IL6;CDKN2C;CCND1;CDKN2A;FLT4;CXCR4;FGFR3
Enteritis,8/45,5.9049717179651E-6,5.477595311858234E-5,0,0,9.656997959057456,116.26751185300249,STAT5A;STAT5B;JUN;COL3A1;DUSP1;PLA2G4A;TIMP1;FOS
Mammary adenocarcinoma,8/45,5.9049717179651E-6,5.477595311858234E-5,0,0,9.656997959057456,116.26751185300249,MUC1;CXCL12;CCND1;PARP1;CDKN2A;ERBB2;S100A4;ESR1
Purpura,8/45,5.9049717179651E-6,5.477595311858234E-5,0,0,9.656997959057456,116.26751185300249,C4B;C4A;IL6;PROC;PROS1;CTLA4;MET;AGT
Peritoneal Neoplasms,5/13,5.921492062325841E-6,5.4777879739091384E-5,0,0,27.765625,334.2126652735908,MUC1;WT1;BRCA1;VIM;BRCA2
Primary chondrosarcoma of bone,5/13,5.921492062325841E-6,5.4777879739091384E-5,0,0,27.765625,334.2126652735908,CXCL12;KIT;CXCR4;FGFR3;RUNX2
Angiogenic Switch,10/75,6.122426111034644E-6,5.648106285948993E-5,0,0,6.893015030946065,82.7406651646292,EGR1;ZFP36;CXCL12;EPAS1;CDKN2A;ERBB2;E2F1;CXCR4;PTGS2;FGF2
MYOTONIC DYSTROPHY 1,10/75,6.122426111034644E-6,5.648106285948993E-5,0,0,6.893015030946065,82.7406651646292,IL6;ALDH2;HGF;ERBB2;CXCR4;DMD;BRCA1;NKX2-5;BUB1;ESR1
Dejerine-Sottas Disease (disorder),11/92,6.222434268720026E-6,5.7269513086924466E-5,0,0,6.0935882118677815,73.04597078968871,CCNA2;TCF7L2;NR4A1;EGR2;IL6;COL2A1;BCL3;IL18;CCL2;PTGS2;TGFBR2
"Cleft palate, isolated",13/129,6.233474399425519E-6,5.7269513086924466E-5,0,0,5.042844029374201,60.44139386038344,IL18;F13A1;CXCR4;CIB1;FGF2;ESR1;TGFBR2;FGF7;BMP2;COL2A1;SPRY2;FGFR3;TNS1
tumor vasculature,13/129,6.233474399425519E-6,5.7269513086924466E-5,0,0,5.042844029374201,60.44139386038344,ANXA1;CXCR4;ANTXR2;SELE;RCAN1;CXCL10;IL6;ADAM12;CXCR2;KDR;PECAM1;TEK;MET
Dental caries,15/170,6.392101135763213E-6,5.8646654682767404E-5,0,0,4.36609152288072,52.22040855917387,COL17A1;CAV1;INHBA;PKD2;RUNX2;GFAP;CXCL10;IL6;MMP14;COL3A1;TERT;CXCR2;TNFSF11;FGFR3;CDKN3
Nephrosclerosis,6/22,6.467437033610027E-6,5.925689920562748E-5,0,0,16.690489749430522,199.43016657856674,MUC1;CXCL12;BGN;FGFR3;AGT;DCN
Blast Phase,17/214,6.485893185955112E-6,5.934503901481544E-5,0,0,3.9030077328146495,46.62486599093862,CDKN2A;CXCR4;HMGA2;CIB1;ETS2;AURKA;AKAP12;SOCS3;IL6;CCND2;CXCL12;MECOM;CCND1;WT1;KIT;LEPR;ZNF423
Cognition Disorders,18/237,6.524437818134435E-6,5.96164957640692E-5,0,0,3.7219210163292806,44.43957230177903,EGR1;GAD1;PRKCA;BRCA1;SYP;ENO2;MAPK8IP2;PTGS2;AGT;ETS2;GFAP;BMP2;IL6;DMD;CD36;PAK3;MET;RUNX1T1
Albuminuria,7/33,6.667772824734975E-6,6.076087149378575E-5,0,0,12.004127151387426,143.06788427503764,IL6;NPHS1;LEPR;CCL2;PTGS2;AGT;DCN
Trigeminal Neuralgia,7/33,6.667772824734975E-6,6.076087149378575E-5,0,0,12.004127151387426,143.06788427503764,PARP1;ERBB2;BRCA1;FOS;FGF2;ESR1;GFAP
Uveitis,13/130,6.788308858857878E-6,6.177545026570394E-5,0,0,4.999485596707819,59.49542199657996,ANXA1;CISH;CAV2;STAT1;CAV1;IL18;CXCR4;AQP1;CXCL10;ACAN;IL6;CXCL12;CCL2
Chest Pain,10/76,6.911875790650423E-6,6.253199494011039E-5,0,0,6.788227098571926,80.6595437902144,RET;ACTA2;PLA2G2A;CTLA4;PPARG;PRTN3;SCN4A;CALR;MYLK;TGFBR2
Petit mal status,10/76,6.911875790650423E-6,6.253199494011039E-5,0,0,6.788227098571926,80.6595437902144,RET;GRIA2;MEF2C;JUN;CCL2;DMD;FOS;GATA3;SSTR2;PTGS2
Stable angina,10/76,6.911875790650423E-6,6.253199494011039E-5,0,0,6.788227098571926,80.6595437902144,CXCL10;COL3A1;IL6;CXCL12;ALDH2;TERT;STAT1;CXCR4;CCL2;TIMP1
"PARKINSON DISEASE, LATE-ONSET",11/93,6.9179976534398485E-6,6.253199494011039E-5,0,0,6.01896706755086,71.51366013633988,PRKN;COL1A1;MUC1;IL6;PARP1;ERBB2;CCL2;PTGS2;SNCAIP;PPARGC1A;CIT
Childhood Medulloblastoma,11/93,6.9179976534398485E-6,6.253199494011039E-5,0,0,6.01896706755086,71.51366013633988,ALK;MYCN;MELK;HGF;ERBB2;CXCR4;IRS2;S100A4;BRCA2;FLI1;EZH2
Thrombus,8/46,7.010371974839515E-6,6.328179863309433E-5,0,0,9.402384680236059,111.58862774247079,PROC;VWF;SERPINC1;PROS1;HGF;PTGS2;KLF4;AGT
"Lung Diseases, Interstitial",14/151,7.330263880060274E-6,6.599202710252655E-5,0,0,4.603993428963368,54.435311899970685,ALK;HGF;IL18;PDGFA;HMGA2;FGF2;VTN;CXCL10;IL6;MUC1;TERT;KIT;CCL2;EZR
Malignant Squamous Cell Neoplasm,14/151,7.330263880060274E-6,6.599202710252655E-5,0,0,4.603993428963368,54.435311899970685,ALK;BLM;CDKN2A;KRT5;BRCA2;PTGS2;TGFBR2;MUC1;CCND1;BIN1;FANCD2;STMN1;S100A4;MET
Glomerulosclerosis (disorder),12/112,7.5174402712400545E-6,6.74961615797436E-5,0,0,5.391685912240185,63.61264630821605,RET;IL6;VCAN;MUC1;NPHS1;CDKN2A;HGF;KDR;CCL2;CIB1;PPARG;AGT
Merkel cell carcinoma,12/112,7.5174402712400545E-6,6.74961615797436E-5,0,0,5.391685912240185,63.61264630821605,ALK;CCND1;TERT;CDKN2A;KIT;ERBB2;PDGFA;MCM4;ENO2;ASCL1;SELE;EZH2
Myelodysplasia,11/94,7.680373429249021E-6,6.886700660992847E-5,0,0,5.946144023096997,70.02680097866063,IL6;MECOM;WT1;KIT;IL18;HMGA2;IRS2;CD36;ZFPM2;RUNX1T1;EZH2
Parathyroid Adenoma,10/77,7.787820720920793E-6,6.973733861560539E-5,0,0,6.686567164179104,78.65375181795636,RET;CDKN2C;RAD51;CCND1;CDKN2A;CAV1;CIB1;ESR1;CDKN3;EZH2
Paresis,12/113,8.243996375420398E-6,7.372394095515765E-5,0,0,5.3380284910708165,62.487096753285684,RIMS2;FBN2;TPM3;BIN1;HGF;STMN1;CCL2;DMD;FLNC;UTRN;MET;SYNE1
"Carcinoma, Pancreatic Ductal",8/47,8.285625787418834E-6,7.389941937357886E-5,0,0,9.160828492636274,107.19074771931592,MUC1;CDKN2A;DTX1;PPARG;BRCA2;KLF4;FGF2;TEAD1
Hemangioblastoma,8/47,8.285625787418834E-6,7.389941937357886E-5,0,0,9.160828492636274,107.19074771931592,VTN;CXCL12;CCND1;EPAS1;CXCR4;ELOB;MKI67;AQP1
Increase in blood pressure,15/174,8.483452257625015E-6,7.556348191274483E-5,0,0,4.255375164545853,49.69168852120194,RET;F12;KLHL3;PKD2;PAX2;MYLK;TGFBR2;ACTA2;MUC1;COL3A1;WT1;PPARG;CALR;APOB;NKX2-5
Membranous glomerulonephritis,11/95,8.514908667584588E-6,7.574321405496437E-5,0,0,5.875054860653939,68.58358074994236,C3;CXCL10;NPHS1;PLA2G2A;PECAM1;CTLA4;CCL2;CIB1;PRKCA;A2M;AGT
Migraine Disorders,20/290,8.633576145443556E-6,7.669721877354354E-5,0,0,3.3612200435729847,39.19132741850858,YAP1;FBN2;GRIA2;VWF;LRP1;CXCR4;FHL5;PTGS2;ESR1;AGT;SYNE1;TGFBR2;C3;C4A;LTA;CTLA4;CAPN3;CCL2;RAMP1;GRIA4
Lewy Body Disease,13/133,8.723186148033077E-6,7.739090907554842E-5,0,0,4.8737461419753085,56.77683241213909,PRKN;BRCA2;PTGS2;SNCAIP;AQP1;GFAP;IL6;GRK5;FANCD2;PECAM1;SOSTDC1;SNCG;A2M
Copper-Overload Cirrhosis,5/14,9.043011205562494E-6,8.001694763709842E-5,0,0,24.67929292929293,286.613421078848,ACTA2;KRT19;HGF;MKI67;MET
Takotsubo Cardiomyopathy,5/14,9.043011205562494E-6,8.001694763709842E-5,0,0,24.67929292929293,286.613421078848,VWF;GRK5;ADRB1;ADRB2;ESR1
Tuberous Sclerosis,16/197,9.143509916584889E-6,8.079975342076856E-5,0,0,3.9921183788587102,46.31841867320615,PRKN;ANXA1;CDKN2A;HGF;IL18;HMGA2;BRCA1;GRIN2C;IL6;CCND1;IRF7;CCL2;PRKD1;VIM;PITX1;FGFR3
Aortic Aneurysm,11/96,9.427288938440393E-6,8.319799278655148E-5,0,0,5.805638384386013,67.18227840789828,ACTA2;COL1A1;CDH5;COL3A1;IL6;CCL2;NKX2-5;KLF4;AGT;MYLK;TGFBR2
Influenza,31/589,9.440087884015245E-6,8.320161447381415E-5,0,0,2.549248523886205,29.496195445269635,UBE2L6;GATA3;PTGS2;SOCS3;MUC1;TERT;E2F1;S1PR1;CTLA4;CCL2;KPNA2;TNFRSF4;JUN;CISH;STAT1;SH2D1A;MX1;IL18;TAP1;GZMB;FOS;KRT5;CDC25B;CXCL10;IL6;IRF7;SERPING1;RARB;PPARG;FGFR4;ATF3
Mucosa-Associated Lymphoid Tissue Lymphoma,15/176,9.741482952530796E-6,8.571896084751415E-5,0,0,4.2020800231113675,48.48829386224995,ALK;CCL21;CDKN2A;CIB1;MKI67;PTGS2;FOXO1;CXCL12;CCND1;STMN1;CXCR2;LTA;CTLA4;VIM;RUNX1T1
Neuroblastic tumors,8/48,9.75123378312996E-6,8.571896084751415E-5,0,0,8.931350114416476,103.05096025791842,ALK;RET;VTN;CENPF;MYCN;TERT;KIT;CXCR4
Hypothyroidism,19/268,9.786591555220245E-6,8.591731880373748E-5,0,0,3.458095291965986,39.88739086984679,RET;VAV3;ANXA1;LRP1;STAT1;CAV1;ADRB2;GRK3;COL1A2;COL2A1;NPHS1;DPYSL2;PAEP;CTLA4;APOB;NKX2-5;PPARA;PPARGC1A;NEFH
"Glioblastoma, IDH-Wildtype",10/79,9.830871099049719E-6,8.619338159427925E-5,0,0,6.492087289688489,74.85365615829596,AKAP12;TERT;CDKN2A;KIT;KDR;S100A4;PPARA;PTGS2;FGF2;EZH2
gliosarcoma,9/63,1.006247357036294E-5,8.741203557597138E-5,0,0,7.454510703363915,85.77679998550185,CDKN2A;HGF;KIT;CCL2;PPARG;PTGS2;ESR1;FGFR3;GFAP
"Embolic Infarction, Middle Cerebral Artery",7/35,1.0100020787217659E-5,8.741203557597138E-5,0,0,11.145547945205479,128.20693793072965,C3;IL6;CXCR2;CCL2;FOS;PLD1;ATF3
"Prostate Cancer, Hereditary, 7",7/35,1.0100020787217659E-5,8.741203557597138E-5,0,0,11.145547945205479,128.20693793072965,SATB1;PROS1;CAV1;BGN;CCL2;ESR1;RUNX2
"Thrombotic Infarction, Middle Cerebral Artery",7/35,1.0100020787217659E-5,8.741203557597138E-5,0,0,11.145547945205479,128.20693793072965,C3;IL6;CXCR2;CCL2;FOS;PLD1;ATF3
Abnormal pigmentation,7/35,1.0100020787217659E-5,8.741203557597138E-5,0,0,11.145547945205479,128.20693793072965,COL17A1;FANCD2;CAV1;FANCA;PPARG;FOS;KRT5
Left Middle Cerebral Artery Infarction,7/35,1.0100020787217659E-5,8.741203557597138E-5,0,0,11.145547945205479,128.20693793072965,C3;IL6;CXCR2;CCL2;FOS;PLD1;ATF3
Middle Cerebral Artery Embolus,7/35,1.0100020787217659E-5,8.741203557597138E-5,0,0,11.145547945205479,128.20693793072965,C3;IL6;CXCR2;CCL2;FOS;PLD1;ATF3
Middle Cerebral Artery Syndrome,7/35,1.0100020787217659E-5,8.741203557597138E-5,0,0,11.145547945205479,128.20693793072965,C3;IL6;CXCR2;CCL2;FOS;PLD1;ATF3
Middle Cerebral Artery Thrombosis,7/35,1.0100020787217659E-5,8.741203557597138E-5,0,0,11.145547945205479,128.20693793072965,C3;IL6;CXCR2;CCL2;FOS;PLD1;ATF3
Right Middle Cerebral Artery Infarction,7/35,1.0100020787217659E-5,8.741203557597138E-5,0,0,11.145547945205479,128.20693793072965,C3;IL6;CXCR2;CCL2;FOS;PLD1;ATF3
Ductal Breast Carcinoma,11/97,1.0423553536281957E-5,9.009599169841651E-5,0,0,5.73783624477548,65.82125883994082,RPS6KA3;IL6;CCND1;CDKN2A;ERBB2;HMGA1;E2F1;PAEP;ERG;ESR1;MAD2L1
Mucocutaneous Lymph Node Syndrome,14/156,1.0674368393423456E-5,9.214531893346007E-5,0,0,4.440737230809451,50.83607291512415,STAT1;HGF;IL18;GZMB;GATA3;TGFBR2;IL6;KDR;LTA;PECAM1;CTLA4;CCL2;TIMP1;MET
"Acute Myeloid Leukemia, M1",12/116,1.0806025359751469E-5,9.292351640984747E-5,0,0,5.183247468466868,59.27254270283455,CCND2;WT1;HGF;KIT;MX1;FXYD6;ERG;ENO2;SGK1;MET;FOXO1;RUNX1T1
"Alzheimer Disease, Early Onset",12/116,1.0806025359751469E-5,9.292351640984747E-5,0,0,5.183247468466868,59.27254270283455,PYY;CR1;BIN1;FANCD2;DPYSL2;CIB1;PPARG;SLC2A4;A2M;BRCA2;ESR1;AQP1
Familial (FPAH),12/116,1.0806025359751469E-5,9.292351640984747E-5,0,0,5.183247468466868,59.27254270283455,ACTA2;PRKN;CDKN2A;CTNND2;KIT;KLHL3;BRCA1;APOB;BRCA2;ESR1;MET;ADCY5
Gastroesophageal reflux disease,18/246,1.0894800669849568E-5,9.356711163517865E-5,0,0,3.573339085418464,40.8333493204993,RET;ARNT2;CAV1;IL18;ADRB2;ASCL1;PTGS2;PAX2;COL1A1;COL3A1;IL6;MUC1;COL1A2;TERT;CCND1;NPHS1;EZR;RAMP1
Vasculitis,13/136,1.11285084273401E-5,9.545218722607422E-5,0,0,4.754140319180969,54.22572645532221,VWF;CAV1;SH2D1A;IL18;CXCR4;AGT;C4A;CXCL10;IL6;SERPING1;PAEP;CTLA4;PRTN3
Multiple Endocrine Neoplasia,8/49,1.1429489044000574E-5,9.79087352289641E-5,0,0,8.713065803426913,99.14870979974161,RET;CDKN2C;CCND1;CDKN2A;CXCR4;CIB1;FGF2;CDKN3
"Adenocarcinoma, Endometrioid",9/64,1.1481414393247156E-5,9.797862651213201E-5,0,0,7.3185988323603,83.24745872301966,CDKN2A;ERBB2;CXCR4;S100A4;MKI67;PTGS2;ESR1;PAX2;NDC80
Adult Medulloblastoma,9/64,1.1481414393247156E-5,9.797862651213201E-5,0,0,7.3185988323603,83.24745872301966,MYCN;MELK;ERBB2;CXCR4;IRS2;S100A4;BRCA2;FLI1;EZH2
Mitral Valve Prolapse Syndrome,9/64,1.1481414393247156E-5,9.797862651213201E-5,0,0,7.3185988323603,83.24745872301966,FBN2;COL1A1;RPS6KA3;COL3A1;COL2A1;COL1A2;VWF;PLD1;AGT
"Arthritis, Psoriatic",16/201,1.1780469467348994E-5,1.002758338944434E-4,0,0,3.904995904995905,44.31806222087445,CCL21;PLA2G4A;PTGS2;ESR1;RUNX2;AGT;COL1A1;MMP14;CCND1;TAL1;LTA;PPARG;TIMP1;TEK;VIM;PDLIM4
Cardiac Arrest,16/201,1.1780469467348994E-5,1.002758338944434E-4,0,0,3.904995904995905,44.31806222087445,ALK;CDKN2A;STAT1;IL18;CDC7;BRCA1;ENO2;PTGS2;SELE;TGFBR2;IL6;CCND1;ERBB2;E2F1;CCL2;MAD2L1
Bipolar Disorder,39/837,1.1828676004791542E-5,1.0055871904832909E-4,0,0,2.2578706618763658,25.615506092055494,GRIA2;CNTNAP2;CTNND2;ADRB2;BRCA2;ADRA1A;SYNE1;VTN;GRK3;ALDH2;DPYSL2;ERBB2;S1PR1;CTLA4;CCL2;CD36;APOB;RXRG;GRIA4;EGR1;TCF7L2;EGR2;ARHGEF15;CAV2;GAD1;CAV1;PLA2G2A;PLA2G4A;SYP;GRIN2C;ESR1;AGT;CIT;GFAP;PER2;IL6;DLG2;FEZ1;CALR
Myasthenia Gravis,15/179,1.1939912740804194E-5,1.0137604799904041E-4,0,0,4.124574588769144,46.754625700782874,CCL21;CDKN2A;CXCR4;GZMB;KRT5;ADRB2;ESR1;CXCL10;IL6;KIT;LTA;CTLA4;UTRN;TNFRSF4;FGFR3
Large cell neuroendocrine carcinoma,7/36,1.2299533160053726E-5,1.0416603367329234E-4,0,0,10.76066761139978,121.6595619189266,YAP1;VIL1;KRT19;CCND1;CDKN2A;ERBB2;KIT
Oestrogen deficiency,7/36,1.2299533160053726E-5,1.0416603367329234E-4,0,0,10.76066761139978,121.6595619189266,IL6;TERT;CCL2;BRCA1;ESR1;FOXO1;AGT
"Hamartoma Syndrome, Multiple",13/138,1.3039643370060405E-5,1.099774262055946E-4,0,0,4.6775925925925925,52.61129916738608,STAT5A;RET;STAT5B;VWF;CAV1;BRCA1;BRCA2;FGF2;RIMS2;LTA;SIRPA;ATF3;TNS1
Abdominal discomfort,13/138,1.3039643370060405E-5,1.099774262055946E-4,0,0,4.6775925925925925,52.61129916738608,RET;CDKN2A;BRCA1;BRCA2;SOX10;TGFBR2;C4A;WT1;SAA1;SERPING1;CTLA4;PRTN3;MET
Measles,13/138,1.3039643370060405E-5,1.099774262055946E-4,0,0,4.6775925925925925,52.61129916738608,STAT1;MX1;IL18;ENO2;AURKA;VTN;CXCL10;IL6;CHEK1;ERBB2;TNFSF11;SDC1;RARB
FRIEDREICH ATAXIA 1,9/65,1.3067597693875E-5,1.099774262055946E-4,0,0,7.187540956749673,80.82659231047651,CCT3;ERBB2;PPARG;BRCA1;BRCA2;PTGS2;PPARGC1A;ESR1;SYNE1
Paroxysmal nocturnal hemoglobinuria,9/65,1.3067597693875E-5,1.099774262055946E-4,0,0,7.187540956749673,80.82659231047651,C3;RPS6KA3;CR1;SERPINC1;CXCR2;CXCR4;HMGA2;PRTN3;CD36
Stage 0 Breast Carcinoma,5/15,1.3316944868381735E-5,1.1188780415315381E-4,0,0,22.210227272727273,249.34252309541785,CXCL10;ERBB2;BRCA1;BRCA2;MKI67
"stage, prostate cancer",8/50,1.334456985209592E-5,1.1188780415315381E-4,0,0,8.505175983436853,95.46550588609728,EGR1;IL6;FLT4;PROS1;ERG;PTGS2;MET;EZH2
Renal dysplasia,8/50,1.334456985209592E-5,1.1188780415315381E-4,0,0,8.505175983436853,95.46550588609728,RET;SIX2;SIX1;SLC2A4;GATA3;ESR1;CEP55;PAX2
Immune System Diseases,18/250,1.3568634416276931E-5,1.136246243637355E-4,0,0,3.5110029879673745,39.35044276139414,STAT5B;CISH;STAT1;SH2D1A;FAM107A;CXCR4;GZMB;GATA3;KLF4;ESR1;C4B;C4A;VTN;SOCS3;RCAN1;IL6;SDC1;CTLA4
Prediabetes syndrome,10/82,1.3756914601150643E-5,1.1501058799332331E-4,0,0,6.220625798212005,69.63349222242934,TCF7L2;IL6;PTPRN;GAD1;CTLA4;PPARG;SLC2A4;TNFRSF4;PPARGC1A;AGT
Short stature,36/750,1.376839081992733E-5,1.1501058799332331E-4,0,0,2.3226562018450414,25.99780468911296,RET;BLM;CTNND2;GATA4;BRCA2;RPS6KA3;ACAN;TERT;NDN;TNNI2;DMD;NKX2-5;BUB1;PLK4;ARNT2;STAT1;CAV1;FANCA;HMGA2;LIFR;KIF22;FLI1;RUNX2;CIT;KLF1;COL1A1;COL3A1;BMP2;COL1A2;COL2A1;RAD51;WT1;FANCD2;ALDOA;BMPR1B;FGFR3
Giant Cell Arteritis,12/119,1.4039423036868567E-5,1.1712890076473206E-4,0,0,5.037145755541646,56.28325961880354,PRKN;IL6;CDKN2A;KRT15;ERBB2;MX1;PLA2G2A;IL18;CCL2;PTGS2;SELE;GADD45G
Spondyloepimetaphyseal disorder,6/25,1.4505832028040602E-5,1.2072015848862538E-4,0,0,14.052991248051793,156.5638102912704,ACAN;COL2A1;BGN;KIF22;FGFR3;DCN
Temporomandibular Joint Disorders,6/25,1.4505832028040602E-5,1.2072015848862538E-4,0,0,14.052991248051793,156.5638102912704,IL6;CAPN3;CCL2;DMD;ADRB2;ESR1
Diffuse Astrocytoma,9/66,1.4836844874085205E-5,1.2277776535928945E-4,0,0,7.061081603090295,78.50790817639493,CDKN2A;HGF;CAV1;HMGA2;SYP;ASCL1;PTGS2;MET;ESR1
Paroxysmal atrial fibrillation,9/66,1.4836844874085205E-5,1.2277776535928945E-4,0,0,7.061081603090295,78.50790817639493,CHAF1A;CXCL12;VWF;CAV2;CAV1;NKX2-5;ADRA1A;SELE;SOX5
Proliferative vitreoretinopathy,9/66,1.4836844874085205E-5,1.2277776535928945E-4,0,0,7.061081603090295,78.50790817639493,IL6;CCND1;HGF;CXCR2;LTA;CCL2;PRKCA;OTX1;GFAP
Thyroid Nodule,9/66,1.4836844874085205E-5,1.2277776535928945E-4,0,0,7.061081603090295,78.50790817639493,RET;IL6;TERT;TPM3;KIT;HMGA2;PPARG;SSTR2;PTGS2
Atypical Lipoma,7/37,1.4881045414303396E-5,1.2277776535928945E-4,0,0,10.40144596651446,115.61646418517509,JUN;TERT;CDKN2A;CHEK1;ERBB2;HMGA2;GRIN2C
Paget Disease,7/37,1.4881045414303396E-5,1.2277776535928945E-4,0,0,10.40144596651446,115.61646418517509,IL6;ERBB2;TNFSF11;DMD;FOS;BRCA2;ESR1
Salivary Gland Pleomorphic Adenoma,7/37,1.4881045414303396E-5,1.2277776535928945E-4,0,0,10.40144596651446,115.61646418517509,PROS1;ERBB2;PDGFA;CTLA4;HMGA2;FGF2;FOXO1
Gastrointestinal pain,13/140,1.5233461774756128E-5,1.2537736431282126E-4,0,0,4.603455818022747,51.061606128163106,RET;CDKN2A;BRCA1;BRCA2;SOX10;TGFBR2;C4A;WT1;SAA1;SERPING1;CTLA4;PRTN3;MET
Thyroid Diseases,13/140,1.5233461774756128E-5,1.2537736431282126E-4,0,0,4.603455818022747,51.061606128163106,RET;VAV3;JUN;GAD1;FOS;SSTR2;PTGS2;CXCL10;IL6;CXCL12;KIT;CTLA4;CCL2
"Liver Failure, Acute",12/120,1.529060254840077E-5,1.2569361899028098E-4,0,0,4.990248909417501,55.333237908021694,IL6;CXCL12;VWF;SERPINC1;HGF;IL18;CCL2;INHBA;PPARA;PTGS2;MET;GFAP
"Lymphohistiocytosis, Hemophagocytic",8/51,1.5522632849113094E-5,1.2728937999345976E-4,0,0,8.30695545739982,91.98467399691174,SH2D1A;IL18;SIRPA;CCL2;GZMB;FHL5;PROX1;STX11
Malignant neoplasm of female breast,8/51,1.5522632849113094E-5,1.2728937999345976E-4,0,0,8.30695545739982,91.98467399691174,ALDH2;CCND1;CDKN2A;ERBB2;CXCR4;BRCA1;BRCA2;ESR1
Blonde eyebrow,4/8,1.5767438552362905E-5,1.2882496024047357E-4,0,0,44.333333333333336,490.2186527348688,KIT;PAX3;MITF;SOX10
Grey eyebrow,4/8,1.5767438552362905E-5,1.2882496024047357E-4,0,0,44.333333333333336,490.2186527348688,KIT;PAX3;MITF;SOX10
White eyebrow,4/8,1.5767438552362905E-5,1.2882496024047357E-4,0,0,44.333333333333336,490.2186527348688,KIT;PAX3;MITF;SOX10
Childhood Osteosarcoma,16/206,1.6016511018386265E-5,1.307009574720318E-4,0,0,3.8012513801987486,41.97300123384028,EPAS1;DUSP1;CDKN2A;CXCR4;FOS;KLF4;ESR1;RUNX2;FOXO1;NDC80;BMP2;IL6;KIT;E2F2;ECT2;TEAD1
Proteinuria,15/184,1.6593127215631484E-5,1.3524204172352068E-4,0,0,4.001513692032476,44.04274837056454,RET;PTGS2;PAX2;AGT;VTN;NR4A1;CXCL10;NPHS1;WT1;LEPR;SAA1;SDC1;CTLA4;PRTN3;PPARA
Adult Acute Lymphocytic Leukemia,12/121,1.6638047282756638E-5,1.354437885466589E-4,0,0,4.944212555882789,54.40521749272309,MYCN;CCND1;TAL1;CDKN2A;WT1;KIT;ERBB2;CCL2;GATA3;RUNX2;GFAP;EZH2
Diarrhea,21/329,1.676407299101193E-5,1.3597525870487454E-4,0,0,3.095036449399657,34.03386411418182,RET;CDT1;BLM;CDKN2C;STAT1;CAV2;F12;CAV1;ANTXR2;PTGS2;PER2;PYY;IL6;KIT;ERBB2;SAA1;LEPR;SERPING1;CTLA4;KCNQ5;FGFR4
Mental disorders,21/329,1.676407299101193E-5,1.3597525870487454E-4,0,0,3.095036449399657,34.03386411418182,CNTNAP2;GAD1;CTNND2;PRKCA;ADRB2;PKMYT1;ESR1;QKI;GFAP;IL6;ALDH2;TAL1;DPYSL2;FEZ1;STMN1;CTLA4;NDN;DMD;CALR;FKBP4;ATF3
Osteopenia,21/329,1.676407299101193E-5,1.3597525870487454E-4,0,0,3.095036449399657,34.03386411418182,FBN2;EGR2;STAT1;IRS2;LIFR;BRCA1;ANTXR2;BRCA2;FGF2;ESR1;RUNX2;COL1A1;RPS6KA3;ZFP36;BMP2;IL6;COL1A2;CCND1;TNFSF11;PPARG;DMD
Uremia,9/67,1.680609367168801E-5,1.3615165874433856E-4,0,0,6.938982916798482,76.28557541246424,STAT5A;STAT5B;BMP2;IL6;PROC;PROS1;KDR;SGK1;RUNX2
Inflammatory dermatosis,14/163,1.760059554897823E-5,1.4241638518908167E-4,0,0,4.230585963655616,46.31466905489978,STAT5A;STAT5B;FLT4;IL18;CXCR4;PTGS2;CXCL10;FGF7;IL6;CXCR2;PAEP;CTLA4;CCL2;PPARA
MIXED LINEAGE LEUKEMIA,15/185,1.7696243436291844E-5,1.4301801554529004E-4,0,0,3.9777701778385772,43.52539047427139,PRKN;MEF2C;HLF;CDKN2A;HGF;BRCA1;ESR1;ETS2;RIMS2;RAD51;CCND1;MECOM;KDR;MET;EZH2
Comedone,7/38,1.789460808936033E-5,1.4444734125978846E-4,0,0,10.065399911621741,110.02499830635527,CCND1;PARP1;CISH;ERBB2;BRCA1;KRT5;ESR1
Congenital absence of kidney,8/52,1.7991906421037316E-5,1.4488446465669858E-4,0,0,8.11774495527356,88.6911412902145,RET;FANCD2;FANCA;SIX1;FGFR3;CEP55;PAX2;CIT
Endocrine System Diseases,8/52,1.7991906421037316E-5,1.4488446465669858E-4,0,0,8.11774495527356,88.6911412902145,RET;CDH5;TCF7L2;WT1;LEPR;CTLA4;DMD;CD36
Addictive Behavior,16/208,1.805863097387172E-5,1.4524762349763168E-4,0,0,3.7612665112665113,41.08012712528264,STAT5A;OPRD1;ALK;STAT5B;JUN;MITF;FOS;ESR1;MYCN;ALDH2;KIT;ERBB2;LEPR;E2F1;MET;EZH2
Epilepsy,49/1177,1.8375600626357758E-5,1.4762025574954388E-4,0,0,2.021372859803711,22.042033720670602,RET;CNTNAP2;CTNND2;PROS1;AQP1;RPS6KA3;CCND2;ALDH2;SIX3;LEPR;SOSTDC1;MEF2C;ARHGEF15;FOS;TUBG1;SSTR2;SOX10;PAX2;SYN1;TGFBR2;ACTA2;KCNQ5;SCN4A;SGK1;OPRD1;GRIA2;GATA4;ASCL1;CCL2;DMD;FADD;OTX1;PAK3;MPDZ;PLK4;EGR1;ARNT2;GAD1;GRIN2C;ESR1;GRIN2D;GFAP;COL1A1;COL3A1;IL6;PROC;VIM;FGFR3;EZH2
"Osteoarthrosis, localized, not specified whether primary or secondary",6/26,1.8505223134123496E-5,1.4848396483724418E-4,0,0,13.349658314350798,145.47733457610116,ACAN;COL2A1;CDKN2A;CAV1;PECAM1;ERG
Eosinophilia,15/186,1.886377568509354E-5,1.5100014004897286E-4,0,0,3.9543043655650756,43.01597910467948,CCL13;PARP1;IL18;GATA3;IL2RG;PTGS2;CXCL10;IL6;WT1;KIT;IRF7;CAPN3;CTLA4;FLNC;FKBP4
Hashimoto Disease,15/186,1.886377568509354E-5,1.5100014004897286E-4,0,0,3.9543043655650756,43.01597910467948,RET;VAV3;EGR1;GATA3;PTGS2;ESR1;CXCL10;IL6;CCND1;TERT;ERBB2;CTLA4;PPARG;TK1;MET
Persistent infection,9/68,1.899344735354152E-5,1.5168223209290256E-4,0,0,6.821023169025035,74.15418392491661,FBN2;VTN;SOCS3;IL6;CCND1;CDKN2A;IL18;PAEP;RUNX1T1
Abnormality of the fallopian tube,5/16,1.901674202236807E-5,1.5168223209290256E-4,0,0,20.1900826446281,219.47005077071478,BARD1;RAD51;WT1;BRCA1;BRCA2
Condyloma,5/16,1.901674202236807E-5,1.5168223209290256E-4,0,0,20.1900826446281,219.47005077071478,JUN;CDKN2A;ERBB2;MKI67;ESR1
Carcinoid tumor no ICD-O subtype,11/104,2.033508718789502E-5,1.6181332411599876E-4,0,0,5.304048362320995,57.30049759144112,RET;JUN;KRT19;ERBB2;PDGFA;CIB1;FOS;SYP;SSTR2;ASCL1;PITX1
Enterovirus Infections,11/104,2.033508718789502E-5,1.6181332411599876E-4,0,0,5.304048362320995,57.30049759144112,EGR1;CXCL10;IL6;CISH;CAV2;CAV1;GAD1;CCL2;DMD;VIM;PTGS2
Experimental Lung Inflammation,8/53,2.0782784082317226E-5,1.644018585357391E-4,0,0,7.936943808797356,85.57125170667213,IL6;PARP1;CXCR2;IL18;CCL2;CCL19;AGT;MYLK
Myeloid neoplasm,8/53,2.0782784082317226E-5,1.644018585357391E-4,0,0,7.936943808797356,85.57125170667213,ALK;HOXA10;EGR1;NGFR;NR4A1;TERT;WT1;KIT
Nodular glomerulosclerosis,8/53,2.0782784082317226E-5,1.644018585357391E-4,0,0,7.936943808797356,85.57125170667213,MDK;KDR;TXNIP;CCL2;PPARG;CD36;AGT;TGFBR2
Polycystic Kidney - body part,8/53,2.0782784082317226E-5,1.644018585357391E-4,0,0,7.936943808797356,85.57125170667213,FGF7;SIX1;RCC1;PRKD1;GATA3;PKD2;ZNF423;AQP1
Thrombocytosis,8/53,2.0782784082317226E-5,1.644018585357391E-4,0,0,7.936943808797356,85.57125170667213,ALK;NFE2;IL6;CXCL12;CXCR4;PAEP;CALR;AQP1
"Status Epilepticus, Subclinical",9/69,2.1418224350333867E-5,1.6823952600800263E-4,0,0,6.706995412844036,72.1087077953845,RET;GRIA2;MEF2C;JUN;CCL2;DMD;FOS;SSTR2;PTGS2
Complex Partial Status Epilepticus,9/69,2.1418224350333867E-5,1.6823952600800263E-4,0,0,6.706995412844036,72.1087077953845,RET;GRIA2;MEF2C;JUN;CCL2;DMD;FOS;SSTR2;PTGS2
Diabetic Angiopathies,9/69,2.1418224350333867E-5,1.6823952600800263E-4,0,0,6.706995412844036,72.1087077953845,RIMS2;TCF7L2;CMA1;E2F1;CCL2;SGK1;FGF2;ATF3;AGT
Grand Mal Status Epilepticus,9/69,2.1418224350333867E-5,1.6823952600800263E-4,0,0,6.706995412844036,72.1087077953845,RET;GRIA2;MEF2C;JUN;CCL2;DMD;FOS;SSTR2;PTGS2
Non-Convulsive Status Epilepticus,9/69,2.1418224350333867E-5,1.6823952600800263E-4,0,0,6.706995412844036,72.1087077953845,RET;GRIA2;MEF2C;JUN;CCL2;DMD;FOS;SSTR2;PTGS2
Simple Partial Status Epilepticus,9/69,2.1418224350333867E-5,1.6823952600800263E-4,0,0,6.706995412844036,72.1087077953845,RET;GRIA2;MEF2C;JUN;CCL2;DMD;FOS;SSTR2;PTGS2
Acute GVH disease,14/166,2.161824899395088E-5,1.6921696998062252E-4,0,0,4.14644645255831,44.54101475767317,CMA1;HGF;CAV1;IL18;GZMB;AURKA;C3;IL6;FANCD2;KRT15;LTA;PECAM1;S1PR1;CTLA4
Contracture,14/166,2.161824899395088E-5,1.6921696998062252E-4,0,0,4.14644645255831,44.54101475767317,DST;TPM3;CAV1;GAD1;BGN;ANTXR2;DCN;COL1A2;COL2A1;BIN1;CAPN3;DMD;TIMP1;CRYAB
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding),14/166,2.161824899395088E-5,1.6921696998062252E-4,0,0,4.14644645255831,44.54101475767317,NFE2;PARP1;HGF;TAP1;MITF;PTGS2;FGF2;ESR1;C4B;IL6;KIT;LTA;CTLA4;CALR
Biliary Atresia,11/105,2.2267570486915387E-5,1.740966279279671E-4,0,0,5.247352681635454,56.21163159684403,CXCL10;IL6;EPAS1;STAT1;CXCR2;MX1;PDGFA;CCL2;TIMP1;TEK;SELE
Congenital contractural arachnodactyly,16/212,2.2848709343579147E-5,1.7843247901334599E-4,0,0,3.6837448266019694,39.36676613161241,FBN2;ANXA1;CDKN2A;PDGFA;CXCR4;PTGS2;TGFBR2;COL1A1;FGF7;IL6;COL1A2;CXCL12;PRKAR2B;ERBB2;VIM;FKBP4
Chronic active hepatitis,10/87,2.3306217108201693E-5,1.815830093952234E-4,0,0,5.815196297954919,62.02948007018639,C4B;ACTA2;KRT19;STAT1;HGF;ERBB2;IL18;MKI67;MET;ESR1
DOSAGE-SENSITIVE SEX REVERSAL,10/87,2.3306217108201693E-5,1.815830093952234E-4,0,0,5.815196297954919,62.02948007018639,CCNA2;TCF7L2;NR4A1;IL6;COL2A1;BCL3;IL18;CCL2;PTGS2;TGFBR2
Vascular anomaly,6/27,2.334803115000153E-5,1.8169800371194703E-4,0,0,12.713309469573707,135.58741875007615,WT1;FLT4;PECAM1;ADRB1;TEK;SYNE1
"Brain Injuries, Focal",9/70,2.4101008224166023E-5,1.8626279773705296E-4,0,0,6.596706271619793,70.14447236990898,CXCL10;JUN;IL6;PARP1;SERPINC1;CCL2;FOS;PTGS2;FGF2
"Injuries, Acute Brain",9/70,2.4101008224166023E-5,1.8626279773705296E-4,0,0,6.596706271619793,70.14447236990898,CXCL10;JUN;IL6;PARP1;SERPINC1;CCL2;FOS;PTGS2;FGF2
Brain Injuries,9/70,2.4101008224166023E-5,1.8626279773705296E-4,0,0,6.596706271619793,70.14447236990898,CXCL10;JUN;IL6;PARP1;SERPINC1;CCL2;FOS;PTGS2;FGF2
Brain Lacerations,9/70,2.4101008224166023E-5,1.8626279773705296E-4,0,0,6.596706271619793,70.14447236990898,CXCL10;JUN;IL6;PARP1;SERPINC1;CCL2;FOS;PTGS2;FGF2
Neurofibromatosis 2,9/70,2.4101008224166023E-5,1.8626279773705296E-4,0,0,6.596706271619793,70.14447236990898,CCNA2;YAP1;CDKN2A;BRCA1;SEMA3F;MKI67;SGK1;EZR;NEFH
Pulmonary arterial hypertension,9/70,2.4101008224166023E-5,1.8626279773705296E-4,0,0,6.596706271619793,70.14447236990898,ACTA2;COL1A1;COL1A2;TERT;FLT4;CAV1;LIFR;BMPR1B;AQP1
Juvenile-Onset Still Disease,14/168,2.472582215296005E-5,1.9087197882675826E-4,0,0,4.092174646699009,43.40840725318299,EGR1;TCF7L2;JUN;MAML2;DUSP1;PROS1;PLAUR;CXCR4;FOS;KLF4;IL6;ERBB2;CXCR2;CTLA4
Left-Sided Heart Failure,12/126,2.5047398222543065E-5,1.9313240696050427E-4,0,0,4.726145618086788,50.07228685767105,ACTA2;IL6;VWF;PRKAR2B;ADRB1;PPARG;APOB;PTGS2;PPARGC1A;AGT;MYLK;TGFBR2
AIDS Dementia Complex,7/40,2.5440410916192668E-5,1.9548947335600681E-4,0,0,9.454407084544071,100.01979555952,CXCL10;IL6;CXCR4;CCL2;ADRB2;PTGS2;FGF2
Anthrax disease,7/40,2.5440410916192668E-5,1.9548947335600681E-4,0,0,9.454407084544071,100.01979555952,MMP14;PARP1;VWF;ERBB2;PLA2G2A;CALR;ANTXR2
Osteoarthritis of the hand,7/40,2.5440410916192668E-5,1.9548947335600681E-4,0,0,9.454407084544071,100.01979555952,ACAN;IL6;COL2A1;CCND1;TIMP1;PTGS2;ESR1
Hematological Disease,13/147,2.5674465185326513E-5,1.9706252363960327E-4,0,0,4.361404781647319,46.10010799903247,EGR1;VWF;FANCA;CXCR4;KLF1;KRT19;CXCL12;BIN1;WT1;KIT;CTLA4;FADD;TEK
"Brain Tumor, Primary",10/88,2.577980099121804E-5,1.9719492421072933E-4,0,0,5.740347774830534,60.65205122790564,ALK;YAP1;NRP1;MYCN;CCND1;MDK;CDKN2A;TIMP1;SOX10;TGFBR2
Retroviridae Infections,10/88,2.577980099121804E-5,1.9719492421072933E-4,0,0,5.740347774830534,60.65205122790564,ALK;CXCL10;IL6;CCND1;PARP1;TERT;TRAT1;ADRB2;EZR;AURKA
Spina Bifida,10/88,2.577980099121804E-5,1.9719492421072933E-4,0,0,5.740347774830534,60.65205122790564,JUN;CFL1;LEPR;IL18;PAX3;CCL2;PRKCA;BRCA1;FOS;LMNB1
Neurofibromatoses,9/71,2.7063697893688086E-5,2.0654522165228318E-4,0,0,6.4899748446285885,68.25712463995794,RET;MDK;CDKN2A;HGF;KIT;PDGFA;FGF2;AURKA;EZH2
Pterygium,9/71,2.7063697893688086E-5,2.0654522165228318E-4,0,0,6.4899748446285885,68.25712463995794,IL6;CXCL12;LRP1;TERT;CDKN2A;KDR;PECAM1;CXCR4;PMAIP1
Crohn's disease of the ileum,8/55,2.7462309778988698E-5,2.0911210031257152E-4,0,0,7.598422513267442,79.80392209239415,VTN;TCF7L2;FGF7;IL6;PLA2G2A;CCL2;PPARG;PPARA
Hypocholesterolemia,8/55,2.7462309778988698E-5,2.0911210031257152E-4,0,0,7.598422513267442,79.80392209239415,CXCL10;IL6;CAV2;CAV1;CXCR4;SLC2A4;APOB;AGT
Chronic Periodontitis,13/148,2.7587933486429034E-5,2.0983076024332659E-4,0,0,4.3288751714677645,45.44510327915045,CDKN2A;IL18;PTGS2;AGT;C4B;C4A;VTN;IL6;CXCL12;LTA;TNFSF11;PPARG;TIMP1
Calcaneovalgus deformity,4/9,2.7882225571303903E-5,2.1040115386165956E-4,0,0,35.46485260770975,371.9383917501472,COL1A2;TNNI2;HOXD10;EZH2
Carcinoma in situ of fallopian tube,4/9,2.7882225571303903E-5,2.1040115386165956E-4,0,0,35.46485260770975,371.9383917501472,CDKN2A;STMN1;BRCA1;BRCA2
Grey eyelashes,4/9,2.7882225571303903E-5,2.1040115386165956E-4,0,0,35.46485260770975,371.9383917501472,KIT;PAX3;MITF;SOX10
Hypopharyngeal Cancer,4/9,2.7882225571303903E-5,2.1040115386165956E-4,0,0,35.46485260770975,371.9383917501472,NGFR;CDKN2A;HGF;ETS2
Medullary carcinoma of breast,4/9,2.7882225571303903E-5,2.1040115386165956E-4,0,0,35.46485260770975,371.9383917501472,ERBB2;BRCA1;KRT5;ESR1
Premature osteoarthritis,4/9,2.7882225571303903E-5,2.1040115386165956E-4,0,0,35.46485260770975,371.9383917501472,COL1A1;ACAN;COL1A2;COL2A1
White eyelashes,4/9,2.7882225571303903E-5,2.1040115386165956E-4,0,0,35.46485260770975,371.9383917501472,KIT;PAX3;MITF;SOX10
Nasopharyngeal Neoplasms,10/89,2.8474993555720897E-5,2.146330602920556E-4,0,0,5.667394151025753,59.31769176162421,BARD1;COL1A1;NR5A2;ALDH2;MECOM;TERT;FLT4;HGF;ERBB2;BAK1
"Carcinoma, Lewis Lung",11/108,2.9048459967008912E-5,2.1871015374263662E-4,0,0,5.084279538220343,53.11315544239775,IL6;TERT;HGF;CXCR2;KDR;IL18;PECAM1;PRTN3;IL2RG;PTGS2;FGF2
"Hyperglycemia, Postprandial",6/28,2.9160854249535064E-5,2.1931052311296471E-4,0,0,12.134810519776352,126.71998384309883,COL3A1;LEPR;HMGA1;IRS2;SCN4A;PTGS2
Biliary Tract Cancer,12/128,2.9327287214978586E-5,2.2031550440245658E-4,0,0,4.644182527673808,48.471296682354065,RET;IL6;KRT19;CCND2;FANCD2;CDKN2A;PRC1;ERBB2;NEK2;PTGS2;ESR1;TGFBR2
secondary acute myeloid leukemia,9/72,3.032955807972337E-5,2.2759029280829292E-4,0,0,6.386631716906947,66.44260653000926,RET;MMP14;MAML2;MECOM;FLT4;LMO2;KDR;KLF1;EZH2
Vitiligo,17/243,3.383607084780453E-5,2.536194774708206E-4,0,0,3.3970825407327765,34.969510398356775,NFE2;PARP1;HGF;FANCA;TAP1;GZMB;MITF;PTGS2;FGF2;ESR1;FLI1;C4B;IL6;KIT;LTA;CTLA4;CALR
Post-Traumatic Stress Disorder,11/110,3.4500300300758495E-5,2.583099407133713E-4,0,0,4.981054787506401,51.178059256477454,EGR1;STAT5B;IL6;FLT4;STMN1;PRKCA;ADRB2;BRCA1;FKBP4;SGK1;ESR1
Lymphadenopathy,10/91,3.459547026727413E-5,2.5873405157573836E-4,0,0,5.52689087554988,56.771050276257526,IL6;CCND1;CDKN2A;SH2D1A;CTLA4;TNFSF11;MCM4;BRCA1;BRCA2;IL2RG
Clear Cell Sarcoma of Soft Tissue,7/42,3.542923057247294E-5,2.6467487488846306E-4,0,0,8.91324200913242,91.34266662659049,IL6;CDKN2A;KIT;MITF;PPARG;FOS;MET
"Central Nervous System Embryonal Tumor, Not Otherwise Specified",5/18,3.595451150579843E-5,2.677056532959449E-4,0,0,17.082167832167833,174.80619625259487,NGFR;MUC1;MYCN;CDKN2A;CDKN3
Disease due to Papilloma virus,5/18,3.595451150579843E-5,2.677056532959449E-4,0,0,17.082167832167833,174.80619625259487,TERT;CDKN2A;ERBB2;SDC1;ESR1
Nongerminomatous Germ Cell Tumor,5/18,3.595451150579843E-5,2.677056532959449E-4,0,0,17.082167832167833,174.80619625259487,CXCL12;KIT;MKI67;ESR1;FGFR3
Anthracosis,6/29,3.608180129441844E-5,2.683558997711121E-4,0,0,11.606615826483115,118.73245255777076,IL6;CDKN2A;IL18;LTA;CCL2;SELE
Allergic asthma,15/197,3.69771695123431E-5,2.747109186337348E-4,0,0,3.713199591106568,37.89398113862577,CCL13;CAV1;IL18;TAP1;PLA2G4A;GATA3;ADRB2;MYLK;C3;IL6;IRF7;LTA;CTLA4;CCL2;PPARG
Multiple Endocrine Neoplasia Type 1,11/111,3.7542108383650695E-5,2.7859977890010835E-4,0,0,4.930990783410138,50.247029637981164,RIMS2;RET;FKBP2;CDKN2C;CCND1;CIB1;BRCA2;FGF2;GFAP;PPP1CA;CDKN3
Hamartoma,9/74,3.787098091642467E-5,2.8073014109791176E-4,0,0,6.189484827099506,63.01715917084893,NGFR;CCND1;CDKN2A;KIT;HMGA1;HMGA2;TIMP1;PTGS2;PITX1
Abdominal Pain,13/153,3.914625411638944E-5,2.895443200943518E-4,0,0,4.173197751322752,42.35046970966075,RET;CDKN2A;BRCA1;BRCA2;SOX10;TGFBR2;C4A;WT1;SAA1;SERPING1;CTLA4;PRTN3;MET
Cervical Squamous Cell Carcinoma,13/153,3.914625411638944E-5,2.895443200943518E-4,0,0,4.173197751322752,42.35046970966075,TPM3;CDKN2A;HGF;CIB1;KRT5;KLF4;IL6;KRT19;CCND1;ERBB2;CTLA4;RARB;VIM
Leukopenia,17/246,3.950663265729567E-5,2.9188838825786327E-4,0,0,3.3520589315594007,33.986666242533644,STAT5B;PARP1;STAT1;FANCA;CXCR4;BRCA2;ESR1;SELE;SOCS3;GRK3;IL6;CXCL12;RAD51;ALDH2;FANCD2;CTLA4;MET
Microphthalmos,16/222,4.00788269568463E-5,2.9579055147492284E-4,0,0,3.503111774956435,35.46782396286174,PLK4;YAP1;FANCA;CIB1;MITF;FGF2;PAX2;RIMS2;FANCD2;KIT;SIX3;E2F1;RARB;E2F2;MET;BUB1
Carcinoma of Male Breast,8/58,4.0788255707739606E-5,2.998843936894303E-4,0,0,7.14141876430206,72.17915048550145,CA12;CCND1;ERBB2;BRCA1;BRCA2;MKI67;HOXD10;ESR1
Intestinal Cancer,8/58,4.0788255707739606E-5,2.998843936894303E-4,0,0,7.14141876430206,72.17915048550145,TCF7L2;NR5A2;ERBB2;HMGA1;CXCR4;HMGA2;PRKCA;PTGS2
Nerve Sheath Tumors,8/58,4.0788255707739606E-5,2.998843936894303E-4,0,0,7.14141876430206,72.17915048550145,MDK;CDKN2A;HGF;KIT;ERBB2;PDGFA;FGF2;AURKA
Skin Erosion,11/112,4.08121405348629E-5,2.998843936894303E-4,0,0,4.881918145731624,49.33925687761735,CXCL10;IL6;COL2A1;TERT;CDKN2A;TNFSF11;PRTN3;DMD;BRCA1;TIMP1;VIM
Acute respiratory failure,7/43,4.1515208655134964E-5,3.0438443376406817E-4,0,0,8.665208016235413,87.42718929513967,MUC1;IL6;PARP1;CDKN2A;RARB;IL2RG;RUNX1T1
Flushing,7/43,4.1515208655134964E-5,3.0438443376406817E-4,0,0,8.665208016235413,87.42718929513967,RET;CXCL10;RAD51;ALDH2;VWF;PLA2G4A;PTGS2
Mucinous Adenocarcinoma,10/93,4.180716065441098E-5,3.058571796895688E-4,0,0,5.393158842265614,54.376216215747576,ALK;MUC1;TERT;CDKN2A;ERBB2;GATA3;ESR1;SELE;NDC80;CDKN3
Subarachnoid Hemorrhage,10/93,4.180716065441098E-5,3.058571796895688E-4,0,0,5.393158842265614,54.376216215747576,IL6;PLA2G2A;CTSG;ADRB1;TIMP1;ADRB2;KLF4;AGT;AQP1;GFAP
Breast Fibrocystic Disease,9/75,4.2200356616029136E-5,3.083978183169224E-4,0,0,6.095391993327773,61.39938267813923,KRT19;CCND1;HGF;ERBB2;CXCR4;BRCA1;TIMP1;PTGS2;ESR1
Dengue Fever,14/177,4.409973321927353E-5,3.2192805250069674E-4,0,0,3.8644328356084436,38.75661650463317,TCF7L2;STAT1;IL18;TAP1;GZMB;PTGS2;SELE;CXCL10;IL6;LTA;CTLA4;CCL2;VIM;KPNA2
familial atrial fibrillation,6/30,4.426079673370787E-5,3.2205364123898383E-4,0,0,11.122437357630979,111.50700830441033,VWF;CAV2;CAV1;NKX2-5;SELE;SOX5
Persistent atrial fibrillation,6/30,4.426079673370787E-5,3.2205364123898383E-4,0,0,11.122437357630979,111.50700830441033,VWF;CAV2;CAV1;NKX2-5;SELE;SOX5
ST segment elevation myocardial infarction,6/30,4.426079673370787E-5,3.2205364123898383E-4,0,0,11.122437357630979,111.50700830441033,ALDH2;IL18;ADRB1;ADRB2;TIMP1;AGT
Erythema,11/113,4.432441129478282E-5,3.2216747430277213E-4,0,0,4.833807716635041,48.45396764667752,COL1A1;NGFR;BLM;IL6;COL2A1;ALDH2;KIT;SERPING1;CTLA4;KRT5;PTGS2
Dermatologic disorders,23/406,4.439946700707994E-5,3.2236413018329606E-4,0,0,2.7282491678319083,27.343285508098074,RET;COL17A1;ALK;JUN;DST;CDKN2A;IL18;GATA3;FOS;KRT5;PTGS2;GFAP;RIMS2;CXCL10;FGF7;IL6;CXCL12;RARB;PPARG;CCL19;CALR;PPARA;FGFR3
Abdominal Migraine,4/10,4.565361108109982E-5,3.282758586945037E-4,0,0,29.552532123960695,295.3606501099457,LRP1;FHL5;ESR1;TGFBR2
Acute Confusional Migraine,4/10,4.565361108109982E-5,3.282758586945037E-4,0,0,29.552532123960695,295.3606501099457,LRP1;FHL5;ESR1;TGFBR2
Amputation Stumps,4/10,4.565361108109982E-5,3.282758586945037E-4,0,0,29.552532123960695,295.3606501099457,ALK;TERT;CIB1;PTGS2
Cervical Migraine Syndrome,4/10,4.565361108109982E-5,3.282758586945037E-4,0,0,29.552532123960695,295.3606501099457,LRP1;FHL5;ESR1;TGFBR2
Hemicrania migraine,4/10,4.565361108109982E-5,3.282758586945037E-4,0,0,29.552532123960695,295.3606501099457,LRP1;FHL5;ESR1;TGFBR2
Melanosis,4/10,4.565361108109982E-5,3.282758586945037E-4,0,0,29.552532123960695,295.3606501099457,RET;ALDH2;HGF;MET
Melanosis coli,4/10,4.565361108109982E-5,3.282758586945037E-4,0,0,29.552532123960695,295.3606501099457,RET;ALDH2;HGF;MET
Sick Headaches,4/10,4.565361108109982E-5,3.282758586945037E-4,0,0,29.552532123960695,295.3606501099457,LRP1;FHL5;ESR1;TGFBR2
Status Migrainosus,4/10,4.565361108109982E-5,3.282758586945037E-4,0,0,29.552532123960695,295.3606501099457,LRP1;FHL5;ESR1;TGFBR2
Hereditary Diffuse Gastric Cancer,19/300,4.672602673454191E-5,3.356278027263994E-4,0,0,3.059211735418442,30.50404029541188,JUN;FKBP2;CDKN2A;TPM3;CAV1;MX1;IRS2;ADRB1;ADRB2;PTGS2;BMP2;IL6;MUC1;ACTC1;CCND1;ERBB2;RARB;PPARG;MET
"Papilloma, Squamous Cell",5/19,4.790659149109702E-5,3.426418194400507E-4,0,0,15.8612012987013,157.75959164021398,CCND1;KRT15;ERBB2;MKI67;PTGS2
Carcinoma of extrahepatic bile duct,5/19,4.790659149109702E-5,3.426418194400507E-4,0,0,15.8612012987013,157.75959164021398,MUC1;CCND1;CIB1;MKI67;PTGS2
Fallopian Tube Carcinoma,5/19,4.790659149109702E-5,3.426418194400507E-4,0,0,15.8612012987013,157.75959164021398,BARD1;ERBB2;CIB1;BRCA1;BRCA2
THROMBOCYTOPENIA 1 (disorder),5/19,4.790659149109702E-5,3.426418194400507E-4,0,0,15.8612012987013,157.75959164021398,PAEP;CIB1;TIMP1;PPARA;FLI1
Head and Neck Carcinoma,11/114,4.809359086562787E-5,3.42883817678935E-4,0,0,4.786631470627713,47.590421098126065,MMP14;CCND1;CDKN2A;ERBB2;IL18;E2F1;SDC1;RARB;BRCA1;FGFR4;TGFBR2
Testicular Germ Cell Tumor,11/114,4.809359086562787E-5,3.42883817678935E-4,0,0,4.786631470627713,47.590421098126065,CCND2;MYCN;CCND1;CISH;TERT;KIT;GATA4;BAK1;PITX1;ESR1;FGFR3
Urticaria,11/114,4.809359086562787E-5,3.42883817678935E-4,0,0,4.786631470627713,47.590421098126065,KIT;IL18;E2F1;SERPING1;PLA2G4A;GZMB;ADRB2;ANTXR2;PTGS2;ESR1;SELE
"Liposarcoma, Myxoid",7/44,4.843288120638418E-5,3.4420659278526576E-4,0,0,8.430581266197704,83.7606205543094,IL6;LRP1;TERT;CDKN2A;PDGFA;HMGA2;ERG
Endometriosis of uterus,7/44,4.843288120638418E-5,3.4420659278526576E-4,0,0,8.430581266197704,83.7606205543094,IL6;HGF;FGF1;PTGS2;FGF2;ESR1;PAK4
Strawberry nevus of skin,7/44,4.843288120638418E-5,3.4420659278526576E-4,0,0,8.430581266197704,83.7606205543094,IL6;FLT4;KDR;PECAM1;CCL2;ADRB1;ADRB2
Hormone refractory prostate cancer,12/135,4.97058863373259E-5,3.5288026706287607E-4,0,0,4.378302258773165,43.38629233675518,IL6;MUC1;ANXA1;PARP1;PROS1;ERBB2;KDR;FKBP4;PTGS2;ESR1;MET;EZH2
Rheumatism,10/95,5.026462756830931E-5,3.5609413370122923E-4,0,0,5.265720081135902,52.12119767477924,C3;SPTA1;VIL1;NRP1;IL6;IL18;BAK1;INHBA;CALR;PTGS2
Sciatic Neuropathy,10/95,5.026462756830931E-5,3.5609413370122923E-4,0,0,5.265720081135902,52.12119767477924,C3;NGFR;IL6;CAV1;RARB;CCL2;PCSK5;NEFH;PPARGC1A;AGT
Bacterial Infections,18/276,5.0450132741100894E-5,3.570317086293294E-4,0,0,3.1529328467948368,31.196773443543755,STAT1;HGF;IL18;CXCR4;PLA2G4A;GZMB;PTGS2;FGF2;TGFBR2;C3;IL6;MUC1;TERT;SAA1;CTLA4;FADD;EZH2;RUNX1T1
Hypertrophic Cardiomyopathy,20/328,5.057775274868423E-5,3.5755809206332973E-4,0,0,2.9407181054239877,29.089579815169266,PRKN;TRIM63;VWF;TPM3;CMA1;CAV1;BRCA1;FOS;ESR1;AGT;MYLK;COL1A1;ACTA2;COL1A2;ACTC1;PPARG;CD36;FLNC;PPARGC1A;CRYAB
Hypertriglyceridemia,13/157,5.123280209713023E-5,3.618080955671153E-4,0,0,4.0564396862139915,40.07409728955343,VWF;CAV1;ADRB2;FOXO1;C3;SOCS3;IL6;LTA;TXNIP;PPARG;CD36;APOB;PPARA
Autoimmune thyroiditis,8/60,5.2374324187954026E-5,3.694810517293059E-4,0,0,6.866044710438303,67.67924868982128,RET;CXCL10;IL6;TERT;ERBB2;CTLA4;CCL2;PTGS2
Primary biliary cirrhosis,20/329,5.276634954875994E-5,3.7185603732368494E-4,0,0,2.9310489244241387,28.86976761116742,CDKN2A;HGF;IL18;CIB1;BRCA1;PTGS2;AGT;FOXO1;TGFBR2;C4B;COL1A1;C4A;CDH5;CXCL10;IL6;BCL3;TNFSF11;CTLA4;PPARG;PPARGC1A
Endocrine Gland Neoplasms,6/31,5.3859849054889534E-5,3.783710734860231E-4,0,0,10.676993166287016,104.94550337179261,RET;CDKN2C;ERBB2;CIB1;ESR1;RUNX1T1
Large hand,6/31,5.3859849054889534E-5,3.783710734860231E-4,0,0,10.676993166287016,104.94550337179261,RPS6KA3;CAV1;KIT;PPARG;FOS;EZH2
Plasma Cell Neoplasm,6/31,5.3859849054889534E-5,3.783710734860231E-4,0,0,10.676993166287016,104.94550337179261,IL6;CCND1;CDKN2A;FLT4;KIT;MET
Endometrial Stromal Sarcoma,7/45,5.626702345373927E-5,3.9445650262558764E-4,0,0,8.208303292477769,80.32154682678612,ALK;PPP4C;CCND1;CAV1;KIT;VIM;ESR1
Myxoid/Round Cell Liposarcoma,7/45,5.626702345373927E-5,3.9445650262558764E-4,0,0,8.208303292477769,80.32154682678612,RET;IL6;CDKN2A;PDGFA;HMGA2;PPARG;ERG
Peripheral Vascular Diseases,9/78,5.7778937677666336E-5,4.0463331120251E-4,0,0,5.829477463103311,56.88920745199617,IL6;TRIM63;CCND1;HGF;F12;PPARG;APOB;FGF2;AGT
"Leukemia, Large Granular Lymphocytic",8/61,5.9122442474270745E-5,4.136107538095858E-4,0,0,6.7361512888044555,65.5824951193837,STAT5A;STAT5B;CDKN2A;IL18;CXCR4;FOS;ERG;FGF2
Adult Hepatocellular Carcinoma,10/97,6.0138456243387335E-5,4.189728964010263E-4,0,0,5.144140573391465,49.995187455050605,C3;TERT;CDKN2A;CAPN3;TXNIP;TEK;A2M;PTGS2;MET;TGFBR2
Hyperhidrosis disorder,10/97,6.0138456243387335E-5,4.189728964010263E-4,0,0,5.144140573391465,49.995187455050605,RET;TERT;DST;CAV1;LIFR;PPARG;KRT5;FOS;ASCL1;FGFR3
Increased sweating,10/97,6.0138456243387335E-5,4.189728964010263E-4,0,0,5.144140573391465,49.995187455050605,RET;TERT;DST;CAV1;LIFR;PPARG;KRT5;FOS;ASCL1;FGFR3
Sweating,10/97,6.0138456243387335E-5,4.189728964010263E-4,0,0,5.144140573391465,49.995187455050605,RET;TERT;DST;CAV1;LIFR;PPARG;KRT5;FOS;ASCL1;FGFR3
Myopathy,23/415,6.204055475125086E-5,4.317765447765811E-4,0,0,2.664359464164813,25.811574537227294,RET;TRIM63;TPM3;PRKCA;PTGS2;SPTB;GFAP;RIMS2;VTN;BIN1;FLAD1;STMN1;CNTN1;TNNI2;CAPN3;PPARG;DMD;SCN4A;FLNC;PPARA;UTRN;NEFH;CRYAB
Hypotrophic malar bone,13/160,6.231384069758591E-5,4.327815451137404E-4,0,0,3.9730410682791635,38.4722558277783,BLM;BGN;PAX3;LIFR;KIF22;RUNX2;TGFBR2;COL1A1;BMP2;COL1A2;COL2A1;SIX3;FGFR3
Malar flattening,13/160,6.231384069758591E-5,4.327815451137404E-4,0,0,3.9730410682791635,38.4722558277783,BLM;BGN;PAX3;LIFR;KIF22;RUNX2;TGFBR2;COL1A1;BMP2;COL1A2;COL2A1;SIX3;FGFR3
malignant neoplasm of breast staging,5/20,6.271254557499507E-5,4.337563914332306E-4,0,0,14.803030303030303,143.24816990109616,CCND1;SIX1;BRCA1;BRCA2;ESR1
Soft skin,5/20,6.271254557499507E-5,4.337563914332306E-4,0,0,14.803030303030303,143.24816990109616,COL1A1;COL3A1;COL1A2;KIF22;PAX2
Solitary fibrous tumor,5/20,6.271254557499507E-5,4.337563914332306E-4,0,0,14.803030303030303,143.24816990109616,EGR1;CCND1;TERT;CDKN2A;MET
Velvety skin,5/20,6.271254557499507E-5,4.337563914332306E-4,0,0,14.803030303030303,143.24816990109616,COL1A1;COL3A1;COL1A2;KIF22;PAX2
Immune thrombocytopenic purpura,14/183,6.345228084593845E-5,4.3842131498078466E-4,0,0,3.7260808083581596,36.013399757657254,VWF;STAT1;SIAH2;IL18;CXCR4;GZMB;GATA4;GATA3;FGF2;IL6;CXCL12;LTA;PECAM1;CTLA4
Arthrogryposis,19/307,6.367626741771856E-5,4.390655153772052E-4,0,0,2.983771844027126,28.828304346076404,FBN2;EGR2;ANXA3;TPM3;ANTXR2;SYNE1;TGFBR2;BIN1;STMN1;ERBB2;CNTN1;CAPN3;TNNI2;DMD;SCN4A;FLNC;UTRN;CRYAB;FGFR3
Serum total cholesterol measurement,19/307,6.367626741771856E-5,4.390655153772052E-4,0,0,2.983771844027126,28.828304346076404,TCF7L2;LRP1;CDKN2A;PLA2G4A;BRCA2;PCSK5;ESR1;ACAN;MMP14;MECOM;ADAM12;BCL3;KDR;PPARG;CD36;APOB;PPARA;NECTIN2;MATN2
"Sarcoidosis, Pulmonary",7/46,6.510801997328428E-5,4.480178915374767E-4,0,0,7.997424189205011,77.09087314091396,CXCL10;CMA1;IL18;CXCR4;PPARG;CCL19;PTGS2
Malignant neoplasm of male breast,7/46,6.510801997328428E-5,4.480178915374767E-4,0,0,7.997424189205011,77.09087314091396,CA12;CCND1;CHEK1;ERBB2;BRCA1;BRCA2;ESR1
Visual seizure,15/207,6.526287119526059E-5,4.4862379012013316E-4,0,0,3.517986918604651,33.90314695464864,EGR1;NGFR;CNTNAP2;DUSP1;FOS;ENO2;PTGS2;PLD1;SSTR2;FGF2;AGT;VTN;IL6;CCND1;MPDZ
Eosinophilic disorder,13/161,6.64432307928858E-5,4.5627069325666767E-4,0,0,3.9459928678678677,37.95714720061588,CCL13;PARP1;IL18;GATA3;PTGS2;CXCL10;IL6;WT1;KIT;IRF7;CTLA4;FLNC;FKBP4
Nijmegen Breakage Syndrome,8/62,6.657825486452612E-5,4.5673090875399125E-4,0,0,6.611068734638529,63.579524234003806,PARP1;TERT;FANCD2;CDKN2A;PECAM1;BRCA1;ERG;KPNA2
Peripheral Neuropathy,19/309,6.942888031074787E-5,4.7580036751732925E-4,0,0,2.9628865144892345,28.370253572831484,RET;PRKN;NGFR;EGR2;JUN;DST;CDKN2A;MKI67;SOX10;GFAP;AURKA;IL6;PTPRB;CTLA4;CCL2;SCN4A;FLNC;NEFH;ATF3
"CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)",4/11,7.048132081850519E-5,4.8007358074754654E-4,0,0,25.32944606413994,242.15362892344896,ACTC1;FLNC;CRYAB;AGT
High Grade Ovarian Serous Adenocarcinoma,4/11,7.048132081850519E-5,4.8007358074754654E-4,0,0,25.32944606413994,242.15362892344896,CDKN2A;STMN1;BRCA1;BRCA2
Lipoblastoma,4/11,7.048132081850519E-5,4.8007358074754654E-4,0,0,25.32944606413994,242.15362892344896,COL3A1;COL1A2;CDKN2A;HMGA2
Nasopharyngeal Angiofibroma,4/11,7.048132081850519E-5,4.8007358074754654E-4,0,0,25.32944606413994,242.15362892344896,IL6;KIT;PDGFA;FGF2
Prehypertension,4/11,7.048132081850519E-5,4.8007358074754654E-4,0,0,25.32944606413994,242.15362892344896,PECAM1;ADRB2;SELE;AGT
Sinonasal undifferentiated carcinoma,4/11,7.048132081850519E-5,4.8007358074754654E-4,0,0,25.32944606413994,242.15362892344896,ERBB2;KIT;PAX3;ASCL1
Intestinal Diseases,9/80,7.065301451715113E-5,4.807554665624995E-4,0,0,5.664685359865616,54.141531966356645,ALK;STAT5B;MUC1;IL6;ANXA1;HGF;GZMB;FHL5;LMNB1
Neutrophilia (disorder),8/63,7.479878219640958E-5,5.084500214889542E-4,0,0,6.490534636987726,61.664680541312,CXCL10;IL6;CXCL12;CXCR2;CXCR4;PPARG;TEK;SELE
Post MI,7/47,7.50520037848202E-5,5.091406640594469E-4,0,0,7.797089041095891,74.05152221180302,RCAN1;MMP14;CCL21;WT1;CCL2;TIMP1;DCN
Tracheoesophageal Fistula,7/47,7.50520037848202E-5,5.091406640594469E-4,0,0,7.797089041095891,74.05152221180302,RET;MYCN;TERT;FANCD2;FANCA;BRCA2;PCSK5
Metabolic Diseases,23/421,7.7051604876574E-5,5.221781819889717E-4,0,0,2.6233715973231084,24.84604465537269,PRKN;KLF11;PARP1;DUSP1;CDKN2A;PLA2G4A;GATA4;ADRB2;SLC2A4;BRCA2;ADRA1A;PPL;FOXO1;NR4A1;IL6;FANCD2;LEPR;LTA;CCL2;PPARG;CD36;PPARA;PPARGC1A
Lobar Pneumonia,9/81,7.794461949353996E-5,5.250857596592E-4,0,0,5.58572247706422,52.838208744276066,IL6;PARP1;CXCR2;IL18;CCL2;CCL19;AGT;MYLK;CDKN3
"Albinism, Oculocutaneous",6/33,7.802793152767743E-5,5.250857596592E-4,0,0,9.885092381675525,93.49758975017951,CDKN2A;KIT;CTLA4;MITF;BRCA1;BRCA2
"Nephritis, Interstitial",6/33,7.802793152767743E-5,5.250857596592E-4,0,0,9.885092381675525,93.49758975017951,MUC1;CCL2;GZMB;FGF2;AGT;DCN
"Stickler syndrome, type 1",6/33,7.802793152767743E-5,5.250857596592E-4,0,0,9.885092381675525,93.49758975017951,RPS6KA3;IL6;COL2A1;CXCR4;PTGS2;KLF4
Childhood T Acute Lymphoblastic Leukemia,6/33,7.802793152767743E-5,5.250857596592E-4,0,0,9.885092381675525,93.49758975017951,PRKN;CCND2;CDKN2A;TAL1;S100A4;CDKN3
CREST Syndrome,6/33,7.802793152767743E-5,5.250857596592E-4,0,0,9.885092381675525,93.49758975017951,IL6;CAV1;MITF;TIMP1;SOX10;SOX5
Periapical Periodontitis,6/33,7.802793152767743E-5,5.250857596592E-4,0,0,9.885092381675525,93.49758975017951,IL6;MDK;CXCR2;CCL2;TNFSF11;FGF2
Atrophic scar,5/21,8.081245489887582E-5,5.416531408192116E-4,0,0,13.877130681818182,130.76946822423463,COL17A1;COL1A1;COL1A2;DST;KRT5
Intestinal Polyposis,5/21,8.081245489887582E-5,5.416531408192116E-4,0,0,13.877130681818182,130.76946822423463,TCF7L2;PARP1;PLA2G2A;CXCR2;HMGA1
Lumbar disc disease,5/21,8.081245489887582E-5,5.416531408192116E-4,0,0,13.877130681818182,130.76946822423463,PRKN;COL1A1;ACAN;ESR1;FGFR3
Simple renal cyst,5/21,8.081245489887582E-5,5.416531408192116E-4,0,0,13.877130681818182,130.76946822423463,PRKD1;PKD2;FGF2;FGFR3;PAX2
Mastocytosis,8/64,8.384417445690515E-5,5.614132359447407E-4,0,0,6.374305328538738,59.83273917392413,ALK;STAT5A;STAT5B;IL6;TPM3;KIT;MITF;RUNX2
Alcoholic Steatohepatitis,7/48,8.620098669953221E-5,5.76045598680655E-4,0,0,7.606526339235995,71.18817878881993,CXCL10;IL6;LEPR;CXCR4;CD36;APOB;PPARA
Embryonal Neoplasm,7/48,8.620098669953221E-5,5.76045598680655E-4,0,0,7.606526339235995,71.18817878881993,ALK;PLK4;MYCN;TPM3;BRCA2;PAK4;EZH2
Acute Megakaryocytic Leukemias,11/122,8.948810332703186E-5,5.974175963661491E-4,0,0,4.439822310790053,41.3853812885947,IL6;MYCN;MECOM;SH2D1A;CXCR4;ERG;CD36;TEK;ETS2;AURKA;RUNX1T1
Sclerocystic Ovaries,13/166,9.084994546717816E-5,6.059068855586579E-4,0,0,3.8160554345194866,35.51336189297747,CBX2;FLT4;LIFR;ANTXR2;CCNE2;RACGAP1;WT1;RHPN1;ZNF205;DMD;PDLIM4;CEP55;MAD2L1
Childhood Acute Myeloid Leukemia,10/102,9.229508915099657E-5,6.125037734566137E-4,0,0,4.8633183408295855,45.18275447919447,MEF2C;IL6;MECOM;WT1;KIT;CXCR4;GATA4;IL2RG;RHEBL1;RUNX1T1
Hypertrophy of lower jaw,10/102,9.229508915099657E-5,6.125037734566137E-4,0,0,4.8633183408295855,45.18275447919447,RPS6KA3;ACAN;CAV1;TNFSF11;PAX3;TNNI2;PPARG;FOS;RUNX2;EZH2
mandibular excess (physical finding),10/102,9.229508915099657E-5,6.125037734566137E-4,0,0,4.8633183408295855,45.18275447919447,RPS6KA3;ACAN;CAV1;TNFSF11;PAX3;TNNI2;PPARG;FOS;RUNX2;EZH2
Mandibular hyperplasia,10/102,9.229508915099657E-5,6.125037734566137E-4,0,0,4.8633183408295855,45.18275447919447,RPS6KA3;ACAN;CAV1;TNFSF11;PAX3;TNNI2;PPARG;FOS;RUNX2;EZH2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,10/102,9.229508915099657E-5,6.125037734566137E-4,0,0,4.8633183408295855,45.18275447919447,CXCL12;HLF;DUSP1;CDKN2A;PLA2G4A;CXCR4;GATA3;PTGS2;KLF4;SELE
Idiopathic osteoarthritis,6/34,9.298329902531251E-5,6.152471293142845E-4,0,0,9.531565245688252,88.48238431992021,COL1A1;BMP2;COL2A1;FGFR4;PITX1;ESR1
Neuroectodermal Tumors,6/34,9.298329902531251E-5,6.152471293142845E-4,0,0,9.531565245688252,88.48238431992021,IL6;HGF;E2F1;PAX3;ASCL1;MET
Renal interstitial fibrosis,6/34,9.298329902531251E-5,6.152471293142845E-4,0,0,9.531565245688252,88.48238431992021,EGR1;BMP2;IL6;HGF;PDGFA;AGT
Psychotic Disorders,19/317,9.731618551306455E-5,6.432829743166747E-4,0,0,2.8821485962756404,26.623978035317705,OPRD1;EGR1;CNTNAP2;GAD1;PLA2G4A;PRKCA;ESR1;PER2;RPS6KA3;IL6;ALDH2;DPYSL2;FEZ1;LEPR;RARB;CALR;PAK3;FGFR3;PAK5
"Breast cancer, lobular",5/22,1.0267879976536279E-4,6.747463984580983E-4,0,0,13.060160427807487,119.94327123160554,MUC1;CTNND2;ERBB2;BRCA1;BRCA2
"Leukemia, T-Cell, Chronic",5/22,1.0267879976536279E-4,6.747463984580983E-4,0,0,13.060160427807487,119.94327123160554,STAT5A;STAT5B;CD5;IL2RG;EZH2
AIDS with Kaposi's sarcoma,5/22,1.0267879976536279E-4,6.747463984580983E-4,0,0,13.060160427807487,119.94327123160554,IL6;FLT4;HGF;KDR;FGF2
Disorder of Achilles tendon,5/22,1.0267879976536279E-4,6.747463984580983E-4,0,0,13.060160427807487,119.94327123160554,FBN2;COL1A1;ACAN;IL6;BGN
Fibromyxosarcoma,5/22,1.0267879976536279E-4,6.747463984580983E-4,0,0,13.060160427807487,119.94327123160554,CCND1;CIB1;EZR;MET;DCN
Squamous cell carcinoma of tonsil,5/22,1.0267879976536279E-4,6.747463984580983E-4,0,0,13.060160427807487,119.94327123160554,CCND1;CDKN2A;HGF;MET;CDKN3
Uterine Cervical Neoplasm,11/124,1.0365100263884822E-4,6.798894161786557E-4,0,0,4.360792789853595,40.00801079524593,PRKN;CXCL10;IL6;CCND1;TERT;EPAS1;CDKN2A;E2F1;RARB;PTGS2;FGFR3
Skin Ulcer,9/84,1.0371967987538212E-4,6.798894161786557E-4,0,0,5.361467889908257,49.18513430065626,COL17A1;COL1A1;CXCL12;TERT;HGF;CAV1;TAP1;ANTXR2;MET
Heterochromia iridis,4/12,1.0386637001180773E-4,6.798894161786557E-4,0,0,22.162131519274375,203.28005457362545,KIT;PAX3;MITF;SOX10
Migraine Variant,4/12,1.0386637001180773E-4,6.798894161786557E-4,0,0,22.162131519274375,203.28005457362545,LRP1;FHL5;ESR1;TGFBR2
Bronchiolitis,8/66,1.0466625560219341E-4,6.837923858213336E-4,0,0,6.1538704332044505,56.398584286774856,JUN;CXCR2;IL18;LTA;CTLA4;TAP1;CCL2;ADRB2
Giant Cell Tumor of Bone,8/66,1.0466625560219341E-4,6.837923858213336E-4,0,0,6.1538704332044505,56.398584286774856,IL6;CXCL12;HGF;TNFSF11;CCL2;ESR1;RUNX2;DCN
Acute pancreatitis,10/104,1.0872371210002814E-4,7.089208256929989E-4,0,0,4.759354365370506,43.43720255636377,IL6;ALDH2;BCL3;KIT;ERBB2;PLA2G2A;LTA;CCL2;PTGS2;AGT
Increased size of the mandible,10/104,1.0872371210002814E-4,7.089208256929989E-4,0,0,4.759354365370506,43.43720255636377,RPS6KA3;ACAN;CAV1;TNFSF11;PAX3;TNNI2;PPARG;FOS;RUNX2;EZH2
Acanthosis Nigricans,6/35,1.1013167698386168E-4,7.167096343252083E-4,0,0,9.202419291493205,83.86932039093192,CAV1;KDR;PPARG;FOS;ESR1;FGFR3
Acinar Cell Carcinoma,6/35,1.1013167698386168E-4,7.167096343252083E-4,0,0,9.202419291493205,83.86932039093192,CENPF;ERBB2;CD36;ERG;BRCA2;MKI67
Myotonic Dystrophy,11/125,1.1142165285031233E-4,7.244025368273937E-4,0,0,4.3223178915029505,39.342553843836924,CCT3;MEF2C;IL6;FEN1;BIN1;BCL3;E2F1;SCN4A;DMD;NKX2-5;SYN1
Lymphedema,7/50,1.1255210827522226E-4,7.303381248081089E-4,0,0,7.251991079961771,65.93578646362786,IL6;CCL21;FLT4;HGF;BRCA2;ANTXR2;MET
Moyamoya Disease,7/50,1.1255210827522226E-4,7.303381248081089E-4,0,0,7.251991079961771,65.93578646362786,ACTA2;LRP1;HGF;SIX3;KDR;BRCA1;TIMP1
Lesion of brain,9/85,1.1375662442763769E-4,7.367090344961344E-4,0,0,5.290650651859005,48.04677547423861,ALK;IL6;ERBB2;LTA;PECAM1;S1PR1;CCL2;SELE;AGT
Primary physiologic amenorrhea,9/85,1.1375662442763769E-4,7.367090344961344E-4,0,0,5.290650651859005,48.04677547423861,RET;WT1;LEPR;PPARG;GATA4;ZFPM2;BMPR1B;ESR1;PAX2
Ankylosing spondylitis,20/348,1.1386301039413155E-4,7.367090344961344E-4,0,0,2.7585365853658534,25.04893144938256,TAP1;GATA3;ANTXR2;PTGS2;IL2RG;FOXO1;AQP1;ACTA2;BMP2;IL6;NR5A2;KDR;SAA1;LTA;TNFSF11;CTLA4;E2F2;CCL2;TIMP1;SKAP2
Respiratory function loss,13/170,1.1562376232075988E-4,7.473813164063747E-4,0,0,3.7180644019815996,33.70488240388226,DST;TPM3;LIFR;AGT;COL1A1;COL3A1;COL1A2;FLAD1;CTLA4;PRTN3;DMD;FLNC;FGFR3
Oxyphilic Adenoma,8/67,1.1657956500225636E-4,7.528349601491863E-4,0,0,6.04925726253733,54.787739241822784,CAV1;KIT;MITF;SLC2A4;PTGS2;ESR1;PAX2;AP1M2
Myopia,17/269,1.1905420803502528E-4,7.680769079377808E-4,0,0,3.0424918409731494,27.491748286849486,FBN2;LRP1;LAMA1;CTNND2;HGF;ESR1;PAX2;COL1A1;BMP2;VCAN;COL2A1;COL8A1;SIRPA;KCNQ5;TEAD1;SOX5;GRIA4
Cytomegalovirus Infections,17/270,1.2450897214707658E-4,8.024973675045742E-4,0,0,3.030309186952828,27.245912261976212,JUN;LRP1;STAT1;IL18;GZMB;FOS;FGF2;ADRA1A;CXCL10;IL6;SIX3;CTLA4;CCL2;VIM;FKBP4;NEFH;MAD2L1
Premature coronary artery disease,7/51,1.2798870723784253E-4,8.241343794912277E-4,0,0,7.086809879618099,63.52310596288633,IL6;PLA2G2A;CCL2;APOB;ESR1;SELE;AGT
Cryptogenic Chronic Hepatitis,5/23,1.2881576940593472E-4,8.286654284772581E-4,0,0,12.333964646464647,110.4768916804155,ACTA2;KRT19;HGF;MKI67;MET
High density lipoprotein measurement,19/324,1.2940201798753416E-4,8.28785272982203E-4,0,0,2.81497729546679,25.201327961388255,TCF7L2;LRP1;CDKN2A;HGF;PLAUR;ESR1;ADRA1A;SYN1;AGT;VIL1;ACAN;BCL3;KDR;TNFSF11;PPARG;CD36;APOB;PPARA;NECTIN2
Human papilloma virus infection,8/68,1.2959111923354185E-4,8.28785272982203E-4,0,0,5.948131197559115,53.24247360323834,CCND1;TERT;CDKN2A;CAV1;STMN1;ERBB2;MKI67;ESR1
Precocious Puberty,8/68,1.2959111923354185E-4,8.28785272982203E-4,0,0,5.948131197559115,53.24247360323834,COL1A1;CAV1;PPARG;DMD;FOS;PTGS2;ADRA1A;ESR1
Thin skin,8/68,1.2959111923354185E-4,8.28785272982203E-4,0,0,5.948131197559115,53.24247360323834,COL1A1;COL3A1;COL1A2;PROC;PROS1;LIFR;PPARG;PRKD1
Barrett's Adenocarcinoma,6/36,1.2969823137348055E-4,8.28785272982203E-4,0,0,8.895216400911162,79.61485626948338,SOCS3;RAD51;ERBB2;PECAM1;MKI67;PTGS2
Endometriosis of ovary,6/36,1.2969823137348055E-4,8.28785272982203E-4,0,0,8.895216400911162,79.61485626948338,HOXA10;NR4A1;MUC1;TERT;SNCG;ESR1
Inflammatory Myofibroblastic Tumor,6/36,1.2969823137348055E-4,8.28785272982203E-4,0,0,8.895216400911162,79.61485626948338,ALK;IL6;CCND1;TPM3;ERBB2;MKI67
Fever,13/173,1.3784226174102837E-4,8.799530684845464E-4,0,0,3.6477864583333335,32.42663497608367,FBN2;PARP1;DST;IL2RG;PTGS2;STX11;COL1A1;C4A;IL6;CCND1;CTLA4;CCL2;PRTN3
Hairy Cell Leukemia,10/107,1.37967626729337E-4,8.799530684845464E-4,0,0,4.611446853892641,40.9888061139313,IL6;SHC3;ANXA1;CCND1;CDKN2A;ERBB2;LTA;RHOH;CIB1;SKAP1
Hereditary Breast and Ovarian Cancer Syndrome,7/52,1.450994198073422E-4,9.245613884498199E-4,0,0,6.928970065956367,61.238870727596286,RIMS2;BARD1;RAD51;CDKN2A;ERBB2;BRCA1;BRCA2
"Breast Cancer, Familial Male",4/13,1.4739777958223916E-4,9.312544568902336E-4,0,0,19.698664651045604,173.78901920154723,RAD51;ERBB2;BRCA1;BRCA2
"Ceroid lipofuscinosis, neuronal 1, infantile",4/13,1.4739777958223916E-4,9.312544568902336E-4,0,0,19.698664651045604,173.78901920154723,PARP1;SYP;PPARGC1A;GFAP
Behavioral tic,4/13,1.4739777958223916E-4,9.312544568902336E-4,0,0,19.698664651045604,173.78901920154723,SIX1;BRCA1;VIM;ECT2
Canine Osteosarcoma,4/13,1.4739777958223916E-4,9.312544568902336E-4,0,0,19.698664651045604,173.78901920154723,CAV2;CDKN2A;PTGS2;MET
Extramedullary Plasmacytoma,4/13,1.4739777958223916E-4,9.312544568902336E-4,0,0,19.698664651045604,173.78901920154723,IL6;CDKN2A;PECAM1;TEK
Micropapillary carcinoma,4/13,1.4739777958223916E-4,9.312544568902336E-4,0,0,19.698664651045604,173.78901920154723,MUC1;CXCL12;ERBB2;CXCR4
Neonatal short-limb short stature,4/13,1.4739777958223916E-4,9.312544568902336E-4,0,0,19.698664651045604,173.78901920154723,COL1A1;COL1A2;COL2A1;FGFR3
Tendinosis,4/13,1.4739777958223916E-4,9.312544568902336E-4,0,0,19.698664651045604,173.78901920154723,ACAN;VCAN;BGN;DCN
White forelock,4/13,1.4739777958223916E-4,9.312544568902336E-4,0,0,19.698664651045604,173.78901920154723,KIT;PAX3;MITF;SOX10
Class III malocclusion,10/108,1.4908188103691537E-4,9.392438208667201E-4,0,0,4.564156697161623,40.21485250852511,RPS6KA3;ACAN;CAV1;TNFSF11;PAX3;TNNI2;PPARG;FOS;RUNX2;EZH2
Myocardial Failure,10/108,1.4908188103691537E-4,9.392438208667201E-4,0,0,4.564156697161623,40.21485250852511,IL6;VWF;CCL21;PRKAR2B;ADRB1;PPARG;ADRB2;PTGS2;PPARGC1A;AGT
Waldenstrom Macroglobulinemia,10/108,1.4908188103691537E-4,9.392438208667201E-4,0,0,4.564156697161623,40.21485250852511,STAT5A;STAT5B;BLM;IL6;CCND2;CXCL12;CCND1;CDKN2A;CXCR4;FGFR3
Aplasia/Hypoplasia of the radius,6/37,1.519210510007808E-4,9.553387439337489E-4,0,0,8.607833051656991,75.68135569271658,RAD51;FANCD2;FANCA;TNNI2;BRCA2;PITX1
Ovarian Hyperstimulation Syndrome,6/37,1.519210510007808E-4,9.553387439337489E-4,0,0,8.607833051656991,75.68135569271658,IL6;CISH;VWF;KDR;IL18;PTGS2
Attention deficit hyperactivity disorder,22/412,1.5224606516293584E-4,9.56486972529726E-4,0,0,2.5557980238831304,22.465496567917473,PRKN;CNTNAP2;NRP1;MEF2C;RAB3A;GATA4;SYP;PKMYT1;ADRA1A;FLI1;SYNE1;TGFBR2;C4B;PER2;COL2A1;MYCN;ALDH2;ADAM12;ERBB2;NDN;DMD;RXRG
Benign Neoplasm,8/70,1.5922005479963118E-4,9.962281130978098E-4,0,0,5.7556654609876725,50.334579812286684,TERT;CDKN2A;IL18;PLAUR;HMGA2;BRCA1;PPARA;PTGS2
Neck Neoplasms,8/70,1.5922005479963118E-4,9.962281130978098E-4,0,0,5.7556654609876725,50.334579812286684,CDC20;RAD51;CCND1;DST;CDKN2A;ERBB2;E2F1;RARB
Squamous cell carcinoma of oropharynx,8/70,1.5922005479963118E-4,9.962281130978098E-4,0,0,5.7556654609876725,50.334579812286684,CDKN2A;ERBB2;E2F1;RARB;E2F2;PTGS2;MET;FGFR3
"CONSTRICTING BANDS, CONGENITAL",5/24,1.5975843922071787E-4,9.962281130978098E-4,0,0,11.68421052631579,102.14158819638371,IL6;FANCD2;IL18;CXCR4;BRCA2
bilateral breast cancer,5/24,1.5975843922071787E-4,9.962281130978098E-4,0,0,11.68421052631579,102.14158819638371,RPS6KA3;ERBB2;BRCA1;BRCA2;ESR1
Endemic Cretinism,5/24,1.5975843922071787E-4,9.962281130978098E-4,0,0,11.68421052631579,102.14158819638371,EGR1;NGFR;NEFH;PPARGC1A;RUNX2
Healing ulcer,5/24,1.5975843922071787E-4,9.962281130978098E-4,0,0,11.68421052631579,102.14158819638371,HGF;CXCR4;PTGS2;FGF2;MET
Pure gonadal dysgenesis,5/24,1.5975843922071787E-4,9.962281130978098E-4,0,0,11.68421052631579,102.14158819638371,WT1;KIT;GATA4;ZFPM2;FGFR3
Flexion contracture of proximal interphalangeal joint,10/109,1.6094138625430296E-4,0.001002673794140908,0,0,4.517821897132242,39.460781270636026,COL17A1;FBN2;CDT1;PAX3;TNNI2;LIFR;ANTXR2;FGFR3;EZH2;TGFBR2
Cerebral Palsy,9/89,1.6241416441316488E-4,0.0010109115182565479,0,0,5.025086009174312,43.84568905769248,IL6;GAD1;IL18;RFX2;LTA;SCN4A;ADRB2;PTGS2;ESR1
granulosa cell tumor,7/53,1.6401727580791053E-4,0.001019944466968451,0,0,6.777992852888624,59.07385966426651,CCND2;ERBB2;KDR;LEPR;GATA4;ESR1;FOXO1
Juvenile rheumatoid arthritis,11/131,1.692700245165762E-4,0.0010516350459327712,0,0,4.104934715821813,35.64731604159212,C3;VIL1;CXCL10;IL6;IL18;LTA;CTLA4;CXCR4;CCL2;VIM;SELE
Deep Vein Thrombosis,10/110,1.735855541477302E-4,0.0010774497057820297,0,0,4.472413793103448,38.725915325889105,IL6;PROC;VWF;SERPINC1;PROS1;CXCR2;KDR;PECAM1;F13A1;A2M
Skin carcinoma,9/90,1.7697048860244958E-4,0.0010959222102760794,0,0,4.962793068297655,42.876187539505516,COL1A1;KRT19;CCND1;TERT;TAL1;CDKN2A;HMGA1;CTLA4;PTGS2
"Nephritis, Tubulointerstitial",6/38,1.770511611300694E-4,0.0010959222102760794,0,0,8.338411161731207,72.03613290108822,MUC1;CCL2;GZMB;FGF2;AGT;DCN
Painful Bladder Syndrome,6/38,1.770511611300694E-4,0.0010959222102760794,0,0,8.338411161731207,72.03613290108822,CXCL10;IL6;CXCR4;CCL2;SYP;SELE
Malignant neoplasm of gallbladder,14/203,1.9098688305115694E-4,0.0011810938366220718,0,0,3.328349230901435,28.501672298035984,YAP1;FEN1;CDKN2A;HGF;HMGA2;PTGS2;ESR1;AGT;TGFBR2;ERBB2;FADD;TIMP1;VIM;APOB
"Apraxia, Developmental Verbal",5/25,1.9607182978225796E-4,0.0012069829595028822,0,0,11.099431818181818,94.75617672508949,CNTNAP2;LRP1;CXCR2;PECAM1;CCL2
Cyanosis,5/25,1.9607182978225796E-4,0.0012069829595028822,0,0,11.099431818181818,94.75617672508949,ALDH2;FANCD2;SOSTDC1;BRCA2;PPARGC1A
Sclerosis,5/25,1.9607182978225796E-4,0.0012069829595028822,0,0,11.099431818181818,94.75617672508949,VTN;WT1;GZMB;TIMP1;PTGS2
Tooth Attrition,5/25,1.9607182978225796E-4,0.0012069829595028822,0,0,11.099431818181818,94.75617672508949,RCAN1;TERT;CDKN2A;SAA1;EZH2
Ulnar deviation of the fingers,5/25,1.9607182978225796E-4,0.0012069829595028822,0,0,11.099431818181818,94.75617672508949,FBN2;TNNI2;PAX3;LIFR;BMPR1B
Brachydactyly,14/204,2.0098768333724382E-4,0.0012344538056732741,0,0,3.3106606423250704,28.1812270978516,BGN;PAX3;GATA4;ANTXR2;RUNX2;TGFBR2;RPS6KA3;ACAN;COL2A1;ZFPM2;NKX2-5;BMPR1B;PITX1;FGFR3
"Muscular Dystrophy, Facioscapulohumeral",10/112,2.0139289108981104E-4,0.0012344538056732741,0,0,4.384268649988731,37.311234886721195,ACAN;COL3A1;CAPN3;PAX3;DMD;FGF1;FGF2;PITX1;DCN;CDKN3
"Histiocytoma, Angiomatoid Fibrous",4/14,2.0274010536891325E-4,0.0012344538056732741,0,0,17.727891156462587,150.75064116702606,MUC1;MITF;ERG;MET
Atresia of vagina,4/14,2.0274010536891325E-4,0.0012344538056732741,0,0,17.727891156462587,150.75064116702606,RET;WT1;PAX3;PAX2
Contralateral breast cancer,4/14,2.0274010536891325E-4,0.0012344538056732741,0,0,17.727891156462587,150.75064116702606,ERBB2;BRCA1;BRCA2;ESR1
Desmoplastic melanoma,4/14,2.0274010536891325E-4,0.0012344538056732741,0,0,17.727891156462587,150.75064116702606,RET;KIT;NFKBIE;SOX10
Fibromatosis,4/14,2.0274010536891325E-4,0.0012344538056732741,0,0,17.727891156462587,150.75064116702606,CAV1;KIT;PTGS2;ANTXR2
Peritoneal Surface Malignancy,4/14,2.0274010536891325E-4,0.0012344538056732741,0,0,17.727891156462587,150.75064116702606,MUC1;WT1;PAEP;VIM
Pigmented lesions,4/14,2.0274010536891325E-4,0.0012344538056732741,0,0,17.727891156462587,150.75064116702606,MMP14;CDKN2A;KIT;PAX3
POEMS Syndrome,4/14,2.0274010536891325E-4,0.0012344538056732741,0,0,17.727891156462587,150.75064116702606,IL6;HGF;SDC1;FGF2
Thrombocytopenic purpura,4/14,2.0274010536891325E-4,0.0012344538056732741,0,0,17.727891156462587,150.75064116702606,STAT5B;IL6;VWF;CTLA4
Uterine Polyp,4/14,2.0274010536891325E-4,0.0012344538056732741,0,0,17.727891156462587,150.75064116702606,HOXA10;KIT;HMGA1;HMGA2
Triglycerides measurement,19/336,2.064214251549358E-4,0.0012548921216028618,0,0,2.706728277128597,22.96818836538939,TCF7L2;MEF2C;VWF;LRP1;GATA4;PROX1;ESR1;TGFBR2;C3;VIL1;GRK3;COL1A2;BCL3;LEPR;CAPN3;CD36;APOB;MET;NECTIN2
Adenosquamous carcinoma,7/55,2.0783889164906216E-4,0.0012548921216028618,0,0,6.494910578386606,55.06870577554035,ALK;MAML2;KIT;ERBB2;KDR;KRT5;TGFBR2
"Dissection, Blood Vessel",3/6,2.081521476273955E-4,0.0012548921216028618,0,0,44.23529411764706,374.9932607380858,COL1A1;AGT;TGFBR2
"HEMANGIOMA, CAPILLARY INFANTILE",3/6,2.081521476273955E-4,0.0012548921216028618,0,0,44.23529411764706,374.9932607380858,FLT4;KDR;TIMP1
"Leiomyosarcoma, Myxoid",3/6,2.081521476273955E-4,0.0012548921216028618,0,0,44.23529411764706,374.9932607380858,HMGA1;DMD;PTGS2
Aplasia/Hypoplasia of the middle phalanx of the 2nd finger,3/6,2.081521476273955E-4,0.0012548921216028618,0,0,44.23529411764706,374.9932607380858,BMP2;MYCN;BMPR1B
Aplasia/Hypoplasia of the middle phalanx of the 5th finger,3/6,2.081521476273955E-4,0.0012548921216028618,0,0,44.23529411764706,374.9932607380858,BMP2;MYCN;BMPR1B
Bursitis,3/6,2.081521476273955E-4,0.0012548921216028618,0,0,44.23529411764706,374.9932607380858,IL6;CXCL12;PTGS2
Familial Atypical Multiple Mole-Melanoma,3/6,2.081521476273955E-4,0.0012548921216028618,0,0,44.23529411764706,374.9932607380858,CDKN2A;BRCA1;BRCA2
Megakaryocytic hyperplasia,3/6,2.081521476273955E-4,0.0012548921216028618,0,0,44.23529411764706,374.9932607380858,CXCL12;PAEP;CXCR4
Waardenburg Syndrome Type 1,3/6,2.081521476273955E-4,0.0012548921216028618,0,0,44.23529411764706,374.9932607380858,RET;PAX3;MITF
Hyperkyphosis,12/157,2.109849431413076E-4,0.0012708294871184053,0,0,3.709803296965836,31.398750407967267,COL1A1;RET;RPS6KA3;COL1A2;COL2A1;BIN1;BGN;NDN;KIF22;FGFR3;RUNX2;EZH2
"Epilepsy, Temporal Lobe",13/181,2.1589282398132357E-4,0.0012992259909126965,0,0,3.472649360670194,29.311690285668895,GRIA2;EGR2;CXCR4;PLD1;SSTR2;PTGS2;ESR1;AGT;C3;BIN1;DPYSL2;KDR;TEK
"Liver Cirrhosis, Alcoholic",9/93,2.2730628364187952E-4,0.0013666866615388209,0,0,4.784813237221494,40.140813502030255,COL3A1;IL6;ALDH2;CAV1;CTLA4;PPARG;TIMP1;APOB;SELE
Respiratory Insufficiency,13/182,2.2790095674209065E-4,0.001368028511365126,0,0,3.451923076923077,28.94989608738286,DST;TPM3;LIFR;AGT;COL1A1;COL3A1;COL1A2;FLAD1;CTLA4;PRTN3;DMD;FLNC;FGFR3
"Alcoholic Intoxication, Chronic",22/424,2.2793685292102087E-4,0.001368028511365126,0,0,2.47795302447573,20.78120914068055,ALK;OPRD1;CNTNAP2;KLF11;DST;VWF;GAD1;GATA4;GRIN2C;AGT;ADCY5;GFAP;CDH5;IL6;GRK5;ALDH2;DPYSL2;PPARG;PPARA;FGFR4;PPARGC1A;MPDZ
Caries (morphologic abnormality),7/56,2.330412371388508E-4,0.0013949241966350462,0,0,6.362035225048924,53.21394029194386,CXCL10;MMP14;CXCR2;SOSTDC1;INHBA;RUNX2;GFAP
Cystitis,7/56,2.330412371388508E-4,0.0013949241966350462,0,0,6.362035225048924,53.21394029194386,NGFR;MUC1;ERBB2;KDR;IL18;LTA;PTGS2
Parathyroid Neoplasms,7/56,2.330412371388508E-4,0.0013949241966350462,0,0,6.362035225048924,53.21394029194386,RET;RAD51;CCND1;CDKN2A;MKI67;ESR1;EZH2
Chronic heart failure,8/74,2.3528052958589983E-4,0.001405921751074432,0,0,5.405727758130504,45.16340675358284,IL6;CXCL12;ERBB2;CXCR4;CCL2;ADRB1;ADRB2;AGT
Cholelithiasis,11/136,2.3529720789274293E-4,0.001405921751074432,0,0,3.9397235023041475,32.91505480158291,FEN1;MUC1;CXCR2;PLA2G2A;IL18;PPARG;APOB;ALDOA;PTGS2;PPARGC1A;ESR1
Chronic rejection of renal transplant,6/40,2.3710187647329228E-4,0.0014154455132396719,0,0,7.8471124212783065,65.50000942841947,CDKN2A;HGF;PELI2;GZMB;CIB1;AGT
Clinodactyly of the 5th finger,12/159,2.373324903345735E-4,0.001415563947679392,0,0,3.6589527265871706,30.53779686842447,PLK4;CDT1;BLM;BMP2;MECOM;GATA4;DMD;ZFPM2;NKX2-5;BMPR1B;PITX1;FGFR3
Aortic root dilatation,5/26,2.3834986042922275E-4,0.0014203705968435316,0,0,10.57034632034632,88.17540799212566,FBN2;ACTA2;COL1A1;CCL19;TGFBR2
Orbital separation excessive,20/368,2.390936125338781E-4,0.0014235396292353946,0,0,2.597295469912103,21.657951891627203,RET;MEF2C;CTNND2;BGN;PAX3;HMGA2;RUNX2;FLI1;PAX2;CIT;TGFBR2;COL1A1;RPS6KA3;COL3A1;BMP2;COL2A1;CCND2;CNTN1;FGFR3;EZH2
AMYOTROPHIC LATERAL SCLEROSIS 1,9/94,2.465172837946271E-4,0.001465291943317587,0,0,4.7282784673502425,39.282908440785896,CTNND2;SIX2;HGF;PDGFA;SNCG;FOS;VIM;NEFH;GFAP
Mental deficiency,41/1032,2.4654256937892697E-4,0.001465291943317587,0,0,1.9010800171843623,15.794126936592777,RET;YAP1;CNTNAP2;LAMA1;ASCL1;BRCA2;RPS6KA3;TERT;SIX3;DMD;NEK2;ZNF423;PAK3;MPDZ;BUB1;SOX5;PLK4;MEF2C;PARP1;GAD1;CAV1;FANCA;PAX3;FOS;SYP;SOX10;FLI1;PAX2;CIT;CCNA2;ACTA2;COL3A1;RAD51;MYCN;WT1;FANCD2;RARB;PPARG;FGFR3;EZH2;ARHGEF6
Lymphopenia,11/137,2.5082688940312553E-4,0.0014894371257571982,0,0,3.908254699729354,32.40235303914167,STAT5A;STAT5B;HLF;TERT;ALDH2;STAT1;RHOH;CXCR4;CALR;IL2RG;MYLK
Ameloblastoma,7/57,2.606479869913179E-4,0.0015463885871322362,0,0,6.234474885844749,51.44900504436,FGF7;IL6;TERT;TNFSF11;PDGFA;FOS;VIM
Juvenile psoriatic arthritis,12/161,2.664290807136052E-4,0.0015792918853244243,0,0,3.6094672721918255,29.707368328673898,EGR1;TCF7L2;JUN;MAML2;DUSP1;PROS1;CXCR2;PLAUR;CTLA4;CXCR4;FOS;KLF4
Limb ischemia,9/95,2.670554457702878E-4,0.0015809632845591073,0,0,4.67305845956902,38.450178561101666,PER2;HGF;KDR;BGN;BRCA1;FGF1;EZR;FGF2;EZH2
Collecting Duct Carcinoma of the Kidney,11/138,2.672133514103483E-4,0.0015809632845591073,0,0,3.877281468848652,31.900190405955478,ALK;IL6;MUC1;KRT19;EPAS1;ERBB2;MITF;VIM;PTGS2;CRYAB;MET
Respiratory Failure,13/185,2.674172559945125E-4,0.0015809632845591073,0,0,3.391190245478036,27.89830602301352,ALK;CDT1;FGF1;FGF2;RUNX2;DEPP1;MUC1;STMN1;DMD;FLNC;PPARGC1A;NEFH;CRYAB
"Liver Neoplasms, Experimental",10/116,2.6832371403265136E-4,0.001583534326400076,0,0,4.217957059206246,34.68559553615701,IL6;CCND1;HGF;F12;KDR;TK1;BAK1;TEK;ENO2;MET
Experimental Hepatoma,10/116,2.6832371403265136E-4,0.001583534326400076,0,0,4.217957059206246,34.68559553615701,IL6;CCND1;HGF;F12;KDR;TK1;BAK1;TEK;ENO2;MET
"Chromosome 10, monosomy 10q",4/15,2.716217428093332E-4,0.0015931979255087176,0,0,16.115440115440116,132.3254921200219,MYCN;TERT;CDKN2A;ERG
"FANCONI ANEMIA, COMPLEMENTATION GROUP D2",4/15,2.716217428093332E-4,0.0015931979255087176,0,0,16.115440115440116,132.3254921200219,PRKN;RAD51;FANCD2;BRCA1
Atypical meningioma,4/15,2.716217428093332E-4,0.0015931979255087176,0,0,16.115440115440116,132.3254921200219,CDKN2C;CDKN2A;STMN1;MKI67
Body Temperature Changes,4/15,2.716217428093332E-4,0.0015931979255087176,0,0,16.115440115440116,132.3254921200219,RET;TNFSF11;ASCL1;PTGS2
Malignant tumor of peritoneum,4/15,2.716217428093332E-4,0.0015931979255087176,0,0,16.115440115440116,132.3254921200219,VCAN;PARP1;BRCA1;BRCA2
Salivary gland carcinoma,4/15,2.716217428093332E-4,0.0015931979255087176,0,0,16.115440115440116,132.3254921200219,CDKN2A;ERBB2;KIT;BRCA1
Urinary Stress Incontinence,4/15,2.716217428093332E-4,0.0015931979255087176,0,0,16.115440115440116,132.3254921200219,FBN2;COL1A1;BGN;DCN
Alcohol withdrawal syndrome,6/41,2.7258885809523987E-4,0.0015946923092052534,0,0,7.62251871135698,62.562172290537674,GAD1;GATA4;PPARG;PPARA;MPDZ;PPARGC1A
Irregular hyperpigmentation,6/41,2.7258885809523987E-4,0.0015946923092052534,0,0,7.62251871135698,62.562172290537674,COL3A1;RAD51;FANCD2;FANCA;CTLA4;BRCA2
Laryngeal neoplasm,6/41,2.7258885809523987E-4,0.0015946923092052534,0,0,7.62251871135698,62.562172290537674,ANXA1;CCND1;TERT;ERBB2;BRCA1;PTGS2
Acromegaly,8/76,2.8320503340454185E-4,0.001652480455555954,0,0,5.246197334769148,42.857966707670236,RET;CDKN2C;CAV1;CCL2;CIB1;PPARG;FOS;SSTR2
Acute Undifferentiated Leukemia,8/76,2.8320503340454185E-4,0.001652480455555954,0,0,5.246197334769148,42.857966707670236,STAT5A;STAT5B;MECOM;TAL1;KDR;CTSG;ERG;EZH2
Platyspondyly,8/76,2.8320503340454185E-4,0.001652480455555954,0,0,5.246197334769148,42.857966707670236,COL1A1;ACAN;COL2A1;COL1A2;BGN;KIF22;FGFR3;RUNX2
"Gonadal Dysgenesis, Mixed",5/27,2.872142096126361E-4,0.0016700698110462893,0,0,10.089359504132231,82.28157443399944,WT1;KIT;GATA4;ZFPM2;FGFR3
Flared metaphysis,5/27,2.872142096126361E-4,0.0016700698110462893,0,0,10.089359504132231,82.28157443399944,COL2A1;LIFR;KIF22;FGFR3;RUNX2
Leg Ulcer,5/27,2.872142096126361E-4,0.0016700698110462893,0,0,10.089359504132231,82.28157443399944,NRP1;IL6;HGF;F13A1;SELE
Mixed Oligodendroglioma-Astrocytoma,5/27,2.872142096126361E-4,0.0016700698110462893,0,0,10.089359504132231,82.28157443399944,DTX1;TIMP1;MKI67;GFAP;EZH2
Heart valve disease,7/58,2.9082496558768426E-4,0.0016837762662817997,0,0,6.111916912883875,49.76804959070951,COL1A1;BMP2;COL1A2;IL18;CCL2;TIMP1;CALR
Hepatosplenomegaly,7/58,2.9082496558768426E-4,0.0016837762662817997,0,0,6.111916912883875,49.76804959070951,MECOM;CDKN2A;STAT1;CAV1;RHOJ;TNFSF11;TIMP1
Oncocytic Neoplasm,7/58,2.9082496558768426E-4,0.0016837762662817997,0,0,6.111916912883875,49.76804959070951,KIT;MITF;PRKCA;SLC2A4;PTGS2;ESR1;PAX2
Severe Dengue,7/58,2.9082496558768426E-4,0.0016837762662817997,0,0,6.111916912883875,49.76804959070951,IL6;IL18;LTA;CTLA4;TAP1;CCL2;GATA3
Silicosis,7/58,2.9082496558768426E-4,0.0016837762662817997,0,0,6.111916912883875,49.76804959070951,C4B;C4A;EGR1;MUC1;CCL2;CD36;PTGS2
Craniofacial Abnormalities,13/187,2.968962423188754E-4,0.0017174463078497566,0,0,3.3518651553852705,27.224277269881497,ANXA1;SIX1;PAX3;PKD2;ETS2;RUNX2;FLI1;TGFBR2;RCAN1;COL2A1;SPRY2;FADD;BMPR1B
Non-small cell lung cancer stage I,8/77,3.099973188365056E-4,0.0017916884623975658,0,0,5.1699001757702385,41.76734904713668,CXCL12;TERT;CDKN2A;ERBB2;RARB;BRCA1;ESR1;EZH2
"Mitral regurgitation, mild",6/42,3.1211567623627793E-4,0.0017992865936505087,0,0,7.410402429764616,59.81778127946687,FBN2;RPS6KA3;CCND2;COL1A2;BGN;CRYAB
Diffuse Scleroderma,6/42,3.1211567623627793E-4,0.0017992865936505087,0,0,7.410402429764616,59.81778127946687,COL1A1;IL6;CAV1;PECAM1;CCL19;TIMP1
Optic Neuritis,6/42,3.1211567623627793E-4,0.0017992865936505087,0,0,7.410402429764616,59.81778127946687,RASL12;IL6;CISH;PLA2G2A;SDC1;GFAP
"Hepatoma, Novikoff",10/119,3.299423864094221E-4,0.0019004228706052133,0,0,4.101233786776336,32.87792003789834,IL6;CCND1;HGF;F12;KDR;TK1;BAK1;TEK;ENO2;MET
Hypercalcemia,9/98,3.3734695590654384E-4,0.0019414071601271195,0,0,4.514843830532935,36.09346126339787,RET;IL6;HLF;CDKN2C;TNFSF11;VIM;FGFR4;ESR1;FGFR3
"Multiple Sclerosis, Relapsing-Remitting",8/78,3.3882240890238956E-4,0.0019432376585725433,0,0,5.095782935599869,40.715481232656536,IL6;LEPR;IL18;PECAM1;CCL2;PLD1;KLF4;CRYAB
Androgen-Insensitivity Syndrome,8/78,3.3882240890238956E-4,0.0019432376585725433,0,0,5.095782935599869,40.715481232656536,HOXA10;FBN2;CNTNAP2;RARB;MKI67;FKBP4;ESR1;AGT
Crohn's disease of large bowel,8/78,3.3882240890238956E-4,0.0019432376585725433,0,0,5.095782935599869,40.715481232656536,VTN;SOCS3;FGF7;IL6;CCL2;PPARG;PPARA;PTGS2
Marinesco-Sjogren syndrome,8/78,3.3882240890238956E-4,0.0019432376585725433,0,0,5.095782935599869,40.715481232656536,IL6;PARP1;CDKN2A;CTNND2;PECAM1;PTGS2;FGF2;TGFBR2
Condylomata Acuminata,5/28,3.4331309351797915E-4,0.0019622899881419132,0,0,9.650197628458498,76.97834993539689,JUN;IL6;CDKN2A;STAT1;MKI67
Hyperemia,5/28,3.4331309351797915E-4,0.0019622899881419132,0,0,9.650197628458498,76.97834993539689,HGF;ADRB1;PTGS2;ESR1;AGT
Malignant Bone Neoplasm,5/28,3.4331309351797915E-4,0.0019622899881419132,0,0,9.650197628458498,76.97834993539689,CDKN2A;PTGS2;ESR1;RUNX2;TGFBR2
Ovarian epithelial cancer recurrent,5/28,3.4331309351797915E-4,0.0019622899881419132,0,0,9.650197628458498,76.97834993539689,STAT5A;STAT5B;PARP1;BRCA1;BRCA2
Keratoconus,12/166,3.527231847320264E-4,0.001990073704612104,0,0,3.4913769832938426,27.755842966686423,NGFR;IL6;COL3A1;PARP1;HGF;NEK2;S100A4;CTSG;TIMP1;A2M;MPDZ;FOXO1
"Gonadal Dysgenesis, 46,XY",4/16,3.5582397121351067E-4,0.001990073704612104,0,0,14.771730914588057,117.30341439096091,WT1;CBX2;GATA4;ZFPM2
"Heart Failure, Systolic",4/16,3.5582397121351067E-4,0.001990073704612104,0,0,14.771730914588057,117.30341439096091,GRK5;CMA1;ADRB1;AGT
Benign neurologic neoplasms,4/16,3.5582397121351067E-4,0.001990073704612104,0,0,14.771730914588057,117.30341439096091,RET;CCND1;MECOM;BAK1
Cervical Disc Degenerative Disorder,4/16,3.5582397121351067E-4,0.001990073704612104,0,0,14.771730914588057,117.30341439096091,NGFR;ACAN;COL2A1;TIMP1
Codependency,4/16,3.5582397121351067E-4,0.001990073704612104,0,0,14.771730914588057,117.30341439096091,RPS6KA3;ERBB2;SOSTDC1;ESR1
cystic disease,4/16,3.5582397121351067E-4,0.001990073704612104,0,0,14.771730914588057,117.30341439096091,ALK;HGF;PRKD1;PKD2
Diffuse mesangial sclerosis (disorder),4/16,3.5582397121351067E-4,0.001990073704612104,0,0,14.771730914588057,117.30341439096091,NPHS1;WT1;BGN;DCN
Growth hormone excess,4/16,3.5582397121351067E-4,0.001990073704612104,0,0,14.771730914588057,117.30341439096091,CDKN2C;CAV1;PPARG;FOS
Inverted Papilloma,4/16,3.5582397121351067E-4,0.001990073704612104,0,0,14.771730914588057,117.30341439096091,CDKN2A;STMN1;MKI67;FGFR3
Latent Autoimmune Diabetes in Adults,4/16,3.5582397121351067E-4,0.001990073704612104,0,0,14.771730914588057,117.30341439096091,TCF7L2;IL6;GAD1;CTLA4
Mammary Analogue Secretory Carcinoma,4/16,3.5582397121351067E-4,0.001990073704612104,0,0,14.771730914588057,117.30341439096091,STAT5A;STAT5B;IL6;VIM
Obstructive Ureterocele,4/16,3.5582397121351067E-4,0.001990073704612104,0,0,14.771730914588057,117.30341439096091,ACTA2;BMP2;MMP14;AGT
psychological distress,4/16,3.5582397121351067E-4,0.001990073704612104,0,0,14.771730914588057,117.30341439096091,CDKN2A;ADRB2;BRCA1;BRCA2
"Sarcoma, Epithelioid",6/43,3.559970638274059E-4,0.001990073704612104,0,0,7.209751893123191,57.249669904959944,RIMS2;CCND1;PAX3;VIM;MKI67;EZH2
Gemistocytic astrocytoma,6/43,3.559970638274059E-4,0.001990073704612104,0,0,7.209751893123191,57.249669904959944,TERT;HGF;MKI67;ESR1;MET;GFAP
Pyruvate Carboxylase Deficiency Disease,6/43,3.559970638274059E-4,0.001990073704612104,0,0,7.209751893123191,57.249669904959944,MMP14;PROC;PROS1;ERBB2;SDC1;PTGS2
"Leiomyosarcoma, Epithelioid",3/7,3.582488250262111E-4,0.001990073704612104,0,0,33.17477375565611,263.21803584201285,HMGA1;DMD;PTGS2
"Peroxisome Biogenesis Disorder, Complementation Group H",3/7,3.582488250262111E-4,0.001990073704612104,0,0,33.17477375565611,263.21803584201285,CCND1;ERBB2;BRCA1
Abnormality of the sacrum,3/7,3.582488250262111E-4,0.001990073704612104,0,0,33.17477375565611,263.21803584201285,RET;KIF22;RUNX2
Adenosarcoma,3/7,3.582488250262111E-4,0.001990073704612104,0,0,33.17477375565611,263.21803584201285,CDKN2A;ERBB2;S100A4
Adenosis,3/7,3.582488250262111E-4,0.001990073704612104,0,0,33.17477375565611,263.21803584201285,ERBB2;ERG;PTGS2
Angiodysplasia,3/7,3.582488250262111E-4,0.001990073704612104,0,0,33.17477375565611,263.21803584201285,VWF;TEK;FGF2
Angiodysplasia of colon,3/7,3.582488250262111E-4,0.001990073704612104,0,0,33.17477375565611,263.21803584201285,VWF;TEK;FGF2
Atypical fibroxanthoma of skin,3/7,3.582488250262111E-4,0.001990073704612104,0,0,33.17477375565611,263.21803584201285,ALK;CDKN2A;MKI67
Autonomic dysregulation,3/7,3.582488250262111E-4,0.001990073704612104,0,0,33.17477375565611,263.21803584201285,RET;ASCL1;SOX10
Broad long bones,3/7,3.582488250262111E-4,0.001990073704612104,0,0,33.17477375565611,263.21803584201285,COL1A1;COL1A2;COL2A1
Craniofacial Dysostosis,3/7,3.582488250262111E-4,0.001990073704612104,0,0,33.17477375565611,263.21803584201285,BGN;TK1;FGFR3
Ehlers-Danlos syndrome type 1,3/7,3.582488250262111E-4,0.001990073704612104,0,0,33.17477375565611,263.21803584201285,COL1A1;COL3A1;COL1A2
Excessive sputum secretion,3/7,3.582488250262111E-4,0.001990073704612104,0,0,33.17477375565611,263.21803584201285,COL3A1;CTLA4;PRTN3
Myelolipoma,3/7,3.582488250262111E-4,0.001990073704612104,0,0,33.17477375565611,263.21803584201285,NGFR;KIT;SDC1
Secondary malignant neoplasm of bone marrow,3/7,3.582488250262111E-4,0.001990073704612104,0,0,33.17477375565611,263.21803584201285,KRT19;CXCL12;ERBB2
Unilateral Breast Carcinoma,3/7,3.582488250262111E-4,0.001990073704612104,0,0,33.17477375565611,263.21803584201285,ERBB2;BRCA1;BRCA2
Unilateral Breast Neoplasms,3/7,3.582488250262111E-4,0.001990073704612104,0,0,33.17477375565611,263.21803584201285,ERBB2;BRCA1;BRCA2
"Fatty Liver, Alcoholic",7/60,3.5958619043548147E-4,0.0019909157913971095,0,0,5.880675454467132,46.63702988293195,IL6;IL18;PPARG;PPARA;PTGS2;APOB;PPARGC1A
Dry Eye Syndromes,7/60,3.5958619043548147E-4,0.0019909157913971095,0,0,5.880675454467132,46.63702988293195,MUC1;IL6;IL18;CCL2;PTGS2;ESR1;TGFBR2
Gastrointestinal Stromal Sarcoma,7/60,3.5958619043548147E-4,0.0019909157913971095,0,0,5.880675454467132,46.63702988293195,CDKN2A;KIT;E2F1;PAX3;DMD;SLC2A4;TGFBR2
Post-Traumatic Osteoporosis,7/60,3.5958619043548147E-4,0.0019909157913971095,0,0,5.880675454467132,46.63702988293195,COL1A1;IL6;COL1A2;TNFSF11;ANTXR2;PDLIM4;ADCY5
Malignancy,8/79,3.6979479449483353E-4,0.002044067357882553,0,0,5.023753505011764,39.70052513183136,YAP1;TERT;ERBB2;LAMC1;VIM;IKBKE;RUNX2;EZH2
Osteitis Deformans,8/79,3.6979479449483353E-4,0.002044067357882553,0,0,5.023753505011764,39.70052513183136,IL6;ERBB2;TNFSF11;DMD;FOS;BRCA2;FGF2;ESR1
"Hepatoma, Morris",10/121,3.772502015789277E-4,0.002083562790957301,0,0,4.026923475199338,31.74263474137505,IL6;CCND1;HGF;F12;KDR;TK1;BAK1;TEK;ENO2;MET
Oral Cavity Carcinoma,9/100,3.921960886319924E-4,0.002164329442278111,0,0,4.415162818832544,34.63142725467966,IL6;ANXA1;CCND1;ALDH2;CDKN2A;ERBB2;PTGS2;TGFBR2;AURKA
Brain Infarction,7/61,3.985353794563236E-4,0.002192107787410868,0,0,5.77147809910367,45.17748154519935,IL6;MDK;HGF;CTSG;UTRN;FGF2;AGT
Epithelial hyperplasia of skin,7/61,3.985353794563236E-4,0.002192107787410868,0,0,5.77147809910367,45.17748154519935,NGFR;IL6;CCND1;PLA2G2A;E2F1;TIMP1;VIM
Ganglioglioma,7/61,3.985353794563236E-4,0.002192107787410868,0,0,5.77147809910367,45.17748154519935,CCNA2;ANXA1;CDKN2A;HGF;SYP;FGFR3;GFAP
Leukoplakia,7/61,3.985353794563236E-4,0.002192107787410868,0,0,5.77147809910367,45.17748154519935,KRT19;CDKN2A;BRCA1;PTGS2;FGF2;FGFR3;GFAP
Paroxysmal kinesigenic choreoathetosis,8/80,4.030329170945199E-4,0.002212561468671336,0,0,4.953724891939995,38.720752569367725,EGR1;JUN;ERBB2;PPARG;PRKD1;PKD2;TEAD1;PAX2
CARCINOMA OF VULVA,6/44,4.0456007795241226E-4,0.002212561468671336,0,0,7.019661911041841,54.84258497463853,CA12;CCND1;CDKN2A;KIT;LTA;PTGS2
Chromosome Breakage,6/44,4.0456007795241226E-4,0.002212561468671336,0,0,7.019661911041841,54.84258497463853,BLM;RAD51;FANCD2;FANCA;BRCA1;BRCA2
Medullomyoblastoma,6/44,4.0456007795241226E-4,0.002212561468671336,0,0,7.019661911041841,54.84258497463853,MYCN;ERBB2;IRS2;S100A4;BRCA2;FLI1
Melanotic medulloblastoma,6/44,4.0456007795241226E-4,0.002212561468671336,0,0,7.019661911041841,54.84258497463853,MYCN;ERBB2;IRS2;S100A4;BRCA2;FLI1
Muscle damage,6/44,4.0456007795241226E-4,0.002212561468671336,0,0,7.019661911041841,54.84258497463853,IL6;CCL2;GZMB;DMD;PPARGC1A;MYLK
Neoplasm of uncertain or unknown behavior of breast,6/44,4.0456007795241226E-4,0.002212561468671336,0,0,7.019661911041841,54.84258497463853,BARD1;ERBB2;BRCA1;GATA3;BRCA2;ESR1
Angiofibroma,5/29,4.0731997378649324E-4,0.0022132370096683567,0,0,9.247632575757576,72.1862015172748,CDKN2C;CCL2;TIMP1;ESR1;AURKA
Breast cancer recurrent,5/29,4.0731997378649324E-4,0.0022132370096683567,0,0,9.247632575757576,72.1862015172748,MUC1;ANXA1;ERBB2;FGFR4;ESR1
Contiguous gene syndrome,5/29,4.0731997378649324E-4,0.0022132370096683567,0,0,9.247632575757576,72.1862015172748,WT1;DMD;PRKD1;ASCL1;FLI1
Exostoses,5/29,4.0731997378649324E-4,0.0022132370096683567,0,0,9.247632575757576,72.1862015172748,ACAN;TCF7L2;COL2A1;S100A4;DCN
Intermittent Claudication,5/29,4.0731997378649324E-4,0.0022132370096683567,0,0,9.247632575757576,72.1862015172748,IL6;EPAS1;ADRB2;BAK1;FGF2
Pigmented Basal Cell Carcinoma,5/29,4.0731997378649324E-4,0.0022132370096683567,0,0,9.247632575757576,72.1862015172748,IL6;MYCN;TERT;ERBB2;KRT5
Staphylococcus aureus infection,5/29,4.0731997378649324E-4,0.0022132370096683567,0,0,9.247632575757576,72.1862015172748,MDK;CD36;APOB;FOXO1;GFAP
T-Cell Prolymphocytic Leukemia,5/29,4.0731997378649324E-4,0.0022132370096683567,0,0,9.247632575757576,72.1862015172748,ALK;STAT5A;STAT5B;IL2RG;EZH2
Papillary Renal Cell Carcinoma,12/169,4.1505734924882136E-4,0.0022534560691633665,0,0,3.424133213692061,26.664046711562882,ALK;IL6;EPAS1;CMA1;ERBB2;KDR;MITF;TIMP1;SYP;PTGS2;CRYAB;MET
Mean Corpuscular Volume (result),13/194,4.2291574809299835E-4,0.0022942666915933578,0,0,3.2210712093308778,25.02236850990627,MEF2C;ITSN1;FOXO1;SPTA1;CHAF1A;TERT;ALDH2;EPB41L2;LEPR;MCM4;E2F2;CD36;ERG
Nonorganic psychosis,14/220,4.342499435721708E-4,0.00235385199437506,0,0,3.050999031378821,23.62049975382197,OPRD1;GAD1;PRKCA;FOS;ESR1;RPS6KA3;IL6;DPYSL2;SOSTDC1;RARB;CALR;PAK3;FGFR3;PAK5
"Neoplasms, Experimental",8/81,4.3865918676490453E-4,0.002375834756704112,0,0,4.885614871007179,37.77453738841577,CCND1;EPAS1;HGF;ERBB2;KDR;IL18;ENO2;KPNA2
Pemphigus Vulgaris,7/62,4.407846640861867E-4,0.002385422887995834,0,0,5.666251556662516,43.78286565105661,COL17A1;C3;IL6;DST;MAPKAPK2;PRKCA;EZH2
Intervertebral Disc Degeneration,9/102,4.541894150573513E-4,0.0024559872073471587,0,0,4.319769162474104,33.249246971639344,ACAN;BMP2;IL6;MMP14;COL2A1;BGN;KRT5;TIMP1;HOXD10
Childhood Astrocytoma,4/17,4.57170702611382E-4,0.002457583367779038,0,0,13.634746206174778,104.85738452061233,MYCN;PLA2G2A;SIRPA;FLI1
Endomyocardial Fibrosis,4/17,4.57170702611382E-4,0.002457583367779038,0,0,13.634746206174778,104.85738452061233,COL3A1;CCL2;ADRB1;AGT
Malignant Female Reproductive System Neoplasm,4/17,4.57170702611382E-4,0.002457583367779038,0,0,13.634746206174778,104.85738452061233,RARB;BRCA1;BRCA2;ESR1
Myoepithelioma,4/17,4.57170702611382E-4,0.002457583367779038,0,0,13.634746206174778,104.85738452061233,IL6;HMGA2;SDC1;GFAP
Pseudopelade,4/17,4.57170702611382E-4,0.002457583367779038,0,0,13.634746206174778,104.85738452061233,ZFP36;PARP1;KRT15;PPARG
"MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA",6/45,4.5814389167054127E-4,0.002457583367779038,0,0,6.8393201331697915,52.582931346119885,RET;ERBB2;CXCR2;KIT;CXCR4;CCL2
Atypical Teratoid Rhabdoid Tumor,6/45,4.5814389167054127E-4,0.002457583367779038,0,0,6.8393201331697915,52.582931346119885,RIMS2;MYCN;CCND1;HMGA2;AURKA;EZH2
Chondrodysplasia,6/45,4.5814389167054127E-4,0.002457583367779038,0,0,6.8393201331697915,52.582931346119885,STAT5A;STAT5B;COL2A1;STAT1;BMPR1B;FGFR3
LATERAL MENINGOCELE SYNDROME,6/45,4.5814389167054127E-4,0.002457583367779038,0,0,6.8393201331697915,52.582931346119885,VCAN;CDKN2A;KIT;DMD;ESR1;MYLK
Lipoatrophy,6/45,4.5814389167054127E-4,0.002457583367779038,0,0,6.8393201331697915,52.582931346119885,COL3A1;CAV1;IL18;PPARG;FOS;ESR1
Coinfection,12/171,4.615835029933878E-4,0.002474058105429842,0,0,3.3807137565907013,25.966747083278612,ALK;EGR1;CXCL10;IL6;SH3BP1;E2F1;PAEP;CXCR4;BRCA1;KIF22;UTRN;GFAP
Small head,26/570,4.7484782375507693E-4,0.002543124389425117,0,0,2.1685297627404183,16.594709088161963,BLM;CTNND2;GATA4;BRCA2;RPS6KA3;TERT;SIX3;PAK3;BUB1;PLK4;CDT1;ARNT2;GAD1;FANCA;PAX3;TUBG1;AGT;GRIN2D;CIT;RAD51;MYCN;WT1;FANCD2;MCM4;PRKD1;FGFR3
Downward slant of palpebral fissure,14/222,4.7540437442690573E-4,0.002544076317650278,0,0,3.0213501695520257,23.11739191334145,PLK4;RET;CTNND2;BGN;PAX3;ASCL1;FLI1;COL1A1;RPS6KA3;BMP2;TNNI2;FGFR3;SOX5;EZH2
"Osteoporosis, Age-Related",8/82,4.7679999498747503E-4,0.0025474850965281483,0,0,4.8193456614509245,36.860348190377834,COL1A1;IL6;COL1A2;TNFSF11;DMD;ANTXR2;PDLIM4;ADCY5
Cholecystolithiasis,8/82,4.7679999498747503E-4,0.0025474850965281483,0,0,4.8193456614509245,36.860348190377834,FEN1;MUC1;PLA2G2A;PPARG;PTGS2;APOB;PPARGC1A;ESR1
Bilateral Wilms Tumor,5/30,4.799322042878951E-4,0.002548003702764825,0,0,8.877272727272727,67.83892600940655,MYCN;WT1;SIX2;SIX1;BRCA2
Broad foot,5/30,4.799322042878951E-4,0.002548003702764825,0,0,8.877272727272727,67.83892600940655,CAV1;PPARG;FOS;BMPR1B;EZH2
Childhood Rhabdomyosarcoma,5/30,4.799322042878951E-4,0.002548003702764825,0,0,8.877272727272727,67.83892600940655,CDKN2C;CDKN2A;PAX3;HMGA2;FOXO1
Generalized osteoarthritis,5/30,4.799322042878951E-4,0.002548003702764825,0,0,8.877272727272727,67.83892600940655,BMP2;COL2A1;FGFR4;PITX1;ESR1
Lymphoid neoplasm,5/30,4.799322042878951E-4,0.002548003702764825,0,0,8.877272727272727,67.83892600940655,STAT5A;STAT5B;CCND1;CDKN2A;BRCA1
Prostatic Hypertrophy,5/30,4.799322042878951E-4,0.002548003702764825,0,0,8.877272727272727,67.83892600940655,EGR1;FGF7;ERBB2;ADRA1A;ESR1
Tendinopathy,5/30,4.799322042878951E-4,0.002548003702764825,0,0,8.877272727272727,67.83892600940655,COL1A1;ACAN;VCAN;LMO2;BGN
Tongue Neoplasms,5/30,4.799322042878951E-4,0.002548003702764825,0,0,8.877272727272727,67.83892600940655,PARP1;ERBB2;BRCA1;PTGS2;CRYAB
Lymphangioleiomyomatosis,7/63,4.8653310712977704E-4,0.0025810081733677586,0,0,5.564783105022831,42.449309683470716,MMP14;PARP1;CCL2;HMGA2;PTGS2;ESR1;AGT
Severe Sepsis,9/103,4.8807978324755843E-4,0.0025871695535048165,0,0,4.273594573492095,32.58629398989481,IL6;PROC;VWF;SH2D1A;CXCR2;IL18;LTA;TIMP1;MYLK
Congenital hypoplasia of lung,10/125,4.889087680591069E-4,0.002589519941865112,0,0,3.886056971514243,29.624712779457646,RET;COL2A1;RAD51;CMA1;ERBB2;RARB;LIFR;FGFR4;PAX2;AGT
Congenital clubfoot,13/198,5.134755793951293E-4,0.002717495658957989,0,0,3.150775775775776,23.86494643844437,RET;DST;LIFR;HOXD10;PAX2;TGFBR2;COL1A1;COL3A1;COL2A1;TNNI2;BMPR1B;PITX1;EZH2
Chromophobe Renal Cell Carcinoma,11/149,5.155440373878567E-4,0.002724220784798058,0,0,3.566202497829426,26.997179374351457,ALK;IL6;CCND1;EPAS1;PROS1;KIT;ERBB2;MITF;PTGS2;CRYAB;MET
Acute periodontitis,6/46,5.170995583774007E-4,0.002724220784798058,0,0,6.667995444191344,50.45855610911653,IL6;CDKN2A;STAT1;IL18;GATA3;PTGS2
Drusen,6/46,5.170995583774007E-4,0.002724220784798058,0,0,6.667995444191344,50.45855610911653,VTN;CCL2;SERPING1;PTGS2;APOB;CRYAB
Thrombasthenia,6/46,5.170995583774007E-4,0.002724220784798058,0,0,6.667995444191344,50.45855610911653,VTN;IL6;VWF;PLA2G2A;PECAM1;BRCA1
bone destruction,8/83,5.175857238538299E-4,0.002724220784798058,0,0,4.754843630816171,35.97674166906685,SOCS3;CXCL10;MMP14;IL6;CXCL12;PECAM1;TNFSF11;TIMP1
Maturity onset diabetes mellitus in young,8/83,5.175857238538299E-4,0.002724220784798058,0,0,4.754843630816171,35.97674166906685,KLF11;FANCD2;PTPRN;GAD1;LEPR;CD36;BRCA2;APOB
Testicular Neoplasms,8/83,5.175857238538299E-4,0.002724220784798058,0,0,4.754843630816171,35.97674166906685,CCND2;CDKN2A;KIT;KDR;HMGA2;GATA4;FGFR3;TDGF1
Generalized seizures,10/126,5.207386454843432E-4,0.0027386693367837506,0,0,3.852358303606817,29.12483918035423,NGFR;IL6;CTNND2;FOS;SSTR2;PTGS2;FGF2;MPDZ;FGFR3;AGT
Patent ductus arteriosus,15/251,5.322789628072798E-4,0.002797171763860478,0,0,2.8555873078439102,21.526396135724312,FBN2;PARP1;CDKN2A;HGF;PTGS2;KLF4;AGT;TGFBR2;PER2;ACTA2;MUC1;MYCN;ERBB2;CTLA4;CCL2
"Osteoporosis, Senile",7/64,5.359863538528074E-4,0.0028144521911457818,0,0,5.466874949931907,41.17323214688296,COL1A1;IL6;COL1A2;TNFSF11;ANTXR2;PDLIM4;ADCY5
Decreased projection of maxilla,8/84,5.61150750028102E-4,0.002912363415961237,0,0,4.692039022040227,35.12235650051061,RPS6KA3;CDT1;BMP2;COL2A1;BGN;PAX3;FGFR3;RUNX2
Deficiency of upper jaw bones,8/84,5.61150750028102E-4,0.002912363415961237,0,0,4.692039022040227,35.12235650051061,RPS6KA3;CDT1;BMP2;COL2A1;BGN;PAX3;FGFR3;RUNX2
Hypoplasia of the maxilla,8/84,5.61150750028102E-4,0.002912363415961237,0,0,4.692039022040227,35.12235650051061,RPS6KA3;CDT1;BMP2;COL2A1;BGN;PAX3;FGFR3;RUNX2
Hypotrophic maxilla,8/84,5.61150750028102E-4,0.002912363415961237,0,0,4.692039022040227,35.12235650051061,RPS6KA3;CDT1;BMP2;COL2A1;BGN;PAX3;FGFR3;RUNX2
Maxillary retrognathia,8/84,5.61150750028102E-4,0.002912363415961237,0,0,4.692039022040227,35.12235650051061,RPS6KA3;CDT1;BMP2;COL2A1;BGN;PAX3;FGFR3;RUNX2
Retrusion of upper jaw bones,8/84,5.61150750028102E-4,0.002912363415961237,0,0,4.692039022040227,35.12235650051061,RPS6KA3;CDT1;BMP2;COL2A1;BGN;PAX3;FGFR3;RUNX2
"Lipomatosis, Multiple",5/31,5.618696258727449E-4,0.002912363415961237,0,0,8.535402097902098,63.88100392063264,STAT5A;STAT5B;CDKN2A;HMGA2;DCN
Atherosclerosis of aorta,5/31,5.618696258727449E-4,0.002912363415961237,0,0,8.535402097902098,63.88100392063264,CCL2;PAEP;PTGS2;APOB;AGT
Intervertebral disc disorder,5/31,5.618696258727449E-4,0.002912363415961237,0,0,8.535402097902098,63.88100392063264,ACAN;BMP2;IL6;MMP14;TIMP1
Invasive Skin Melanoma,5/31,5.618696258727449E-4,0.002912363415961237,0,0,8.535402097902098,63.88100392063264,BLM;ANXA1;CDKN2A;CCL2;EZH2
"Atrophy, Disuse",3/8,5.637391960615855E-4,0.002912363415961237,0,0,26.53846153846154,198.53207668861904,TRIM63;PITX1;PPARGC1A
"Ehlers-Danlos Syndrome, Type IV",3/8,5.637391960615855E-4,0.002912363415961237,0,0,26.53846153846154,198.53207668861904,COL1A1;COL3A1;COL1A2
"Thanatophoric dysplasia, type 2",3/8,5.637391960615855E-4,0.002912363415961237,0,0,26.53846153846154,198.53207668861904,STAT1;FGF2;FGFR3
acute aortic dissection,3/8,5.637391960615855E-4,0.002912363415961237,0,0,26.53846153846154,198.53207668861904,ACTA2;IL6;CXCR2
Apocrine Carcinoma,3/8,5.637391960615855E-4,0.002912363415961237,0,0,26.53846153846154,198.53207668861904,ERBB2;KRT5;ESR1
Chondromyxoid fibroma,3/8,5.637391960615855E-4,0.002912363415961237,0,0,26.53846153846154,198.53207668861904,VCAN;CCND1;CDKN2A
Chromosomal breakage induced by crosslinking agents,3/8,5.637391960615855E-4,0.002912363415961237,0,0,26.53846153846154,198.53207668861904,FANCD2;FANCA;BRCA2
Extraosseous Ewings sarcoma-primitive neuroepithelial tumor,3/8,5.637391960615855E-4,0.002912363415961237,0,0,26.53846153846154,198.53207668861904,IL18;ERG;FLI1
Pfeiffer Syndrome,3/8,5.637391960615855E-4,0.002912363415961237,0,0,26.53846153846154,198.53207668861904,FGF2;FGFR3;RUNX2
Secretory breast carcinoma,3/8,5.637391960615855E-4,0.002912363415961237,0,0,26.53846153846154,198.53207668861904,STAT5A;ERBB2;BRCA2
Supratentorial Neoplasms,3/8,5.637391960615855E-4,0.002912363415961237,0,0,26.53846153846154,198.53207668861904,CDKN2A;VIM;GFAP
"Ovarian Failure, Premature",12/175,5.679127500169104E-4,0.00293166950738937,0,0,3.2970713668371614,24.640803843381004,RET;CXCL12;WT1;KIT;KDR;FANCA;DMD;BRCA1;LAMC1;ESR1;FOXO1;AGT
"Teratoma, Malignant",4/18,5.775189024675884E-4,0.002967572263942099,0,0,12.660187884677681,94.40410142122148,ERBB2;KIT;KPNA2;TEAD1
Heat Stroke,4/18,5.775189024675884E-4,0.002967572263942099,0,0,12.660187884677681,94.40410142122148,JUN;IL6;PROC;FOS
Mouth Abnormalities,4/18,5.775189024675884E-4,0.002967572263942099,0,0,12.660187884677681,94.40410142122148,RET;TEK;ASCL1;PCSK5
Papillomatosis,4/18,5.775189024675884E-4,0.002967572263942099,0,0,12.660187884677681,94.40410142122148,CCND1;ERBB2;PLA2G4A;PTGS2
Pleural Diseases,4/18,5.775189024675884E-4,0.002967572263942099,0,0,12.660187884677681,94.40410142122148,ALK;IL6;CDKN2A;CCL2
Proliferative Inflammatory Atrophy,4/18,5.775189024675884E-4,0.002967572263942099,0,0,12.660187884677681,94.40410142122148,CIB1;VIM;PTGS2;MET
"Hypertension, Renovascular",6/47,5.817897500569356E-4,0.002978124970565838,0,0,6.505028057114284,48.45856530889638,CXCL10;STAT1;PDGFA;ADRB1;PTGS2;AGT
Colonic Polyps,6/47,5.817897500569356E-4,0.002978124970565838,0,0,6.505028057114284,48.45856530889638,PER2;TERT;CXCR4;PPARG;BRCA1;DCN
LIMB-MAMMARY SYNDROME,6/47,5.817897500569356E-4,0.002978124970565838,0,0,6.505028057114284,48.45856530889638,VCAN;CDKN2A;KIT;DMD;ESR1;MYLK
Lumbar hyperlordosis,6/47,5.817897500569356E-4,0.002978124970565838,0,0,6.505028057114284,48.45856530889638,ACAN;COL2A1;TPM3;BGN;FGFR3;SOX5
Mitral Valve Insufficiency,6/47,5.817897500569356E-4,0.002978124970565838,0,0,6.505028057114284,48.45856530889638,FBN2;RPS6KA3;CCND2;COL1A2;BGN;CRYAB
Hereditary Nonpolyposis Colorectal Cancer,10/128,5.895621388553997E-4,0.0030156125853411,0,0,3.786674459380479,28.158205191496933,BARD1;BLM;CCND1;CDKN2A;ERBB2;BRCA1;BRCA2;PTGS2;TGFBR2;AURKA
"Alzheimer's Disease, Focal Onset",8/85,6.076334447763987E-4,0.0030962566123811028,0,0,4.630865701803917,34.29590772243829,PYY;CR1;BIN1;DPYSL2;PPARG;SLC2A4;A2M;ESR1
Acute Confusional Senile Dementia,8/85,6.076334447763987E-4,0.0030962566123811028,0,0,4.630865701803917,34.29590772243829,PYY;CR1;BIN1;DPYSL2;PPARG;SLC2A4;A2M;ESR1
Alcoholic Liver Diseases,8/85,6.076334447763987E-4,0.0030962566123811028,0,0,4.630865701803917,34.29590772243829,IL6;ALDH2;CDKN2A;CTLA4;CCL2;PPARG;PPARA;SELE
Increased tendency to bruise,8/85,6.076334447763987E-4,0.0030962566123811028,0,0,4.630865701803917,34.29590772243829,COL1A1;COL3A1;COL1A2;VWF;FANCD2;FANCA;F13A1;KRT5
Severe Acute Respiratory Syndrome,8/85,6.076334447763987E-4,0.0030962566123811028,0,0,4.630865701803917,34.29590772243829,VTN;CXCL10;IL6;CR1;MX1;CCL2;CALR;AGT
Decreased platelet count,11/152,6.096742242659376E-4,0.003104300295807458,0,0,3.4897865803836976,25.8334445920891,RAD51;TERT;MECOM;VWF;FANCD2;SH2D1A;FANCA;TNFSF11;CD36;BRCA2;FLI1
"Seizures, Focal",10/129,6.266959324134996E-4,0.0031861391991590184,0,0,3.7546604848836087,27.69080539695181,NGFR;IL6;CTNND2;FOS;SSTR2;PTGS2;FGF2;MPDZ;SYN1;AGT
Malignant neoplasm of larynx,10/129,6.266959324134996E-4,0.0031861391991590184,0,0,3.7546604848836087,27.69080539695181,ANXA1;CCND1;CDKN2A;ERBB2;PRKD1;BRCA1;BRCA2;PTGS2;CRYAB;AURKA
Hyperlipoproteinemia Type IIa,11/153,6.440673585469304E-4,0.0032719791074139067,0,0,3.4650321282533914,25.460041667078045,IL6;MYCN;ACTC1;STMN1;IL18;CD36;TIMP1;APOB;BRCA2;ESR1;AGT
Barrett Epithelium,6/48,6.525884707257452E-4,0.003304297868062363,0,0,6.349821021802798,46.57316766104677,CDKN2A;HGF;LEPR;PPARG;PTGS2;KLF4
keratoacanthoma,6/48,6.525884707257452E-4,0.003304297868062363,0,0,6.349821021802798,46.57316766104677,CCND1;TERT;CDKN2A;LTA;PTGS2;FGFR3
Synovial Cyst,6/48,6.525884707257452E-4,0.003304297868062363,0,0,6.349821021802798,46.57316766104677,MYCN;PARP1;KDR;PTGS2;UTRN;RAMP1
Bowen's Disease,5/32,6.538731189182371E-4,0.003304297868062363,0,0,8.218855218855218,60.265555037021485,COL17A1;S100A4;PPARGC1A;FGFR3;TGFBR2
Chronic Persistent Hepatitis,5/32,6.538731189182371E-4,0.003304297868062363,0,0,8.218855218855218,60.265555037021485,ACTA2;KRT19;HGF;MKI67;MET
Oropharyngeal disorders,5/32,6.538731189182371E-4,0.003304297868062363,0,0,8.218855218855218,60.265555037021485,JUN;CDKN2A;ERBB2;FOS;EZH2
Subacute Sclerosing Panencephalitis,5/32,6.538731189182371E-4,0.003304297868062363,0,0,8.218855218855218,60.265555037021485,IL6;MX1;IL18;SDC1;TIMP1
"Cystadenocarcinoma, Serous",8/86,6.571761687161854E-4,0.003311024117852889,0,0,4.571260928240333,33.496181570125124,ALK;NR5A2;ERBB2;BRCA1;BRCA2;PTGS2;ESR1;PAX2
"Malaria, Cerebral",8/86,6.571761687161854E-4,0.003311024117852889,0,0,4.571260928240333,33.496181570125124,CXCL10;IL6;CR1;VWF;LTA;CD36;SELE;AGT
Chronic gastritis,8/86,6.571761687161854E-4,0.003311024117852889,0,0,4.571260928240333,33.496181570125124,MUC1;IL6;TERT;CDKN2A;CAV1;ERBB2;IL18;GATA4
Diabetic Neuropathies,8/86,6.571761687161854E-4,0.003311024117852889,0,0,4.571260928240333,33.496181570125124,NGFR;PARP1;HGF;LEPR;TNFSF11;ENO2;SGK1;PTGS2
Dull intelligence,37/947,6.741847469637058E-4,0.003391629034163482,0,0,1.8580720749838397,13.56765414477682,RET;YAP1;CNTNAP2;ASCL1;BRCA2;RPS6KA3;TERT;SIX3;DMD;NEK2;ZNF423;PAK3;MPDZ;BUB1;SOX5;PLK4;GAD1;CAV1;FANCA;PAX3;FOS;SYP;SOX10;FLI1;PAX2;CIT;ACTA2;COL3A1;RAD51;MYCN;WT1;FANCD2;RARB;PPARG;FGFR3;EZH2;ARHGEF6
Low intelligence,37/947,6.741847469637058E-4,0.003391629034163482,0,0,1.8580720749838397,13.56765414477682,RET;YAP1;CNTNAP2;ASCL1;BRCA2;RPS6KA3;TERT;SIX3;DMD;NEK2;ZNF423;PAK3;MPDZ;BUB1;SOX5;PLK4;GAD1;CAV1;FANCA;PAX3;FOS;SYP;SOX10;FLI1;PAX2;CIT;ACTA2;COL3A1;RAD51;MYCN;WT1;FANCD2;RARB;PPARG;FGFR3;EZH2;ARHGEF6
"Hypercholesterolemia, Familial",11/154,6.800609416013689E-4,0.003418629703439217,0,0,3.4406238922367955,25.093599065507952,IL6;STMN1;IL18;F13A1;GATA4;CD36;TIMP1;APOB;ESR1;SELE;AGT
Congenital Hypothyroidism,7/67,7.087290598098931E-4,0.0035574173136646054,0,0,5.192732115677321,37.6578867248963,EGR1;NGFR;NKX2-5;NEFH;PPARGC1A;RUNX2;PAX2
Cushing Syndrome,7/67,7.087290598098931E-4,0.0035574173136646054,0,0,5.192732115677321,37.6578867248963,RET;IL6;VWF;IL18;TXNIP;SSTR2;AGT
Adrenal Gland Neoplasms,8/87,7.099252632245222E-4,0.0035607603195040257,0,0,4.513165136285954,32.72203071154805,TERT;CDKN2A;GATA4;SYP;BAK1;PTGS2;AGT;CDKN3
"Aneurysm, Dissecting",4/19,7.187496498184849E-4,0.003575646406059959,0,0,11.81557067271353,85.52107043557338,COL1A1;COL3A1;AGT;TGFBR2
"stage, cervical cancer",4/19,7.187496498184849E-4,0.003575646406059959,0,0,11.81557067271353,85.52107043557338,IL6;MDK;SIX1;EZR
"THANATOPHORIC DYSPLASIA, TYPE I (disorder)",4/19,7.187496498184849E-4,0.003575646406059959,0,0,11.81557067271353,85.52107043557338,STAT1;CTLA4;FGF2;FGFR3
Apert syndrome,4/19,7.187496498184849E-4,0.003575646406059959,0,0,11.81557067271353,85.52107043557338,RET;CCND1;FGF2;FGFR3
Borderline ovarian tumour,4/19,7.187496498184849E-4,0.003575646406059959,0,0,11.81557067271353,85.52107043557338,CDKN2A;ERBB2;BRCA1;BRCA2
Cone-shaped epiphyses of the phalanges of the hand,4/19,7.187496498184849E-4,0.003575646406059959,0,0,11.81557067271353,85.52107043557338,COL2A1;BGN;FGFR3;RUNX2
Differentiating Neuroblastoma,4/19,7.187496498184849E-4,0.003575646406059959,0,0,11.81557067271353,85.52107043557338,MYCN;STMN1;ASCL1;CDKN3
Female Urogenital Diseases,4/19,7.187496498184849E-4,0.003575646406059959,0,0,11.81557067271353,85.52107043557338,HOXA10;TIMP1;ESR1;PAX2
Lipidemias,4/19,7.187496498184849E-4,0.003575646406059959,0,0,11.81557067271353,85.52107043557338,LEPR;ADRB2;APOB;PPARA
Skeletal muscle hypertrophy,4/19,7.187496498184849E-4,0.003575646406059959,0,0,11.81557067271353,85.52107043557338,CAV1;PPARG;SCN4A;FOS
Thromboembolism,4/19,7.187496498184849E-4,0.003575646406059959,0,0,11.81557067271353,85.52107043557338,PROC;F12;PROS1;A2M
Cardiovascular Abnormalities,6/49,7.298807463063743E-4,0.003622970504208137,0,0,6.201832918366266,44.793540760100505,RET;IL6;PKD2;ASCL1;AGT;FLI1
Dryness of eye,6/49,7.298807463063743E-4,0.003622970504208137,0,0,6.201832918366266,44.793540760100505,MUC1;IL18;CCL2;PTGS2;ESR1;TGFBR2
Medullary carcinoma,6/49,7.298807463063743E-4,0.003622970504208137,0,0,6.201832918366266,44.793540760100505,RET;ERBB2;PLAUR;BRCA1;PTGS2;ESR1
Hypoglycemia,14/232,7.346223947878741E-4,0.003643813887293473,0,0,2.881266097618085,20.7916597006521,SIAH2;IRS2;ADRB2;SLC2A4;AGT;DEPP1;SOCS3;IL6;SH3BP1;KIT;KDR;TXNIP;CD36;PPARA
Convulsive Seizures,9/109,7.377919792185954E-4,0.003656834636481245,0,0,4.015940366972477,28.962354090234125,NGFR;IL6;ERG;FOS;SSTR2;PTGS2;FGF2;MPDZ;AGT
Cholestasis,17/315,7.430449929043556E-4,0.003680154994355201,0,0,2.5667142319513268,18.492544525181643,FBN2;EGR1;PLA2G2A;ESR1;AGT;AQP1;COL1A1;VIL1;IL6;CXCR2;BCL3;SAA1;CTLA4;PPARG;TIMP1;EZR;PPARA
Language Delay,13/206,7.444641640244735E-4,0.0036844667100872247,0,0,3.0189263097294186,21.74486081517789,CNTNAP2;MEF2C;LAMA1;HMGA2;RPS6KA3;COL2A1;NDN;DMD;PRKD1;PAK3;BMPR1B;SOX5;EZH2
"Sleep Apnea, Obstructive",10/132,7.498648005360242E-4,0.0037057336279616914,0,0,3.661767476917279,26.348678627179847,IL6;LEPR;IL18;CCL2;TIMP1;ALDOA;PTGS2;FGFR3;MET;AGT
Nausea and vomiting,10/132,7.498648005360242E-4,0.0037057336279616914,0,0,3.661767476917279,26.348678627179847,RET;C4A;WT1;CAV1;KIT;CTLA4;PRTN3;BRCA1;MYLK;TGFBR2
"Preauricular Fistulae, Congenital",5/33,7.567031205766226E-4,0.0037203646835963383,0,0,7.9249188311688314,56.95274269270914,SIX1;GATA4;MITF;NKX2-5;ZFPM2
Congenital preauricular sinus,5/33,7.567031205766226E-4,0.0037203646835963383,0,0,7.9249188311688314,56.95274269270914,SIX1;GATA4;MITF;NKX2-5;ZFPM2
Disproportionate short-limb short stature,5/33,7.567031205766226E-4,0.0037203646835963383,0,0,7.9249188311688314,56.95274269270914,COL1A1;COL1A2;COL2A1;BMPR1B;FGFR3
Epithelial hyperplasia,5/33,7.567031205766226E-4,0.0037203646835963383,0,0,7.9249188311688314,56.95274269270914,NRP1;CCND1;FANCD2;ESR1;EZH2
Megacolon,5/33,7.567031205766226E-4,0.0037203646835963383,0,0,7.9249188311688314,56.95274269270914,RET;KIT;PAX3;ASCL1;SOX10
Mixed oligoastrocytoma,5/33,7.567031205766226E-4,0.0037203646835963383,0,0,7.9249188311688314,56.95274269270914,CAV1;HGF;ESR1;MET;GFAP
Preauricular dimple,5/33,7.567031205766226E-4,0.0037203646835963383,0,0,7.9249188311688314,56.95274269270914,SIX1;GATA4;MITF;NKX2-5;ZFPM2
Abnormality of the skeletal system,8/88,7.660310356743477E-4,0.0037634706917256174,0,0,4.456521739130435,31.972369866568553,RPS6KA3;IL6;COL2A1;COL1A2;CALR;FGFR3;ETS2;RUNX2
Adenomatous polyp of colon,7/68,7.751877838236697E-4,0.0038001176322334054,0,0,5.107343364024254,36.58086295597764,MUC1;CCND1;MECOM;PARP1;PLA2G2A;PROX1;TGFBR2
Primary hypogonadism,7/68,7.751877838236697E-4,0.0038001176322334054,0,0,5.107343364024254,36.58086295597764,FANCD2;WT1;LEPR;FANCA;GATA4;ZFPM2;BMPR1B
Undifferentiated leukemia,7/68,7.751877838236697E-4,0.0038001176322334054,0,0,5.107343364024254,36.58086295597764,STAT5A;STAT5B;MECOM;TAL1;KDR;CTSG;EZH2
Curvature of little finger,11/157,7.982244239785528E-4,0.0039101934583807155,0,0,3.3694053405719337,24.03437520726506,PLK4;CDT1;BLM;BMP2;MECOM;GATA4;ZFPM2;NKX2-5;BMPR1B;PITX1;FGFR3
Cervical Squamous Intraepithelial Neoplasia,6/50,8.14062292396026E-4,0.003979862527279426,0,0,6.060571546904121,43.111716115597176,NRP1;TERT;CDKN2A;PTGS2;MET;BUB1
Small Lymphocytic Lymphoma,6/50,8.14062292396026E-4,0.003979862527279426,0,0,6.060571546904121,43.111716115597176,CCL13;RAD51;CCND1;CD5;KIT;ETS2
Constipation,13/208,8.142244062659217E-4,0.003979862527279426,0,0,2.9876543209876543,21.252005435467343,RET;BRCA1;FOS;ASCL1;SNCAIP;SOX10;FLI1;LMNB1;TGFBR2;PYY;KIT;SIX3;NKX2-5
"Malaria, Falciparum",8/89,8.256477417173417E-4,0.004006809336035808,0,0,4.401276944373817,31.24617175340856,CR1;IL18;IRF7;PECAM1;CD36;ADRB2;PTGS2;SELE
Chagas Disease,8/89,8.256477417173417E-4,0.004006809336035808,0,0,4.401276944373817,31.24617175340856,IL6;SH2D1A;IL18;CCL2;PPARG;CALR;PTGS2;PPARGC1A
Osteoarthrosis Deformans,8/89,8.256477417173417E-4,0.004006809336035808,0,0,4.401276944373817,31.24617175340856,COL2A1;COL1A2;DPYSL2;PPARG;S100A4;VIM;EZR;RUNX2
"Cardiomyopathy, Alcoholic",3/9,8.316694780276826E-4,0.004006809336035808,0,0,22.11425339366516,156.83595376649893,ALDH2;PPARG;AGT
"Osteogenesis imperfecta, dominant perinatal lethal",3/9,8.316694780276826E-4,0.004006809336035808,0,0,22.11425339366516,156.83595376649893,COL1A1;COL1A2;COL2A1
"WAARDENBURG SYNDROME, TYPE 4A",3/9,8.316694780276826E-4,0.004006809336035808,0,0,22.11425339366516,156.83595376649893,RET;PAX3;SOX10
Capillary Leak Syndrome,3/9,8.316694780276826E-4,0.004006809336035808,0,0,22.11425339366516,156.83595376649893,C4A;CXCL10;RPS6KA3
Chronic fatigue,3/9,8.316694780276826E-4,0.004006809336035808,0,0,22.11425339366516,156.83595376649893,CDKN2A;BRCA1;BRCA2
Congenital kyphosis,3/9,8.316694780276826E-4,0.004006809336035808,0,0,22.11425339366516,156.83595376649893,PARP1;DMD;UTRN
Craniofacial dysostosis type 1,3/9,8.316694780276826E-4,0.004006809336035808,0,0,22.11425339366516,156.83595376649893,BGN;TK1;FGFR3
Dilatation of the cerebral artery,3/9,8.316694780276826E-4,0.004006809336035808,0,0,22.11425339366516,156.83595376649893,ACTA2;COL3A1;STAT1
Functional intestinal obstruction,3/9,8.316694780276826E-4,0.004006809336035808,0,0,22.11425339366516,156.83595376649893,CDKN2A;BRCA1;BRCA2
Glycogen Storage Disease Type VI,3/9,8.316694780276826E-4,0.004006809336035808,0,0,22.11425339366516,156.83595376649893,VWF;CDKN2A;ENO2
Metaplastic breast carcinoma,3/9,8.316694780276826E-4,0.004006809336035808,0,0,22.11425339366516,156.83595376649893,ERBB2;BRCA1;MET
Myelofibrosis due to another disorder,3/9,8.316694780276826E-4,0.004006809336035808,0,0,22.11425339366516,156.83595376649893,STAT5A;STAT5B;RUNX1T1
proliferative nephritis unspecified,3/9,8.316694780276826E-4,0.004006809336035808,0,0,22.11425339366516,156.83595376649893,ACAN;CR1;GATA3
Spindle Cell Neoplasm,3/9,8.316694780276826E-4,0.004006809336035808,0,0,22.11425339366516,156.83595376649893,ALK;WT1;KIT
Vasculitic neuropathy,3/9,8.316694780276826E-4,0.004006809336035808,0,0,22.11425339366516,156.83595376649893,IL6;SERPING1;PTGS2
Waardenburg Syndrome Type 2,3/9,8.316694780276826E-4,0.004006809336035808,0,0,22.11425339366516,156.83595376649893,PAX3;MITF;SOX10
WHIM syndrome,3/9,8.316694780276826E-4,0.004006809336035808,0,0,22.11425339366516,156.83595376649893,GRK3;CXCL12;CXCR4
Plasmacytoma,9/111,8.410987023967817E-4,0.004049332534262929,0,0,3.9367916891527255,27.875640662071863,IL6;CCND1;CDKN2A;STAT1;KIT;PECAM1;SDC1;FLNC;CDKN3
Diphtheria,7/69,8.464762927555176E-4,0.004072302852540155,0,0,5.024709088230962,35.54694448949824,MUC1;RAD51;PLAUR;PAX3;FADD;SNCAIP;FOXO1
Malignant neoplasm of vulva,5/34,8.711381147835613E-4,0.004184952488473818,0,0,7.651253918495298,53.908516424529566,TERT;CDKN2A;KIT;LTA;PTGS2
Secondary malignant neoplasm of pancreas,5/34,8.711381147835613E-4,0.004184952488473818,0,0,7.651253918495298,53.908516424529566,EPS8;RAD51;WT1;ERBB2;BRCA1
"Adenocarcinoma of lung, stage I",4/20,8.827598060781337E-4,0.004198735734858886,0,0,11.076530612244898,77.8952298328024,MUC1;ADAM12;MET;AURKA
"Thymoma, type C",4/20,8.827598060781337E-4,0.004198735734858886,0,0,11.076530612244898,77.8952298328024,EGR1;CDKN2A;ERBB2;KIT
Abnormal nasal morphology,4/20,8.827598060781337E-4,0.004198735734858886,0,0,11.076530612244898,77.8952298328024,CCND2;GATA4;NKX2-5;ZFPM2
Adenosis of Breast,4/20,8.827598060781337E-4,0.004198735734858886,0,0,11.076530612244898,77.8952298328024,ERBB2;BRCA1;ERG;PTGS2
Alveolar Soft Part Sarcoma,4/20,8.827598060781337E-4,0.004198735734858886,0,0,11.076530612244898,77.8952298328024,RET;PER2;KDR;MET
Dyslipoproteinemias,4/20,8.827598060781337E-4,0.004198735734858886,0,0,11.076530612244898,77.8952298328024,LEPR;PPARG;APOB;PPARA
Fibrosis of pancreas,4/20,8.827598060781337E-4,0.004198735734858886,0,0,11.076530612244898,77.8952298328024,MMP14;ALDH2;PLA2G2A;CCL2
Ovarian Clear Cell Adenocarcinoma,4/20,8.827598060781337E-4,0.004198735734858886,0,0,11.076530612244898,77.8952298328024,BARD1;IL6;ESR1;MET
Overnutrition,4/20,8.827598060781337E-4,0.004198735734858886,0,0,11.076530612244898,77.8952298328024,FGF1;PPARGC1A;FOXO1;DEPP1
Piebaldism,4/20,8.827598060781337E-4,0.004198735734858886,0,0,11.076530612244898,77.8952298328024,TERT;KIT;PAX3;MITF
Pseudoachondroplasia,4/20,8.827598060781337E-4,0.004198735734858886,0,0,11.076530612244898,77.8952298328024,ACAN;DMD;FGFR3;DCN
Sick Sinus Syndrome,4/20,8.827598060781337E-4,0.004198735734858886,0,0,11.076530612244898,77.8952298328024,IL6;COL1A2;CCL2;FGFR3
Squamous cell carcinoma of penis,4/20,8.827598060781337E-4,0.004198735734858886,0,0,11.076530612244898,77.8952298328024,ANXA1;CCND1;CDKN2A;ERBB2
Vulval intraepithelial neoplasia,4/20,8.827598060781337E-4,0.004198735734858886,0,0,11.076530612244898,77.8952298328024,CCNA2;CCND1;CDKN2A;MKI67
"Periodontitis, Juvenile",8/90,8.889335620475909E-4,0.004225108140631013,0,0,4.347379583635654,30.54246335102432,IL6;CDKN2A;STAT1;IL18;PRTN3;GATA3;PTGS2;SELE
Hirschsprung Disease,10/135,8.923104367217296E-4,0.00423516388199515,0,0,3.5733333333333333,25.090862026713467,ALK;RET;ARNT2;KIT;ERBB2;PAX3;CXCR4;MITF;ASCL1;SOX10
Mycoses,10/135,8.923104367217296E-4,0.00423516388199515,0,0,3.5733333333333333,25.090862026713467,CXCL10;IL6;CCND1;MECOM;FLAD1;FANCD2;MDK;STAT1;PLA2G2A;ATF3
Convex nasal ridge,6/51,9.055391603847169E-4,0.004291884969049935,0,0,5.925588458618071,41.52048002117009,PLK4;COL1A1;COL3A1;COL1A2;FGFR3;RUNX2
Metaplasia,6/51,9.055391603847169E-4,0.004291884969049935,0,0,5.925588458618071,41.52048002117009,CDKN2A;GATA3;MKI67;PTGS2;MET;ESR1
"Angina, Unstable",7/70,9.228383969106374E-4,0.00437079173036096,0,0,4.944698122780315,34.55382947864111,IL6;PARP1;IL18;CXCR4;CCL2;TIMP1;AGT
"Amyotrophic Lateral Sclerosis, Sporadic",10/136,9.444545149180112E-4,0.0044668707902742,0,0,3.5447910965152345,24.68912624892307,GRIA2;CTNND2;HGF;SIX2;PDGFA;SNCG;FOS;VIM;NEFH;GFAP
Flexion contracture,10/136,9.444545149180112E-4,0.0044668707902742,0,0,3.5447910965152345,24.68912624892307,FBN2;COL2A1;DST;TPM3;BIN1;CAV1;GAD1;CAPN3;DMD;CRYAB
Lipodystrophy,9/113,9.558724436259876E-4,0.004515355599100103,0,0,3.860687191249118,26.842918235071284,RIMS2;IL6;CAV1;LEPR;IL18;CCL2;PPARG;PPARA;ESR1
Meningitis,8/91,9.560505750328093E-4,0.004515355599100103,0,0,4.294780954481542,29.86032244086241,C4B;C4A;IL6;PARP1;MDK;SH2D1A;CCL2;TIMP1
Weight decreased,11/161,9.818138874140413E-4,0.00463377517067653,0,0,3.278878648233487,22.70987023208683,RET;RPS6KA3;COL2A1;CCND1;CDKN2A;CTLA4;PRTN3;GATA4;BRCA1;BRCA2;TGFBR2
Follicular neoplasm,5/35,9.979731023361835E-4,0.004690264069482021,0,0,7.395833333333333,51.10361256087398,RET;TERT;CDKN2A;HMGA2;PPARG
HTLV-I Infections,5/35,9.979731023361835E-4,0.004690264069482021,0,0,7.395833333333333,51.10361256087398,IL6;LRP1;CDKN2A;CCL2;TNFRSF4
Inflammatory abnormality of the eye,5/35,9.979731023361835E-4,0.004690264069482021,0,0,7.395833333333333,51.10361256087398,IL6;CTLA4;PRTN3;FGFR3;AGT
Leiomyosarcoma of uterus,5/35,9.979731023361835E-4,0.004690264069482021,0,0,7.395833333333333,51.10361256087398,ERBB2;HMGA2;BRCA1;FGFR3;AURKA
Neoplasm of uncertain or unknown behavior of ovary,5/35,9.979731023361835E-4,0.004690264069482021,0,0,7.395833333333333,51.10361256087398,BARD1;ERBB2;BRCA1;BRCA2;ESR1
Pre-renal acute kidney injury,5/35,9.979731023361835E-4,0.004690264069482021,0,0,7.395833333333333,51.10361256087398,IL6;HGF;SOSTDC1;PPARG;PPARA
Memory impairment,15/267,0.0010014557961657972,0.00470334064828636,0,0,2.672065337763012,18.454086289009872,PRKN;NGFR;GAD1;PLA2G4A;PRKCA;BRCA1;SYP;AKAP5;GFAP;RPS6KA3;IL6;BIN1;MDK;PPARG;PPARGC1A
Cakut,7/71,0.001004523952638478,0.004708826924785163,0,0,4.8671875,33.5993708777705,ACTA2;MUC1;KIT;SIX1;LIFR;GATA3;PAX2
Desmoplastic Medulloblastoma,6/52,0.001004727364981706,0.004708826924785163,0,0,5.796474200257502,40.01328777349885,MYCN;ERBB2;IRS2;S100A4;BRCA2;FLI1
Idiopathic crescentic glomerulonephritis,6/52,0.001004727364981706,0.004708826924785163,0,0,5.796474200257502,40.01328777349885,JUN;BGN;CCL2;PRTN3;FOS;DCN
Big calvaria,13/213,0.0010130130080183962,0.004737740502682137,0,0,2.912210648148148,20.079186313795912,MITF;KIF22;ANTXR2;FLI1;SYN1;BMP2;COL2A1;CCND2;TNFSF11;PITX1;MPDZ;FGFR3;EZH2
Increased size of skull,13/213,0.0010130130080183962,0.004737740502682137,0,0,2.912210648148148,20.079186313795912,MITF;KIF22;ANTXR2;FLI1;SYN1;BMP2;COL2A1;CCND2;TNFSF11;PITX1;MPDZ;FGFR3;EZH2
Speech Delay,13/213,0.0010130130080183962,0.004737740502682137,0,0,2.912210648148148,20.079186313795912,CNTNAP2;MEF2C;LAMA1;HMGA2;RPS6KA3;COL2A1;NDN;DMD;PRKD1;PAK3;BMPR1B;SOX5;EZH2
Joint hyperflexibility,9/114,0.0010178460911439476,0.004757031557496696,0,0,3.823722149410223,26.34570011548479,PLK4;COL1A1;RPS6KA3;CDT1;COL3A1;COL1A2;COL2A1;KIF22;FGFR3
Bronchopulmonary Dysplasia,12/188,0.0010656774146239167,0.004977113711136456,0,0,3.0514906571488556,20.884843339566032,FGF7;IL6;CXCL12;GAD1;KDR;IL18;CXCR4;PRTN3;CTSG;PPARG;TIMP1;PTGS2
"Genetic Diseases, Inborn",23/507,0.0010666896397197028,0.004978379166336013,0,0,2.1475510164114215,14.69611085201515,MEF2C;VWF;TPM3;LAMA1;CAV1;ITSN1;IL2RG;BRCA2;PLD1;PKD2;ADCY5;ACAN;COL1A2;COL2A1;RAD51;CCND2;MYCN;ACTC1;DPYSL2;RARB;SCN4A;FGFR3;CEP55
AORTIC VALVE DISEASE 2,4/21,0.0010714542647899349,0.004979852486040971,0,0,10.424436441243165,71.28999407380229,ACTA2;ACAN;NKX2-5;TGFBR2
External exotoses,4/21,0.0010714542647899349,0.004979852486040971,0,0,10.424436441243165,71.28999407380229,TCF7L2;S100A4;FGF2;DCN
Limited elbow extension,4/21,0.0010714542647899349,0.004979852486040971,0,0,10.424436441243165,71.28999407380229,COL2A1;BGN;FGFR3;EZH2
Pancreatic Intraductal Papillary-Mucinous Neoplasm,4/21,0.0010714542647899349,0.004979852486040971,0,0,10.424436441243165,71.28999407380229,MUC1;CDKN2A;VIM;EZH2
Polymyalgia Rheumatica,4/21,0.0010714542647899349,0.004979852486040971,0,0,10.424436441243165,71.28999407380229,IL6;KRT15;MX1;CXCR4
Shared Paranoid Disorder,4/21,0.0010714542647899349,0.004979852486040971,0,0,10.424436441243165,71.28999407380229,DPYSL2;CALR;ESR1;GRIN2D
Allergic rhinitis (disorder),11/163,0.0010859273982270128,0.005043629603383553,0,0,3.2354020130972594,22.0826570192581,EGR1;CCL13;ADAM12;CXCR2;IL18;CXCR4;GATA3;FLNC;VIM;AGT;TGFBR2
Familial primary gastric lymphoma,7/72,0.001091788749214297,0.005053379214144189,0,0,4.79206181945908,32.681563894559375,ALK;CXCL12;CCND1;CCL21;CDKN2A;CXCR4;MKI67
Frequent fractures,7/72,0.001091788749214297,0.005053379214144189,0,0,4.79206181945908,32.681563894559375,COL1A1;COL2A1;COL1A2;TERT;TNFSF11;LIFR;ANTXR2
Increased fracture rate,7/72,0.001091788749214297,0.005053379214144189,0,0,4.79206181945908,32.681563894559375,COL1A1;COL2A1;COL1A2;TERT;TNFSF11;LIFR;ANTXR2
Rectal Neoplasms,7/72,0.001091788749214297,0.005053379214144189,0,0,4.79206181945908,32.681563894559375,TCF7L2;CXCL12;PPARG;CALR;MKI67;PTGS2;TGFBR2
Varying degree of multiple fractures,7/72,0.001091788749214297,0.005053379214144189,0,0,4.79206181945908,32.681563894559375,COL1A1;COL2A1;COL1A2;TERT;TNFSF11;LIFR;ANTXR2
Joint laxity,8/93,0.0011024457841505074,0.005088486530469397,0,0,4.193296540584197,28.55728927330028,RET;COL1A1;ACAN;COL3A1;COL1A2;KIF22;PAX2;TGFBR2
Low Birth Weights,8/93,0.0011024457841505074,0.005088486530469397,0,0,4.193296540584197,28.55728927330028,RET;COL1A1;COL1A2;NPHS1;FANCD2;FANCA;CNTN1;ASCL1
Pregnancy Complications,8/93,0.0011024457841505074,0.005088486530469397,0,0,4.193296540584197,28.55728927330028,IL6;ELF5;LEPR;IL18;LTA;PPARG;SGK1;AGT
Small for gestational age (disorder),8/93,0.0011024457841505074,0.005088486530469397,0,0,4.193296540584197,28.55728927330028,RET;COL1A1;COL1A2;NPHS1;FANCD2;FANCA;CNTN1;ASCL1
Increased head circumference,13/215,0.0011031620590177848,0.005088486530469397,0,0,2.8830789328932895,19.63254113992864,MITF;KIF22;ANTXR2;FLI1;SYN1;BMP2;COL2A1;CCND2;TNFSF11;PITX1;MPDZ;FGFR3;EZH2
"Turner Syndrome, Male",6/53,0.0011120524923759671,0.005122458531410834,0,0,5.6728541656569575,38.58418921769802,PRKN;STAT5A;RPS6KA3;STAT5B;SIRPA;DTX1
Interstitial Cystitis,6/53,0.0011120524923759671,0.005122458531410834,0,0,5.6728541656569575,38.58418921769802,CXCL10;IL6;CCND1;PLA2G2A;ADRB2;VIM
"Benign neoplasm of brain, unspecified",5/36,0.0011380180575644376,0.00522058010560298,0,0,7.156891495601173,48.51275336655149,ALK;YAP1;CCND1;CDKN2A;TGFBR2
Almond-shaped palpebral fissure,5/36,0.0011380180575644376,0.00522058010560298,0,0,7.156891495601173,48.51275336655149,RAD51;FANCD2;FANCA;NDN;BRCA2
Autoimmune state,5/36,0.0011380180575644376,0.00522058010560298,0,0,7.156891495601173,48.51275336655149,IL6;CAV1;CTLA4;SERPING1;PRTN3
Lichen Sclerosus et Atrophicus,5/36,0.0011380180575644376,0.00522058010560298,0,0,7.156891495601173,48.51275336655149,CXCL10;CCND1;CDKN2A;GZMB;MKI67
Paranoid Schizophrenia,5/36,0.0011380180575644376,0.00522058010560298,0,0,7.156891495601173,48.51275336655149,IL6;TERT;DPYSL2;CCL2;CALR
Somatotropin deficiency,5/36,0.0011380180575644376,0.00522058010560298,0,0,7.156891495601173,48.51275336655149,STAT5B;BMP2;LEPR;FOS;ESR1
Frontal bossing,13/216,0.0011506906163414451,0.005275111385221259,0,0,2.8687283342455756,19.413811993303824,FBN2;BGN;LIFR;MITF;KIF22;RUNX2;FLI1;COL1A1;RPS6KA3;COL1A2;COL2A1;FGFR3;SOX5
"stage, endometrial cancer",3/10,0.0011685354694117092,0.005309799873186089,0,0,18.9541047188106,127.97819182161604,CCND1;ERBB2;S100A4
"Thrombocytosis, Autosomal Dominant",3/10,0.0011685354694117092,0.005309799873186089,0,0,18.9541047188106,127.97819182161604,PDGFA;CALR;FGF2
Adenosquamous cell lung cancer,3/10,0.0011685354694117092,0.005309799873186089,0,0,18.9541047188106,127.97819182161604,ALK;RET;ERBB2
Childhood Soft Tissue Sarcoma,3/10,0.0011685354694117092,0.005309799873186089,0,0,18.9541047188106,127.97819182161604,PAX3;MAPK8IP2;FOXO1
Extra-Adrenal Paraganglioma,3/10,0.0011685354694117092,0.005309799873186089,0,0,18.9541047188106,127.97819182161604,RET;TERT;CDKN2A
Hemoptysis,3/10,0.0011685354694117092,0.005309799873186089,0,0,18.9541047188106,127.97819182161604,COL3A1;CTLA4;PRTN3
Infection by Leishmania braziliensis,3/10,0.0011685354694117092,0.005309799873186089,0,0,18.9541047188106,127.97819182161604,IL6;CCL2;FLI1
Liver Dysplastic Nodule,3/10,0.0011685354694117092,0.005309799873186089,0,0,18.9541047188106,127.97819182161604,STAT5A;STAT5B;CDKN2A
Medullary Neoplasms,3/10,0.0011685354694117092,0.005309799873186089,0,0,18.9541047188106,127.97819182161604,CDKN2A;BRCA1;BRCA2
Splenic Hypoplasia,3/10,0.0011685354694117092,0.005309799873186089,0,0,18.9541047188106,127.97819182161604,CCL2;NKX2-5;SELE
Spondylitis,3/10,0.0011685354694117092,0.005309799873186089,0,0,18.9541047188106,127.97819182161604,ACAN;VCAN;IL6
Vaso-Occlusive Crisis,3/10,0.0011685354694117092,0.005309799873186089,0,0,18.9541047188106,127.97819182161604,TERT;CXCR2;SELE
Ventricular Dysfunction,3/10,0.0011685354694117092,0.005309799873186089,0,0,18.9541047188106,127.97819182161604,ALDH2;ADRB1;DMD
airway disease,8/94,0.0011820673155814863,0.005367656586507953,0,0,4.144324410622106,27.93477895005098,C3;IL6;CXCR4;CCL2;ADRB2;EZR;PTGS2;ATF3
"Fractures, Multiple",7/73,0.001184894384214133,0.005369602351135033,0,0,4.719212674692127,31.79853464214659,COL1A1;COL2A1;COL1A2;TERT;TNFSF11;LIFR;ANTXR2
"Hepatitis, Alcoholic",7/73,0.001184894384214133,0.005369602351135033,0,0,4.719212674692127,31.79853464214659,HGF;CAV1;CXCR2;IRF7;CXCR4;CCL2;BRCA1
Failure to Thrive,7/73,0.001184894384214133,0.005369602351135033,0,0,4.719212674692127,31.79853464214659,STAT5B;NR4A1;IL6;HMGA2;IL2RG;APOB;FGFR3
Platelet Count measurement,12/191,0.001221327411162073,0.005530974304359058,0,0,2.9998838814558684,20.122672007427575,MEF2C;FEN1;TERT;MECOM;TPM3;CDKN2A;ERG;CD36;BAK1;ZFPM2;AP1M2;FLI1
"Leukemia, B-Cell",9/117,0.0012235527143963352,0.005537318079437862,0,0,3.716934250764526,24.92574841494135,NR4A1;IL6;CCND2;CCND1;CD5;BCL3;CCL19;IL2RG;AQP1
Hepatocellular Adenoma,6/54,0.0012279492919923885,0.005553473026950089,0,0,5.554384965831435,37.22776391289201,TERT;CDKN2A;SAA1;SSTR2;A2M;GFAP
Pectus excavatum,10/141,0.0012440412597666066,0.0056224637285279475,0,0,3.408616302535755,22.8015642109188,COL1A1;RET;RPS6KA3;COL3A1;COL1A2;COL2A1;TPM3;DMD;SOX10;FGFR3
Congenital diaphragmatic hernia,8/95,0.0012662066243341774,0.0057187919899316314,0,0,4.096478076751098,27.330594688486368,COL1A1;TCF7L2;FGF7;WT1;RARB;GATA4;TEK;ZFPM2
Spondylarthritis,7/74,0.001284108131039082,0.0057735989784341735,0,0,4.648538131261501,30.948529843063813,IL6;CXCL12;STAT1;TNFSF11;CCL2;ALDOA;RUNX2
"Pancreatic carcinoma, familial",4/22,0.0012867387501940815,0.0057735989784341735,0,0,9.844797178130511,65.52346883637364,CCND1;CDKN2A;BRCA1;BRCA2
Benign neoplasm of aortic body and other paraganglia,4/22,0.0012867387501940815,0.0057735989784341735,0,0,9.844797178130511,65.52346883637364,RET;EPAS1;MITF;MET
Diabetic Polyneuropathies,4/22,0.0012867387501940815,0.0057735989784341735,0,0,9.844797178130511,65.52346883637364,PARP1;HGF;LEPR;SGK1
Impaired left ventricular function,4/22,0.0012867387501940815,0.0057735989784341735,0,0,9.844797178130511,65.52346883637364,ACTA2;APOB;MYLK;TGFBR2
Malignant Adrenal Medulla Neoplasm,4/22,0.0012867387501940815,0.0057735989784341735,0,0,9.844797178130511,65.52346883637364,RET;EPAS1;MITF;MET
Malignant neoplasm of aortic body and other paraganglia,4/22,0.0012867387501940815,0.0057735989784341735,0,0,9.844797178130511,65.52346883637364,RET;EPAS1;MITF;MET
Pneumoconiosis,4/22,0.0012867387501940815,0.0057735989784341735,0,0,9.844797178130511,65.52346883637364,ACAN;IL6;ERBB2;IL18
Renal Artery Stenosis,4/22,0.0012867387501940815,0.0057735989784341735,0,0,9.844797178130511,65.52346883637364,RET;STAT1;APOB;AGT
"Glomerulonephritis, Membranoproliferative",5/37,0.0012920963765018707,0.0057735989784341735,0,0,6.9328835227272725,46.114000441919146,C3;VTN;VWF;CCL2;TGFBR2
"Meningitis, Bacterial",5/37,0.0012920963765018707,0.0057735989784341735,0,0,6.9328835227272725,46.114000441919146,C3;IL18;ADRB2;TIMP1;VIM
ACTH-Secreting Pituitary Adenoma,5/37,0.0012920963765018707,0.0057735989784341735,0,0,6.9328835227272725,46.114000441919146,IL6;CCND1;CDKN2A;TXNIP;PPARG
Aggressive Non-Hodgkin Lymphoma,5/37,0.0012920963765018707,0.0057735989784341735,0,0,6.9328835227272725,46.114000441919146,NR4A1;CDKN2A;GATA3;AURKA;EZH2
Cervical intraepithelial neoplasia grade 1,5/37,0.0012920963765018707,0.0057735989784341735,0,0,6.9328835227272725,46.114000441919146,CCND1;CDKN2A;CCL2;GATA3;VIM
Influenza due to Influenza A virus subtype H1N1,5/37,0.0012920963765018707,0.0057735989784341735,0,0,6.9328835227272725,46.114000441919146,DLG2;ADAM12;GIPC2;DMD;MITF
Juvenile Pilocytic Astrocytoma,5/37,0.0012920963765018707,0.0057735989784341735,0,0,6.9328835227272725,46.114000441919146,HGF;KIT;KDR;ESR1;MET
"Anemia, Hemolytic",9/118,0.0012991315248175644,0.005797320478853663,0,0,3.6826445585388434,24.47507410065811,SPTA1;SIRPA;PAEP;A2M;ALDOA;PPARA;PTGS2;SPTB;KLF1
Erectile dysfunction,9/118,0.0012991315248175644,0.005797320478853663,0,0,3.6826445585388434,24.47507410065811,IL6;CCND2;CCND1;CFL1;KDR;TEK;FGF2;AGT;LMNB1
Clear-cell metastatic renal cell carcinoma,10/142,0.0013123709505313418,0.00585251215389674,0,0,3.3826192964124,22.446790675237306,PRKN;KRT19;CCND1;FLT4;KIT;ERBB2;TNFSF11;CXCR4;SLC2A4;TEK
Hereditary hemochromatosis,11/167,0.0013215463872187998,0.005889519267791281,0,0,3.1517930993737444,20.893087447140694,PRKN;BMP2;IL6;MYCN;TERT;CDKN2A;ERBB2;E2F1;SDC1;CALR;AGT
"PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE",8/96,0.0013550447099811606,0.006022819505118117,0,0,4.049719159558976,26.744024709001984,RET;PRKN;PARP1;UBE2L6;DMD;ENO2;PTGS2;ESR1
Broad forehead,8/96,0.0013550447099811606,0.006022819505118117,0,0,4.049719159558976,26.744024709001984,COL1A1;MEF2C;COL2A1;GATA4;ZFPM2;NKX2-5;FGFR3;EZH2
Cardiac fibrosis,8/96,0.0013550447099811606,0.006022819505118117,0,0,4.049719159558976,26.744024709001984,NR4A1;IL6;GRK5;HGF;CCL2;DCN;ATF3;AGT
Retinal Detachment,8/96,0.0013550447099811606,0.006022819505118117,0,0,4.049719159558976,26.744024709001984,IL6;COL2A1;CXCL12;LTA;CCL2;TEK;FBLN2;GFAP
Poor school performance,37/985,0.0013635143541805524,0.006056456615526845,0,0,1.779957288822702,11.743606099242351,RET;YAP1;CNTNAP2;ASCL1;BRCA2;RPS6KA3;TERT;SIX3;DMD;NEK2;ZNF423;PAK3;MPDZ;BUB1;SOX5;PLK4;GAD1;CAV1;FANCA;PAX3;FOS;SYP;SOX10;FLI1;PAX2;CIT;ACTA2;COL3A1;RAD51;MYCN;WT1;FANCD2;RARB;PPARG;FGFR3;EZH2;ARHGEF6
Fetal Growth Retardation,16/304,0.0013660241214820412,0.0060635941836572295,0,0,2.495078995078995,16.457168934238755,PLK4;CDT1;BLM;CTNND2;HMGA2;GATA4;LIFR;PTGS2;AGT;ACTA2;TERT;MCM4;CCL2;ZFPM2;NKX2-5;FGFR3
Hyperalgesia,9/119,0.0013784290674426856,0.006110580605244275,0,0,3.648978315262719,24.035129721783775,IL6;IL18;CCL2;CTSG;FOS;AKAP5;PTGS2;AGT;GFAP
Muscle Rigidity,9/119,0.0013784290674426856,0.006110580605244275,0,0,3.648978315262719,24.035129721783775,PRKN;BMP2;ACTC1;ERBB2;DMD;CD36;SNCAIP;CRYAB;LMNB1
Leprosy,10/143,0.0013837263909204514,0.006125976559935235,0,0,3.3570132227119522,22.09913457550487,PRKN;IL6;DDX39A;ERBB2;CXCR2;LTA;CTLA4;CCL2;GATA3;TGFBR2
Myositis,10/143,0.0013837263909204514,0.006125976559935235,0,0,3.3570132227119522,22.09913457550487,ZFP36;IL6;CCL21;CXCR4;CCL2;GZMB;S100A4;DMD;CCL19;PTGS2
Mitral Valve Stenosis,7/75,0.001389702799603782,0.006144334431954576,0,0,4.579942250872952,30.129907472962607,C3;CISH;NPHS1;MX1;CCL2;ADRB2;PLD1
Ovarian Cysts,7/75,0.001389702799603782,0.006144334431954576,0,0,4.579942250872952,30.129907472962607,PRKN;IL6;COL1A2;ERBB2;NMT2;PTGS2;ESR1
Eclampsia,12/194,0.0013953595184164518,0.006165285872161111,0,0,2.949978428038474,19.394937546885636,MMP14;IL6;CXCL12;ELF5;ADAM12;PLA2G2A;KDR;LEPR;TAP1;CALR;INHBA;AGT
Anti-Basement Membrane Glomerulonephritis,5/38,0.0014610433241423685,0.006438561000616894,0,0,6.722451790633609,43.888228963593335,MMP14;CXCL12;DUSP1;CCL2;AGT
Gross motor development delay,5/38,0.0014610433241423685,0.006438561000616894,0,0,6.722451790633609,43.888228963593335,COL1A1;CNTNAP2;COL1A2;COL2A1;PAK3
Milroy Disease,5/38,0.0014610433241423685,0.006438561000616894,0,0,6.722451790633609,43.888228963593335,IL6;CCND1;CDKN2A;FLT4;FGFR3
Prostatic Diseases,5/38,0.0014610433241423685,0.006438561000616894,0,0,6.722451790633609,43.888228963593335,FLT4;PROS1;FOS;ERG;FGF2
Hyperandrogenism,6/56,0.0014872401596949232,0.006545416063244498,0,0,5.3316628701594535,34.71356719097143,YAP1;IL6;IRS2;PPARG;FOS;RAD54B
Treatment related acute myeloid leukaemia,6/56,0.0014872401596949232,0.006545416063244498,0,0,5.3316628701594535,34.71356719097143,RAD51;TAL1;BRCA1;BRCA2;RUNX1T1;KLF1
Primary infection NOS,7/76,0.001501956586677702,0.006605854902506513,0,0,4.513334656872477,29.34112825984551,RET;IL6;IL18;IRF7;CXCR4;TIMP1;CDKN3
Brain Diseases,14/250,0.0015031807129428898,0.00660691208646888,0,0,2.659031027566951,17.284158874610892,ALK;CNTNAP2;GFAP;PER2;RCAN1;IL6;MUC1;CXCL12;RAD51;CXCR2;PAEP;NDN;CCL2;SCN4A
Antibody Deficiency Syndrome,4/23,0.0015305131432173378,0.00667896443784772,0,0,9.326172574292874,60.45367018272906,C3;C4A;LEPR;CD36
Benign neoplasm of adrenal gland,4/23,0.0015305131432173378,0.00667896443784772,0,0,9.326172574292874,60.45367018272906,RET;EPAS1;MITF;MET
Camurati-Engelmann Syndrome,4/23,0.0015305131432173378,0.00667896443784772,0,0,9.326172574292874,60.45367018272906,COL1A2;TNFSF11;MITF;TGFBR2
Chronic glomerulonephritis,4/23,0.0015305131432173378,0.00667896443784772,0,0,9.326172574292874,60.45367018272906,IL6;LTA;CCL2;GADD45G
Elevated circulating follicle stimulating hormone level,4/23,0.0015305131432173378,0.00667896443784772,0,0,9.326172574292874,60.45367018272906,WT1;CBX2;GATA4;ZFPM2
Esophageal Achalasia,4/23,0.0015305131432173378,0.00667896443784772,0,0,9.326172574292874,60.45367018272906,LTA;SPRY2;CALR;MKI67
Hypofibrinogenemia,4/23,0.0015305131432173378,0.00667896443784772,0,0,9.326172574292874,60.45367018272906,EGR1;VTN;VWF;SERPINC1
Pyridoxine-responsive sideroblastic anemia,4/23,0.0015305131432173378,0.00667896443784772,0,0,9.326172574292874,60.45367018272906,RAD51;FANCD2;FANCA;BRCA2
Retinal Vein Occlusion,4/23,0.0015305131432173378,0.00667896443784772,0,0,9.326172574292874,60.45367018272906,NRP1;IL6;FGF2;AQP1
Stage IV Bladder Cancer AJCC v6,4/23,0.0015305131432173378,0.00667896443784772,0,0,9.326172574292874,60.45367018272906,CAV1;ERBB2;FOXO1;ATF3
Superficial spreading malignant melanoma of skin,4/23,0.0015305131432173378,0.00667896443784772,0,0,9.326172574292874,60.45367018272906,YAP1;CCND1;CDKN2A;PLD1
Frontotemporal Lobar Degeneration,8/98,0.0015475593548730927,0.006748966641121877,0,0,3.9593185863208746,25.621052267451514,RIMS2;IL6;IL18;CCL2;CDC7;SYP;DCN;GFAP
"Arteriosclerotic cardiovascular disease, NOS",3/11,0.001580308066840836,0.006812162372851768,0,0,16.583993212669682,106.96900288738678,CCL2;CD36;PPARA
Flat capital femoral epiphysis,3/11,0.001580308066840836,0.006812162372851768,0,0,16.583993212669682,106.96900288738678,ACAN;COL2A1;KIF22
Gastrooesophageal cancer,3/11,0.001580308066840836,0.006812162372851768,0,0,16.583993212669682,106.96900288738678,HGF;ERBB2;MET
Lipoatrophic Diabetes Mellitus,3/11,0.001580308066840836,0.006812162372851768,0,0,16.583993212669682,106.96900288738678,CAV1;PPARG;FOS
Malignant neoplasm of body of pancreas,3/11,0.001580308066840836,0.006812162372851768,0,0,16.583993212669682,106.96900288738678,RAD51;MET;EZH2
Malignant neoplasm of body of stomach,3/11,0.001580308066840836,0.006812162372851768,0,0,16.583993212669682,106.96900288738678,ANXA1;CDKN2A;TXNIP
Malignant neoplasm of fallopian tube,3/11,0.001580308066840836,0.006812162372851768,0,0,16.583993212669682,106.96900288738678,BARD1;BRCA1;BRCA2
malignant neoplasm of head of pancreas,3/11,0.001580308066840836,0.006812162372851768,0,0,16.583993212669682,106.96900288738678,RAD51;MET;EZH2
Malignant neoplasm of other specified sites of pancreas,3/11,0.001580308066840836,0.006812162372851768,0,0,16.583993212669682,106.96900288738678,RAD51;MET;EZH2
Malignant neoplasm of tail of pancreas,3/11,0.001580308066840836,0.006812162372851768,0,0,16.583993212669682,106.96900288738678,RAD51;MET;EZH2
Malignant tumor of greater curve of stomach,3/11,0.001580308066840836,0.006812162372851768,0,0,16.583993212669682,106.96900288738678,ANXA1;CDKN2A;TXNIP
Malignant tumor of lesser curve of stomach,3/11,0.001580308066840836,0.006812162372851768,0,0,16.583993212669682,106.96900288738678,ANXA1;CDKN2A;TXNIP
Muscle fiber splitting,3/11,0.001580308066840836,0.006812162372851768,0,0,16.583993212669682,106.96900288738678,FLNC;CRYAB;NEFH
Polyomavirus Infections,3/11,0.001580308066840836,0.006812162372851768,0,0,16.583993212669682,106.96900288738678,CDKN2A;HGF;IL18
Potter's facies,3/11,0.001580308066840836,0.006812162372851768,0,0,16.583993212669682,106.96900288738678,RET;AGT;PAX2
Pulmonary Blastoma,3/11,0.001580308066840836,0.006812162372851768,0,0,16.583993212669682,106.96900288738678,ALK;ERBB2;KIT
Retinoschisis,3/11,0.001580308066840836,0.006812162372851768,0,0,16.583993212669682,106.96900288738678,COL2A1;DMD;ERG
Serum creatinine raised,3/11,0.001580308066840836,0.006812162372851768,0,0,16.583993212669682,106.96900288738678,MUC1;CCND1;PKD2
"Neoplastic Syndromes, Hereditary",7/77,0.0016211529197521597,0.006979271159650964,0,0,4.448630136986301,28.580747936638133,RET;BARD1;BLM;CDKN2A;BRCA1;BRCA2;MET
"Niemann-Pick Disease, Type C",7/77,0.0016211529197521597,0.006979271159650964,0,0,4.448630136986301,28.580747936638133,EGR1;ANXA1;TERT;CDKN2A;KDR;PTGS2;FGF2
Atrophic,6/57,0.0016315456516867736,0.007019513514880443,0,0,5.2268524721961676,33.54712807113475,TRIM63;COL2A1;VIM;PTGS2;TEAD1;FOXO1
Lymphatic Diseases,5/39,0.0016457044834854747,0.007062333106126804,0,0,6.524398395721925,41.81869737194685,TERT;CDKN2A;FLT4;MITF;AQP1
Primary malignant neoplasm of brain,5/39,0.0016457044834854747,0.007062333106126804,0,0,6.524398395721925,41.81869737194685,ALK;YAP1;CCND1;CDKN2A;TGFBR2
Recurrent Brain Neoplasm,5/39,0.0016457044834854747,0.007062333106126804,0,0,6.524398395721925,41.81869737194685,ALK;YAP1;CCND1;CDKN2A;TGFBR2
Short toe,5/39,0.0016457044834854747,0.007062333106126804,0,0,6.524398395721925,41.81869737194685,COL2A1;MYCN;BMPR1B;FGFR3;FLI1
Muscle Weakness,17/339,0.001647831687592978,0.007066946113585212,0,0,2.3724458698554596,15.203332967666888,FBN2;TPM3;CAV1;SYNE1;COL1A1;RIMS2;COL1A2;BIN1;STMN1;CAPN3;CCL2;DMD;SCN4A;FLNC;NKX2-5;UTRN;MET
Hydrocephalus,14/253,0.0016807217889093177,0.00720339983044989,0,0,2.625246337698648,16.77147008290019,GPSM2;PAX2;AQP1;GFAP;RPS6KA3;CENPF;CCND2;RAD51;E2F1;TNFSF11;PPARA;E2F5;MPDZ;FGFR3
Micrognathism,19/400,0.0016872744735069165,0.007226872043413553,0,0,2.244562739516715,14.330726821261255,PLK4;CCT3;CDT1;GATA4;MITF;LIFR;RUNX2;TGFBR2;COL1A1;RPS6KA3;COL3A1;COL1A2;COL2A1;MYCN;WT1;RARB;TNNI2;BUB1;EZH2
Depressive Symptoms,10/147,0.0017014060027554683,0.007282755076166811,0,0,3.2583270408591325,20.77607171843586,PER2;IL6;TAL1;KDR;PAEP;ADRB2;BRCA1;TIMP1;BRCA2;ESR1
Graft-vs-Host Disease,13/226,0.0017272877113067076,0.007388830744672515,0,0,2.7326334550512956,17.38283585258233,STAT1;CAV1;IL18;IL2RG;AURKA;FGF7;IL6;NR5A2;FANCD2;KRT15;PECAM1;CTLA4;CCL2
Absence Seizures,9/123,0.0017354852465037804,0.007419171811279052,0,0,3.5202197006277163,22.376164667499502,NGFR;IL6;FOS;SSTR2;PTGS2;FGF2;MPDZ;FGFR3;AGT
Acute monocytic leukemia,7/78,0.0017475802940822179,0.007456638662678637,0,0,4.38574827963213,27.847410174315623,MMP14;MECOM;IL18;PLA2G4A;CCL2;IL2RG;RUNX1T1
Giant Cell Glioblastoma,7/78,0.0017475802940822179,0.007456638662678637,0,0,4.38574827963213,27.847410174315623,PRKN;WT1;CTNND2;PPARG;MET;BUB1;FGFR3
Pulmonary Embolism,7/78,0.0017475802940822179,0.007456638662678637,0,0,4.38574827963213,27.847410174315623,IL6;PROC;SERPINC1;PROS1;HGF;F13A1;CCL2
Childhood Neuroblastoma,8/100,0.0017611309868971604,0.007509686163810369,0,0,3.8728484727887773,24.560826843460916,ALK;MYCN;TERT;PARP1;ITSN1;CHEK1;FAM107A;UTRN
Celiac Disease,16/312,0.0017813964779709152,0.007591280930236464,0,0,2.4266364266364264,15.36147654982986,CDKN2A;STAT1;IL18;PLA2G4A;GATA3;SELE;IL6;ERBB2;PAEP;SDC1;CTLA4;CCL2;DMD;TIMP1;BAK1;APOB
"Angioedemas, Hereditary",4/24,0.0018046653029958415,0.007653565432490935,0,0,8.859410430839002,55.96826343785105,C4B;F12;SERPING1;A2M
"Asthma, Occupational",4/24,0.0018046653029958415,0.007653565432490935,0,0,8.859410430839002,55.96826343785105,PLA2G4A;PRKCA;PRKD1;PTGS2
Basophilic leukemia,4/24,0.0018046653029958415,0.007653565432490935,0,0,8.859410430839002,55.96826343785105,IL6;CR1;FOS;CD36
Decreased fertility in females,4/24,0.0018046653029958415,0.007653565432490935,0,0,8.859410430839002,55.96826343785105,BLM;WT1;GATA4;ZFPM2
Intestinal Pseudo-Obstruction,4/24,0.0018046653029958415,0.007653565432490935,0,0,8.859410430839002,55.96826343785105,CDKN2A;HGF;BRCA1;BRCA2
Ostium secundum atrial septal defect,4/24,0.0018046653029958415,0.007653565432490935,0,0,8.859410430839002,55.96826343785105,ACTC1;VWF;GATA4;NKX2-5
Uterine Neoplasms,4/24,0.0018046653029958415,0.007653565432490935,0,0,8.859410430839002,55.96826343785105,HMGA1;INHBA;ESR1;AURKA
Speech impairment,12/200,0.0018051291907483088,0.007653565432490935,0,0,2.8549457029138616,18.035043494621586,RPS6KA3;MEF2C;COL2A1;LAMA1;NDN;HMGA2;DMD;PRKD1;PAK3;BMPR1B;SOX5;EZH2
"Hernia, Inguinal",9/124,0.0018354071032601268,0.007777030981384866,0,0,3.4894295971280416,21.985112679377902,COL1A1;RPS6KA3;COL3A1;COL1A2;COL2A1;ADRB2;PLD1;EZH2;TGFBR2
Neuropathy,15/284,0.0018429151151830039,0.007786572616864993,0,0,2.500994207659722,15.747276584012836,NGFR;EGR2;TPM3;GAD1;HGF;SLC2A4;SOX10;IL6;ALDH2;STMN1;SERPING1;CTLA4;CCL2;PPARGC1A;PAK5
"Degenerative Diseases, Spinal Cord",5/40,0.001846934213619109,0.007786572616864993,0,0,6.337662337662338,39.890692984749215,NGFR;IL6;VIM;PKD2;CRYAB
"Neoplasm Recurrence, Local",5/40,0.001846934213619109,0.007786572616864993,0,0,6.337662337662338,39.890692984749215,ALK;ERBB2;KIT;PTGS2;ESR1
"stage, ovarian epithelial cancer",5/40,0.001846934213619109,0.007786572616864993,0,0,6.337662337662338,39.890692984749215,IL6;S100A4;BRCA1;BRCA2;MKI67
Hypoplasia of thumb,5/40,0.001846934213619109,0.007786572616864993,0,0,6.337662337662338,39.890692984749215,ACAN;COL2A1;FANCD2;FANCA;BMPR1B
Islet Cell Tumor,5/40,0.001846934213619109,0.007786572616864993,0,0,6.337662337662338,39.890692984749215,KRT19;CDKN2A;STMN1;KIT;ASCL1
Malignant neoplasm of stomach stage IV,5/40,0.001846934213619109,0.007786572616864993,0,0,6.337662337662338,39.890692984749215,CXCL12;ERBB2;CXCR4;CALR;MET
Prostate cancer recurrent,5/40,0.001846934213619109,0.007786572616864993,0,0,6.337662337662338,39.890692984749215,IL6;PROS1;ERBB2;E2F1;PTGS2
"Seizures, Auditory",8/101,0.0018763032582684066,0.0078365999269469,0,0,3.8310080952732464,24.052799633017287,NGFR;IL6;FOS;SSTR2;PTGS2;FGF2;MPDZ;AGT
"Seizures, Clonic",8/101,0.0018763032582684066,0.0078365999269469,0,0,3.8310080952732464,24.052799633017287,NGFR;IL6;FOS;SSTR2;PTGS2;FGF2;MPDZ;AGT
"Seizures, Sensory",8/101,0.0018763032582684066,0.0078365999269469,0,0,3.8310080952732464,24.052799633017287,NGFR;IL6;FOS;SSTR2;PTGS2;FGF2;MPDZ;AGT
"Seizures, Somatosensory",8/101,0.0018763032582684066,0.0078365999269469,0,0,3.8310080952732464,24.052799633017287,NGFR;IL6;FOS;SSTR2;PTGS2;FGF2;MPDZ;AGT
Atonic Absence Seizures,8/101,0.0018763032582684066,0.0078365999269469,0,0,3.8310080952732464,24.052799633017287,NGFR;IL6;FOS;SSTR2;PTGS2;FGF2;MPDZ;AGT
Generalized Absence Seizures,8/101,0.0018763032582684066,0.0078365999269469,0,0,3.8310080952732464,24.052799633017287,NGFR;IL6;FOS;SSTR2;PTGS2;FGF2;MPDZ;AGT
Gustatory seizure,8/101,0.0018763032582684066,0.0078365999269469,0,0,3.8310080952732464,24.052799633017287,NGFR;IL6;FOS;SSTR2;PTGS2;FGF2;MPDZ;AGT
Jacksonian Seizure,8/101,0.0018763032582684066,0.0078365999269469,0,0,3.8310080952732464,24.052799633017287,NGFR;IL6;FOS;SSTR2;PTGS2;FGF2;MPDZ;AGT
Neuromuscular Diseases,8/101,0.0018763032582684066,0.0078365999269469,0,0,3.8310080952732464,24.052799633017287,RIMS2;MEF2C;STMN1;BGN;SCN4A;DMD;TIMP1;FLNC
Non-epileptic convulsion,8/101,0.0018763032582684066,0.0078365999269469,0,0,3.8310080952732464,24.052799633017287,NGFR;IL6;FOS;SSTR2;PTGS2;FGF2;MPDZ;AGT
Nonepileptic Seizures,8/101,0.0018763032582684066,0.0078365999269469,0,0,3.8310080952732464,24.052799633017287,NGFR;IL6;FOS;SSTR2;PTGS2;FGF2;MPDZ;AGT
Olfactory seizure,8/101,0.0018763032582684066,0.0078365999269469,0,0,3.8310080952732464,24.052799633017287,NGFR;IL6;FOS;SSTR2;PTGS2;FGF2;MPDZ;AGT
Otitis Media,8/101,0.0018763032582684066,0.0078365999269469,0,0,3.8310080952732464,24.052799633017287,IL6;MUC1;MECOM;DUSP1;TNFSF11;CCL2;IL2RG;FGFR3
Single Seizure,8/101,0.0018763032582684066,0.0078365999269469,0,0,3.8310080952732464,24.052799633017287,NGFR;IL6;FOS;SSTR2;PTGS2;FGF2;MPDZ;AGT
Vertiginous seizure,8/101,0.0018763032582684066,0.0078365999269469,0,0,3.8310080952732464,24.052799633017287,NGFR;IL6;FOS;SSTR2;PTGS2;FGF2;MPDZ;AGT
Gliosis,7/79,0.0018815321012182892,0.007853554749398403,0,0,4.324613140537798,27.139840132538318,CXCL10;HGF;CCL2;FGF2;PAX2;LMNB1;GFAP
Tetralogy of Fallot,9/125,0.0019398771024211538,0.008090939461215271,0,0,3.4591703574818093,21.602970847921394,RET;NRP1;ALDH2;FLT4;GATA4;DMD;ZFPM2;NKX2-5;PPARGC1A
No development of motor milestones,13/229,0.0019408135008960397,0.008090939461215271,0,0,2.6942622599451305,16.82471960397263,FBN2;MEF2C;EGR2;TPM3;LAMA1;RPS6KA3;COL2A1;BIN1;NDN;DMD;SCN4A;FGFR3;SOX5
Waddling gait,6/59,0.0019518113764637954,0.008131740201197798,0,0,5.029097004340912,31.376523268055074,ACAN;COL2A1;BIN1;DMD;FLNC;NEFH
Adult Acute Myeloblastic Leukemia,8/102,0.0019973345893557893,0.008311089902176877,0,0,3.790057938555918,23.558779157585644,TERT;MECOM;CDKN2A;WT1;FANCA;ERG;ESR1;AURKA
Heart Decompensation,8/102,0.0019973345893557893,0.008311089902176877,0,0,3.790057938555918,23.558779157585644,IL6;VWF;PRKAR2B;ADRB1;PPARG;PTGS2;PPARGC1A;AGT
Behcet Syndrome,14/258,0.002015271059702494,0.008380532778304615,0,0,2.570784679167776,15.956864544061846,VWF;IL18;TAP1;GATA3;MKI67;FOXO1;C4A;CXCL10;IL6;CXCR2;LTA;CTLA4;CCL2;APOB
Bloom Syndrome,7/80,0.002023306451069374,0.008403541203080962,0,0,4.265152936761118,26.45683856123941,RIMS2;BLM;RAD51;FANCD2;PMAIP1;BRCA1;BRCA2
Extrahepatic Cholangiocarcinoma,7/80,0.002023306451069374,0.008403541203080962,0,0,4.265152936761118,26.45683856123941,IL6;STMN1;ERBB2;CIB1;PTGS2;DEPP1;EZH2
Myocarditis,9/126,0.0020490419085678444,0.008481795698959807,0,0,3.4294283697953425,21.229474931788197,CCNA2;CXCL10;IL6;TNFSF11;CTLA4;CCL2;GZMB;ADRB2;PTGS2
"Nephrotic Syndrome, Minimal Change",5/41,0.0020655941192969183,0.008481795698959807,0,0,6.161300505050505,38.09123845164948,IL6;NPHS1;IL18;TIMP1;EZR
Endometrioid carcinoma ovary,5/41,0.0020655941192969183,0.008481795698959807,0,0,6.161300505050505,38.09123845164948,HOXA10;CCND1;TERT;ERBB2;BRCA2
Hypoplastic Left Heart Syndrome,5/41,0.0020655941192969183,0.008481795698959807,0,0,6.161300505050505,38.09123845164948,WT1;ADRB1;PROX1;NKX2-5;ADCY5
Microcalcification,5/41,0.0020655941192969183,0.008481795698959807,0,0,6.161300505050505,38.09123845164948,COL1A1;IL18;CCL2;DMD;TIMP1
"46,XY partial gonadal dysgenesis",3/12,0.002072457823405754,0.008481795698959807,0,0,14.740573152337857,91.08229664036905,WT1;GATA4;ZFPM2
"Melanoma, Experimental",3/12,0.002072457823405754,0.008481795698959807,0,0,14.740573152337857,91.08229664036905,IL18;KDR;CALR
Abdominal obesity metabolic syndrome,3/12,0.002072457823405754,0.008481795698959807,0,0,14.740573152337857,91.08229664036905,PPARG;PPARA;PPARGC1A
Abnormality of temperature regulation,3/12,0.002072457823405754,0.008481795698959807,0,0,14.740573152337857,91.08229664036905,RET;TNFSF11;ASCL1
Abnormality of the labia,3/12,0.002072457823405754,0.008481795698959807,0,0,14.740573152337857,91.08229664036905,WT1;GATA4;ZFPM2
Abnormality of the scrotum,3/12,0.002072457823405754,0.008481795698959807,0,0,14.740573152337857,91.08229664036905,WT1;GATA4;ZFPM2
Adenocarcinoma of the gastroesophageal junction,3/12,0.002072457823405754,0.008481795698959807,0,0,14.740573152337857,91.08229664036905,HGF;ERBB2;PTGS2
Alacrima,3/12,0.002072457823405754,0.008481795698959807,0,0,14.740573152337857,91.08229664036905,DST;FGFR3;SOX10
Breast cancer stage II,3/12,0.002072457823405754,0.008481795698959807,0,0,14.740573152337857,91.08229664036905,ERBB2;BRCA1;ESR1
Chondroblastoma,3/12,0.002072457823405754,0.008481795698959807,0,0,14.740573152337857,91.08229664036905,ACAN;BMP2;PTGS2
Coprophilia (disorder),3/12,0.002072457823405754,0.008481795698959807,0,0,14.740573152337857,91.08229664036905,IL6;PLA2G2A;PTGS2
Gigantism,3/12,0.002072457823405754,0.008481795698959807,0,0,14.740573152337857,91.08229664036905,STMN1;HMGA2;DMD
Hereditary Connective Tissue Disorder,3/12,0.002072457823405754,0.008481795698959807,0,0,14.740573152337857,91.08229664036905,COL1A1;FBN2;COL1A2
Inverted Squamous Cell Papilloma,3/12,0.002072457823405754,0.008481795698959807,0,0,14.740573152337857,91.08229664036905,CDKN2A;STMN1;FGFR3
Menstrual spotting,3/12,0.002072457823405754,0.008481795698959807,0,0,14.740573152337857,91.08229664036905,STAT5A;NRP1;KIT
Non-small cell lung cancer recurrent,3/12,0.002072457823405754,0.008481795698959807,0,0,14.740573152337857,91.08229664036905,KRT19;ERBB2;ENO2
Papillary Thyroid Microcarcinoma,3/12,0.002072457823405754,0.008481795698959807,0,0,14.740573152337857,91.08229664036905,RET;CCND1;S100A4
recurrent muscle twitches (symptom),3/12,0.002072457823405754,0.008481795698959807,0,0,14.740573152337857,91.08229664036905,SIX1;VIM;ECT2
Waardenburg Syndrome,3/12,0.002072457823405754,0.008481795698959807,0,0,14.740573152337857,91.08229664036905,PAX3;MITF;SOX10
CNS metastases,4/25,0.0021110653632153615,0.008608327249152623,0,0,8.437101824856926,51.977293511173166,ALK;MYCN;TERT;ERBB2
Diabetes Insipidus,4/25,0.0021110653632153615,0.008608327249152623,0,0,8.437101824856926,51.977293511173166,ARNT2;ERBB2;SIX3;LEPR
Excessive wrinkled skin,4/25,0.0021110653632153615,0.008608327249152623,0,0,8.437101824856926,51.977293511173166,COL3A1;COL1A2;TERT;FGFR3
Malignant lymphoma - lymphoplasmacytic,4/25,0.0021110653632153615,0.008608327249152623,0,0,8.437101824856926,51.977293511173166,BLM;CCND2;CCND1;CXCR4
Non-infiltrating lobular carcinoma,4/25,0.0021110653632153615,0.008608327249152623,0,0,8.437101824856926,51.977293511173166,CISH;ERBB2;BRCA1;ESR1
Perianal Squamous Intraepithelial Neoplasia,4/25,0.0021110653632153615,0.008608327249152623,0,0,8.437101824856926,51.977293511173166,COL17A1;S100A4;FGFR3;TGFBR2
Epileptic Seizures,8/103,0.002124430108547164,0.008652318137660856,0,0,3.7499698904010597,23.078258560899656,NGFR;IL6;FOS;SSTR2;PTGS2;FGF2;MPDZ;AGT
Specific learning disability,8/103,0.002124430108547164,0.008652318137660856,0,0,3.7499698904010597,23.078258560899656,RPS6KA3;BLM;MYCN;TERT;NDN;HMGA2;DMD;SYN1
Factor V Leiden mutation,6/60,0.002128725891306415,0.008659311378566858,0,0,4.935712477853708,30.36564652813222,VTN;ZFP36;PROC;VWF;SERPINC1;PLA2G2A
Ventricular arrhythmia,6/60,0.002128725891306415,0.008659311378566858,0,0,4.935712477853708,30.36564652813222,ADRB1;ADRB2;SGK1;MET;AGT;TGFBR2
Peptic Ulcer,7/81,0.002173205989005846,0.008834897955304637,0,0,4.207299765518943,25.797276397580806,CDKN2C;CCND1;CMA1;GZMB;PPARG;PTGS2;AGT
Motor delay,13/232,0.002175662751155389,0.008839534807477066,0,0,2.656942330458312,16.288177576367605,FBN2;MEF2C;EGR2;TPM3;LAMA1;RPS6KA3;COL2A1;BIN1;NDN;DMD;SCN4A;FGFR3;SOX5
Osteochondrodysplasias,10/152,0.0021789574677821845,0.008847568533026089,0,0,3.142787761049053,19.261859384061566,ACAN;BMP2;COL2A1;STAT1;KDR;LIFR;KIF22;BMPR1B;FGFR3;RUNX2
Congenital deafness,15/289,0.0021809627357548766,0.008850359959715861,0,0,2.454719062977423,15.042491115954746,CDKN2A;FANCA;PAX3;SIX1;MITF;SOX10;RUNX2;COL1A1;COL1A2;COL2A1;MYCN;FANCD2;RCC1;TNFSF11;FGFR3
Dyschezia,11/178,0.0021933668394176977,0.008889952742021277,0,0,2.942520488975965,18.01504481941467,RET;SIX3;KIT;BRCA1;NKX2-5;ASCL1;SNCAIP;SOX10;FLI1;LMNB1;TGFBR2
Neutropenia,11/178,0.0021933668394176977,0.008889952742021277,0,0,2.942520488975965,18.01504481941467,SOCS3;STAT5B;GRK3;IL6;PARP1;CTLA4;CXCR4;BRCA2;ESR1;SELE;MET
Tonic Seizures,8/104,0.0022577980971071826,0.009145580229295439,0,0,3.7107170099160944,22.610754021233255,NGFR;IL6;FOS;SSTR2;PTGS2;FGF2;MPDZ;AGT
Sarcomatoid Renal Cell Carcinoma,9/128,0.0022820541547867767,0.009238261424682334,0,0,3.3714439904402127,20.50741256009922,ALK;IL6;EPAS1;ERBB2;MITF;VIM;PTGS2;CRYAB;MET
"Degenerative Diseases, Central Nervous System",5/42,0.00230255153663298,0.009287649321337594,0,0,5.994471744471745,36.40884727069847,NGFR;IL6;VIM;PKD2;CRYAB
Arrhythmogenic Right Ventricular Dysplasia,5/42,0.00230255153663298,0.009287649321337594,0,0,5.994471744471745,36.40884727069847,MEF2C;PPARG;PPARA;MET;GFAP
Cervical intraepithelial neoplasia grade 2,5/42,0.00230255153663298,0.009287649321337594,0,0,5.994471744471745,36.40884727069847,CCND1;CDKN2A;CCL2;GATA3;VIM
EMG: myopathic abnormalities,5/42,0.00230255153663298,0.009287649321337594,0,0,5.994471744471745,36.40884727069847,TPM3;BIN1;CAPN3;DMD;CRYAB
Gonadal Dysgenesis,5/42,0.00230255153663298,0.009287649321337594,0,0,5.994471744471745,36.40884727069847,WT1;KIT;GATA4;ZFPM2;FGFR3
Hyperextensible skin,5/42,0.00230255153663298,0.009287649321337594,0,0,5.994471744471745,36.40884727069847,COL1A1;COL3A1;COL1A2;FGFR3;PAX2
Disorders of Sex Development,6/61,0.002317474577741747,0.00933103073388104,0,0,4.845723752329675,29.40034938671332,WT1;CBX2;GATA4;ZFPM2;SOX10;GADD45G
Noonan Syndrome,6/61,0.002317474577741747,0.00933103073388104,0,0,4.845723752329675,29.40034938671332,PRKN;STAT5A;RPS6KA3;STAT5B;SIRPA;DTX1
Sinusitis,6/61,0.002317474577741747,0.00933103073388104,0,0,4.845723752329675,29.40034938671332,BLM;CTLA4;PRTN3;IL2RG;MET;RUNX2
M5b Acute differentiated monocytic leukemia,8/105,0.002397649904382262,0.009648062766825208,0,0,3.6722734671730874,22.15580348900404,EGR1;IL6;MMP14;WT1;IL18;PLA2G4A;CCL2;PPARG
Pervasive Development Disorder,9/129,0.0024062063580841315,0.009670904788086791,0,0,3.343176605504587,20.158365006546024,PRKN;CNTNAP2;WT1;CTNND2;OTX1;MPDZ;MET;SYN1;GFAP
Rett Syndrome,9/129,0.0024062063580841315,0.009670904788086791,0,0,3.343176605504587,20.158365006546024,RIMS2;BLM;EGR2;NDN;ENO2;MET;RUNX2;SYN1;GFAP
Coronary Thrombosis,4/26,0.0024515604783613134,0.009812085919353147,0,0,8.053184910327767,48.40794033745568,VCAN;VWF;PLA2G2A;ESR1
Epidermolysis Bullosa Simplex,4/26,0.0024515604783613134,0.009812085919353147,0,0,8.053184910327767,48.40794033745568,COL17A1;KRT5;VIM;GFAP
Familial Atypical Mole Melanoma Syndrome,4/26,0.0024515604783613134,0.009812085919353147,0,0,8.053184910327767,48.40794033745568,TERT;CDKN2A;MITF;BRCA2
Klatskin Tumor,4/26,0.0024515604783613134,0.009812085919353147,0,0,8.053184910327767,48.40794033745568,DUSP1;HGF;KDR;AQP1
Metastatic osteosarcoma,4/26,0.0024515604783613134,0.009812085919353147,0,0,8.053184910327767,48.40794033745568,VWF;ERBB2;EZR;MET
Pituitary carcinoma,4/26,0.0024515604783613134,0.009812085919353147,0,0,8.053184910327767,48.40794033745568,TLE4;ERBB2;CIB1;ASCL1
Tibial bowing,4/26,0.0024515604783613134,0.009812085919353147,0,0,8.053184910327767,48.40794033745568,COL1A1;COL1A2;LIFR;FGFR3
Cryptorchidism,19/414,0.002481611539459024,0.009926446157836097,0,0,2.163427824329946,12.978072763671804,CDT1;ARNT2;BLM;FANCA;GATA4;SOX10;ADRA1A;ESR1;FLI1;HOXA10;ACTA2;COL3A1;WT1;FANCD2;KIT;NKX2-5;ZFPM2;FGFR3;EZH2
"Lymphoma, Large-Cell, Follicular",7/83,0.0024986127350999387,0.00997662492802092,0,0,4.096160778658976,24.544275699498368,CXCL12;CCND1;FLT4;KIT;CXCR4;CIB1;EZH2
Paraganglioma,7/83,0.0024986127350999387,0.00997662492802092,0,0,4.096160778658976,24.544275699498368,RET;EPAS1;CDKN2A;KIT;ERBB2;SYP;SSTR2
Protein Deficiency,7/83,0.0024986127350999387,0.00997662492802092,0,0,4.096160778658976,24.544275699498368,C4B;C4A;CDKN2A;STAT1;STMN1;CAPN3;KLF1
Platelet hematocrit measurement,10/155,0.0025137078388231256,0.01003093395456691,0,0,3.0772889417360285,18.420640493884935,MEF2C;TERT;MECOM;CDKN2A;ERG;BAK1;POLR2H;ZFPM2;AP1M2;FLI1
Xerostomia,6/62,0.0025185491533317073,0.010044285103192248,0,0,4.758948909860072,28.477894234686534,CA12;CAV1;PTGS2;NEFH;PPARGC1A;FGFR3
"Heart Failure, Right-Sided",8/106,0.0025441998594561786,0.010134547008367554,0,0,3.634614486526876,21.712965505379614,IL6;VWF;PRKAR2B;ADRB1;PPARG;PTGS2;PPARGC1A;AGT
Teratocarcinoma,8/106,0.0025441998594561786,0.010134547008367554,0,0,3.634614486526876,21.712965505379614,FGF7;PPP4C;PARP1;FLT4;LMO2;PLA2G2A;PTGS2;TDGF1
Autoimmune hemolytic anemia,5/43,0.002558678038633142,0.010180143191623331,0,0,5.836423444976076,34.83331911640588,IL6;CR1;STAT1;CTLA4;SIRPA
Insulin resistance syndrome,5/43,0.002558678038633142,0.010180143191623331,0,0,5.836423444976076,34.83331911640588,VWF;PPARG;CD36;APOB;PPARA
"Breast Neoplasms, Male",3/13,0.002649978581949671,0.010432154839609608,0,0,13.265837104072398,78.70891407203946,BRCA1;BRCA2;ESR1
"LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS",3/13,0.002649978581949671,0.010432154839609608,0,0,13.265837104072398,78.70891407203946,ALK;KRT19;TGFBR2
"Neoplasms, Vascular Tissue",3/13,0.002649978581949671,0.010432154839609608,0,0,13.265837104072398,78.70891407203946,KRT19;KDR;PECAM1
"Polycystic kidney disease, type 2",3/13,0.002649978581949671,0.010432154839609608,0,0,13.265837104072398,78.70891407203946,PPARG;PRKD1;PKD2
Bethlem myopathy,3/13,0.002649978581949671,0.010432154839609608,0,0,13.265837104072398,78.70891407203946,VWF;CAPN3;DMD
Brain and/or spinal cord issue,3/13,0.002649978581949671,0.010432154839609608,0,0,13.265837104072398,78.70891407203946,COL1A1;COL1A2;PROC
Diverticulosis,3/13,0.002649978581949671,0.010432154839609608,0,0,13.265837104072398,78.70891407203946,COL3A1;NPHS1;PTGS2
Epithelioid hemangioendothelioma,3/13,0.002649978581949671,0.010432154839609608,0,0,13.265837104072398,78.70891407203946,YAP1;FLT4;KIT
Hydrosalpinx (disease),3/13,0.002649978581949671,0.010432154839609608,0,0,13.265837104072398,78.70891407203946,HOXA10;KDR;TAP1
IMMUNODEFICIENCY 13,3/13,0.002649978581949671,0.010432154839609608,0,0,13.265837104072398,78.70891407203946,STAT5A;STAT5B;FANCD2
Lentivirus Infections,3/13,0.002649978581949671,0.010432154839609608,0,0,13.265837104072398,78.70891407203946,SIAH2;APOB;EZH2
Lower Urinary Tract Symptoms,3/13,0.002649978581949671,0.010432154839609608,0,0,13.265837104072398,78.70891407203946,PPP1R14A;GATA3;ADRA1A
Malignant Mixed Mesodermal (Mullerian) Tumor,3/13,0.002649978581949671,0.010432154839609608,0,0,13.265837104072398,78.70891407203946,MYCN;ERBB2;S100A4
Osteitis Fibrosa Disseminata,3/13,0.002649978581949671,0.010432154839609608,0,0,13.265837104072398,78.70891407203946,IL6;FOS;RUNX2
Renal Cell Dysplasia,3/13,0.002649978581949671,0.010432154839609608,0,0,13.265837104072398,78.70891407203946,GATA3;ESR1;PAX2
Secondary Open Angle Glaucoma,3/13,0.002649978581949671,0.010432154839609608,0,0,13.265837104072398,78.70891407203946,CAV2;CAV1;PTGS2
Status Dysraphicus,3/13,0.002649978581949671,0.010432154839609608,0,0,13.265837104072398,78.70891407203946,CFL1;PAX3;CCL2
Testicular regression syndrome,3/13,0.002649978581949671,0.010432154839609608,0,0,13.265837104072398,78.70891407203946,WT1;GATA4;ZFPM2
Disorder of eye,9/131,0.002670581364284787,0.010500951078768517,0,0,3.288032034892465,19.48309931212428,NRP1;PROC;KDR;IL18;CTLA4;DMD;ADRB2;ENO2;PPARGC1A
Pseudohyperkalemia Cardiff,9/131,0.002670581364284787,0.010500951078768517,0,0,3.288032034892465,19.48309931212428,SOCS3;CXCL10;IL6;MUC1;STAT1;KDR;PECAM1;PAEP;CTLA4
Chronic sinusitis,7/84,0.002674746165793104,0.010511173346674363,0,0,4.042756330427563,23.94888743750242,SOCS3;MUC1;IL6;TAP1;PTGS2;MET;SELE
"Lichen Planus, Oral",6/63,0.002732446261214083,0.010700355154701913,0,0,4.675218798705191,27.595750143714056,NGFR;CXCL10;IL6;IL18;PTGS2;SELE
Abdomen distended,6/63,0.002732446261214083,0.010700355154701913,0,0,4.675218798705191,27.595750143714056,COL2A1;NPHS1;WT1;BRCA1;NKX2-5;MYLK
Iron deficiency,6/63,0.002732446261214083,0.010700355154701913,0,0,4.675218798705191,27.595750143714056,STAT5A;STAT5B;CENPF;EPAS1;PPARG;PPARGC1A
Narrow face,6/63,0.002732446261214083,0.010700355154701913,0,0,4.675218798705191,27.595750143714056,PLK4;BLM;TPM3;SIX1;PAX3;TNNI2
Rheumatic Fever,6/63,0.002732446261214083,0.010700355154701913,0,0,4.675218798705191,27.595750143714056,MUC1;PARP1;CDKN2A;RARB;IL2RG;RUNX1T1
Thin face,6/63,0.002732446261214083,0.010700355154701913,0,0,4.675218798705191,27.595750143714056,PLK4;BLM;TPM3;SIX1;PAX3;TNNI2
Cocaine Dependence,10/157,0.0027589098178893694,0.01079769133854604,0,0,3.03510829619204,17.885649381644146,OPRD1;PER2;GRIA2;EGR1;GRK3;RAB3A;GAD1;FOS;FGF2;ADRA1A
Feeding difficulties,13/239,0.00281553178822144,0.010960759313353163,0,0,2.5737155850540807,15.11441275595475,RET;CA12;CDT1;DST;TPM3;LIFR;ANTXR2;ASCL1;GRIN2D;FLAD1;SCN4A;PRKD1;NKX2-5
Anterior uveitis,4/27,0.0028279699959403307,0.010960759313353163,0,0,7.702652075322883,45.200673181127826,C3;LTA;CCL2;SERPING1
Congenital vascular anomaly,4/27,0.0028279699959403307,0.010960759313353163,0,0,7.702652075322883,45.200673181127826,FLT4;PECAM1;TEK;SYNE1
Coronary Microvascular Disease,4/27,0.0028279699959403307,0.010960759313353163,0,0,7.702652075322883,45.200673181127826,BGN;CAPN3;TNFSF11;PPARG
Episodic abdominal pain,4/27,0.0028279699959403307,0.010960759313353163,0,0,7.702652075322883,45.200673181127826,RET;CDKN2C;F12;ESR1
Fluid overload,4/27,0.0028279699959403307,0.010960759313353163,0,0,7.702652075322883,45.200673181127826,GRK5;DUSP1;DMD;ADRB2
Hereditary Leiomyomatosis and Renal Cell Cancer,4/27,0.0028279699959403307,0.010960759313353163,0,0,7.702652075322883,45.200673181127826,CCND1;KIT;LTA;CIB1
Idiopathic Interstitial Pneumonias,4/27,0.0028279699959403307,0.010960759313353163,0,0,7.702652075322883,45.200673181127826,CXCL12;CXCR4;PPARG;SELE
Intermittent abdominal pain,4/27,0.0028279699959403307,0.010960759313353163,0,0,7.702652075322883,45.200673181127826,RET;CDKN2C;F12;ESR1
Lobular carcinoma in situ of breast,4/27,0.0028279699959403307,0.010960759313353163,0,0,7.702652075322883,45.200673181127826,CISH;ERBB2;BRCA1;ESR1
Localized scleroderma,4/27,0.0028279699959403307,0.010960759313353163,0,0,7.702652075322883,45.200673181127826,IL6;COL1A2;DCN;FLI1
Pregnancy in Diabetics,4/27,0.0028279699959403307,0.010960759313353163,0,0,7.702652075322883,45.200673181127826,MMP14;LEPR;TXNIP;FGF2
Premenopausal breast cancer,4/27,0.0028279699959403307,0.010960759313353163,0,0,7.702652075322883,45.200673181127826,CCND1;LEPR;BRCA1;ESR1
Primary Malignant Liver Neoplasm,4/27,0.0028279699959403307,0.010960759313353163,0,0,7.702652075322883,45.200673181127826,CCNA2;IL6;HGF;NDC80
Short femoral neck,4/27,0.0028279699959403307,0.010960759313353163,0,0,7.702652075322883,45.200673181127826,COL2A1;BMPR1B;FGFR3;RUNX2
Skin toxicity,4/27,0.0028279699959403307,0.010960759313353163,0,0,7.702652075322883,45.200673181127826,CCND1;FANCD2;HGF;LIFR
"AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED",5/44,0.002834847964159387,0.010960759313353163,0,0,5.686480186480186,33.35556766139269,GPSM2;PYY;PLA2G2A;BGN;PTGS2
Acute anterior uveitis,5/44,0.002834847964159387,0.010960759313353163,0,0,5.686480186480186,33.35556766139269,CCL2;SERPING1;GATA3;ANTXR2;FOXO1
Birthmark,5/44,0.002834847964159387,0.010960759313353163,0,0,5.686480186480186,33.35556766139269,RET;BLM;FANCD2;FANCA;SOX10
Paranasal Sinus Diseases,5/44,0.002834847964159387,0.010960759313353163,0,0,5.686480186480186,33.35556766139269,BLM;CTLA4;PRTN3;IL2RG;RUNX2
Tumoral calcinosis,5/44,0.002834847964159387,0.010960759313353163,0,0,5.686480186480186,33.35556766139269,COL1A1;IL18;CCL2;DMD;TIMP1
Flatfoot,8/108,0.00285826587696732,0.011025912481167445,0,0,3.5615560640732267,20.86195773001013,COL1A1;RPS6KA3;COL1A2;COL2A1;HOXD10;FLI1;GRIN2D;TGFBR2
RDW - Red blood cell distribution width result,8/108,0.00285826587696732,0.011025912481167445,0,0,3.5615560640732267,20.86195773001013,SPTA1;CHAF1A;ITSN1;E2F2;NEK2;PLD1;SPTB;AP1M2
Red cell distribution width determination,8/108,0.00285826587696732,0.011025912481167445,0,0,3.5615560640732267,20.86195773001013,SPTA1;CHAF1A;ITSN1;E2F2;NEK2;PLD1;SPTB;AP1M2
Vesico-Ureteral Reflux,8/108,0.00285826587696732,0.011025912481167445,0,0,3.5615560640732267,20.86195773001013,RET;PRKN;ARNT2;SIX1;GATA3;PAX2;AGT;CIT
Demyelinating Diseases,7/85,0.0028602568228516265,0.011027258795793067,0,0,3.990721227022597,23.373031115387622,CXCL12;CXCR2;CXCR4;PPARG;CRYAB;QKI;LMNB1
Allergic disposition,13/240,0.0029183513695640144,0.011244777853122157,0,0,2.5622450644477075,14.955149088759113,PLA2G2A;IL18;TAP1;ADRB2;PTGS2;TGFBR2;IL6;FLAD1;KIT;CTLA4;CCL2;S100A4;MET
Vesicular Stomatitis,9/133,0.002957446620867867,0.0113888827441219,0,0,3.234666321396863,18.836849696956456,VTN;IL6;PARP1;STAT1;ERBB2;IRF7;PMAIP1;CXCR4;IKBKE
Allergic Reaction,6/64,0.0029596669590912215,0.011390901603012402,0,0,4.594375932762548,26.751574106106272,IL6;CXCR2;IL18;CCL2;CCL19;MYLK
"Hyperalgesia, Thermal",8/109,0.003026224656439464,0.011633729131452455,0,0,3.526111878922446,20.452998357075565,EGR1;IL6;CCL2;FOS;AKAP5;PTGS2;AGT;GFAP
Schizoaffective Disorder,8/109,0.003026224656439464,0.011633729131452455,0,0,3.526111878922446,20.452998357075565,CNTNAP2;TCF7L2;GAD1;PLA2G4A;RARB;PRKCA;CALR;ADRA1A
Fatigue,16/330,0.003113269722152961,0.011961509985114006,0,0,2.285391890487432,13.191468816909614,RET;MEF2C;PTGS2;TGFBR2;C4A;IL6;CCND1;KIT;E2F1;CTLA4;DMD;PRTN3;NKX2-5;PPARGC1A;NEFH;MET
"Limb Deformities, Congenital",5/45,0.003131936971552978,0.011998909698202966,0,0,5.544034090909091,31.96747506916523,NKX2-5;BMPR1B;HOXD10;PCSK5;PITX1
Abetalipoproteinemia,5/45,0.003131936971552978,0.011998909698202966,0,0,5.544034090909091,31.96747506916523,ALK;PECAM1;CCL2;CIB1;APOB
Bronchogenic Carcinoma,5/45,0.003131936971552978,0.011998909698202966,0,0,5.544034090909091,31.96747506916523,IL6;CISH;FANCD2;E2F1;PTGS2
Cafe-au-Lait Spots,5/45,0.003131936971552978,0.011998909698202966,0,0,5.544034090909091,31.96747506916523,RET;BLM;FANCD2;FANCA;SOX10
RENAL ADYSPLASIA,5/45,0.003131936971552978,0.011998909698202966,0,0,5.544034090909091,31.96747506916523,RET;SIX1;GATA3;CEP55;PAX2
"Multiple, subcutaneous nodules",6/65,0.003200716205075849,0.01223155060682969,0,0,4.516273502953554,25.943194256562485,COL1A1;C4A;KIT;HMGA2;TEK;ANTXR2
Melanocytic nevus of skin,6/65,0.003200716205075849,0.01223155060682969,0,0,4.516273502953554,25.943194256562485,VCAN;CCND1;CDKN2A;HGF;PTGS2;EZH2
Subcutaneous nodule,6/65,0.003200716205075849,0.01223155060682969,0,0,4.516273502953554,25.943194256562485,COL1A1;C4A;KIT;HMGA2;TEK;ANTXR2
Congenital myopathy (disorder),8/110,0.003201766820548927,0.01223155060682969,0,0,3.4913626777942297,20.054570483307803,TPM3;BIN1;CNTN1;TNNI2;SCN4A;DMD;FLNC;CRYAB
Hyperplastic Polyp,8/110,0.003201766820548927,0.01223155060682969,0,0,3.4913626777942297,20.054570483307803,SOCS3;MUC1;CDKN2A;BGN;CALR;MKI67;PTGS2;KLF4
"CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT",4/28,0.0032420810318680745,0.012301591079110727,0,0,7.381330309901738,42.30638890264492,BGN;CAPN3;TNFSF11;PPARG
Aortic valve disorder,4/28,0.0032420810318680745,0.012301591079110727,0,0,7.381330309901738,42.30638890264492,IL6;BGN;NKX2-5;RUNX2
Double Outlet Right Ventricle,4/28,0.0032420810318680745,0.012301591079110727,0,0,7.381330309901738,42.30638890264492,MEF2C;PAX3;NKX2-5;ZFPM2
Esophageal atresia with or without tracheoesophageal fistula,4/28,0.0032420810318680745,0.012301591079110727,0,0,7.381330309901738,42.30638890264492,MYCN;FANCD2;FANCA;BRCA2
Hereditary spherocytosis,4/28,0.0032420810318680745,0.012301591079110727,0,0,7.381330309901738,42.30638890264492,SPTA1;SPTB;AQP1;KLF1
Immunoglobulin G subclass deficiency (finding),4/28,0.0032420810318680745,0.012301591079110727,0,0,7.381330309901738,42.30638890264492,BLM;SH2D1A;CXCR4;IL2RG
Low serum estradiol levels,4/28,0.0032420810318680745,0.012301591079110727,0,0,7.381330309901738,42.30638890264492,WT1;LEPR;GATA4;ZFPM2
Malignant Mesothelioma of Peritoneum,4/28,0.0032420810318680745,0.012301591079110727,0,0,7.381330309901738,42.30638890264492,ALK;VTN;CXCL12;WT1
Plasma cell dyscrasia,4/28,0.0032420810318680745,0.012301591079110727,0,0,7.381330309901738,42.30638890264492,IL6;CCND2;CCND1;CDKN2A
Premature canities,4/28,0.0032420810318680745,0.012301591079110727,0,0,7.381330309901738,42.30638890264492,TERT;PAX3;MITF;SOX10
Psoriasiform eczema,4/28,0.0032420810318680745,0.012301591079110727,0,0,7.381330309901738,42.30638890264492,IL6;CAV1;CXCR4;GATA3
Tumor Expansion,4/28,0.0032420810318680745,0.012301591079110727,0,0,7.381330309901738,42.30638890264492,VCAN;IL6;MMP14;CXCR4
Actinic keratosis,7/87,0.0032607025416108433,0.012358283447775634,0,0,3.8905536529680367,22.276581139821552,COL17A1;CDKN2A;VIM;SSTR2;PPARA;PTGS2;FGFR3
Gynecomastia,7/87,0.0032607025416108433,0.012358283447775634,0,0,3.8905536529680367,22.276581139821552,WT1;KIT;LEPR;GATA4;BRCA2;ZFPM2;HOXD10
Flexion contractures of joints,9/135,0.0032681060839154534,0.012379357281204843,0,0,3.1829947575360418,18.218012587121898,COL2A1;DST;TPM3;BIN1;CAV1;GAD1;CAPN3;DMD;CRYAB
Abnormal sex determination,3/14,0.003317410210292477,0.012425949231636518,0,0,12.059234882764294,68.84099681667077,WT1;GATA4;ZFPM2
Active Hyperemia,3/14,0.003317410210292477,0.012425949231636518,0,0,12.059234882764294,68.84099681667077,ADRB1;PTGS2;AGT
Acute myocarditis,3/14,0.003317410210292477,0.012425949231636518,0,0,12.059234882764294,68.84099681667077,CCL2;DMD;PTGS2
Benign tumor of pancreas,3/14,0.003317410210292477,0.012425949231636518,0,0,12.059234882764294,68.84099681667077,CDKN2A;BRCA1;BRCA2
Diastolic hypertension,3/14,0.003317410210292477,0.012425949231636518,0,0,12.059234882764294,68.84099681667077,KDR;ANTXR2;AGT
Dysferlinopathy,3/14,0.003317410210292477,0.012425949231636518,0,0,12.059234882764294,68.84099681667077,TRIM63;CAPN3;DMD
Germinoma,3/14,0.003317410210292477,0.012425949231636518,0,0,12.059234882764294,68.84099681667077,CDKN2A;KIT;KLF4
Granulomatous disorder,3/14,0.003317410210292477,0.012425949231636518,0,0,12.059234882764294,68.84099681667077,LTA;PPARG;IL2RG
Hypochondroplasia (disorder),3/14,0.003317410210292477,0.012425949231636518,0,0,12.059234882764294,68.84099681667077,KRT19;CCND1;FGFR3
Junctional Epidermolysis Bullosa,3/14,0.003317410210292477,0.012425949231636518,0,0,12.059234882764294,68.84099681667077,COL17A1;DST;LAMC1
Loeys-Dietz Syndrome,3/14,0.003317410210292477,0.012425949231636518,0,0,12.059234882764294,68.84099681667077,COL3A1;AGT;TGFBR2
Lymphoid interstitial pneumonia,3/14,0.003317410210292477,0.012425949231636518,0,0,12.059234882764294,68.84099681667077,CXCL10;IL6;IL18
Mucocutaneous leishmaniasis,3/14,0.003317410210292477,0.012425949231636518,0,0,12.059234882764294,68.84099681667077,CXCL10;LTA;FLI1
Neural crest tumor,3/14,0.003317410210292477,0.012425949231636518,0,0,12.059234882764294,68.84099681667077,ALK;RET;MYCN
Reactive Hyperemia,3/14,0.003317410210292477,0.012425949231636518,0,0,12.059234882764294,68.84099681667077,ADRB1;PTGS2;AGT
Refractory Neoplasm,3/14,0.003317410210292477,0.012425949231636518,0,0,12.059234882764294,68.84099681667077,SOCS3;KIT;ESR1
Stage II Colorectal Cancer AJCC v7,3/14,0.003317410210292477,0.012425949231636518,0,0,12.059234882764294,68.84099681667077,RET;KPNA2;EZR
Testicular dysgenesis,3/14,0.003317410210292477,0.012425949231636518,0,0,12.059234882764294,68.84099681667077,WT1;CBX2;GATA4
Testicular Hydrocele,3/14,0.003317410210292477,0.012425949231636518,0,0,12.059234882764294,68.84099681667077,MECOM;FLT4;EZH2
Venous Engorgement,3/14,0.003317410210292477,0.012425949231636518,0,0,12.059234882764294,68.84099681667077,ADRB1;PTGS2;AGT
Acquired Immunodeficiency Syndrome,11/188,0.0033453119296190845,0.01251649856229625,0,0,2.7748444375016272,15.817155324234552,CXCL10;IL6;CXCL12;LRP1;IL18;PLAUR;CXCR4;CCL2;TIMP1;FGF1;FGF2
Dyspnea,11/188,0.0033453119296190845,0.01251649856229625,0,0,2.7748444375016272,15.817155324234552,STAT5B;CDT1;EGR2;COL2A1;CAV1;LIFR;ADRB2;FLNC;APOB;PPARGC1A;NEFH
Deafness,14/273,0.0033647451511860473,0.01258219846067121,0,0,2.420016304007023,13.780548232058447,FANCA;PAX3;SIX1;MITF;GATA3;SOX10;RUNX2;COL1A1;COL1A2;COL2A1;MYCN;FANCD2;TNFSF11;FGFR3
Alopecia,12/216,0.003399838000435191,0.012699283654573273,0,0,2.6288547751664177,14.94248282352785,COL1A1;COL3A1;ZFP36;TERT;PARP1;ERBB2;MX1;CTLA4;GZMB;SNRPE;PTGS2;IL2RG
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site,12/216,0.003399838000435191,0.012699283654573273,0,0,2.6288547751664177,14.94248282352785,NGFR;CXCL10;IL6;STAT1;IL18;LTA;TAP1;CCL2;PPARG;ADRB2;SELE;AURKA
Early gastric cancer,5/46,0.003450820623301008,0.01282551815500253,0,0,5.408536585365853,30.661768482745444,RET;PER2;IL6;ERBB2;PTGS2
IIeocolitis,5/46,0.003450820623301008,0.01282551815500253,0,0,5.408536585365853,30.661768482745444,VTN;IL6;CCL2;PPARG;PPARA
Malonic aciduria,5/46,0.003450820623301008,0.01282551815500253,0,0,5.408536585365853,30.661768482745444,MUC1;IL6;NPHS1;KDR;TUBG1
Moyamoya disease 1,5/46,0.003450820623301008,0.01282551815500253,0,0,5.408536585365853,30.661768482745444,ACTA2;LRP1;SIX3;KDR;TIMP1
Peptic Esophagitis,5/46,0.003450820623301008,0.01282551815500253,0,0,5.408536585365853,30.661768482745444,IL6;CXCR2;CCL2;PTGS2;ESR1
Refractive Errors,5/46,0.003450820623301008,0.01282551815500253,0,0,5.408536585365853,30.661768482745444,ACTC1;HGF;KCNQ5;TIMP1;GRIA4
Regional enteritis,5/46,0.003450820623301008,0.01282551815500253,0,0,5.408536585365853,30.661768482745444,VTN;IL6;CCL2;PPARG;PPARA
Single tumor,5/46,0.003450820623301008,0.01282551815500253,0,0,5.408536585365853,30.661768482745444,RET;CDKN2A;ERBB2;FGF1;ESR1
Systemic candidiasis,5/46,0.003450820623301008,0.01282551815500253,0,0,5.408536585365853,30.661768482745444,IL6;NR5A2;CHEK1;CXCR2;SH2D1A
Arachnodactyly,6/66,0.0034561023386364136,0.012830947101316834,0,0,4.4407744874715265,25.168594841619672,RET;FBN2;COL2A1;CNTN1;FGFR3;TGFBR2
Cleft palate with cleft lip,6/66,0.0034561023386364136,0.012830947101316834,0,0,4.4407744874715265,25.168594841619672,TERT;PAX3;KLF4;FGF2;DCN;TGFBR2
Cholera,8/112,0.003576514852725833,0.013270648481163919,0,0,3.4238690371413485,19.28790898890449,IL6;HGF;CAV1;KIT;ERBB2;APOB;ESR1;GFAP
Aplasia/Hypoplasia of the mandible,18/397,0.0036190309020217282,0.013420989253438943,0,0,2.1328653612056874,11.990007129053149,PLK4;CDT1;GATA4;MITF;LIFR;RUNX2;TGFBR2;COL1A1;COL3A1;COL1A2;COL2A1;MYCN;WT1;RARB;TNNI2;FGFR3;BUB1;EZH2
"Hyalinosis, Segmental Glomerular",4/29,0.0036956444338000394,0.013555405798689822,0,0,7.085714285714285,39.68425378674449,ACTA2;NPHS1;AGT;PAX2
"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C",4/29,0.0036956444338000394,0.013555405798689822,0,0,7.085714285714285,39.68425378674449,CCND1;CDKN2A;CIB1;ESR1
Alport Syndrome,4/29,0.0036956444338000394,0.013555405798689822,0,0,7.085714285714285,39.68425378674449,SOSTDC1;PAX3;MITF;MKI67
Alveolar Bone Loss,4/29,0.0036956444338000394,0.013555405798689822,0,0,7.085714285714285,39.68425378674449,IL6;HGF;CXCR2;TNFSF11
Autoinflammatory disorder,4/29,0.0036956444338000394,0.013555405798689822,0,0,7.085714285714285,39.68425378674449,IL6;STAT1;IL18;SAA1
Cardiac Lymphoma,4/29,0.0036956444338000394,0.013555405798689822,0,0,7.085714285714285,39.68425378674449,IL6;CCND1;CDKN2A;FGFR3
Childhood Brain Neoplasm,4/29,0.0036956444338000394,0.013555405798689822,0,0,7.085714285714285,39.68425378674449,NGFR;TERT;ERBB2;KIT
Cholesterol gallstones,4/29,0.0036956444338000394,0.013555405798689822,0,0,7.085714285714285,39.68425378674449,PLA2G2A;APOB;PPARGC1A;ESR1
Collagen Diseases,4/29,0.0036956444338000394,0.013555405798689822,0,0,7.085714285714285,39.68425378674449,COL1A1;VIL1;COL1A2;COL2A1
Community acquired pneumonia,4/29,0.0036956444338000394,0.013555405798689822,0,0,7.085714285714285,39.68425378674449,IL6;LTA;TIMP1;MYLK
Diffusely thickened skin,4/29,0.0036956444338000394,0.013555405798689822,0,0,7.085714285714285,39.68425378674449,COL1A1;KIT;IL2RG;ANTXR2
Disease of capillaries,4/29,0.0036956444338000394,0.013555405798689822,0,0,7.085714285714285,39.68425378674449,VWF;APOB;SELE;AGT
Gall Bladder Diseases,4/29,0.0036956444338000394,0.013555405798689822,0,0,7.085714285714285,39.68425378674449,CDKN2A;ERBB2;APOB;TGFBR2
Lymphoid hyperplasia,4/29,0.0036956444338000394,0.013555405798689822,0,0,7.085714285714285,39.68425378674449,CXCL10;CCND1;TXNIP;FGFR3
Malignant melanoma of eye,4/29,0.0036956444338000394,0.013555405798689822,0,0,7.085714285714285,39.68425378674449,TERT;CDKN2A;KIT;BRCA2
Metaphyseal irregularity,4/29,0.0036956444338000394,0.013555405798689822,0,0,7.085714285714285,39.68425378674449,COL2A1;BGN;KIF22;FGFR3
Primary peritoneal carcinoma,4/29,0.0036956444338000394,0.013555405798689822,0,0,7.085714285714285,39.68425378674449,BARD1;RAD51;BRCA1;BRCA2
Renal hypertension,4/29,0.0036956444338000394,0.013555405798689822,0,0,7.085714285714285,39.68425378674449,IL6;SERPINC1;PKD2;AGT
Salivary duct carcinoma,4/29,0.0036956444338000394,0.013555405798689822,0,0,7.085714285714285,39.68425378674449,CDKN2A;ERBB2;HMGA2;ESR1
Scrub Typhus,4/29,0.0036956444338000394,0.013555405798689822,0,0,7.085714285714285,39.68425378674449,JUN;IL6;CCL2;FOS
"Mastocytosis, Systemic",6/67,0.0037263365611609617,0.013630760536360033,0,0,4.367750849546287,24.425902724484565,STAT5A;STAT5B;KIT;SIRPA;MITF;RUNX1T1
Abnormal blistering of the skin,6/67,0.0037263365611609617,0.013630760536360033,0,0,4.367750849546287,24.425902724484565,COL17A1;C4A;TERT;KIT;TNFSF11;KRT5
Cerebral Hemorrhage,6/67,0.0037263365611609617,0.013630760536360033,0,0,4.367750849546287,24.425902724484565,RET;SERPINC1;PROS1;KDR;APOB;ESR1
Idiopathic Inflammatory Myopathies,6/67,0.0037263365611609617,0.013630760536360033,0,0,4.367750849546287,24.425902724484565,CXCL10;CXCL12;WT1;CXCR4;CCL2;S100A4
Skin blisters,6/67,0.0037263365611609617,0.013630760536360033,0,0,4.367750849546287,24.425902724484565,COL17A1;C4A;TERT;KIT;TNFSF11;KRT5
Ureteral obstruction,9/138,0.003781638167304371,0.013825520920858005,0,0,3.108491572434393,17.337916332782267,BMP2;COL3A1;KDR;IL18;CCL2;PTGS2;PAX2;AGT;GADD45G
Muscular Atrophy,5/47,0.003792373000628219,0.013849688456889135,0,0,5.279491341991342,29.43191475699431,TRIM63;COL1A2;CFL1;DMD;FOXO1
Peripheral demyelinating neuropathy,5/47,0.003792373000628219,0.013849688456889135,0,0,5.279491341991342,29.43191475699431,CXCL10;EGR2;DMD;PTGS2;SOX10
Delayed speech and language development,12/220,0.003938727305617341,0.014357088660474925,0,0,2.5777669213004084,14.272831548819005,RPS6KA3;MEF2C;COL2A1;LAMA1;NDN;HMGA2;DMD;PRKD1;PAK3;BMPR1B;SOX5;EZH2
Adenovirus Infections,7/90,0.00393986218005588,0.014357088660474925,0,0,3.749353578698355,20.758706777527113,TERT;CHEK1;PLA2G2A;E2F1;VIM;PTGS2;APOB
Bacteremia,7/90,0.00393986218005588,0.014357088660474925,0,0,3.749353578698355,20.758706777527113,VTN;IL6;CISH;PLA2G4A;ADRB2;VIM;PTGS2
Micromelia,7/90,0.00393986218005588,0.014357088660474925,0,0,3.749353578698355,20.758706777527113,ACAN;COL2A1;LIFR;KIF22;ANTXR2;BMPR1B;FGFR3
Prominent globes,9/139,0.003966177680940154,0.014445146044031493,0,0,3.0844213126323217,17.05670319105822,COL3A1;COL2A1;BGN;GATA4;DMD;ZFPM2;NKX2-5;FGFR3;TGFBR2
Dermatomyositis,8/114,0.00398436025975613,0.014495646535494133,0,0,3.3589223263244246,18.55931726114507,IL6;CCL21;STAT1;HGF;CCL2;DMD;TIMP1;CCL19
Lymphocyte Count measurement,8/114,0.00398436025975613,0.014495646535494133,0,0,3.3589223263244246,18.55931726114507,TLE4;SPTA1;CDKN2A;LTA;S1PR1;ANTXR2;IKBKE;ADCY5
Migraine with Aura,6/68,0.004011932414733036,0.014517025409799657,0,0,4.297082812844441,23.7133752501042,LRP1;LTA;CTLA4;ESR1;AGT;TGFBR2
Short palpebral fissure,6/68,0.004011932414733036,0.014517025409799657,0,0,4.297082812844441,23.7133752501042,MYCN;RAD51;FANCD2;FANCA;LIFR;BRCA2
Skin bullae,6/68,0.004011932414733036,0.014517025409799657,0,0,4.297082812844441,23.7133752501042,COL17A1;C4A;TERT;KIT;TNFSF11;KRT5
Wiskott-Aldrich Syndrome,6/68,0.004011932414733036,0.014517025409799657,0,0,4.297082812844441,23.7133752501042,IL6;CXCL12;CIB1;TIMP1;SYP;IL2RG
"Breast Fibrocystic Change, Proliferative Type",3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,ERBB2;KRT5;ESR1
Ascending aortic dissection,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,ACTA2;MYLK;TGFBR2
Asymmetric Diabetic Proximal Motor Neuropathy,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,HGF;LEPR;SGK1
Brachydactyly type A3,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,BMP2;BMPR1B;RUNX2
Carpal synostosis,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,PAX3;BMPR1B;FGFR3
Chorioamnionitis,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,BMP2;IL6;LTA
Cystic medial necrosis of aorta,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,ACTA2;MYLK;TGFBR2
Descending aortic dissection,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,ACTA2;MYLK;TGFBR2
Diabetic Amyotrophy,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,HGF;LEPR;SGK1
Diabetic Asymmetric Polyneuropathy,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,HGF;LEPR;SGK1
Diabetic Autonomic Neuropathy,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,HGF;LEPR;SGK1
Diabetic Mononeuropathy,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,HGF;LEPR;SGK1
Diffuse Intrinsic Pontine Glioma,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,MYCN;PAX3;GFAP
Duchenne and Becker Muscular Dystrophy,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,CCL2;DMD;UTRN
Epithelial cyst,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,PKD2;PTGS2;PAX2
Foot-and-Mouth Disease,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,RIMS2;IRF7;VIM
Hemangioendothelioma,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,FLT4;CCL2;PROX1
Hereditary Paraganglioma,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,RET;KIT;ESR1
Left ventricular systolic dysfunction,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,IL6;ADRB1;AGT
Maternal hypertension,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,COL1A1;AGT;ATF3
Metaphyseal chondrodysplasia,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,CCNA2;CCND1;FGFR3
Monoblastic leukemia,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,KIT;SCN4A;FGFR4
Mucosal Melanoma,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,CDKN2A;KIT;FGFR3
Nevi and Melanomas,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,CCND1;KIT;PAX3
Progesterone Resistance,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,HOXA10;CIB1;FKBP4
Progressive pseudorheumatoid dysplasia,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,PER2;COL2A1;ESR1
Retinal depigmentation,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,PAX3;MITF;SOX10
Sclerosis of the skin,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,COL1A2;CCL2;FLI1
Short middle phalanx of the 5th finger,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,BMP2;BMPR1B;RUNX2
Stage II Colorectal Cancer,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,RET;KPNA2;EZR
Stromal keratitis,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,CXCL10;PECAM1;CCL2
Symmetric Diabetic Proximal Motor Neuropathy,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,HGF;LEPR;SGK1
Synostosis of carpal bones,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,PAX3;BMPR1B;PITX1
Systolic hypertension,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,PPARG;ANTXR2;AGT
Thanatophoric Dysplasia,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,STAT1;FGF2;FGFR3
Tic disorder,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,SIX1;VIM;ECT2
Triglyceride storage disease with ichthyosis,3/15,0.004078860474730785,0.014517025409799657,0,0,11.053733031674208,60.81694966351241,CCND1;CDKN2A;ESR1
"Mental Retardation, X-Linked 1",5/48,0.004157465349412292,0.01474975488820216,0,0,5.156448202959831,28.272030386799408,RPS6KA3;DMD;SYP;PAK3;ARHGEF6
"Myasthenic Syndromes, Congenital",5/48,0.004157465349412292,0.01474975488820216,0,0,5.156448202959831,28.272030386799408,TPM3;CAV1;SCN4A;UTRN;FGFR3
Right Ventricular Hypertrophy,5/48,0.004157465349412292,0.01474975488820216,0,0,5.156448202959831,28.272030386799408,PPARG;TEK;KLF4;AGT;EZH2
Acid reflux,9/140,0.004157688311618381,0.01474975488820216,0,0,3.060718537712725,16.781295519405166,COL1A1;RET;RPS6KA3;ARNT2;COL1A2;TERT;NPHS1;CAV1;ASCL1
Contracture of joint,9/140,0.004157688311618381,0.01474975488820216,0,0,3.060718537712725,16.781295519405166,COL2A1;DST;TPM3;BIN1;CAV1;GAD1;CAPN3;DMD;CRYAB
"Carcinoma, Signet Ring Cell",4/30,0.004190371102842424,0.01474975488820216,0,0,6.812837955695098,37.300056036540525,MUC1;CDKN2A;GATA3;ESR1
"Delirium, Dementia, Amnestic, Cognitive Disorders",4/30,0.004190371102842424,0.01474975488820216,0,0,6.812837955695098,37.300056036540525,ZFP36;STAT1;CCL2;FGF2
"Ventricular Dysfunction, Left",4/30,0.004190371102842424,0.01474975488820216,0,0,6.812837955695098,37.300056036540525,IL6;ADRB2;AGT;ADCY5
Arteriovenous fistula,4/30,0.004190371102842424,0.01474975488820216,0,0,6.812837955695098,37.300056036540525,IL6;LRP1;CCL2;S100A4
Dysequilibrium syndrome,4/30,0.004190371102842424,0.01474975488820216,0,0,6.812837955695098,37.300056036540525,FGF7;MUC1;PKD2;ESR1
gastritis h pylori,4/30,0.004190371102842424,0.01474975488820216,0,0,6.812837955695098,37.300056036540525,MUC1;IL6;CDKN2A;PTGS2
Hypergammaglobulinemia,4/30,0.004190371102842424,0.01474975488820216,0,0,6.812837955695098,37.300056036540525,STAT5A;STAT5B;IL6;TERT
Hyperplasia of supraorbital margins,4/30,0.004190371102842424,0.01474975488820216,0,0,6.812837955695098,37.300056036540525,RPS6KA3;CAV1;PPARG;FOS
Hyperplasia of supraorbital ridge,4/30,0.004190371102842424,0.01474975488820216,0,0,6.812837955695098,37.300056036540525,RPS6KA3;CAV1;PPARG;FOS
Hypertrophy of supraorbital margins,4/30,0.004190371102842424,0.01474975488820216,0,0,6.812837955695098,37.300056036540525,RPS6KA3;CAV1;PPARG;FOS
Hypertrophy of supraorbital ridge,4/30,0.004190371102842424,0.01474975488820216,0,0,6.812837955695098,37.300056036540525,RPS6KA3;CAV1;PPARG;FOS
Narrow palate,4/30,0.004190371102842424,0.01474975488820216,0,0,6.812837955695098,37.300056036540525,RPS6KA3;FGFR3;RUNX2;SOX5
Poorly differentiated carcinoma,4/30,0.004190371102842424,0.01474975488820216,0,0,6.812837955695098,37.300056036540525,CDKN2A;PPARG;PTGS2;MET
Prominent supraorbital ridges,4/30,0.004190371102842424,0.01474975488820216,0,0,6.812837955695098,37.300056036540525,RPS6KA3;CAV1;PPARG;FOS
Protoplasmic astrocytoma,4/30,0.004190371102842424,0.01474975488820216,0,0,6.812837955695098,37.300056036540525,HGF;PTGS2;ESR1;MET
Welts,4/30,0.004190371102842424,0.01474975488820216,0,0,6.812837955695098,37.300056036540525,F12;E2F1;GZMB;SERPING1
Epileptic drop attack,8/115,0.004201282249706505,0.014780414661618066,0,0,3.3273594388246113,18.208527008231677,NGFR;IL6;FOS;SSTR2;PTGS2;FGF2;MPDZ;AGT
Adenomatous Polyps,6/69,0.004313405262735818,0.015158989923879514,0,0,4.228658205879163,23.029389311420907,MUC1;CDKN2A;ERBB2;TIMP1;CALR;PTGS2
Kallmann Syndrome,6/69,0.004313405262735818,0.015158989923879514,0,0,4.228658205879163,23.029389311420907,NRP1;ARNT2;LEPR;NDN;ADRA1A;SOX10
Complex partial seizures,8/116,0.004427187912658031,0.015542600115740374,0,0,3.2963810492414614,17.866354561916403,NGFR;IL6;FOS;SSTR2;PTGS2;FGF2;MPDZ;AGT
Primary microcephaly,8/116,0.004427187912658031,0.015542600115740374,0,0,3.2963810492414614,17.866354561916403,PLK4;CDT1;BLM;CENPF;MYCN;FANCD2;FANCA;BRCA2
Premature aging syndrome,7/92,0.004448860850213192,0.015610527413809718,0,0,3.660757453666398,19.82339406051026,RIMS2;C3;BLM;RAD51;CDKN2A;CAV1;BRCA1
Airway Obstruction,5/49,0.004546964765204428,0.015929794138295744,0,0,5.038997933884297,27.17680414155041,CXCL10;ALDH2;SERPING1;TIMP1;ADRB2
Polyarthritis,5/49,0.004546964765204428,0.015929794138295744,0,0,5.038997933884297,27.17680414155041,ACAN;ZFP36;VCAN;MMP14;COL2A1
Thromboangiitis Obliterans,5/49,0.004546964765204428,0.015929794138295744,0,0,5.038997933884297,27.17680414155041,CXCL10;IL6;STAT1;PTGS2;SELE
Exophthalmos,9/142,0.004562330287298491,0.015975292080029544,0,0,3.0143822859902047,16.247284670398802,COL3A1;COL2A1;BGN;GATA4;PPARG;ZFPM2;NKX2-5;FGFR3;TGFBR2
"Chromosome 8, trisomy",6/70,0.004631271769170901,0.016199802709245714,0,0,4.162371867881549,22.37243148574249,CCND1;MECOM;TERT;WT1;KIT;ERBB2
Respiratory Tract Infections,6/70,0.004631271769170901,0.016199802709245714,0,0,4.162371867881549,22.37243148574249,IL6;STAT1;PROS1;SH2D1A;LEPR;IL18
"Tuberculosis, Pulmonary",10/169,0.0046599505380406645,0.016291428390863602,0,0,2.804308537555122,15.055632709071373,CA12;CXCL10;IL6;CR1;IL18;LTA;CTLA4;CXCR4;CCL2;CD36
Joint stiffness,8/117,0.004662317654443098,0.016291428390863602,0,0,3.2659710704763505,17.532525043125258,FBN2;COL2A1;PAX3;TNNI2;ANTXR2;BMPR1B;PITX1;EZH2
Coughing,7/93,0.004721244152740698,0.016460740750618263,0,0,3.618004672400977,19.3768858372734,PER2;TERT;STMN1;CTLA4;PRTN3;ADRB2;TGFBR2
Edema,7/93,0.004721244152740698,0.016460740750618263,0,0,3.618004672400977,19.3768858372734,IL6;COL2A1;NPHS1;TIMP1;IL2RG;PLD1;PTGS2
"Alopecia, Male Pattern",4/31,0.004727928664077223,0.016460740750618263,0,0,6.560174687158814,35.1249339723523,ZFP36;VCAN;PARP1;CDKN2A
Activated Protein C Resistance,4/31,0.004727928664077223,0.016460740750618263,0,0,6.560174687158814,35.1249339723523,PROC;VWF;SERPINC1;PROS1
Bulimia,4/31,0.004727928664077223,0.016460740750618263,0,0,6.560174687158814,35.1249339723523,DST;LEPR;APOB;CIT
Sebaceous Adenocarcinoma,4/31,0.004727928664077223,0.016460740750618263,0,0,6.560174687158814,35.1249339723523,CDKN2A;ERBB2;BRCA1;BRCA2
Thick skin,4/31,0.004727928664077223,0.016460740750618263,0,0,6.560174687158814,35.1249339723523,COL1A1;KIT;IL2RG;ANTXR2
Complete atrioventricular block,10/170,0.004855914232293977,0.016897575121288262,0,0,2.7866379310344827,14.845974889350982,CXCL10;IL6;STAT1;TAP1;PAEP;GZMB;PPARG;CALR;NKX2-5;ESR1
Congenital Epicanthus,13/255,0.004864575534651356,0.016918948363914294,0,0,2.4015629782675236,12.790186030108115,RET;CTNND2;GATA4;FLI1;COL1A1;RPS6KA3;COL3A1;BMP2;MYCN;ALDOA;BUB1;SOX5;EZH2
Convulsions,8/118,0.004906913575511745,0.017015794305367593,0,0,3.23611400041606,17.20677454807247,NGFR;IL6;FOS;SSTR2;PTGS2;FGF2;MPDZ;AGT
"Cystadenocarcinoma, Mucinous",3/16,0.004938026072239642,0.017015794305367593,0,0,10.202923773059519,54.185581546753575,CDKN2A;ERBB2;ESR1
"Dyspnea, Paroxysmal",3/16,0.004938026072239642,0.017015794305367593,0,0,10.202923773059519,54.185581546753575,ACTA2;MYLK;TGFBR2
"Female external genitalia in individual with 46,XY karyotype",3/16,0.004938026072239642,0.017015794305367593,0,0,10.202923773059519,54.185581546753575,WT1;GATA4;ZFPM2
"Glioblastoma, IDH-Mutant",3/16,0.004938026072239642,0.017015794305367593,0,0,10.202923773059519,54.185581546753575,CDKN2A;KIT;KDR
"HYPERTRICHOSIS, CONGENITAL GENERALIZED",3/16,0.004938026072239642,0.017015794305367593,0,0,10.202923773059519,54.185581546753575,CCND1;ERBB2;BRCA1
"Nuchal bleb, familial",3/16,0.004938026072239642,0.017015794305367593,0,0,10.202923773059519,54.185581546753575,C3;LEPR;APOB
"Other specified forms of pleural effusion, except tuberculous",3/16,0.004938026072239642,0.017015794305367593,0,0,10.202923773059519,54.185581546753575,ANXA1;PTGS2;ESR1
"Primary hyperoxaluria, type I",3/16,0.004938026072239642,0.017015794305367593,0,0,10.202923773059519,54.185581546753575,PAEP;SOSTDC1;AGT
Abnormality of the iris,3/16,0.004938026072239642,0.017015794305367593,0,0,10.202923773059519,54.185581546753575,ACTA2;MYLK;TGFBR2
Abnormality of the lymphatic system,3/16,0.004938026072239642,0.017015794305367593,0,0,10.202923773059519,54.185581546753575,TERT;CDKN2A;MITF
Achalasia,3/16,0.004938026072239642,0.017015794305367593,0,0,10.202923773059519,54.185581546753575,LTA;CALR;MKI67
Adenocarcinoma of salivary gland,3/16,0.004938026072239642,0.017015794305367593,0,0,10.202923773059519,54.185581546753575,ERBB2;FGF1;FGF2
Blastoma,3/16,0.004938026072239642,0.017015794305367593,0,0,10.202923773059519,54.185581546753575,ASCL1;EZR;ADRA1A
Choroidal Neovascularization,3/16,0.004938026072239642,0.017015794305367593,0,0,10.202923773059519,54.185581546753575,EPAS1;KDR;CALR
Congenital absence of kidneys syndrome,3/16,0.004938026072239642,0.017015794305367593,0,0,10.202923773059519,54.185581546753575,RET;SIX1;PAX2
Disproportionate tall stature,3/16,0.004938026072239642,0.017015794305367593,0,0,10.202923773059519,54.185581546753575,FBN2;RET;COL2A1
Rachischisis,3/16,0.004938026072239642,0.017015794305367593,0,0,10.202923773059519,54.185581546753575,CFL1;PAX3;CCL2
Advanced bone age,5/50,0.004961732913529789,0.017033701545438144,0,0,4.9267676767676765,26.141430384384254,CAV1;LEPR;PPARG;FOS;EZH2
Calcinosis,5/50,0.004961732913529789,0.017033701545438144,0,0,4.9267676767676765,26.141430384384254,COL1A1;IL18;CCL2;DMD;TIMP1
Candidiasis,5/50,0.004961732913529789,0.017033701545438144,0,0,4.9267676767676765,26.141430384384254,STAT1;CHEK1;SH2D1A;RFX2;PLD1
Chronic inflammatory disorder,5/50,0.004961732913529789,0.017033701545438144,0,0,4.9267676767676765,26.141430384384254,CCNA2;IL6;CXCR2;SELE;ETS2
Clostridium; difficile (disorder),5/50,0.004961732913529789,0.017033701545438144,0,0,4.9267676767676765,26.141430384384254,JUN;IL6;MAPKAPK2;CCL2;FOS
Idiopathic generalized epilepsy,5/50,0.004961732913529789,0.017033701545438144,0,0,4.9267676767676765,26.141430384384254,IL6;DST;PROS1;IL18;F13A1
Nephrosis,5/50,0.004961732913529789,0.017033701545438144,0,0,4.9267676767676765,26.141430384384254,CCL13;NPHS1;CD36;VIM;AGT
"Leukemia, Myeloid, Chronic-Phase",6/71,0.004966049378494325,0.017033701545438144,0,0,4.098125109514631,21.74108912041526,FBN2;BMP2;CXCL12;MECOM;BRCA1;FGFR4
Abnormality of the skull,6/71,0.004966049378494325,0.017033701545438144,0,0,4.098125109514631,21.74108912041526,PLK4;CDT1;TNFSF11;ANTXR2;FGFR3;TGFBR2
Global developmental delay,38/1102,0.005055433287105462,0.017331439487595853,0,0,1.6225868725868726,8.579090129305685,RET;FBN2;GATA4;BRCA2;STX11;MUC1;CCND2;TERT;SIX3;NDN;DMD;NKX2-5;ZNF423;BUB1;SOX5;PLK4;VAV3;ARNT2;MEF2C;CDKN2A;GAD1;FANCA;HMGA2;KIF22;TUBG1;SOX10;FLI1;GRIN2D;CIT;COL3A1;BMP2;RAD51;PROC;FANCD2;MCM4;PRKD1;FGFR3;EZH2
Blood Coagulation Disorders,10/171,0.00505829340312559,0.017332397191526256,0,0,2.7691868351538518,14.63993238553156,TERT;VWF;SERPINC1;F12;F13A1;PLA2G4A;CTSG;CD36;TEK;FLI1
Premature Birth,8/119,0.005161219344009892,0.017676057681983902,0,0,3.206794895582081,16.88884962298474,COL1A1;IL6;COL3A1;COL1A2;LTA;PPARG;PTGS2;FLI1
Nerve Degeneration,9/145,0.005226036485175759,0.01788891999716636,0,0,2.9474332164058286,15.48611514163421,PRKN;NGFR;PPARG;BAK1;FGF2;PPARGC1A;NEFH;ETS2;GRIN2D
Rotting teeth,7/95,0.005303490978624019,0.018102307969473052,0,0,3.5354140722291407,18.523413136049687,COL17A1;COL3A1;TERT;CAV1;TNFSF11;FGFR3;RUNX2
"MICROPHTHALMIA, SYNDROMIC 7",4/32,0.00530993846037253,0.018102307969473052,0,0,6.32555879494655,33.134384150595814,RET;TERT;ERG;MET
Folic Acid Deficiency,4/32,0.00530993846037253,0.018102307969473052,0,0,6.32555879494655,33.134384150595814,PAX3;BRCA1;BRCA2;ESR1
Gastrinoma,4/32,0.00530993846037253,0.018102307969473052,0,0,6.32555879494655,33.134384150595814,CDKN2A;HGF;ERBB2;MET
Hallopeau-Siemens Disease,4/32,0.00530993846037253,0.018102307969473052,0,0,6.32555879494655,33.134384150595814,RIMS2;CDKN2A;TIMP1;DCN
Intestinal Obstruction,4/32,0.00530993846037253,0.018102307969473052,0,0,6.32555879494655,33.134384150595814,RET;KIT;PTGS2;SOX10
Lipid Metabolism Disorders,4/32,0.00530993846037253,0.018102307969473052,0,0,6.32555879494655,33.134384150595814,IL6;APOB;PPARA;RXRG
Squamous cell carcinoma of the hypopharynx,4/32,0.00530993846037253,0.018102307969473052,0,0,6.32555879494655,33.134384150595814,CXCL12;HGF;CXCR4;PTGS2
Cockayne Syndrome,6/72,0.005318255803101513,0.01811227483449785,0,0,4.0358252226133775,21.134042258684048,RIMS2;FEN1;BLM;CHEK1;SYT9;ATF3
Hyperuricemia,6/72,0.005318255803101513,0.01811227483449785,0,0,4.0358252226133775,21.134042258684048,COL1A1;MUC1;IL6;ALDH2;SAA1;PPARG
Angioimmunoblastic Lymphadenopathy,5/51,0.005402624785053684,0.018362362376731042,0,0,4.819416996047431,25.161551405941452,ALK;IL6;HGF;KDR;TEK
Bicuspid aortic valve,5/51,0.005402624785053684,0.018362362376731042,0,0,4.819416996047431,25.161551405941452,ACTA2;FBN2;ACAN;NKX2-5;TGFBR2
Breast Diseases,5/51,0.005402624785053684,0.018362362376731042,0,0,4.819416996047431,25.161551405941452,CCND2;CCND1;ERBB2;CXCR4;ESR1
Rabies (disorder),5/51,0.005402624785053684,0.018362362376731042,0,0,4.819416996047431,25.161551405941452,NGFR;CXCL10;IL6;STAT1;GFAP
"Cardiomyopathy, Hypertrophic, Familial",6/73,0.005688408510225898,0.019304371679978338,0,0,3.975385033828579,20.55005632327268,ACTA2;ACTC1;CAV1;CD36;FLNC;AGT
Cystic Kidney Diseases,6/73,0.005688408510225898,0.019304371679978338,0,0,3.975385033828579,20.55005632327268,MUC1;PRKD1;PKD2;ZNF423;FGF2;STX11
Urinary tract infection,6/73,0.005688408510225898,0.019304371679978338,0,0,3.975385033828579,20.55005632327268,PER2;IL6;NPHS1;LTA;CCL2;GZMB
"Hearing Loss, Partial",13/260,0.00570687193123214,0.019357248429371237,0,0,2.3523391812865495,12.152382344116706,FANCA;PAX3;SIX1;MITF;SOX10;RUNX2;COL1A1;COL1A2;COL2A1;MYCN;FANCD2;TNFSF11;FGFR3
Coronary Stenosis,5/52,0.0058704874982786065,0.019756806767080814,0,0,4.716634429400387,24.233207381686725,COL3A1;IL6;MDK;PLA2G2A;PECAM1
Drug usage,5/52,0.0058704874982786065,0.019756806767080814,0,0,4.716634429400387,24.233207381686725,ZFP36;PPARG;PTGS2;SELE;AGT
Malignant ascites,5/52,0.0058704874982786065,0.019756806767080814,0,0,4.716634429400387,24.233207381686725,CXCL12;HGF;ERBB2;CTLA4;PTGS2
Non-arthropod borne lymphocytic choriomeningitis,5/52,0.0058704874982786065,0.019756806767080814,0,0,4.716634429400387,24.233207381686725,EGR2;STAT1;CTLA4;GZMB;STX11
"Hearing Loss, Mixed Conductive-Sensorineural",3/17,0.005898212860035294,0.019756806767080814,0,0,9.473658694246929,48.62929313940271,COL2A1;SIX1;FGFR3
Aplasia/Hypoplasia of the lungs,3/17,0.005898212860035294,0.019756806767080814,0,0,9.473658694246929,48.62929313940271,COL2A1;WT1;FGFR3
Bicornuate uterus,3/17,0.005898212860035294,0.019756806767080814,0,0,9.473658694246929,48.62929313940271,RET;RARB;PAX2
Blastic plasmacytoid dendritic cell neoplasm,3/17,0.005898212860035294,0.019756806767080814,0,0,9.473658694246929,48.62929313940271,ALK;CDKN2A;CIB1
Bone Cysts,3/17,0.005898212860035294,0.019756806767080814,0,0,9.473658694246929,48.62929313940271,CAV1;PPARG;FOS
Childhood Myelodysplastic Syndrome,3/17,0.005898212860035294,0.019756806767080814,0,0,9.473658694246929,48.62929313940271,PPARG;SCN4A;EZH2
Familial partial lipodystrophy,3/17,0.005898212860035294,0.019756806767080814,0,0,9.473658694246929,48.62929313940271,CAV1;RARB;PPARG
Genu recurvatum,3/17,0.005898212860035294,0.019756806767080814,0,0,9.473658694246929,48.62929313940271,COL1A1;CDT1;COL1A2
Ileus,3/17,0.005898212860035294,0.019756806767080814,0,0,9.473658694246929,48.62929313940271,MUC1;WT1;SOX10
Mature B-Cell Non-Hodgkin Lymphoma,3/17,0.005898212860035294,0.019756806767080814,0,0,9.473658694246929,48.62929313940271,PER2;CCND1;CHEK1
Melnick-Needles Syndrome,3/17,0.005898212860035294,0.019756806767080814,0,0,9.473658694246929,48.62929313940271,RET;COL2A1;KDR
Mild short stature,3/17,0.005898212860035294,0.019756806767080814,0,0,9.473658694246929,48.62929313940271,COL1A1;COL1A2;COL2A1
Mouth Diseases,3/17,0.005898212860035294,0.019756806767080814,0,0,9.473658694246929,48.62929313940271,CHAF1A;BRCA1;PTGS2
Non-Functioning Pituitary Gland Neoplasm,3/17,0.005898212860035294,0.019756806767080814,0,0,9.473658694246929,48.62929313940271,CDKN2C;SSTR2;GADD45G
Otosclerosis,3/17,0.005898212860035294,0.019756806767080814,0,0,9.473658694246929,48.62929313940271,COL1A1;BMP2;COL1A2
Overlapping fingers,3/17,0.005898212860035294,0.019756806767080814,0,0,9.473658694246929,48.62929313940271,MECOM;CNTN1;TNNI2
Pathologic Neovascularization,3/17,0.005898212860035294,0.019756806767080814,0,0,9.473658694246929,48.62929313940271,NRP1;KDR;TEK
Portal vein thrombosis,3/17,0.005898212860035294,0.019756806767080814,0,0,9.473658694246929,48.62929313940271,VWF;ESR1;MET
Relative short stature,3/17,0.005898212860035294,0.019756806767080814,0,0,9.473658694246929,48.62929313940271,COL1A1;COL1A2;COL2A1
Scleroatonic muscular dystrophy,3/17,0.005898212860035294,0.019756806767080814,0,0,9.473658694246929,48.62929313940271,VWF;BGN;DMD
Zollinger-Ellison syndrome,3/17,0.005898212860035294,0.019756806767080814,0,0,9.473658694246929,48.62929313940271,IL6;CDKN2C;MET
"Chromosome 5, trisomy 5q",4/33,0.005937972854571421,0.019791278258710503,0,0,6.107123309093752,31.307480434691563,EGR1;FGF1;FLI1;KLF1
"Foramen Ovale, Patent",4/33,0.005937972854571421,0.019791278258710503,0,0,6.107123309093752,31.307480434691563,VWF;GATA4;PLD1;NKX2-5
"Hyperkinesia, Generalized",4/33,0.005937972854571421,0.019791278258710503,0,0,6.107123309093752,31.307480434691563,GRIA2;CNTNAP2;SNCG;FOS
Anemia of chronic disease,4/33,0.005937972854571421,0.019791278258710503,0,0,6.107123309093752,31.307480434691563,CXCL10;IL6;IL18;CCL19
Fibrillary Astrocytoma,4/33,0.005937972854571421,0.019791278258710503,0,0,6.107123309093752,31.307480434691563,TERT;HGF;ESR1;MET
Fibrous Dysplasia,4/33,0.005937972854571421,0.019791278258710503,0,0,6.107123309093752,31.307480434691563,COL1A1;VCAN;IL6;RUNX2
Fulminant hepatitis,4/33,0.005937972854571421,0.019791278258710503,0,0,6.107123309093752,31.307480434691563,CXCL10;SH2D1A;IL18;LTA
Osteomalacia,4/33,0.005937972854571421,0.019791278258710503,0,0,6.107123309093752,31.307480434691563,FGF7;TNFSF11;ANTXR2;FGF2
Soluble Interleukin 6 Receptor Measurement,4/33,0.005937972854571421,0.019791278258710503,0,0,6.107123309093752,31.307480434691563,CR1;WT1;IL18;SORBS2
Spastic,4/33,0.005937972854571421,0.019791278258710503,0,0,6.107123309093752,31.307480434691563,GRIA2;IL6;IL18;LTA
Uveomeningoencephalitic Syndrome,6/74,0.006077024212749559,0.020244689788108155,0,0,3.9167224976550985,19.987975473191867,EGR2;IL6;CTLA4;CCL2;GATA3;FOXO1
"Hyperparathyroidism, Primary",5/53,0.006366159135985408,0.02116590334518713,0,0,4.61813446969697,23.352792824117753,RET;IL6;RAD51;CCND1;ESR1
"Prostate cancer, familial",5/53,0.006366159135985408,0.02116590334518713,0,0,4.61813446969697,23.352792824117753,CBX4;PROS1;BRCA1;ERG;BRCA2
Rous Sarcoma,5/53,0.006366159135985408,0.02116590334518713,0,0,4.61813446969697,23.352792824117753,COL1A2;CDKN2A;CAV1;DMD;BRCA1
Tachycardia,5/53,0.006366159135985408,0.02116590334518713,0,0,4.61813446969697,23.352792824117753,RET;VAV3;IL6;DST;ADRB2
hearing impairment,14/294,0.006413591587876308,0.021297615962393976,0,0,2.2360788863109047,11.290713294908295,STAT1;FANCA;PAX3;SIX1;MITF;SOX10;RUNX2;COL1A1;COL1A2;COL2A1;MYCN;FANCD2;TNFSF11;FGFR3
Carcinoma of larynx,10/177,0.006415288429410812,0.021297615962393976,0,0,2.6688691582352537,13.475310724235605,ANXA1;CCND1;CDKN2A;RARB;PRKD1;BRCA1;PTGS2;CRYAB;AURKA;PAK4
Hemoglobin low,10/177,0.006415288429410812,0.021297615962393976,0,0,2.6688691582352537,13.475310724235605,COL17A1;MUC1;CCND1;TERT;MECOM;FANCD2;SH2D1A;FANCA;TNFSF11;KLF1
Central Nervous System Neoplasms,6/75,0.006484618366777294,0.021517142762488294,0,0,3.859760324848965,19.44671656193495,YAP1;MYCN;PARP1;HGF;ERBB2;BRCA2
"Sarcoma, Spindle Cell",4/34,0.006613552822076582,0.021837080016256796,0,0,5.903250188964475,29.62625374712648,IL6;PAX3;MET;GFAP
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,4/34,0.006613552822076582,0.021837080016256796,0,0,5.903250188964475,29.62625374712648,LEPR;IL18;CTLA4;PRTN3
Cancer of Urinary Tract,4/34,0.006613552822076582,0.021837080016256796,0,0,5.903250188964475,29.62625374712648,CCND1;ERBB2;FGFR3;EZH2
Coxa valga,4/34,0.006613552822076582,0.021837080016256796,0,0,5.903250188964475,29.62625374712648,RPS6KA3;COL2A1;BGN;EZH2
Coxa valga deformity,4/34,0.006613552822076582,0.021837080016256796,0,0,5.903250188964475,29.62625374712648,RPS6KA3;COL2A1;BGN;EZH2
Infant Acute Lymphoblastic Leukemia,4/34,0.006613552822076582,0.021837080016256796,0,0,5.903250188964475,29.62625374712648,TERT;CDKN2A;TIMP1;RUNX1T1
Metastatic Carcinoma,4/34,0.006613552822076582,0.021837080016256796,0,0,5.903250188964475,29.62625374712648,CDKN2A;ERBB2;BRCA1;CRYAB
Myelodysplastic Syndrome with Isolated del(5q),4/34,0.006613552822076582,0.021837080016256796,0,0,5.903250188964475,29.62625374712648,EGR1;FGF1;FLI1;KLF1
Prolonged bleeding time,4/34,0.006613552822076582,0.021837080016256796,0,0,5.903250188964475,29.62625374712648,VWF;CD36;CALR;TEK
prostatitis,4/34,0.006613552822076582,0.021837080016256796,0,0,5.903250188964475,29.62625374712648,IL6;NPHS1;PTGS2;RUNX2
Congenital pectus carinatum,6/76,0.006911704674492649,0.022299112392347286,0,0,3.8044256426944356,18.925263636633144,FBN2;COL1A1;RPS6KA3;COL2A1;BGN;SOX5
Granulomatosis with polyangiitis,6/76,0.006911704674492649,0.022299112392347286,0,0,3.8044256426944356,18.925263636633144,CTLA4;TNFSF11;PRTN3;TIMP1;TNFRSF4;PPARGC1A
"Papillary renal cell carcinoma, sporadic",3/18,0.006962355297133161,0.022299112392347286,0,0,8.841628959276019,43.91847054848402,CDKN2A;ERBB2;FGFR3
Aneurysmal disease,3/18,0.006962355297133161,0.022299112392347286,0,0,8.841628959276019,43.91847054848402,JUN;IL6;FOS
Chorioretinal atrophy,3/18,0.006962355297133161,0.022299112392347286,0,0,8.841628959276019,43.91847054848402,VCAN;ERG;PAX2
Congenital cystic kidney disease,3/18,0.006962355297133161,0.022299112392347286,0,0,8.841628959276019,43.91847054848402,PRKD1;PKD2;STX11
Diabetic Neuralgia,3/18,0.006962355297133161,0.022299112392347286,0,0,8.841628959276019,43.91847054848402,HGF;LEPR;SGK1
Diastrophic dysplasia,3/18,0.006962355297133161,0.022299112392347286,0,0,8.841628959276019,43.91847054848402,COL2A1;A2M;FGFR3
Hypoplasia of vagina,3/18,0.006962355297133161,0.022299112392347286,0,0,8.841628959276019,43.91847054848402,WT1;GATA4;ZFPM2
Narrowing,3/18,0.006962355297133161,0.022299112392347286,0,0,8.841628959276019,43.91847054848402,BMP2;CD36;ESR1
Primary Cutaneous Anaplastic Large Cell Lymphoma,3/18,0.006962355297133161,0.022299112392347286,0,0,8.841628959276019,43.91847054848402,ALK;MUC1;CCND1
Pseudohypoaldosteronism,3/18,0.006962355297133161,0.022299112392347286,0,0,8.841628959276019,43.91847054848402,NR4A1;KLHL3;SGK1
Recurrent Carcinoma,3/18,0.006962355297133161,0.022299112392347286,0,0,8.841628959276019,43.91847054848402,CDKN2A;PAEP;BRCA1
Rudimentary vagina,3/18,0.006962355297133161,0.022299112392347286,0,0,8.841628959276019,43.91847054848402,WT1;GATA4;ZFPM2
Tarsal Coalition,3/18,0.006962355297133161,0.022299112392347286,0,0,8.841628959276019,43.91847054848402,TNNI2;BMPR1B;FGFR3
Thymus Hyperplasia,3/18,0.006962355297133161,0.022299112392347286,0,0,8.841628959276019,43.91847054848402,CCL21;CCND1;ESR1
Urogenital sinus anomaly,3/18,0.006962355297133161,0.022299112392347286,0,0,8.841628959276019,43.91847054848402,WT1;GATA4;ZFPM2
Venous malformation,3/18,0.006962355297133161,0.022299112392347286,0,0,8.841628959276019,43.91847054848402,STAT1;PECAM1;TEK
"Anemia, hereditary spherocytic hemolytic",2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,SPTA1;SPTB
"Carcinoma, Giant Cell",2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,ALK;TGFBR2
Abnormality of the carpal bones,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,COL2A1;PITX1
Acinar cell carcinoma of pancreas,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,BRCA1;BRCA2
Adrenal incidentaloma,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,C4B;CCND1
Adult Rhabdomyosarcoma,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,PAX3;FOXO1
Aplasia/Hypoplasia of the middle phalanges of the toes,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,BMP2;BMPR1B
Bile duct adenoma,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,KRT19;PPARG
Bile Reflux,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,MUC1;PTGS2
Centrocytic lymphoma,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,IL6;CCND1
Cerebrovascular Occlusion,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,ASCL1;GFAP
Chagas' disease without mention of organ involvement,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,CCL2;VIM
Chronic kidney disease stage 3,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,PRKD1;PKD2
Cigarette-paper scars,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,COL1A1;COL3A1
Classic medulloblastoma,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,PARP1;OTX1
Congenital lamellar cataract,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,IL2RG;CRYAB
Cri-du-Chat Syndrome,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,TERT;CTNND2
Critical illness myopathy,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,SAA1;SLC2A4
Crumpled long bones,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,COL1A1;COL1A2
Embryopathies,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,EGR1;PAEP
Endometrial neoplasm malignant metastatic,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,STMN1;EZR
Epithelial tumor of ovary,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,ERBB2;VIM
Familial Neuroblastoma,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,ALK;RET
hazardous drinking,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,PER2;ALDH2
Headache associated with sexual activity,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,IL6;KIT
Hepatoblastoma Caused By Somatic Mutation,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,MET;CDKN3
Hereditary Ovarian Carcinoma,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,BRCA1;BRCA2
Immune dysregulation,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,STAT1;LEPR
Intermediate Grade Ductal Breast Carcinoma In Situ,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,CCND1;ERBB2
Lacrimation abnormality,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,PAX3;LIFR
LEPTIN RECEPTOR DEFICIENCY,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,IL6;LEPR
Myocardial necrosis,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,IL6;SELE
Orthostatic hypotension due to autonomic dysfunction,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,LEPR;LMNB1
Pilomyxoid astrocytoma,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,COL1A1;COL2A1
Pineal germinoma,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,CDKN2A;KIT
Pleomorphic carcinoma,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,ALK;KRT19
Posterior polar cataract,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,VIM;CRYAB
Prostate Stromal Proliferation of Uncertain Malignant Potential,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,ALK;PTGS2
Radial deviation of the 2nd finger,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,BMP2;BMPR1B
Secondary malignant neoplasm of prostate,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,CXCR4;AURKA
Severe autosomal recessive muscular dystrophy of childhood - North African type (disorder),2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,DMD;UTRN
Severe platyspondyly,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,COL2A1;FGFR3
Small cell carcinoma of esophagus,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,PARP1;BRCA2
Somatostatinoma,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,EPAS1;SSTR2
Spherocytosis,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,SPTA1;SPTB
Squamous Lung Dysplasia,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,ERBB2;RARB
Superficial thrombophlebitis,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,PROC;PROS1
Tension Headache,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,LTA;ESR1
Triple vessel disease,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,IL6;APOB
Ulnar deviation of the 2nd finger,2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,BMP2;BMPR1B
Virchow's node (disorder),2/6,0.006982583883428581,0.022299112392347286,0,0,22.066591422121896,109.54597964097579,CCND1;ESR1
Esophageal Atresia,4/35,0.007338145822784945,0.023379026255134577,0,0,5.712530173359666,28.075195417103373,MYCN;FANCD2;FANCA;BRCA2
Hepatitis B Virus-Related Hepatocellular Carcinoma,4/35,0.007338145822784945,0.023379026255134577,0,0,5.712530173359666,28.075195417103373,KRT19;CDKN2A;CAV1;ESR1
Hereditary Melanoma,4/35,0.007338145822784945,0.023379026255134577,0,0,5.712530173359666,28.075195417103373,COL17A1;TERT;CDKN2A;S100A4
Nephrogenic Diabetes Insipidus,4/35,0.007338145822784945,0.023379026255134577,0,0,5.712530173359666,28.075195417103373,VWF;PRKCA;ADRA1A;AQP1
Varicose Ulcer,4/35,0.007338145822784945,0.023379026255134577,0,0,5.712530173359666,28.075195417103373,NRP1;F13A1;ESR1;ATF3
aggressive cancer,6/77,0.00735879459051047,0.023433695813119163,0,0,3.7506496839808783,18.422662924139967,RET;YAP1;MUC1;SATB1;EZR;PTGS2
"Hypertension, Portal",7/101,0.007374962598412673,0.02345182235366454,0,0,3.3087292334596325,16.24475028614013,NGFR;IL6;COL1A2;DUSP1;TIMP1;PTGS2;AGT
Forced expiratory volume function,7/101,0.007374962598412673,0.02345182235366454,0,0,3.3087292334596325,16.24475028614013,MECOM;LRP1;RUVBL1;RARB;ADRB2;TNS1;SYNE1
Xeroderma Pigmentosum,7/101,0.007374962598412673,0.02345182235366454,0,0,3.3087292334596325,16.24475028614013,CDKN2A;HGF;CHEK1;KIT;BRCA1;MET;ATF3
"Bone Diseases, Developmental",5/55,0.00744422966411305,0.023605026640313147,0,0,4.432954545454545,21.722878478382583,RPS6KA3;IL6;BMPR1B;PCSK5;FGFR3
"Osteoporosis, Postmenopausal",5/55,0.00744422966411305,0.023605026640313147,0,0,4.432954545454545,21.722878478382583,IL6;COL1A2;TNFSF11;DMD;ESR1
Common Migraine,5/55,0.00744422966411305,0.023605026640313147,0,0,4.432954545454545,21.722878478382583,DLG2;LRP1;LTA;FHL5;RAMP1
Gingivitis,5/55,0.00744422966411305,0.023605026640313147,0,0,4.432954545454545,21.722878478382583,IL6;IL18;LTA;ESR1;SELE
Immunoglobulin A deficiency (disorder),5/55,0.00744422966411305,0.023605026640313147,0,0,4.432954545454545,21.722878478382583,C4B;C4A;BLM;MUC1;GATA3
Lymphocytic Choriomeningitis,5/55,0.00744422966411305,0.023605026640313147,0,0,4.432954545454545,21.722878478382583,EGR2;STAT1;CTLA4;GZMB;STX11
Decreased projection of lower jaw,17/395,0.00764028603527879,0.024181037235123635,0,0,2.0150880185926914,9.822184309031435,PLK4;CDT1;GATA4;MITF;LIFR;RUNX2;TGFBR2;COL1A1;COL3A1;COL1A2;COL2A1;MYCN;WT1;RARB;TNNI2;BUB1;EZH2
Decreased projection of mandible,17/395,0.00764028603527879,0.024181037235123635,0,0,2.0150880185926914,9.822184309031435,PLK4;CDT1;GATA4;MITF;LIFR;RUNX2;TGFBR2;COL1A1;COL3A1;COL1A2;COL2A1;MYCN;WT1;RARB;TNNI2;BUB1;EZH2
Hypoplastic mandible condyle,17/395,0.00764028603527879,0.024181037235123635,0,0,2.0150880185926914,9.822184309031435,PLK4;CDT1;GATA4;MITF;LIFR;RUNX2;TGFBR2;COL1A1;COL3A1;COL1A2;COL2A1;MYCN;WT1;RARB;TNNI2;BUB1;EZH2
Retrusion of lower jaw,17/395,0.00764028603527879,0.024181037235123635,0,0,2.0150880185926914,9.822184309031435,PLK4;CDT1;GATA4;MITF;LIFR;RUNX2;TGFBR2;COL1A1;COL3A1;COL1A2;COL2A1;MYCN;WT1;RARB;TNNI2;BUB1;EZH2
Premature Menopause,9/154,0.007672110199877251,0.024270321291745466,0,0,2.763207845618475,13.457274207068028,CXCL12;WT1;KDR;FANCA;PPARG;BRCA1;LAMC1;ESR1;FOXO1
Abnormal skeletal development,6/78,0.007826396841798245,0.024735097030360947,0,0,3.698367501898254,17.938018250011666,COL2A1;LIFR;KIF22;BMPR1B;FGFR3;RUNX2
Bronchial Hyperreactivity,6/78,0.007826396841798245,0.024735097030360947,0,0,3.698367501898254,17.938018250011666,LTA;CTLA4;PLA2G4A;CCL2;ADRB2;ESR1
HER2 gene amplification,5/56,0.008028249679555084,0.025349188927076605,0,0,4.3458110516934045,20.967620260715538,CCND1;KDR;BRCA1;MET;ESR1
Pituitary-dependent Cushing's disease,5/56,0.008028249679555084,0.025349188927076605,0,0,4.3458110516934045,20.967620260715538,CCND1;CDKN2A;PPARG;SSTR2;FGFR4
5q-syndrome,4/36,0.008113163925984178,0.02538172118725872,0,0,5.533730158730159,26.640856484578737,EGR1;FGF1;FLI1;KLF1
Decreased testosterone in males,4/36,0.008113163925984178,0.02538172118725872,0,0,5.533730158730159,26.640856484578737,WT1;LEPR;GATA4;ZFPM2
Mesenchymal Cell Neoplasm,4/36,0.008113163925984178,0.02538172118725872,0,0,5.533730158730159,26.640856484578737,ALK;MMP14;KIT;SDC1
Plexiform Neurofibroma,4/36,0.008113163925984178,0.02538172118725872,0,0,5.533730158730159,26.640856484578737,CCNA2;CMA1;KIT;CD36
Scaphycephaly,4/36,0.008113163925984178,0.02538172118725872,0,0,5.533730158730159,26.640856484578737,FBN2;BMP2;CNTN1;EZH2
Squamous intraepithelial lesion,4/36,0.008113163925984178,0.02538172118725872,0,0,5.533730158730159,26.640856484578737,CDKN2A;TAL1;CCL2;MKI67
Growth failure,11/212,0.00811892073439546,0.02538172118725872,0,0,2.4404933856065294,11.747456577684044,STAT5B;IL6;RAD51;DST;NPHS1;TNFSF11;HMGA2;KRT5;NKX2-5;IL2RG;FGFR3
"Anaplastic Large Cell Lymphoma, ALK-Positive",3/19,0.008133035139216909,0.02538172118725872,0,0,8.288602941176471,39.8832745155279,ALK;STAT1;TPM3
"Histiocytoma, Benign Fibrous",3/19,0.008133035139216909,0.02538172118725872,0,0,8.288602941176471,39.8832745155279,ALK;PRKCA;MKI67
absence of radius and ulna,3/19,0.008133035139216909,0.02538172118725872,0,0,8.288602941176471,39.8832745155279,FANCD2;FANCA;FGFR3
Aortic Rupture,3/19,0.008133035139216909,0.02538172118725872,0,0,8.288602941176471,39.8832745155279,STAT1;CXCR2;AGT
Back Pain,3/19,0.008133035139216909,0.02538172118725872,0,0,8.288602941176471,39.8832745155279,CDKN2A;BRCA1;BRCA2
blue iris (physical finding),3/19,0.008133035139216909,0.02538172118725872,0,0,8.288602941176471,39.8832745155279,PAX3;MITF;SOX10
Cerebral Small Vessel Diseases,3/19,0.008133035139216909,0.02538172118725872,0,0,8.288602941176471,39.8832745155279,CDKN2A;AGT;MYLK
Chronic berylliosis,3/19,0.008133035139216909,0.02538172118725872,0,0,8.288602941176471,39.8832745155279,CXCR4;CTLA4;FGF2
Endogenous Hyperinsulinism,3/19,0.008133035139216909,0.02538172118725872,0,0,8.288602941176471,39.8832745155279,COL3A1;FANCA;LEPR
Epidermolysis Bullosa Acquisita,3/19,0.008133035139216909,0.02538172118725872,0,0,8.288602941176471,39.8832745155279,IL6;MMP14;TIMP1
Exogenous Hyperinsulinism,3/19,0.008133035139216909,0.02538172118725872,0,0,8.288602941176471,39.8832745155279,COL3A1;FANCA;LEPR
Lobular Neoplasia,3/19,0.008133035139216909,0.02538172118725872,0,0,8.288602941176471,39.8832745155279,CDKN2A;PTGS2;ESR1
Milium Cyst,3/19,0.008133035139216909,0.02538172118725872,0,0,8.288602941176471,39.8832745155279,COL17A1;KRT5;TGFBR2
Parathyroid hyperplasia,3/19,0.008133035139216909,0.02538172118725872,0,0,8.288602941176471,39.8832745155279,RET;CDKN2C;CCND1
Pulmonary Infiltrate,3/19,0.008133035139216909,0.02538172118725872,0,0,8.288602941176471,39.8832745155279,CAV1;CTLA4;PRTN3
Smooth Muscle Tumor,3/19,0.008133035139216909,0.02538172118725872,0,0,8.288602941176471,39.8832745155279,WT1;KIT;HMGA2
Squamous cell carcinoma of vulva,3/19,0.008133035139216909,0.02538172118725872,0,0,8.288602941176471,39.8832745155279,CCND1;CDKN2A;FGFR3
Thrombosis of cerebral veins,3/19,0.008133035139216909,0.02538172118725872,0,0,8.288602941176471,39.8832745155279,PROC;SERPINC1;PROS1
Hypoplastic feet,7/103,0.008182954906110927,0.025525650324868084,0,0,3.2394644216133943,15.567900514244558,BMP2;COL3A1;COL2A1;BGN;NDN;BMPR1B;FGFR3
"Hepatitis, Autoimmune",8/129,0.00829279413972841,0.025844271667014387,0,0,2.9402575789095446,14.09079726557009,OPRD1;C4A;CXCL10;IL6;CXCL12;IL18;CTLA4;CCL2
early pregnancy,8/129,0.00829279413972841,0.025844271667014387,0,0,2.9402575789095446,14.09079726557009,IL6;EPAS1;PTPRN;KDR;PAEP;ESR1;PCSK5;RAMP1
Conduction disorder of the heart,6/79,0.008315016944824758,0.0259015091843428,0,0,3.6475177083658377,17.470486856240516,ACTC1;DMD;FLNC;NKX2-5;CRYAB;SYNE1
Recurrent respiratory infections,11/213,0.008395707495985647,0.026140737850273345,0,0,2.428286261805904,11.607292632126127,BLM;TERT;STAT1;TPM3;TNFSF11;CTLA4;NDN;MCM4;PRTN3;RUNX2;FLI1
Acquired flat foot,7/104,0.008610544408538368,0.026797227176896976,0,0,3.2059031210281033,15.243324714174182,COL1A1;RPS6KA3;COL1A2;COL2A1;FLI1;GRIN2D;TGFBR2
Abnormality of epiphysis morphology,5/57,0.008643318846439856,0.026833548996386146,0,0,4.262019230769231,20.24871972626922,ACAN;CDT1;COL2A1;TNFSF11;BMPR1B
Cardiac defects,5/57,0.008643318846439856,0.026833548996386146,0,0,4.262019230769231,20.24871972626922,RCAN1;MMP14;ALDH2;GATA4;TEK
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,5/57,0.008643318846439856,0.026833548996386146,0,0,4.262019230769231,20.24871972626922,IL6;CCND2;CCND1;DUSP1;ADRA1A
Heart Septal Defects,5/57,0.008643318846439856,0.026833548996386146,0,0,4.262019230769231,20.24871972626922,ACTA2;ACTC1;GATA4;NKX2-5;PCSK5
Peutz-Jeghers Syndrome,5/57,0.008643318846439856,0.026833548996386146,0,0,4.262019230769231,20.24871972626922,CDKN2A;BRCA1;BRCA2;PTGS2;AGT
Malignant neoplasm of testis,10/185,0.008646188211462123,0.026833548996386146,0,0,2.545812807881773,12.094231818460758,RIMS2;MYCN;SHC3;WT1;KIT;ERBB2;PTGS2;ESR1;TEAD1;NDC80
Delayed Puberty,8/130,0.008670311664654252,0.02687116434693953,0,0,2.9160070525565516,13.844765663077009,STAT1;WT1;LEPR;NDN;GATA4;ZFPM2;ALDOA;SOX10
Lyme Disease,8/130,0.008670311664654252,0.02687116434693953,0,0,2.9160070525565516,13.844765663077009,JUN;IL6;RAD51;IRF7;CCL2;ENO2;PTGS2;DCN
Tauopathies,8/130,0.008670311664654252,0.02687116434693953,0,0,2.9160070525565516,13.844765663077009,PRKN;RCAN1;IL6;PROS1;LEPR;FKBP4;PPARGC1A;NECTIN3
Parkinsonian Disorders,11/214,0.008679759123204608,0.02688803610306372,0,0,2.4161994052348414,11.469122316662347,PRKN;RIMS2;CHAF1A;PARP1;ZFPM2;SGK1;SNCAIP;TNS1;CIT;RUNX1T1;GFAP
"Dementia, Vascular",6/80,0.008825156739244838,0.027325842628293375,0,0,3.5980422335775413,17.0192755690784,GRIA2;IL6;PLA2G2A;APOB;ESR1;AGT
"Simple syndactyly of toes, first web space",4/37,0.008939962186225897,0.027566935740446795,0,0,5.3657665086236515,25.31152212111557,BMP2;BMPR1B;CEP55;SOX5
Abnormality of the hair,4/37,0.008939962186225897,0.027566935740446795,0,0,5.3657665086236515,25.31152212111557,TERT;CDKN2A;MITF;ANTXR2
Abnormality of the hair shaft,4/37,0.008939962186225897,0.027566935740446795,0,0,5.3657665086236515,25.31152212111557,TERT;CDKN2A;MITF;ANTXR2
Blood Platelet Disorders,4/37,0.008939962186225897,0.027566935740446795,0,0,5.3657665086236515,25.31152212111557,VWF;PLA2G4A;CD36;FLI1
Cone-shaped epiphysis,4/37,0.008939962186225897,0.027566935740446795,0,0,5.3657665086236515,25.31152212111557,PLK4;COL2A1;BMPR1B;FGFR3
Hemorrhage,4/37,0.008939962186225897,0.027566935740446795,0,0,5.3657665086236515,25.31152212111557,IL6;VWF;TIMP1;FOS
Multiple Epiphyseal Dysplasia,4/37,0.008939962186225897,0.027566935740446795,0,0,5.3657665086236515,25.31152212111557,ACAN;COL2A1;VWF;KDR
QRS complex feature,4/37,0.008939962186225897,0.027566935740446795,0,0,5.3657665086236515,25.31152212111557,HLF;TRIM63;MITF;PRKCA
Tubular Aggregate Myopathy,4/37,0.008939962186225897,0.027566935740446795,0,0,5.3657665086236515,25.31152212111557,TPM3;BIN1;VIM;ESR1
Decreased projection of midface,9/158,0.00900445056115475,0.02771488999482828,0,0,2.6884736161566405,12.662808369606852,COL1A1;ACAN;COL1A2;COL2A1;SIX3;LIFR;KIF22;FGFR3;RUNX2
Hypotrophic midface,9/158,0.00900445056115475,0.02771488999482828,0,0,2.6884736161566405,12.662808369606852,COL1A1;ACAN;COL1A2;COL2A1;SIX3;LIFR;KIF22;FGFR3;RUNX2
Midface retrusion,9/158,0.00900445056115475,0.02771488999482828,0,0,2.6884736161566405,12.662808369606852,COL1A1;ACAN;COL1A2;COL2A1;SIX3;LIFR;KIF22;FGFR3;RUNX2
Small midface,9/158,0.00900445056115475,0.02771488999482828,0,0,2.6884736161566405,12.662808369606852,COL1A1;ACAN;COL1A2;COL2A1;SIX3;LIFR;KIF22;FGFR3;RUNX2
Cutis Laxa,5/58,0.009290214135866394,0.028535826359821128,0,0,4.181389365351629,19.563858120650565,RPS6KA3;MMP14;COL3A1;FOS;EZH2
Large cell carcinoma of lung,5/58,0.009290214135866394,0.028535826359821128,0,0,4.181389365351629,19.563858120650565,IL18;PLAUR;HMGA1;VIM;BMX
Acute myelomonocytic leukemia,6/81,0.009357313927307721,0.028535826359821128,0,0,3.549886104783599,16.583637289005996,RET;EGR1;KIT;SIRPA;FLI1;RUNX1T1
Congenital ear anomaly NOS (disorder),6/81,0.009357313927307721,0.028535826359821128,0,0,3.549886104783599,16.583637289005996,KIT;SIX1;TNNI2;GATA4;FGFR3;FLI1
Connective Tissue Diseases,6/81,0.009357313927307721,0.028535826359821128,0,0,3.549886104783599,16.583637289005996,ACTA2;FBN2;COL1A1;COL3A1;COL1A2;TGFBR2
Absent radius,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,FANCD2;FANCA;FGFR3
Acute Kidney Tubular Necrosis,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,TEK;PTGS2;PPARA
Adenomatous goiter,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,RET;PLA2G2A;MET
Carcinoma of ampulla of Vater,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,ERBB2;MKI67;PTGS2
Cartilaginous exostosis,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,BMP2;S100A4;FGFR3
Chronic myocardial ischemia,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,HGF;CCL2;FGF2
Clear cell sarcoma of kidney,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,NGFR;TERT;WT1
Compensatory Hyperinsulinemia,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,COL3A1;FANCA;LEPR
Congenital abnormality of vein,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,STAT1;PECAM1;TEK
Cutaneous Fibrous Histiocytoma,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,COL1A1;ESR1;TGFBR2
Elevated circulating luteinizing hormone level,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,WT1;GATA4;ZFPM2
Endometrial Endometrioid Adenocarcinoma,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,GATA4;ESR1;FOXO1
Gastric dysplasia,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,CDKN2A;SIX1;VIM
Glycogen Storage Disease Type I,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,VWF;HGF;APOB
Hereditary Motor and Sensory Neuropathy Type I,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,EGR2;ERBB2;HOXD10
High Grade Intraepithelial Neoplasia,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,ALDH2;CDKN2A;ERBB2
Hypernatremia,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,ARNT2;SGK1;AGT
Hypoventilation,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,RET;NDN;DMD
Infantile neuronal ceroid lipofuscinosis,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,DPYSL2;VIM;GFAP
Morphologically abnormal structure (morphologic abnormality),3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,CDKN2C;CDKN2A;CFL1
Peyronie Disease,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,PARP1;CCND1;CCL2
Pregnancy associated hypertension,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,TIMP1;ESR1;AGT
Radial aplasia,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,FANCD2;FANCA;FGFR3
Rokitansky Kuster Hauser syndrome,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,HOXA10;LAMC1;ESR1
Streak ovary,3/20,0.009412499398464572,0.028535826359821128,0,0,7.800638807559222,36.395571143290276,WT1;GATA4;ZFPM2
Chronic graft-versus-host disease,7/106,0.009514636142854886,0.028535826359821128,0,0,3.140814538074812,14.62025303356976,IL6;PARP1;HGF;CAV1;PECAM1;A2M;AGT
Malignant Testicular Germ Cell Tumor,7/106,0.009514636142854886,0.028535826359821128,0,0,3.140814538074812,14.62025303356976,SHC3;TERT;WT1;KIT;PTGS2;ESR1;TEAD1
Splenomegaly,12/247,0.009615682456425424,0.028535826359821128,0,0,2.278413837157879,10.581773915931391,MECOM;CCND1;SH2D1A;TNFSF11;CTLA4;MCM4;CALR;ALDOA;IL2RG;TNFRSF4;SPTB;KLF1
"Adenocarcinoma, Scirrhous",2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,MMP14;MET
"Aortic Aneurysm, Thoracoabdominal",2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,ACTA2;TGFBR2
Acral Lentiginous Malignant Melanoma,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,TERT;PLD1
Acute-Phase Reaction,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,IL6;IL18
Acute peritonitis,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,COL3A1;ANXA1
Acute urticaria,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,IL6;IL18
Adenitis,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,CXCL10;CCL19
Adult Angiosarcoma,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,RET;EFNA3
Advanced breast cancer,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,ERBB2;ESR1
asthma with copd,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,CXCR2;CXCR4
Brachydactyly type C,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,MUC1;BMPR1B
Branchioma,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,CDKN2A;SIX1
Breathing dysregulation,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,RET;ASCL1
Carcinoma of unknown primary,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,CDKN2A;MET
CD4+ T-cell lymphopenia,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,LEPR;IL2RG
Central Neurocytoma,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,MYCN;SYP
Childhood Acute Promyelocytic Leukemia with PML-RARA,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,KIT;BAK1
CHROMOSOME 8p11 MYELOPROLIFERATIVE SYNDROME,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,STAT5A;STAT5B
Chronic intestinal pseudo-obstruction,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,APOB;SOX10
Chronic osteomyelitis,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,TERT;STMN1
Circadian Rhythm Disorders,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,PER2;PPARG
colon (non-specific) lesion,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,ERBB2;KIT
Decreased number of CD4+ T cells,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,LEPR;IL2RG
Enlarged joints,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,COL2A1;LIFR
Epidermolysis bullosa inversa dystrophica,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,COL17A1;LAMC1
Fenestration (morphologic abnormality),2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,MEF2C;FLT4
Fetid chronic bronchitis,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,CXCL10;IL6
Fibrosis of bile duct,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,HGF;TIMP1
GIANT AXONAL NEUROPATHY 1,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,VIM;GFAP
Hyperplasia of foramen magnum,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,GPSM2;RUNX2
Idiopathic osteoporosis,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,COL1A1;ESR1
Immunodeficiency congenital,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,SH2D1A;CXCR4
Increased circumference of foramen magnum,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,GPSM2;RUNX2
Increased diameter of foramen magnum,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,GPSM2;RUNX2
Intracortical osteosarcoma,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,CDKN2A;ERBB2
Intratubular malignant germ cells,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,CISH;KLF4
Large foramen magnum,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,GPSM2;RUNX2
Lymphangiectasis,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,FLT4;KDR
Malignant neoplasm of appendix,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,KDR;BRCA1
Malignant neoplasm of muscle,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,PAX3;SIX1
Microcolon,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,SOX10;MYLK
Microcolon on contrast enema,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,SOX10;MYLK
Molluscoid pseudotumors,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,COL1A1;COL3A1
Non-small cell lung cancer stage III,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,CCND2;CCND1
Oxalosis,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,IL6;CCL2
Papillary cystic tumor,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,CCND1;VIM
Primary malignant neoplasm of appendix,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,KDR;BRCA1
Prominent joints,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,COL2A1;LIFR
Pulmonary Valve Insufficiency,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,COL1A1;COL1A2
Spinocerebellar ataxia type 31,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,LMNB1;SYNE1
Subacute Bacterial Endocarditis,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,ERG;ASCL1
Temporomandibular Joint Dysfunction Syndrome,2/7,0.009632328522590008,0.028535826359821128,0,0,17.65237020316027,81.9534284822553,CAPN3;CCL2
Turner Syndrome,9/160,0.009732950928809778,0.028821207424112198,0,0,2.6525912874415214,12.28743455083924,VWF;WT1;KIT;BGN;DMD;BRCA1;ZFPM2;ESR1;AGT
"Infant, Premature",13/278,0.009746008800421955,0.028847155180094248,0,0,2.1905136268343814,10.144043928355769,GRIA2;CHPF;GAD1;HGF;GATA3;PTGS2;RIMS2;COL1A2;MYCN;STMN1;KDR;PPARGC1A;RUNX1T1
"Eczema, Infantile",4/38,0.009819837244998799,0.029001770860779215,0,0,5.207683073229291,24.07694534125496,CXCL10;IL6;PPARA;SELE
DOWN SYNDROME CRITICAL REGION,4/38,0.009819837244998799,0.029001770860779215,0,0,5.207683073229291,24.07694534125496,RCAN1;CXCL12;ETS2;CIT
Idiopathic Membranous Glomerulonephritis,4/38,0.009819837244998799,0.029001770860779215,0,0,5.207683073229291,24.07694534125496,C3;C4A;PLA2G2A;CCL2
Lipoid nephrosis,4/38,0.009819837244998799,0.029001770860779215,0,0,5.207683073229291,24.07694534125496,MUC1;MMP14;NPHS1;CTLA4
Septic Shock,4/38,0.009819837244998799,0.029001770860779215,0,0,5.207683073229291,24.07694534125496,IL6;VWF;SAA1;AQP1
beta Thalassemia,8/133,0.009880130416240442,0.02916701357163552,0,0,2.84558352402746,13.138712383319046,SPTA1;COL1A1;TERT;FANCD2;TNFSF11;HMGA2;BRCA2;KLF1
Libman-Sacks Disease,5/59,0.00996969741322719,0.029392663664281744,0,0,4.1037457912457915,18.910902059418298,IL6;TERT;ANXA3;CTLA4;PTGS2
Radial club hand,5/59,0.00996969741322719,0.029392663664281744,0,0,4.1037457912457915,18.910902059418298,FANCD2;FANCA;BRCA2;PITX1;FGFR3
Sleep Apnea Syndromes,5/59,0.00996969741322719,0.029392663664281744,0,0,4.1037457912457915,18.910902059418298,LEPR;NDN;PTGS2;FGFR3;AGT
White Blood Cell Count procedure,7/107,0.009991825024983093,0.029444974492227494,0,0,3.109246575342466,14.321152470484869,TERT;CDKN2A;CXCR2;LEPR;PLAUR;LTA;E2F2
Mechanical Allodynia,7/108,0.01048623104452645,0.030884908069156405,0,0,3.0783037207830373,14.029960892708136,IL6;GAD1;CCL2;FOS;PTGS2;AGT;GFAP
Van der Woude syndrome,6/83,0.010489647901391567,0.030884908069156405,0,0,3.4573262728160223,15.756302666684233,RIMS2;IL6;STAT1;MAPKAPK2;CCL2;FOS
Heartburn,9/162,0.010505063671217719,0.030916743039394477,0,0,2.6176470588235294,11.925732695474077,COL1A1;RET;ACAN;ARNT2;COL1A2;TERT;NPHS1;CAV1;ASCL1
Deglutition Disorders,10/191,0.010677547183087395,0.031370252690910656,0,0,2.460659173175843,11.170438245925586,RAD51;FLAD1;TPM3;CAV1;KIT;SERPING1;LIFR;SCN4A;SNCAIP;GRIN2D
"AURAL ATRESIA, CONGENITAL",5/60,0.010682514577741614,0.031370252690910656,0,0,4.028925619834711,18.28788574447995,FBN2;IL6;LRP1;PPARA;A2M
Absence Epilepsy,5/60,0.010682514577741614,0.031370252690910656,0,0,4.028925619834711,18.28788574447995,EGR1;MEF2C;ACTC1;ESR1;GRIA4
Cavernous Hemangioma of Brain,5/60,0.010682514577741614,0.031370252690910656,0,0,4.028925619834711,18.28788574447995,IL6;PECAM1;VIM;PTGS2;KLF4
Oropharyngeal Carcinoma,5/60,0.010682514577741614,0.031370252690910656,0,0,4.028925619834711,18.28788574447995,IL6;ALDH2;CDKN2A;E2F1;PMAIP1
Benign Ovarian Neoplasm,4/39,0.01075402615115288,0.03140726527761378,0,0,5.0586329770003235,22.928127850650988,BMP2;CCND1;ERBB2;SLC2A4
Broad hallux,4/39,0.01075402615115288,0.03140726527761378,0,0,5.0586329770003235,22.928127850650988,BMP2;NKX2-5;BMPR1B;FGFR3
Myofibrillar Myopathy,4/39,0.01075402615115288,0.03140726527761378,0,0,5.0586329770003235,22.928127850650988,DMD;FLNC;CRYAB;GFAP
Stage 4S neuroblastoma,4/39,0.01075402615115288,0.03140726527761378,0,0,5.0586329770003235,22.928127850650988,IL6;MYCN;CXCL12;CCND1
"Leukomalacia, Periventricular",3/21,0.010802677604420465,0.03140726527761378,0,0,7.366892911010558,33.35700562839637,IL6;CDKN2A;IL18
"Oncocytoma, renal",3/21,0.010802677604420465,0.03140726527761378,0,0,7.366892911010558,33.35700562839637,DLG2;CCND1;PROS1
Anaplastic Ependymoma,3/21,0.010802677604420465,0.03140726527761378,0,0,7.366892911010558,33.35700562839637,RAB3A;CDKN2A;PDGFA
Chronic venous insufficiency,3/21,0.010802677604420465,0.03140726527761378,0,0,7.366892911010558,33.35700562839637,TIMP1;SELE;SKAP2
Diabetic Ketoacidosis,3/21,0.010802677604420465,0.03140726527761378,0,0,7.366892911010558,33.35700562839637,CDKN2A;PTPRN;CTLA4
Early tooth exfoliation,3/21,0.010802677604420465,0.03140726527761378,0,0,7.366892911010558,33.35700562839637,COL3A1;TERT;RUNX2
Fibrolamellar Hepatocellular Carcinoma,3/21,0.010802677604420465,0.03140726527761378,0,0,7.366892911010558,33.35700562839637,CCND1;ERBB2;PRKCA
Helicobacter-associated gastritis,3/21,0.010802677604420465,0.03140726527761378,0,0,7.366892911010558,33.35700562839637,CXCL10;MUC1;CAV1
Hyperkalemia,3/21,0.010802677604420465,0.03140726527761378,0,0,7.366892911010558,33.35700562839637,CA12;KLHL3;SCN4A
Indolent Non-Hodgkin Lymphoma,3/21,0.010802677604420465,0.03140726527761378,0,0,7.366892911010558,33.35700562839637,CDKN2A;BCL3;CDC25B
Lung Injury,3/21,0.010802677604420465,0.03140726527761378,0,0,7.366892911010558,33.35700562839637,FGF7;IL6;CCL2
Myomatous neoplasm,3/21,0.010802677604420465,0.03140726527761378,0,0,7.366892911010558,33.35700562839637,CDKN2A;PAX3;FOXO1
Nodular Goiter,3/21,0.010802677604420465,0.03140726527761378,0,0,7.366892911010558,33.35700562839637,RET;CCND1;PTGS2
Oropharynx (excludes nasopharynx),3/21,0.010802677604420465,0.03140726527761378,0,0,7.366892911010558,33.35700562839637,CDKN2A;SERPING1;FGFR4
Pathological accumulation of air in tissues,3/21,0.010802677604420465,0.03140726527761378,0,0,7.366892911010558,33.35700562839637,FGF7;HGF;MET
Periapical Granuloma,3/21,0.010802677604420465,0.03140726527761378,0,0,7.366892911010558,33.35700562839637,MDK;TNFSF11;IL2RG
Premature tooth loss,3/21,0.010802677604420465,0.03140726527761378,0,0,7.366892911010558,33.35700562839637,COL3A1;TERT;RUNX2
Progressive renal failure,3/21,0.010802677604420465,0.03140726527761378,0,0,7.366892911010558,33.35700562839637,SAA1;GATA3;PKD2
SMITH-MCCORT DYSPLASIA 1,3/21,0.010802677604420465,0.03140726527761378,0,0,7.366892911010558,33.35700562839637,BMP2;KLF4;RUNX2
"Hyperalgesia, Secondary",6/84,0.011090795381029885,0.032203104962817426,0,0,3.412826353600841,15.363314806082283,IL6;CCL2;FOS;PTGS2;AGT;GFAP
Allodynia,6/84,0.011090795381029885,0.032203104962817426,0,0,3.412826353600841,15.363314806082283,IL6;CCL2;FOS;PTGS2;AGT;GFAP
Hemochromatosis,6/84,0.011090795381029885,0.032203104962817426,0,0,3.412826353600841,15.363314806082283,BMP2;IL6;ALDH2;CCL2;TIMP1;CALR
Aura,5/61,0.011429394751032726,0.033157587536905314,0,0,3.9567775974025974,17.69299516243578,OPRD1;CNTNAP2;MEF2C;FOS;GFAP
Awakening Epilepsy,5/61,0.011429394751032726,0.033157587536905314,0,0,3.9567775974025974,17.69299516243578,OPRD1;CNTNAP2;MEF2C;FOS;GFAP
Weight Gain,7/110,0.011528048394592115,0.03342934931696055,0,0,3.0182205080462827,13.470234288155224,CAV1;SORBS2;CD36;VIM;FGF1;FBLN2;MEST
Prominent eyes,8/137,0.011682902005627643,0.033849167329506144,0,0,2.7567807283628687,12.266651125610663,COL3A1;COL2A1;BGN;GATA4;ZFPM2;NKX2-5;FGFR3;TGFBR2
Protruding eyes,8/137,0.011682902005627643,0.033849167329506144,0,0,2.7567807283628687,12.266651125610663,COL3A1;COL2A1;BGN;GATA4;ZFPM2;NKX2-5;FGFR3;TGFBR2
"Hip Dislocation, Congenital",6/85,0.011715900789196206,0.033879177577239815,0,0,3.3694530146189554,14.983311692612919,PLK4;COL1A1;IL6;COL2A1;SIX1;KIF22
"Hyperalgesia, Primary",6/85,0.011715900789196206,0.033879177577239815,0,0,3.3694530146189554,14.983311692612919,IL6;CCL2;FOS;PTGS2;AGT;GFAP
Syndactyly,6/85,0.011715900789196206,0.033879177577239815,0,0,3.3694530146189554,14.983311692612919,FBN2;BLM;BMP2;PRKD1;BMPR1B;HOXD10
"Dermatomyositis, Childhood Type",4/40,0.011743705390085511,0.033879177577239815,0,0,4.917863441672965,21.85713863482992,CCL21;WT1;MX1;CCL19
Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,4/40,0.011743705390085511,0.033879177577239815,0,0,4.917863441672965,21.85713863482992,EGR1;MECOM;CDKN2A;CXCR2
Contracture of joint of hand,4/40,0.011743705390085511,0.033879177577239815,0,0,4.917863441672965,21.85713863482992,CNTN1;FGFR3;TGFBR2;EZH2
Hereditary Nonpolyposis Colorectal Neoplasms,4/40,0.011743705390085511,0.033879177577239815,0,0,4.917863441672965,21.85713863482992,BARD1;MUC1;AURKA;TGFBR2
Hypokalemia,4/40,0.011743705390085511,0.033879177577239815,0,0,4.917863441672965,21.85713863482992,COL3A1;SCN4A;ADRB2;AGT
Polyglandular Type I Autoimmune Syndrome,4/40,0.011743705390085511,0.033879177577239815,0,0,4.917863441672965,21.85713863482992,RIMS2;CXCL10;CTLA4;GATA3
Rhizomelia,4/40,0.011743705390085511,0.033879177577239815,0,0,4.917863441672965,21.85713863482992,COL1A1;ACAN;COL2A1;FGFR3
Congenital cataract,7/111,0.012076131077874813,0.03482322727308169,0,0,2.9890454864769933,13.201192361949937,RET;CAV1;DMD;VIM;IL2RG;CRYAB;NECTIN3
Cancer of Nasopharynx,5/62,0.012211049506531488,0.03515191105266416,0,0,3.8871610845295055,17.12455401707129,IL6;MECOM;TERT;HGF;SAA1
Multiple polyps,5/62,0.012211049506531488,0.03515191105266416,0,0,3.8871610845295055,17.12455401707129,ALK;CHEK1;PLA2G2A;CALR;PTGS2
Precursor cell lymphoblastic lymphoma,5/62,0.012211049506531488,0.03515191105266416,0,0,3.8871610845295055,17.12455401707129,CDT1;CCND1;TAL1;CDKN2A;LMO2
Reticulosarcoma,5/62,0.012211049506531488,0.03515191105266416,0,0,3.8871610845295055,17.12455401707129,ALK;TAL1;CDKN2A;LMNB1;RAD54B
"Cockayne Syndrome, Type II",3/22,0.012305198377721569,0.03521163711324161,0,0,6.97880447725649,30.6909220550094,RIMS2;PARP1;SYT9
"THYROID CARCINOMA, SPORADIC MEDULLARY",3/22,0.012305198377721569,0.03521163711324161,0,0,6.97880447725649,30.6909220550094,RET;CDKN2C;CDKN2A
Adenoid cystic carcinoma of salivary gland,3/22,0.012305198377721569,0.03521163711324161,0,0,6.97880447725649,30.6909220550094,CCND1;KIT;MET
Adrenal Cancer,3/22,0.012305198377721569,0.03521163711324161,0,0,6.97880447725649,30.6909220550094,TERT;CDKN2A;PTGS2
Adult Rickets,3/22,0.012305198377721569,0.03521163711324161,0,0,6.97880447725649,30.6909220550094,FGF7;TNFSF11;FGF2
CAMPOMELIC DYSPLASIA,3/22,0.012305198377721569,0.03521163711324161,0,0,6.97880447725649,30.6909220550094,COL1A1;HOXB2;SOX10
Epidermodysplasia Verruciformis,3/22,0.012305198377721569,0.03521163711324161,0,0,6.97880447725649,30.6909220550094,RAD51;CDKN2A;RHOH
Familial generalized lipodystrophy,3/22,0.012305198377721569,0.03521163711324161,0,0,6.97880447725649,30.6909220550094,CAV1;PPARG;FOS
Histiocytosis haematophagic,3/22,0.012305198377721569,0.03521163711324161,0,0,6.97880447725649,30.6909220550094,SH2D1A;IL18;GZMB
Hypoplastic iliac wing,3/22,0.012305198377721569,0.03521163711324161,0,0,6.97880447725649,30.6909220550094,COL2A1;RUNX2;EZH2
Peritoneal adhesion,3/22,0.012305198377721569,0.03521163711324161,0,0,6.97880447725649,30.6909220550094,EGR1;VTN;EZH2
Saethre-Chotzen Syndrome,3/22,0.012305198377721569,0.03521163711324161,0,0,6.97880447725649,30.6909220550094,PRKN;FGFR3;RUNX2
Shock,3/22,0.012305198377721569,0.03521163711324161,0,0,6.97880447725649,30.6909220550094,IL6;TAP1;CCL2
Shwachman syndrome,3/22,0.012305198377721569,0.03521163711324161,0,0,6.97880447725649,30.6909220550094,MDK;TAL1;PTGS2
Acquired Hypogammaglobulinemia,6/86,0.01236543455084647,0.03536893460114349,0,0,3.3271640091116175,14.615733199334397,IL6;TERT;SH2D1A;LTA;CTLA4;CCL19
Bilateral cataracts (disorder),7/112,0.0126427731489615,0.035383987842381476,0,0,2.9604261796042617,12.939044468312813,BLM;COL2A1;CDKN2A;VIM;IL2RG;PTGS2;CRYAB
"Aphasia, Progressive",2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,FANCD2;BRCA2
"ARTHROGRYPOSIS, DISTAL, TYPE 1",2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,FBN2;TNNI2
"BREAST CANCER, SUSCEPTIBILITY TO",2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,BARD1;BRCA2
"Eye Diseases, Hereditary",2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,PLK4;ERG
"NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE",2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,NPHS1;WT1
"Polycystic Kidney, Type 1 Autosomal Dominant Disease",2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,PPARG;PKD2
"Total Hypotrichosis, Mari type",2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,CCL2;ESR1
"Vasospasm, Intracranial",2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,CCL2;S100A4
Allergic bronchitis,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,PLA2G2A;PLA2G4A
Amyloid Neuropathies,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,NGFR;BRCA1
Avascular retina,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,NRP1;KDR
Beading of ribs,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,COL1A1;COL1A2
Brenner Tumor,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,CDKN2A;SIX2
COMPLEMENT COMPONENT 2 DEFICIENCY,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,C4B;C4A
Complete duplication of thumb phalanx,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,FANCD2;FANCA
Congenital anomaly of cartilage,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,ACAN;COL2A1
Cytomegalovirus encephalitis,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,CXCL10;CCL2
Dermal translucency,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,COL3A1;TGFBR2
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,CXCR4;EZH2
Duplicated collecting system,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,FANCD2;FANCA
Endometrial Stromal Tumors,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,CCND1;WT1
Epidermolysis Bullosa Simplex Kobner,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,DST;KRT5
Genitourinary Neoplasms,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,CDKN2A;GATA3
Glomerulocystic kidney disease,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,MUC1;PKD2
Hereditary Renal Cell Carcinoma,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,PRKN;MET
Hypocomplementaemia,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,C3;IL18
Infantile Colic,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,PPARG;PTGS2
Krukenberg Tumor,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,ALK;BRCA1
Macrocytosis,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,ALDH2;TERT
Malignant neoplasm of border of tongue,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,CDKN2A;FOS
Malignant neoplasm of dorsal surface of tongue,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,CDKN2A;FOS
Malignant neoplasm of ventral surface of tongue,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,CDKN2A;FOS
Malignant tumor of base of tongue,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,CDKN2A;FOS
Malignant tumor of junctional zone of tongue,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,CDKN2A;FOS
malignant tumor of lingual tonsil,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,CDKN2A;FOS
Meningeal Carcinomatosis,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,ALK;ERBB2
Mowat-Wilson syndrome,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,MEF2C;SOX10
Multiple prenatal fractures,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,COL1A1;COL1A2
Narrow iliac wings,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,RPS6KA3;COL2A1
Non-obstructive reflux-associated chronic pyelonephritis (disorder),2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,PTGS2;PAX2
Optic nerve dysplasia,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,MITF;PAX2
Osteoglophonic dwarfism,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,CCL2;FGFR3
Peripheral hypomyelination,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,EGR2;SOX10
Poxviridae Infections,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,IL6;DUSP1
Proximal weakness,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,DMD;NEFH
Reflux nephropathy (disorder),2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,PTGS2;PAX2
RETINITIS PIGMENTOSA 3,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,RET;RCC1
Secondary malignant neoplasm of ovary,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,ALK;BRCA1
Short 2nd finger,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,BMP2;BMPR1B
Spinal Cord Ischemia,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,HGF;TIMP1
Sprains and Strains,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,MUC1;IL18
Uterine carcinoma,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,CAV1;LAMC1
Visually threatening diabetic retinopathy,2/8,0.012655202322424107,0.035383987842381476,0,0,14.709556057185853,64.27615437207585,CXCL12;LTA
Ventricular Septal Defects,11/226,0.012700234052188269,0.03549511939013584,0,0,2.2799271246383026,9.954469288892364,YAP1;FBN2;RPS6KA3;NRP1;CCND2;GATA4;FADD;ZFPM2;NKX2-5;PCSK5;FLI1
Alcoholic Intoxication,4/41,0.012789990094353847,0.03564214666957694,0,0,4.784703070417356,20.856962971735296,PER2;ALDH2;IL18;FGFR3
Freckles,4/41,0.012789990094353847,0.03564214666957694,0,0,4.784703070417356,20.856962971735296,TERT;CDKN2A;FANCA;MITF
Growth Hormone-Secreting Pituitary Adenoma,4/41,0.012789990094353847,0.03564214666957694,0,0,4.784703070417356,20.856962971735296,IL6;CXCR4;SSTR2;FGFR4
Intestinal Polyps,4/41,0.012789990094353847,0.03564214666957694,0,0,4.784703070417356,20.856962971735296,JUN;CCND1;PLA2G2A;PTGS2
Malabsorption Syndrome,4/41,0.012789990094353847,0.03564214666957694,0,0,4.784703070417356,20.856962971735296,PYY;APOB;PPARA;EZR
Rheumatic Heart Disease,4/41,0.012789990094353847,0.03564214666957694,0,0,4.784703070417356,20.856962971735296,IL6;DUSP1;BGN;VIM
Unilateral agenesis of kidney,4/41,0.012789990094353847,0.03564214666957694,0,0,4.784703070417356,20.856962971735296,RET;GATA3;FGFR3;CIT
"Bulbo-Spinal Atrophy, X-Linked",5/63,0.013028172138205492,0.03623072632720003,0,0,3.8199451410658307,16.581011179737512,RIMS2;STAT1;PPARG;NEFH;MET
"Epilepsy, Cryptogenic",5/63,0.013028172138205492,0.03623072632720003,0,0,3.8199451410658307,16.581011179737512,OPRD1;CNTNAP2;MEF2C;FOS;GFAP
Brain Edema,5/63,0.013028172138205492,0.03623072632720003,0,0,3.8199451410658307,16.581011179737512,IL18;DMD;AQP1;MYLK;GFAP
Dystrophia myotonica 2,5/63,0.013028172138205492,0.03623072632720003,0,0,3.8199451410658307,16.581011179737512,CCT3;SCN4A;PPARA;APOB;NKX2-5
Necrotizing Enterocolitis,5/63,0.013028172138205492,0.03623072632720003,0,0,3.8199451410658307,16.581011179737512,SIGIRR;ALDH2;PARP1;HGF;IL18
Adult type dermatomyositis,6/87,0.013039860398253316,0.036233224011034036,0,0,3.285919176579769,14.260049438065613,IL6;STAT1;HGF;CCL2;DMD;TIMP1
Triangular face,6/87,0.013039860398253316,0.036233224011034036,0,0,3.285919176579769,14.260049438065613,COL1A1;RPS6KA3;MYCN;COL1A2;TNNI2;BUB1
Erythrocyte Mean Corpuscular Hemoglobin Test,16/387,0.013497169178636668,0.03747291781881929,0,0,1.9285368719330984,8.302882171438714,MEF2C;CTNND2;ITSN1;PLA2G4A;SPTA1;CCNA2;CHAF1A;TERT;ALDH2;TAL1;ADAM12;LEPR;KCTD13;E2F2;ERG;CALR
Finding of Mean Corpuscular Hemoglobin,16/387,0.013497169178636668,0.03747291781881929,0,0,1.9285368719330984,8.302882171438714,MEF2C;CTNND2;ITSN1;PLA2G4A;SPTA1;CCNA2;CHAF1A;TERT;ALDH2;TAL1;ADAM12;LEPR;KCTD13;E2F2;ERG;CALR
Cleft upper lip,9/169,0.013573178490195518,0.03766837468601368,0,0,2.502221903669725,10.758702437867056,FGF7;GAD1;F13A1;COL8A1;SPRY2;FGF1;FGF2;FGFR3;RAD54B
Alcohol Use Disorder,6/88,0.013739634964856657,0.03809949404624716,0,0,3.2456803155730873,13.915758799778832,ALK;PER2;IL6;ALDH2;VWF;GATA4
Congenital Camptodactyly,5/64,0.013881436979127727,0.03809949404624716,0,0,3.7550077041602465,16.060929468158104,CNTN1;FGFR3;PAX2;TGFBR2;EZH2
High-Grade Squamous Intraepithelial Lesions,5/64,0.013881436979127727,0.03809949404624716,0,0,3.7550077041602465,16.060929468158104,TERT;CDKN2A;ERBB2;CCL2;MKI67
Muscle biopsy shows dystrophic changes,5/64,0.013881436979127727,0.03809949404624716,0,0,3.7550077041602465,16.060929468158104,CAPN3;DMD;CRYAB;BUB1;SYNE1
Oligohydramnios,5/64,0.013881436979127727,0.03809949404624716,0,0,3.7550077041602465,16.060929468158104,RET;PDGFA;LIFR;PAX2;AGT
Osteopetrosis,5/64,0.013881436979127727,0.03809949404624716,0,0,3.7550077041602465,16.060929468158104,TNFSF11;MITF;DMD;FKBP4;FGFR4
"Memory Disorder, Semantic",4/42,0.013893933446179271,0.03809949404624716,0,0,4.658551139754147,19.921376106669914,PRKN;MDK;AKAP5;SYP
"Memory Disorder, Spatial",4/42,0.013893933446179271,0.03809949404624716,0,0,4.658551139754147,19.921376106669914,PRKN;MDK;AKAP5;SYP
Age-Related Memory Disorders,4/42,0.013893933446179271,0.03809949404624716,0,0,4.658551139754147,19.921376106669914,PRKN;MDK;AKAP5;SYP
Aortic aneurysm without mention of rupture NOS,4/42,0.013893933446179271,0.03809949404624716,0,0,4.658551139754147,19.921376106669914,CCL2;NKX2-5;KLF4;AGT
Bulimia Nervosa,4/42,0.013893933446179271,0.03809949404624716,0,0,4.658551139754147,19.921376106669914,DST;SOSTDC1;ESR1;CIT
Defective tooth enamel,4/42,0.013893933446179271,0.03809949404624716,0,0,4.658551139754147,19.921376106669914,PLK4;LIFR;KRT5;RUNX2
Dystrophic tooth enamel,4/42,0.013893933446179271,0.03809949404624716,0,0,4.658551139754147,19.921376106669914,PLK4;LIFR;KRT5;RUNX2
Epiretinal Membrane,4/42,0.013893933446179271,0.03809949404624716,0,0,4.658551139754147,19.921376106669914,HGF;TEK;MET;GFAP
Ganglioneuroblastoma,4/42,0.013893933446179271,0.03809949404624716,0,0,4.658551139754147,19.921376106669914,ALK;RET;MYCN;ASCL1
PITUITARY ADENOMA PREDISPOSITION (disorder),4/42,0.013893933446179271,0.03809949404624716,0,0,4.658551139754147,19.921376106669914,RET;MUC1;PPARG;CD36
Ptosis,4/42,0.013893933446179271,0.03809949404624716,0,0,4.658551139754147,19.921376106669914,COL1A1;COL3A1;LAMC1;DCN
Reduced bone mineral density,4/42,0.013893933446179271,0.03809949404624716,0,0,4.658551139754147,19.921376106669914,COL1A1;COL1A2;TNFSF11;SOX10
Short phalanx of finger,4/42,0.013893933446179271,0.03809949404624716,0,0,4.658551139754147,19.921376106669914,COL2A1;BGN;LIFR;BMPR1B
"Bone Cysts, Aneurysmal",3/23,0.013921405358768693,0.03809949404624716,0,0,6.629524886877828,28.336761659556387,ERBB2;TNFSF11;RUNX2
Cholesteatoma,3/23,0.013921405358768693,0.03809949404624716,0,0,6.629524886877828,28.336761659556387,HGF;SIX1;FGF2
Enlarged thorax,3/23,0.013921405358768693,0.03809949404624716,0,0,6.629524886877828,28.336761659556387,COL2A1;GATA4;KIF22
Familial benign pemphigus,3/23,0.013921405358768693,0.03809949404624716,0,0,6.629524886877828,28.336761659556387,PARP1;ERBB2;PPARA
fibroma,3/23,0.013921405358768693,0.03809949404624716,0,0,6.629524886877828,28.336761659556387,CCL2;MKI67;ANTXR2
Granulomatous Slack Skin,3/23,0.013921405358768693,0.03809949404624716,0,0,6.629524886877828,28.336761659556387,STAT5B;CDKN2A;CTLA4
Hunger,3/23,0.013921405358768693,0.03809949404624716,0,0,6.629524886877828,28.336761659556387,PYY;PPARG;CD36
Job Syndrome,3/23,0.013921405358768693,0.03809949404624716,0,0,6.629524886877828,28.336761659556387,IL6;STAT1;CCL2
Liver cyst,3/23,0.013921405358768693,0.03809949404624716,0,0,6.629524886877828,28.336761659556387,KRT19;CXCR2;PKD2
Myasthenias,3/23,0.013921405358768693,0.03809949404624716,0,0,6.629524886877828,28.336761659556387,CXCL10;CCL21;SCN4A
Neuroepithelioma,3/23,0.013921405358768693,0.03809949404624716,0,0,6.629524886877828,28.336761659556387,NGFR;MYCN;FLI1
Pseudoaphakia,3/23,0.013921405358768693,0.03809949404624716,0,0,6.629524886877828,28.336761659556387,COL2A1;VIM;CRYAB
Renal sclerosis with hypertension,3/23,0.013921405358768693,0.03809949404624716,0,0,6.629524886877828,28.336761659556387,CDKN2A;ADRB1;ADRA1A
Sporadic Burkitt's lymphoma,3/23,0.013921405358768693,0.03809949404624716,0,0,6.629524886877828,28.336761659556387,MYCN;CDKN2A;E2F1
Squamous Cell Neoplasms,3/23,0.013921405358768693,0.03809949404624716,0,0,6.629524886877828,28.336761659556387,CCND1;BRCA2;PTGS2
Congenital clinodactyly,6/89,0.01446520742083461,0.039507252150599935,0,0,3.2064110656750007,13.582386135615515,RPS6KA3;PAX3;NDN;FGFR3;SOX5;EZH2
Hemophilia A,6/89,0.01446520742083461,0.039507252150599935,0,0,3.2064110656750007,13.582386135615515,CCND1;VWF;TAL1;CTLA4;CXCR4;BRCA1
Hypotension,6/89,0.01446520742083461,0.039507252150599935,0,0,3.2064110656750007,13.582386135615515,MUC1;IL6;SAA1;FGF1;AGT;LMNB1
Retinal Degeneration,6/89,0.01446520742083461,0.039507252150599935,0,0,3.2064110656750007,13.582386135615515,C3;LAMA1;CCL2;DMD;CD36;APOB
Tactile Allodynia,6/89,0.01446520742083461,0.039507252150599935,0,0,3.2064110656750007,13.582386135615515,IL6;CCL2;FOS;PTGS2;AGT;GFAP
"Stress, Psychological",5/65,0.014771498758364376,0.04032739254519315,0,0,3.6922348484848486,15.562975597164403,PER2;IL6;GAD1;ADRB1;ADRB2
"CATARACT, ANTERIOR POLAR",4/43,0.015056526235908863,0.040939121538608875,0,0,4.538868538868539,19.04483705433064,IL6;TIMP1;FGF1;FGF2
"Macular dystrophy, corneal type 1",4/43,0.015056526235908863,0.040939121538608875,0,0,4.538868538868539,19.04483705433064,IL6;NPHS1;KDR;TUBG1
Acute intermittent porphyria,4/43,0.015056526235908863,0.040939121538608875,0,0,4.538868538868539,19.04483705433064,LTA;CTLA4;PPARGC1A;FOXO1
Becker Muscular Dystrophy,4/43,0.015056526235908863,0.040939121538608875,0,0,4.538868538868539,19.04483705433064,CAPN3;CCL2;DMD;UTRN
Broad thumbs,4/43,0.015056526235908863,0.040939121538608875,0,0,4.538868538868539,19.04483705433064,ACAN;COL2A1;PRKD1;EZH2
Cleft uvula,4/43,0.015056526235908863,0.040939121538608875,0,0,4.538868538868539,19.04483705433064,SIX3;BGN;SIX1;TGFBR2
High Grade Lymphoma (neoplasm),4/43,0.015056526235908863,0.040939121538608875,0,0,4.538868538868539,19.04483705433064,CCND1;CDKN2A;TIMP1;RAD54B
intracranial glioma,4/43,0.015056526235908863,0.040939121538608875,0,0,4.538868538868539,19.04483705433064,MMP14;HGF;PLAUR;CD36
Pulmonary Cystic Fibrosis,4/43,0.015056526235908863,0.040939121538608875,0,0,4.538868538868539,19.04483705433064,ZFP36;CXCR2;PPARG;ADRA1A
Tooth Abnormalities,4/43,0.015056526235908863,0.040939121538608875,0,0,4.538868538868539,19.04483705433064,RPS6KA3;ANTXR2;HOXD10;RUNX2
Male infertility,12/263,0.015184811245729813,0.041271223118705555,0,0,2.1314096960886246,8.925192016593204,RIMS2;CATSPER1;ALDH2;WT1;LAMA1;KIT;GATA4;ZFPM2;APOB;ESR1;MEST;GADD45G
"Acute myeloid leukemia, minimal differentiation",3/24,0.015652372491057668,0.04218352072630148,0,0,6.313510019392372,26.246099437090134,RET;SIRPA;EZH2
"Focal Segmental Glomerulosclerosis, Not Otherwise Specified",3/24,0.015652372491057668,0.04218352072630148,0,0,6.313510019392372,26.246099437090134,NPHS1;CXCR4;AGT
"Hydrops Fetalis, Non-Immune",3/24,0.015652372491057668,0.04218352072630148,0,0,6.313510019392372,26.246099437090134,COL1A1;COL1A2;FLT4
Acute Lung Injury,3/24,0.015652372491057668,0.04218352072630148,0,0,6.313510019392372,26.246099437090134,PPARG;ASCL1;MYLK
Alcohol or Other Drugs use,3/24,0.015652372491057668,0.04218352072630148,0,0,6.313510019392372,26.246099437090134,ALDH2;LTA;PTGS2
Asphyxia Neonatorum,3/24,0.015652372491057668,0.04218352072630148,0,0,6.313510019392372,26.246099437090134,COL1A1;KDR;PTGS2
Carotid artery occlusion,3/24,0.015652372491057668,0.04218352072630148,0,0,6.313510019392372,26.246099437090134,EGR1;HGF;GFAP
Childhood Solid Neoplasm,3/24,0.015652372491057668,0.04218352072630148,0,0,6.313510019392372,26.246099437090134,MYCN;MDK;FOXO1
Chronic thromboembolic pulmonary hypertension,3/24,0.015652372491057668,0.04218352072630148,0,0,6.313510019392372,26.246099437090134,CDH5;CXCL10;KDR
Dupuytren's Disease,3/24,0.015652372491057668,0.04218352072630148,0,0,6.313510019392372,26.246099437090134,YAP1;ACTA2;MMP14
Heart Block,3/24,0.015652372491057668,0.04218352072630148,0,0,6.313510019392372,26.246099437090134,EGR2;CALR;NKX2-5
Hyperlipoproteinemia Type IIb,3/24,0.015652372491057668,0.04218352072630148,0,0,6.313510019392372,26.246099437090134,C3;APOB;PPARA
Lens dislocation,3/24,0.015652372491057668,0.04218352072630148,0,0,6.313510019392372,26.246099437090134,FBN2;COL1A1;TAP1
Orchitis,3/24,0.015652372491057668,0.04218352072630148,0,0,6.313510019392372,26.246099437090134,C4A;PECAM1;CCL2
Penis carcinoma,3/24,0.015652372491057668,0.04218352072630148,0,0,6.313510019392372,26.246099437090134,ANXA1;CISH;CDKN2A
Pinched bridge of nose,3/24,0.015652372491057668,0.04218352072630148,0,0,6.313510019392372,26.246099437090134,PAX3;NDN;BMPR1B
Pinched nasal bridge,3/24,0.015652372491057668,0.04218352072630148,0,0,6.313510019392372,26.246099437090134,PAX3;NDN;BMPR1B
POLYCYSTIC KIDNEY DISEASE 1,3/24,0.015652372491057668,0.04218352072630148,0,0,6.313510019392372,26.246099437090134,IL6;PRKD1;PKD2
Synostotic Posterior Plagiocephaly,3/24,0.015652372491057668,0.04218352072630148,0,0,6.313510019392372,26.246099437090134,BMP2;FGF2;EZH2
Thymus Neoplasms,3/24,0.015652372491057668,0.04218352072630148,0,0,6.313510019392372,26.246099437090134,TAL1;KIT;DTX1
X-linked centronuclear myopathy,3/24,0.015652372491057668,0.04218352072630148,0,0,6.313510019392372,26.246099437090134,TPM3;BIN1;VIM
Congenital arteriovenous malformation,5/66,0.015698992008717036,0.042292190264959326,0,0,3.6315201192250375,15.085911158811296,IL6;PECAM1;TEK;FGF2;GFAP
Acute Cerebrovascular Accidents,6/91,0.01599550315304124,0.042327075834657314,0,0,3.130644512930457,12.946616491416702,IL6;VWF;ENO2;PTGS2;NKX2-5;FGF2
Abnormally small eyeball,8/145,0.015998393894388604,0.042327075834657314,0,0,2.5947318311647094,10.729908768355529,PLK4;YAP1;FANCD2;SIX3;FANCA;RARB;BUB1;PAX2
Decreased size of eyeball,8/145,0.015998393894388604,0.042327075834657314,0,0,2.5947318311647094,10.729908768355529,PLK4;YAP1;FANCD2;SIX3;FANCA;RARB;BUB1;PAX2
Generalized osteopenia,8/145,0.015998393894388604,0.042327075834657314,0,0,2.5947318311647094,10.729908768355529,FBN2;COL1A1;COL1A2;CCND1;STAT1;LIFR;ANTXR2;ESR1
"Epithelioid hemangioendothelioma, malignant",2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,YAP1;FLT4
"Lymphoproliferative Syndrome, X-Linked, 2",2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,SH2D1A;IL18
"Multiple Sclerosis, Chronic Progressive",2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,MX1;CTLA4
"MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B",2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,CAPN3;AQP1
"TIBIAL MUSCULAR DYSTROPHY, TARDIVE",2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,CAPN3;CCL2
Adult-onset citrullinemia type 2,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,CD36;PPARA
Atresia,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,STAT1;FGFR3
Avascular Necrosis of Femur Head,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,COL2A1;STAT1
Carcinoma in situ of prostate,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,LRP1;ESR1
Central hypoventilation,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,RET;ASCL1
Cerebral Thrombosis,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,VWF;SERPINC1
Chondromalacia,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,ACAN;COL2A1
Chronic anemia,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,PPARA;PTGS2
Congenital hypomyelinating neuropathy,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,EGR2;SOX10
Congenital Myotonic Dystrophy,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,BIN1;NKX2-5
Corneal infection,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,SIGIRR;SDC1
Cutaneous Candidiasis,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,CXCL10;SH2D1A
Cystadenofibroma,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,CIB1;MET
Decreased calvarial ossification,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,COL1A1;COL1A2
Delayed eruption of permanent teeth,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,NPHS1;RUNX2
Duodenal atresia,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,CENPF;MYCN
Dyggve-Melchior-Clausen syndrome,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,LRP1;CXCR4
Dysglycemia,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,ALDH2;CD36
Elevated urinary catecholamines,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,ALK;MYCN
Factor XII Deficiency,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,VWF;F12
Glycogen storage disease type Ia,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,VWF;APOB
High weight,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,PAEP;DMD
Hypomenorrhea,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,SOCS3;LIFR
Increased nuchal translucency,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,BUB1;FGFR3
Magnesium measurement,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,MUC1;MECOM
Malignant neoplasm of duodenum,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,MDK;ERBB2
Nephrogenic Fibrosing Dermopathy,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,ACTA2;COL1A1
Obsessions,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,TAL1;ESR1
Organ dysfunction syndrome,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,IL6;LTA
Oropharyngeal Neoplasms,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,CDKN2A;MET
Other specified peritonitis,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,A2M;ESR1
Ovarian cancer stage III,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,HGF;BRCA2
Protrusio acetabuli,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,COL1A1;COL1A2
psychosocial stressor,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,IL6;CCND1
Psychoticism,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,TAL1;ESR1
Renal medullary carcinoma,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,ALK;CCND1
Secondary malignant neoplasm of axilla,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,ERBB2;FGF2
Small vessel vasculitis,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,CTLA4;PRTN3
Stage I Endometrial Carcinoma,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,ERBB2;MKI67
Tophus,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,IL6;TNFSF11
Wasting Syndrome,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,IL6;DMD
West Nile Fever,2/9,0.016033365235760603,0.042327075834657314,0,0,12.607545952918413,52.108038902630256,STAT1;CXCR4
Encephalopathies,11/234,0.016078200350684083,0.042428759746638234,0,0,2.197226757041599,9.07518576770034,ALK;IL6;MUC1;RAD51;CXCR2;CXCR4;CCL2;SCN4A;FADD;PPARGC1A;GFAP
Azoospermia,9/174,0.016139775187775474,0.04257452088024355,0,0,2.425771476230192,10.009869694321976,PLK4;BLM;WT1;E2F1;GATA4;ZFPM2;BRCA2;ESR1;SOX5
"Arthritis, Adjuvant-Induced",4/44,0.016278696593989138,0.042689467522542386,0,0,4.425170068027211,18.22239889936288,IL6;COL2A1;STAT1;SAA1
"Arthritis, Collagen-Induced",4/44,0.016278696593989138,0.042689467522542386,0,0,4.425170068027211,18.22239889936288,IL6;COL2A1;STAT1;SAA1
"Arthritis, Experimental",4/44,0.016278696593989138,0.042689467522542386,0,0,4.425170068027211,18.22239889936288,IL6;COL2A1;STAT1;SAA1
"Leprosy, Lepromatous",4/44,0.016278696593989138,0.042689467522542386,0,0,4.425170068027211,18.22239889936288,IL6;LRP1;CTLA4;SELE
Acquired aplastic anemia,4/44,0.016278696593989138,0.042689467522542386,0,0,4.425170068027211,18.22239889936288,CXCL10;TERT;CXCR4;EZH2
Autonomic nervous system disorders,4/44,0.016278696593989138,0.042689467522542386,0,0,4.425170068027211,18.22239889936288,RET;LIFR;ASCL1;LMNB1
Birth Weight,4/44,0.016278696593989138,0.042689467522542386,0,0,4.425170068027211,18.22239889936288,HMGA2;ADRB1;ESR1;ADCY5
Memory Disorders,4/44,0.016278696593989138,0.042689467522542386,0,0,4.425170068027211,18.22239889936288,PRKN;MDK;AKAP5;SYP
Muscular stiffness,4/44,0.016278696593989138,0.042689467522542386,0,0,4.425170068027211,18.22239889936288,TPM3;SCN4A;ESR1;CRYAB
Neurocognitive Disorders,4/44,0.016278696593989138,0.042689467522542386,0,0,4.425170068027211,18.22239889936288,ZFP36;STAT1;CCL2;FGF2
Neuromyelitis Optica,4/44,0.016278696593989138,0.042689467522542386,0,0,4.425170068027211,18.22239889936288,RASL12;IL6;AQP1;GFAP
Pneumococcal Infections,4/44,0.016278696593989138,0.042689467522542386,0,0,4.425170068027211,18.22239889936288,IL6;VWF;LTA;CCL2
Short ribs,4/44,0.016278696593989138,0.042689467522542386,0,0,4.425170068027211,18.22239889936288,COL2A1;FGFR3;RUNX2;EZH2
Sickle Cell Trait,4/44,0.016278696593989138,0.042689467522542386,0,0,4.425170068027211,18.22239889936288,ALK;TERT;TPM3;CD36
Toxic Shock Syndrome,4/44,0.016278696593989138,0.042689467522542386,0,0,4.425170068027211,18.22239889936288,IL6;ENO2;A2M;AQP1
Dilated ventricles (finding),10/204,0.01630193996807852,0.042717061578468725,0,0,2.2942291740727576,9.444128233641708,ACTA2;RPS6KA3;GPSM2;MEF2C;CCND2;TERT;NDN;FGFR3;FLI1;CIT
Short neck,10/204,0.01630193996807852,0.042717061578468725,0,0,2.2942291740727576,9.444128233641708,FBN2;ACAN;COL2A1;CTNND2;TNNI2;GATA4;LIFR;ANTXR2;ALDOA;FLI1
Anorexia,7/118,0.0164505746702367,0.04307292767458466,0,0,2.79953926529269,11.498813211083824,PYY;IL6;CCND1;CDKN2A;LEPR;BRCA1;BRCA2
Red Blood Cell Count measurement,7/118,0.0164505746702367,0.04307292767458466,0,0,2.79953926529269,11.498813211083824,MEF2C;TERT;MECOM;MCM4;MITF;CD36;PROX1
Cognitive delay,32/966,0.016512918316907516,0.04321931388010556,0,0,1.5447423407355174,6.339023632864002,RET;GATA4;BRCA2;CCND2;TERT;SIX3;NDN;DMD;NKX2-5;ZNF423;BUB1;SOX5;PLK4;ARNT2;GAD1;FANCA;HMGA2;KIF22;TUBG1;SOX10;FLI1;GRIN2D;CIT;COL3A1;BMP2;RAD51;PROC;FANCD2;MCM4;PRKD1;FGFR3;EZH2
"High, narrow palate",5/67,0.01666453050129774,0.04349746865398975,0,0,3.5727639296187683,14.628584517560887,RET;CDT1;CNTN1;FGFR3;RUNX2
Abnormality of cardiovascular system morphology,5/67,0.01666453050129774,0.04349746865398975,0,0,3.5727639296187683,14.628584517560887,RET;RARB;GATA4;NKX2-5;EZH2
Bipolar I disorder,5/67,0.01666453050129774,0.04349746865398975,0,0,3.5727639296187683,14.628584517560887,EGR1;EGR2;ALDH2;RARB;CCL2
Flat face,5/67,0.01666453050129774,0.04349746865398975,0,0,3.5727639296187683,14.628584517560887,COL3A1;COL2A1;PAX3;PAK3;FGFR3
Joint swelling,5/67,0.01666453050129774,0.04349746865398975,0,0,3.5727639296187683,14.628584517560887,SOCS3;IL6;CTLA4;CCL2;PAEP
Metastatic Renal Cell Cancer,5/67,0.01666453050129774,0.04349746865398975,0,0,3.5727639296187683,14.628584517560887,CCL21;KDR;HMGA1;EZR;AURKA
Multiple Chronic Conditions,5/67,0.01666453050129774,0.04349746865398975,0,0,3.5727639296187683,14.628584517560887,RET;OPRD1;LRP1;ERBB2;PAEP
Drug Dependence,9/175,0.016693057179813092,0.04355500078462499,0,0,2.411034044434619,9.867789442973852,RET;OPRD1;PER2;PTPRB;PMAIP1;PARVA;MET;GRIA4;SYNE1
Prader-Willi Syndrome,7/119,0.017156160456007843,0.044728561188877594,0,0,2.774400684931507,11.279042883655311,IL6;MAGED1;STMN1;LEPR;NDN;DMD;CD36
Retrognathia,7/119,0.017156160456007843,0.044728561188877594,0,0,2.774400684931507,11.279042883655311,RET;CDT1;ARNT2;RARB;PAX2;EZH2;TGFBR2
Liver Failure,9/176,0.017260092846263436,0.04496461736055284,0,0,2.396473108828215,9.728142799114076,CISH;PARP1;CAV1;IL18;PLA2G4A;CXCR4;PPARG;FOS;MET
Small nose,9/176,0.017260092846263436,0.04496461736055284,0,0,2.396473108828215,9.728142799114076,MEF2C;BLM;COL2A1;PAX3;LIFR;GATA4;KIF22;PAK3;FLI1
"Aganglionosis, Colonic",3/25,0.017498918696404287,0.04532307673160478,0,0,6.026223776223776,24.379788466052194,RET;PAX3;PPARG
Acrocephaly,3/25,0.017498918696404287,0.04532307673160478,0,0,6.026223776223776,24.379788466052194,BMP2;FGFR3;EZH2
Adolescent idiopathic scoliosis,3/25,0.017498918696404287,0.04532307673160478,0,0,6.026223776223776,24.379788466052194,FBN2;COL1A2;ESR1
Aortic Diseases,3/25,0.017498918696404287,0.04532307673160478,0,0,6.026223776223776,24.379788466052194,ACTA2;COL3A1;LAMC1
Cancer of Digestive System,3/25,0.017498918696404287,0.04532307673160478,0,0,6.026223776223776,24.379788466052194,CCL2;PTGS2;KLF4
Congenital infectious disease,3/25,0.017498918696404287,0.04532307673160478,0,0,6.026223776223776,24.379788466052194,IL6;COL2A1;ADAM12
ESR raised,3/25,0.017498918696404287,0.04532307673160478,0,0,6.026223776223776,24.379788466052194,IL6;CTLA4;PRTN3
Familial erythrocytosis,3/25,0.017498918696404287,0.04532307673160478,0,0,6.026223776223776,24.379788466052194,STAT5A;STAT5B;EPAS1
Hepatic Form of Wilson Disease,3/25,0.017498918696404287,0.04532307673160478,0,0,6.026223776223776,24.379788466052194,IL6;TIMP1;A2M
Lymphomatoid Papulosis,3/25,0.017498918696404287,0.04532307673160478,0,0,6.026223776223776,24.379788466052194,ALK;KIT;CXCR4
Malignant neoplasm of penis,3/25,0.017498918696404287,0.04532307673160478,0,0,6.026223776223776,24.379788466052194,ANXA1;CISH;CDKN2A
Pyemia,3/25,0.017498918696404287,0.04532307673160478,0,0,6.026223776223776,24.379788466052194,PROC;CXCR2;LTA
Specific language impairment,3/25,0.017498918696404287,0.04532307673160478,0,0,6.026223776223776,24.379788466052194,CNTNAP2;CCDC136;SYN1
Urgency of micturition,3/25,0.017498918696404287,0.04532307673160478,0,0,6.026223776223776,24.379788466052194,SNCAIP;LMNB1;CIT
X-linked retinitis pigmentosa,3/25,0.017498918696404287,0.04532307673160478,0,0,6.026223776223776,24.379788466052194,RCC1;TIMP1;ERG
"Obesity, Visceral",4/45,0.017561309852185413,0.04537966793662072,0,0,4.317017864056192,17.449632710860026,SLC2A4;APOB;PPARA;AGT
Congenital neutropenia,4/45,0.017561309852185413,0.04537966793662072,0,0,4.317017864056192,17.449632710860026,STAT5A;STAT5B;CXCR2;CXCR4
Distal Muscular Dystrophies,4/45,0.017561309852185413,0.04537966793662072,0,0,4.317017864056192,17.449632710860026,CAPN3;DMD;FLNC;CRYAB
gallbladder neoplasm,4/45,0.017561309852185413,0.04537966793662072,0,0,4.317017864056192,17.449632710860026,YAP1;CDKN2A;ERBB2;APOB
Infectious Otitis Media,4/45,0.017561309852185413,0.04537966793662072,0,0,4.317017864056192,17.449632710860026,IL6;DUSP1;CCL2;SOSTDC1
Inherited neuropathies,4/45,0.017561309852185413,0.04537966793662072,0,0,4.317017864056192,17.449632710860026,EGR2;DST;CCL2;SOX10
Leishmaniasis,5/68,0.01766870673923776,0.04562208168424483,0,0,3.515873015873016,14.189923507435324,CXCL10;IL6;IL18;FLI1;AQP1
Osteoarthritis of hip,5/68,0.01766870673923776,0.04562208168424483,0,0,3.515873015873016,14.189923507435324,COL1A1;SOCS3;IL6;COL2A1;ESR1
Platelet mean volume determination (procedure),9/177,0.017841065286574184,0.046049421393017764,0,0,2.382085517693316,9.590877628473205,NFE2;MEF2C;GRK5;VWF;PRC1;RFX2;CD36;ZFPM2;NECTIN2
Traditional Serrated Adenoma,6/94,0.0184951910421179,0.04771944027616743,0,0,3.023452060468006,12.0643130289425,JUN;STMN1;CALR;VIM;PTGS2;AQP1
"Histiocytosis, Langerhans-Cell",5/69,0.018712091474295606,0.04822348670044869,0,0,3.4607599431818183,13.768928848486343,CDKN2A;KIT;PECAM1;CTLA4;FADD
Hepatolenticular Degeneration,5/69,0.018712091474295606,0.04822348670044869,0,0,3.4607599431818183,13.768928848486343,IL6;PPARG;DMD;TIMP1;A2M
Thin lips,5/69,0.018712091474295606,0.04822348670044869,0,0,3.4607599431818183,13.768928848486343,COL3A1;GATA4;ZFPM2;NKX2-5;RUNX2
"Sleep Apnea, Central",4/46,0.018905168566322964,0.048516282801461606,0,0,4.214015765036173,16.722562725435857,RET;IL18;ASCL1;FGFR3
Abnormality of dental enamel,4/46,0.018905168566322964,0.048516282801461606,0,0,4.214015765036173,16.722562725435857,PLK4;LIFR;KRT5;RUNX2
Absence of eyebrow,4/46,0.018905168566322964,0.048516282801461606,0,0,4.214015765036173,16.722562725435857,COL3A1;SNRPE;IL2RG;FLI1
Aplasia/Hypoplasia of the eyebrow,4/46,0.018905168566322964,0.048516282801461606,0,0,4.214015765036173,16.722562725435857,COL3A1;SNRPE;IL2RG;FLI1
Cutaneous Mastocytosis,4/46,0.018905168566322964,0.048516282801461606,0,0,4.214015765036173,16.722562725435857,IL6;CXCL12;CISH;KIT
Facial asymmetry,4/46,0.018905168566322964,0.048516282801461606,0,0,4.214015765036173,16.722562725435857,MYCN;FGFR3;FLI1;SOX5
Nodular Sclerosis Classical Hodgkin Lymphoma,4/46,0.018905168566322964,0.048516282801461606,0,0,4.214015765036173,16.722562725435857,ALK;GPSM2;CXCL10;GATA3
Obstructive nephropathy,4/46,0.018905168566322964,0.048516282801461606,0,0,4.214015765036173,16.722562725435857,HGF;CCL2;S100A4;AGT
Sparse or absent eyebrows,4/46,0.018905168566322964,0.048516282801461606,0,0,4.214015765036173,16.722562725435857,COL3A1;SNRPE;IL2RG;FLI1
Sparse/absent eyebrows,4/46,0.018905168566322964,0.048516282801461606,0,0,4.214015765036173,16.722562725435857,COL3A1;SNRPE;IL2RG;FLI1
Telangiectasia of the skin,4/46,0.018905168566322964,0.048516282801461606,0,0,4.214015765036173,16.722562725435857,COL3A1;TERT;CAV1;ANTXR2
Short nose,9/179,0.019045546144684698,0.04885786398307961,0,0,2.35381813275769,9.323290032920863,MEF2C;BLM;COL2A1;PAX3;LIFR;GATA4;KIF22;PAK3;FLI1
Anorexia Nervosa,6/95,0.01938452052081131,0.04945495942293845,0,0,2.9893271224181617,11.787755178699765,OPRD1;PYY;IL6;STMN1;LEPR;ESR1
Renal cyst,6/95,0.01938452052081131,0.04945495942293845,0,0,2.9893271224181617,11.787755178699765,FGF7;PRKD1;PKD2;FGF2;FGFR3;PAX2
"Arthritis, Gouty",3/26,0.019461621966348024,0.04945495942293845,0,0,5.763918945504623,22.70586848068912,MUC1;IL6;IL18
"Hypotension, Orthostatic",3/26,0.019461621966348024,0.04945495942293845,0,0,5.763918945504623,22.70586848068912,OPRD1;CAV1;AGT
Carotid Artery Plaque,3/26,0.019461621966348024,0.04945495942293845,0,0,5.763918945504623,22.70586848068912,STAT1;CCL2;PTGS2
Cortical gyral simplification,3/26,0.019461621966348024,0.04945495942293845,0,0,5.763918945504623,22.70586848068912,PLK4;MPDZ;CIT
Cyclic neutropenia,3/26,0.019461621966348024,0.04945495942293845,0,0,5.763918945504623,22.70586848068912,CCND1;PPARGC1A;AURKA
Increased drug resistance,3/26,0.019461621966348024,0.04945495942293845,0,0,5.763918945504623,22.70586848068912,BMP2;MYCN;ERBB2
Pathological fracture,3/26,0.019461621966348024,0.04945495942293845,0,0,5.763918945504623,22.70586848068912,COL1A1;CCND1;LIFR
Pharyngeal Carcinoma,3/26,0.019461621966348024,0.04945495942293845,0,0,5.763918945504623,22.70586848068912,ALDH2;PPL;EZH2
Plasmablastic lymphoma,3/26,0.019461621966348024,0.04945495942293845,0,0,5.763918945504623,22.70586848068912,ALK;CDKN2A;SDC1
Spondyloepiphyseal Dysplasia,3/26,0.019461621966348024,0.04945495942293845,0,0,5.763918945504623,22.70586848068912,ACAN;COL2A1;KDR
Tangier Disease,3/26,0.019461621966348024,0.04945495942293845,0,0,5.763918945504623,22.70586848068912,TERT;PLA2G2A;APOB
"Congenital secretory diarrhea, sodium type (disorder)",2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,CAV1;HGF
"FAMILIAL ADENOMATOUS POLYPOSIS, ATTENUATED (disorder)",2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,PLA2G2A;PTGS2
"Hyalinosis, Systemic",2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,VWF;ANTXR2
"Meningitis, Cryptococcal",2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,ACTA2;CAV1
"Spondyloepiphyseal dysplasia, congenita",2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,ACAN;COL2A1
"Toxoplasmosis, Cerebral",2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,IL6;GFAP
Anal intraepithelial neoplasia,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,CDKN2A;CCL2
Asymptomatic bacteriuria,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,SIGIRR;CCL2
Bile Duct Neoplasms,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,APOB;PTGS2
Bladder Adenocarcinoma,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,ALK;CDKN2A
Burn injury,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,IL6;PTGS2
CCHS WITH HIRSCHSPRUNG DISEASE,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,RET;ASCL1
Chronic skin ulcer,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,PDGFA;DCN
Congenital musculoskeletal anomalies,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,PAX3;TGFBR2
Corneal fibrosis,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,MMP14;CIB1
Denys-Drash Syndrome,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,WT1;PKD2
Diarrhea-associated hemolytic uremic syndrome,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,CXCL12;CXCR4
Duodenal Cancer,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,MDK;ERBB2
Exercise-induced muscle fatigue,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,DMD;SCN4A
Femoral artery occlusion,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,CCL2;FGF2
Generalized osteoporosis with pathologic fractures,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,MMP14;STAT1
Histiocytoid hemangioma,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,ZFP36;FOS
Infections specific to perinatal period,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,CCL2;GFAP
Jaw Abnormalities,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,COL2A1;PCSK5
Laron Syndrome,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,STAT5A;STAT5B
Left ventricular dilatation,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,HGF;AGT
Liver mass,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,IL6;PPARA
Lobstein Disease,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,COL1A1;COL1A2
Loss of subcutaneous adipose tissue in limbs,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,CAV1;PPARG
Lymphangioma,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,FLT4;KDR
Malignant melanoma of iris,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,CDKN2A;KIT
Medullary cystic kidney disease 1,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,CCT3;MUC1
Metastatic Malignant Neoplasm to the Leptomeninges,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,C3;ERBB2
Mild dementia,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,ESR1;RUNX1T1
Nodular thyroid disease,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,RET;PPARG
Paraneoplastic pemphigus,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,COL17A1;PPL
Perihilar Cholangiocarcinoma,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,JUN;FOS
Pilomatrixoma,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,BMP2;CCND1
Platelet thrombus,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,VWF;CTSG
Poor wound healing,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,COL1A1;COL1A2
Primary acquired melanosis,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,TERT;KIT
Proliferative glomerulonephritis,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,CXCL10;IL6
Retinal thinning,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,COL2A1;LAMA1
Schnitzler Syndrome,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,IL6;IL18
Seropositive rheumatoid arthritis,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,TNFSF11;VIM
Simple syndactyly of fingers - first web,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,FGFR3;PITX1
Small cell carcinoma of the cervix,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,VIL1;CDKN2A
Stage 0 Skin Melanoma,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,CCND1;CDKN2A
Stage III Breast Cancer AJCC v6,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,ERBB2;BRCA1
Stage III Breast Cancer AJCC v7,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,ERBB2;BRCA1
Vascular Endothelial Growth Factor Measurement,2/10,0.019749583259726165,0.04945495942293845,0,0,11.031038374717832,43.292665690784396,MEF2C;ZFPM2
"Leukoplakia, Oral",5/70,0.01979523327948471,0.049532334837935656,0,0,3.4073426573426575,13.364668195193628,CCND1;TERT;KRT5;PTGS2;EZH2
Knee joint valgus deformity,5/70,0.01979523327948471,0.049532334837935656,0,0,3.4073426573426575,13.364668195193628,ACAN;COL2A1;TNFSF11;LIFR;KIF22
IMMUNE SUPPRESSION,6/96,0.02030255370862091,0.05067190225887105,0,0,2.955960516324981,11.51940356044992,IL6;DUSP1;STAT1;CTLA4;DMD;PTGS2
Renal failure in adulthood,6/96,0.02030255370862091,0.05067190225887105,0,0,2.955960516324981,11.51940356044992,C3;NPHS1;WT1;GATA3;PKD2;PAX2
Telecanthus,6/96,0.02030255370862091,0.05067190225887105,0,0,2.955960516324981,11.51940356044992,RPS6KA3;COL3A1;CCND2;PAX3;SOX10;FGFR3
Cholestasis of pregnancy,4/47,0.020311012638606442,0.05067190225887105,0,0,4.115804461319412,16.037610924887655,IL6;IL18;PPARG;ADRA1A
Disseminated neuroblastoma,4/47,0.020311012638606442,0.05067190225887105,0,0,4.115804461319412,16.037610924887655,IL6;MYCN;CCND1;PROX1
Kidney damage,4/47,0.020311012638606442,0.05067190225887105,0,0,4.115804461319412,16.037610924887655,CCND1;WT1;SAA1;ZNF423
Serum triglycerides raised,4/47,0.020311012638606442,0.05067190225887105,0,0,4.115804461319412,16.037610924887655,CAV1;LEPR;PPARG;FOS
Severe congenital neutropenia,4/47,0.020311012638606442,0.05067190225887105,0,0,4.115804461319412,16.037610924887655,STAT5A;STAT5B;CXCR2;CXCR4
Hepatomegaly,15/373,0.020517766491410433,0.05116870395704139,0,0,1.8705664544627778,7.269889390735867,KLF11;CAV1;SH2D1A;FOS;IL2RG;KLF1;WT1;SAA1;LEPR;TNFSF11;CTLA4;MCM4;PPARG;PPARA;MET
Common Variable Immunodeficiency,8/152,0.0206309825369003,0.05143195201106994,0,0,2.4677091278921943,9.577083690218506,IL6;TERT;CCL21;SH2D1A;LTA;SDC1;CTLA4;CCL19
"Infant, Small for Gestational Age",12/275,0.02075687752180388,0.051726600904057465,0,0,2.032894563527955,7.877217689480543,PLK4;CDT1;BLM;TERT;CTNND2;HMGA2;MCM4;GATA4;LIFR;ZFPM2;NKX2-5;FGFR3
Gout,5/71,0.02091865814622108,0.052052503931093286,0,0,3.355544077134986,12.976270753483616,MUC1;HGF;RARB;PRKCA;PKD2
Pediatric Obesity,5/71,0.02091865814622108,0.052052503931093286,0,0,3.355544077134986,12.976270753483616,PYY;PPARG;BRCA1;CALR;PPARA
Proximal muscle weakness,5/71,0.02091865814622108,0.052052503931093286,0,0,3.355544077134986,12.976270753483616,FLAD1;TPM3;DMD;FLNC;SYNE1
Proximal neurogenic muscle weakness,5/71,0.02091865814622108,0.052052503931093286,0,0,3.355544077134986,12.976270753483616,FLAD1;TPM3;DMD;FLNC;SYNE1
Hemoglobin measurement,6/97,0.02124966786459176,0.05285658125133269,0,0,2.923327242233848,11.25894350718164,SPTA1;ALDH2;MITF;PPARG;PROX1;VAV2
"stage, neuroblastoma",3/27,0.021540832869153908,0.05322598732495866,0,0,5.523472850678733,21.198011402444397,MYCN;TERT;STAT1
Childhood Cerebral Astrocytoma,3/27,0.021540832869153908,0.05322598732495866,0,0,5.523472850678733,21.198011402444397,HGF;ESR1;MET
Chronic Lung Injury,3/27,0.021540832869153908,0.05322598732495866,0,0,5.523472850678733,21.198011402444397,FGF7;IL6;CCL2
Congenital central hypoventilation,3/27,0.021540832869153908,0.05322598732495866,0,0,5.523472850678733,21.198011402444397,PRKN;RET;ASCL1
Cryoglobulinemia,3/27,0.021540832869153908,0.05322598732495866,0,0,5.523472850678733,21.198011402444397,CXCL10;CCL2;PAEP
Ectopia Lentis,3/27,0.021540832869153908,0.05322598732495866,0,0,5.523472850678733,21.198011402444397,FBN2;COL1A1;TAP1
Elevated C-reactive protein,3/27,0.021540832869153908,0.05322598732495866,0,0,5.523472850678733,21.198011402444397,IL6;CTLA4;PRTN3
Elevated C-reactive protein level,3/27,0.021540832869153908,0.05322598732495866,0,0,5.523472850678733,21.198011402444397,IL6;CTLA4;PRTN3
Extraskeletal Myxoid Chondrosarcoma,3/27,0.021540832869153908,0.05322598732495866,0,0,5.523472850678733,21.198011402444397,SIX3;PPARG;PPARGC1A
Homocystinuria,3/27,0.021540832869153908,0.05322598732495866,0,0,5.523472850678733,21.198011402444397,SERPINC1;CCL2;PAEP
Increased susceptibility to fractures,3/27,0.021540832869153908,0.05322598732495866,0,0,5.523472850678733,21.198011402444397,COL1A1;COL1A2;RUNX2
Intracranial Astrocytoma,3/27,0.021540832869153908,0.05322598732495866,0,0,5.523472850678733,21.198011402444397,HGF;ESR1;MET
Loss of appetite (finding),3/27,0.021540832869153908,0.05322598732495866,0,0,5.523472850678733,21.198011402444397,CDKN2A;BRCA1;BRCA2
Neck muscle weakness,3/27,0.021540832869153908,0.05322598732495866,0,0,5.523472850678733,21.198011402444397,TPM3;CRYAB;SYNE1
Protein S Deficiency,3/27,0.021540832869153908,0.05322598732495866,0,0,5.523472850678733,21.198011402444397,VTN;SERPINC1;PROS1
Thymic Lymphoma,3/27,0.021540832869153908,0.05322598732495866,0,0,5.523472850678733,21.198011402444397,RIMS2;EGR1;GATA3
Urogenital Abnormalities,3/27,0.021540832869153908,0.05322598732495866,0,0,5.523472850678733,21.198011402444397,RET;WT1;PAX2
Visual field defects,3/27,0.021540832869153908,0.05322598732495866,0,0,5.523472850678733,21.198011402444397,COL3A1;VCAN;FGFR3
Corneal Neovascularization,4/48,0.02177951958910513,0.05365783329436172,0,0,4.022057307771593,15.391549455969782,PROX1;VIM;FGF2;DCN
Cutis marmorata,4/48,0.02177951958910513,0.05365783329436172,0,0,4.022057307771593,15.391549455969782,ACTA2;RPS6KA3;MYLK;TGFBR2
Dupuytren Contracture,4/48,0.02177951958910513,0.05365783329436172,0,0,4.022057307771593,15.391549455969782,YAP1;ACTA2;MMP14;FGF2
Fabry Disease,4/48,0.02177951958910513,0.05365783329436172,0,0,4.022057307771593,15.391549455969782,BMP2;IL6;ERBB2;SELE
Paresthesia,4/48,0.02177951958910513,0.05365783329436172,0,0,4.022057307771593,15.391549455969782,CAPN3;SERPING1;LIFR;CALR
Renal tubular disorder,4/48,0.02177951958910513,0.05365783329436172,0,0,4.022057307771593,15.391549455969782,CHEK1;IL18;CCL2;FHL5
Underdeveloped brows,4/48,0.02177951958910513,0.05365783329436172,0,0,4.022057307771593,15.391549455969782,GATA4;NKX2-5;ZFPM2;FGFR3
Underdeveloped supraorbital ridges,4/48,0.02177951958910513,0.05365783329436172,0,0,4.022057307771593,15.391549455969782,GATA4;NKX2-5;ZFPM2;FGFR3
Depressed nasal bridge,12/277,0.021816375516732753,0.05372892481495312,0,0,2.0173428036080003,7.7165267026841775,COL1A1;RPS6KA3;MEF2C;COL2A1;CCND2;PAX3;PRKD1;KIF22;FGFR3;RUNX2;SOX5;EZH2
Isolated somatotropin deficiency,5/72,0.022082869139131853,0.05432547587487529,0,0,3.305291723202171,12.602922398805164,STAT5B;ARNT2;BMP2;LEPR;NDN
Learning Disabilities,5/72,0.022082869139131853,0.05432547587487529,0,0,3.305291723202171,12.602922398805164,PRKN;COL1A1;CTNND2;SYP;PPL
West Nile viral infection,5/72,0.022082869139131853,0.05432547587487529,0,0,3.305291723202171,12.602922398805164,SOCS3;STAT1;MX1;IRF7;TAP1
Icterus,8/154,0.022113146562057224,0.054380041124414615,0,0,2.433654117425786,9.276074613820505,SPTA1;CDKN2A;BRCA1;NKX2-5;BRCA2;ALDOA;SPTB;AGT
Intrauterine retardation,12/278,0.02236090391159302,0.054969191314150345,0,0,2.0096546215423086,7.637574233794999,PLK4;CDT1;BLM;TERT;CTNND2;HMGA2;MCM4;GATA4;LIFR;ZFPM2;NKX2-5;FGFR3
Hypogonadotropic hypogonadism,7/126,0.022702305353617343,0.05576762353873228,0,0,2.6102605425731937,9.88059000268765,NRP1;WT1;CBX2;LEPR;S1PR1;NDN;SOX10
Memory Loss,7/126,0.022702305353617343,0.05576762353873228,0,0,2.6102605425731937,9.88059000268765,PRKN;IL6;ALDH2;MDK;GATA3;SYP;AKAP5
Substance abuse problem,8/155,0.022881748997266672,0.05618787066385483,0,0,2.416974112299382,9.129915893527688,OPRD1;TAL1;PMAIP1;CXCR4;PARVA;ESR1;GRIA4;SYNE1
Hypersensitivity,9/185,0.023012063032740924,0.05648721320463745,0,0,2.272870621351126,8.57266958431392,STAT5B;IL6;CXCR2;IL18;CCL2;GZMB;CCL19;FOXO1;MYLK
Dysplastic Nevus,5/73,0.023288346062656753,0.05695362034803744,0,0,3.2565173796791442,12.243861249232046,CCND1;CDKN2A;STAT1;BRCA2;PTGS2
Guillain-Barre Syndrome,5/73,0.023288346062656753,0.05695362034803744,0,0,3.2565173796791442,12.243861249232046,IL18;SERPING1;CXCR4;PTGS2;GFAP
Abnormality of vision,4/49,0.023311304909507703,0.05695362034803744,0,0,3.932476694381456,14.781459648597416,PAX3;LIFR;SOX10;BUB1
Amenorrhea,4/49,0.023311304909507703,0.05695362034803744,0,0,3.932476694381456,14.781459648597416,OPRD1;PYY;PAEP;BRCA1
cardiac event,4/49,0.023311304909507703,0.05695362034803744,0,0,3.932476694381456,14.781459648597416,ERBB2;PLA2G4A;CCL2;CD36
Chronic schizophrenia,4/49,0.023311304909507703,0.05695362034803744,0,0,3.932476694381456,14.781459648597416,IL6;IL2RG;PAK3;ADRA1A
Malignant hyperpyrexia due to anesthesia,4/49,0.023311304909507703,0.05695362034803744,0,0,3.932476694381456,14.781459648597416,IL6;SCN4A;DMD;RUNX2
Byzanthine arch palate,12/280,0.02348001795157855,0.05695362034803744,0,0,1.9944503808900071,7.482391057265758,FBN2;RPS6KA3;MYCN;TPM3;CTNND2;SIX1;TNNI2;GATA4;PAK3;FGFR3;RUNX2;TGFBR2
Myoclonic Seizures,8/156,0.023668978684407923,0.05695362034803744,0,0,2.400519512647659,8.986560853130744,NGFR;IL6;FOS;SSTR2;PTGS2;FGF2;MPDZ;AGT
"Creutzfeldt-Jakob Disease, Sporadic",3/28,0.023736687519296976,0.05695362034803744,0,0,5.302262443438914,19.834350382945026,PRKN;ENO2;GFAP
"GASTRIC CANCER, INTESTINAL",3/28,0.023736687519296976,0.05695362034803744,0,0,5.302262443438914,19.834350382945026,COL1A2;ERBB2;EZH2
"Liposarcoma, well differentiated",3/28,0.023736687519296976,0.05695362034803744,0,0,5.302262443438914,19.834350382945026,JUN;CDKN2A;HMGA2
Agammaglobulinemia,3/28,0.023736687519296976,0.05695362034803744,0,0,5.302262443438914,19.834350382945026,IL6;SH2D1A;IL2RG
Anasarca,3/28,0.023736687519296976,0.05695362034803744,0,0,5.302262443438914,19.834350382945026,IL6;COL2A1;PTGS2
Cerebral Astrocytoma,3/28,0.023736687519296976,0.05695362034803744,0,0,5.302262443438914,19.834350382945026,HGF;ESR1;MET
Childhood Burkitt Lymphoma,3/28,0.023736687519296976,0.05695362034803744,0,0,5.302262443438914,19.834350382945026,PARP1;KIT;BRCA2
Incontinentia Pigmenti Achromians,3/28,0.023736687519296976,0.05695362034803744,0,0,5.302262443438914,19.834350382945026,IL6;CCL2;MITF
Odontogenic Tumors,3/28,0.023736687519296976,0.05695362034803744,0,0,5.302262443438914,19.834350382945026,MDK;KRT5;VIM
Seborrheic keratosis,3/28,0.023736687519296976,0.05695362034803744,0,0,5.302262443438914,19.834350382945026,CDKN2A;FGFR3;CDKN3
Short ulnae,3/28,0.023736687519296976,0.05695362034803744,0,0,5.302262443438914,19.834350382945026,COL2A1;BMPR1B;FGFR3
ULNAR HYPOPLASIA,3/28,0.023736687519296976,0.05695362034803744,0,0,5.302262443438914,19.834350382945026,COL2A1;BMPR1B;FGFR3
Viral myocarditis,3/28,0.023736687519296976,0.05695362034803744,0,0,5.302262443438914,19.834350382945026,IL6;IL18;CCL2
"ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE IIA",2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,FBN2;KLHL3
"Depressive episode, unspecified",2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,ESR1;GFAP
"Familial Partial Lipodystrophy, Type 1",2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,CAV1;PPARG
"Familial Partial Lipodystrophy, Type 3",2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,CAV1;PPARG
"FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, OF SORSBY",2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,KDR;TIMP1
"Hernia, Femoral",2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,COL1A1;COL2A1
"Nephrogenic Diabetes Insipidus, Type I",2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,VWF;PRKCA
"Nevus, Blue",2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,CCND1;KIT
Abnormal diaphysis morphology,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,RPS6KA3;ANTXR2
Abnormality of the ulna,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,BMPR1B;PITX1
Acute recurrent pancreatitis,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,ERBB2;CCL2
Arterial aneurysm,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,COL3A1;IL6
Arterial thrombosis,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,PROS1;CALR
Bilateral pheochromocytoma and islet cell adenoma of the pancreas,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,RET;EPAS1
Carney Triad,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,EPAS1;KIT
Choledochal Cyst,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,MX1;AQP1
Chondroma,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,HMGA2;RUNX2
Dimple chin,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,RUNX2;EZH2
Ear Inflammation,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,IL6;CCL2
Ectromelia,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,IL18;GZMB
extranodal lymphoma,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,MUC1;CCND1
Granulomatosis,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,CTLA4;PRTN3
HIV-Associated Lipodystrophy Syndrome,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,IL6;PPARG
HSAN Type IV,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,RET;NGFR
HYPERPARATHYROIDISM 3,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,RET;CCND1
Indolent Systemic Mastocytosis,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,IL6;KIT
Intestinal Perforation,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,IL6;SELE
Marek Disease,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,TERT;SATB1
Multi-centric Castleman's Disease,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,IL6;TGFBR2
Multiple Endocrine Neoplasia Type 2b,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,RET;CXCR4
Muscle fibrosis,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,TIMP1;DCN
Non-Hereditary Clear Cell Renal Cell Carcinoma,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,VCAN;EPAS1
Overweight or obesity,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,CDKN2A;PPARGC1A
Peripheral Nerve Sheath Neoplasm,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,CDKN2A;SOX10
Pigmentation Disorders,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,MITF;KRT5
Pseudomonas Infections,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,PRTN3;VIM
Pyogenic granuloma,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,IL6;FLT4
Rudiger syndrome 1,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,LRP1;PMAIP1
Sarcoglycanopathies,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,CAPN3;DMD
Sturge-Weber Syndrome,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,KDR;TEK
Subcutaneous hemorrhage,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,COL1A2;KRT5
Supraventricular tachycardia,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,SERPINC1;CALR
Swyer Syndrome,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,WT1;CBX2
Systemic Anaplastic Large Cell Lymphoma,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,ALK;CIB1
Thecoma,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,GATA4;ZFPM2
Ulnar deviation of the wrist,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,PAX3;TNNI2
Vitreoretinal degeneration,2/11,0.023787210404443867,0.05695362034803744,0,0,9.804865813895159,36.65654212990673,VCAN;COL2A1
Body Height,13/314,0.024199471137185083,0.05792004567260692,0,0,1.9249261720191952,7.163467417038678,NGFR;MAML2;HMGA2;PRKCA;PCSK5;ESR1;FLI1;SYNE1;ACAN;CCND2;GRK5;FGFR4;TEAD1
Neuralgia,6/100,0.0242691123236199,0.05806603433039945,0,0,2.829593369844424,10.521986788029642,MMP14;DPYSL2;HGF;GAD1;CXCR4;CCL2
Arthralgia,7/128,0.024490518142710527,0.05855404764914343,0,0,2.5668515793048794,9.521657005117598,C4A;IL6;COL2A1;CAV1;CTLA4;PRTN3;PTGS2
Cocaine Abuse,7/128,0.024490518142710527,0.05855404764914343,0,0,2.5668515793048794,9.521657005117598,GRIA2;EGR1;GRK3;GAD1;FOS;FGF2;ADRA1A
Marginal Zone B-Cell Lymphoma,5/74,0.02453554518898985,0.058619964955267105,0,0,3.2091567852437417,11.898373637769293,CCND1;STMN1;LTA;RHOH;CIB1
Necrotizing enterocolitis in fetus OR newborn,5/74,0.02453554518898985,0.058619964955267105,0,0,3.2091567852437417,11.898373637769293,SIGIRR;IL6;HGF;TIMP1;ASCL1
"Leishmaniasis, Cutaneous",4/50,0.02490692255966141,0.05944381375646269,0,0,3.846790890269151,14.204696584790739,COL1A1;CXCL10;IL6;CCL2
Dyspnea on exertion,4/50,0.02490692255966141,0.05944381375646269,0,0,3.846790890269151,14.204696584790739,ACTA2;TERT;MYLK;TGFBR2
Muscular fasciculation,4/50,0.02490692255966141,0.05944381375646269,0,0,3.846790890269151,14.204696584790739,FEZ1;NDN;SCN4A;SOX10
Hematocrit procedure,6/101,0.02533611270649102,0.060446654684473786,0,0,2.799664308835871,10.290234818488516,TCF7L2;MECOM;MITF;PPARG;PROX1;VAV2
Endometrial Hyperplasia,5/75,0.025824899008740423,0.06156905280181067,0,0,3.1631493506493507,11.565790448341204,CDKN2A;RARB;PTGS2;FGFR4;ESR1
Polycythemia,5/75,0.025824899008740423,0.06156905280181067,0,0,3.1631493506493507,11.565790448341204,PRKN;NFE2;EPAS1;ELOB;APOB
"Charcot-Marie-Tooth Disease, Type Ia (disorder)",3/29,0.026049120012432102,0.06181833569028057,0,0,5.098068221371388,18.596586902913145,NGFR;ERBB2;HOXD10
"Sterility, Postpartum",3/29,0.026049120012432102,0.06181833569028057,0,0,5.098068221371388,18.596586902913145,NR5A2;LEPR;ESR1
"Subfertility, Female",3/29,0.026049120012432102,0.06181833569028057,0,0,5.098068221371388,18.596586902913145,NR5A2;LEPR;ESR1
Brain Aneurysm,3/29,0.026049120012432102,0.06181833569028057,0,0,5.098068221371388,18.596586902913145,ACTA2;COL3A1;STAT1
Diastematomyelia,3/29,0.026049120012432102,0.06181833569028057,0,0,5.098068221371388,18.596586902913145,PYY;CCL2;PAX3
Dysgerminoma,3/29,0.026049120012432102,0.06181833569028057,0,0,5.098068221371388,18.596586902913145,PRKN;KIT;BRCA1
Female sterility,3/29,0.026049120012432102,0.06181833569028057,0,0,5.098068221371388,18.596586902913145,NR5A2;LEPR;ESR1
Iniencephaly,3/29,0.026049120012432102,0.06181833569028057,0,0,5.098068221371388,18.596586902913145,PYY;CCL2;PAX3
Keratosis Follicularis,3/29,0.026049120012432102,0.06181833569028057,0,0,5.098068221371388,18.596586902913145,IL6;PTGS2;A2M
Neurenteric Cyst,3/29,0.026049120012432102,0.06181833569028057,0,0,5.098068221371388,18.596586902913145,PYY;CCL2;PAX3
Other cataract,3/29,0.026049120012432102,0.06181833569028057,0,0,5.098068221371388,18.596586902913145,ANXA1;IL18;BRCA2
Paget Disease Extramammary,3/29,0.026049120012432102,0.06181833569028057,0,0,5.098068221371388,18.596586902913145,STAT5A;KRT19;ERBB2
Spinal Cord Myelodysplasia,3/29,0.026049120012432102,0.06181833569028057,0,0,5.098068221371388,18.596586902913145,PYY;CCL2;PAX3
"Amaurosis congenita of Leber, type 1",4/51,0.02656686549904464,0.06289145882678315,0,0,3.764751290587157,13.658858383213602,RIMS2;MEF2C;MYCN;ERBB2
"Cockayne Syndrome, Type I",4/51,0.02656686549904464,0.06289145882678315,0,0,3.764751290587157,13.658858383213602,IL6;STAT1;IL18;TXNIP
"Tachycardia, Ventricular",4/51,0.02656686549904464,0.06289145882678315,0,0,3.764751290587157,13.658858383213602,SCN4A;ADRB1;MET;AGT
Abnormality of the ribs,4/51,0.02656686549904464,0.06289145882678315,0,0,3.764751290587157,13.658858383213602,CDT1;TNFSF11;FGFR3;RUNX2
Adrenal Cushing's syndrome,4/51,0.02656686549904464,0.06289145882678315,0,0,3.764751290587157,13.658858383213602,IL6;VWF;TXNIP;AGT
Epistaxis,4/51,0.02656686549904464,0.06289145882678315,0,0,3.764751290587157,13.658858383213602,VWF;F13A1;CTLA4;PRTN3
Frequent nosebleeds,4/51,0.02656686549904464,0.06289145882678315,0,0,3.764751290587157,13.658858383213602,VWF;F13A1;CTLA4;PRTN3
"Arterial Diseases, Common Carotid",2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,CCL2;AGT
"ARTHROGRYPOSIS, DISTAL, TYPE 2B",2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,FBN2;TNNI2
"Dental Fluorosis, Acquired",2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,COL1A2;TIMP1
"MYCOBACTERIUM TUBERCULOSIS, PROTECTION AGAINST",2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,CISH;CCL2
"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding)",2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,CISH;CCL2
"Xeroderma pigmentosum, group G",2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,FEN1;BRCA1
Abdominal Neoplasms,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,MYCN;ENO2
Aplasia/Hypoplasia of the earlobes,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,COL3A1;FLI1
Biliary System Disorder,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,CDKN2A;TGFBR2
Carcinoma of anal margin,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,RIMS2;CDKN2A
Carditis,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,IL6;DCN
Cerebellar dysplasia,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,GPSM2;LAMA1
Childhood Pre-B Acute Lymphoblastic Leukemia,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,MECOM;RUNX1T1
Congenital exomphalos,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,LRP1;PCSK5
CONOTRUNCAL HEART MALFORMATIONS (disorder),2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,NKX2-5;ZFPM2
Coronavirus Infections,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,MX1;CCL2
External Carotid Artery Diseases,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,CCL2;AGT
Glucose tolerance test,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,TCF7L2;ADCY5
Hemarthrosis,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,VWF;F13A1
HYPERPARATHYROIDISM 1,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,RET;CCND1
Hypoplasia of the capital femoral epiphysis,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,COL2A1;KIF22
Idiopathic urticaria,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,SOCS3;CCL2
Impaired platelet aggregation,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,VWF;CALR
Infarction,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,LTA;AGT
Internal Carotid Artery Diseases,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,CCL2;AGT
Lower limb atrophy,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,TPM3;FLNC
Lower limb muscle hypotrophy,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,TPM3;FLNC
Lymphoepithelial carcinoma,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,ALK;ERBB2
Myelokathexis,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,CXCL12;CXCR4
Myotonia,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,LIFR;SCN4A
Onchocerciasis,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,SOSTDC1;CALR
Round cell tumor,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,WT1;ENO2
Secondary hypertension,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,SGK1;AGT
Secondary pulmonary hypertension,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,CDKN2A;S100A4
Short tibia,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,LIFR;BMPR1B
Social Anxiety,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,CNTNAP2;ADRB1
Vulvar Lichen Sclerosus,2/12,0.02813017115577252,0.065734944148284,0,0,8.82392776523702,31.509474591675207,CDKN2A;DCN
Congenital neurologic anomalies,4/52,0.028291566380210294,0.06597436104496261,0,0,3.686130007558579,13.141759468571319,COL1A1;COL1A2;PROC;PAX3
Decreased antibody level in blood,4/52,0.028291566380210294,0.06597436104496261,0,0,3.686130007558579,13.141759468571319,CCND1;SH2D1A;CTLA4;CXCR4
Flexion contracture - elbow,4/52,0.028291566380210294,0.06597436104496261,0,0,3.686130007558579,13.141759468571319,BGN;CAPN3;LIFR;PITX1
Hoarseness,4/52,0.028291566380210294,0.06597436104496261,0,0,3.686130007558579,13.141759468571319,ACAN;LIFR;FLNC;EZH2
Range of joint movement increased,4/52,0.028291566380210294,0.06597436104496261,0,0,3.686130007558579,13.141759468571319,RET;COL1A1;COL3A1;BGN
X-linked agammaglobulinemia,4/52,0.028291566380210294,0.06597436104496261,0,0,3.686130007558579,13.141759468571319,IL6;CR1;IL2RG;FGFR4
Autoimmune thyroid disease,7/132,0.028352108943540854,0.06609259412177035,0,0,2.484200913242009,8.851341657990991,VAV3;CXCL10;IL6;CXCL12;CDKN2A;IL18;CTLA4
"Hemorrhagic Fevers, Viral",3/30,0.028477874342844964,0.06615614115757412,0,0,4.908999497234792,17.469302238438775,IL6;CDKN2C;CFL1
Amyotrophic Lateral Sclerosis With Dementia,3/30,0.028477874342844964,0.06615614115757412,0,0,4.908999497234792,17.469302238438775,PLA2G4A;PTGS2;GFAP
Dilatation of ureter,3/30,0.028477874342844964,0.06615614115757412,0,0,4.908999497234792,17.469302238438775,SIX1;PLD1;MYLK
Femoral bowing,3/30,0.028477874342844964,0.06615614115757412,0,0,4.908999497234792,17.469302238438775,COL1A1;LIFR;FGFR3
genetic hypertension,3/30,0.028477874342844964,0.06615614115757412,0,0,4.908999497234792,17.469302238438775,ADRB2;ADRA1A;AGT
Lymphadenitis,3/30,0.028477874342844964,0.06615614115757412,0,0,4.908999497234792,17.469302238438775,SOCS3;CXCL10;CCL19
Pancreatic Insufficiency,3/30,0.028477874342844964,0.06615614115757412,0,0,4.908999497234792,17.469302238438775,CDKN2A;BRCA1;BRCA2
Stage II Colon Cancer AJCC v7,3/30,0.028477874342844964,0.06615614115757412,0,0,4.908999497234792,17.469302238438775,RET;IL6;PTGS2
Stomach Diseases,3/30,0.028477874342844964,0.06615614115757412,0,0,4.908999497234792,17.469302238438775,ANXA1;HGF;PTGS2
TUBEROUS SCLEROSIS 2 (disorder),3/30,0.028477874342844964,0.06615614115757412,0,0,4.908999497234792,17.469302238438775,CCND1;SSTR2;PAX2
Xerosis,6/104,0.028723194381042233,0.06670296454463336,0,0,2.713541908790851,9.633210310837832,TERT;CDKN2A;CTLA4;MITF;PRKD1;IL2RG
Protruding ear,5/78,0.029949852591993783,0.06952755271615287,0,0,3.032689912826899,10.6393763902288,PLK4;RPS6KA3;BLM;COL3A1;TNNI2
"Leukemia, Lymphocytic, Acute, L2",4/53,0.03008139827027302,0.06976059074003924,0,0,3.6107177564903514,12.65140725816986,HLF;TAL1;CDKN2A;ERG
Abnormality of pelvic girdle bone morphology,4/53,0.03008139827027302,0.06976059074003924,0,0,3.6107177564903514,12.65140725816986,COL1A1;COL2A1;COL1A2;FGFR3
Hypophosphatemia,4/53,0.03008139827027302,0.06976059074003924,0,0,3.6107177564903514,12.65140725816986,PER2;FGF7;FGF2;FGFR3
Tremor,10/226,0.03042054885413283,0.07052274977713362,0,0,2.0582162622392506,7.188602168117568,PRKN;EGR2;IL6;GAD1;CTNND2;TNFSF11;HMGA2;ADRB2;GFAP;LMNB1
Autoimmune Lymphoproliferative Syndrome,3/31,0.03102251581844073,0.07159698152462128,0,0,4.733435681965093,16.439421029122542,CTLA4;TIMP1;FADD
Chronic interstitial cystitis,3/31,0.03102251581844073,0.07159698152462128,0,0,4.733435681965093,16.439421029122542,CXCL10;IL6;ADRB2
ESTROGEN RESISTANCE,3/31,0.03102251581844073,0.07159698152462128,0,0,4.733435681965093,16.439421029122542,CCND1;ERBB2;ESR1
Hallux Valgus,3/31,0.03102251581844073,0.07159698152462128,0,0,4.733435681965093,16.439421029122542,COL1A1;BMP2;BMPR1B
Histiocytic sarcoma,3/31,0.03102251581844073,0.07159698152462128,0,0,4.733435681965093,16.439421029122542,CDKN2A;MET;LMNB1
HIV Encephalopathy,3/31,0.03102251581844073,0.07159698152462128,0,0,4.733435681965093,16.439421029122542,IL6;CCL2;ADRB2
Latent autoimmune diabetes mellitus in adult,3/31,0.03102251581844073,0.07159698152462128,0,0,4.733435681965093,16.439421029122542,TCF7L2;GAD1;CTLA4
Metatarsus Varus,3/31,0.03102251581844073,0.07159698152462128,0,0,4.733435681965093,16.439421029122542,FBN2;TNNI2;EZH2
Myxoma,3/31,0.03102251581844073,0.07159698152462128,0,0,4.733435681965093,16.439421029122542,STAT1;KIT;CCL2
Pericardial effusion,3/31,0.03102251581844073,0.07159698152462128,0,0,4.733435681965093,16.439421029122542,ERBB2;PTGS2;MET
Pulmonary Eosinophilia,3/31,0.03102251581844073,0.07159698152462128,0,0,4.733435681965093,16.439421029122542,CXCR2;CCL2;CCL16
Recurrent upper respiratory tract infection,3/31,0.03102251581844073,0.07159698152462128,0,0,4.733435681965093,16.439421029122542,STAT1;LEPR;CXCR4
Stage II Colon Cancer,3/31,0.03102251581844073,0.07159698152462128,0,0,4.733435681965093,16.439421029122542,RET;IL6;PTGS2
Motor Neuron Disease,7/135,0.03150536216426589,0.07268636629859487,0,0,2.4256028824200913,8.386758511247095,RIMS2;COL17A1;STMN1;SNCG;VIM;NEFH;GFAP
Atrial Septal Defects,8/165,0.0316251135514095,0.07293759018244031,0,0,2.2618606888309114,7.8120229095701905,FBN2;ACTA2;NRP1;ACTC1;IL18;GATA4;DMD;NKX2-5
Spinal Muscular Atrophy,9/196,0.031759209211822195,0.07322171269021555,0,0,2.1379581023401855,7.37504156532007,STAT5A;STAT5B;ANXA1;PAX3;CCL2;DMD;CD36;VIM;FOXO1
Autistic behavior,4/54,0.03193667545501649,0.07350469923094267,0,0,3.5383219954648526,12.18598176197359,CNTNAP2;MEF2C;ZNF423;SYN1
Drug Withdrawal Symptoms,4/54,0.03193667545501649,0.07350469923094267,0,0,3.5383219954648526,12.18598176197359,OPRD1;PER2;GRIA2;FOS
Malignant neoplasm of nasopharynx,4/54,0.03193667545501649,0.07350469923094267,0,0,3.5383219954648526,12.18598176197359,IL6;TERT;HGF;SAA1
Pancreatic Diseases,4/54,0.03193667545501649,0.07350469923094267,0,0,3.5383219954648526,12.18598176197359,IL6;KRT19;CDKN2A;LEPR
Reduced tendon reflexes,4/54,0.03193667545501649,0.07350469923094267,0,0,3.5383219954648526,12.18598176197359,CNTNAP2;TPM3;SCN4A;APOB
Microstomia,6/107,0.032395573258245665,0.07426119747826634,0,0,2.6325356909267237,9.02889583161122,CDT1;BMP2;CCND2;COL2A1;PAX3;TNNI2
Mental and motor retardation,32/1021,0.03260879880178628,0.07426119747826634,0,0,1.4545276491772696,4.979099958423825,RET;GATA4;BRCA2;CCND2;TERT;SIX3;NDN;DMD;NKX2-5;ZNF423;BUB1;SOX5;PLK4;ARNT2;GAD1;FANCA;HMGA2;KIF22;TUBG1;SOX10;FLI1;GRIN2D;CIT;COL3A1;BMP2;RAD51;PROC;FANCD2;MCM4;PRKD1;FGFR3;EZH2
"Antley-Bixler Syndrome, Autosomal Dominant",2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,FANCD2;BRCA2
"Cerebral Amyloid Angiopathy, Hereditary",2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,SYP;GFAP
"Charcot-Marie-Tooth Disease, Type Ib",2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,SERPINC1;HOXD10
"DISORGANIZATION, MOUSE, HOMOLOG OF",2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,RCAN1;ETS2
"MYOPATHY, MYOFIBRILLAR, DESMIN-RELATED",2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,CRYAB;GFAP
"Pseudohypoaldosteronism, Type I, Autosomal Dominant",2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,KLHL3;SGK1
"Trigeminal Neuralgia, Idiopathic",2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,FOS;GFAP
Absent earlobe,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,PLK4;COL3A1
Age-related cognitive decline,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,PER2;ESR1
American cutaneous leishmaniasis,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,LTA;FLI1
Ataxia with vitamin E deficiency,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,ZFP36;APOB
Bacteroides fragilis infection in conditions classified elsewhere and of unspecified site,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,PER2;PITX1
Barakat syndrome,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,GATA3;ZFPM2
Breech Presentation,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,COL1A1;COL1A2
cancer angiogenesis,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,FLT4;CCL2
Cerebral metastasis,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,ERBB2;SELE
Chronic superficial gastritis,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,CCL2;PTGS2
Coffin-Lowry syndrome,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,RPS6KA3;COL2A1
Curling Ulcer,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,PLA2G4A;PTGS2
Delayed eruption of primary teeth,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,FGFR3;RUNX2
Diabetes in children,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,NRP1;GAD1
Generalized joint laxity,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,COL2A1;FGFR3
Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,CDKN2A;STAT1
Infection in children,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,IL6;LEPR
Infrequent generalized seizures,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,CTNND2;FGFR3
Insulin-dependent diabetes mellitus secretory diarrhea syndrome,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,CTLA4;IL2RG
Liver and Intrahepatic Bile Duct Epithelial Neoplasm,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,COL1A1;MET
Liver and Intrahepatic Bile Duct Neoplasm,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,COL1A1;MET
Macrophage Activation Syndrome,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,IL6;IL18
Monosomy 22,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,ERBB2;ERG
Mycetoma,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,TIMP1;TEAD1
Neoplastic Processes,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,HMGA2;ERG
Non-toxic nodular goiter,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,RET;PTGS2
obsolete Combined hyperlipidemia,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,TXNIP;PPARA
Osteogenesis imperfecta type III (disorder),2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,COL1A1;COL1A2
Osteogenesis imperfecta type IV (disorder),2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,COL1A1;COL1A2
Prelingual sensorineural hearing impairment,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,HGF;MITF
Reticulocytopenia,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,FANCD2;FANCA
Secondary malignant neoplasm of skin,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,KIT;TGFBR2
Secondary Trigeminal Neuralgia,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,FOS;GFAP
Sex reversal,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,CBX2;ZFPM2
Sotos' syndrome,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,FGFR4;FGFR3
Urolithiasis,2/13,0.032762943437775936,0.07426119747826634,0,0,8.021342089062179,27.420614421538456,IL6;AGT
Drug abuse,10/229,0.03286061952597749,0.07445746313645912,0,0,2.029706607883273,6.932422960496326,STAT5A;OPRD1;IL6;CCND1;CXCR4;PMAIP1;PARVA;ADRA1A;GRIA4;SYNE1
Lordosis,5/80,0.03291743709957725,0.07451078785330664,0,0,2.9515151515151516,10.07574299049365,RET;COL2A1;BIN1;DMD;FGFR3
Prion Diseases,5/80,0.03291743709957725,0.07451078785330664,0,0,2.9515151515151516,10.07574299049365,PRKN;IL6;FANCD2;BRCA2;PTGS2
Prominent ear,5/80,0.03291743709957725,0.07451078785330664,0,0,2.9515151515151516,10.07574299049365,PLK4;RPS6KA3;BLM;COL3A1;TNNI2
Irritable Bowel Syndrome,8/167,0.033614293879945155,0.07576160718572136,0,0,2.2331793388310808,7.576739546473319,EGR1;PYY;IL6;CXCL12;KCNQ5;GATA3;FGFR4;CCL16
"Myopathies, Nemaline",3/32,0.033682442049471774,0.07576160718572136,0,0,4.569979716024341,15.495789354200202,ACTA2;ACTC1;TPM3
Acrania,3/32,0.033682442049471774,0.07576160718572136,0,0,4.569979716024341,15.495789354200202,PYY;CCL2;PAX3
Bone marrow hypocellularity,3/32,0.033682442049471774,0.07576160718572136,0,0,4.569979716024341,15.495789354200202,TERT;BRCA2;FLI1
Bunion,3/32,0.033682442049471774,0.07576160718572136,0,0,4.569979716024341,15.495789354200202,COL1A1;BMP2;BMPR1B
Cardiovascular morbidity,3/32,0.033682442049471774,0.07576160718572136,0,0,4.569979716024341,15.495789354200202,CDKN2A;FGFR4;FGF2
Columnar Cell Change of the Breast,3/32,0.033682442049471774,0.07576160718572136,0,0,4.569979716024341,15.495789354200202,FBN2;IL18;PROX1
Congenital malrotation of intestine,3/32,0.033682442049471774,0.07576160718572136,0,0,4.569979716024341,15.495789354200202,ACTA2;SIX1;MYLK
Decrease in appetite,3/32,0.033682442049471774,0.07576160718572136,0,0,4.569979716024341,15.495789354200202,CDKN2A;BRCA1;BRCA2
Dysphonia,3/32,0.033682442049471774,0.07576160718572136,0,0,4.569979716024341,15.495789354200202,RET;BIN1;FLNC
Fibrillation,3/32,0.033682442049471774,0.07576160718572136,0,0,4.569979716024341,15.495789354200202,NGFR;SCN4A;CALR
Gastro-esophageal reflux disease with esophagitis,3/32,0.033682442049471774,0.07576160718572136,0,0,4.569979716024341,15.495789354200202,IL6;PTGS2;ESR1
Grade I Astrocytoma,3/32,0.033682442049471774,0.07576160718572136,0,0,4.569979716024341,15.495789354200202,HGF;ESR1;MET
Hypereosinophilia,3/32,0.033682442049471774,0.07576160718572136,0,0,4.569979716024341,15.495789354200202,IL6;KIT;CAPN3
Increased bilirubin level (finding),3/32,0.033682442049471774,0.07576160718572136,0,0,4.569979716024341,15.495789354200202,F12;SPTB;KLF1
Slender long bone,3/32,0.033682442049471774,0.07576160718572136,0,0,4.569979716024341,15.495789354200202,COL1A1;CDT1;COL1A2
Verrucous carcinoma,3/32,0.033682442049471774,0.07576160718572136,0,0,4.569979716024341,15.495789354200202,CCND1;CDKN2A;KRT5
"Leukemia, Myelomonocytic, Chronic",6/108,0.03368435959746337,0.07576160718572136,0,0,2.606592523114029,8.838229717154993,RET;EGR2;KIT;IL18;CTLA4;EZH2
Congenital ocular coloboma (disorder),6/108,0.03368435959746337,0.07576160718572136,0,0,2.606592523114029,8.838229717154993,YAP1;SIX3;RARB;MITF;FADD;PAX2
Bone pain,4/55,0.03385765433336809,0.07604950050264217,0,0,3.4687652838913343,11.743817682296495,MEF2C;CCND1;TNFSF11;TEK
Dysmorphic features,4/55,0.03385765433336809,0.07604950050264217,0,0,3.4687652838913343,11.743817682296495,MEF2C;BMP2;NDN;SOX5
Early Rheumatoid Arthritis,4/55,0.03385765433336809,0.07604950050264217,0,0,3.4687652838913343,11.743817682296495,IL6;CTLA4;TNFSF11;VIM
Hantavirus Infections,4/55,0.03385765433336809,0.07604950050264217,0,0,3.4687652838913343,11.743817682296495,CXCL10;IL6;SH2D1A;KDR
Primary immune deficiency disorder,5/81,0.034467447151216975,0.0773933049373364,0,0,2.9125299043062203,9.808643346959512,STAT1;SH2D1A;CXCR4;IL2RG;STX11
Carotid Stenosis,4/56,0.035844534351165656,0.08045852028824484,0,0,3.401883830455259,11.323388670682505,IL6;ANXA1;TIMP1;APOB
"Abortion, Tubal",6/110,0.036360377465746094,0.0813707198134244,0,0,2.5562029087086033,8.471961001528506,COL1A1;CXCL10;FGF7;IL6;COL1A2;PAEP
Dry skin,6/110,0.036360377465746094,0.0813707198134244,0,0,2.5562029087086033,8.471961001528506,TERT;CDKN2A;CTLA4;MITF;PRKD1;IL2RG
Eosinophil count procedure,9/201,0.036411762130474146,0.0813707198134244,0,0,2.0817445527522938,6.8965353808536785,TERT;CXCR2;LEPR;PLAUR;E2F2;PPARG;GATA3;ERG;FOXO1
Eosinophil count result,9/201,0.036411762130474146,0.0813707198134244,0,0,2.0817445527522938,6.8965353808536785,TERT;CXCR2;LEPR;PLAUR;E2F2;PPARG;GATA3;ERG;FOXO1
"Muscular Dystrophy, Emery-Dreifuss",3/33,0.03645689337680078,0.0813707198134244,0,0,4.417420814479638,14.628839966561598,CAPN3;FLNC;SYNE1
"Pneumonia, Interstitial",3/33,0.03645689337680078,0.0813707198134244,0,0,4.417420814479638,14.628839966561598,MUC1;IL6;TERT
Atrioventricular Block,3/33,0.03645689337680078,0.0813707198134244,0,0,4.417420814479638,14.628839966561598,CAV1;PKD2;NKX2-5
Craniopharyngioma,3/33,0.03645689337680078,0.0813707198134244,0,0,4.417420814479638,14.628839966561598,VTN;IL6;ESR1
Gastric Cardia Adenocarcinoma,3/33,0.03645689337680078,0.0813707198134244,0,0,4.417420814479638,14.628839966561598,CXCR2;PTGS2;GADD45G
Harlequin Fetus,3/33,0.03645689337680078,0.0813707198134244,0,0,4.417420814479638,14.628839966561598,IL6;EPAS1;SOX10
Meniere Disease,3/33,0.03645689337680078,0.0813707198134244,0,0,4.417420814479638,14.628839966561598,CAV1;ESR1;AQP1
Metabolic Bone Disorder,3/33,0.03645689337680078,0.0813707198134244,0,0,4.417420814479638,14.628839966561598,COL1A1;IL6;ESR1
Metaphyseal widening,3/33,0.03645689337680078,0.0813707198134244,0,0,4.417420814479638,14.628839966561598,COL2A1;LIFR;PITX1
Pleural Tuberculosis,3/33,0.03645689337680078,0.0813707198134244,0,0,4.417420814479638,14.628839966561598,SOCS3;IL18;CCL2
Refractory anaemia with excess blasts,3/33,0.03645689337680078,0.0813707198134244,0,0,4.417420814479638,14.628839966561598,AKAP12;MECOM;CHEK1
Toeing-in,3/33,0.03645689337680078,0.0813707198134244,0,0,4.417420814479638,14.628839966561598,FBN2;TNNI2;EZH2
Ventricular hypertrophy,3/33,0.03645689337680078,0.0813707198134244,0,0,4.417420814479638,14.628839966561598,PTGS2;AGT;ATF3
"Cystadenoma, Serous",2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,CDKN2A;PAEP
"Familial Partial Lipodystrophy, Type 2",2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,CAV1;PPARG
"Fracture, spiral",2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,BMP2;TGFBR2
"Supratentorial Embryonal Tumor, Not Otherwise Specified",2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,CDKN2A;ASCL1
Adenocarcinoma of small intestine,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,CDKN2A;ERBB2
Amelanotic Skin Melanoma,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,CAV1;KIT
Anal squamous cell carcinoma,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,RIMS2;CDKN2A
Angioedema,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,F12;SERPING1
Biconcave vertebral bodies,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,COL1A1;COL1A2
Cancer Relapse,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,NRP1;MET
Coronary Occlusion,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,IL6;CCL2
Delayed epiphyseal ossification,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,COL2A1;ESR1
Delayed maturation of end part of long bone,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,COL2A1;ESR1
Disorder of endocrine ovary,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,PPARG;ESR1
Disorder of face,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,CAV1;PPARG
Distal lower limb amyotrophy,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,TPM3;FLNC
dowling-degos disease,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,ACAN;KRT5
Dull foveal reflex,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,WT1;MITF
Enterovirus 71 infection,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,CXCL10;MX1
Exudative retinopathy,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,TERT;KDR
Eye Neoplasms,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,MYCN;FLI1
Female pattern alopecia (disorder),2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,ZFP36;PARP1
Foveal hypoplasia (finding),2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,WT1;MITF
Freeman-Sheldon syndrome,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,FBN2;TNNI2
Gastric Gastrointestinal Stromal Tumor,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,VCAN;KIT
growth hormone treatment,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,ACAN;FGFR3
Hip Dysplasia,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,IL6;COL2A1
Hyperextensibility of the finger joints,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,COL1A1;RPS6KA3
Hypokalemic periodic paralysis,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,SCN4A;ADRB2
Hypoparathyroidism - autosomal dominant,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,GATA3;ESR1
Inflammatory neuropathy,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,CXCL10;IL6
Leiomyomatosis,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,ALK;MET
Limbic Encephalitis,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,CNTNAP2;SH2D1A
Low Grade Cervical Squamous Intraepithelial Neoplasia,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,CCND1;CDKN2A
Maxillary Sinus Squamous Cell Carcinoma,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,FGF2;PPP1CA
Mesenchymal Chondrosarcoma,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,COL2A1;MKI67
Milk-Alkali Syndrome,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,IL6;TNFSF11
Mirror movements disorder,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,MEF2C;RAD51
Nephrogenic rest,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,WT1;HGF
Neuroma,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,NRP1;SEMA3F
Paramyotonia Congenita (disorder),2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,SCN4A;BAK1
Recurrent erosion of cornea,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,COL17A1;FGFR3
Sensory hearing loss,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,COL2A1;FADD
Short extremities,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,COL2A1;FGFR3
Stickler syndrome (disorder),2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,RPS6KA3;COL2A1
Syringomyelia,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,COL1A1;RUNX2
Thoracolumbar scoliosis,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,RPS6KA3;SOX5
Urticaria Pigmentosa,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,KIT;CTSG
Vasculitis of the skin,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,C3;SELE
Viral meningitis,2/14,0.037670542035364234,0.08270525018290494,0,0,7.352520692249812,24.108010021777286,TIMP1;ENO2
Hay fever,5/83,0.03770121257759549,0.08274553714742854,0,0,2.837558275058275,9.301694851921681,VAV3;CXCL10;IL6;IL18;TNS1
Hydronephrosis,6/111,0.0377480502019341,0.08282126924409978,0,0,2.531727953140254,8.296020474822367,EGR1;ARNT2;SIX1;GATA3;PLD1;PTGS2
Hypertrophy of clitoris,4/57,0.03789745900881635,0.08309478769285361,0,0,3.3375262054507338,10.923293443001391,CDT1;WT1;GATA4;ZFPM2
Necrosis,4/57,0.03789745900881635,0.08309478769285361,0,0,3.3375262054507338,10.923293443001391,IL6;MYCN;DMD;AGT
Body mass index,14/370,0.03829198266074924,0.08390504259366784,0,0,1.7517792434630726,5.715205593765587,PRKN;TCF7L2;HMGA2;PROX1;PCSK5;FGF2;ADCY5;ACAN;ALDH2;PPARG;DMD;SCAND1;ZNF423;SKAP1
Finding of body mass index,14/370,0.03829198266074924,0.08390504259366784,0,0,1.7517792434630726,5.715205593765587,PRKN;TCF7L2;HMGA2;PROX1;PCSK5;FGF2;ADCY5;ACAN;ALDH2;PPARG;DMD;SCAND1;ZNF423;SKAP1
Mood Disorders,13/336,0.03862943959819088,0.08461686769127527,0,0,1.7917669991973397,5.829945047720579,DST;GAD1;ADRB1;ADRB2;PTGS2;FGF2;ESR1;GFAP;VTN;PPARG;DMD;CALR;FKBP4
Infectious disease of lung,6/112,0.03916910513132765,0.08574306064602234,0,0,2.5077147891864016,8.12466233405167,VCAN;COL2A1;IL18;RARB;CXCR4;DCN
Neonatal Hypotonia,6/112,0.03916910513132765,0.08574306064602234,0,0,2.5077147891864016,8.12466233405167,EGR2;DST;TPM3;BIN1;CNTN1;SOX10
"Amyotrophic Lateral Sclerosis, Guam Form",3/34,0.03934496297250898,0.08584820380876228,0,0,4.274704422712013,13.830324477840147,PLA2G4A;PTGS2;GFAP
Abnormality of the urinary system,3/34,0.03934496297250898,0.08584820380876228,0,0,4.274704422712013,13.830324477840147,COL3A1;PAX2;LMNB1
Adducted thumb,3/34,0.03934496297250898,0.08584820380876228,0,0,4.274704422712013,13.830324477840147,FBN2;TNNI2;LIFR
Anastomosis,3/34,0.03934496297250898,0.08584820380876228,0,0,4.274704422712013,13.830324477840147,CXCL10;PROS1;PTGS2
Dysautonomia,3/34,0.03934496297250898,0.08584820380876228,0,0,4.274704422712013,13.830324477840147,RET;LIFR;ASCL1
Female infertility,3/34,0.03934496297250898,0.08584820380876228,0,0,4.274704422712013,13.830324477840147,NR5A2;LEPR;ESR1
Narrow nose,3/34,0.03934496297250898,0.08584820380876228,0,0,4.274704422712013,13.830324477840147,NDN;PAX3;BMPR1B
Nonnuclear polymorphic congenital cataract,3/34,0.03934496297250898,0.08584820380876228,0,0,4.274704422712013,13.830324477840147,RET;CXCL10;DUSP1
Richter's syndrome,3/34,0.03934496297250898,0.08584820380876228,0,0,4.274704422712013,13.830324477840147,CCND1;CDKN2A;TK1
Short long bone,3/34,0.03934496297250898,0.08584820380876228,0,0,4.274704422712013,13.830324477840147,COL2A1;BGN;FGFR3
Amnesia,4/58,0.04001651690779506,0.08711537359894704,0,0,3.275552196187117,10.542243506733008,IL6;ALDH2;PARP1;GATA3
Congenital defects,4/58,0.04001651690779506,0.08711537359894704,0,0,3.275552196187117,10.542243506733008,MMP14;ALDH2;VWF;PAX3
Inclusion Body Myositis (disorder),4/58,0.04001651690779506,0.08711537359894704,0,0,3.275552196187117,10.542243506733008,IL6;SDC1;CD36;TIMP1
Maternal oligohydramnios,4/58,0.04001651690779506,0.08711537359894704,0,0,3.275552196187117,10.542243506733008,RET;LIFR;PAX2;AGT
Mycoplasma Infections,4/58,0.04001651690779506,0.08711537359894704,0,0,3.275552196187117,10.542243506733008,BMP2;IL6;IL18;KRT5
Nausea,4/58,0.04001651690779506,0.08711537359894704,0,0,3.275552196187117,10.542243506733008,RET;ALDH2;SAA1;SERPING1
Substance Withdrawal Syndrome,4/58,0.04001651690779506,0.08711537359894704,0,0,3.275552196187117,10.542243506733008,OPRD1;PER2;GRIA2;FOS
Tonic - clonic seizures,8/173,0.04008725947853765,0.08724110001874881,0,0,2.1513071215588377,6.9201025484920935,NGFR;IL6;FOS;SSTR2;PTGS2;FGF2;MPDZ;AGT
Hypogammaglobulinemia,5/85,0.04111476493962899,0.08944825440056633,0,0,2.766335227272727,8.82844898666015,CXCL12;CCND1;SH2D1A;CTLA4;CXCR4
Calcification of coronary artery,14/375,0.0420448699350411,0.09144214588203887,0,0,1.7270664755673528,5.473104574133471,PRKN;ALK;CNTNAP2;FEN1;LAMA1;CTNND2;PLD1;SYNE1;CLEC3B;CD5;APOB;PPARGC1A;NECTIN2;ARHGEF6
Posteriorly rotated ear,6/114,0.042112103788916944,0.091537824587876,0,0,2.4610225259427994,7.795092162779308,RET;CDT1;MYCN;MITF;ASCL1;SOX5
Alopecia Areata,4/59,0.04220174286463607,0.091537824587876,0,0,3.215831787260359,10.179052285190052,CXCL10;MX1;CTLA4;GZMB
Body fluid retention,4/59,0.04220174286463607,0.091537824587876,0,0,3.215831787260359,10.179052285190052,COL2A1;NPHS1;IL2RG;PLD1
Chronic lung disease,4/59,0.04220174286463607,0.091537824587876,0,0,3.215831787260359,10.179052285190052,BLM;IL6;PDGFA;A2M
Hemorrhagic Disorders,4/59,0.04220174286463607,0.091537824587876,0,0,3.215831787260359,10.179052285190052,C3;VWF;TERT;TEK
Leukocyte adhesion deficiency type 1,4/59,0.04220174286463607,0.091537824587876,0,0,3.215831787260359,10.179052285190052,RET;COL17A1;HGF;VIM
Urinary Incontinence,4/59,0.04220174286463607,0.091537824587876,0,0,3.215831787260359,10.179052285190052,COL1A1;COL3A1;A2M;DCN
"Polyradiculoneuropathy, Chronic Inflammatory Demyelinating",3/35,0.04234560642307747,0.091537824587876,0,0,4.1409078054298645,13.093097497353838,IL6;CTLA4;PTGS2
Coagulation factor measurement,3/35,0.04234560642307747,0.091537824587876,0,0,4.1409078054298645,13.093097497353838,VWF;F13A1;FGFR4
Epidermolysis Bullosa,3/35,0.04234560642307747,0.091537824587876,0,0,4.1409078054298645,13.093097497353838,COL17A1;DST;KRT5
Sparse axillary hair,3/35,0.04234560642307747,0.091537824587876,0,0,4.1409078054298645,13.093097497353838,WT1;GATA4;ZFPM2
Ventricular Fibrillation,3/35,0.04234560642307747,0.091537824587876,0,0,4.1409078054298645,13.093097497353838,IL6;SCN4A;MET
Disease Exacerbation,7/144,0.04234742757353521,0.091537824587876,0,0,2.265206812652068,7.162238728151896,FKBP2;TERT;STAT1;ERBB2;TXNIP;FGF2;ESR1
"Heart Failure, Diastolic",2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,IL6;AGT
"Leukemia, Prolymphocytic, B-Cell",2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,CCND1;CTSG
Abnormality of the face,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,CAV1;PPARG
Abnormality of the hypothalamus-pituitary axis,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,CTLA4;PRTN3
Autonomic neuropathy,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,TCF7L2;DST
Cervix Intraepithelial Neoplasia Grade 3 AJCC v7,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,CDKN2A;KLF4
Chronic ulcer,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,ADAM12;TIMP1
Complex Regional Pain Syndromes,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,CCL2;ADRB2
Congenital hypoplasia of femur,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,COL2A1;FGFR3
Congenital Thrombotic Thrombocytopenic Purpura,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,ZFP36;VWF
Core binding factor acute myeloid leukemia,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,KIT;RUNX1T1
Fracture,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,BMP2;TGFBR2
Gastroschisis,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,LRP1;KIT
Glycogen Storage Disease Type V,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,SLC2A4;PPL
Group B streptococcal pneumonia,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,MYCN;CCND1
Helicobacter Infections,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,MUC1;TIMP1
Hyperparathyroidism-Jaw Tumor Syndrome,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,RET;RIMS2
Hypoplastic ilia,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,COL2A1;FGFR3
Leptospirosis,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,CISH;SELE
Lethal skeletal dysplasia,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,COL2A1;FGFR3
Malignant histiocytosis,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,ALK;MYCN
Malignant melanoma of ciliary body,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,CCND1;KIT
Mast-Cell Sarcoma,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,COL17A1;KIT
Mesomelia,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,ACAN;FGFR3
Middle East Respiratory Syndrome,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,VTN;PPP1CA
Multiple renal cysts,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,MUC1;EPAS1
Neonatal thrombocytopenia (disorder),2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,PLA2G2A;CD36
Oestrogen receptor positive breast cancer,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,MUC1;ERBB2
Paraneoplastic Syndromes,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,IL6;ERBB2
Pemphigus Foliaceus,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,C3;IL6
Phobic anxiety disorder,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,GAD1;ESR1
Platybasia,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,COL1A1;COL1A2
Pneumothorax,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,ALK;COL3A1
Poikiloderma of Kindler,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,CDKN2A;KRT5
Primary congenital glaucoma,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,ADRB2;TEK
Psammomatous Meningioma,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,ALK;RET
Pulmonary Pathology,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,EPAS1;CCL2
Reiter Syndrome,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,TAP1;PTGS2
Selective immunoglobulin A deficiency,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,C3;SDC1
Small wings of the pelvic girdle,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,COL2A1;FGFR3
Sudden sensorineural hearing loss,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,CAV1;ESR1
Thyroid stimulating hormone measurement,2/15,0.04283850248357568,0.091537824587876,0,0,6.786594894947039,21.37993198870518,VAV3;FGF7
Curvature of digit,5/86,0.042889416914591943,0.09155922568289877,0,0,2.7320426487093155,8.603557945664631,PAX3;NDN;FGFR3;SOX5;EZH2
Muscle Cramp,5/86,0.042889416914591943,0.09155922568289877,0,0,2.7320426487093155,8.603557945664631,STMN1;SCN4A;DMD;NEFH;PPARGC1A
Recurrent urinary tract infection,5/86,0.042889416914591943,0.09155922568289877,0,0,2.7320426487093155,8.603557945664631,PER2;IL6;LTA;CCL2;PKD2
Cataract,18/519,0.04313631686655653,0.09205703974445302,0,0,1.60321978992834,5.0395450842609675,PLK4;BLM;CDKN2A;PLA2G4A;PTGS2;IL2RG;ESR1;IL6;VCAN;COL2A1;WT1;RHOJ;SIX3;NEK2;VIM;CRYAB;NECTIN3;BUB1
Drug-Induced Liver Disease,14/377,0.04361661106208488,0.09305246502317727,0,0,1.717371990310189,5.37935384726918,VWF;IL18;PTGS2;CDC25B;C3;CXCL10;COL3A1;IL6;SERPING1;CTLA4;CCL2;PPARG;VIM;PPARA
Androgenetic Alopecia,4/60,0.044453119019752844,0.09477687217036829,0,0,3.1582442500809846,9.832625463379948,ZFP36;PARP1;CDKN2A;KRT5
Bullous pemphigoid,4/60,0.044453119019752844,0.09477687217036829,0,0,3.1582442500809846,9.832625463379948,COL17A1;NFE2;DST;SELE
Concave bridge of nose,11/275,0.04461125599769068,0.09505367870573941,0,0,1.8520545314900154,5.759461907552237,RPS6KA3;MEF2C;COL2A1;CCND2;PAX3;PRKD1;KIF22;FGFR3;RUNX2;SOX5;EZH2
Depressed nasal root/bridge,11/275,0.04461125599769068,0.09505367870573941,0,0,1.8520545314900154,5.759461907552237,RPS6KA3;MEF2C;COL2A1;CCND2;PAX3;PRKD1;KIF22;FGFR3;RUNX2;SOX5;EZH2
"DEAFNESS, AUTOSOMAL RECESSIVE (disorder)",3/36,0.04545765095439701,0.09645926818632869,0,0,4.0152200740436035,12.410941393978344,EPS8;CLIC5;HGF
Craniorachischisis,3/36,0.04545765095439701,0.09645926818632869,0,0,4.0152200740436035,12.410941393978344,PYY;CCL2;PAX3
Exencephaly,3/36,0.04545765095439701,0.09645926818632869,0,0,4.0152200740436035,12.410941393978344,PYY;CCL2;PAX3
Exocrine pancreatic insufficiency,3/36,0.04545765095439701,0.09645926818632869,0,0,4.0152200740436035,12.410941393978344,CDKN2A;BRCA1;BRCA2
Familial medullary thyroid carcinoma,3/36,0.04545765095439701,0.09645926818632869,0,0,4.0152200740436035,12.410941393978344,RET;KIT;FOS
Germ Cell Cancer,3/36,0.04545765095439701,0.09645926818632869,0,0,4.0152200740436035,12.410941393978344,KIT;ESR1;TDGF1
Nail abnormality,3/36,0.04545765095439701,0.09645926818632869,0,0,4.0152200740436035,12.410941393978344,ACAN;FLT4;KRT5
Parvovirus B19 (disease),3/36,0.04545765095439701,0.09645926818632869,0,0,4.0152200740436035,12.410941393978344,SERPINC1;SH2D1A;CALR
Peripheral arterial occlusive disease,3/36,0.04545765095439701,0.09645926818632869,0,0,4.0152200740436035,12.410941393978344,IL6;VWF;APOB
Redundant skin,3/36,0.04545765095439701,0.09645926818632869,0,0,4.0152200740436035,12.410941393978344,RPS6KA3;FGFR3;EZH2
Seckel syndrome,3/36,0.04545765095439701,0.09645926818632869,0,0,4.0152200740436035,12.410941393978344,PLK4;CHEK1;BRCA1
Stage IV Skin Melanoma,3/36,0.04545765095439701,0.09645926818632869,0,0,4.0152200740436035,12.410941393978344,ADAM12;CTLA4;FGFR4
Tethered Cord Syndrome,3/36,0.04545765095439701,0.09645926818632869,0,0,4.0152200740436035,12.410941393978344,PYY;CCL2;PAX3
Gastrointestinal Hemorrhage,4/61,0.046770576048442945,0.0991739256562922,0,0,3.102677328241238,9.501952391553484,C4A;VWF;KIT;TGFBR2
"Hypogonadism, Isolated Hypogonadotropic",6/117,0.04678126808801872,0.0991739256562922,0,0,2.394139013728991,7.331505849149792,WT1;CBX2;LEPR;NDN;SOX10;ADRA1A
Muscle Hypertonia,6/117,0.04678126808801872,0.0991739256562922,0,0,2.394139013728991,7.331505849149792,PLK4;TERT;SCN4A;SOX10;EZH2;TGFBR2
"Depression, Postpartum",2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,PER2;ESR1
"Malignant melanoma, metastatic",2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,ERBB2;KIT
"Nephrosis, congenital",2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,NPHS1;SIRPA
"RETINOSCHISIS 1, X-LINKED, JUVENILE",2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,CXCL10;ESR1
"SPHEROCYTOSIS, TYPE 1 (disorder)",2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,SPTA1;PMAIP1
AIDS (Disease),2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,CXCL12;CXCR4
Alobar Holoprosencephaly,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,SIX3;TDGF1
Arachnoid Cysts,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,GPSM2;COL1A2
Asymmetric crying face association,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,PARP1;CMA1
Auricular swelling,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,CXCL10;CCL2
Autosomal Dominant Myotubular Myopathy,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,TPM3;BIN1
Carotid Artery Thrombosis,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,CD36;F2RL2
Central nervous system lymphoma,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,CXCL12;SERPINC1
Cerebellar malformation,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,E2F1;PAX2
Cervical Squamous Intraepithelial Neoplasia 1,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,CISH;CDKN2A
Childhood Synovial Sarcoma,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,MYCN;MET
Common Cold,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,CXCL10;IL6
Cortical cataract,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,BLM;CTNND2
Dermatofibrosarcoma,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,COL1A1;VCAN
Desmoplastic Small Round Cell Tumor,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,WT1;PDGFA
Disease caused by Shigella dysenteriae,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,IL6;LTA
Disorder of skeletal muscle,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,DMD;CRYAB
Empyema,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,BAK1;NFKBIE
Fibrous Meningioma,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,DMD;RAMP1
Hereditary Sensory and Autonomic Neuropathies,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,DST;LIFR
Hyperoxaluria,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,IL6;CCL2
Infantile Neuroaxonal Dystrophy,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,IL6;PLA2G4A
Juvenile polyp,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,PTGS2;CDKN3
Lateral Sclerosis,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,GRIA2;VIM
Lepidic Predominant Adenocarcinoma,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,ALK;CCND1
Lhermitte-Duclos disease,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,PRKN;FGFR3
Limb-girdle muscle weakness,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,CAPN3;CRYAB
Morphine Dependence,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,FADD;FGFR3
Mucolipidosis Type IV,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,PKD2;APOB
Myxoma of the Endocardium,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,IL6;PLA2G2A
Nephropathic cystinosis,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,COL1A2;IL18
Osteoblastoma,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,IL6;RUNX2
Ovarian Granulosa Cell Tumor,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,ERBB2;GATA4
Papillary neoplasm,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,ALK;RET
Paraganglioma of head and neck,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,RET;FGF2
Pineal Gland Neoplasm,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,SYP;ENO2
Pleomorphic Xanthoastrocytoma,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,CDKN2A;GFAP
premalignant lesion,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,CCND1;SOSTDC1
Pyle metaphyseal dysplasia,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,COL2A1;RUNX2
Sacroiliitis,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,ACAN;VCAN
Secondary polycythemia,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,NFE2;EPAS1
Selenium deficiency,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,PTGS2;FKBP4
Serous cystadenocarcinoma ovary,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,ERBB2;ESR1
Severe [Duchenne] muscular dystrophy,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,CAPN3;DMD
Severe periodontitis,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,COL17A1;IL6
Symmetrical dyschromatosis of extremities,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,CHAF1A;PAX3
Tubular atrophy,2/16,0.048252865378906745,0.10064169064743407,0,0,6.301515640116092,19.101784781260555,MUC1;NPHS1
Acute Kidney Insufficiency,5/89,0.04848648036089539,0.1010975479986878,0,0,2.6340638528138527,7.971915953898367,C3;IL6;VWF;PPARG;A2M
Brucellosis,3/37,0.048679804207536904,0.10118649491111663,0,0,3.89692573862124,11.778423100866828,IL6;IL18;SELE
Carcinoma testes,3/37,0.048679804207536904,0.10118649491111663,0,0,3.89692573862124,11.778423100866828,TERT;BAK1;PITX1
Chronic leukemia (category),3/37,0.048679804207536904,0.10118649491111663,0,0,3.89692573862124,11.778423100866828,CCNA2;CCND1;CDKN2A
Congenital hypoplasia of breast,3/37,0.048679804207536904,0.10118649491111663,0,0,3.89692573862124,11.778423100866828,CDT1;ESR1;SOX10
Fuchs Endothelial Dystrophy,3/37,0.048679804207536904,0.10118649491111663,0,0,3.89692573862124,11.778423100866828,CDKN2A;COL8A1;LAMC1
Fundus coloboma,3/37,0.048679804207536904,0.10118649491111663,0,0,3.89692573862124,11.778423100866828,YAP1;ZNF423;PAX2
Immunoblastic Large-Cell Lymphoma,3/37,0.048679804207536904,0.10118649491111663,0,0,3.89692573862124,11.778423100866828,CDKN2A;SDC1;CIB1
Malignant neoplasm of oropharynx,3/37,0.048679804207536904,0.10118649491111663,0,0,3.89692573862124,11.778423100866828,ALDH2;CDKN2A;PMAIP1
Malignant neoplasm of pharynx,3/37,0.048679804207536904,0.10118649491111663,0,0,3.89692573862124,11.778423100866828,ALDH2;PPL;EZH2
Pseudoxanthoma Elasticum,3/37,0.048679804207536904,0.10118649491111663,0,0,3.89692573862124,11.778423100866828,VWF;SELE;AGT
Bardet-Biedl Syndrome,4/62,0.04915399434866662,0.10207737354534478,0,0,3.049026507154586,9.186098423328474,PRKN;FEZ1;PECAM1;NDN
Heroin Dependence,4/62,0.04915399434866662,0.10207737354534478,0,0,3.049026507154586,9.186098423328474,OPRD1;ALDH2;ENO2;MPDZ
Osteomyelitis,4/62,0.04915399434866662,0.10207737354534478,0,0,3.049026507154586,9.186098423328474,STAT1;CCL2;TIMP1;PTGS2
Ciliopathies,8/181,0.049939131690848654,0.10367579858910034,0,0,2.050978161664528,6.146679783698267,NRP1;MUC1;CENPF;KCTD13;PRKD1;ZNF423;PKD2;CEP55
Cystic kidney,5/90,0.050443509418645754,0.10462588303138506,0,0,2.6029411764705883,7.774728108438903,YAP1;PRKD1;PKD2;PAX2;STX11
Degenerative disorder,5/90,0.050443509418645754,0.10462588303138506,0,0,2.6029411764705883,7.774728108438903,IL6;STMN1;F13A1;DMD;LMNB1
Short palm,5/90,0.050443509418645754,0.10462588303138506,0,0,2.6029411764705883,7.774728108438903,COL2A1;BGN;NDN;ANTXR2;FGFR3
Intelligence,9/214,0.050636007064427474,0.10499272103880669,0,0,1.948422465876035,5.812324159719693,MEF2C;PDE1A;CCDC136;PRKD1;SEMA3F;TEAD1;SKAP1;SYT7;RUNX1T1
Mild cognitive disorder,7/150,0.05077323048296281,0.10524475800110439,0,0,2.169492607848772,6.4659254438856815,CCL2;DMD;CD36;ESR1;GFAP;SYNE1;RUNX1T1
"Inclusion Body Myopathy, Sporadic",4/63,0.05160320529522582,0.10670170158951252,0,0,2.9971943579691764,8.884198066778264,RIMS2;CXCL10;CXCR4;TIMP1
"Large, late-closing fontanelle",4/63,0.05160320529522582,0.10670170158951252,0,0,2.9971943579691764,8.884198066778264,COL1A1;COL1A2;NKX2-5;RUNX2
Large bregma sutures,4/63,0.05160320529522582,0.10670170158951252,0,0,2.9971943579691764,8.884198066778264,COL1A1;COL1A2;NKX2-5;RUNX2
Large fontanelle,4/63,0.05160320529522582,0.10670170158951252,0,0,2.9971943579691764,8.884198066778264,COL1A1;COL1A2;NKX2-5;RUNX2
Monocytic leukemia,4/63,0.05160320529522582,0.10670170158951252,0,0,2.9971943579691764,8.884198066778264,EGR1;IL6;WT1;PPARG
Papule,4/63,0.05160320529522582,0.10670170158951252,0,0,2.9971943579691764,8.884198066778264,C4A;CTLA4;PRTN3;ANTXR2
Viral hepatitis,4/63,0.05160320529522582,0.10670170158951252,0,0,2.9971943579691764,8.884198066778264,CXCL10;ALDH2;LTA;AGT
Wide bregma sutures,4/63,0.05160320529522582,0.10670170158951252,0,0,2.9971943579691764,8.884198066778264,COL1A1;COL1A2;NKX2-5;RUNX2
Autosomal Recessive Polycystic Kidney Disease,3/38,0.05201066271762746,0.10727997875048709,0,0,3.7853910795087264,11.190776363771825,PRKD1;PKD2;AQP1
Bacterial Vaginosis,3/38,0.05201066271762746,0.10727997875048709,0,0,3.7853910795087264,11.190776363771825,SIGIRR;CXCL10;IL6
Chronic eosinophilic leukemia,3/38,0.05201066271762746,0.10727997875048709,0,0,3.7853910795087264,11.190776363771825,STAT5A;STAT5B;KIT
Genu varum,3/38,0.05201066271762746,0.10727997875048709,0,0,3.7853910795087264,11.190776363771825,ACAN;COL2A1;FGFR3
Growth abnormality,3/38,0.05201066271762746,0.10727997875048709,0,0,3.7853910795087264,11.190776363771825,COL1A1;ACAN;COL2A1
Keratosis,3/38,0.05201066271762746,0.10727997875048709,0,0,3.7853910795087264,11.190776363771825,CCND1;CDKN2A;FGFR3
Pelvic Inflammatory Disease,3/38,0.05201066271762746,0.10727997875048709,0,0,3.7853910795087264,11.190776363771825,CXCL12;IL2RG;PTGS2
Salmonella infections,3/38,0.05201066271762746,0.10727997875048709,0,0,3.7853910795087264,11.190776363771825,IL18;PTGS2;EZR
Narrow cranium shape,5/91,0.05244630240014002,0.10804581807341729,0,0,2.5725422832980973,7.583765755006519,BLM;NDN;GATA4;ZFPM2;NKX2-5
Narrow head shape,5/91,0.05244630240014002,0.10804581807341729,0,0,2.5725422832980973,7.583765755006519,BLM;NDN;GATA4;ZFPM2;NKX2-5
Narrow skull shape,5/91,0.05244630240014002,0.10804581807341729,0,0,2.5725422832980973,7.583765755006519,BLM;NDN;GATA4;ZFPM2;NKX2-5
Turridolichocephaly,5/91,0.05244630240014002,0.10804581807341729,0,0,2.5725422832980973,7.583765755006519,BLM;NDN;GATA4;ZFPM2;NKX2-5
Delayed bone age,8/183,0.05262650204228393,0.10838380488070495,0,0,2.027329192546584,5.969542666168528,PLK4;RPS6KA3;CDT1;ACAN;BLM;COL2A1;STAT1;ESR1
Anteverted nostril,11/283,0.05276277489308991,0.10863114536541749,0,0,1.7968368799132557,5.286203105072816,PLK4;COL1A1;RPS6KA3;MEF2C;COL2A1;MYCN;NEK2;KIF22;PAK3;FGFR3;FLI1
Muscle Spasticity,13/353,0.05334426119108759,0.10959536252729972,0,0,1.7006740196078431,4.984656633295445,ARNT2;GRIA2;IL18;SOX10;CIT;GFAP;LMNB1;IL6;LTA;RCC1;PPARGC1A;NEFH;EZH2
Polyhydramnios,6/121,0.053487677378751215,0.10959536252729972,0,0,2.3103892245221354,6.765521963779605,MYCN;COL2A1;CNTN1;FGFR3;BUB1;MYLK
"Colitis, Collagenous",2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,IL6;TIMP1
"Elliptocytosis, Hereditary",2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,SPTA1;SPTB
"HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE",2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,APOB;LMNB1
"Motor Neuron Disease, Lower",2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,STMN1;VIM
Abnormality of female internal genitalia,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,TERT;CXCR4
Acute hepatitis C,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,CXCL10;PAEP
Acute monoblastic leukemia,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,IL2RG;RUNX1T1
Aggressive natural killer-cell leukemia,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,CDKN2A;GZMB
Alagille Syndrome,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,HGF;MPDZ
Aplastic clavicles,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,CDT1;RUNX2
Autosome Abnormalities,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,MYCN;EPAS1
Biliary stricture,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,CDKN2A;NEK2
Biliary Tract Neoplasm,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,CDKN2A;ERBB2
Cervical Intraepithelial Neoplasia Grade 2/3,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,IL6;CDKN2A
Chromosome Aberrations,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,MYCN;EPAS1
Complement deficiency disease,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,C4A;CALR
Congenital atresia of pulmonary artery,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,GATA4;FADD
Distal arthrogryposis syndrome,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,FBN2;TNNI2
Dopa-Responsive Dystonia,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,PRKN;CIT
Early severe fetal akinesia sequence,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,FBN2;CNTN1
Fish-Eye Disease,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,PPARG;PPARA
Flat acetabular roof,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,COL2A1;BGN
Hepatic necrosis,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,CCNA2;MET
Hypertrophy of kidney,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,HGF;DCN
Interrupted aortic arch,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,NKX2-5;ZFPM2
Lobomycosis,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,CTLA4;GATA3
Macroangiopathy,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,APOB;AGT
Meconium Aspiration Syndrome,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,PTGS2;AGT
Mesangial proliferative glomerulonephritis,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,IL6;VWF
Neonatal Deformity,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,RET;ESR1
Parainfluenza,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,IL6;STAT1
Polycystic liver disease,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,PKD2;ADCY5
Psychological symptom,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,TAL1;MPDZ
Rhinosinusitis,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,PTGS2;MET
Ridged nails,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,TERT;KRT5
Semilobar Holoprosencephaly,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,SIX3;TDGF1
Synostotic Anterior Plagiocephaly,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,BMP2;EZH2
TUMOR PREDISPOSITION SYNDROME,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,BRCA1;BRCA2
Viral respiratory infection,2/17,0.053900161171481685,0.10959536252729972,0,0,5.881113619262604,17.176508708665256,IL6;CCL2
Cytogenetically normal acute myeloid leukemia,4/64,0.0541179924872407,0.10993842635943997,0,0,2.947089947089947,8.595448854736894,MECOM;CDKN2A;WT1;ERG
Febrile Convulsions,4/64,0.0541179924872407,0.10993842635943997,0,0,2.947089947089947,8.595448854736894,C3;IL6;TIMP1;FGF2
Polyp of large intestine,4/64,0.0541179924872407,0.10993842635943997,0,0,2.947089947089947,8.595448854736894,ALDH2;TERT;PPARG;PTGS2
Acute kidney injury,5/92,0.054494880069585055,0.11067058196169739,0,0,2.5428422152560084,7.398777101952805,C3;IL6;CCND1;PPARG;A2M
Atypical Hemolytic Uremic Syndrome,3/39,0.05544871989341828,0.1123020515091065,0,0,3.680052790346908,10.643804361883586,C3;CR1;VWF
Dislocations,3/39,0.05544871989341828,0.1123020515091065,0,0,3.680052790346908,10.643804361883586,COL1A1;COL3A1;COL2A1
Fasting blood glucose measurement,3/39,0.05544871989341828,0.1123020515091065,0,0,3.680052790346908,10.643804361883586,TCF7L2;PROX1;ADCY5
heavy drinking,3/39,0.05544871989341828,0.1123020515091065,0,0,3.680052790346908,10.643804361883586,IL6;ALDH2;ADRB2
Malignant neoplasm of adrenal cortex,3/39,0.05544871989341828,0.1123020515091065,0,0,3.680052790346908,10.643804361883586,CDKN2A;KRT5;ESR1
Skin lesion,3/39,0.05544871989341828,0.1123020515091065,0,0,3.680052790346908,10.643804361883586,BLM;IL18;FGF2
Stage IV Ovarian Carcinoma,3/39,0.05544871989341828,0.1123020515091065,0,0,3.680052790346908,10.643804361883586,MMP14;CXCL12;CXCR4
Streptococcal pneumonia,3/39,0.05544871989341828,0.1123020515091065,0,0,3.680052790346908,10.643804361883586,IL6;PTGS2;CDKN3
Subependymal Giant Cell Astrocytoma,3/39,0.05544871989341828,0.1123020515091065,0,0,3.680052790346908,10.643804361883586,HGF;ESR1;MET
"Muscular Dystrophies, Limb-Girdle",5/93,0.0565892400417174,0.11457743024424905,0,0,2.5138171487603307,7.219523015493763,ANXA1;CAPN3;DMD;FLNC;SYNE1
Adult Liver Carcinoma,4/65,0.05669809305248637,0.11469409425918628,0,0,2.8986283037805287,8.319105844716084,YAP1;CAV1;HMGA2;GATA4
Open mouth (finding),4/65,0.05669809305248637,0.11469409425918628,0,0,2.8986283037805287,8.319105844716084,RPS6KA3;DST;PAK3;SOX5
Systemic Inflammatory Response Syndrome,4/65,0.05669809305248637,0.11469409425918628,0,0,2.8986283037805287,8.319105844716084,IL6;HGF;LTA;SELE
Long narrow head,5/94,0.05872935703996701,0.1187673477508035,0,0,2.485444330949949,7.045776256018659,BLM;NDN;GATA4;ZFPM2;NKX2-5
"Depression, Neurotic",3/40,0.05899237377779329,0.11882706549827948,0,0,3.580408462761404,10.13379871452814,IL6;PTGS2;FGF2
"Pneumonia, Bacterial",3/40,0.05899237377779329,0.11882706549827948,0,0,3.580408462761404,10.13379871452814,IL6;CR1;PECAM1
"Purpura, Thrombotic Thrombocytopenic",3/40,0.05899237377779329,0.11882706549827948,0,0,3.580408462761404,10.13379871452814,C3;ZFP36;VWF
Chemical Carcinogenesis,3/40,0.05899237377779329,0.11882706549827948,0,0,3.580408462761404,10.13379871452814,RAD51;CDKN2A;PTGS2
Fibrodysplasia Ossificans Progressiva,3/40,0.05899237377779329,0.11882706549827948,0,0,3.580408462761404,10.13379871452814,C3;KDR;ENO2
Short thorax,3/40,0.05899237377779329,0.11882706549827948,0,0,3.580408462761404,10.13379871452814,ACAN;COL2A1;FGFR3
Sparse pubic hair,3/40,0.05899237377779329,0.11882706549827948,0,0,3.580408462761404,10.13379871452814,WT1;GATA4;ZFPM2
"stage, non-small cell lung cancer",4/66,0.059343198935820726,0.11882706549827948,0,0,2.851729939287543,8.054476678637966,ALK;CCND1;CDKN2A;ERBB2
Beckwith-Wiedemann Syndrome,4/66,0.059343198935820726,0.11882706549827948,0,0,2.851729939287543,8.054476678637966,CISH;TERT;WT1;CDKN3
GRN-related frontotemporal dementia,4/66,0.059343198935820726,0.11882706549827948,0,0,2.851729939287543,8.054476678637966,RIMS2;SOSTDC1;CCL2;CDC7
Severe psychomotor retardation,4/66,0.059343198935820726,0.11882706549827948,0,0,2.851729939287543,8.054476678637966,RPS6KA3;CTNND2;FGFR3;SOX5
Shigella Infections,4/66,0.059343198935820726,0.11882706549827948,0,0,2.851729939287543,8.054476678637966,PRKN;IL6;EZR;PTGS2
"B-CELL MALIGNANCY, LOW-GRADE",2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,CCND1;CDKN2A
"Infarction, Lacunar",2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,ALDH2;AGT
"Myopathy, Centronuclear, Autosomal Dominant",2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,TPM3;BIN1
"Pseudohypoaldosteronism, Type I",2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,KLHL3;SGK1
3-Methylglutaconic aciduria type 2,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,DMD;MEST
Acquired partial lipodystrophy,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,PPARG;LMNB1
Adult Burkitt Lymphoma,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,PARP1;BRCA2
Alexander Disease,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,CRYAB;GFAP
Autosomal Recessive Centronuclear Myopathy,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,TPM3;BIN1
Barrel chest,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,ACAN;COL2A1
Benign neoplasm of stomach,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,ERBB2;MET
Carcinoma in situ of stomach,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,ERBB2;MET
Cellulitis of periorbital region,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,CTLA4;PRTN3
Centrally nucleated skeletal muscle fibers,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,TPM3;BIN1
Choroid Plexus Carcinoma,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,CAV1;TGFBR2
Cleidocranial Dysplasia,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,TNFSF11;RUNX2
Congenital hernia of foramen of Bochdalek,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,WT1;GATA4
Congenital hernia of foramen of Morgagni,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,WT1;GATA4
Coxsackievirus Infections,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,IL6;CCND1
Degeneration of lumbar intervertebral disc,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,PRKN;FGFR3
Dental Plaque,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,BGN;PTGS2
Diffuse cutaneous leishmaniasis,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,IL6;CCL2
Ectopic kidney,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,FANCD2;FANCA
Erythroid hyperplasia,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,APOB;KLF1
Heart murmur,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,APOB;NKX2-5
Hyperlipoproteinemia Type I,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,CCND1;APOB
Hypertensive heart disease,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,PPARA;AGT
Hypoplastic scapulae,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,COL2A1;RUNX2
Infective vaginitis,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,IL6;CXCR2
Liddle Syndrome,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,PRKN;AGT
Neoplasm of uncertain or unknown behavior of stomach,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,ERBB2;MET
Periorbital edema,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,CTLA4;PRTN3
Periorbital swelling,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,CTLA4;PRTN3
Post-kala-azar dermal leishmaniasis,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,IL6;AQP1
Precocious exfoliation of primary tooth,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,TNFSF11;PRKD1
Primary cutaneous B-cell lymphoma,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,CDKN2A;TEK
Pseudoprimary hyperaldosteronism,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,PRKN;AGT
Reduced subcutaneous adipose tissue,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,CAV1;PPARG
Residual Cancer,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,VIM;ESR1
Sexually Transmitted Diseases,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,CXCL10;KIT
Short middle phalanx of finger,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,BMPR1B;FGFR3
Tobacco Use Disorder,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,IL6;SHC3
Vitamin B 12 Deficiency,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,CFL1;CALR
Wolfram Syndrome,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,PAX3;TXNIP
Xanthomatosis,2/18,0.059767395362297214,0.11882706549827948,0,0,5.513261851015802,15.532485017732286,CXCL10;PPARG
"Hepatitis, Toxic",12/325,0.060766904646036596,0.12067135765901295,0,0,1.7037239262445676,4.771636585835686,C3;CXCL10;COL3A1;IL6;VWF;IL18;SERPING1;CCL2;VIM;PPARA;PTGS2;CDC25B
Chemical and Drug Induced Liver Injury,12/325,0.060766904646036596,0.12067135765901295,0,0,1.7037239262445676,4.771636585835686,C3;CXCL10;COL3A1;IL6;VWF;IL18;SERPING1;CCL2;VIM;PPARA;PTGS2;CDC25B
Chemically-Induced Liver Toxicity,12/325,0.060766904646036596,0.12067135765901295,0,0,1.7037239262445676,4.771636585835686,C3;CXCL10;COL3A1;IL6;VWF;IL18;SERPING1;CCL2;VIM;PPARA;PTGS2;CDC25B
Drug-Induced Acute Liver Injury,12/325,0.060766904646036596,0.12067135765901295,0,0,1.7037239262445676,4.771636585835686,C3;CXCL10;COL3A1;IL6;VWF;IL18;SERPING1;CCL2;VIM;PPARA;PTGS2;CDC25B
Congenital muscular dystrophy (disorder),4/67,0.0620529582186152,0.12315238398233441,0,0,2.806320411762589,7.800917135029502,BGN;CAPN3;DMD;SYNE1
Meningococcal Infections,4/67,0.0620529582186152,0.12315238398233441,0,0,2.806320411762589,7.800917135029502,CXCL10;SERPING1;CXCR4;ADRB1
"Anemia, Macrocytic",3/41,0.06263993438298283,0.12406068986025147,0,0,3.486008573469874,9.657471781575046,EGR1;ALDH2;KIT
Bowing of the long bones,3/41,0.06263993438298283,0.12406068986025147,0,0,3.486008573469874,9.657471781575046,TNFSF11;BMPR1B;FGFR3
Chronic viral hepatitis,3/41,0.06263993438298283,0.12406068986025147,0,0,3.486008573469874,9.657471781575046,CXCL10;TERT;LEPR
Lytic lesion,3/41,0.06263993438298283,0.12406068986025147,0,0,3.486008573469874,9.657471781575046,CAV1;TNFSF11;ANTXR2
Malignant Meningioma,3/41,0.06263993438298283,0.12406068986025147,0,0,3.486008573469874,9.657471781575046,TERT;CDKN2A;KLF4
Schwartz-Jampel Syndrome,3/41,0.06263993438298283,0.12406068986025147,0,0,3.486008573469874,9.657471781575046,COL2A1;KDR;GZMB
TNF receptor-associated periodic fever syndrome (TRAPS),3/41,0.06263993438298283,0.12406068986025147,0,0,3.486008573469874,9.657471781575046,IL6;HGF;CCL2
Low set ears,11/293,0.06428473462885506,0.12728074226632977,0,0,1.732220479131941,4.75396319257104,RET;RPS6KA3;CDT1;MEF2C;COL2A1;MYCN;GATA4;LIFR;ASCL1;PAX2;SOX5
"Gastritis, Atrophic",6/127,0.0645883125504323,0.1278064546519456,0,0,2.195146745985429,6.014091404785745,MUC1;CDKN2A;GAD1;LTA;CCL2;PTGS2
Childhood asthma,6/127,0.0645883125504323,0.1278064546519456,0,0,2.195146745985429,6.014091404785745,TLE4;IL6;LTA;PPARG;ADRB2;TIMP1
Dystrophia unguium,4/68,0.06482697647192098,0.12824093489997684,0,0,2.762329931972789,7.5578271177774665,COL17A1;TERT;CTLA4;KRT5
Muscle degeneration,10/259,0.06508485837685608,0.1287131651528167,0,0,1.7823939435904537,4.869613163266311,CCT3;RIMS2;BMP2;COL2A1;HGF;CAPN3;DMD;UTRN;PPARGC1A;NEFH
"Hepatitis, Drug-Induced",12/329,0.06532811591863805,0.12899507027376475,0,0,1.681876133788913,4.588717770891769,C3;CXCL10;COL3A1;IL6;VWF;IL18;SERPING1;CCL2;VIM;PPARA;PTGS2;CDC25B
Gilles de la Tourette syndrome,5/97,0.06542365981961261,0.12899507027376475,0,0,2.4040266798418974,6.555471393756098,CNTNAP2;COL8A1;CCL2;ADRA1A;MET
"Melanoma, Amelanotic",2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,CAV1;MITF
"Spondyloepiphyseal Dysplasia Tarda, X-Linked",2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,COL2A1;KDR
"Tuberculosis, Drug-Resistant",2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,DST;PTGS2
ABLEPHARON-MACROSTOMIA SYNDROME,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,EPAS1;AGT
Amyloid angiopathy,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,SYP;GFAP
Angiolymphoid hyperplasia,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,IL6;HMGA2
Aortopulmonary Septal Defect,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,ACTC1;IL18
Congenital absence of spleen,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,MYCN;NKX2-5
Congenital dyserythropoietic anemia,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,AQP1;KLF1
Congenital Hydrocephalus,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,FEN1;MPDZ
Congenital Structural Myopathy,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,TPM3;BIN1
Dyschondroplasias,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,COL2A1;KDR
Enchondroma,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,COL2A1;CDKN2A
Fragile nails,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,COL17A1;PRKD1
Holt-Oram syndrome,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,NKX2-5;MET
Hypopigmentation of hair,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,MITF;SOX10
Infective cystitis,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,CDKN2A;ERBB2
Inflammatory disease of mucous membrane,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,MKI67;PTGS2
Injury wounds,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,IL6;FGF2
Legg-Calve-Perthes Disease,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,COL2A1;SERPINC1
Mixed Connective Tissue Disease,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,COL17A1;HNRNPAB
Peri-Implantitis,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,TERT;RUNX2
Proximal amyotrophy,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,CAPN3;SYNE1
Research-Related Injuries,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,IL6;FGF2
Short hallux,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,BMP2;BMPR1B
T-Lymphocytopenia,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,STAT5B;CCL21
Taste sweet,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,PYY;ADRA1A
Thumb aplasia,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,FANCD2;FANCA
Traumatic injury,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,IL6;FGF2
Wounds and Injuries,2/19,0.0658420340825589,0.12899507027376475,0,0,5.18868676138627,14.11580587979327,IL6;FGF2
Cerebellar Diseases,3/42,0.0663896306771826,0.12968957522628224,0,0,3.396449704142012,9.211899793715412,CCL21;FLNC;ZNF423
Chronic diarrhea,3/42,0.0663896306771826,0.12968957522628224,0,0,3.396449704142012,9.211899793715412,SAA1;IL2RG;ANTXR2
Hernia,3/42,0.0663896306771826,0.12968957522628224,0,0,3.396449704142012,9.211899793715412,ACAN;IL6;COL1A2
High urine occult blood,3/42,0.0663896306771826,0.12968957522628224,0,0,3.396449704142012,9.211899793715412,YAP1;CTLA4;PRTN3
Isochromosomes,3/42,0.0663896306771826,0.12968957522628224,0,0,3.396449704142012,9.211899793715412,MYCN;TERT;RHOJ
Melancholia,3/42,0.0663896306771826,0.12968957522628224,0,0,3.396449704142012,9.211899793715412,IL6;PTGS2;FGF2
Nail Diseases,3/42,0.0663896306771826,0.12968957522628224,0,0,3.396449704142012,9.211899793715412,ACAN;FLT4;KRT5
Oligoarticular Juvenile Idiopathic Arthritis,3/42,0.0663896306771826,0.12968957522628224,0,0,3.396449704142012,9.211899793715412,IL6;STAT1;ESR1
Other ureteric obstruction,3/42,0.0663896306771826,0.12968957522628224,0,0,3.396449704142012,9.211899793715412,COL1A1;COL1A2;CFL1
Rat Adrenal Gland Pheochromocytoma,3/42,0.0663896306771826,0.12968957522628224,0,0,3.396449704142012,9.211899793715412,RET;CXCL12;RFX2
beta^+^ Thalassemia,6/128,0.06656033666694562,0.1299852343865097,0,0,2.1770417117890886,5.899013290085947,FBN2;FANCD2;TNFSF11;HMGA2;BRCA2;KLF1
Chronic otitis media,4/69,0.06766481804867386,0.13202699535586684,0,0,2.719693005407291,7.324647036577443,TAP1;CCL2;FGFR3;RUNX2
Progressive supranuclear palsy,4/69,0.06766481804867386,0.13202699535586684,0,0,2.719693005407291,7.324647036577443,PRKN;SNCAIP;RUNX1T1;GFAP
Williams Syndrome,4/69,0.06766481804867386,0.13202699535586684,0,0,2.719693005407291,7.324647036577443,RIMS2;PRKN;FGFR4;SYN1
Henoch-Schoenlein Purpura,5/98,0.06774610411427977,0.13210883717523314,0,0,2.3780547409579667,6.401695598213416,C3;CXCL10;SOSTDC1;CCL2;GATA3
Mycobacterium Infections,5/98,0.06774610411427977,0.13210883717523314,0,0,2.3780547409579667,6.401695598213416,PRKN;IL6;ANXA1;STAT1;CTSG
Malformations of Cortical Development,5/99,0.070113845698954,0.13661432671163337,0,0,2.3526353965183753,6.25244615063519,CCNA2;CNTNAP2;GPSM2;CCND2;TUBG1
Depressive Syndrome,3/43,0.07023961735188654,0.13661432671163337,0,0,3.311368778280543,8.794474853083797,IL6;PTGS2;FGF2
Hyperlipoproteinemias,3/43,0.07023961735188654,0.13661432671163337,0,0,3.311368778280543,8.794474853083797,SERPINC1;SDC1;PPARA
Hyponatremia,3/43,0.07023961735188654,0.13661432671163337,0,0,3.311368778280543,8.794474853083797,CA12;ENO2;AGT
Macrocephaly,3/43,0.07023961735188654,0.13661432671163337,0,0,3.311368778280543,8.794474853083797,CCND2;PAK3;FGFR3
Proliferative retinopathy,3/43,0.07023961735188654,0.13661432671163337,0,0,3.311368778280543,8.794474853083797,CXCL12;ALDH2;AGT
Radial deviation of finger,3/43,0.07023961735188654,0.13661432671163337,0,0,3.311368778280543,8.794474853083797,BMPR1B;FGFR3;EZH2
Transient Cerebral Ischemia,3/43,0.07023961735188654,0.13661432671163337,0,0,3.311368778280543,8.794474853083797,C3;COL3A1;CALR
Triploidy syndrome,3/43,0.07023961735188654,0.13661432671163337,0,0,3.311368778280543,8.794474853083797,NGFR;MYCN;KRT5
Congenital pes cavus,6/130,0.0706088384024732,0.13726735179345356,0,0,2.141707693438166,5.676810310457115,RET;EGR2;TPM3;SOX10;NEFH;EZH2
Charcot-Marie-Tooth Disease,11/298,0.07061624485503008,0.13726735179345356,0,0,1.7016008606432345,4.510084681785417,PRKN;EGR2;ACTC1;STMN1;ERBB2;CCL2;DMD;SOX10;NEFH;CRYAB;HOXD10
"46, XY Disorders of Sex Development",2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,WT1;ZFPM2
"ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA",2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,RIMS2;PARP1
"Deafness, Acquired",2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,PAX3;MITF
"Hearing Loss, Extreme",2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,PAX3;MITF
"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,CCND1;CDKN2A
"stage, gastric cancer",2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,KRT19;ERBB2
Acral pseudolymphomatous angiokeratoma of children (APACHE),2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,IL6;TIMP1
Adult Myelodysplastic Syndrome,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,SCN4A;EZH2
Arteriosclerosis Obliterans,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,CXCL12;HGF
Atrophy of testis,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,ALDH2;E2F1
Autoimmune pancreatitis,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,LTA;CTLA4
Bilateral Deafness,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,PAX3;MITF
Calf muscle hypertrophy,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,CAPN3;DMD
Cerebral Vasospasm,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,S100A4;TIMP1
Chronic Chagas' disease,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,IL18;CTLA4
Complete Hearing Loss,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,PAX3;MITF
Constitutional Symptom,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,CXCL10;HGF
Corneal pannus,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,MMP14;FGF2
Deaf Mutism,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,PAX3;MITF
Destructive Arthritis,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,JUN;TIMP1
Disproportionate short-trunk short stature,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,COL2A1;BGN
Eczema Herpeticum,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,CAV2;CAV1
Enteropathy-Associated T-Cell Lymphoma,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,CDKN2A;GZMB
Filarial Elephantiases,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,SOCS3;CISH
Hypophosphatasia,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,FGFR3;TNS1
Idiopathic Nephrotic Syndrome,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,IL6;NPHS1
Mastocytoma,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,NGFR;KIT
Morbilliform Drug Reaction,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,C4B;IL18
Multiple System Atrophy,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,PRKN;CRYAB
Perineurioma,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,ALK;CDKN2A
PITUITARY DWARFISM I,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,PLK4;BRCA2
Prune Belly Syndrome,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,CXCR4;SYP
Renal glomerular fibrosis,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,RET;MUC1
Sprengel deformity,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,COL3A1;PAX3
Tonsillar Carcinoma,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,CDKN2A;VIM
Wolf-Hirschhorn Syndrome,2/20,0.07211199013417019,0.1387293399430212,0,0,4.900175570604464,12.8851829232882,CDKN2A;FGFR3
Neural Tube Defects,7/163,0.07244326354329123,0.1393267348100641,0,0,1.9873697459313897,5.216749385048169,PYY;TCF7L2;PAX3;CCL2;KIF22;F2RL2;LMNB1
Rhinitis,5/100,0.07252672819092583,0.1394473250873913,0,0,2.327751196172249,6.107553868683056,C3;CCL13;IL18;ADRB2;GATA3
Tracheal Diseases,4/71,0.07353003075826778,0.14133591487479288,0,0,2.6382373845060414,6.885961493968781,IL6;COL2A1;HGF;IL18
Abnormal form of the vertebral bodies,3/44,0.0741879811616658,0.14227483765897989,0,0,3.2304381414854872,8.402864253541548,RPS6KA3;FGFR3;FLI1
Blue sclera,3/44,0.0741879811616658,0.14227483765897989,0,0,3.2304381414854872,8.402864253541548,COL1A1;COL1A2;TGFBR2
Confusion,3/44,0.0741879811616658,0.14227483765897989,0,0,3.2304381414854872,8.402864253541548,C4A;PRKD1;BRCA2
Congenital anomaly of brain,3/44,0.0741879811616658,0.14227483765897989,0,0,3.2304381414854872,8.402864253541548,GPSM2;COL3A1;PAX2
Japanese Encephalitis,3/44,0.0741879811616658,0.14227483765897989,0,0,3.2304381414854872,8.402864253541548,IL6;ATF3;PAK4
Linear atrophy,3/44,0.0741879811616658,0.14227483765897989,0,0,3.2304381414854872,8.402864253541548,COL3A1;SOX10;TGFBR2
Monoclonal Gammapathies,3/44,0.0741879811616658,0.14227483765897989,0,0,3.2304381414854872,8.402864253541548,KIT;CXCR4;SDC1
Osteosclerosis,3/44,0.0741879811616658,0.14227483765897989,0,0,3.2304381414854872,8.402864253541548,COL1A1;DMD;RUNX2
Eating Disorders,4/72,0.07655633678039796,0.14673297882909608,0,0,2.5993063892223556,6.679511398462674,OPRD1;TAL1;PPARA;ESR1
Neutrophil count decreased,4/72,0.07655633678039796,0.14673297882909608,0,0,2.5993063892223556,6.679511398462674,MECOM;FANCD2;FANCA;CXCR4
"HYDATIDIFORM MOLE, RECURRENT, 1",3/45,0.07823274705954297,0.14884249158666651,0,0,3.153361344537815,8.034975850966791,ERBB2;PPARG;APOB
Hypopituitarism,3/45,0.07823274705954297,0.14884249158666651,0,0,3.153361344537815,8.034975850966791,ARNT2;BMP2;SIX3
Melanoderma (disorder),3/45,0.07823274705954297,0.14884249158666651,0,0,3.153361344537815,8.034975850966791,KIT;HMGA2;ANTXR2
Tall stature,3/45,0.07823274705954297,0.14884249158666651,0,0,3.153361344537815,8.034975850966791,FGFR3;TGFBR2;EZH2
Young onset Parkinson disease,3/45,0.07823274705954297,0.14884249158666651,0,0,3.153361344537815,8.034975850966791,PRKN;SOSTDC1;CIT
"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE, X-LINKED",2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,ALK;TERT
"Anaplastic large cell lymphoma, ALK negative",2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,ALK;GZMB
"Neoplasms, Neuroepithelial",2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,ANXA1;SOX10
Abnormality of the hip bone,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,TNNI2;BMPR1B
Adult-Onset Still Disease,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,IL6;IL18
Allergic Conjunctivitis,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,SOCS3;CCL2
allergic symptom,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,IL18;SERPING1
Arhinencephaly,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,SIX3;TDGF1
Bone Marrow failure syndromes,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,TERT;FANCD2
Chediak-Higashi Syndrome,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,IL6;CTLA4
Choroid Plexus Papilloma,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,SHC3;LEPR
Cryopyrin-Associated Periodic Syndromes,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,IL6;IL18
Difficulty walking up stairs,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,DMD;FLNC
Esophageal Stenosis,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,TERT;KIT
Generalized hypopigmentation,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,NDN;MITF
Gitelman Syndrome,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,DMD;AGT
Hypoalphalipoproteinemias,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,PPARG;ESR1
Hypoplasia of the odontoid process,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,COL2A1;BGN
Increased CSF protein,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,EGR2;GFAP
Infantile nystagmus syndrome,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,IL6;SLC2A4
inflammatory joint disease,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,SOCS3;IL6
Irregular vertebral endplates,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,COL2A1;KIF22
Latent Tuberculosis,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,CXCL10;CCL2
Neonatal Death,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,FBN2;FGFR3
Neonatal respiratory distress,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,NPHS1;RUNX2
Oculo-dento-digital syndrome,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,NRP1;BMP2
Pleurisy,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,IL6;PLA2G2A
response to risperidone,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,PRKAR2B;SOX5
Rheumatoid Nodule,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,IL18;SELE
Sialadenitis,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,IL18;CTLA4
Siderosis,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,GAD1;GFAP
Stillbirth,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,CENPF;COL2A1
Sudden Cardiac Arrest,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,MAML2;ESR1
Urgency frequency syndrome,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,SNCAIP;LMNB1
Van Buchem disease,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,COL2A1;KDR
Xanthoma,2/21,0.07856560939171126,0.14884249158666651,0,0,4.642033978852322,11.808504515417276,CCL2;APOB
"ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1",4/73,0.07964433859604382,0.1507160828433447,0,0,2.561503828584574,6.481076832106004,IL6;CCND1;ESR1;FOXO1
Inborn Errors of Metabolism,4/73,0.07964433859604382,0.1507160828433447,0,0,2.561503828584574,6.481076832106004,MUC1;LEPR;PLA2G4A;TNS1
Infertility,4/73,0.07964433859604382,0.1507160828433447,0,0,2.561503828584574,6.481076832106004,C3;LEPR;NDN;ESR1
Withdrawal Symptoms,4/73,0.07964433859604382,0.1507160828433447,0,0,2.561503828584574,6.481076832106004,OPRD1;PER2;GRIA2;FOS
Death in infancy,5/103,0.08003434919522494,0.15136882264013818,0,0,2.2561456400742115,5.697443166934046,RET;CNTN1;ANTXR2;ASCL1;TGFBR2
Hydrops Fetalis,5/103,0.08003434919522494,0.15136882264013818,0,0,2.2561456400742115,5.697443166934046,COL2A1;FLT4;CD36;PLD1;KLF1
"Dysautonomia, Familial",3/46,0.08237188402569912,0.15548329767189298,0,0,3.0798695148900346,7.688928472279375,DST;TNFSF11;FKBP4
Basal Cell Nevus Syndrome,3/46,0.08237188402569912,0.15548329767189298,0,0,3.0798695148900346,7.688928472279375,NRP1;CCND1;TERT
Bilateral single transverse palmar creases,3/46,0.08237188402569912,0.15548329767189298,0,0,3.0798695148900346,7.688928472279375,TNNI2;BMPR1B;FGFR3
Exfoliative dermatitis,3/46,0.08237188402569912,0.15548329767189298,0,0,3.0798695148900346,7.688928472279375,KIT;CTLA4;IL2RG
Hereditary Diseases,3/46,0.08237188402569912,0.15548329767189298,0,0,3.0798695148900346,7.688928472279375,STMN1;DMD;BRCA1
Hypoalbuminemia,3/46,0.08237188402569912,0.15548329767189298,0,0,3.0798695148900346,7.688928472279375,IL6;NPHS1;A2M
Toxoplasmosis,3/46,0.08237188402569912,0.15548329767189298,0,0,3.0798695148900346,7.688928472279375,SOCS3;IL6;CCL2
Death in early childhood,5/104,0.08262582336260654,0.1559188057609625,0,0,2.233241505968779,5.568438103250191,RET;CNTN1;ANTXR2;ASCL1;TGFBR2
Keratitis,4/74,0.08279341482035711,0.1561911724532355,0,0,2.5247813411078717,6.290257280329508,SIGIRR;IL6;KIF22;PROX1
"ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)",2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,GATA4;NKX2-5
"CATARACT, MARNER TYPE",2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,IL6;PECAM1
"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A",2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,DMD;TIMP1
"Psychoses, Drug",2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,CALR;ESR1
Adrenal Gland Hyperfunction,2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,VWF;SSTR2
Adult Hodgkin Lymphoma,2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,IL6;GATA3
Anaplastic large B-cell lymphoma,2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,ALK;MYCN
Angiomyolipoma of kidney,2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,KIT;VIM
ANOPHTHALMIA AND PULMONARY HYPOPLASIA,2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,RARB;BRCA2
Benign Mastocytoma,2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,NGFR;KIT
Benign Rolandic Epilepsy,2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,CNTNAP2;ERBB2
Conduct Disorder,2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,ALDH2;SOSTDC1
Disorder of skeletal system,2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,FGFR3;RUNX2
Fragile skin,2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,COL1A1;COL3A1
Hemoglobin F Disease,2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,RIMS2;KLF1
Hypotrichosis simplex,2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,CCL2;SNRPE
Infantile muscular hypotonia,2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,COL1A1;FGFR3
Liver calculus,2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,CDKN2A;EZH2
Mastitis,2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,RPS6KA3;CXCR2
myeloblastosis,2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,E2F1;PKMYT1
Prelingual Deafness,2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,PAX3;MITF
Resting Tremor,2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,ADRB2;SNCAIP
Restrictive cardiomyopathy,2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,FLNC;CRYAB
Roussy-Levy Syndrome (disorder),2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,EGR2;HOXD10
Spade-like hand,2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,RPS6KA3;COL2A1
Weak cry,2/22,0.08519165754635596,0.159550243190554,0,0,4.409706546275395,10.860453555316337,TPM3;CRYAB
Bulging forehead,5/105,0.08526135378223659,0.15959176477187875,0,0,2.2107954545454547,5.443053552901231,RPS6KA3;ARNT2;CCND2;COL2A1;PRKD1
Prominent forehead,5/105,0.08526135378223659,0.15959176477187875,0,0,2.2107954545454547,5.443053552901231,RPS6KA3;ARNT2;CCND2;COL2A1;PRKD1
Apnea,4/75,0.08600291094614183,0.16093495400230945,0,0,2.489093289898119,6.106677097263403,DST;LIFR;ZNF423;CRYAB
Abnormality of the outer ear,3/47,0.08660331056088592,0.16187805002140548,0,0,3.009718222953517,7.363026536012402,SIX1;GATA4;FGFR3
ATRICHIA WITH PAPULAR LESIONS,3/47,0.08660331056088592,0.16187805002140548,0,0,3.009718222953517,7.363026536012402,KIT;HOXB2;PPARG
Diabetic Foot,3/47,0.08660331056088592,0.16187805002140548,0,0,3.009718222953517,7.363026536012402,CCL2;TIMP1;TGFBR2
Phospholipid measurement,3/47,0.08660331056088592,0.16187805002140548,0,0,3.009718222953517,7.363026536012402,FEN1;DLG2;SYT9
Uranostaphyloschisis,10/274,0.08692626532449041,0.1624365047076454,0,0,1.6798153953326367,4.103276742165921,ARNT2;CENPF;BMP2;COL2A1;F13A1;SIX1;CIB1;RUNX2;TNS1;TGFBR2
Drug habituation,6/138,0.0881870120375137,0.16470077109119632,0,0,2.011078898322634,4.883494005103373,OPRD1;IL6;PMAIP1;PARVA;GRIA4;SYNE1
Spontaneous abortion,6/138,0.0881870120375137,0.16470077109119632,0,0,2.011078898322634,4.883494005103373,COL1A1;CXCL10;FGF7;IL6;COL1A2;PAEP
Blood Pressure,4/76,0.08927214068334316,0.16649588915005073,0,0,2.4543965734441926,5.929983655599123,MECOM;PRC1;AGT;TGFBR2
Blood pressure finding,4/76,0.08927214068334316,0.16649588915005073,0,0,2.4543965734441926,5.929983655599123,MECOM;PRC1;AGT;TGFBR2
Familial dilated cardiomyopathy,4/76,0.08927214068334316,0.16649588915005073,0,0,2.4543965734441926,5.929983655599123,ACTC1;DMD;FLNC;CRYAB
Respiration Disorders,4/76,0.08927214068334316,0.16649588915005073,0,0,2.4543965734441926,5.929983655599123,CCL13;MUC1;ADRB2;PTGS2
Systemic arterial pressure,4/76,0.08927214068334316,0.16649588915005073,0,0,2.4543965734441926,5.929983655599123,MECOM;PRC1;AGT;TGFBR2
Alcohol abuse,5/107,0.09066346595878946,0.16904381937235702,0,0,2.167223707664884,5.202638974856862,CCND1;ALDH2;SOSTDC1;GATA4;MPDZ
Foot Deformities,3/48,0.09092490001731661,0.1694842155193723,0,0,2.942684766214178,7.055738201289494,RET;COL2A1;PAX2
"Neoplasms, Second Primary",2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,BRCA1;PTGS2
"Schizophrenia, Childhood",2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,GAD1;MEST
Abnormality of the thorax,2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,COL1A1;COL1A2
Acute pyelonephritis,2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,CCL2;TIMP1
Alveolitis,2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,CCL2;CCL19
Aniridia,2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,WT1;PAX3
beta^0^ Thalassemia,2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,IL6;APOB
Childhood Non-Hodgkin Lymphoma,2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,ALK;ADAM12
Chronic arthritis,2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,DUSP1;PLD1
Congenital hypoplasia of clavicle,2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,BGN;RUNX2
Enthesitis-Related Arthritis,2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,IL6;ESR1
Granuloma,2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,CXCL10;PRTN3
Hemimegalencephaly,2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,CCND1;GFAP
Hypoplastic myelodysplasia,2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,TERT;KIT
Hypoxic-Ischemic Encephalopathy,2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,CCL2;TEK
Increased gastric cancer,2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,KIT;FGFR3
Macule,2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,COL3A1;KIT
Menorrhagia,2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,VWF;FLT4
Neonatal Alloimmune Thrombocytopenia,2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,PLA2G2A;CD36
Neurocysticercosis,2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,ALK;GFAP
Osteophyte,2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,COL2A1;FGF2
Pena-Shokeir syndrome type I,2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,COL1A2;CNTN1
Severe hereditary factor VIII deficiency disease,2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,VWF;CTLA4
Stage III Colon Cancer AJCC v7,2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,CXCL12;CXCR4
Tumor Necrosis Factor Receptor 1-Associated Periodic Syndrome,2/23,0.09197930730994182,0.17026819952964975,0,0,4.199505535848651,10.020825034429558,FOS;ERG
Liver Dysfunction,8/207,0.09211114449223351,0.17046526492417755,0,0,1.7806193438588824,4.246348609084277,ACTA2;NRP1;SOCS3;COL3A1;GRK5;CCL2;DMD;FADD
Substance Dependence,6/140,0.09292370087470045,0.17192164602602983,0,0,1.9808588039302348,4.706474053648846,OPRD1;ALDH2;PMAIP1;PARVA;GRIA4;SYNE1
Very poor growth,7/174,0.094471411947651,0.1747369877830967,0,0,1.8554124627457413,4.377767795823229,RAD51;DST;NPHS1;TNFSF11;KRT5;NKX2-5;FGFR3
Endogenous depression,3/49,0.09533448559658714,0.17628480321219142,0,0,2.8785658075939407,6.765676496523421,IL6;PTGS2;FGF2
Klinefelter Syndrome,4/78,0.09598690479021833,0.1773853185760546,0,0,2.387816387816388,5.59595158740617,NRP1;LEPR;NDN;INHBA
Narrow thorax,4/78,0.09598690479021833,0.1773853185760546,0,0,2.387816387816388,5.59595158740617,COL2A1;TNFSF11;FGFR3;RUNX2
Smoking Behaviors,8/209,0.09600887924716475,0.1773853185760546,0,0,1.7627195828637134,4.130606533584361,RET;PRKN;ACAN;TCF7L2;REPS2;EVL;ZNF423;PAK5
Oligospermia,5/109,0.0962382700992441,0.17776023707000094,0,0,2.125327797202797,4.975239737181872,CATSPER1;SIRPA;ESR1;MEST;SOX5
"Epilepsy, Benign Psychomotor, Childhood",2/24,0.0989181259246389,0.18166096081757585,0,0,4.008413708187975,9.273315928238109,KDR;TEK
"Leukemia, Mast-Cell",2/24,0.0989181259246389,0.18166096081757585,0,0,4.008413708187975,9.273315928238109,KIT;KDR
Adenoma of lung,2/24,0.0989181259246389,0.18166096081757585,0,0,4.008413708187975,9.273315928238109,CDKN2A;MET
Aplasia/Hypoplasia of the skin,2/24,0.0989181259246389,0.18166096081757585,0,0,4.008413708187975,9.273315928238109,TERT;ANTXR2
Cellular immunodeficiency,2/24,0.0989181259246389,0.18166096081757585,0,0,4.008413708187975,9.273315928238109,TERT;SH2D1A
Cognitive changes,2/24,0.0989181259246389,0.18166096081757585,0,0,4.008413708187975,9.273315928238109,CTNND2;ESR1
Complications of Diabetes Mellitus,2/24,0.0989181259246389,0.18166096081757585,0,0,4.008413708187975,9.273315928238109,ALDH2;LTA
Congenital hypoplasia of adrenal gland,2/24,0.0989181259246389,0.18166096081757585,0,0,4.008413708187975,9.273315928238109,CXCL10;SOCS3
CONOTRUNCAL ANOMALY FACE SYNDROME,2/24,0.0989181259246389,0.18166096081757585,0,0,4.008413708187975,9.273315928238109,NKX2-5;ZFPM2
Dentinogenesis Imperfecta,2/24,0.0989181259246389,0.18166096081757585,0,0,4.008413708187975,9.273315928238109,COL1A1;COL1A2
Eosinophilic granulomatosis with polyangiitis,2/24,0.0989181259246389,0.18166096081757585,0,0,4.008413708187975,9.273315928238109,LEPR;PRTN3
Familial primary pulmonary hypertension,2/24,0.0989181259246389,0.18166096081757585,0,0,4.008413708187975,9.273315928238109,IL6;CAV1
Gardner Syndrome,2/24,0.0989181259246389,0.18166096081757585,0,0,4.008413708187975,9.273315928238109,CCND1;ERG
Increased thickness of cranium,2/24,0.0989181259246389,0.18166096081757585,0,0,4.008413708187975,9.273315928238109,RPS6KA3;RUNX2
Paroxysmal nonkinesigenic dyskinesia,2/24,0.0989181259246389,0.18166096081757585,0,0,4.008413708187975,9.273315928238109,RET;MUC1
Postural instability,2/24,0.0989181259246389,0.18166096081757585,0,0,4.008413708187975,9.273315928238109,PRKN;SNCAIP
Secondary hypothyroidism,2/24,0.0989181259246389,0.18166096081757585,0,0,4.008413708187975,9.273315928238109,ARNT2;LEPR
Senile lentigo,2/24,0.0989181259246389,0.18166096081757585,0,0,4.008413708187975,9.273315928238109,MITF;FGFR3
Stage III Colon Cancer,2/24,0.0989181259246389,0.18166096081757585,0,0,4.008413708187975,9.273315928238109,CXCL12;CXCR4
Thickened calvaria,2/24,0.0989181259246389,0.18166096081757585,0,0,4.008413708187975,9.273315928238109,RPS6KA3;RUNX2
Uncinate Epilepsy,2/24,0.0989181259246389,0.18166096081757585,0,0,4.008413708187975,9.273315928238109,KDR;TEK
Bone Density,5/110,0.09908959987191567,0.18187640140469682,0,0,2.104978354978355,4.866143273269145,MEF2C;TNFSF11;ESR1;RUNX2;AQP1
Small testicle,5/110,0.09908959987191567,0.18187640140469682,0,0,2.104978354978355,4.866143273269145,WT1;LEPR;GATA4;ZFPM2;SOX10
"Polyendocrinopathies, Autoimmune",4/79,0.09943091952965903,0.1823533739926789,0,0,2.3558578987150414,5.4380082988845455,C4A;PLA2G2A;CCL2;VIM
Chronic granulomatous disease,4/79,0.09943091952965903,0.1823533739926789,0,0,2.3558578987150414,5.4380082988845455,MECOM;PPARG;DMD;ESR1
Distal sensory impairment,4/79,0.09943091952965903,0.1823533739926789,0,0,2.3558578987150414,5.4380082988845455,EGR2;CAV1;NEFH;SOX10
Biparietal narrowing,3/50,0.09982986516854211,0.1827855437491627,0,0,2.817175315297969,6.491582963739185,PLK4;GATA4;ZNF423
Childhood onset,3/50,0.09982986516854211,0.1827855437491627,0,0,2.817175315297969,6.491582963739185,WT1;DMD;SYNE1
Decreased width of the skull,3/50,0.09982986516854211,0.1827855437491627,0,0,2.817175315297969,6.491582963739185,PLK4;GATA4;ZNF423
Fibromyalgia,3/50,0.09982986516854211,0.1827855437491627,0,0,2.817175315297969,6.491582963739185,IL6;TAL1;ADRB2
Microscopic Polyarteritis,3/50,0.09982986516854211,0.1827855437491627,0,0,2.817175315297969,6.491582963739185,CTLA4;PRTN3;ESR1
Sudden Cardiac Death,3/50,0.09982986516854211,0.1827855437491627,0,0,2.817175315297969,6.491582963739185,IL18;ADRB2;APOB
Substance Use Disorders,6/143,0.10028076246265615,0.18356107950373363,0,0,1.937183047071147,4.455097544667274,OPRD1;CNTNAP2;PMAIP1;PARVA;GRIA4;SYNE1
Kartagener Syndrome,5/111,0.10198307071591206,0.18662624057985433,0,0,2.0850128644939967,4.7599768931613715,CDKN2A;ERBB2;SDC1;PPARG;RUNX1T1
Abnormality of the fingernails,4/80,0.10293163117688241,0.1882082316863442,0,0,2.3247404224847834,5.285739716378271,TERT;BMPR1B;PITX1;EZH2
Abnormality of the metaphysis,4/80,0.10293163117688241,0.1882082316863442,0,0,2.3247404224847834,5.285739716378271,COL2A1;TNFSF11;FGFR3;EZH2
Dyslexia,4/80,0.10293163117688241,0.1882082316863442,0,0,2.3247404224847834,5.285739716378271,RIMS2;CNTNAP2;PARP1;CCDC136
Adult Lymphoma,3/51,0.10440880573378661,0.19054607046416056,0,0,2.7583427601809953,6.232313444282442,RHOJ;SH2D1A;EZH2
Gingival Hyperplasia,3/51,0.10440880573378661,0.19054607046416056,0,0,2.7583427601809953,6.232313444282442,FGF7;MMP14;ANTXR2
Hematuria,3/51,0.10440880573378661,0.19054607046416056,0,0,2.7583427601809953,6.232313444282442,YAP1;CTLA4;PRTN3
Hyperpigmentation,3/51,0.10440880573378661,0.19054607046416056,0,0,2.7583427601809953,6.232313444282442,KIT;HMGA2;ANTXR2
Lafora Disease,3/51,0.10440880573378661,0.19054607046416056,0,0,2.7583427601809953,6.232313444282442,PRKN;GRK5;SNCG
Pauci-immune Glomerulonephritis associated with Granulomatosis with Polyangiitis,3/51,0.10440880573378661,0.19054607046416056,0,0,2.7583427601809953,6.232313444282442,CTLA4;PRTN3;TIMP1
Tumors of Adrenal Cortex,3/51,0.10440880573378661,0.19054607046416056,0,0,2.7583427601809953,6.232313444282442,BMP2;CCND2;PPARG
Bronchiectasis,5/112,0.10491830425305301,0.1913718987950853,0,0,2.0654205607476634,4.656642021441175,BLM;TERT;STAT1;TAP1;CXCR4
Synovitis,5/112,0.10491830425305301,0.1913718987950853,0,0,2.0654205607476634,4.656642021441175,IL6;COL2A1;STAT1;IL18;PRTN3
Frontotemporal dementia,6/145,0.1053513593104598,0.19210961963862289,0,0,1.909113256092165,4.296372014196651,RIMS2;CHAF1A;CDC7;FLNC;NEFH;SYN1
"Lymphoma, Follicular, Grade 1",2/25,0.105998062989128,0.19224493411692783,0,0,3.833938561193444,8.604640425519106,CD5;EZH2
Astrocytosis,2/25,0.105998062989128,0.19224493411692783,0,0,3.833938561193444,8.604640425519106,FGF2;GFAP
Atrioventricular Septal Defect,2/25,0.105998062989128,0.19224493411692783,0,0,3.833938561193444,8.604640425519106,GATA4;NKX2-5
Depressed cheekbone,2/25,0.105998062989128,0.19224493411692783,0,0,3.833938561193444,8.604640425519106,BLM;RUNX2
Diabetic foot ulcer,2/25,0.105998062989128,0.19224493411692783,0,0,3.833938561193444,8.604640425519106,CCL2;TIMP1
Enterocolitis,2/25,0.105998062989128,0.19224493411692783,0,0,3.833938561193444,8.604640425519106,STAT1;CTLA4
Flattening of the zygomatic bone,2/25,0.105998062989128,0.19224493411692783,0,0,3.833938561193444,8.604640425519106,BLM;RUNX2
Hyperostosis,2/25,0.105998062989128,0.19224493411692783,0,0,3.833938561193444,8.604640425519106,FGFR3;RUNX2
Hypoplasia of the zygomatic bone,2/25,0.105998062989128,0.19224493411692783,0,0,3.833938561193444,8.604640425519106,BLM;RUNX2
Hypotrophic cheekbone,2/25,0.105998062989128,0.19224493411692783,0,0,3.833938561193444,8.604640425519106,BLM;RUNX2
Insulin-resistant diabetes mellitus,2/25,0.105998062989128,0.19224493411692783,0,0,3.833938561193444,8.604640425519106,LEPR;PPARG
Invasive Pulmonary Aspergillosis,2/25,0.105998062989128,0.19224493411692783,0,0,3.833938561193444,8.604640425519106,IL6;CCL2
Leukokeratosis,2/25,0.105998062989128,0.19224493411692783,0,0,3.833938561193444,8.604640425519106,TERT;KRT5
Lupus anticoagulant disorder,2/25,0.105998062989128,0.19224493411692783,0,0,3.833938561193444,8.604640425519106,VWF;SERPINC1
Parathyroid Diseases,2/25,0.105998062989128,0.19224493411692783,0,0,3.833938561193444,8.604640425519106,RET;ADRA1A
Port-Wine Stain,2/25,0.105998062989128,0.19224493411692783,0,0,3.833938561193444,8.604640425519106,KDR;TEK
Prematurely aged appearance,2/25,0.105998062989128,0.19224493411692783,0,0,3.833938561193444,8.604640425519106,PLK4;KRT5
Small cheekbone,2/25,0.105998062989128,0.19224493411692783,0,0,3.833938561193444,8.604640425519106,BLM;RUNX2
Steroid resistant nephrotic syndrome of childhood,2/25,0.105998062989128,0.19224493411692783,0,0,3.833938561193444,8.604640425519106,NPHS1;WT1
Uroureter,2/25,0.105998062989128,0.19224493411692783,0,0,3.833938561193444,8.604640425519106,PLD1;MYLK
Granulocyte count,4/81,0.10648821416691193,0.19302964813629703,0,0,2.294431192390376,5.138885644474954,TERT;CXCR2;LEPR;PLAUR
Reduced fetal movement,4/81,0.10648821416691193,0.19302964813629703,0,0,2.294431192390376,5.138885644474954,MYCN;TPM3;NDN;FGFR3
Penile hypospadias,7/180,0.10789347453745794,0.19547401966144545,0,0,1.7905086177316758,3.986765978811249,ARNT2;WT1;GATA4;FKBP4;ZFPM2;ESR1;ATF3
Cocaine-Related Disorders,5/113,0.10789490632593483,0.19547401966144545,0,0,2.0461910774410774,4.556044173256674,GRIA2;EGR1;GAD1;FOS;FGF2
Allergic sensitization,3/52,0.10906904786402317,0.19738823105760703,0,0,2.701911533844307,5.986825680039984,CXCR2;ADRB2;GATA3
Friedreich Ataxia,3/52,0.10906904786402317,0.19738823105760703,0,0,2.701911533844307,5.986825680039984,PPARG;PTGS2;PPARGC1A
Generalized hirsutism,3/52,0.10906904786402317,0.19738823105760703,0,0,2.701911533844307,5.986825680039984,CAV1;PPARG;FOS
Gingival Hypertrophy,3/52,0.10906904786402317,0.19738823105760703,0,0,2.701911533844307,5.986825680039984,RET;MMP14;ANTXR2
Mild Mental Retardation,6/147,0.11055274262104565,0.20001945566889617,0,0,1.8818397712402462,4.144305277978004,RPS6KA3;BIN1;CTNND2;HMGA2;GATA4;DMD
"Epilepsy, Lateral Temporal",2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,KDR;TEK
"Tuberculosis, Meningeal",2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,CCL2;TIMP1
AA amyloidosis,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,IL18;SAA1
Abnormality of the eyelashes,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,PLK4;COL3A1
Adult T Acute Lymphoblastic Leukemia,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,KIT;EZH2
ANONYCHIA,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,COL17A1;COL2A1
Defect of vertebral segmentation,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,COL2A1;TNNI2
Dermatitis Herpetiformis,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,COL17A1;SELE
Drug Eruptions,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,C4B;IL18
Hereditary nonpolyposis colorectal carcinoma,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,FGFR3;TGFBR2
Hyperprolactinemia,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,STAT5B;GAD1
Hypersomnia,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,PER2;NKX2-5
Indian childhood cirrhosis,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,CISH;ERBB2
Malignant Uterine Corpus Neoplasm,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,MYCN;ERBB2
Mast Cell Neoplasm,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,NGFR;KIT
Overactive Bladder,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,SNCAIP;LMNB1
Overactive bladder syndrome,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,SNCAIP;LMNB1
Personality change,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,SNCAIP;LMNB1
Radial polydactyly,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,PITX1;FGFR3
Reticulocytosis,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,SPTB;KLF1
Retinal Dysplasia,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,COL2A1;MPDZ
Septo-Optic Dysplasia,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,ARNT2;PAX3
Severe Aplastic Anemia,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,IL6;KIT
Steroid-resistant nephrotic syndrome,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,NPHS1;WT1
Tachypnea,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,ACTA2;ZNF423
Thin rib,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,COL2A1;LIFR
Tick-Borne Encephalitis,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,TRAT1;CXCR4
Trichothiodystrophy Syndromes,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,CHEK1;PPARGC1A
Zinc deficiency,2/26,0.11320943873729689,0.20323832947331885,0,0,3.674003009781791,8.00387336951582,IL6;PARP1
Hydatidiform Mole,4/83,0.11376557302091976,0.20398628453651646,0,0,2.2361146990441747,4.860453177949981,TERT;ERBB2;PPARG;APOB
MRSA - Methicillin resistant Staphylococcus aureus infection,4/83,0.11376557302091976,0.20398628453651646,0,0,2.2361146990441747,4.860453177949981,PER2;VWF;RARB;PAEP
Cerebellar vermis hypoplasia,3/53,0.11380830973173425,0.20398628453651646,0,0,2.647737556561086,5.754168477595202,CENPF;LAMA1;ZNF423
Childhood Lymphoma,3/53,0.11380830973173425,0.20398628453651646,0,0,2.647737556561086,5.754168477595202,RHOJ;SH2D1A;EZH2
Thick vermilion border,3/53,0.11380830973173425,0.20398628453651646,0,0,2.647737556561086,5.754168477595202,RET;MYCN;CIT
Thrombocytopenia due to platelet alloimmunization,3/53,0.11380830973173425,0.20398628453651646,0,0,2.647737556561086,5.754168477595202,STAT1;IL18;CXCR4
"Low-set, posteriorly rotated ears",6/149,0.11588308024430982,0.20764961764161813,0,0,1.8553291810695,3.9985563313977344,COL1A1;ACAN;CTNND2;ZNF423;FLI1;EZH2
"Organic Mental Disorders, Substance-Induced",5/116,0.11706875563970857,0.20966233676700874,0,0,1.9905814905814905,4.269785078601989,OPRD1;PMAIP1;PARVA;GRIA4;SYNE1
Prescription Drug Abuse,5/116,0.11706875563970857,0.20966233676700874,0,0,1.9905814905814905,4.269785078601989,OPRD1;PMAIP1;PARVA;GRIA4;SYNE1
Distal muscle weakness,4/84,0.1174845826075049,0.21035096155478616,0,0,2.2080498866213154,4.728424379828122,EGR2;BIN1;SOX10;CRYAB
"Hemophilia, NOS",3/54,0.11862429100056149,0.21116911487379822,0,0,2.595688048975246,5.53347220577743,VWF;TAL1;CXCR4
Congenital ichthyosis,3/54,0.11862429100056149,0.21116911487379822,0,0,2.595688048975246,5.53347220577743,F13A1;DMD;GATA3
Diabetic Cardiomyopathies,3/54,0.11862429100056149,0.21116911487379822,0,0,2.595688048975246,5.53347220577743,TXNIP;FGF1;AGT
Rotavirus Infections,3/54,0.11862429100056149,0.21116911487379822,0,0,2.595688048975246,5.53347220577743,JUN;STAT1;PTGS2
Strabismus,13/404,0.11872713965068188,0.21116911487379822,0,0,1.4749218527990906,3.1429513341275297,PLK4;RET;ARNT2;LAMA1;FANCA;MITF;ASCL1;FLI1;FANCD2;ERG;FGFR3;EZH2;SOX5
Diastolic blood pressure,5/117,0.12020659124387982,0.21116911487379822,0,0,1.9727069805194806,4.179265398582397,TCF7L2;MECOM;PDE1A;PPL;AGT
Broad flat nasal bridge,11/330,0.12035742427419079,0.21116911487379822,0,0,1.528364849833148,3.2359907381137694,PLK4;MYCN;CTNND2;PAX3;RARB;TNNI2;GATA4;NEK2;MITF;SOX10;SOX5
Appendicitis,2/27,0.12054293253427602,0.21116911487379822,0,0,3.52686230248307,7.46195645795547,IL6;LEPR
Cervical dysplasia,2/27,0.12054293253427602,0.21116911487379822,0,0,3.52686230248307,7.46195645795547,CDKN2A;ESR1
Conotruncal defect,2/27,0.12054293253427602,0.21116911487379822,0,0,3.52686230248307,7.46195645795547,GATA4;ZFPM2
Cutaneous lymphoma,2/27,0.12054293253427602,0.21116911487379822,0,0,3.52686230248307,7.46195645795547,CCND1;RHOJ
Extramedullary Hematopoiesis (disorder),2/27,0.12054293253427602,0.21116911487379822,0,0,3.52686230248307,7.46195645795547,IL6;TNFSF11
Failure to thrive in infant,2/27,0.12054293253427602,0.21116911487379822,0,0,3.52686230248307,7.46195645795547,NR4A1;APOB
Gastric lymphoma,2/27,0.12054293253427602,0.21116911487379822,0,0,3.52686230248307,7.46195645795547,ALK;CDKN2A
Generalized vitiligo,2/27,0.12054293253427602,0.21116911487379822,0,0,3.52686230248307,7.46195645795547,CTLA4;GZMB
Metopic synostosis,2/27,0.12054293253427602,0.21116911487379822,0,0,3.52686230248307,7.46195645795547,BMP2;EZH2
Mildly elevated creatine phosphokinase,2/27,0.12054293253427602,0.21116911487379822,0,0,3.52686230248307,7.46195645795547,SCN4A;FLNC
Mucinous neoplasm,2/27,0.12054293253427602,0.21116911487379822,0,0,3.52686230248307,7.46195645795547,MUC1;CDKN2A
Mumps,2/27,0.12054293253427602,0.21116911487379822,0,0,3.52686230248307,7.46195645795547,IL6;STAT1
Pelizaeus-Merzbacher Disease,2/27,0.12054293253427602,0.21116911487379822,0,0,3.52686230248307,7.46195645795547,CDT1;LMNB1
Primary amyloidosis,2/27,0.12054293253427602,0.21116911487379822,0,0,3.52686230248307,7.46195645795547,CCND1;CALR
Reactive systemic amyloidosis,2/27,0.12054293253427602,0.21116911487379822,0,0,3.52686230248307,7.46195645795547,IL18;SAA1
Rothmund-Thomson syndrome,2/27,0.12054293253427602,0.21116911487379822,0,0,3.52686230248307,7.46195645795547,BLM;RUNX2
Convex nasal bridge,4/85,0.1212559334320529,0.21116911487379822,0,0,2.1806780325298845,4.600907504514379,PAX3;PRKD1;SOX10;FGFR3
Prominent nasal bridge,4/85,0.1212559334320529,0.21116911487379822,0,0,2.1806780325298845,4.600907504514379,PAX3;PRKD1;SOX10;FGFR3
"Mental Retardation, X-Linked",5/118,0.12338360420045534,0.21116911487379822,0,0,1.9551488334674176,4.091064947549961,PRKN;RPS6KA3;CALR;SYP;PAK3
"Lymphoma, Diffuse",3/55,0.12351467656145033,0.21116911487379822,0,0,2.545640445527323,5.323940441425664,SPRY2;FLNC;RAD54B
Agnosia for Pain,3/55,0.12351467656145033,0.21116911487379822,0,0,2.545640445527323,5.323940441425664,OPRD1;IL6;PPARA
Russell-Silver syndrome,3/55,0.12351467656145033,0.21116911487379822,0,0,2.545640445527323,5.323940441425664,HMGA2;KPNA2;MEST
Spastic Quadriplegia,3/55,0.12351467656145033,0.21116911487379822,0,0,2.545640445527323,5.323940441425664,IL6;GAD1;SOX10
Systemic onset juvenile chronic arthritis,3/55,0.12351467656145033,0.21116911487379822,0,0,2.545640445527323,5.323940441425664,IL6;STAT1;GZMB
"Leishmaniasis, Visceral",4/86,0.12507869207166986,0.21116911487379822,0,0,2.1539737846358054,4.477706988833952,CXCL10;IL6;PPARA;AQP1
Distal limb muscle weakness due to peripheral neuropathy,4/86,0.12507869207166986,0.21116911487379822,0,0,2.1539737846358054,4.477706988833952,EGR2;BIN1;SOX10;CRYAB
Myocardial Reperfusion Injury,4/86,0.12507869207166986,0.21116911487379822,0,0,2.1539737846358054,4.477706988833952,CCL2;ADRB1;PPARA;AGT
Nasal bridge wide,11/333,0.12583424004580804,0.21116911487379822,0,0,1.5138892864298594,3.137974261135997,PLK4;MYCN;CTNND2;PAX3;RARB;TNNI2;GATA4;NEK2;MITF;SOX10;SOX5
"Achondrogenesis, type IB (disorder)",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,DCN
"Brain Infarction, Posterior Circulation",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,FGF2
"Cerebellar Ataxia, Late Onset",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,FLNC
"Choledochal Cyst, Type I",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,AQP1
"Choledochal Cyst, Type II",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,AQP1
"Choledochal Cyst, Type III",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,AQP1
"Choledochal Cyst, Type IV",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,AQP1
"Choledochal Cyst, Type V",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,AQP1
"Congenital dyserythropoietic anemia, type I",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,KLF1
"Corneal dystrophy, Fuchs' endothelial, 1",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,JUN
"Dysfibrinogenemia, Congenital",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,F13A1
"EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,COL1A2
"EHLERS-DANLOS SYNDROME, PROGEROID FORM",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,DCN
"EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder)",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,COL17A1
"Gastritis, Hypertrophic",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,HGF
"Hereditary, Type VII, Motor and Sensory Neuropathy",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,EGR2
"Hypospadias, perineal",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,GATA4
"Leukemia, Natural Killer Cell Large Granular Lymphocytic",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,STAT5B
"Ovarian Small Cell Carcinoma, Hypercalcemic Type",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,HGF
"Phenylketonuria, Maternal",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,NEFH
"PITUITARY ADENOMA, FAMILIAL ISOLATED (disorder)",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CIB1
"Polymyositis, Idiopathic",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,IL6
"Schwannomatosis, Plexiform",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,WT1
"Serous cystadenoma, borderline malignancy",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,ERBB2
"Spina Bifida, X-Linked",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,PAX3
"stage, chronic lymphocytic leukemia",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,EGR2
"Sterility, Reproductive",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,LEPR
"TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,ETS2
"Uveitis, Intermediate",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,IL6
"Venous Infarction, Brain",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,FGF2
"Von Willebrand disease, platelet type",1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,VWF
3-methylcrotonyl CoA carboxylase 1 deficiency,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,PER2
Abnormality of bone marrow cell morphology,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CCND1
Adamantinoma,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,TNFSF11
Adult junctional epidermolysis bullosa (disorder),1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,COL17A1
Agenesis of punctum lacrimale,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,FGFR3
Alcohol-Induced Disorders,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,ALDH2
Alcoholic Neuropathy,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,ALDH2
Alpha fetoprotein abnormal,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,MET
Anemia in malignant neoplastic disease,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,ERBB2
Aneuploidy,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,AURKA
Anterior Cerebral Circulation Infarction,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,FGF2
Anterior Circulation Brain Infarction,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,FGF2
Aortic aneurysm and dissection,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,ACTA2
Aplasia/Hypoplasia involving the metacarpal bones,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,BMPR1B
Aplasia/Hypoplasia of the fibula,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,BMPR1B
Aplasia/Hypoplasia of the thymus,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,ANTXR2
Arcus juvenilis,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,APOB
Aromatase deficiency,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,ESR1
Atrophy of the spinal cord,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,SYP
Autosomal Recessive Emery-Dreifuss Muscular Dystrophy,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,SYNE1
Bacterial sepsis of newborn,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,IL6
BARDET-BIEDL SYNDROME 11,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,PRKN
Bat ear,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,COL1A1
Benign neoplasm of prostate,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,FKBP4
Bilateral Headache,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,IL6
Biliary papillomatosis,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CDKN2A
Blood group deletion syndrome,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,DMD
Blood Sedimentation,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CR1
Bone marrow biopsy shows erythroid hyperplasia,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,KLF1
Bone marrow smear shows erythroid hyperplasia,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,KLF1
Brain Stem Neoplasms,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CDKN2A
Branchiootorenal Syndrome 2,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,SIX1
Breast Diffuse Large B-Cell Lymphoma,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,MKI67
Broad columella,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,FLI1
Broad phalanx,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,BGN
Bronchopulmonary Sequestration,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,WT1
C3 Glomerulonephritis,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,C3
Calf muscle pseudohypertrophy,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,DMD
carotid disease,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,IL6
Cecal Neoplasms,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CCND1
Central blindness,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,IL18
Childhood Hepatocellular Carcinoma,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,MET
Chorioretinal degeneration,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,TEAD1
Chorioretinitis,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,IL6
Chronic esophagitis,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CDKN2A
Chronic infectious disease,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CTLA4
colon cancer liver metastasis,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,KIF22
Congenital absence of tibia,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,PITX1
Congenital Generalized Lipodystrophy Type 2,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,PPARG
Congenital premature fusion,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,FGF2
Congenital pyloric atresia,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,COL17A1
Craniofacial disproportion,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,COL1A1
Crisponi syndrome,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,LIFR
Cutaneous Follicular Lymphoma,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,STMN1
Cyanotic congenital heart disease,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,ALDH2
Deep-set nails,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,EZH2
Delusional disorder,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,DPYSL2
Dental Diseases,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,FADD
Dilatated internal auditory canal,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,SIX1
Dilated fourth ventricle,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,LAMA1
Disorder of soft tissue,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,PROS1
Disseminated Bacillus Calmette-Guerin infection,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,STAT1
Distal upper limb amyotrophy,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,FLNC
Eisenmenger Complex,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,TGFBR2
Elevated alpha-fetoprotein,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,MET
Endemic goiter,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,SELE
Epidermolysis Bullosa Progressiva,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,COL17A1
Episodic flaccid weakness,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,SCN4A
Episodic hypertension,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,RET
Episodic hypokalemia,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,SCN4A
Erythroleukemia,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,EZH2
Exercise-induced angina,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CD36
Extramedullary erythropoiesis,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,TNFSF11
Exudative age-related macular degeneration,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,KDR
FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1B,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CAPN3
Fatty replacement of skeletal muscle,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,FLAD1
Fused labia minora,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,ZFPM2
Generalized Headache,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,IL6
Genomic Instability,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CCND1
Germ cell neoplasia,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,TDGF1
GLIOMA SUSCEPTIBILITY 1,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,ERBB2
Hematocrit increased,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,EPAS1
Hemicrania,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,IL6
Hemodynamic instability,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,IL6
HEPATIC LIPASE DEFICIENCY (disorder),1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,APOB
Hepatosplenic T-cell lymphoma,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,RHOJ
Hereditary bundle branch system defect,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,NKX2-5
Heterotopic Ossification,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,RUNX2
Histiocytic Necrotizing Lymphadenitis,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CXCL10
HMG CoA lyase deficiency,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,APOB
Hyperphosphatasemia with bone disease,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,TNFSF11
Hyperplasia of columella,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,FLI1
Hypertriglyceridemic Waist,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,APOB
Hypoplasia of lower limb,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,FGFR3
Idiopathic retroperitoneal fibrosis,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,TRIM63
Influenza A/H5N1,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,AGT
Insulin resistance - type A,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CALR
Intestinal metaplasia,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,PTGS2
Intestinal obstruction co-occurrent and due to decreased peristalsis,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,MUC1
Intraductal papillary-mucinous adenoma,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,MUC1
Iodine deficiency syndrome,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,RET
JEB-I,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,COL17A1
Kaposi's sarcoma-associated herpesvirus infection,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,FLT4
Keratitis-Ichthyosis-Deafness Syndrome,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,KIF22
Left Ventricle Remodeling,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,ADRA1A
Lentigo maligna melanoma,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CCND1
Lesion of stomach,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CDKN2A
Lichenification,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CTLA4
Limited hip movement,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,COL2A1
Loeys-Dietz Aortic Aneurysm Syndrome,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,TGFBR2
Loss of gluteal subcutaneous adipose tissue,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,PPARG
Low grade myofibroblastic sarcoma,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,ALK
Male Germ Cell Tumor,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,KIT
Malignant melanoma of conjunctiva,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,TERT
Malignant neoplasm of cecum,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CCND1
Malignant neoplasm of thymus,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,FLT4
Mediastinal Neoplasms,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,KIT
Medullary sponge kidney,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,PAX2
Megacystis microcolon intestinal hypoperistalsis syndrome,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,MYLK
Microcystic stromal tumor,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,VIM
Mixed dementia,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,GRIA2
Mixed phenotype acute leukemia B/myeloid,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,KIT
Mydriasis,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,ACTA2
Myeloid Metaplasia,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CXCR2
Nasopharyngeal cancer recurrent,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,EZH2
Necrotizing vasculitis,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,PRTN3
Neointima,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,AGT
Neointima Formation,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,AGT
Neonatal alloimmune thrombocytopenia (NAIT),1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,PLA2G2A
Neonatal Early-Onset Sepsis,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,IL6
Non-Metastatic Childhood Soft Tissue Sarcoma,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,MAPK8IP2
Nonmotile sperm,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CATSPER1
Numerous nevi,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,FGFR3
Ocular Headache,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,IL6
Opisthorchis Viverrini-Related Cholangiocarcinoma,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CDKN2A
Opsoclonus,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,TNFSF11
Orthostatic Headache,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,IL6
Osteoblastic Osteosarcoma,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,ESR1
Other restrictive cardiomyopathy,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,FLNC
Other specified senile psychotic conditions,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,NGFR
Ovarian Fibromata,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,MKI67
Ovarian papillary adenocarcinoma,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,PRKN
Pallister-Killian syndrome,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,ZFPM2
Palmar hyperhidrosis,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,COL17A1
Papillary transitional cell carcinoma,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,ERBB2
Papillary urothelial carcinoma,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,ESR1
Parietal bossing,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,RUNX2
Periorbital Headache,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,IL6
Physical addiction,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,FGFR3
Polymyositis Ossificans,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,IL6
Posterior rib cupping,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,BGN
Preexcitation Syndrome,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,BMP2
Primary Hypothyroidism,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,STAT1
Processing speed,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,PAX3
Prominent superficial veins,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,PPARG
Proteus Syndrome,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,FGFR3
Pygmy (disorder),1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,HMGA2
Reactive thrombocytosis,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CALR
Rectal polyp,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CDKN2A
Red blood cell disorder,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,KLF1
Reduced factor XIII activity,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,F13A1
Renal cancer metastatic,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CXCR4
Renal cysts and diabetes syndrome,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,PAX2
response to fenofibrate,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CD36
Reticulate acropigmentation of Kitamura,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,KRT5
Retinoblastoma bilateral,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,RET
Retro-Ocular Headache,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,IL6
RIPPLING MUSCLE DISEASE 1,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,NGFR
Round ear,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,TNNI2
Saccular Aneurysm,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,COL3A1
Scleritis,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,STAT1
Secondary Peritonitis,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,LEPR
Serrated polyp,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CALR
Sharp Headache,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,IL6
Short 5th metacarpal,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,RUNX2
Short fourth metatarsal,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,EZH2
Sleep-wake cycle disturbance,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,PER2
Slipped Capital Femoral Epiphyses,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,RET
Small intestine carcinoma,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,ERBB2
Small thenar eminence,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,FGFR3
Speech and language disorder,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CALR
Sphingolipidoses,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,SH2D1A
Squamous cell carcinoma of pharynx,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,IL6
Subcoronal hypospadias,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,FGFR3
SYSTEMIC LUPUS ERYTHEMATOSUS 16,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,C4A
Throbbing Headache,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,IL6
Thymic alymphoplasia,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,IL2RG
Thymic hypoplasia or aplasia,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,ANTXR2
Tricuspid Valve Prolapse,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,PLD1
Tumor Lysis Syndrome,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,TAL1
Ulnar-mammary syndrome,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CDKN2A
Ulnar deviation of the hand or of fingers of the hand,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,TNNI2
Valvular disease,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,TIMP1
Vascular fragility,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,FLI1
Ventricular Remodeling,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,ADRA1A
Vertex Headache,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,IL6
Visual Pathway Glioma,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,CXCR4
Vitreoretinopathy,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,VCAN
Warburton Anyane Yeboa syndrome,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,BUB1
Wide pubic symphysis,1/6,0.1263052910137057,0.21116911487379822,0,0,8.806306306306306,18.22071763529804,RUNX2
Drug Use Disorders,5/119,0.1265993152958902,0.21160801431737145,0,0,1.9378987240829346,4.005109898575531,OPRD1;PMAIP1;PARVA;GRIA4;SYNE1
"AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE",2/28,0.1279895717760244,0.21287220506383853,0,0,3.3910401111304047,6.971322264518416,CTNND2;SNCG
"Parkinsonism, Experimental",2/28,0.1279895717760244,0.21287220506383853,0,0,3.3910401111304047,6.971322264518416,PRKN;PARP1
Absence of secondary sex characteristics,2/28,0.1279895717760244,0.21287220506383853,0,0,3.3910401111304047,6.971322264518416,LEPR;ESR1
Aphthous Stomatitis,2/28,0.1279895717760244,0.21287220506383853,0,0,3.3910401111304047,6.971322264518416,C4A;IL6
Autosomal Dominant Juvenile Parkinson Disease,2/28,0.1279895717760244,0.21287220506383853,0,0,3.3910401111304047,6.971322264518416,PRKN;PARP1
Benign Meningioma,2/28,0.1279895717760244,0.21287220506383853,0,0,3.3910401111304047,6.971322264518416,CDKN2A;HGF
Centronuclear myopathy,2/28,0.1279895717760244,0.21287220506383853,0,0,3.3910401111304047,6.971322264518416,TPM3;BIN1
Chronic colitis,2/28,0.1279895717760244,0.21287220506383853,0,0,3.3910401111304047,6.971322264518416,NR5A2;CCL2
Elevated heart rate,2/28,0.1279895717760244,0.21287220506383853,0,0,3.3910401111304047,6.971322264518416,RET;DST
Extrinsic allergic alveolitis,2/28,0.1279895717760244,0.21287220506383853,0,0,3.3910401111304047,6.971322264518416,IL18;TAP1
Familial Juvenile Parkinsonism,2/28,0.1279895717760244,0.21287220506383853,0,0,3.3910401111304047,6.971322264518416,PRKN;PARP1
Fetal Death,2/28,0.1279895717760244,0.21287220506383853,0,0,3.3910401111304047,6.971322264518416,CENPF;COL2A1
Hereditary non-polyposis colorectal cancer syndrome,2/28,0.1279895717760244,0.21287220506383853,0,0,3.3910401111304047,6.971322264518416,BARD1;TGFBR2
Increased circulating gonadotropin level,2/28,0.1279895717760244,0.21287220506383853,0,0,3.3910401111304047,6.971322264518416,WT1;ESR1
Oligomenorrhea,2/28,0.1279895717760244,0.21287220506383853,0,0,3.3910401111304047,6.971322264518416,NDN;PPARG
Placental Insufficiency,2/28,0.1279895717760244,0.21287220506383853,0,0,3.3910401111304047,6.971322264518416,KDR;PPARGC1A
Ramsay Hunt Paralysis Syndrome,2/28,0.1279895717760244,0.21287220506383853,0,0,3.3910401111304047,6.971322264518416,PRKN;PARP1
Rat Insulinoma,2/28,0.1279895717760244,0.21287220506383853,0,0,3.3910401111304047,6.971322264518416,IL18;IRS2
Sarcopenia,2/28,0.1279895717760244,0.21287220506383853,0,0,3.3910401111304047,6.971322264518416,TRIM63;FOXO1
Single kidney,2/28,0.1279895717760244,0.21287220506383853,0,0,3.3910401111304047,6.971322264518416,GATA3;CIT
Severe mental retardation (I.Q. 20-34),8/224,0.1281507976588445,0.21308758531240396,0,0,1.6390372065429273,3.3674799619243116,CNTNAP2;MEF2C;CTNND2;ITSN1;DMD;NKX2-5;FGFR3;CIT
Autoimmune arthritis,3/56,0.12847714001658603,0.21331334297933047,0,0,2.4974814308887563,5.124842608321952,IL6;PECAM1;PLD1
Claw hand,3/56,0.12847714001658603,0.21331334297933047,0,0,2.4974814308887563,5.124842608321952,EGR2;BRCA2;FGFR3
Congenital hypoplasia of kidney,3/56,0.12847714001658603,0.21331334297933047,0,0,2.4974814308887563,5.124842608321952,MUC1;CEP55;PAX2
Gastrointestinal Diseases,3/56,0.12847714001658603,0.21331334297933047,0,0,2.4974814308887563,5.124842608321952,RET;MYLK;TGFBR2
Glucocorticoid Receptor Deficiency,3/56,0.12847714001658603,0.21331334297933047,0,0,2.4974814308887563,5.124842608321952,JUN;FOS;ENO2
Respiratory insufficiency due to muscle weakness,3/56,0.12847714001658603,0.21331334297933047,0,0,2.4974814308887563,5.124842608321952,TPM3;CNTN1;CRYAB
Contact Dermatitis,4/87,0.12895190717874438,0.21399580148565536,0,0,2.127913012594596,4.358637752584945,DUSP1;IL18;SAA1;CCL2
Generalized muscle weakness,4/87,0.12895190717874438,0.21399580148565536,0,0,2.127913012594596,4.358637752584945,CCND1;TPM3;NEFH;PPARGC1A
Neurologic Symptoms,5/120,0.12985323280361744,0.2154383180605471,0,0,1.9209486166007905,3.9213293128139646,IL6;ANXA1;CCL2;SOX10;SYN1
Hypodontia,5/121,0.13314485277597776,0.2208448582967317,0,0,1.9042907523510972,3.8396550067156645,COL17A1;RPS6KA3;COL1A2;TERT;FGFR3
Geographic Atrophy,3/57,0.13350934698141187,0.22134010721480182,0,0,2.451106083459025,4.935507474161364,C3;IL6;COL8A1
Hyperaldosteronism,3/57,0.13350934698141187,0.22134010721480182,0,0,2.451106083459025,4.935507474161364,GRK5;ADRB2;AGT
Elevated creatine kinase,6/156,0.1355247543747872,0.22343924455745187,0,0,1.768109339407745,3.5337450341497734,CAPN3;SCN4A;DMD;FLNC;CRYAB;SYNE1
"alpha-1-Antitrypsin Deficiency, Autosomal Recessive",2/29,0.13554072101355852,0.22343924455745187,0,0,3.2652788228408998,6.525604739255504,PRTN3;A2M
Acquired CJD,2/29,0.13554072101355852,0.22343924455745187,0,0,3.2652788228408998,6.525604739255504,ENO2;AQP1
Aspartate aminotransferase measurement,2/29,0.13554072101355852,0.22343924455745187,0,0,3.2652788228408998,6.525604739255504,APOB;NECTIN2
Central Core Myopathy (disorder),2/29,0.13554072101355852,0.22343924455745187,0,0,3.2652788228408998,6.525604739255504,IL6;RUNX2
Congenital Fiber Type Disproportion,2/29,0.13554072101355852,0.22343924455745187,0,0,3.2652788228408998,6.525604739255504,TPM3;BIN1
Congenital sensorineural hearing loss,2/29,0.13554072101355852,0.22343924455745187,0,0,3.2652788228408998,6.525604739255504,PAX3;MITF
Costello syndrome (disorder),2/29,0.13554072101355852,0.22343924455745187,0,0,3.2652788228408998,6.525604739255504,PLK4;VCAN
Deep philtrum,2/29,0.13554072101355852,0.22343924455745187,0,0,3.2652788228408998,6.525604739255504,RPS6KA3;EZH2
Erythema Nodosum,2/29,0.13554072101355852,0.22343924455745187,0,0,3.2652788228408998,6.525604739255504,LTA;SELE
Head Neoplasms,2/29,0.13554072101355852,0.22343924455745187,0,0,3.2652788228408998,6.525604739255504,RAD51;RARB
Hereditary hemorrhagic telangiectasia,2/29,0.13554072101355852,0.22343924455745187,0,0,3.2652788228408998,6.525604739255504,IL6;TEK
High Grade Cervical Intraepithelial Neoplasia,2/29,0.13554072101355852,0.22343924455745187,0,0,3.2652788228408998,6.525604739255504,MMP14;CDKN2A
Hypoplastic labia minora,2/29,0.13554072101355852,0.22343924455745187,0,0,3.2652788228408998,6.525604739255504,CDT1;NDN
Keratoconjunctivitis Sicca,2/29,0.13554072101355852,0.22343924455745187,0,0,3.2652788228408998,6.525604739255504,IL18;KLF4
Macrothrombocytopenia,2/29,0.13554072101355852,0.22343924455745187,0,0,3.2652788228408998,6.525604739255504,VWF;FLI1
Muckle-Wells Syndrome,2/29,0.13554072101355852,0.22343924455745187,0,0,3.2652788228408998,6.525604739255504,RET;IL18
Open Bite,2/29,0.13554072101355852,0.22343924455745187,0,0,3.2652788228408998,6.525604739255504,FGFR3;RUNX2
Phenylketonurias,2/29,0.13554072101355852,0.22343924455745187,0,0,3.2652788228408998,6.525604739255504,NEFH;GFAP
Pierre Robin Syndrome,2/29,0.13554072101355852,0.22343924455745187,0,0,3.2652788228408998,6.525604739255504,COL2A1;BMPR1B
Trachoma,2/29,0.13554072101355852,0.22343924455745187,0,0,3.2652788228408998,6.525604739255504,IL6;CCL2
Upper Aerodigestive Tract Neoplasms,2/29,0.13554072101355852,0.22343924455745187,0,0,3.2652788228408998,6.525604739255504,RAD51;RARB
Upper Respiratory Infections,2/29,0.13554072101355852,0.22343924455745187,0,0,3.2652788228408998,6.525604739255504,IL6;LEPR
Creutzfeldt-Jakob disease,4/89,0.13684581824444797,0.22553534118520552,0,0,2.0776310524209682,4.132201233668855,PRKN;ENO2;AQP1;GFAP
Anxiety disease,6/157,0.13845202569195428,0.22606521806838653,0,0,1.7563094932794279,3.472630275166267,PAK3;PPARGC1A;NEFH;SOX5;TGFBR2;ADCY5
Ambiguous Genitalia,3/58,0.13860895824657857,0.22606521806838653,0,0,2.406417112299465,4.755317391580695,WT1;GATA4;ZFPM2
Inadequate arch length for tooth size,3/58,0.13860895824657857,0.22606521806838653,0,0,2.406417112299465,4.755317391580695,RPS6KA3;FGFR3;SOX5
Increased susceptibility to bacterial infections,3/58,0.13860895824657857,0.22606521806838653,0,0,2.406417112299465,4.755317391580695,C3;CXCR4;ANTXR2
Prone to bacterial infection,3/58,0.13860895824657857,0.22606521806838653,0,0,2.406417112299465,4.755317391580695,C3;CXCR4;ANTXR2
Recurrent bacterial infection,3/58,0.13860895824657857,0.22606521806838653,0,0,2.406417112299465,4.755317391580695,C3;CXCR4;ANTXR2
Severe global developmental delay,3/58,0.13860895824657857,0.22606521806838653,0,0,2.406417112299465,4.755317391580695,RPS6KA3;CTNND2;FGFR3
Tooth Crowding,3/58,0.13860895824657857,0.22606521806838653,0,0,2.406417112299465,4.755317391580695,RPS6KA3;FGFR3;SOX5
Tooth mass arch size discrepancy,3/58,0.13860895824657857,0.22606521806838653,0,0,2.406417112299465,4.755317391580695,RPS6KA3;FGFR3;SOX5
Tooth size discrepancy,3/58,0.13860895824657857,0.22606521806838653,0,0,2.406417112299465,4.755317391580695,RPS6KA3;FGFR3;SOX5
Wide anterior fontanel,3/58,0.13860895824657857,0.22606521806838653,0,0,2.406417112299465,4.755317391580695,COL1A1;COL1A2;FGFR3
Substance-Related Disorders,5/123,0.13983912656698794,0.22606521806838653,0,0,1.8718220338983051,3.682365505552384,OPRD1;PMAIP1;PARVA;GRIA4;SYNE1
Dehydration,4/90,0.14086453179467381,0.22606521806838653,0,0,2.0533670832674153,4.024510403726296,CA12;PLA2G4A;PPARG;SGK1
Gaucher Disease,4/90,0.14086453179467381,0.22606521806838653,0,0,2.0533670832674153,4.024510403726296,PRKN;IL6;SH2D1A;CXCR4
Hip circumference,4/90,0.14086453179467381,0.22606521806838653,0,0,2.0533670832674153,4.024510403726296,ACAN;TCF7L2;HMGA2;SCAND1
"ALBINOIDISM, OCULOCUTANEOUS, AUTOSOMAL DOMINANT",2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,MITF;SOX10
"Pheochromocytoma, Extra-Adrenal",2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,RET;ERBB2
Abnormality of the sternum,2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,COL2A1;TGFBR2
Acute Chest Syndrome,2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,IL6;IL18
Adult Learning Disorders,2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,PRKN;SYP
Bone necrosis,2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,COL2A1;PPARG
Brain hemorrhage,2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,RET;PROS1
Cancer of Head,2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,RAD51;RARB
Cancer of Neck,2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,RAD51;RARB
Christ-Siemens-Touraine syndrome,2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,KRT19;PTGS2
Congenital Nonbullous Ichthyosiform Erythroderma,2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,COL17A1;GATA3
Developmental Academic Disorder,2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,PRKN;SYP
Fasting Hypoglycemia,2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,PPARA;PPARGC1A
High pitched voice,2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,BLM;CTNND2
Horseshoe Kidney,2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,FANCD2;FANCA
Learning Disturbance,2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,PRKN;SYP
Malignant transformation,2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,PER2;TERT
Noncancerous mole,2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,COL3A1;FGFR3
Nuclear non-senile cataract,2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,BLM;CRYAB
Recurrent aphthous ulcer,2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,C4A;IL6
Recurrent bronchitis,2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,TAP1;IL2RG
Respiratory Depression,2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,NDN;DMD
Serum cholesterol raised,2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,CAV1;APOB
X-Linked Emery-Dreifuss Muscular Dystrophy,2/30,0.14318807157655317,0.22606521806838653,0,0,3.1485004837149306,6.11941397561654,CAPN3;SYNE1
AICARDI-GOUTIERES SYNDROME 1,3/59,0.1437736327560125,0.22606521806838653,0,0,2.3633241758241756,4.58370318762061,IL6;CCND1;PTGS2
Cytokine Measurement,3/59,0.1437736327560125,0.22606521806838653,0,0,2.3633241758241756,4.58370318762061,COL1A2;MECOM;SGK1
Well Differentiated Pancreatic Endocrine Tumor,3/59,0.1437736327560125,0.22606521806838653,0,0,2.3633241758241756,4.58370318762061,KIT;SSTR2;FGFR4
Creatine phosphokinase serum increased,6/159,0.14439443734137264,0.22606521806838653,0,0,1.7331725400866498,3.354046896627301,CAPN3;SCN4A;DMD;FLNC;CRYAB;SYNE1
Nonsyndromic Deafness,4/91,0.14492973922078287,0.22606521806838653,0,0,2.029660906508197,3.9203026473379814,GPSM2;CLIC5;SIX1;CIB1
Waist Circumference,4/91,0.14492973922078287,0.22606521806838653,0,0,2.029660906508197,3.9203026473379814,ACAN;TCF7L2;ZNF423;PCSK5
Gait abnormality,7/195,0.14558764856070566,0.22606521806838653,0,0,1.6463737491499078,3.1725243120123547,PRKN;C4A;RPS6KA3;COL2A1;SCN4A;ADCY5;LMNB1
Hypospadias,7/195,0.14558764856070566,0.22606521806838653,0,0,1.6463737491499078,3.1725243120123547,ARNT2;WT1;GATA4;ZFPM2;FKBP4;ESR1;ATF3
"ACTH Syndrome, Ectopic",1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,PAK3
"Chondrodysplasia punctata, X-linked dominant type",1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,FGFR3
"Congenital dyserythropoietic anemia, type III",1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,KLF1
"Cutis laxa, x-linked",1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,FBN2
"Empyema, Pleural",1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,NFKBIE
"Fibromatosis, Abdominal",1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,KIT
"Hypomagnesemia 1, Intestinal",1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,PKD2
"Infections, Parvovirus",1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,STMN1
"Lacrimal Puncta, Absence of",1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,FGFR3
"Mental Retardation, X-Linked 46",1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,ARHGEF6
"Myopathy, Centronuclear, Autosomal Recessive",1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,BIN1
"MYOPATHY, MYOSIN STORAGE (disorder)",1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,TRIM63
"Nemaline Myopathy, Autosomal Recessive",1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,TPM3
"Neoplasms, Bone Tissue",1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,BRCA2
"Pyloric Stenosis, Infantile Hypertrophic 1",1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,NKX2-5
"Spina Bifida, Folate-Sensitive",1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,PAX3
"Spinal Muscular Atrophy, Childhood, Proximal, Autosomal Dominant",1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,STMN1
"Squamous cell carcinoma, metastatic",1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,CDKN2A
Abnormal macular morphology,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,SOX10
Abnormality of hair consistency,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,TNFSF11
Abnormality of hair curl pattern,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,TNFSF11
Abnormality of hair texture,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,TNFSF11
Abnormality of hair volume,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,TNFSF11
Abnormality of internal carotid artery,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,APOB
Abnormality of oral mucosa,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,SAA1
Abnormality of the humerus,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,PITX1
Abnormality of the wrist,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,COL2A1
Absent axillary hair,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,SNRPE
Absent phalangeal crease,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,TNNI2
Acquired haemophilia,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,CTLA4
Acute glomerulonephritis,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,DCN
Adenoid cystic breast carcinoma,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,ESR1
Adnexal mass,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,ESR1
Adult-onset obesity,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,PROX1
Adult onset asthma,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,ADRB2
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,FLI1
Alcohol-Related Disorders,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,ALDH2
Angiosarcoma of Soft Tissue,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,KIT
Annular pancreas,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,MYCN
Anterior Horn Cell Disease,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,VIM
Anus Neoplasms,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,CCND1
Aplasia of muscle,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,DMD
Aplasia of the interphalangeal creases,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,TNNI2
Arcus Senilis,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,APOB
Arthritis by pattern of joint involvement,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,COL2A1
Ascending aorta dilatation,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,ACTA2
Bacterial keratitis,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,IL6
Basal Cell Cancer,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,CDKN2A
Benign neoplasm of esophagus,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,TGFBR2
Benign neoplasm of thyroid gland,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,ALK
Bladder Squamous Cell Carcinoma,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,CDKN2A
Bowel diverticula,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,COL1A1
Bowel diverticulosis,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,COL1A1
Broad distal phalanx of finger,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,KIF22
Broad metacarpals,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,BGN
Bronchial Diseases,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,IL18
Bulbar signs,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,GFAP
Calvarial hyperostosis,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,COL1A1
Carcinoma in situ of esophagus,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,TGFBR2
Carcinoma of Endocrine Gland,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,ESR1
Cellular Ependymoma,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,RAB3A
Cerebral artery atherosclerosis,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,APOB
Cervical myelopathy,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,COL2A1
Chemical Burns,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,IL6
Chiari malformation type II,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,SELE
Chromosome 17 trisomy,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,RET
Chronic neutropenia,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,CXCR4
Chylomicron retention disease,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,APOB
Cleft Soft Palate,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,TGFBR2
Clinodactyly of the 5th toe,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,TGFBR2
Cloverleaf cranium shape,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,FGFR3
Cold intolerance,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,PPARA
Complement C3 Measurement,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,C3
Congenital atresia of pulmonary valve,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,GATA4
Congenital Bleeding Disorder,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,VWF
Congenital kyphoscoliosis,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,FBN2
Congenital malformation of genital organs,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,WT1
Congenital melanocytic nevus,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,MET
Congenital Nephrogenic Diabetes Insipidus,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,PRKCA
Congo hemorrhagic fever,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,IL6
Conjunctivochalasis,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,TIMP1
Curvature of the little toe,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,TGFBR2
Cytokine release syndrome,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,IL6
Decreased T cell activation,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,LEPR
Deficiency of vitamin D3,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,CTLA4
Delayed Graft Function,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,IL18
Desquamative interstitial pneumonia,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,CXCR4
Dianzani autoimmune lymphoproliferative syndrome,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,TIMP1
Digitotalar Dysmorphism,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,TNNI2
Drinking behavior processes,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,ALDH2
Elephantiasis,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,HGF
Endotoxic shock,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,AQP1
Enlargement of calvarial bones,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,COL1A1
Entamoeba histolytica Infection,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,IL6
Entamoebiasis,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,IL6
Epstein-Barr virus associated gastric carcinoma,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,CDKN2A
Euthyroid Goiter,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,SIX1
Familial juvenile gout,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,MUC1
Familial Motor Neuron Disease,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,VIM
Familial restrictive cardiomyopathy (disorder),1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,FLNC
Fat redistribution,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,IL6
Finnish congenital nephrotic syndrome,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,NPHS1
Foot acroosteolysis,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,COL3A1
Generalized hypopigmentation of hair,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,TERT
GLOMUVENOUS MALFORMATIONS,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,PRKN
Hearing problem,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,COL2A1
Heart Neoplasm,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,CCND1
Hemangioma of retina,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,ELOB
Hemoglobin increased,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,EPAS1
Hemoglobin SC Disease,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,SPTA1
Hirschsprung disease 1,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,RET
HIV Wasting Syndrome,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,IL6
Hyperchloremia,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,KLHL3
Hyperkalemic periodic paralysis,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,SCN4A
Hypertrophic nerve changes,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,EGR2
Hypocalcemic seizures,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,GATA3
HYPOPLASTIC LEFT HEART SYNDROME 2,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,NKX2-5
impaired motor coordination,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,CCND1
Incontinence,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,IL6
Increased megakaryocyte count,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,CALR
Increased ossification of calvarial bones,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,COL1A1
Increased vertebral height,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,FGFR3
Ineffective erythropoiesis,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,KLF1
Infantile myofibromatosis,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,VIM
Infected ascites,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,CCL2
Infectious colitis,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,PPARG
Intraocular Lymphoma,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,CXCL12
Intraspinal Neoplasm,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,GFAP
Invasive Prostate Carcinoma,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,PTGS2
Keratosis pilaris,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,LRP1
Laryngismus,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,SCN4A
Left Atrial Isomerism,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,TDGF1
LEPTIN DEFICIENCY OR DYSFUNCTION,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,PPARG
Leukocyte-Adhesion Deficiency Syndrome,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,SELE
Limited pronation/supination of forearm,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,MECOM
Lymphoepithelioid lymphoma (clinical),1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,BCL3
Malignant Cystosarcoma Phyllodes,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,KIT
Malignant myoepithelioma,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,CENPF
Mature T ALL,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,CDKN2A
Megacystis,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,MYLK
Mild depression,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,TAL1
Moderate obesity,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,IL6
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,BUB1
Multiple fibrofolliculomas,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,MET
Myeloid hyperplasia,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,ZFP36
Myocardial rupture,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,AGT
Myocardial steatosis,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,APOB
Myotonia Congenita,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,SCN4A
Myxoid transformation of mitral valve,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,AGT
Myxoinflammatory fibroblastic sarcoma,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,VIM
NADH cytochrome B5 reductase deficiency,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,PPARG
Narrow foramen obturatorium,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,CAV1
Neoplasm of skeletal system,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,TNFSF11
Neural tube defects X-linked,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,PAX3
Neuronal heterotopia,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,GPSM2
Normochromic anemia,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,ALDOA
Normocytic anemia,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,ALDOA
Nose symptoms,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,IL6
Null Cell Pituitary Gland Adenoma,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,ESR1
Oedema auricular,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,PPARA
Olfactory lobe agenesis,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,SOX10
OTOFACIOCERVICAL SYNDROME 1,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,NECTIN2
Overriding aorta,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,MEF2C
Pain in lower limb,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,IL6
Pancreatic Intraepithelial Neoplasia-3,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,CDKN2A
Pancreatic Pseudocyst,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,ALDH2
Papillary adenocarcinoma,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,ERBB2
Papillary ependymoma,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,RAB3A
Paraneoplastic Encephalomyelitis,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,MUC1
Partial duplication of thumb phalanx,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,FGFR3
Pelvic pain female,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,IL6
polyp benign,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,PTGS2
Postpartum Thyroiditis,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,CTLA4
Primary cutaneous marginal zone B-cell lymphoma,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,RHOH
Primary Hyperoxaluria,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,AGT
Primary ulcer of intestine,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,FGF7
Rheumatic mitral stenosis,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,ADRB2
Rippling muscle disease,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,NGFR
Scarlet Fever,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,CALR
Schamberg Disease,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,MITF
Schizencephaly,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,SIX3
Sclerosteosis,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,COL1A1
Sepsis of the newborn,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,IL6
Sertoli-Leydig Cell Tumor,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,VIM
Short stepped shuffling gait,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,SNCAIP
Skin Vesicle,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,KRT5
Small anterior fontanelle,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,MYCN
Social Communication Disorder,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,CNTNAP2
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,SIX3
Southeast Asian ovalocytosis,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,PARP1
Spinal Neoplasms,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,GFAP
Subcutaneous panniculitis-like T-cell lymphoma,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,RHOJ
Synovial sarcoma non-metastatic,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,CIB1
Thickened cortex of long bones,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,LIFR
Thrombotic stroke,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,AGT
Thymic Carcinoid Tumor,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,PAK3
Thyroid Hypoplasia,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,NKX2-5
Transitional cell carcinoma in situ,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,CDKN2A
Tularemia,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,IL18
Type 1 fibers relatively smaller than type 2 fibers,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,TPM3
Ulcerative colitis in remission,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,SOCS3
Vaginal intraepithelial neoplasia,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,MKI67
Vegetative State,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,RUNX1T1
Venous Insufficiency,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,F13A1
Vitreous Hemorrhage,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,PROC
Vulvar Neoplasms,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,PTGS2
Waardenburg Anophthalmia Syndrome,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,PAX3
Weaver syndrome,1/7,0.14575080319179776,0.22606521806838653,0,0,7.338213213213213,14.132348866004438,EZH2
"Subfertility, Male",3/60,0.14900103034940734,0.23105308700683902,0,0,2.3217432722076685,4.420139619692783,IL6;ALDH2;ESR1
Adrenal Cortical Adenoma,4/92,0.1490404160518372,0.23106081121979197,0,0,2.0064935064935066,3.8194361571084467,CDKN2C;SYP;ESR1;AGT
Congenital anomaly of face,5/126,0.15015006045378815,0.2327273958014404,0,0,1.8251314800901577,3.460668451562023,VWF;CAV1;PAX3;PPARG;FGFR3
"Aggressive periodontitis, generalized",2/31,0.150923631180985,0.23290512569197963,0,0,3.0397758231493732,5.748159310333402,IL18;TIMP1
"HETEROTAXY, VISCERAL, 2, AUTOSOMAL",2/31,0.150923631180985,0.23290512569197963,0,0,3.0397758231493732,5.748159310333402,ADRB2;PCSK5
21-hydroxylase deficiency,2/31,0.150923631180985,0.23290512569197963,0,0,3.0397758231493732,5.748159310333402,C4B;C4A
Acute interstitial pneumonia,2/31,0.150923631180985,0.23290512569197963,0,0,3.0397758231493732,5.748159310333402,LTA;CTLA4
Adenocarcinoma in Situ,2/31,0.150923631180985,0.23290512569197963,0,0,3.0397758231493732,5.748159310333402,CDKN2A;CAV1
AIDS-Associated Nephropathy,2/31,0.150923631180985,0.23290512569197963,0,0,3.0397758231493732,5.748159310333402,TERT;KDR
Antisocial Personality Disorder,2/31,0.150923631180985,0.23290512569197963,0,0,3.0397758231493732,5.748159310333402,ALDH2;FLT4
Clitoral hypoplasia,2/31,0.150923631180985,0.23290512569197963,0,0,3.0397758231493732,5.748159310333402,CDT1;NDN
Deformity of limb,2/31,0.150923631180985,0.23290512569197963,0,0,3.0397758231493732,5.748159310333402,PAX3;DMD
Drug-Induced Stevens Johnson Syndrome,2/31,0.150923631180985,0.23290512569197963,0,0,3.0397758231493732,5.748159310333402,PARP1;CAV1
Exotropia,2/31,0.150923631180985,0.23290512569197963,0,0,3.0397758231493732,5.748159310333402,SOX5;TGFBR2
Generalized elastolysis,2/31,0.150923631180985,0.23290512569197963,0,0,3.0397758231493732,5.748159310333402,RPS6KA3;EZH2
Hanging skin,2/31,0.150923631180985,0.23290512569197963,0,0,3.0397758231493732,5.748159310333402,RPS6KA3;EZH2
Hyperdiploid B Acute Lymphoblastic Leukemia,2/31,0.150923631180985,0.23290512569197963,0,0,3.0397758231493732,5.748159310333402,CDKN2A;GATA3
Impaired pain sensation,2/31,0.150923631180985,0.23290512569197963,0,0,3.0397758231493732,5.748159310333402,NDN;LIFR
Male Pseudohermaphroditism,2/31,0.150923631180985,0.23290512569197963,0,0,3.0397758231493732,5.748159310333402,WT1;CBX2
Mycoplasma-Induced Stevens-Johnson Syndrome,2/31,0.150923631180985,0.23290512569197963,0,0,3.0397758231493732,5.748159310333402,PARP1;CAV1
Neoplastic disease,2/31,0.150923631180985,0.23290512569197963,0,0,3.0397758231493732,5.748159310333402,IL6;KIT
Protein C Deficiency,2/31,0.150923631180985,0.23290512569197963,0,0,3.0397758231493732,5.748159310333402,PROC;SERPINC1
Manic,4/93,0.15319552642948006,0.2363025161920965,0,0,1.983846722209483,3.721776247040356,PER2;GRK3;GAD1;CCL2
Panic Disorder,4/93,0.15319552642948006,0.2363025161920965,0,0,1.983846722209483,3.721776247040356,CALCOCO1;GAD1;SOSTDC1;IKBKE
"Depression, Bipolar",3/61,0.15428881449989185,0.23793425446183092,0,0,2.2815961928537996,4.2641413233764816,GRK3;GAD1;GFAP
Microcephaly,8/235,0.154842783926514,0.23873373205933607,0,0,1.5587253903769192,2.907560572877337,PLK4;CDT1;CENPF;MYCN;CHEK1;KCTD13;BRCA1;TUBG1
African Trypanosomiasis,2/32,0.1587397142035675,0.24218827229403977,0,0,2.9382994732881866,5.407909139588904,CXCL10;IL6
Amblyopia,2/32,0.1587397142035675,0.24218827229403977,0,0,2.9382994732881866,5.407909139588904,LAMA1;PPARGC1A
Aortic valve calcification,2/32,0.1587397142035675,0.24218827229403977,0,0,2.9382994732881866,5.407909139588904,MMP14;NKX2-5
Cervical high grade squamous intraepithelial lesion,2/32,0.1587397142035675,0.24218827229403977,0,0,2.9382994732881866,5.407909139588904,CDKN2A;PTGS2
Complete hydatidiform mole,2/32,0.1587397142035675,0.24218827229403977,0,0,2.9382994732881866,5.407909139588904,ERBB2;APOB
HIV encephalitis,2/32,0.1587397142035675,0.24218827229403977,0,0,2.9382994732881866,5.407909139588904,E2F1;CCL2
Idiopathic Hypereosinophilic Syndrome,2/32,0.1587397142035675,0.24218827229403977,0,0,2.9382994732881866,5.407909139588904,WT1;KIT
Juvenile polyposis syndrome,2/32,0.1587397142035675,0.24218827229403977,0,0,2.9382994732881866,5.407909139588904,BMP2;PTGS2
Lobar Holoprosencephaly,2/32,0.1587397142035675,0.24218827229403977,0,0,2.9382994732881866,5.407909139588904,SIX3;TDGF1
Nodular Lymphocyte Predominant Hodgkin Lymphoma,2/32,0.1587397142035675,0.24218827229403977,0,0,2.9382994732881866,5.407909139588904,GATA3;SGK1
Pulmonary Alveolar Proteinosis,2/32,0.1587397142035675,0.24218827229403977,0,0,2.9382994732881866,5.407909139588904,MUC1;PPARG
Macular degeneration,3/62,0.15963465473135055,0.24218827229403977,0,0,2.242810031444129,4.115259196410037,FBN2;COL8A1;CD36
Marijuana Abuse,3/62,0.15963465473135055,0.24218827229403977,0,0,2.242810031444129,4.115259196410037,PTGS2;ADRA1A;ESR1
Sparse scalp hair,3/62,0.15963465473135055,0.24218827229403977,0,0,2.242810031444129,4.115259196410037,PLK4;TERT;PRKD1
Fragile X Syndrome,4/95,0.16163485357103513,0.24218827229403977,0,0,1.9400463482096135,3.5355704932313246,CYFIP2;RCAN1;IL6;DMD
Primary sclerosing cholangitis,5/130,0.16437747180745346,0.24218827229403977,0,0,1.7663636363636364,3.1893282330046837,IL6;CDKN2A;BCL3;PTGS2;FOXO1
"Amyloidosis, Primary Cutaneous",1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,RET
"Aplastic anemia, idiopathic",1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,TERT
"BRACHYDACTYLY, TYPE A1 (disorder)",1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,BMPR1B
"Bronchiolitis, Viral",1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,STAT5A
"Charcot-Marie-Tooth disease, X-linked, 1",1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,SOX10
"Collagenopathy, type 2 alpha 1",1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,ACAN
"Endometrial stromal sarcoma, high grade",1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CCND1
"Hypergonadotropic Ovarian Failure, X-Linked",1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,WT1
"Motor Neuron Disease, Upper",1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,VIM
"Nemaline Myopathy, Childhood Onset",1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,TPM3
"Nephrogenic rest, intralobar",1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,WT1
"Neuroepithelioma, Peripheral",1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,ERBB2
"PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS",1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CCL2
"Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia",1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CAV1
"PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED",1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CAV1
"Pulmonary Hypertension, Primary, Fenfluramine-Associated",1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CAV1
"Rett Syndrome, Atypical",1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,MEF2C
"Rhinitis, Allergic, Perennial",1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,PTGS2
"Shock, Hemorrhagic",1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,IL6
"Skin Diseases, Bullous",1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,DST
"SPHEROCYTOSIS, HEREDITARY, 2",1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,SPTB
"stage, bladder cancer",1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,EGR1
"Thrombotic thrombocytopenic purpura, acquired",1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,VWF
Abnormality of femur morphology,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,FGFR3
Abnormality of the cervical spine,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,FGFR3
Abnormality of the elbow,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,FGFR3
Abnormality of the larynx,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,SERPING1
Abnormality of the thymus,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,ADRB2
Absence of scalp hair,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,COL3A1
Acquired long QT syndrome,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,AGT
Acute Q fever,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,PER2
Acute respiratory infections,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,IL6
Adenofibroma,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,ESR1
Adenomyoma,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CCND1
Adult Fibrosarcoma,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,COL1A1
Alcohol Withdrawal Seizures,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,MPDZ
Alkaptonuria,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,SH2D1A
Alpha-Sarcoglycanopathies,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CAPN3
Altitude Sickness,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,EPAS1
anaphylaxis,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,PECAM1
Angiosarcoma of liver,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CDKN2A
Anterior pituitary agenesis,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,SIX3
Anterior rib cupping,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,COL2A1
Aplasia/Hypoplasia involving the nose,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,PAX3
Arima syndrome,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,ZNF423
Arterial tortuosity,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,TGFBR2
Aseptic Meningitis,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,IL6
Athyroidal hypothyroidism,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,NKX2-5
Avitaminosis,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,APOB
Axial muscle weakness,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,BIN1
Branchio-Oculo-Facial Syndrome,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,SIX1
Cap Myopathy,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,TPM3
Cardiac Carcinoma,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CCND1
Caudal Regression Syndrome,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,PCSK5
Cerebral dysmyelination,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,SOX10
Chronic cholecystitis,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CDKN2A
Chronic iridocyclitis,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,IL6
Chronic mountain sickness,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,EPAS1
Chronic pelvic pain of female,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,IL6
Claudication (finding),1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,COL2A1
Cleft palate and bilateral cleft lip,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,YAP1
Cloverleaf skull,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,FGFR3
Collapsing glomerulopathy,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,TERT
Compensated liver disease,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,PAEP
Compression of optic nerve,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,TNFSF11
Congenital hypoplasia of nose,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,PAX3
Cranial asymmetry,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,COL1A1
Craniofacial asymmetry,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,ESR1
Cystadenocarcinoma,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,ERBB2
Cytotoxic Brain Edema,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,MYLK
Cytotoxic Cerebral Edema,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,MYLK
Decreased pneumatization of frontal sinus,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,RUNX2
Deficiency of testosterone biosynthesis,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,IL6
Delayed maturation of wrist bone,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,BGN
Delayed ossification of carpal bones,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,BGN
Developmental Psychomotor Disorders,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,RPS6KA3
Diabetic cataract,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CAPN3
Diaphragmatic Eventration,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,ZFPM2
Dilatation of the aortic arch,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,NKX2-5
Disorder of lymph node,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,MKI67
Distichiasis,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,FLT4
Ectopic Pregnancy,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,MUC1
Emotional problems,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,BRCA1
Epidermolysis Bullosa Dystrophica,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,COL1A1
Familial hypercholesterolemia - homozygous,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,APOB
Familial Nonmedullary Thyroid Gland Carcinoma,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,TERT
Feeling despair,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,PER2
fertility disorders,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,IL6
Fibular bowing,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,FGFR3
Gastric erosions,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,PTGS2
Giant platelet (morphologic abnormality),1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CD36
Glucocorticoid-remediable aldosteronism,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,AGT
Gonadotropin-Resistant Ovary Syndrome,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,WT1
High-functioning autism,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CNTNAP2
Histoplasmosis,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,STAT1
Hodgkin's-like,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,ALK
Hooked clavicle,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CDT1
Hot flushes,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,ESR1
HYPERALPHALIPOPROTEINEMIA 1,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,APOB
Hyperhidrosis Palmaris Et Plantaris,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,COL17A1
Hypoplasia of the cochlea,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,SIX1
Hypoplastic frontal sinuses,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,RUNX2
Hypotrophic frontal sinus,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,RUNX2
Hypotrophic nose,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,PAX3
Increased circulating cortisol level,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,RET
Infant length,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,ACAN
Intestinal Graft Versus Host Disease,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CXCL10
Invasive Candidiasis,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CXCR4
Leg Length Inequality,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,COL2A1
Leukocytoclastic vasculitis,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,VWF
Lichen planus follicularis,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,PPARG
Lobulated tongue,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,RET
Long hallux,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,FLI1
Loss of scalp hair,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,COL3A1
Lubs X-linked mental retardation syndrome,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CDT1
Lymphedema praecox,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,FLT4
Lymphomatoid Granulomatosis,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,PECAM1
Malignant tumor of extrahepatic bile duct,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,PTGS2
Malrotation of kidney,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,SIX1
mass lesion,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,GRIA2
Medullary cystic disease,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,MUC1
metabolic disturbance,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,PPARG
Methylmalonic acidemia with homocystinuria,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CBLC
Mixed Oligodendroglioma-Ependymoma,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,DTX1
Morphological abnormality of the middle ear,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,SIX1
MYD88 Deficiency,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,IL6
Myofibromatosis,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,VIM
Myotonia Fluctuans (disorder),1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,SCN4A
Myotonic Disorders,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,SCN4A
Myxoid chondrosarcoma,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CDKN2A
Neonatal disorder,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,PKD2
Neonatal infection,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,IL6
Non-small cell lung cancer stage II,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CDKN2A
North Carolina macular dystrophy,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,ERG
Oligodendroblastoma,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,DTX1
Opsoclonus-Myoclonus Syndrome,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,MYCN
OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,BMP2
Osteoporosis of vertebrae,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,RUNX2
Oval face,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CNTN1
Ovarian Small Cell Carcinoma,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,KIT
Pancreatic adenocarcinoma metastatic,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,BRCA2
Panniculitis,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,RHOJ
Penile Neoplasms,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CDKN2A
Periosteal Disorder,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,FGFR3
Peritoneal Mesothelioma,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,E2F1
Persistence of hemoglobin F,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,KLF1
Pitting of nails,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,TERT
Plantar hyperkeratosis,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,COL17A1
Pleural Mesothelioma,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CDKN2A
Polymorphous low grade adenocarcinoma,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,PRKD1
Polyostotic fibrous dysplasia,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,BGN
Polysplenia Syndrome,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,TDGF1
Postural Orthostatic Tachycardia Syndrome,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,ADRB2
Precocious atherosclerosis,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,APOB
Premature plaque build-up in arteries,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,APOB
Premenstrual Dysphoric Disorder,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,ESR1
Prieto X-linked mental retardation syndrome,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,PAX2
Progressive spasticity,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,RPS6KA3
Pseudoepiphyses of the metacarpals,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,RPS6KA3
Psychomotor Disorders,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,RPS6KA3
Recurrent mycobacterial infections,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,STAT1
Renal corticomedullary cysts,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,MUC1
Renal Osteodystrophy,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,IL6
Reticular hyperpigmentation,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,TERT
Reticular pigmentation pattern,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,KRT5
Reticulated skin pigmentation,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,KRT5
Retinal Neovascularization,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,HGF
Rheumatic disease of heart valve,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CALR
Romberg's sign positive,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CAPN3
Segmental vitiligo,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,ENO2
Sensory denervation disorder,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,STAT1
Separation Anxiety Disorder,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,GAD1
Short distal phalanx of the thumb,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,BMPR1B
Shortening of all middle phalanges of the fingers,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,COL2A1
Shprintzen-Goldberg syndrome,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,TGFBR2
Skin appendage adenoma,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,MAML2
Skin nodule,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,RET
Small penis,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,GATA4
Spondylolysis,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,RUNX2
Squamous cell carcinoma of lip,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,CCL2
T-cell/histiocyte rich large B-cell lymphoma,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,MUC1
Thickening of glomerular basement membrane,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,GATA3
Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,ESR1
trisomy 2,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,ALK
Upper airway obstruction,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,FGFR3
Uterine Anomalies,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,HOXA10
Uterine Diseases,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,ESR1
Vasogenic Brain Edema,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,MYLK
Vasogenic Cerebral Edema,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,MYLK
Very Low Birth Weight,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,IL6
Vitamin Deficiency,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,APOB
Weakness,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,DMD
Wernicke-Korsakoff Syndrome,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,ALDH2
White hair,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,PAX3
White matter dysmyelination/demyelination,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,SOX10
Xanthelasma of periocular region,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,APOB
Xanthoma of periocular region,1/8,0.16476447529950383,0.24218827229403977,0,0,6.289575289575289,11.341602721099976,APOB
Chronic ear infection,3/63,0.16503622903493514,0.2424285464126475,0,0,2.205316742081448,3.97307716114958,TAP1;FGFR3;RUNX2
Idiopathic hypogonadotropic hypogonadism,3/63,0.16503622903493514,0.2424285464126475,0,0,2.205316742081448,3.97307716114958,NDN;SOX10;FGFR3
Neuro-degenerative disease,3/63,0.16503622903493514,0.2424285464126475,0,0,2.205316742081448,3.97307716114958,SPTA1;NEFH;PPARGC1A
MAJOR AFFECTIVE DISORDER 2,4/96,0.1659169506313965,0.24359597446343537,0,0,1.9188602977422853,3.4467871827811027,GAD1;ADAM12;DMD;TNS1
Acute biphenotypic leukemia,2/33,0.16662893190664416,0.24359597446343537,0,0,2.843369984708367,5.095278930811979,WT1;ERG
Angiomyolipoma,2/33,0.16662893190664416,0.24359597446343537,0,0,2.843369984708367,5.095278930811979,KIT;VIM
Autosomal Dominant Parkinsonism,2/33,0.16662893190664416,0.24359597446343537,0,0,2.843369984708367,5.095278930811979,PRKN;PARP1
Chronic Airflow Obstruction,2/33,0.16662893190664416,0.24359597446343537,0,0,2.843369984708367,5.095278930811979,IL6;MMP14
Congenital adrenal hyperplasia due to 21 hydroxylase deficiency,2/33,0.16662893190664416,0.24359597446343537,0,0,2.843369984708367,5.095278930811979,C4B;C4A
Corneal Ulcer,2/33,0.16662893190664416,0.24359597446343537,0,0,2.843369984708367,5.095278930811979,IL6;FGFR3
Ectopic Tissue,2/33,0.16662893190664416,0.24359597446343537,0,0,2.843369984708367,5.095278930811979,FGFR3;CIT
Gastric Mucosa-Associated Lymphoid Tissue Lymphoma,2/33,0.16662893190664416,0.24359597446343537,0,0,2.843369984708367,5.095278930811979,CXCR4;CTLA4
High altitude pulmonary edema,2/33,0.16662893190664416,0.24359597446343537,0,0,2.843369984708367,5.095278930811979,VWF;ADRB2
Microlissencephaly,2/33,0.16662893190664416,0.24359597446343537,0,0,2.843369984708367,5.095278930811979,PLK4;TUBG1
Nuclear cataract,2/33,0.16662893190664416,0.24359597446343537,0,0,2.843369984708367,5.095278930811979,BLM;CRYAB
Oral cleft,2/33,0.16662893190664416,0.24359597446343537,0,0,2.843369984708367,5.095278930811979,PAX3;TGFBR2
Pemphigus,2/33,0.16662893190664416,0.24359597446343537,0,0,2.843369984708367,5.095278930811979,C3;IL6
Scapular weakness,2/33,0.16662893190664416,0.24359597446343537,0,0,2.843369984708367,5.095278930811979,CAPN3;PAX3
Severe Congenital Microcephaly,2/33,0.16662893190664416,0.24359597446343537,0,0,2.843369984708367,5.095278930811979,PLK4;TUBG1
Short metatarsal,2/33,0.16662893190664416,0.24359597446343537,0,0,2.843369984708367,5.095278930811979,COL2A1;BMPR1B
Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum,2/33,0.16662893190664416,0.24359597446343537,0,0,2.843369984708367,5.095278930811979,PARP1;CAV1
Superinfection,2/33,0.16662893190664416,0.24359597446343537,0,0,2.843369984708367,5.095278930811979,CXCR4;CCL2
Taste bitter,2/33,0.16662893190664416,0.24359597446343537,0,0,2.843369984708367,5.095278930811979,RET;ADRA1A
Thrombotic Microangiopathies,2/33,0.16662893190664416,0.24359597446343537,0,0,2.843369984708367,5.095278930811979,VWF;KLF4
X-Linked Combined Immunodeficiency Diseases,2/33,0.16662893190664416,0.24359597446343537,0,0,2.843369984708367,5.095278930811979,LMO2;IL2RG
Sensorineural Hearing Loss (disorder),14/471,0.16807272639117538,0.24565319487336973,0,0,1.3574456634867769,2.420812259641167,YAP1;CLIC5;GPSM2;PAX3;SIX1;MITF;GATA3;SOX10;PAX2;RPS6KA3;COL2A1;NEK2;FADD;FGFR3
Autosomal dominant retinitis pigmentosa,3/64,0.17049122598031557,0.24880901209991294,0,0,2.1690527408945925,3.8372092646823575,TPM3;ERG;ADRA1A
Chronic Fatigue Syndrome,3/64,0.17049122598031557,0.24880901209991294,0,0,2.1690527408945925,3.8372092646823575,IL6;LTA;PTGS2
Cortical Dysplasia,3/64,0.17049122598031557,0.24880901209991294,0,0,2.1690527408945925,3.8372092646823575,CNTNAP2;IL6;TUBG1
Esophagitis,3/64,0.17049122598031557,0.24880901209991294,0,0,2.1690527408945925,3.8372092646823575,IL6;CDKN2C;PTGS2
Nephronophthisis,3/64,0.17049122598031557,0.24880901209991294,0,0,2.1690527408945925,3.8372092646823575,MUC1;RCC1;ZNF423
Short metacarpal,3/64,0.17049122598031557,0.24880901209991294,0,0,2.1690527408945925,3.8372092646823575,RPS6KA3;COL2A1;BGN
Synophrys,3/64,0.17049122598031557,0.24880901209991294,0,0,2.1690527408945925,3.8372092646823575,PAX3;MITF;SOX10
Growth retardation,6/168,0.17251632146836396,0.2516549989099766,0,0,1.6361258753058296,2.8751041671896673,RAD51;DST;NPHS1;TNFSF11;KRT5;NKX2-5
Poor growth,6/168,0.17251632146836396,0.2516549989099766,0,0,1.6361258753058296,2.8751041671896673,RAD51;DST;NPHS1;TNFSF11;KRT5;NKX2-5
"Biliary Cirrhosis, Secondary",2/34,0.17458418312748852,0.2539233433834982,0,0,2.7543735891647856,4.807341065494308,CDH5;CXCL10
"Carcinoma, Ehrlich Tumor",2/34,0.17458418312748852,0.2539233433834982,0,0,2.7543735891647856,4.807341065494308,ERBB2;VIM
Angle Closure Glaucoma,2/34,0.17458418312748852,0.2539233433834982,0,0,2.7543735891647856,4.807341065494308,VAV3;PTGS2
Autosomal Recessive Parkinsonism,2/34,0.17458418312748852,0.2539233433834982,0,0,2.7543735891647856,4.807341065494308,PRKN;PARP1
Generalized Anxiety Disorder,2/34,0.17458418312748852,0.2539233433834982,0,0,2.7543735891647856,4.807341065494308,PDE1A;GAD1
Ichthyosis linearis circumflexa,2/34,0.17458418312748852,0.2539233433834982,0,0,2.7543735891647856,4.807341065494308,NPHS1;PTGS2
Increased appetite (finding),2/34,0.17458418312748852,0.2539233433834982,0,0,2.7543735891647856,4.807341065494308,LEPR;NDN
Infective endocarditis,2/34,0.17458418312748852,0.2539233433834982,0,0,2.7543735891647856,4.807341065494308,IL6;SELE
Left ventricular noncompaction cardiomyopathy,2/34,0.17458418312748852,0.2539233433834982,0,0,2.7543735891647856,4.807341065494308,PRKN;ACTC1
Monocytosis,2/34,0.17458418312748852,0.2539233433834982,0,0,2.7543735891647856,4.807341065494308,EGR1;AGT
Poor suck,2/34,0.17458418312748852,0.2539233433834982,0,0,2.7543735891647856,4.807341065494308,CNTN1;NDN
Trigonocephaly,2/34,0.17458418312748852,0.2539233433834982,0,0,2.7543735891647856,4.807341065494308,BMP2;EZH2
Winged scapula,2/34,0.17458418312748852,0.2539233433834982,0,0,2.7543735891647856,4.807341065494308,CAPN3;PAX3
Central Serous Chorioretinopathy,4/98,0.1746006551139063,0.2539233433834982,0,0,1.8778404979012882,3.277308421554756,CDH5;BMP2;VIM;KLF4
Growth delay,6/169,0.1757730924114584,0.2555730869528804,0,0,1.6260044440096706,2.826908503073414,RAD51;DST;NPHS1;TNFSF11;KRT5;NKX2-5
"HEMOCHROMATOSIS, TYPE 1",3/65,0.17599734693029842,0.25567773782909026,0,0,2.1339585461976354,3.707297071523708,IL6;ALDH2;CALR
Lymphocytosis,3/65,0.17599734693029842,0.25567773782909026,0,0,2.1339585461976354,3.707297071523708,CCND1;CD5;SH2D1A
Rhabdomyolysis,3/65,0.17599734693029842,0.25567773782909026,0,0,2.1339585461976354,3.707297071523708,SCN4A;DMD;ALDOA
Small hand,3/65,0.17599734693029842,0.25567773782909026,0,0,2.1339585461976354,3.707297071523708,COL3A1;CTNND2;NDN
Absent tendon reflex,5/134,0.1791182516422812,0.2559056656667011,0,0,1.7112403100775193,2.9428354780098194,EGR2;DST;BIN1;CNTN1;SOX10
High forehead,5/134,0.1791182516422812,0.2559056656667011,0,0,1.7112403100775193,2.9428354780098194,MEF2C;CCND2;GATA4;FGFR3;FLI1
"Round, full face",3/66,0.18155230785190155,0.2559056656667011,0,0,2.0999784529196295,3.5830073215850944,COL2A1;CTNND2;EZH2
Dentatorubral-Pallidoluysian Atrophy,3/66,0.18155230785190155,0.2559056656667011,0,0,2.0999784529196295,3.5830073215850944,VWF;GATA3;EZH2
Hip Dislocation,3/66,0.18155230785190155,0.2559056656667011,0,0,2.0999784529196295,3.5830073215850944,ARNT2;COL2A1;KIF22
Round face,3/66,0.18155230785190155,0.2559056656667011,0,0,2.0999784529196295,3.5830073215850944,COL2A1;CTNND2;EZH2
"COLORBLINDNESS, PARTIAL, DEUTAN SERIES",2/35,0.18259864521732516,0.2559056656667011,0,0,2.6707709145632395,4.541551742792535,CXCR4;CTLA4
Abnormality of the metacarpal bones,2/35,0.18259864521732516,0.2559056656667011,0,0,2.6707709145632395,4.541551742792535,FGFR3;RUNX2
Asthenozoospermia,2/35,0.18259864521732516,0.2559056656667011,0,0,2.6707709145632395,4.541551742792535,CATSPER1;CDC25B
Deficiency of glucose-6-phosphate dehydrogenase,2/35,0.18259864521732516,0.2559056656667011,0,0,2.6707709145632395,4.541551742792535,IL6;CCND1
Hyperphagia,2/35,0.18259864521732516,0.2559056656667011,0,0,2.6707709145632395,4.541551742792535,LEPR;NDN
Intracranial Hypertension,2/35,0.18259864521732516,0.2559056656667011,0,0,2.6707709145632395,4.541551742792535,FGFR3;TGFBR2
Intrahepatic Cholestasis,2/35,0.18259864521732516,0.2559056656667011,0,0,2.6707709145632395,4.541551742792535,EGR1;TEK
Lipoidosis,2/35,0.18259864521732516,0.2559056656667011,0,0,2.6707709145632395,4.541551742792535,PPARG;DEPP1
Low Grade Squamous Intraepithelial Neoplasia,2/35,0.18259864521732516,0.2559056656667011,0,0,2.6707709145632395,4.541551742792535,TERT;CDKN2A
Multinodular goiter,2/35,0.18259864521732516,0.2559056656667011,0,0,2.6707709145632395,4.541551742792535,RET;CXCL10
Ataxia,7/208,0.18263663146511616,0.2559056656667011,0,0,1.5388582203139554,2.61645403099713,ALK;CCND1;CHEK1;ENO2;APOB;LMNB1;SYNE1
Neurodevelopmental Disorders,7/208,0.18263663146511616,0.2559056656667011,0,0,1.5388582203139554,2.61645403099713,CNTNAP2;TCF7L2;MEF2C;DLG2;ADRA1A;EZH2;ADCY5
"Amyotrophy, monomelic",1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,STMN1
"Arthritis, Bacterial",1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,CXCL10
"Bare Lymphocyte Syndrome, Type I",1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,TAP1
"Cardiomyopathy, Familial Hypertrophic, 1 (disorder)",1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,SATB1
"Clinically Isolated Syndrome, CNS Demyelinating",1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,QKI
"Dementia, familial Danish",1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,SYP
"Hypoxia-Ischemia, Brain",1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,IL6
"Neural tube defect, folate-sensitive",1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,PAX3
"PHEOCHROMOCYTOMA, SUSCEPTIBILITY TO",1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,RET
"RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL",1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,COL2A1
"Retinoschisis, Juvenile, X-Linked",1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,DMD
"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2 (disorder)",1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,CDKN2A
"Thyroid cancer, follicular",1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,PPARG
"Urea Cycle Disorders, Inborn",1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,PPARA
"von Willebrand Disease, Type 2B",1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,VWF
"von Willebrand Disease, Type 3",1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,VWF
Abnormal amniotic fluid,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,FLT4
Abnormality of the intestine,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,RET
Abruptio Placentae,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,AGT
Absent ear,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,CDT1
Absent frontal sinuses,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,RUNX2
Acrocyanosis,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,CALR
Acute alcoholic liver disease,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,IL6
Addicted to cocaine,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,PER2
Adult Oligodendroglioma,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,DTX1
Adult Soft Tissue Sarcoma,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,MAPK8IP2
Aggressive Systemic Mastocytosis,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,KIT
Anemia of inadequate production,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,KLF1
Anuria,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,AGT
Aplasia of frontal sinus,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,RUNX2
Argyrophilic grain disease,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,A2M
Asplenia Syndrome,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,TDGF1
Asthma attack,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,CCL2
Atypical polypoid adenomyoma,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,CCND1
Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder),1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,SYNE1
Benign Hereditary Chorea,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,ADCY5
Birth length less than 3rd percentile,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,CDT1
Bone Resorption,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,COL2A1
Bone Sarcoma,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,KIT
Bronchial carcinoid,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,CDKN2A
Brooke-Spiegler syndrome,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,VWF
Burkitt-like lymphoma,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,CCND1
Buruli Ulcer,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,PRKN
Camptodactyly of toe,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,FGFR3
Capitate-hamate fusion,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,FGFR3
Carbamoyl-Phosphate Synthase I Deficiency Disease,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,FLAD1
Childhood Oligodendroglioma,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,DTX1
Childhood Renal Cell Carcinoma,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,IL6
Chloasma,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,MITF
Chromosomal Instability,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,AURKA
Chronic acquired lymphedema,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,HGF
Chronic periaortitis,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,TRIM63
Congenital absence of external ear,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,CDT1
Cranial hyperostosis,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,TNFSF11
Cranial nerve abnormality,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,EGR2
Decreased glomerular filtration rate,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,MUC1
Decreased LDL,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,APOB
Decreased serum leptin,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,LEPR
Deficiency of steroid 21-monooxygenase,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,C4B
Demyelination,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,QKI
Developmental stagnation,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,ACAN
Dilation of lateral ventricles,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,EZH2
Diseases of mitral valve,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,VWF
Disturbance in mood,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,IL6
Dysembryoplastic neuroepithelial tumor,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,SYP
Dysgammaglobulinemia,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,SH2D1A
Elliptocytosis found,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,SPTA1
Endocrine hypertension,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,AGT
Endometrial Diseases,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,ESR1
Enlargement of skull bones,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,TNFSF11
Enteritis due to Norovirus,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,IL18
Erythema Infectiosum,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,STAT5A
Excessive growth of skull bones,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,TNFSF11
Exercise-induced muscle cramps,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,DMD
Experimental Autoimmune Encephalomyelitis,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,PPARA
eyelids (symptom),1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,APOB
Factor VIII Deficiency,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,VWF
Failure of exfoliation of primary tooth,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,TNFSF11
Familial Colorectal Cancer Type X,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,BRCA2
Familial pulmonary arterial hypertension,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,CAV1
Fatal Familial Insomnia,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,GFAP
Feeling powerless,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,SGK1
Fibular aplasia,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,BMPR1B
Flexion contracture of toe,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,LIFR
Frontonasal dysplasia,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,SIX2
Gastric Carcinoid Tumor,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,FGF2
Glycogen Storage Disease Type IV,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,COL1A2
Gram-Negative Bacterial Infections,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,IL6
Hepatopulmonary Syndrome,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,CCL2
Hyperchloremic metabolic acidosis,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,KLHL3
Hypertrophy of cranial bones,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,TNFSF11
Hyperventilation,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,VAV3
Hypoalgesia,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,NRP1
Hypophonia,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,SNCAIP
Hypoplastic pubic bone,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,COL2A1
Ileal Pouches,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,PTGS2
Infection of ear,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,IL6
Influenza-like symptoms,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,IL6
Inherited bone marrow failure syndrome,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,TERT
Isovaleryl-CoA dehydrogenase deficiency,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,AGT
Kaposi's sarcoma classical type,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,CXCR2
Langer-Giedion Syndrome,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,VIM
Late-onset muscular dystrophy,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,COL17A1
Limb-girdle muscular dystrophy type 2H,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,PRKN
Low Grade Prostatic Intraepithelial Neoplasia,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,ERG
Luft Disease,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,IL6
Maladaptive behavior associated with physical illness,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,KLF4
Megaconial Myopathies,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,IL6
Megalencephaly cutis marmorata telangiectatica congenita,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,CIB1
Microvillus inclusion disease,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,EZR
Mild hereditary factor VIII deficiency disease,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,VWF
Monogenic Obesity,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,LEPR
Motor Skills Disorders,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,AKAP5
Narrow internal auditory canal,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,FGFR3
Narrow pelvis bone,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,BGN
Neurogenic hypertension,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,AGT
neurological disability,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,IL6
Nonketotic hypoglycemia,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,RET
Nonproliferative fibrocystic disease,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,BRCA1
Nose Diseases,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,PTGS2
Other emphysema,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,JUN
Other lesions of median nerve,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,ERBB2
Partial atrioventricular canal,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,GATA4
Pericytic Neoplasm,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,GZMB
Periodic hypokalemic paresis,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,SCN4A
Peripheral Nervous System Neoplasms,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,HGF
Persistent bleeding after trauma,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,VWF
Pituitary growth hormone cell adenoma,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,CDKN2C
Pleoconial Myopathies,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,IL6
Post-Traumatic Myelopathy,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,AQP1
Potassium aggravated myotonia,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,SCN4A
Precursor B-lymphoblastic lymphoma/leukemia,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,PARP1
Premature hardening of arteries,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,APOB
Progression of prostate cancer,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,EZH2
Progressive Muscular Atrophy,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,CAPN3
Prominent fingertip pads,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,EZH2
Prominent nasolabial fold,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,TNNI2
Psychomotor Impairment,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,RPS6KA3
Radicular Cyst,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,FGF2
Refractory Thrombocytopenia,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,SATB1
Renal vascular disorder,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,AGT
Retinal defect,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,PAX2
Rhegmatogenous retinal detachment,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,COL2A1
Right Atrial Isomerism,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,TDGF1
Sacral agenesis,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,PCSK5
Seronegative rheumatoid arthritis,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,CCL2
Somatization,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,TAL1
Spinal Cord Contusion,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,AQP1
Spinal Cord Injuries,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,AQP1
Spinal Cord Laceration,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,AQP1
Spinal Cord transection injury,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,AQP1
Spinal Diseases,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,STMN1
Spindle cell hemangioma,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,SIX3
Spondylolisthesis,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,RUNX2
Spontaneous hematomas,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,F13A1
Status Asthmaticus,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,ADRB2
Talipes Calcaneovalgus,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,HOXD10
Thalassemia trait,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,IL6
Thick skull bones,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,TNFSF11
Thrombocytopenia-Absent Radius Syndrome,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,HOXA10
THROMBOCYTOPENIA 2 (disorder),1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,FLI1
Tremor of hands,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,CTNND2
Ulnar claw,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,EGR2
Urine color abnormal,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,DMD
Venous retinal branch occlusion,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,CCL2
Voice Fatigue,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,SNCAIP
von Willebrand's factor (lab test),1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,VWF
Vulvar Vestibulitis,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,ESR1
Wernicke Encephalopathy,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,PTGS2
Wide cranial sutures,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,COL1A1
X-Linked Dyskeratosis Congenita,1/9,0.18335587599585554,0.2559056656667011,0,0,5.503096846846847,9.3350481163971,TERT
Nail dysplasia,3/67,0.18715384124999648,0.2610978807301571,0,0,2.067060237556561,3.4640298167178143,COL17A1;KIF22;KRT5
Pustulosis of Palms and Soles,3/67,0.18715384124999648,0.2610978807301571,0,0,2.067060237556561,3.4640298167178143,IL6;PPARG;MKI67
Sleep disturbances,4/101,0.18790873711371217,0.26209658950273956,0,0,1.819482432148117,3.0418086829678472,PER2;IL6;FKBP4;SNCAIP
"Reflex, Deep Tendon, Absent",5/137,0.19048702607324425,0.26511620676034003,0,0,1.672090220385675,2.7726118327598575,EGR2;DST;BIN1;CNTN1;SOX10
Absent reflex,5/137,0.19048702607324425,0.26511620676034003,0,0,1.672090220385675,2.7726118327598575,EGR2;DST;BIN1;CNTN1;SOX10
"Astrocytoma, low grade",2/36,0.19066576513586098,0.26511620676034003,0,0,2.5920860443500198,4.29569132105993,CCL2;CIB1
"EAR, PATELLA, SHORT STATURE SYNDROME",2/36,0.19066576513586098,0.26511620676034003,0,0,2.5920860443500198,4.29569132105993,COL1A1;CDT1
Avellino corneal dystrophy,2/36,0.19066576513586098,0.26511620676034003,0,0,2.5920860443500198,4.29569132105993,CXCL10;CCL19
Fatigable weakness of respiratory muscles,2/36,0.19066576513586098,0.26511620676034003,0,0,2.5920860443500198,4.29569132105993,NEFH;PPARGC1A
Hepatic Encephalopathy,2/36,0.19066576513586098,0.26511620676034003,0,0,2.5920860443500198,4.29569132105993,SH2D1A;LTA
Hip joint varus deformity - observation,2/36,0.19066576513586098,0.26511620676034003,0,0,2.5920860443500198,4.29569132105993,COL2A1;RUNX2
Invasive Streptococcus pneumoniae disease,2/36,0.19066576513586098,0.26511620676034003,0,0,2.5920860443500198,4.29569132105993,CCL2;NFKBIE
Learning Disorders,2/36,0.19066576513586098,0.26511620676034003,0,0,2.5920860443500198,4.29569132105993,PRKN;SYP
Ocular Hypertension,2/36,0.19066576513586098,0.26511620676034003,0,0,2.5920860443500198,4.29569132105993,C3;JUN
Ovarian Mucinous Adenocarcinoma,2/36,0.19066576513586098,0.26511620676034003,0,0,2.5920860443500198,4.29569132105993,MELK;MYLK
pricking of skin,2/36,0.19066576513586098,0.26511620676034003,0,0,2.5920860443500198,4.29569132105993,IL18;GATA3
Rapidly progressive,2/36,0.19066576513586098,0.26511620676034003,0,0,2.5920860443500198,4.29569132105993,NPHS1;CRYAB
Rapidly progressive disorder,2/36,0.19066576513586098,0.26511620676034003,0,0,2.5920860443500198,4.29569132105993,NPHS1;CRYAB
Recurrent infections,3/68,0.19279969784791098,0.2680278970702898,0,0,2.0351548903585104,3.3500755147667944,NPHS1;FADD;ANTXR2
"Mental Retardation, Psychosocial",5/138,0.19433289183875607,0.2700475277444829,0,0,1.6594326725905673,2.718453818298371,CCNA2;MEF2C;PARP1;LAMA1;ASCL1
Psoriasis vulgaris,5/138,0.19433289183875607,0.2700475277444829,0,0,1.6594326725905673,2.718453818298371,IL6;DST;CDKN2A;PROS1;VIM
HIV Coinfection,4/103,0.19695640301704362,0.27091768981760006,0,0,1.7825419730181635,2.8962258538269627,CCT3;CXCL12;CCL2;ADRB2
Visual Impairment,8/251,0.19791492822818083,0.27091768981760006,0,0,1.4548878906875347,2.356799076329649,PLK4;COL17A1;FBN2;ARNT2;WT1;TNFSF11;MITF;PAX2
hiv-infection/aids,3/69,0.19848764811402772,0.27091768981760006,0,0,2.0042163718634307,3.2408748069109374,DDX39A;CXCL12;CXCR4
Underdeveloped nasal alae,3/69,0.19848764811402772,0.27091768981760006,0,0,2.0042163718634307,3.2408748069109374,PAX3;MITF;SOX10
Bacterial Endocarditis,2/37,0.1987792509644351,0.27091768981760006,0,0,2.5178974524346986,4.067815318759853,IL6;SELE
Combined immunodeficiency,2/37,0.1987792509644351,0.27091768981760006,0,0,2.5178974524346986,4.067815318759853,STAT1;IL2RG
Corpus Luteum Cyst,2/37,0.1987792509644351,0.27091768981760006,0,0,2.5178974524346986,4.067815318759853,PRKN;NMT2
Fatigable weakness of swallowing muscles,2/37,0.1987792509644351,0.27091768981760006,0,0,2.5178974524346986,4.067815318759853,NEFH;PPARGC1A
Gowers sign,2/37,0.1987792509644351,0.27091768981760006,0,0,2.5178974524346986,4.067815318759853,BIN1;DMD
Hematopoetic Myelodysplasia,2/37,0.1987792509644351,0.27091768981760006,0,0,2.5178974524346986,4.067815318759853,EGR1;EZH2
Infantile uterus,2/37,0.1987792509644351,0.27091768981760006,0,0,2.5178974524346986,4.067815318759853,BMPR1B;ESR1
Rubella,2/37,0.1987792509644351,0.27091768981760006,0,0,2.5178974524346986,4.067815318759853,IL6;CHAF1A
Thyroid Hormone Resistance Syndrome,2/37,0.1987792509644351,0.27091768981760006,0,0,2.5178974524346986,4.067815318759853,DMD;RXRG
X-linked Adrenal Hypoplasia,2/37,0.1987792509644351,0.27091768981760006,0,0,2.5178974524346986,4.067815318759853,MCM4;DMD
Respiratory distress,4/104,0.2015296269207613,0.27091768981760006,0,0,1.764625850340136,2.8266109971029922,STAT5B;CDT1;COL2A1;LIFR
"46, XX Testicular Disorders of Sex Development",1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,SOX10
"Ambiguous genitalia, female",1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,WT1
"Ambiguous genitalia, male",1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,WT1
"Aneurysm, Ruptured",1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,SHC3
"Apraxia, Verbal",1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CNTNAP2
"CEROID LIPOFUSCINOSIS, NEURONAL, 6",1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,SYP
"Dystonia, Secondary",1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,PRKN
"Encephalomyelitis, Acute Disseminated",1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,RASL12
"FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED",1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,RIMS2
"Hypocalciuric hypercalcemia, familial, type 1",1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,RET
"Leukemia, Megakaryoblastic, of Down Syndrome",1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,EZH2
"Membranoproliferative Glomerulonephritis, Type II",1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,C3
"Microtia, third degree",1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CDT1
"Post-transplant lymphoproliferative disorder, polymorphic",1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,SDC1
"PSEUDOHYPOALDOSTERONISM, TYPE IID",1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,KLHL3
"Stuttering, Developmental",1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CNTNAP2
"Tremor, Muscle",1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ADRB2
"Tremor, Neonatal",1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ADRB2
"Tremor, Perioral",1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ADRB2
"Tremor, Semirhythmic",1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ADRB2
"Tuberculosis, Central Nervous System",1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,TIMP1
"Tuberculosis, Spinal",1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CCL2
"Vasculitis, Leukocytoclastic, Cutaneous",1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,VWF
Abnormal shape/structure of ear,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CDT1
Abnormality of female external genitalia,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CXCR4
Abnormality of oral frenula,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,COL3A1
Abnormality of the cerebral vasculature,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ACTA2
Abnormality of the cranial nerves,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,EGR2
Abnormality of the renal tubule,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,NPHS1
Abnormality of tibia morphology,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,BMPR1B
Accessory spleen,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,MYCN
Acute otitis media,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,IL6
Adult onset autosomal dominant leukodystrophy,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,LMNB1
Advanced Sleep Phase Syndrome,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,PER2
Ambiguous genitalia due to virilization,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,WT1
Amegakaryocytic thrombocytopenia,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,MECOM
Arthus Reaction,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CR1
Bisphosphonate-associated osteonecrosis,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,SYP
Bladder Exstrophy,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,IL18
Bone marrow myeloid dysplasia,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,MECOM
Branchio-Oto-Renal Syndrome,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,SIX1
Bundle-Branch Block,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,NKX2-5
Carpal bone hypoplasia,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,KIF22
Cerebellar cyst,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,LAMA1
Chronic idiopathic pulmonary fibrosis,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CXCR2
Coarse Tremor,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ADRB2
COLCHICINE RESISTANCE,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,PAK3
Congenital Hand Deformities,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,PAX3
Congenital posterior urethral valves,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,AGT
Constitutional delay of growth and puberty,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,LEPR
Continuous Tremor,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ADRB2
COPD exacerbation,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ADRB2
Coronal cleft vertebrae,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,COL2A1
Darkness Tremor,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ADRB2
Decrease in jaw opening,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,LIFR
Dementia due to Alzheimer's disease (disorder),1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ESR1
Developmental Coordination Disorder,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,AKAP5
Dextrocardia,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,PKD2
Disorder of vein,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,FGF2
Distemper,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,STAT1
Donohue Syndrome,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,AURKA
Dysgenesis of corpus callosum,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,GPSM2
Dysmenorrhea,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,PTGS2
Emotional Stress,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,RCAN1
Enchondromatosis,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,COL2A1
Enlarged polycystic ovaries,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ESR1
Epithelial inclusion cyst,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ERBB2
Epithelioid and spindle cell nevus,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CCND1
Ewing's sarcoma of bone,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ERBB2
Facial paralysis,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,TNFSF11
Fasting hyperinsulinemia,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CDKN2C
Fatty Liver Disease,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CD36
Fine Tremor,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ADRB2
Flattened epiphysis,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,COL2A1
Friend leukemia,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,FLI1
Gangrene,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,IL6
Genital infection,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,GATA3
Gliomatosis cerebri,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,FGFR4
Hand clenching,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,DST
Heterotaxy Syndrome,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,TDGF1
Hibernoma,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,PPARA
Hyperconvex fingernails,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,RPS6KA3
Hyperlipoproteinemia Type IV,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,APOB
Hypoadiponectinemia,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,PPARG
Hypokalemic periodic paralysis type 1,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,SCN4A
Insulin resistance in diabetes,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,TXNIP
Intermittent Tremor,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ADRB2
Intestinal carcinoma,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CAV1
Intrauterine infection,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CISH
Invasive meningococcal disease,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,IL6
Involuntary Quiver,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ADRB2
Laryngostenosis,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,KIF22
Lentigo,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,FGF7
Leukostasis,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,PPARG
Limited jaw mobility,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,LIFR
Limited jaw opening,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,LIFR
Massive Tremor,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ADRB2
Median cleft lip and palate,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,SIX3
Melanoma astrocytoma syndrome,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CDKN2A
Merkel Cell Polyomavirus Infection,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,KIT
Muscle weakness of upper limb,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,EGR2
Narrow sacrosciatic notch,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,COL2A1
Nematode infections,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,IL18
Nerve Tremors,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ADRB2
Night sweats,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ESR1
NUT midline carcinoma,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,RIMS2
Oculocutaneous albinism type 1,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CALR
Oliguria,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CAV1
Ossifying Fibroma,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,RUNX2
Osteitis,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,TNFSF11
Paranoid ideation,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,TAL1
PARIETAL FORAMINA,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,SCN4A
Passive Tremor,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ADRB2
Pelvic Pain,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,IL6
Persistent Hyperplastic Primary Vitreous,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CDKN2A
Persistent Tremor,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ADRB2
Phototoxicity,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,PARP1
Pill Rolling Tremor,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ADRB2
Precursor T cell lymphoblastic leukemia/lymphoblastic lymphoma,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CXCR4
Premature adrenarche,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,TCF7L2
Premature arteriosclerosis,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,APOB
Pressure Ulcer,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,FGF2
Primary bacterial peritonitis,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CCL2
Proportionate short stature,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ACAN
Prostatic Adenoma,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,FGF7
Pulmonary lymphangioleiomyomatosis,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ESR1
Pulmonary Veno-Occlusive Disease (disorder),1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ERG
Refractory anemia with ring sideroblasts associated with marked thrombocytosis,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CXCR4
Retinal Drusen,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CCL2
Retinal Vasculitis,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,SELE
Rickettsia Infections,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,PTGS2
Saturnine Tremor,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ADRB2
Senile Tremor,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,ADRB2
Shoulder girdle muscle atrophy,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,TPM3
Small wrist bones,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,KIF22
Spinal ataxia,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,EGR2
Sporadic Parkinson disease,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,PRKN
Stuttering,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CNTNAP2
Subacute progressive viral hepatitis,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,MET
Subcutaneous lipoma,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CDKN2C
Symptomatic dermographism,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,SERPING1
TROPICAL CALCIFIC PANCREATITIS,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,PAEP
True Hermaphroditism (disorder),1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,WT1
Trypanosomiasis,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,A2M
Tuberculoid leprosy,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CDKN2A
Urban cutaneous leishmaniasis,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,CCL2
WAGR Syndrome,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,WT1
Xanthoma tendinosum,1/10,0.2015343624670533,0.27091768981760006,0,0,4.891391391391392,7.835008126629427,IL6
"Cholangitis, Sclerosing",5/140,0.20210515779943924,0.271630626332006,0,0,1.6346801346801347,2.613799809746661,ACTA2;NR5A2;CDKN2A;ANTXR2;SKAP2
"Anemia, Diamond-Blackfan",3/70,0.20421548385277843,0.2742473884333653,0,0,1.9742013912338758,3.1361759561701654,COL3A1;FLI1;KLF1
Abnormality of brain morphology,3/70,0.20421548385277843,0.2742473884333653,0,0,1.9742013912338758,3.1361759561701654,ZNF423;SYNE1;SOX5
alpha-Thalassemia,3/70,0.20421548385277843,0.2742473884333653,0,0,1.9742013912338758,3.1361759561701654,CR1;TEK;KLF1
Philadelphia chromosome-positive acute lymphoblastic leukemia,3/70,0.20421548385277843,0.2742473884333653,0,0,1.9742013912338758,3.1361759561701654,STAT5A;STAT5B;CDKN2A
"Arthritis, Reactive",2/38,0.20693306352140078,0.2775639014599017,0,0,2.447830448959117,3.856213937754639,CCL21;PTGS2
"Hyperparathyroidism, Secondary",2/38,0.20693306352140078,0.2775639014599017,0,0,2.447830448959117,3.856213937754639,IL6;PTGS2
Arteriovenous hemangioma,2/38,0.20693306352140078,0.2775639014599017,0,0,2.447830448959117,3.856213937754639,IL6;TEK
Infectious Mononucleosis,2/38,0.20693306352140078,0.2775639014599017,0,0,2.447830448959117,3.856213937754639,IL6;SH2D1A
Lichen Planus,2/38,0.20693306352140078,0.2775639014599017,0,0,2.447830448959117,3.856213937754639,IL6;PTGS2
Weight less than 3rd percentile,2/38,0.20693306352140078,0.2775639014599017,0,0,2.447830448959117,3.856213937754639,RPS6KA3;DMD
Essential Tremor,3/71,0.2099810195321985,0.2815959519125889,0,0,1.945069204152249,3.035743683164393,PRKN;SCN4A;APOB
Abnormality of coagulation,2/39,0.21512140826891363,0.28649675475731307,0,0,2.3815508510768106,3.6593784394902977,TERT;TEK
Absent auditory canals,2/39,0.21512140826891363,0.28649675475731307,0,0,2.3815508510768106,3.6593784394902977,CDT1;SIX1
Absent external auditory canals,2/39,0.21512140826891363,0.28649675475731307,0,0,2.3815508510768106,3.6593784394902977,CDT1;SIX1
Alcohol consumption,2/39,0.21512140826891363,0.28649675475731307,0,0,2.3815508510768106,3.6593784394902977,ALDH2;MYLK
Atresia of the external auditory canal,2/39,0.21512140826891363,0.28649675475731307,0,0,2.3815508510768106,3.6593784394902977,CDT1;SIX1
Atretic auditory canal,2/39,0.21512140826891363,0.28649675475731307,0,0,2.3815508510768106,3.6593784394902977,CDT1;SIX1
Disorder of macula of retina,2/39,0.21512140826891363,0.28649675475731307,0,0,2.3815508510768106,3.6593784394902977,FBN2;PAX2
Gowers sign present,2/39,0.21512140826891363,0.28649675475731307,0,0,2.3815508510768106,3.6593784394902977,BIN1;DMD
Low Grade Lymphoma (neoplasm),2/39,0.21512140826891363,0.28649675475731307,0,0,2.3815508510768106,3.6593784394902977,CDKN2A;RAD54B
Neonatal diabetes mellitus,2/39,0.21512140826891363,0.28649675475731307,0,0,2.3815508510768106,3.6593784394902977,KLF11;GATA4
Neuronal Ceroid-Lipofuscinoses,2/39,0.21512140826891363,0.28649675475731307,0,0,2.3815508510768106,3.6593784394902977,DPYSL2;GAD1
Pyelonephritis,2/39,0.21512140826891363,0.28649675475731307,0,0,2.3815508510768106,3.6593784394902977,NPHS1;TIMP1
Sialorrhea,2/39,0.21512140826891363,0.28649675475731307,0,0,2.3815508510768106,3.6593784394902977,CA12;PAK3
Talipes foot deformities,2/39,0.21512140826891363,0.28649675475731307,0,0,2.3815508510768106,3.6593784394902977,TNNI2;LIFR
Contact hypersensitivity,3/72,0.21578209357507236,0.28649675475731307,0,0,1.9167814282903797,2.9393578812483545,DUSP1;IL18;SAA1
"Brain Stem Ischemia, Transient",1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,C3
"Crigler Najjar syndrome, type 2",1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,AGT
"DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST",1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,SLC2A4
"Epilepsy, Tonic-Clonic, Familial",1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,FGF2
"Epilepsy, Tonic-Clonic, Symptomatic",1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,FGF2
"Hyperpotassemia and Hypertension, Familial",1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,KLHL3
"INSULIN RESISTANCE, SUSCEPTIBILITY TO",1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,SLC2A4
"Mixed Tumor, Mullerian",1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,S100A4
"Parkinson Disease, Secondary Vascular",1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,PRKN
"Pseudohypoaldosteronism, Type I, Autosomal Recessive",1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,KLHL3
"Spastic paraplegia 10, autosomal dominant",1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,S100A4
"Synovial sarcoma, biphasic",1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,PAEP
"Transient Ischemic Attack, Anterior Circulation",1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,C3
"Transient Ischemic Attack, Vertebrobasilar Circulation",1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,C3
Abnormal platelet morphology,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,CALR
Abnormality of brainstem morphology,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,COL3A1
Abnormality of the endocrine system,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,CD36
Absence of rib,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,FLI1
Adenolymphoma,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,MAML2
Analgesic Overuse Headache,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,RAMP1
Angioendotheliomatosis,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,ALK
Angioma,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,KDR
AROMATASE EXCESS SYNDROME,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,IL6
Aseptic necrosis,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,COL2A1
Atherosclerotic Parkinsonism,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,PRKN
Atrophy of corpus callosum,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,LMNB1
Autosomal dominant late onset Parkinson disease,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,PRKN
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,FGFR3
Benign neoplasm of liver,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,MKI67
Bone infarction,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,COL2A1
Bone Marrow Suppression,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,PAEP
Burn scar,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,FGF2
Burning Mouth Syndrome,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,IL6
Carotid Circulation Transient Ischemic Attack,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,C3
Central hypotonia,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,SOX5
Cerebral abscess,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,CCL2
Chills,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,IL6
Chromosome Breaks,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,BRCA1
Communicable Diseases,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,HGF
Congenital Pain Insensitivity,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,LIFR
Conical incisor,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,FGFR3
Crescendo Transient Ischemic Attacks,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,C3
Cryptogenic Tonic-Clonic Epilepsy,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,FGF2
Dedifferentiated chondrosarcoma,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,RUNX2
Delayed Sleep Phase Syndrome,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,PER2
Diabetic macular edema,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,CCL2
Digestive System Disorders,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,PPARG
Early onset schizophrenia,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,SOX10
Electrocardiogram,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,CAV1
Eosinophilia-Myalgia Syndrome,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,COL1A1
Erosive esophagitis,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,PTGS2
Eyelid Xanthoma,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,APOB
Fetal polyuria,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,RET
Fundus Albipunctatus,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,ERG
Fungal keratitis,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,IL6
Glomus Tumor,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,RET
Glucocorticoid deficiency with achalasia,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,RIMS2
Granular cell tumor,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,MKI67
Hereditary Factor XI Deficiency,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,VWF
HODGKIN'S AND NON-HODGKIN'S LYMPHOMA,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,IL6
Horizontal ribs,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,COL2A1
Hydranencephaly,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,CEP55
Hyperoxia,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,JUN
Hypotrichosis of the scalp,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,SNRPE
Immune reconstitution inflammatory syndrome [IRIS],1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,IL6
Immunoproliferative Small Intestinal Disease,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,SDC1
Inflammatory polyarthritis,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,CCL21
Isaacs syndrome,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,CNTNAP2
Jaw Keratocyst,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,CCND1
Kallmann Syndrome 1,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,EZR
Laryngeal Paralysis,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,MYCN
Lean body mass,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,VCAN
Leukemic Infiltration,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,RUNX1T1
Limbal stem cell deficiency,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,KRT19
Limited elbow movement,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,COL2A1
Lymphohistiocytosis,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,STX11
Miyoshi myopathy,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,CAPN3
Myokymia,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,ADCY5
Myxopapillary ependymoma,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,RAB3A
Nemaline bodies,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,TPM3
Odontome,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,RUNX2
Oral mucosal blisters,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,COL17A1
Organic aciduria,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,FLAD1
Ornithine carbamoyltransferase deficiency,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,DMD
Orofacial cleft,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,NECTIN2
Osteochondritis Dissecans,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,ACAN
Ovarian dysgenesis,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,RAD51
Pathological Dilatation,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,IL6
pediatric AIDS,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,CXCL12
Pediatric Neoplasm,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,IL6
Peg shaped front tooth,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,FGFR3
Placental Steroid Sulfatase Deficiency,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,DMD
Plasma cell inflammation,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,IL6
Pointed front tooth,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,FGFR3
Pointed incisor,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,FGFR3
Polymorphous corneal dystrophy,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,KRT19
Polysplenia,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,MYCN
Posterior Circulation Transient Ischemic Attack,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,C3
Primary Hyperthyroidism,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,AQP1
Recurrent Endometrial Cancer,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,ERBB2
REM Sleep Behavior Disorder,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,PRKN
Rotator cuff syndrome,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,IL6
Segmental peripheral demyelination/remyelination,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,EGR2
Severe sensorineural hearing impairment,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,GPSM2
Short Bowel Syndrome,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,LEPR
Sjogren-Larsson Syndrome,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,FANCA
Small face,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,FGFR3
Spermatocytic seminoma,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,FGFR3
Splanchnic vein thrombosis,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,CALR
Spontaneous pneumothorax,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,COL3A1
Thick nasal alae,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,RPS6KA3
Thin nails,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,EZH2
Thoracic kyphosis,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,COL2A1
Trisomy 4,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,KIT
Tuberculosis of intestines,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,SDC1
Urologic Diseases,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,CDKN2A
Uterus bilocularis,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,HOXA10
Yersinia infections,1/11,0.2193090852006174,0.28649675475731307,0,0,4.402027027027027,6.6790776172014725,IL6
Blepharoptosis,10/337,0.21994661174219302,0.2872737153754509,0,0,1.3517522584273614,2.047053656930205,BIN1;WT1;TPM3;DMD;SCN4A;KRT5;ALDOA;ZNF423;FGFR3;FLI1
Malabsorption,4/108,0.2201261347307543,0.28745228871315304,0,0,1.6964067678353392,2.567604194391535,TERT;CAV1;SAA1;TGFBR2
Hypopigmentation disorder,3/73,0.22161656955202658,0.2892860799050361,0,0,1.8893018745959922,2.84681244817926,KIT;MITF;SOX10
Photosensitivity of skin,3/73,0.22161656955202658,0.2892860799050361,0,0,1.8893018745959922,2.84681244817926,C4A;BLM;NDN
"Anemia, severe",2/40,0.22333872746666159,0.29108148528354344,0,0,2.3187596530830463,3.4759730687902985,PER2;KLF1
"Anxiety States, Neurotic",2/40,0.22333872746666159,0.29108148528354344,0,0,2.3187596530830463,3.4759730687902985,MDK;FOS
"Muscular Dystrophy, Oculopharyngeal",2/40,0.22333872746666159,0.29108148528354344,0,0,2.3187596530830463,3.4759730687902985,RIMS2;CAPN3
Aspirin exacerbated respiratory disease,2/40,0.22333872746666159,0.29108148528354344,0,0,2.3187596530830463,3.4759730687902985,ADRB2;PTGS2
Congenital omphalocele,2/40,0.22333872746666159,0.29108148528354344,0,0,2.3187596530830463,3.4759730687902985,LRP1;PCSK5
Syncope,2/40,0.22333872746666159,0.29108148528354344,0,0,2.3187596530830463,3.4759730687902985,ADRB1;NKX2-5
Talipes,2/40,0.22333872746666159,0.29108148528354344,0,0,2.3187596530830463,3.4759730687902985,TNNI2;LIFR
X-Linked Lymphoproliferative Disorder,2/40,0.22333872746666159,0.29108148528354344,0,0,2.3187596530830463,3.4759730687902985,SH2D1A;IL2RG
Low Vision,8/261,0.2270663119590679,0.2958822955213621,0,0,1.3966588580059875,2.070565166344087,PLK4;COL17A1;FBN2;ARNT2;WT1;TNFSF11;MITF;PAX2
Muscle hypotonia,13/460,0.2271580402647506,0.29594440318488163,0,0,1.286374181788052,1.9065471266904463,RET;MEF2C;TPM3;CTNND2;ASCL1;ANTXR2;SOX10;TGFBR2;RPS6KA3;NKX2-5;ZNF423;FGFR3;SOX5
DiGeorge Syndrome,3/74,0.22748233733115134,0.29619452840558597,0,0,1.862596392836658,2.7579142218886714,SIX1;LAMC1;TGFBR2
Photoreceptor degeneration,3/74,0.22748233733115134,0.29619452840558597,0,0,1.862596392836658,2.7579142218886714,PARP1;CCL2;FGF2
Thick eyebrow,3/74,0.22748233733115134,0.29619452840558597,0,0,1.862596392836658,2.7579142218886714,RET;RPS6KA3;PAX3
Aggressive reaction,4/110,0.22959118542777304,0.2988244963823496,0,0,1.6642279553330765,2.4488365564455115,LEPR;TIMP1;PAK3;SYN1
Neutrophil count (procedure),4/110,0.22959118542777304,0.2988244963823496,0,0,1.6642279553330765,2.4488365564455115,TERT;CXCR2;LEPR;PLAUR
AIDS related complex,2/41,0.2315796925858527,0.3007714591774486,0,0,2.2591885165248597,3.304811494432305,BLM;IL6
alpha 1-Antitrypsin Deficiency,2/41,0.2315796925858527,0.3007714591774486,0,0,2.2591885165248597,3.304811494432305,PRTN3;A2M
Breaking out,2/41,0.2315796925858527,0.3007714591774486,0,0,2.2591885165248597,3.304811494432305,C4A;ESR1
Cloudy cornea,2/41,0.2315796925858527,0.3007714591774486,0,0,2.2591885165248597,3.304811494432305,WT1;LIFR
Congenital anomaly of the kidney,2/41,0.2315796925858527,0.3007714591774486,0,0,2.2591885165248597,3.304811494432305,RET;PAX2
Corneal stromal opacities,2/41,0.2315796925858527,0.3007714591774486,0,0,2.2591885165248597,3.304811494432305,WT1;LIFR
Gastrointestinal mucositis,2/41,0.2315796925858527,0.3007714591774486,0,0,2.2591885165248597,3.304811494432305,FGF7;KDR
Genitourinary Cancer,2/41,0.2315796925858527,0.3007714591774486,0,0,2.2591885165248597,3.304811494432305,TERT;CDKN2A
Gestational Trophoblastic Neoplasms,2/41,0.2315796925858527,0.3007714591774486,0,0,2.2591885165248597,3.304811494432305,MUC1;ERBB2
Monoclonal B-Cell Lymphocytosis,2/41,0.2315796925858527,0.3007714591774486,0,0,2.2591885165248597,3.304811494432305,CCND1;VIM
Prolymphocytic Leukemia,2/41,0.2315796925858527,0.3007714591774486,0,0,2.2591885165248597,3.304811494432305,RIMS2;CCND1
Blood basophil count (lab test),7/224,0.2329366076770649,0.30106122579267297,0,0,1.4242156429518338,2.075066429259558,TERT;CXCR2;LEPR;PLAUR;E2F2;ERG;ZFPM2
Clouding of corneal stroma,3/75,0.23337731400881864,0.30106122579267297,0,0,1.8366327300150829,2.67248201125167,MMP14;CAV2;BUB1
Shy-Drager Syndrome,3/75,0.23337731400881864,0.30106122579267297,0,0,1.8366327300150829,2.67248201125167,SNCAIP;CRYAB;GFAP
Umbilical hernia,4/111,0.23436158255460576,0.30106122579267297,0,0,1.648589653930108,2.3919224600492326,COL1A1;COL2A1;NKX2-5;EZH2
"Arthritis, Infectious",1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,CXCL10
"Auditory Processing Disorder, Central",1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,CNTNAP2
"Autoimmune polyendocrinopathy syndrome, type 1",1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,RIMS2
"CATARACT, COPPOCK-LIKE",1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,VIM
"Cataract, Pulverulent",1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,VIM
"Leishmaniasis, New World",1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,CCL2
"Lymphoma, Lymphocytic, Intermediate",1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,CCND1
"NEVUS, EPIDERMAL (disorder)",1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,FGFR3
"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,MUC1
"Radiation Injuries, Experimental",1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,IL18
Acanthocytosis,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,APOB
Accessory rib,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,PAX3
Activated Partial Thromboplastin Time measurement,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,F12
Acute mountain sickness,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,EPAS1
Adrenal hypoplasia,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,SIX3
Adrenocortical hyperplasia,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,GATA4
Amaurosis Fugax,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,CALR
Amebiasis,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,LEPR
Anterior chamber anomalies,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,MITF
Aseptic Necrosis of Bone,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,COL2A1
Aspiration Pneumonia,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,KDR
Atelectasis,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,PAX3
Berylliosis,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,IL6
Bladder Diverticulum,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,COL3A1
Bleeding ulcer,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,AGT
Brain Abscess,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,CCL2
Broad hallux phalanx,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,FLI1
Central Precocious Puberty,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,LEPR
Choroid Diseases,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,TEAD1
Citrullinemia,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,PPARA
Complicated pneumoconiosis,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,IL6
Congenital laryngeal adductor palsy,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,PARP1
Congenital leukocyte adherence deficiency,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,COL17A1
Contractures of the joints of the lower limbs,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,CAPN3
Corneal Scar,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,DST
Cranioschisis,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,PAX3
Cystic renal dysplasia,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,FGFR3
Decreased circulating high-density lipoprotein levels,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,PPARG
Distal lower limb muscle weakness,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,TPM3
Dysplastic Nevus Syndrome,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,CDKN2A
Dyssomnias,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,IL6
Early Hepatocellular Carcinoma,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,CCNA2
Elevated immunoglobulin levels,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,TERT
Enterochromaffin-like cell carcinoid,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,FGF2
Familial benign hypercalcemia,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,RET
Female Genital Diseases,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,IL6
Foot Ulcer,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,TGFBR2
Ganglioneuromatosis,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,RET
Gastric adenoma,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,ERBB2
Generalized Myotonia of Thomsen,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,SCN4A
Globulin gamma serum plasma increased result,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,TERT
Hereditary Angioedema Type III,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,F12
Hospital acquired pneumonia,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,RARB
HOYERAAL-HREIDARSSON SYNDROME,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,TERT
HUNTINGTON DISEASE-LIKE 2,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,RIMS2
Hyaline Membrane Disease,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,EPAS1
Hyperglobulinemia,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,TERT
hyperparathyroid,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,CCND1
Hypersplenism,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,ALK
Idiopathic gingival hyperplasia,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,ANTXR2
Immediate hypersensitivity,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,IL18
Increased antibody level in blood,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,TERT
Insulin measurement,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,TCF7L2
Intestinal metaplasia of gastric mucosa,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,TIMP1
Intracranial Arteriovenous Malformation,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,IL6
Kleine-Levin Syndrome,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,PER2
Lacrimal Duct Obstruction,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,FGFR3
Leri-Weill dyschondrosteosis,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,FGFR3
Long Qt Syndrome 2,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,ADRA1A
Malignant neoplasm of anus,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,CDKN2A
Mandibuloacral dysostosis,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,RET
Metaphyseal cupping,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,COL2A1
MPS III B,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,SYP
Mucopolysaccharidosis II,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,PER2
Multiple lentigines,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,MITF
Nevus sebaceous,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,FGFR3
Noisy respiration,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,SCN4A
Obstruction of nasolacrimal duct,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,FGFR3
Ocular Toxoplasmosis,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,IL6
OROFACIAL CLEFT 1,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,NECTIN2
Parkinsonian tremor,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,SNCAIP
Pelizaeus Merzbacher like disease,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,SOX10
Persistent Fetal Circulation Syndrome,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,SIRPA
pineoblastoma,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,MYCN
Placental dysfunction,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,PPARG
Plaque build-up in arteries,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,COL3A1
Poorly Differentiated Thyroid Carcinoma,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,PER2
Prenatal Exposure Delayed Effects,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,FGF2
Primary cutaneous lymphoma,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,ALK
Proximal muscle weakness in lower limbs,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,DMD
Pseudorabies,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,NECTIN2
Recurrent respiratory papillomatosis,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,TAP1
Retinal Pigment Epithelial Detachment,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,COL2A1
Sagittal craniosynostosis,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,BMP2
Secondary Parkinson Disease,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,PRKN
Semantic-Pragmatic Disorder,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,CNTNAP2
Senile dementia,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,ESR1
Sleep Wake Disorders,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,PER2
Small adrenal gland,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,SIX3
Small Fiber Neuropathy,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,IL6
Stage IV Colorectal Cancer,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,PTGS2
Thyrotoxic periodic paralysis,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,ADRB2
Trismus,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,LIFR
Urologic Neoplasms,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,CCND1
VATER Association,1/12,0.23668899228488882,0.30106122579267297,0,0,4.0016380016380015,5.766393447767713,PCSK5
Adrenoleukodystrophy,5/149,0.23827866656453872,0.3030258520445829,0,0,1.531802398989899,2.1970862730212284,SOCS3;TCF7L2;IL6;CCL2;PPARA
Uric acid measurement (procedure),4/112,0.23915577831136678,0.3040837196401248,0,0,1.6332409507012682,2.3365800742502056,MUC1;HLF;ALDH2;PKD2
Autoimmune thrombocytopenia,3/76,0.23929944492210847,0.30409367494737566,0,0,1.8113804004214964,2.590345709897188,STAT1;IL18;CTLA4
Axonal neuropathy,3/76,0.23929944492210847,0.30409367494737566,0,0,1.8113804004214964,2.590345709897188,PRKN;CTLA4;SERPING1
Inflammatory pain,3/76,0.23929944492210847,0.30409367494737566,0,0,1.8113804004214964,2.590345709897188,IL6;PTGS2;ADRA1A
"Parkinsonism, Juvenile",2/42,0.2398391968312523,0.3043764259105613,0,0,2.2025959367945824,3.1448369492379444,PRKN;PARP1
Disease due to Parvoviridae,2/42,0.2398391968312523,0.3043764259105613,0,0,2.2025959367945824,3.1448369492379444,RIMS2;CCL2
exudative macular degeneration,2/42,0.2398391968312523,0.3043764259105613,0,0,2.2025959367945824,3.1448369492379444,C3;COL8A1
Eye Abnormalities,2/42,0.2398391968312523,0.3043764259105613,0,0,2.2025959367945824,3.1448369492379444,BMPR1B;TGFBR2
Infection by Cryptococcus neoformans,2/42,0.2398391968312523,0.3043764259105613,0,0,2.2025959367945824,3.1448369492379444,IL18;TAP1
Mixed cryoglobulinemia,2/42,0.2398391968312523,0.3043764259105613,0,0,2.2025959367945824,3.1448369492379444,CXCL10;IL6
Vertical Talus,2/42,0.2398391968312523,0.3043764259105613,0,0,2.2025959367945824,3.1448369492379444,TNNI2;HOXD10
Recurrent otitis media,3/77,0.24524670438879914,0.31118021286135933,0,0,1.786810566222331,2.5113454876642503,IL6;COL2A1;FGFR3
Thickened facial skin with coarse facial features,5/151,0.2465517264960648,0.3127769919054725,0,0,1.5106631382316313,2.115205545397398,RPS6KA3;MMP14;COL2A1;ANTXR2;NKX2-5
Generalized hypotonia,17/633,0.246743505668331,0.31296116790717865,0,0,1.2211850649350648,1.7089336098899865,RET;MEF2C;EGR2;MITF;LIFR;KIF22;COL1A1;RPS6KA3;COL1A2;COL2A1;FLAD1;SIX3;NDN;DMD;PRKD1;EZH2;SOX5
Defective enamel matrix,2/43,0.2481123479559558,0.3145191636225367,0,0,2.1487639707096844,2.99510541318927,FGFR3;RUNX2
Dysplasia of tooth enamel,2/43,0.2481123479559558,0.3145191636225367,0,0,2.1487639707096844,2.99510541318927,FGFR3;RUNX2
Thin dental enamel,2/43,0.2481123479559558,0.3145191636225367,0,0,2.1487639707096844,2.99510541318927,FGFR3;RUNX2
Coarse facial features,5/152,0.2507162074416249,0.31498131138752977,0,0,1.5003092145949288,2.0755782186049276,RPS6KA3;MMP14;COL2A1;ANTXR2;NKX2-5
Dyskinetic syndrome,3/78,0.25121709667395525,0.31498131138752977,0,0,1.76289592760181,2.435331048402142,MEF2C;PRKD1;ADCY5
Full lower lip,3/78,0.25121709667395525,0.31498131138752977,0,0,1.76289592760181,2.435331048402142,RET;RPS6KA3;CDT1
Sudden infant death syndrome,3/78,0.25121709667395525,0.31498131138752977,0,0,1.76289592760181,2.435331048402142,IL6;FOS;SSTR2
Thick lower lip vermilion,3/78,0.25121709667395525,0.31498131138752977,0,0,1.76289592760181,2.435331048402142,RET;RPS6KA3;CDT1
Spastic Paraplegia,4/115,0.25367036873293974,0.31498131138752977,0,0,1.5888541602827317,2.1794624181121716,CAPN3;PAX3;S100A4;GFAP
"Adenocarcinoma, intestinal type",1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,CDKN2A
"Aganglionosis, Rectosigmoid Colon",1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,RET
"Anemia, Microangiopathic",1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,SPTB
"Diabetes Mellitus, Transient Neonatal, 1",1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,SOSTDC1
"Eosinophilia, Tropical",1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,GATA3
"Fibromatosis, Gingival",1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,ANTXR2
"Hodgkin lymphoma, lymphocyte depletion",1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,GATA3
"Hypoalphalipoproteinemia, Familial",1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,APOB
"Pemphigoid, Benign Mucous Membrane",1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,COL17A1
"Pneumonia, Ventilator-Associated",1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,MDK
"POLYMICROGYRIA, BILATERAL FRONTOPARIETAL",1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,ADRA1A
"Scleroderma, Limited",1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,CAV1
"Short stature, severe disproportionate",1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,COL2A1
"Tooth, Supernumerary",1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,RUNX2
"Tremor, Limb",1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,ADRB2
"Vertigo, Paroxysmal",1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,RET
Abnormality of the abdominal wall,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,COL2A1
Abnormality of the vagina,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,WT1
Abnormally low-pitched voice,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,EZH2
Adrenal Gland Diseases,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,ANTXR2
Adult Anaplastic Large Cell Lymphoma,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,ALK
Akinetic-Rigid Variant of Huntington Disease,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,RCAN1
Arterial disease of legs,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,APOB
B Lymphoblastic Lymphoma,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,CDKN2A
Beaking of vertebral bodies,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,COL2A1
Benign symmetrical lipomatosis,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,HMGA2
Beryllium Disease,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,IL6
Blood urea nitrogen measurement,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,MECOM
Cartilage Diseases,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,COL2A1
Cells in urine,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,KLF4
Cholera Infantum,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,MYLK
Clinically isolated syndrome,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,CISH
Congenital absence of liver,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,IL6
Congenital emphysema,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,IL6
Cow milk allergy,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,GATA3
Currarino triad,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,PCSK5
Cutaneous plaque,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,CTLA4
Diaphyseal thickening,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,FGFR3
Diarrheal disorder,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,SAA1
Elevated urinary epinephrine,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,RET
Elevated urinary norepinephrine,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,RET
Episodic paroxysmal anxiety,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,RET
Epithelial corneal erosions,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,FGFR3
Familial Retinoblastoma,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,MYCN
Folliculitis,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,PPARG
Hamartomatous polyp,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,PTGS2
Hearing abnormality,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,WT1
Hepatic infection,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,VTN
Heymann Nephritis,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,C3
Hypoplastic pelvis,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,COL2A1
Idiopathic achalasia of esophagus,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,LTA
Immune Reconstitution Inflammatory Syndrome,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,BRCA1
Infantile malignant osteopetrosis,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,TNFSF11
Influenza A virus infection,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,MUC1
Irregular epiphyses,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,KIF22
Juvenile Huntington Disease,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,RCAN1
Juvenile Spinal Muscular Atrophy,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,STMN1
Keratoconjunctivitis,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,MUC1
Language Development Disorders,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,CNTNAP2
Lecithin Acyltransferase Deficiency,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,APOB
Low density lipoprotein increased,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,APOB
Lymphatic Abnormalities,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,PECAM1
Lysinuric Protein Intolerance,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,CXCL10
Macular retinal edema,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,KDR
Malignant Hypertension,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,AGT
Mediastinal lymphadenopathy,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,WT1
Metabolic myopathy,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,DMD
Mixed Cellularity Hodgkin Lymphoma,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,GATA3
Morphea,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,DCN
Multiple Acyl Coenzyme A Dehydrogenase Deficiency,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,FLAD1
Musculoskeletal Diseases,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,PPARGC1A
Myoglobinuria,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,DMD
Nesidioblastosis,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,PPARG
Neurogenic Urinary Bladder,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,ARNT2
Nicolaides Baraitser syndrome,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,TERT
Nonspherocytic hemolytic anemia,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,ALDOA
Olfactory Neuroblastoma,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,ASCL1
Oncogenic osteomalacia,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,FGF7
Partial to total absence of eyelashes,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,SNRPE
Patellar Dislocation,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,FBN2
Pemphigus and fogo selvagem,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,IL6
Perivascular Epithelioid Cell Neoplasms,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,VIM
Positive regitine blocking test,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,RET
Primary Cutaneous Follicle Center Lymphoma,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,RHOH
Primary Focal Segmental Glomerulosclerosis,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,PAX2
Proximal spinal muscular atrophy,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,STMN1
Pseudohermaphroditism,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,WT1
Pulmonary Valve Stenosis,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,GATA4
Rectal Prolapse,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,RPS6KA3
Renal hypoplasia/aplasia,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,SIX1
Retinitis,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,CXCL12
Royer Syndrome,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,NDN
Schizophrenia and related disorders,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,DLG2
Skin symptom,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,SH2D1A
Small epiphyses,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,KIF22
Sparse or absent eyelashes,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,SNRPE
Sparse to absent eyelashes,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,SNRPE
Spinal Cord Neoplasms,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,GFAP
Stage III Cutaneous Melanoma AJCC v6,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,PTGS2
Stage IV Colorectal Cancer AJCC v7,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,PTGS2
Strudwick syndrome,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,COL2A1
Subependymal Glioma,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,ERBB2
Transformed migraine,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,PTGS2
Vestibular hypofunction,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,MITF
Wedging of vertebra,1/13,0.25368283402250574,0.31498131138752977,0,0,3.6679804804804803,5.031260535914632,COL2A1
Behavior Disorders,2/44,0.2563944613724748,0.31823049391564234,0,0,2.09749543158121,2.8547713137472432,CNTNAP2;ESR1
Mixed anxiety and depressive disorder,2/44,0.2563944613724748,0.31823049391564234,0,0,2.09749543158121,2.8547713137472432,IL6;ALDH2
Myoclonus,5/154,0.2590977130363193,0.3215262824744864,0,0,1.4800183038438073,1.9988387469272006,IL6;FLAD1;CTNND2;BRCA2;ADCY5
Developmental delay (disorder),6/193,0.2604537309328175,0.323149317743359,0,0,1.415565273531239,1.9044025001403477,FBN2;MEF2C;MUC1;CDKN2A;DMD;FGFR3
Dandy-Walker Syndrome,3/80,0.2632194498035177,0.3264601707997091,0,0,1.7169301286948346,2.29170199443035,LAMC1;ZNF423;BUB1
Eosinophilic esophagitis,3/80,0.2632194498035177,0.3264601707997091,0,0,1.7169301286948346,2.29170199443035,IL18;FKBP4;TNFRSF4
"Skin Diseases, Genetic",2/45,0.26468105323901947,0.3279096022049907,0,0,2.048611475668014,2.723075320784557,COL17A1;KRT5
Ascites,2/45,0.26468105323901947,0.3279096022049907,0,0,2.048611475668014,2.723075320784557,IL6;BUB1
Cerebral Amyloid Angiopathy,2/45,0.26468105323901947,0.3279096022049907,0,0,2.048611475668014,2.723075320784557,CCND1;A2M
Delirium,2/45,0.26468105323901947,0.3279096022049907,0,0,2.048611475668014,2.723075320784557,IL6;CCL2
Malignant Central Nervous System Neoplasm,2/45,0.26468105323901947,0.3279096022049907,0,0,2.048611475668014,2.723075320784557,MAML2;TERT
Widely spaced teeth,2/45,0.26468105323901947,0.3279096022049907,0,0,2.048611475668014,2.723075320784557,RPS6KA3;PRKD1
Decreased tendon reflex,6/195,0.26797112642993515,0.3295206403376427,0,0,1.4004411179809813,1.8442073557685368,CNTNAP2;EGR2;DMD;FLNC;SOX10;NEFH
Sensory neuropathy,3/81,0.2692475742783438,0.3295206403376427,0,0,1.694831186912635,2.2238286291226292,MUC1;EGR2;DST
"Anemia, Hemolytic, Acquired",1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,SPTB
"Anemia, Hemolytic, Congenital",1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,ALDOA
"Dermatitis, Phototoxic",1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,PARP1
"Heredodegenerative Disorders, Nervous System",1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,STMN1
"Huntington Disease, Late Onset",1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,RCAN1
"Opitz-G syndrome, type 2",1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,PRKN
"Skin Diseases, Bacterial",1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,COL1A1
"Toxoplasmosis, Congenital",1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,COL2A1
"von Willebrand Disease, Type 1",1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,VWF
Abnormality of the antihelix,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,FGFR3
Absence of sensation,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,ADRB2
Achromatopsia 1,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,LIFR
AIDS-Related Non-Hodgkin Lymphoma,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,IL6
ALZHEIMER DISEASE 2,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,LRP1
Antibiotic-associated diarrhea,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,CCL2
B lymphocytopenia,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,STAT1
Cardiopulmonary Arrest,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,IL18
Central retinal vein occlusion,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,VWF
Cherubism,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,TNFSF11
Cystinuria,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,DDX39A
Desquamation of skin soon after birth,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,IL2RG
Disproportionate short stature,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,COL2A1
Drug-induced depressive state,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,IL6
Dyspareunia,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,CAV1
Easily distracted,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,PAK3
Elevated urinary dopamine,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,RET
Extranodal marginal zone B-cell lymphoma,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,FGF2
Facial diplegia,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,TPM3
Falls,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,DMD
Familial hypobetalipoproteinemia,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,APOB
Fibular hypoplasia,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,BMPR1B
First myocardial infarction,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,VWF
Fulminant Hepatic Failure with Cerebral Edema,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,LTA
Genital ulcers,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,CXCR4
Glossoptosis,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,COL2A1
Growth Hormone-Producing Pituitary Gland Neoplasm,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,CDKN2A
Hashimoto's encephalitis,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,S1PR1
hemangiopericytoma,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,CDKN2A
Hemophagocytic Syndrome,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,SH2D1A
Hepatic Stupor,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,LTA
Hereditary sideroblastic anemia,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,FBN2
hypertensive nephropathy,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,AGT
Hypertensive Retinopathy,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,RET
Hypoplastic ischia,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,COL2A1
Hypoproteinemia,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,NPHS1
IgM deficiency,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,BLM
Interleukin 18 Measurement,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,IL18
Inversion of nipple (disorder),1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,EZH2
Limb hypertonia,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,ADCY5
Manganese Poisoning,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,PRKN
Meningothelial meningioma,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,TERT
Methemoglobinemia,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,FANCD2
Micronodular cirrhosis,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,MET
Myxoma of heart,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,IL6
Nonspecific interstitial pneumonia,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,COL1A1
Oral Mucositis,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,FGF7
Other specified iron deficiency anemias,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,IL6
Paraneoplastic Cerebellar Degeneration,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,ERBB2
Partial thromboplastin time increased (finding),1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,F12
Peripheral arterial stenosis,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,APOB
Peripheral sensory axonal neuropathy,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,NEFH
Phosphate Diabetes,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,PER2
Pituitary stalk interruption syndrome,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,SIX3
Posterior displacement of the tongue,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,COL2A1
Purpura Fulminans,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,PROC
Radiation Damage,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,FANCD2
Recurrent paroxysmal headache,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,RET
Reduced concentration span,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,PAK3
Restrictive ventilatory defect,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,COL2A1
ROSE Cluster 5,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,CXCR4
SEBASTIAN SYNDROME,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,CXCL12
Sensory axonal neuropathy,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,NEFH
Serum iron measurement,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,ERG
Sex Cord-Stromal Tumor,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,WT1
Skin callus,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,BMP2
Stridor,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,SCN4A
Testicular Feminization,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,FKBP4
Thyroid Dysgenesis,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,NKX2-5
Thyroid Lymphoma,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,RHOH
Trisomy 11,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,CCND1
Tubulointerstitial scarring,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,MUC1
Ulnar deviation of hand,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,PAX3
Urinary Bladder Diseases,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,FGF2
Urinary tract obstruction,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,PAX2
Viral Encephalitis,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,ADRB2
Whooping cough due to unspecified organism,1/14,0.2702991673049544,0.3295206403376427,0,0,3.3856548856548856,4.429201431331101,FHL5
Profound Mental Retardation,6/196,0.27175020144617246,0.33122946513838375,0,0,1.3929984414338807,1.814898681670365,CCNA2;MEF2C;PARP1;LAMA1;ASCL1;FGFR3
Adult Diffuse Large B-Cell Lymphoma,2/46,0.2729678339719828,0.33235169923057223,0,0,2.001949517750872,2.5993338864462903,CCND1;EZH2
Childhood Diffuse Large B-Cell Lymphoma,2/46,0.2729678339719828,0.33235169923057223,0,0,2.001949517750872,2.5993338864462903,CCND1;EZH2
Foot-drop,2/46,0.2729678339719828,0.33235169923057223,0,0,2.001949517750872,2.5993338864462903,EGR2;CRYAB
Infiltrating Cervical Carcinoma,2/46,0.2729678339719828,0.33235169923057223,0,0,2.001949517750872,2.5993338864462903,CDKN2A;ERBB2
Ketosis,2/46,0.2729678339719828,0.33235169923057223,0,0,2.001949517750872,2.5993338864462903,ALDH2;CMA1
Pyloric Stenosis,2/46,0.2729678339719828,0.33235169923057223,0,0,2.001949517750872,2.5993338864462903,NPHS1;NEFH
"Blindness, Legal",5/158,0.2760521500673343,0.33604608298934513,0,0,1.441027926322044,1.854841404775253,COL2A1;PROS1;TNFSF11;NEK2;ZNF423
Antiphospholipid Syndrome,2/47,0.28125070177835076,0.3417499814492047,0,0,1.9573614246300477,2.4829302511431472,CCL2;PPARG
Chronic pain,2/47,0.28125070177835076,0.3417499814492047,0,0,1.9573614246300477,2.4829302511431472,CTSG;ADRB2
Failure to thrive in infancy,2/47,0.28125070177835076,0.3417499814492047,0,0,1.9573614246300477,2.4829302511431472,RET;NDN
Foot dorsiflexor weakness,2/47,0.28125070177835076,0.3417499814492047,0,0,1.9573614246300477,2.4829302511431472,EGR2;CRYAB
Male sterility,2/47,0.28125070177835076,0.3417499814492047,0,0,1.9573614246300477,2.4829302511431472,ALDH2;ESR1
Rhinovirus infection,2/47,0.28125070177835076,0.3417499814492047,0,0,1.9573614246300477,2.4829302511431472,CXCL10;CXCR2
Adverse reaction to drug,3/83,0.28134836918294415,0.3417499814492047,0,0,1.6522907239819005,2.095371696964592,C3;PPARA;PTGS2
Bulbous nasal tip,3/83,0.28134836918294415,0.3417499814492047,0,0,1.6522907239819005,2.095371696964592,COL2A1;SOX5;CIT
Bulbous nose,3/83,0.28134836918294415,0.3417499814492047,0,0,1.6522907239819005,2.095371696964592,COL2A1;SOX5;CIT
Drug toxicity,3/83,0.28134836918294415,0.3417499814492047,0,0,1.6522907239819005,2.095371696964592,C3;PPARA;PTGS2
HIV-1 infection,3/83,0.28134836918294415,0.3417499814492047,0,0,1.6522907239819005,2.095371696964592,PTPRB;CXCL12;CXCR4
Potato nose,3/83,0.28134836918294415,0.3417499814492047,0,0,1.6522907239819005,2.095371696964592,COL2A1;SOX5;CIT
"Adenocarcinoma, metastatic",1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,ERBB2
"Autosomal recessive, childhood type, muscular dystrophy resembling Duchenne or Becker muscular dystrophy",1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,CAPN3
"Down Syndrome, Partial Trisomy 21",1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,RCAN1
"MELORHEOSTOSIS, ISOLATED",1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,SOX10
"Reflex, Ankle, Absent",1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,CAPN3
"Rickets, X-Linked Hypophosphatemic",1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,FGF2
"Septicaemia due to gram-negative organism, unspecified",1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,LTA
"Stroke, Lacunar",1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,IL6
"Trisomy 21, Meiotic Nondisjunction",1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,RCAN1
"Trisomy 21, Mitotic Nondisjunction",1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,RCAN1
Absent mandible,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,CDT1
Acro-Osteolysis,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,COL3A1
Acute onset pain,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,PTGS2
Adult Synovial Sarcoma,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,MET
Afibrinogenemia,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,EGR1
Anovulation,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,NR5A2
Anterior pituitary hypoplasia,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,ARNT2
Aplasia/Hypoplasia of the thumb,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,BMPR1B
Aplastic/hypoplastic toenail,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,TERT
Bagassosis,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,ACAN
Benign scapuloperoneal muscular dystrophy with early contractures [Emery-Dreifuss],1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,CAPN3
Budd-Chiari Syndrome,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,SERPINC1
Clumsiness,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,CAPN3
Congenital abnormal Synostosis,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,FGFR3
Congenital absence of mandible,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,CDT1
Congenital muscular dystrophy with specific morphological abnormalities of the muscle fiber,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,CAPN3
Congenital thrombocytopenia,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,MECOM
Cyclocephaly,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,SIX3
Esophageal Varices,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,KDR
Excessive tearing,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,COL17A1
Familial cold urticaria,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,IL6
Familial Periodic Paralysis,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,SCN4A
Fetal Distress,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,IL6
Fowlpox,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,MUC1
Gross motor impairment,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,NDN
Ground-glass opacification on pulmonary HRCT,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,TERT
Hemoglobin H Disease,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,KLF1
Hepatic Coma,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,LTA
Hepatic Vein Thrombosis,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,SERPINC1
Hereditary liability to pressure palsies,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,EGR2
Honeycomb lung,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,TERT
Humoral hypercalcemia of malignancy (disorder),1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,IL6
Hypoplastic anemia,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,TERT
Immunologic hypersensitivity,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,C4A
Iridocyclitis,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,CTLA4
Jacobsen Distal 11q Deletion Syndrome,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,FLI1
Juvenile hemochromatosis,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,ESR1
Limb-girdle muscular dystrophy type 2A,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,CAPN3
Lymphocyte Rich Classical Hodgkin Lymphoma,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,GATA3
maternal hyperglycemia,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,PPARG
Meleda Disease,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,CXCL12
Microangiopathic hemolytic anemia,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,SPTB
Neurogenic Inflammation,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,PTGS2
Nicotine Use Disorder,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,IL6
Nodular melanoma,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,CDKN2A
Pancreatic Endocrine Carcinoma,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,MYCN
Partial or complete agenesis of corpus callosum,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,GPSM2
Patent ductus arteriosus - persisting type,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,ACTA2
Periodic fever,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,IL6
Periorbital fullness,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,FGFR3
Plasmacytosis,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,IL6
Poliomyelitis,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,NECTIN2
Pulsatile Tinnitus,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,RET
Reticular pattern on pulmonary HRCT,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,TERT
Scarring alopecia of scalp,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,COL17A1
Shoulder girdle weakness,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,CAPN3
Smoker's lung,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,ALK
Systemic amyloidosis,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,CALR
Uterine Corpus Carcinosarcoma,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,ERBB2
Widely patent fontanelles and sutures,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,AGT
X-Linked Lissencephaly,1/15,0.28654635964744174,0.3436509556057533,0,0,3.143661518661519,3.929120885513255,ANXA1
Kyphoscoliosis deformity of spine,3/84,0.28741739807076055,0.3444495441547516,0,0,1.6318082788671024,2.0345708247111753,RPS6KA3;EGR2;COL2A1
Mitochondrial Myopathies,3/84,0.28741739807076055,0.3444495441547516,0,0,1.6318082788671024,2.0345708247111753,IL6;MET;PPARGC1A
Situs Inversus,3/84,0.28741739807076055,0.3444495441547516,0,0,1.6318082788671024,2.0345708247111753,ZFP36;IL6;PKD2
Sloping forehead,3/84,0.28741739807076055,0.3444495441547516,0,0,1.6318082788671024,2.0345708247111753,PLK4;RUNX2;CIT
"Epilepsies, Partial",2/48,0.28952573656799624,0.3466051420304212,0,0,1.914711944253607,2.3733066811276458,CNTNAP2;SYN1
contracture of elbow,2/48,0.28952573656799624,0.3466051420304212,0,0,1.914711944253607,2.3733066811276458,LIFR;PITX1
Manic Disorder,2/48,0.28952573656799624,0.3466051420304212,0,0,1.914711944253607,2.3733066811276458,GRK3;GAD1
Progressive cerebellar ataxia,2/48,0.28952573656799624,0.3466051420304212,0,0,1.914711944253607,2.3733066811276458,CNTN1;GFAP
Psychotic symptom,2/48,0.28952573656799624,0.3466051420304212,0,0,1.914711944253607,2.3733066811276458,IL6;TAL1
Sleep Disorders,2/48,0.28952573656799624,0.3466051420304212,0,0,1.914711944253607,2.3733066811276458,PER2;FKBP4
Hyperopia,3/85,0.2934964757353648,0.35129608466204065,0,0,1.6118254055843726,1.9759200782866628,HGF;NDN;MITF
Antisocial behavior,2/49,0.2977891937974547,0.35586338532806155,0,0,1.8738773353825464,2.2699577499506227,C3;ALDH2
Aortic coarctation,2/49,0.2977891937974547,0.35586338532806155,0,0,1.8738773353825464,2.2699577499506227,NKX2-5;AGT
Dental Enamel Hypoplasia,2/49,0.2977891937974547,0.35586338532806155,0,0,1.8738773353825464,2.2699577499506227,FGFR3;RUNX2
Gingival Overgrowth,2/49,0.2977891937974547,0.35586338532806155,0,0,1.8738773353825464,2.2699577499506227,MMP14;ANTXR2
Hypermelanotic macule,2/49,0.2977891937974547,0.35586338532806155,0,0,1.8738773353825464,2.2699577499506227,TERT;KIT
Intracranial Hemorrhages,2/49,0.2977891937974547,0.35586338532806155,0,0,1.8738773353825464,2.2699577499506227,IL6;F13A1
Low anterior hairline,2/49,0.2977891937974547,0.35586338532806155,0,0,1.8738773353825464,2.2699577499506227,RPS6KA3;FGFR3
Oral soft tissue hyperplasia,2/49,0.2977891937974547,0.35586338532806155,0,0,1.8738773353825464,2.2699577499506227,MMP14;ANTXR2
Sparse body hair,2/49,0.2977891937974547,0.35586338532806155,0,0,1.8738773353825464,2.2699577499506227,COL17A1;SNRPE
Nicotine Dependence,4/124,0.2981548481102644,0.35621488930353695,0,0,1.4690098261526834,1.7777109340086032,IL6;SHC3;TERT;ALDH2
Headache,3/86,0.29958386508297846,0.35621488930353695,0,0,1.5923240473205038,1.9193251207394006,IL6;VWF;PTGS2
Muscular hypotonia of the trunk,3/86,0.29958386508297846,0.35621488930353695,0,0,1.5923240473205038,1.9193251207394006,COL2A1;SOX10;GRIN2D
Blindness,5/164,0.3018826958141485,0.35621488930353695,0,0,1.3862206975414522,1.6602997646114108,COL2A1;PROS1;TNFSF11;NEK2;ZNF423
Leukodystrophy,6/204,0.3024104678912444,0.35621488930353695,0,0,1.3361634568923864,1.5980114352385608,VTN;SLC27A6;SOX10;STX11;GFAP;LMNB1
"Amyloidosis, Familial",1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,RET
"Congenital dyserythropoietic anemia, type II",1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,KLF1
"Dyskinesia, Medication-Induced",1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,GAD1
"Guillain-Barre Syndrome, Familial",1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,IL18
"Nephronophthisis, familial juvenile",1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,MUC1
"Neuralgia, Atypical",1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,CXCR4
"Neuralgia, Iliohypogastric Nerve",1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,CXCR4
"Neuralgia, Ilioinguinal",1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,CXCR4
"Neuralgia, Perineal",1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,CXCR4
"Neuralgia, Stump",1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,CXCR4
"Neuralgia, Supraorbital",1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,CXCR4
"Neuralgia, Vidian",1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,CXCR4
Achromatopsia,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,LIFR
Acute type B viral hepatitis,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,IL6
Adenosine deaminase deficiency,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,PAEP
Anxiety and fear,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,STMN1
Arnold Chiari Malformation,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,FGFR3
Basaloid squamous cell carcinoma,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,CDKN2A
Benign neoplasm of bladder,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,FGFR3
Cancer Pain,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,CCL2
Cellulitis,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,COL1A1
Cerebellar Neoplasms,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,MYCN
Cerebral hypomyelination,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,SOX10
Chronic rhinitis,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,TNFSF11
Congenital absence of jaw,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,CDT1
Congenital heart block,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,CALR
Focal Nodular Hyperplasia,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,KRT19
Focal nodular hyperplasia of liver,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,TEK
Gastrointestinal carcinoma,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,FLT4
Glucagonoma,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,SSTR2
Group B Streptococcal Infection,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,IL18
Hand polydactyly,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,BLM
Hemoglobinuria,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,HMGA2
Hypereosinophilic syndrome,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,WT1
Idiopathic bronchiectasis,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,TAP1
Increased number of platelets,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,CALR
infertility tubal factor,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,IL6
Intestinal infectious disease (disorder),1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,LEPR
Macroencephaly,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,CCND2
Malignant melanoma of choroid,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,FGF2
Meconium ileus,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,MUC1
Microsatellite Instability,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,TGFBR2
Myelodysplastic-Myeloproliferative Diseases,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,EZH2
Neoplasm of uncertain or unknown behavior of bladder,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,FGFR3
Non-small cell carcinoma,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,ALK
Ocular muscular dystrophy,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,CAPN3
Optic Nerve Glioma,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,CXCL12
Papillary Meningioma,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,MKI67
Paracoccidioidomycosis,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,CTLA4
Paroxysmal Nerve Pain,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,CXCR4
Partial agenesis of corpus callosum,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,GPSM2
Patellar aplasia,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,CDT1
Pdgfra-Associated Chronic Eosinophilic Leukemia,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,KIT
periodic paralysis (finding),1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,SCN4A
Pertussis,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,FHL5
Ph-Like Acute Lymphoblastic Leukemia,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,GATA3
Primary Systemic Amyloidosis,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,CALR
Q Fever,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,CCL2
Quadriparesis,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,LMNB1
Reactive hypoglycemia,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,PPARA
Reoviridae Infections,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,STAT1
Replication Error Phenotype,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,TGFBR2
Restrictive lung disease,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,COL2A1
Retinal pigment epithelial atrophy,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,VCAN
Round cell liposarcoma,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,CIB1
Secretory meningioma,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,KLF4
Skin Manifestations,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,FGFR3
Slender build,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,FBN2
social stress,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,IL6
Sore to touch,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,CCL2
Thyroxine measurement,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,FGF7
Tonsillitis,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,IL6
Tumor thrombus,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,VIM
Uterine Corpus Sarcoma,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,ERBB2
Visceral angiomatosis,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,TEK
Vitamin K Deficiency,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,PROS1
Waxy flexibility,1/16,0.30243259362846453,0.35621488930353695,0,0,2.933933933933934,3.5086823711820667,AGT
Everted lower lip vermilion,3/87,0.30567786306505973,0.3599110323185381,0,0,1.5732870071105365,1.8646966805652603,RPS6KA3;MYCN;WT1
Protruding lower lip,3/87,0.30567786306505973,0.3599110323185381,0,0,1.5732870071105365,1.8646966805652603,RPS6KA3;MYCN;WT1
Hepatitis D Infection,2/50,0.3060374987409368,0.3601450572181762,0,0,1.8347441685477803,2.1724245020989477,FLT4;PAEP
Single transverse palmar crease,2/50,0.3060374987409368,0.3601450572181762,0,0,1.8347441685477803,2.1724245020989477,RPS6KA3;LIFR
Turcot syndrome (disorder),2/50,0.3060374987409368,0.3601450572181762,0,0,1.8347441685477803,2.1724245020989477,CDKN2A;PTGS2
Retinitis Pigmentosa,11/410,0.30629425120349324,0.3603840559009567,0,0,1.2168439532009747,1.4397807581957647,FBN2;NRP1;COL2A1;CAV1;STMN1;RCC1;NEK2;ERG;APOB;FGF2;ADRA1A
Iron Overload,3/88,0.31177680083477377,0.36677053676761967,0,0,1.5546978972584509,1.8119502277858268,EPAS1;CCL2;PPARA
Hyperkeratosis,4/127,0.3132042666250957,0.3683852635121091,0,0,1.432959091495677,1.6635217683568224,CDKN2A;CAV1;KRT5;FGFR3
"Pain, Crushing",2/51,0.31426724071210965,0.3690538186085904,0,0,1.797208273828719,2.080289370604364,HGF;AQP1
"Pain, Migratory",2/51,0.31426724071210965,0.3690538186085904,0,0,1.797208273828719,2.080289370604364,HGF;AQP1
"Pain, Splitting",2/51,0.31426724071210965,0.3690538186085904,0,0,1.797208273828719,2.080289370604364,HGF;AQP1
"Suffering, Physical",2/51,0.31426724071210965,0.3690538186085904,0,0,1.797208273828719,2.080289370604364,HGF;AQP1
Ache,2/51,0.31426724071210965,0.3690538186085904,0,0,1.797208273828719,2.080289370604364,HGF;AQP1
Albinism,2/51,0.31426724071210965,0.3690538186085904,0,0,1.797208273828719,2.080289370604364,MITF;CALR
Autoimmune Primary Adrenal Insufficiency,2/51,0.31426724071210965,0.3690538186085904,0,0,1.797208273828719,2.080289370604364,CXCL10;CTLA4
Radiating pain,2/51,0.31426724071210965,0.3690538186085904,0,0,1.797208273828719,2.080289370604364,HGF;AQP1
Tapering fingers (finding),2/51,0.31426724071210965,0.3690538186085904,0,0,1.797208273828719,2.080289370604364,RPS6KA3;GATA4
Non-obstructive azoospermia,3/89,0.3178790437365256,0.3695204687060772,0,0,1.5365410922866463,1.7610056746746778,WT1;SIRPA;SOX5
Wheezing,3/89,0.3178790437365256,0.3695204687060772,0,0,1.5365410922866463,1.7610056746746778,CXCL10;IL6;ADRB2
"Affective Disorders, Psychotic",1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,SKAP2
"Color Blindness, Blue",1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,ERG
"Cutis Laxa, Autosomal Recessive, Type I",1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,FGF2
"Gonadal Dysgenesis, 45,X",1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,DMD
"Liposarcoma, Pleomorphic",1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,LEPR
"Polyposis, Adenomatous Intestinal",1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,PTGS2
Abnormality of the eyebrow,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,SOX10
Acute malaria,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,CD36
Alcohol problem,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,ALDH2
Anal carcinoma,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,CDKN2A
Carcinoma in situ of bladder,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,FGFR3
Central nervous system lesion,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,CCL2
child abuse behavior,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,TAL1
Chronic sinus disease,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,TAP1
Colon diverticulum anatomic structure,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,RET
Congenital Intestinal Aganglionosis,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,RET
Corneal diameter increased,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,TEK
Craniofacial hyperostosis,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,RPS6KA3
Diverticular disease of colon,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,RET
Enlargement of craniofacial bones,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,RPS6KA3
Erythema Multiforme,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,CDKN3
Ethylmalonic encephalopathy,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,MUC1
Familial Hyperaldosteronism,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,AGT
Familial Intestinal Polyposis,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,PTGS2
Hyperkeratosis lenticularis perstans,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,APOB
Hypertrophy of craniofacial bones,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,RPS6KA3
Ileal Diseases,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,TCF7L2
Leydig Cell Tumor,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,PTGS2
Lipoprotein (a) measurement,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,PRKN
Lofgrens syndrome,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,CXCR4
Long foot,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,RPS6KA3
McCune-Albright Syndrome,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,IL6
Metastatic hepatocellular carcinoma,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,EZR
Mitochondrial cardiomyopathy,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,C3
Mucosal telangiectasiae,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,CAV1
Mucosal ulcer,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,MMP14
Multiple Organ Failure,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,PROC
Narrow palm,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,NDN
Nerve Pain,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,CXCR4
Neurofibrosarcoma,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,SYN1
Occlusive vascular disease,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,APOB
Onychogryposis,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,KRT5
Overriding toe,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,EZH2
Pancreatic Cyst,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,PKD2
Parasitic infection,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,ADRB2
Pediatric Crohn's disease,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,STAT5B
Poisoning,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,CDKN2A
Post-transplant lymphoproliferative disorder,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,CDKN2A
Rales,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,TERT
Recurrent fungal infections,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,IL2RG
Sinus Tachycardia,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,RET
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,CCND1
Stiff-Person Syndrome,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,GAD1
T-lymphocyte deficiency,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,RHOH
Thick craniofacial bones,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,RPS6KA3
Tonic-Clonic Epilepsy,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,FGF2
Tricuspid Valve Insufficiency,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,PLD1
Vocal Cord Paralysis,1/17,0.3179658708535468,0.3695204687060772,0,0,2.7504222972972974,3.1514647453683433,MYCN
Behavioral Symptoms,2/52,0.32247516764296813,0.3746960598425907,0,0,1.76117381489842,1.9931717362026953,COL1A1;EZH2
Nystagmus,13/500,0.32267343004115334,0.3748615734572541,0,0,1.1782454939539129,1.332730586008294,PLK4;ARNT2;LAMA1;CAV1;MITF;SOX10;SYNE1;LMNB1;WT1;TNFSF11;NEK2;PRKD1;ZNF423
Age at menarche,3/90,0.3239829916615225,0.37625277053411466,0,0,1.5188016851302855,1.7117870964869148,DST;KCTD13;RXRG
Motor neuron atrophy,3/90,0.3239829916615225,0.37625277053411466,0,0,1.5188016851302855,1.7117870964869148,STMN1;NEFH;TEAD1
Brachycephaly,4/130,0.328320042241022,0.38122361751222406,0,0,1.398625058489004,1.5577416072267847,FBN2;BMP2;FGFR3;EZH2
Ichthyoses,3/91,0.3300870789970138,0.3822761611576559,0,0,1.5014654463183874,1.6642224742899552,F13A1;DMD;GATA3
"Other specified types of schizophrenia, unspecified",2/53,0.330658180756628,0.3822761611576559,0,0,1.7265524720046033,1.9107240378180597,MDK;PTGS2
"Pain, Burning",2/53,0.330658180756628,0.3822761611576559,0,0,1.7265524720046033,1.9107240378180597,HGF;AQP1
Anxiety neurosis (finding),2/53,0.330658180756628,0.3822761611576559,0,0,1.7265524720046033,1.9107240378180597,MDK;FOS
Bradycardia,2/53,0.330658180756628,0.3822761611576559,0,0,1.7265524720046033,1.9107240378180597,DST;AGT
NEUROTICISM,2/53,0.330658180756628,0.3822761611576559,0,0,1.7265524720046033,1.9107240378180597,CNTNAP2;LTA
Situs ambiguus,2/53,0.330658180756628,0.3822761611576559,0,0,1.7265524720046033,1.9107240378180597,PKD2;TDGF1
Stevens-Johnson Syndrome,2/53,0.330658180756628,0.3822761611576559,0,0,1.7265524720046033,1.9107240378180597,PARP1;CAV1
"Adenoma, Villous",1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,CDKN2A
"Carney Complex, Type 1",1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,CAV1
"Dyskinesia, Drug-Induced",1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,GAD1
"ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE",1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,KRT19
"ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE",1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,KRT19
"Hereditary motor and sensory neuropathy, types I-IV",1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,EGR2
"Leprosy, Paucibacillary",1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,LRP1
"Psychoses, Substance-Induced",1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,ESR1
Achromasia,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,MITF
Acrodysostosis,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,ADRA1A
Alkalosis,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,AGT
Amnestic State,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,IL6
Biopsy shows villous atrophy,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,STAT1
Chronic Neutrophilic Leukemia,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,CALR
Chronic Q Fever,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,CCL2
Coloboma of optic disc,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,PAX2
Compression of spinal cord,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,CCL2
Congenital scar,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,COL17A1
Diminished ovarian reserve,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,PTGS2
Disorders of Porphyrin Metabolism,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,PPARGC1A
Dissociative Amnesia,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,IL6
Duodenal villous atrophy,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,STAT1
Elevated circulating parathyroid hormone level,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,CDKN2C
Episodic hyperhidrosis,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,RET
Exercise-induced myalgia,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,DMD
Global Amnesia,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,IL6
Hyperlipoproteinemia Type III,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,APOB
Hypertrophic neuropathy of infancy,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,EGR2
Hypocupremia,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,ERBB2
Hypoplastic fingernail,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,RPS6KA3
Hysterical amnesia,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,IL6
Idiopathic scoliosis,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,ESR1
Increased IgM level,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,SH2D1A
Infection by Candida albicans,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,NR5A2
Invasive Fungal Infections,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,IL6
Laryngitis,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,MUC1
Malignant neoplasm tonsil,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,CDKN2A
Meningococcemia,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,IL6
Myeloid and Lymphoid Neoplasms with FGFR1 Rearrangement,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,KIT
Nail-Patella Syndrome,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,PAX2
Narrowing of ear canal,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,SIX1
Odontogenesis,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,HMGA2
Osteofibrous Dysplasia,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,MET
Overgrowth Syndrome,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,FGFR3
Pancreatic carcinoma resectable,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,CHEK1
Peroneal muscular atrophy (axonal type) (hypertrophic type),1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,EGR2
Pleocytosis,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,IL6
Primary antiphospholipid syndrome,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,SKAP2
Prostate specific antigen measurement,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,TERT
Pulpitis,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,CXCL10
Pyothorax-Associated Lymphoma,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,CDKN2A
Refractory anemia with excess blasts in transformation (clinical),1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,IL6
Rimmed vacuoles on biopsy,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,NEFH
Small intestine biopsy shows villous atrophy,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,STAT1
Stenosis,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,PECAM1
Tactile Amnesia,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,IL6
Temporary Amnesia,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,IL6
Tooth Loss,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,ESR1
Variable degree of villous atrophy,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,STAT1
Villous atrophy,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,STAT1
Villous atrophy of intestine,1/18,0.3331540159701846,0.3822761611576559,0,0,2.588500264970853,2.845151064124307,STAT1
Facial Paresis,3/92,0.33618977460462557,0.3856277585387985,0,0,1.4845187859067568,1.6182434559342511,TPM3;BIN1;TNFSF11
Stereotypic Movement Disorder,3/92,0.33618977460462557,0.3856277585387985,0,0,1.4845187859067568,1.6182434559342511,MEF2C;GAD1;GFAP
Cardiac Arrhythmia,4/132,0.33842157475982865,0.3881214644957324,0,0,1.3766298185941044,1.4915273328399368,DMD;NKX2-5;PTGS2;AGT
Dizziness,2/54,0.3388133292992604,0.3885044083274429,0,0,1.6932627192220873,1.8326283570739963,CCL2;PAEP
Cerebral atrophy,9/338,0.33949660009851523,0.38922143500539913,0,0,1.2062825911156967,1.303136644580775,PLK4;MUC1;TERT;ALDH2;BIN1;LTA;FADD;SYP;FGFR3
Fetal Alcohol Syndrome,2/55,0.34693780552225845,0.3947972016560588,0,0,1.6612291835257038,1.7585934105085723,IL6;PPARA
Primary central nervous system lymphoma,2/55,0.34693780552225845,0.3947972016560588,0,0,1.6612291835257038,1.7585934105085723,CDKN2A;CIB1
Protein C antigen measurement,2/55,0.34693780552225845,0.3947972016560588,0,0,1.6612291835257038,1.7585934105085723,PROC;SCAND1
Protein C measurement,2/55,0.34693780552225845,0.3947972016560588,0,0,1.6612291835257038,1.7585934105085723,PROC;SCAND1
Spinocerebellar Ataxia Type 2,2/55,0.34693780552225845,0.3947972016560588,0,0,1.6612291835257038,1.7585934105085723,PRKN;CIT
"Arteriovenous Malformations, Cerebral",1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,IL6
"Hand, Foot and Mouth Disease",1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,IL6
"Hypothermia, natural",1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,IL6
"Leukemia, Monocytic, Chronic",1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,MECOM
"Lupus Erythematosus, Cutaneous",1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,IL18
"Myasthenic Syndromes, Congenital, Slow Channel",1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,SCN4A
"Night blindness, stationary",1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,ERG
Abnormality of the musculature,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,PPARG
Abnormality of the periventricular white matter,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,LAMA1
Adult Non-Hodgkin Lymphoma,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,ADAM12
Alcohol Withdrawal Delirium,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,ALDH2
Alloimmunisation,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,CTLA4
Anti-Glomerular Basement Membrane Disease,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,PPARA
Asymmetric Septal Hypertrophy,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,CD36
Atrophic retina,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,LAMA1
Bell-shaped thorax,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,FGFR3
Bipolar II disorder,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,ALDH2
Blepharospasm,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,FGFR3
CADASIL Syndrome,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,GFAP
Cavitation,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,CDKN2A
Cholecystitis,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,ALDOA
Communicating Hydrocephalus,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,MPDZ
Congenital keratoglobus,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,TEK
Decreased calcification of skull,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,RUNX2
Defect of skull ossification,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,RUNX2
Delayed closure of the soft spot on the skull,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,RPS6KA3
Dent's disease,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,SYP
Depressed nasal tip,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,MYCN
Endocarditis,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,VWF
Flared iliac wings,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,BGN
Galactosemias,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,DMD
Gastric Cardia Carcinoma,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,CDKN2A
Generalized hyperkeratosis,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,KRT5
HER2-positive carcinoma of breast,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,ERBB2
Homocysteine measurement,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,FANCA
Hypertrophy,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,AGT
Intermittent fever,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,LIFR
Intestinal Volvulus,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,TEK
Late closure of anterior fontanel,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,RPS6KA3
Massive Osteolyses,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,APOB
Mixed phenotype acute leukemia,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,WT1
Multiple adenomatous polyps,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,PTGS2
Myoclonic dystonia,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,ADCY5
Nasal Type Extranodal NK/T-Cell Lymphoma,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,RHOJ
Pyoderma Gangrenosum,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,COL17A1
Refractory anemia with ringed sideroblasts,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,CXCR4
Renal salt wasting,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,MUC1
Rough bone trabeculation,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,TERT
Shallow orbits,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,MITF
Slurred speech,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,EZH2
Somnolence,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,CXCL10
Staphylococcal Infections,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,CD36
Submucous clefting,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,SIX3
Tachyarrhythmia,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,VAV3
Thyrotoxicosis,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,RET
Tracheomalacia,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,COL2A1
Venoocclusive disease,1/19,0.34800468043535854,0.3947972016560588,0,0,2.4445695695695697,2.580339373933961,SERPINC1
Dystonia Disorders,4/135,0.35359226411265754,0.40106834078375414,0,0,1.3448962282113863,1.3981686786513037,RIMS2;PRKN;DST;ADCY5
Agenesis,3/95,0.354474717597131,0.40200138523848894,0,0,1.4358892386385993,1.4891869401689029,RET;COL1A2;GATA4
Gonorrhea,2/56,0.3550289399244564,0.40235814386308627,0,0,1.6303820750773346,1.6883518943501703,IL6;CAV1
Holoprosencephaly,2/56,0.3550289399244564,0.40235814386308627,0,0,1.6303820750773346,1.6883518943501703,SIX3;TDGF1
Paralysed,2/56,0.3550289399244564,0.40235814386308627,0,0,1.6303820750773346,1.6883518943501703,NEFH;PPARGC1A
Vertigo,2/56,0.3550289399244564,0.40235814386308627,0,0,1.6303820750773346,1.6883518943501703,CCL2;PAEP
"Arnold-Chiari Malformation, Type I",1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,PAX2
"Asthma, Aspirin-Induced",1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,PTGS2
"Jaundice, Obstructive",1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,CCL2
"Mental Disorders, Severe",1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,CNTNAP2
"Psychosis, Involutional",1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,GAD1
Amebic colitis,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,LEPR
Aplasia/Hypoplasia of the iris,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,WT1
Asthmatic pulmonary eosinophilia,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,CCL2
Candidiasis of vagina,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,SH2D1A
Central hypothyroidism,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,DEPP1
Cholesteryl Ester Transfer Protein Deficiency,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,APOB
Chronic multifocal osteomyelitis,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,STAT1
Chronic small plaque psoriasis,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,PPARG
Chronic ulcerative colitis,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,CDKN2A
Coronal craniosynostosis,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,FGFR3
Coronary Artery Vasospasm,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,IL6
Cutaneous finger syndactyly,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,PAX3
Endophthalmitis,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,SOX10
Gray Platelet Syndrome,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,CD36
Hair Color,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,FANCA
Hypoplasia of iris,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,SOX10
Hypoplasia of the pituitary gland,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,ARNT2
Involutional Depression,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,GAD1
Involutional paraphrenia,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,GAD1
Leukaemia recurrent,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,NGFR
Mucopolysaccharidosis IV,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,COL2A1
Ophthalmoparesis,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,KRT5
Other Creutzfeldt-Jakob disease,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,PRKN
Placental Choriocarcinoma,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,KDR
Poikiloderma,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,CTLA4
Pouchitis,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,PTGS2
Protuberant abdomen,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,COL2A1
Recurrent viral infection,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,MCM4
Retinoic acid syndrome,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,PECAM1
Small thymus,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,IL2RG
Stenosis of external auditory canal,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,SIX1
Vitamin A Deficiency,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,PARP1
Warts,1/20,0.3625253465492457,0.4082361212985805,0,0,2.3157894736842106,2.349740998270119,CXCR4
"Respiratory Distress Syndrome, Newborn",2/57,0.36308419632935246,0.40845451633968693,0,0,1.6006566796634516,1.6216581369285896,IL6;PLA2G2A
Abnormality of the voice,2/57,0.36308419632935246,0.40845451633968693,0,0,1.6006566796634516,1.6216581369285896,SOX10;TGFBR2
Broad nasal tip,2/57,0.36308419632935246,0.40845451633968693,0,0,1.6006566796634516,1.6216581369285896,RPS6KA3;RARB
Obsessive compulsive behavior,2/57,0.36308419632935246,0.40845451633968693,0,0,1.6006566796634516,1.6216581369285896,TAL1;ESR1
Pallor,2/57,0.36308419632935246,0.40845451633968693,0,0,1.6006566796634516,1.6216581369285896,TNFSF11;KLF1
Pneumocystis jiroveci pneumonia,2/57,0.36308419632935246,0.40845451633968693,0,0,1.6006566796634516,1.6216581369285896,C3;IL6
Retinal Dystrophies,5/178,0.3632939234522531,0.40862200467347715,0,0,1.273121387283237,1.2890902327078675,LAMA1;ERG;ZNF423;FGF2;PAX2
Pruritus,4/137,0.3637080962838382,0.4090193527532246,0,0,1.3245358293693417,1.339640394038823,KIT;CTLA4;IL2RG;ADRA1A
Respiratory Tract Diseases,2/58,0.37110116746642396,0.41719374635160755,0,0,1.5719929055143502,1.5582860154893865,MUC1;PTGS2
SCHIZOPHRENIA 1 (disorder),2/58,0.37110116746642396,0.41719374635160755,0,0,1.5719929055143502,1.5582860154893865,MDK;PTGS2
"46, XY female",1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,GADD45G
"Congenital Myasthenic Syndromes, Presynaptic",1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,SCN4A
"Lymphoma, Follicular, Grade 2",1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,EZH2
"Lymphoma, Mixed-Cell, Follicular",1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,EZH2
"Lymphoma, Small Cleaved-Cell, Follicular",1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,EZH2
"Meningiomas, Multiple",1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,HOXA10
"Neoplasms, Radiation-Induced",1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,RET
"Polyarticular Juvenile Idiopathic Arthritis, Rheumatoid Factor Negative",1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,STAT1
"Pseudohypoaldosteronism, Type II",1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,KLHL3
"Xanthomatosis, Cerebrotendinous",1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,UTRN
Abnormal development of end part of bone,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,COL2A1
Amyloid nephropathy,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,SAA1
Asthma chronic,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,TIMP1
Bilateral Cryptorchidism,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,WT1
Classical galactosemia,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,DMD
Clumsiness - motor delay,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,ADRA1A
Congenital anomaly of neck,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,PPARG
Deformity of neck,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,PPARG
Diabetic peripheral neuropathy,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,HGF
Diastasis recti,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,EZH2
EMG: neuropathic changes,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,CAPN3
Epiphyseal dysplasia,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,COL2A1
Erythema Chronicum Migrans,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,CXCL10
Glucose measurement,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,TCF7L2
Heparin-induced thrombocytopenia,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,CIB1
Hereditary Multiple Exostoses,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,TCF7L2
Herpes encephalitis,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,STAT1
idiopathic epilepsy,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,SYN1
Little's Disease,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,GAD1
Malformation of the neck,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,PPARG
Mental handicap,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,PAK3
Microcytic hypochromic anemia (disorder),1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,KLF1
Mild global developmental delay,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,PLK4
Mycosis fungoides/Sezary syndrome NOS,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,CDKN2A
Neonatal Systemic lupus erythematosus,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,CALR
Olivopontocerebellar Atrophies,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,GRIA2
Otitis Media with Effusion,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,COL2A1
Papillon-Lefevre Disease,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,GZMB
pathologic fistula,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,CTLA4
Pseudomyxoma Peritonei,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,VIM
Rare Diseases,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,KIT
Regurgitation,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,TGFBR2
Respiratory Hypersensitivity,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,IL6
Severe diarrhea,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,FHL5
Small chin,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,MEF2C
Torsades de Pointes,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,ADRB1
Tubulointerstitial fibrosis,1/21,0.3767233311723716,0.4202082531396193,0,0,2.1998873873873874,2.1476273697252033,MUC1
Acne,2/59,0.3790775704413985,0.4227640257529778,0,0,1.5443348778266208,1.4980271061946548,C4A;ESR1
Mental impairment,5/182,0.38095618314628976,0.4247885980425838,0,0,1.2440934771443246,1.2006384307492097,PLK4;MEF2C;COL3A1;DMD;FGFR3
Mood swings,3/100,0.3847888671570985,0.4289198393073981,0,0,1.3615244670429631,1.3003382275186661,LEPR;PPARGC1A;NEFH
Myalgia,3/100,0.3847888671570985,0.4289198393073981,0,0,1.3615244670429631,1.3003382275186661,C4A;SCN4A;DMD
Angelman Syndrome,2/60,0.38701124231030287,0.4313255066969788,0,0,1.5176305752315715,1.4406890368716097,PRKN;MEF2C
"Lymphoma, Follicular, Grade 3",1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,EZH2
"Lymphoma, Mixed-Cell",1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,RAD54B
"Psychomotor retardation, mild",1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,PLK4
"Psychosis, Brief Reactive",1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,CNTNAP2
"SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1",1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,FGF1
22q11 Deletion Syndrome,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,CXCR4
Anorectal Malformations,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,TERT
Bare Lymphocyte Syndrome,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,TAP1
Biliary Tract Diseases,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,KRT19
Cluster Headache,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,SELE
Columnar Cell Hyperplasia of the Breast,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,RET
Cone dysfunction syndrome,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,ERG
Flexion contracture of hip,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,COL2A1
Gastrointestinal inflammation,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,CCL2
Herpes zoster disease,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,ESR1
Hypoplastic finger,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,BMPR1B
Hypothalamic gonadotropin-releasing hormone deficiency,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,SOX10
Intracranial Meningioma,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,VIM
Kashin-Beck Disease,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,ACAN
Lower respiratory tract infection,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,PER2
Microretrognathia,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,CTNND2
Neurodegeneration with brain iron accumulation (NBIA),1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,PLA2G4A
Personality Traits,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,RXRG
Platelet Storage Pool Deficiency,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,FLI1
Relative macrocephaly,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,ACAN
Severe depression,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,ESR1
Short finger,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,BMPR1B
Short lower third of face,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,MEF2C
Spasm,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,ADRB2
Spastic syndrome,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,MYCN
Submucous cleft of hard palate,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,SIX3
Sudden death,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,AGT
TDP-43 Proteinopathies,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,CDC7
Urethral Stricture,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,TERT
Wasting,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,DMD
XX males,1/22,0.39060578906915605,0.43274636743458467,0,0,2.095023595023595,1.9694404217914498,GATA4
Mean corpuscular hemoglobin concentration determination,3/101,0.3908158083506395,0.4329076313512939,0,0,1.3475621017637824,1.266060074818199,SPTA1;ALDH2;SPTB
Bradykinesia,2/61,0.3949001361348045,0.4369993926975362,0,0,1.4918315032329648,1.3860940158933641,PRKN;SNCAIP
Hemiparesis,2/61,0.3949001361348045,0.4369993926975362,0,0,1.4918315032329648,1.3860940158933641,C4A;COL3A1
Hypernasal voice,2/61,0.3949001361348045,0.4369993926975362,0,0,1.4918315032329648,1.3860940158933641,NDN;LIFR
Nasal voice,2/61,0.3949001361348045,0.4369993926975362,0,0,1.4918315032329648,1.3860940158933641,NDN;LIFR
Profound intellectual disabilities,2/61,0.3949001361348045,0.4369993926975362,0,0,1.4918315032329648,1.3860940158933641,EZR;FGFR3
Viremia,2/61,0.3949001361348045,0.4369993926975362,0,0,1.4918315032329648,1.3860940158933641,CCL2;PAEP
Cerebellar Hypoplasia,4/144,0.399021596754881,0.4414874866236871,0,0,1.2578555231616455,1.1556418517182891,GPSM2;TERT;SIX3;CIT
Coloboma of iris,2/62,0.40274231669348043,0.4431789352817101,0,0,1.4668924003009782,1.3340775188550404,YAP1;ZNF423
Leber Congenital Amaurosis,2/62,0.40274231669348043,0.4431789352817101,0,0,1.4668924003009782,1.3340775188550404,MEF2C;ENO2
Hypoplasia of corpus callosum,5/187,0.4030073704155282,0.4431789352817101,0,0,1.2096028971028971,1.099287630996824,GPSM2;ARNT2;MEF2C;WT1;FGFR3
"Congenital Myasthenic Syndromes, Postsynaptic",1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,SCN4A
"Dermatitis, Irritant",1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,CXCL10
"Lupus Erythematosus, Subacute Cutaneous",1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,CTLA4
"Myopia, Degenerative",1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,FLI1
"Skin Diseases, Infectious",1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,CD36
Absence of pubertal development,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,ESR1
Activated B-cell type diffuse large B-cell lymphoma,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,CDC7
Acute-On-Chronic Liver Failure,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,IL6
Akinesia,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,CNTN1
AMYOTROPHIC LATERAL SCLEROSIS 6 (disorder),1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,CTNND2
Anencephaly,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,LMNB1
Antithrombin III Deficiency,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,SERPINC1
Bloch Sulzberger syndrome,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,BGN
Bullet vertebral body,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,COL2A1
C-cell hyperplasia of thyroid,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,RET
Capillary malformation (disorder),1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,STAT1
Chronic urticaria,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,SERPING1
Clubbed Fingers,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,TERT
cocaine use,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,ADRA1A
Congenital dislocation of radial head,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,KIF22
Diffuse Mixed-Cell Lymphoma,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,RAD54B
Electrocardiogram: P-R interval,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,CAV1
Enlarged kidney,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,SAA1
Exfoliation Syndrome,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,CNTNAP2
Ferritin measurement,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,EPS8
Functional Gastrointestinal Disorders,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,MYLK
Hemorrhagic Fever with Renal Syndrome,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,IL6
Hypobetalipoproteinemias,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,APOB
Involuntary Movements,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,PPARGC1A
Irido-corneo-trabecular dysgenesis (disorder),1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,PAX3
Isodicentric Chromosome 15 Syndrome,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,DMD
Large elongated pulp chamber,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,TERT
Leukemia secondary,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,EZH2
Lipids measurement,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,APOB
Listeriosis,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,IL6
Meningomyelocele,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,FGF2
Multi-infarct dementia,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,IL6
Ovoid vertebral bodies,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,COL2A1
Persistant truncus arteriosus,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,NKX2-5
Porphyria Cutanea Tarda,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,IL6
Posterior subcapsular cataract,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,CRYAB
PR interval feature,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,CAV1
Pre B-cell acute lymphoblastic leukemia,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,CCND1
response to statin,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,EPB41L2
Rubinstein-Taybi Syndrome,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,BMP2
Smallpox,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,IL18
Spider Veins,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,ACTA2
Stomatitis,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,FGF7
Taurodontism,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,TERT
Triphalangeal thumb,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,PARP1
Typhoid Fever,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,PRKN
Varicocele,1/23,0.4041797168851213,0.4431789352817101,0,0,1.9996928746928746,1.8115130888375652,STAT1
Photophobia,5/188,0.4074086722069192,0.4466465299610952,0,0,1.202930948832588,1.0801579982086615,COL17A1;C4A;ALDH2;NEK2;MITF
Electrocardiographic changes,3/104,0.4088031153952446,0.4481021255091338,0,0,1.3073339008108955,1.1694384379084617,CAPN3;DMD;NKX2-5
Difficulty walking,2/63,0.4105359566580555,0.4498547046688694,0,0,1.4427709728749585,1.2844871109967382,CAPN3;DMD
Kidney Calculi,2/63,0.4105359566580555,0.4498547046688694,0,0,1.4427709728749585,1.2844871109967382,IL6;PDE1A
Polydactyly,4/147,0.41406526437394303,0.45364801232225144,0,0,1.2312766598480884,1.0856556306492755,CENPF;CCND2;PITX1;FGFR3
Feeding difficulties in infancy,6/233,0.41685598321438383,0.4551310616257055,0,0,1.163718101813292,1.0182701906900467,RPS6KA3;BIN1;LIFR;FLI1;EZH2;TGFBR2
"Candidiasis, Chronic Mucocutaneous",1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,STAT1
"Glossitis, Benign Migratory",1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,CXCL10
"Ichthyosiform Erythroderma, Congenital",1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,GATA3
"Lymphoma, Undifferentiated",1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,RAD54B
Abnormality of the pharynx,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,TERT
Adiponectin Measurement,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,FAM107A
Asymptomatic human immunodeficiency virus infection,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,CXCL10
Candidemia,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,DBF4
Catalepsy,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,AGT
Colonic Diseases,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,IL6
Corneal erosion,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,COL17A1
Elastosis perforans serpiginosa,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,COL1A1
Erectile abnormalities,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,SOX10
Fetal overgrowth,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,ESR1
Generalized overgrowth,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,ESR1
Hyperphenylalaninaemia,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,AGT
Lyme Arthritis,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,ACAN
Norrie disease,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,SYP
Ovarian Diseases,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,CCND1
Overgrowth,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,ESR1
Pelger-Huet Anomaly,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,CA12
Peripheral demyelination,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,SOX10
Poor eye contact,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,MEF2C
Precursor T-cell lymphoblastic lymphoma,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,TAL1
Progressive neurologic deterioration,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,LMNB1
Severe combined immunodeficiency due to adenosine deaminase deficiency,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,PAEP
Skin tag on the posterior cheek,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,SIX1
Staphylococcal toxic shock syndrome,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,IL6
Steatorrhea,1/24,0.41745195646431593,0.4551310616257055,0,0,1.9126517822169997,1.6708654672219938,ANTXR2
"Anus, Imperforate",2/64,0.41827933267620815,0.4557371833636298,0,0,1.4194276560110681,1.2371813913610101,RAD51;PCSK5
Hirsutism,2/64,0.41827933267620815,0.4557371833636298,0,0,1.4194276560110681,1.2371813913610101,CAV1;PPARG
Multiple Endocrine Neoplasia Type 2a,2/64,0.41827933267620815,0.4557371833636298,0,0,1.4194276560110681,1.2371813913610101,RET;NRP1
Smooth philtrum,2/64,0.41827933267620815,0.4557371833636298,0,0,1.4194276560110681,1.2371813913610101,PAX3;FLI1
Limitation of joint mobility,2/65,0.42597082183565016,0.46404217995916086,0,0,1.3968253968253967,1.1920290428473597,COL2A1;BMPR1B
"Hemangioma, Cavernous",1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,TEK
"Human T-cell lymphotrophic virus, type I [HTLV-I]",1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,CDKN2A
"Hydrocephalus, Normal Pressure",1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,MUC1
"Lymphoma, Intermediate-Grade",1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,RAD54B
"Plagiocephaly, Nonsynostotic",1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,FGFR3
Abnormality of the clavicle,1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,FGFR3
Asymmetry of the posterior cranium,1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,FGFR3
Bernard-Soulier Syndrome,1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,VWF
Cervix Diseases,1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,CDKN2A
Down-sloping shoulders,1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,RUNX2
Flat head,1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,FGFR3
Flattening of cranial vault,1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,FGFR3
Flattening of head,1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,FGFR3
Frequent falls,1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,NEFH
Frontal lobe hypoplasia,1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,CIT
Goiter,1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,TEK
Hepatic Veno-Occlusive Disease,1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,IL6
Increased intramyocellular lipid droplets,1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,SCN4A
Onion bulb formation,1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,EGR2
Plagiocephaly,1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,FGFR3
Preauricular skin tag,1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,SIX1
Progressive macrocephaly,1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,GFAP
Pulmonary Sclerosing Hemangioma,1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,ERBB2
Rhomboid shaped head,1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,FGFR3
T-Cell Large Granular Lymphocyte Leukemia,1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,STAT5B
Type II Mucolipidosis,1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,IL6
Uterine Carcinosarcoma,1/25,0.43042919810686536,0.46685440802417766,0,0,1.8328641141141142,1.5450539215743864,ERBB2
Long face,3/108,0.4325268702922778,0.46897811767564385,0,0,1.2572721396250808,1.0537333923238306,TPM3;SIX1;ZNF423
Physical aggression,3/108,0.4325268702922778,0.46897811767564385,0,0,1.2572721396250808,1.0537333923238306,LEPR;PAK3;SYN1
Pediatric failure to thrive,13/543,0.43357110749420585,0.469923730453502,0,0,1.0802105171208944,0.902731351336769,RET;CA12;CDT1;TPM3;HMGA2;ASCL1;IL2RG;ANTXR2;GRIN2D;CIT;NR4A1;TERT;APOB
Addison Disease,2/66,0.43360889779933764,0.469923730453502,0,0,1.3749294582392777,1.1489079783659282,CXCL10;CTLA4
Glycogen storage disease type II,2/66,0.43360889779933764,0.469923730453502,0,0,1.3749294582392777,1.1489079783659282,CXCR4;PPARGC1A
Aplasia/Hypoplasia of the cerebellum,2/67,0.44119212762556526,0.4775255969594353,0,0,1.3537072408404236,1.1077045689462202,PLK4;FGFR3
Fine hair,2/67,0.44119212762556526,0.4775255969594353,0,0,1.3537072408404236,1.1077045689462202,COL3A1;EZH2
Parasitemia,2/67,0.44119212762556526,0.4775255969594353,0,0,1.3537072408404236,1.1077045689462202,CXCL10;IL6
Pyramidal sign,2/67,0.44119212762556526,0.4775255969594353,0,0,1.3537072408404236,1.1077045689462202,SOX10;LMNB1
Schistosomiasis,2/67,0.44119212762556526,0.4775255969594353,0,0,1.3537072408404236,1.1077045689462202,CDKN2A;ERBB2
Short distal phalanx of finger,2/67,0.44119212762556526,0.4775255969594353,0,0,1.3537072408404236,1.1077045689462202,RPS6KA3;COL2A1
Toxic Epidermal Necrolysis,2/67,0.44119212762556526,0.4775255969594353,0,0,1.3537072408404236,1.1077045689462202,PARP1;CAV1
Wide nose,2/67,0.44119212762556526,0.4775255969594353,0,0,1.3537072408404236,1.1077045689462202,RPS6KA3;KIF22
"Malaria, Vivax",1/26,0.44311798428487736,0.4778388539590938,0,0,1.7594594594594595,1.432057860629081,IL6
Abnormal pattern of respiration,1/26,0.44311798428487736,0.4778388539590938,0,0,1.7594594594594595,1.432057860629081,KRT5
Acute hepatitis,1/26,0.44311798428487736,0.4778388539590938,0,0,1.7594594594594595,1.432057860629081,HGF
ATRIOVENTRICULAR CANAL DEFECT,1/26,0.44311798428487736,0.4778388539590938,0,0,1.7594594594594595,1.432057860629081,GATA4
Bare lymphocyte syndrome 2,1/26,0.44311798428487736,0.4778388539590938,0,0,1.7594594594594595,1.432057860629081,TAP1
Borna Disease,1/26,0.44311798428487736,0.4778388539590938,0,0,1.7594594594594595,1.432057860629081,PARP1
Capuchin ears,1/26,0.44311798428487736,0.4778388539590938,0,0,1.7594594594594595,1.432057860629081,FGFR3
Carpal Tunnel Syndrome,1/26,0.44311798428487736,0.4778388539590938,0,0,1.7594594594594595,1.432057860629081,ESR1
Cupped ears (finding),1/26,0.44311798428487736,0.4778388539590938,0,0,1.7594594594594595,1.432057860629081,FGFR3
Fatty acid measurement,1/26,0.44311798428487736,0.4778388539590938,0,0,1.7594594594594595,1.432057860629081,FEN1
Generalized pustular psoriasis,1/26,0.44311798428487736,0.4778388539590938,0,0,1.7594594594594595,1.432057860629081,IL6
Hiatal Hernia,1/26,0.44311798428487736,0.4778388539590938,0,0,1.7594594594594595,1.432057860629081,COL3A1
Human anaplasmosis due to Anaplasma phagocytophilum,1/26,0.44311798428487736,0.4778388539590938,0,0,1.7594594594594595,1.432057860629081,IL6
Meckel-Gruber syndrome,1/26,0.44311798428487736,0.4778388539590938,0,0,1.7594594594594595,1.432057860629081,CEP55
Melioidosis,1/26,0.44311798428487736,0.4778388539590938,0,0,1.7594594594594595,1.432057860629081,IL18
Molar tooth sign on MRI,1/26,0.44311798428487736,0.4778388539590938,0,0,1.7594594594594595,1.432057860629081,ZNF423
Multiple lipomata,1/26,0.44311798428487736,0.4778388539590938,0,0,1.7594594594594595,1.432057860629081,HMGA2
MUTYH-Associate Polyposis,1/26,0.44311798428487736,0.4778388539590938,0,0,1.7594594594594595,1.432057860629081,CCL2
Neonatal onset,1/26,0.44311798428487736,0.4778388539590938,0,0,1.7594594594594595,1.432057860629081,KRT5
Pfaundler-Hurler Syndrome,1/26,0.44311798428487736,0.4778388539590938,0,0,1.7594594594594595,1.432057860629081,VCAN
Recurrent Childhood Acute Lymphoblastic Leukemia,1/26,0.44311798428487736,0.4778388539590938,0,0,1.7594594594594595,1.432057860629081,CDKN2A
Schizophreniform Disorders,1/26,0.44311798428487736,0.4778388539590938,0,0,1.7594594594594595,1.432057860629081,CNTNAP2
Yellow Fever,1/26,0.44311798428487736,0.4778388539590938,0,0,1.7594594594594595,1.432057860629081,FADD
Polymicrogyria,3/110,0.44425921865722495,0.47899260114013853,0,0,1.233644859813084,1.000914131457046,GPSM2;CCND2;PLAUR
Angle class 2 malocclusion,2/68,0.44871916814793883,0.48356834616199573,0,0,1.3331281209385046,1.0683129482186473,RPS6KA3;FGFR3
Angle class 3 malocclusion,2/68,0.44871916814793883,0.48356834616199573,0,0,1.3331281209385046,1.0683129482186473,RPS6KA3;FGFR3
Low posterior hairline,2/68,0.44871916814793883,0.48356834616199573,0,0,1.3331281209385046,1.0683129482186473,RPS6KA3;ALDOA
Congenital hypoplasia of penis,7/285,0.44931170712625146,0.4841292194865883,0,0,1.108201110344601,0.8866034508196846,ARNT2;WT1;NDN;GATA4;NEK2;ZFPM2;SOX10
"Diabetes, Autoimmune",3/111,0.4500897064103135,0.4848119435848702,0,0,1.2221593765711414,0.975660057965289,TCF7L2;GAD1;CTLA4
Physical Activity Measurement,3/111,0.4500897064103135,0.4848119435848702,0,0,1.2221593765711414,0.975660057965289,PRKN;ACAN;TCF7L2
Abnormality of metabolism/homeostasis,4/155,0.45372705865064067,0.48849485827151373,0,0,1.1655629139072847,0.9210971120972287,PRKN;KIT;NKX2-5;FGFR3
Monocyte count procedure,4/155,0.45372705865064067,0.48849485827151373,0,0,1.1655629139072847,0.9210971120972287,SPTA1;CDKN2A;NFKBIE;FOXO1
Monocyte count result,4/155,0.45372705865064067,0.48849485827151373,0,0,1.1655629139072847,0.9210971120972287,SPTA1;CDKN2A;NFKBIE;FOXO1
"Chronic Infantile Neurological, Cutaneous, and Articular Syndrome",1/27,0.45552471259808147,0.48878478507888085,0,0,1.6917013167013166,1.3301937282071303,IL18
"Encephalopathy, Toxic",1/27,0.45552471259808147,0.48878478507888085,0,0,1.6917013167013166,1.3301937282071303,FOS
"Hearing Loss, High-Frequency",1/27,0.45552471259808147,0.48878478507888085,0,0,1.6917013167013166,1.3301937282071303,PAX2
"Night blindness, congenital stationary",1/27,0.45552471259808147,0.48878478507888085,0,0,1.6917013167013166,1.3301937282071303,ERG
Aphasia,1/27,0.45552471259808147,0.48878478507888085,0,0,1.6917013167013166,1.3301937282071303,S100A4
Autosomal Recessive Primary Microcephaly,1/27,0.45552471259808147,0.48878478507888085,0,0,1.6917013167013166,1.3301937282071303,CIT
Bulbar palsy,1/27,0.45552471259808147,0.48878478507888085,0,0,1.6917013167013166,1.3301937282071303,TPM3
Congenital hypoplasia of thymus,1/27,0.45552471259808147,0.48878478507888085,0,0,1.6917013167013166,1.3301937282071303,IL2RG
Corneal Diseases,1/27,0.45552471259808147,0.48878478507888085,0,0,1.6917013167013166,1.3301937282071303,GFAP
Decreased albumin,1/27,0.45552471259808147,0.48878478507888085,0,0,1.6917013167013166,1.3301937282071303,NPHS1
Decreased number of peripheral myelinated nerve fibers,1/27,0.45552471259808147,0.48878478507888085,0,0,1.6917013167013166,1.3301937282071303,EGR2
Fukuyama Type Congenital Muscular Dystrophy,1/27,0.45552471259808147,0.48878478507888085,0,0,1.6917013167013166,1.3301937282071303,DMD
Fused vertebrae,1/27,0.45552471259808147,0.48878478507888085,0,0,1.6917013167013166,1.3301937282071303,SOX5
Generalized hyperpigmentation,1/27,0.45552471259808147,0.48878478507888085,0,0,1.6917013167013166,1.3301937282071303,TERT
Herpesviridae Infections,1/27,0.45552471259808147,0.48878478507888085,0,0,1.6917013167013166,1.3301937282071303,SH2D1A
Idiopathic thrombocytopenia,1/27,0.45552471259808147,0.48878478507888085,0,0,1.6917013167013166,1.3301937282071303,CTLA4
Nevus elasticus,1/27,0.45552471259808147,0.48878478507888085,0,0,1.6917013167013166,1.3301937282071303,VWF
Recurrent skin infections,1/27,0.45552471259808147,0.48878478507888085,0,0,1.6917013167013166,1.3301937282071303,KRT5
Respiratory Distress Syndrome,1/27,0.45552471259808147,0.48878478507888085,0,0,1.6917013167013166,1.3301937282071303,IL6
Toxic Encephalitis,1/27,0.45552471259808147,0.48878478507888085,0,0,1.6917013167013166,1.3301937282071303,FOS
Vertebral body fusion,1/27,0.45552471259808147,0.48878478507888085,0,0,1.6917013167013166,1.3301937282071303,SOX5
Aggressive behavior,3/112,0.45589522515385733,0.4891042064110712,0,0,1.2108846361409773,0.9511405158208597,LEPR;PAK3;SYN1
Cooley's anemia,2/70,0.46359973871320415,0.4972905039447179,0,0,1.2937856858318948,0.9945766975400535,TERT;TNFSF11
Obsessive-Compulsive Disorder,3/114,0.46742799856816875,0.4994077392089498,0,0,1.1889446007093065,0.9042042058204719,CNTNAP2;KIF22;ESR1
"Ataxia, Sensory",1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,EGR2
"Lung Diseases, Obstructive",1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,A2M
"Lymphoma, AIDS-Related",1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,CXCL12
"Lymphoma, Small Noncleaved-Cell",1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,RAD54B
"Pain, Postoperative",1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,PTGS2
"Vitamin D-Resistant Rickets, X-Linked",1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,FGF2
Addison's disease due to autoimmunity,1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,CTLA4
ADENOMAS AND ADENOCARCINOMAS,1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,PTGS2
Agranulocytosis,1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,ALDH2
Cartilage-hair hypoplasia,1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,SPRY2
Corneal dystrophy,1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,COL8A1
Depressed philtrum,1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,EZH2
External Ophthalmoplegia,1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,SCN4A
Familial Hypophosphatemic Rickets,1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,FGF2
Febrile Neutropenia,1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,FGFR4
Granulocytic Sarcoma,1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,KIT
Hyperinsulinemic hypoglycemia,1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,CDKN2C
Paratuberculosis,1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,C3
Philadelphia chromosome positive chronic myelogenous leukemia,1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,MECOM
Pseudomonas aeruginosa infection,1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,PPARG
Pulmonary artery stenosis,1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,GATA4
Radial ray hypoplasia,1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,FGFR3
Reactive airway disease,1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,LIFR
Serum gamma-glutamyl transferase measurement,1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,ALDH2
Small labia majora,1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,CDT1
Spina Bifida Occulta,1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,RUNX2
von Willebrand Disease,1/28,0.467655639053765,0.4994077392089498,0,0,1.6289622956289622,1.2380489214110837,VWF
Reticulocyte count (procedure),5/202,0.46836610679241264,0.5000869273796253,0,0,1.1166359021688972,0.8469739254873301,SPTA1;PTPRN;IRS2;SPTB;TNS1
Epileptic encephalopathy,11/468,0.4696386440652212,0.5013659407951082,0,0,1.0591918845606993,0.8005284587877967,CYFIP2;CNTNAP2;MEF2C;CCND2;SIX3;KCNQ5;TUBG1;FGFR3;GRIN2D;GFAP;SOX5
Malocclusion,2/71,0.4709510028609516,0.5026071722889164,0,0,1.2749697386069945,0.9600537664323581,RPS6KA3;FGFR3
Splenic Marginal Zone B-Cell Lymphoma,2/71,0.4709510028609516,0.5026071722889164,0,0,1.2749697386069945,0.9600537664323581,CCND1;TERT
alpha^+^ Thalassemia,2/72,0.4782415399729189,0.5098852713832326,0,0,1.256691389874234,0.926985033006558,TEK;KLF1
"Ataxia, Spinocerebellar",3/116,0.47885111315607143,0.5098852713832326,0,0,1.167781203699996,0.8599138581195754,PRKN;PLA2G2A;F13A1
"Lymphangioma, Cystic",1/29,0.47951688118768576,0.5098852713832326,0,0,1.5707046332046333,1.154430490380118,COL2A1
Abnormal visual evoked potential,1/29,0.47951688118768576,0.5098852713832326,0,0,1.5707046332046333,1.154430490380118,TNFSF11
Acute monocytic/monoblastic leukemia,1/29,0.47951688118768576,0.5098852713832326,0,0,1.5707046332046333,1.154430490380118,CDKN2A
Anterior hypopituitarism,1/29,0.47951688118768576,0.5098852713832326,0,0,1.5707046332046333,1.154430490380118,SOX10
Bulbar weakness,1/29,0.47951688118768576,0.5098852713832326,0,0,1.5707046332046333,1.154430490380118,TPM3
Congenital hypoplasia of radius,1/29,0.47951688118768576,0.5098852713832326,0,0,1.5707046332046333,1.154430490380118,FGFR3
Coronary Aneurysm,1/29,0.47951688118768576,0.5098852713832326,0,0,1.5707046332046333,1.154430490380118,CCL2
Discordant ventriculoarterial connection,1/29,0.47951688118768576,0.5098852713832326,0,0,1.5707046332046333,1.154430490380118,NKX2-5
Generalized amyotrophy,1/29,0.47951688118768576,0.5098852713832326,0,0,1.5707046332046333,1.154430490380118,BIN1
HMN (Hereditary Motor Neuropathy) Proximal Type I,1/29,0.47951688118768576,0.5098852713832326,0,0,1.5707046332046333,1.154430490380118,STMN1
Ileitis,1/29,0.47951688118768576,0.5098852713832326,0,0,1.5707046332046333,1.154430490380118,CXCL10
Infection of bone,1/29,0.47951688118768576,0.5098852713832326,0,0,1.5707046332046333,1.154430490380118,CCL2
Left ventricular noncompaction,1/29,0.47951688118768576,0.5098852713832326,0,0,1.5707046332046333,1.154430490380118,ACTC1
Mask-like facies,1/29,0.47951688118768576,0.5098852713832326,0,0,1.5707046332046333,1.154430490380118,SNCAIP
Microvascular Angina,1/29,0.47951688118768576,0.5098852713832326,0,0,1.5707046332046333,1.154430490380118,IL6
Multiple endocrine neoplasia Type 2,1/29,0.47951688118768576,0.5098852713832326,0,0,1.5707046332046333,1.154430490380118,RET
Neutrophil abnormality,1/29,0.47951688118768576,0.5098852713832326,0,0,1.5707046332046333,1.154430490380118,TERT
Oral candidiasis,1/29,0.47951688118768576,0.5098852713832326,0,0,1.5707046332046333,1.154430490380118,SH2D1A
Recurrent major depressive episodes,1/29,0.47951688118768576,0.5098852713832326,0,0,1.5707046332046333,1.154430490380118,SYNE1
Smith-Magenis syndrome,1/29,0.47951688118768576,0.5098852713832326,0,0,1.5707046332046333,1.154430490380118,ERBB2
Thyroid Agenesis,1/29,0.47951688118768576,0.5098852713832326,0,0,1.5707046332046333,1.154430490380118,NKX2-5
Lens Opacities,8/339,0.48316057013862407,0.5136783899083424,0,0,1.0632228805298416,0.7733949548581871,PLK4;VCAN;COL2A1;WT1;NEK2;VIM;CRYAB;BUB1
Attention Deficit Disorder,2/73,0.4854704091380485,0.515807509535063,0,0,1.2389279242043685,0.8952950869520314,MYCN;ERBB2
Chorea,2/73,0.4854704091380485,0.515807509535063,0,0,1.2389279242043685,0.8952950869520314,CXCL10;ADCY5
Congenital small ears,2/73,0.4854704091380485,0.515807509535063,0,0,1.2389279242043685,0.8952950869520314,CDT1;FGFR3
Syndactyly of fingers,2/73,0.4854704091380485,0.515807509535063,0,0,1.2389279242043685,0.8952950869520314,FGFR3;FLI1
Systolic Pressure,3/118,0.49015859530774464,0.5205688845726043,0,0,1.147353924847531,0.8180934966918496,FBN2;TCF7L2;MECOM
Cerebellar Ataxia,13/565,0.49069940404108126,0.5205688845726043,0,0,1.0359593062265164,0.737523827353209,ALK;GAD1;ENO2;SOX10;GFAP;SYNE1;LMNB1;RAD51;TERT;CCND1;CHEK1;ZNF423;APOB
"Heterotaxy, Visceral, 3, Autosomal",1/30,0.4911144211810633,0.5205688845726043,0,0,1.5164647406026717,1.0783249291066916,PCSK5
"HETEROTAXY, VISCERAL, 4, AUTOSOMAL",1/30,0.4911144211810633,0.5205688845726043,0,0,1.5164647406026717,1.0783249291066916,PCSK5
"Optic Atrophy, Autosomal Dominant",1/30,0.4911144211810633,0.5205688845726043,0,0,1.5164647406026717,1.0783249291066916,ERG
"POLYARTERITIS NODOSA, CHILDHOOD-ONSET",1/30,0.4911144211810633,0.5205688845726043,0,0,1.5164647406026717,1.0783249291066916,TERT
African Burkitt's lymphoma,1/30,0.4911144211810633,0.5205688845726043,0,0,1.5164647406026717,1.0783249291066916,RET
Bartter Disease,1/30,0.4911144211810633,0.5205688845726043,0,0,1.5164647406026717,1.0783249291066916,AGT
Carney Complex,1/30,0.4911144211810633,0.5205688845726043,0,0,1.5164647406026717,1.0783249291066916,RET
Congenital malformation syndrome,1/30,0.4911144211810633,0.5205688845726043,0,0,1.5164647406026717,1.0783249291066916,BRCA1
Gonadoblastoma,1/30,0.4911144211810633,0.5205688845726043,0,0,1.5164647406026717,1.0783249291066916,WT1
Hypoplasia of the optic nerve,1/30,0.4911144211810633,0.5205688845726043,0,0,1.5164647406026717,1.0783249291066916,WT1
Increased variability in muscle fiber diameter,1/30,0.4911144211810633,0.5205688845726043,0,0,1.5164647406026717,1.0783249291066916,NEFH
Overlap syndrome,1/30,0.4911144211810633,0.5205688845726043,0,0,1.5164647406026717,1.0783249291066916,COL1A1
Tobacco Dependence,1/30,0.4911144211810633,0.5205688845726043,0,0,1.5164647406026717,1.0783249291066916,IL6
Decreased corneal diameter,2/74,0.4926367411328397,0.5221001031163249,0,0,1.2216578881364435,0.8649132730871432,PLK4;FLI1
Congenital Bilateral Cataracts,2/75,0.49973973573890235,0.5294608085222382,0,0,1.2048610037416123,0.8357733355130279,RET;CAV1
Impaired exercise tolerance,2/75,0.49973973573890235,0.5294608085222382,0,0,1.2048610037416123,0.8357733355130279,FLAD1;DMD
Platelet distribution width measurement,3/120,0.5013449101682296,0.5307457997016071,0,0,1.1276250145028426,0.7785810627940727,MEF2C;GRK5;ZFPM2
Platelet distribution width result,3/120,0.5013449101682296,0.5307457997016071,0,0,1.1276250145028426,0.7785810627940727,MEF2C;GRK5;ZFPM2
"Albinism, Ocular",1/31,0.5024541087705208,0.5307457997016071,0,0,1.4658408408408408,1.0088663791805634,MITF
"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 1, X-LINKED",1/31,0.5024541087705208,0.5307457997016071,0,0,1.4658408408408408,1.0088663791805634,PCSK5
"Diagnosis, Psychiatric",1/31,0.5024541087705208,0.5307457997016071,0,0,1.4658408408408408,1.0088663791805634,CNTNAP2
"HETEROTAXY, VISCERAL, 1, X-LINKED",1/31,0.5024541087705208,0.5307457997016071,0,0,1.4658408408408408,1.0088663791805634,PCSK5
"HETEROTAXY, VISCERAL, 6, AUTOSOMAL",1/31,0.5024541087705208,0.5307457997016071,0,0,1.4658408408408408,1.0088663791805634,PCSK5
"Major depression, single episode",1/31,0.5024541087705208,0.5307457997016071,0,0,1.4658408408408408,1.0088663791805634,SOSTDC1
Acute colitis,1/31,0.5024541087705208,0.5307457997016071,0,0,1.4658408408408408,1.0088663791805634,IL6
Childhood Ataxia with Central Nervous System Hypomyelinization,1/31,0.5024541087705208,0.5307457997016071,0,0,1.4658408408408408,1.0088663791805634,IL6
Glycogen Storage Disease,1/31,0.5024541087705208,0.5307457997016071,0,0,1.4658408408408408,1.0088663791805634,VWF
Invasive aspergillosis,1/31,0.5024541087705208,0.5307457997016071,0,0,1.4658408408408408,1.0088663791805634,CXCL10
Longevity,1/31,0.5024541087705208,0.5307457997016071,0,0,1.4658408408408408,1.0088663791805634,IL6
Lymphatic obstruction,1/31,0.5024541087705208,0.5307457997016071,0,0,1.4658408408408408,1.0088663791805634,ANTXR2
Onset of lymphedema around puberty,1/31,0.5024541087705208,0.5307457997016071,0,0,1.4658408408408408,1.0088663791805634,ANTXR2
Oral Ulcer,1/31,0.5024541087705208,0.5307457997016071,0,0,1.4658408408408408,1.0088663791805634,C4A
Progressive muscle weakness,1/31,0.5024541087705208,0.5307457997016071,0,0,1.4658408408408408,1.0088663791805634,DMD
Reduced number of teeth,1/31,0.5024541087705208,0.5307457997016071,0,0,1.4658408408408408,1.0088663791805634,PLK4
Spinal fusion,1/31,0.5024541087705208,0.5307457997016071,0,0,1.4658408408408408,1.0088663791805634,SOX5
Amphetamine-Related Disorders,2/76,0.5067786590625278,0.5349772829713827,0,0,1.18851808919529,0.8078130927983117,FOS;ZNF423
Amphetamine Abuse,2/76,0.5067786590625278,0.5349772829713827,0,0,1.18851808919529,0.8078130927983117,FOS;ZNF423
Machado-Joseph Disease,2/76,0.5067786590625278,0.5349772829713827,0,0,1.18851808919529,0.8078130927983117,PLA2G2A;GFAP
Microcornea,2/76,0.5067786590625278,0.5349772829713827,0,0,1.18851808919529,0.8078130927983117,PLK4;FLI1
"Epilepsy, Rolandic",1/32,0.513541664371444,0.5407246638210123,0,0,1.4184829991281604,0.9453112771784983,CNTNAP2
"POLYDACTYLY, POSTAXIAL",1/32,0.513541664371444,0.5407246638210123,0,0,1.4184829991281604,0.9453112771784983,NKX2-5
Cannabis Dependence,1/32,0.513541664371444,0.5407246638210123,0,0,1.4184829991281604,0.9453112771784983,ADRA1A
Easy fatigability,1/32,0.513541664371444,0.5407246638210123,0,0,1.4184829991281604,0.9453112771784983,SCN4A
Gilbert Disease (disorder),1/32,0.513541664371444,0.5407246638210123,0,0,1.4184829991281604,0.9453112771784983,IL6
Hydrophthalmos,1/32,0.513541664371444,0.5407246638210123,0,0,1.4184829991281604,0.9453112771784983,TEK
Increased hepatocellular carcinoma risk,1/32,0.513541664371444,0.5407246638210123,0,0,1.4184829991281604,0.9453112771784983,MET
Increased incidence of hepatocellular carcinoma,1/32,0.513541664371444,0.5407246638210123,0,0,1.4184829991281604,0.9453112771784983,MET
Iron deficiency anemia,1/32,0.513541664371444,0.5407246638210123,0,0,1.4184829991281604,0.9453112771784983,BMP2
Lipomatosis,1/32,0.513541664371444,0.5407246638210123,0,0,1.4184829991281604,0.9453112771784983,HMGA2
Lymphoproliferative Disorder of the Skin,1/32,0.513541664371444,0.5407246638210123,0,0,1.4184829991281604,0.9453112771784983,IL6
Neurotoxicity Syndromes,1/32,0.513541664371444,0.5407246638210123,0,0,1.4184829991281604,0.9453112771784983,FOS
Omenn Syndrome,1/32,0.513541664371444,0.5407246638210123,0,0,1.4184829991281604,0.9453112771784983,IL2RG
Tires quickly,1/32,0.513541664371444,0.5407246638210123,0,0,1.4184829991281604,0.9453112771784983,SCN4A
Amphetamine Addiction,2/77,0.513752840953228,0.5407246638210123,0,0,1.1726109857035365,0.780974140898587,FOS;ZNF423
Decreased width of tooth,2/77,0.513752840953228,0.5407246638210123,0,0,1.1726109857035365,0.780974140898587,SIX1;PRKD1
Distal amyotrophy,2/77,0.513752840953228,0.5407246638210123,0,0,1.1726109857035365,0.780974140898587,EGR2;SOX10
PANIC DISORDER 1,2/77,0.513752840953228,0.5407246638210123,0,0,1.1726109857035365,0.780974140898587,GAD1;IKBKE
Ulnar polydactyly of fingers,2/77,0.513752840953228,0.5407246638210123,0,0,1.1726109857035365,0.780974140898587,CCND2;BMPR1B
Electromyogram abnormal,2/78,0.5206616727095973,0.5478245016320938,0,0,1.157122490198408,0.7552015806987864,SCN4A;DMD
Sicca Syndrome,2/78,0.5206616727095973,0.5478245016320938,0,0,1.157122490198408,0.7552015806987864,E2F1;TGFBR2
Upward slant of palpebral fissure,3/124,0.5233340082294771,0.5503600702150153,0,0,1.090123779963352,0.7058937157766704,MEF2C;MYCN;CIT
"Hepatic Fibrosis, Congenital",1/33,0.5243826815523948,0.5503600702150153,0,0,1.3740850225225225,0.8870179865761124,PRKD1
Agitation,1/33,0.5243826815523948,0.5503600702150153,0,0,1.3740850225225225,0.8870179865761124,PAK3
Central Diabetes Insipidus,1/33,0.5243826815523948,0.5503600702150153,0,0,1.3740850225225225,0.8870179865761124,FBN2
Death in early adulthood,1/33,0.5243826815523948,0.5503600702150153,0,0,1.3740850225225225,0.8870179865761124,TGFBR2
Gerstmann-Straussler-Scheinker Disease,1/33,0.5243826815523948,0.5503600702150153,0,0,1.3740850225225225,0.8870179865761124,APOB
Hereditary Motor and Sensory Neuropathies,1/33,0.5243826815523948,0.5503600702150153,0,0,1.3740850225225225,0.8870179865761124,EGR2
Hypoplastic toenails,1/33,0.5243826815523948,0.5503600702150153,0,0,1.3740850225225225,0.8870179865761124,EZH2
Mean blood pressure,1/33,0.5243826815523948,0.5503600702150153,0,0,1.3740850225225225,0.8870179865761124,MECOM
Meckel syndrome type 1,1/33,0.5243826815523948,0.5503600702150153,0,0,1.3740850225225225,0.8870179865761124,IL6
Neuronal loss in central nervous system,1/33,0.5243826815523948,0.5503600702150153,0,0,1.3740850225225225,0.8870179865761124,SNCAIP
Paranoia,1/33,0.5243826815523948,0.5503600702150153,0,0,1.3740850225225225,0.8870179865761124,EVL
Polyarteritis Nodosa,1/33,0.5243826815523948,0.5503600702150153,0,0,1.3740850225225225,0.8870179865761124,TERT
Primary angle-closure glaucoma,1/33,0.5243826815523948,0.5503600702150153,0,0,1.3740850225225225,0.8870179865761124,HGF
Thalassemia Intermedia,1/33,0.5243826815523948,0.5503600702150153,0,0,1.3740850225225225,0.8870179865761124,NFE2
Usher Syndrome,1/33,0.5243826815523948,0.5503600702150153,0,0,1.3740850225225225,0.8870179865761124,CIB1
Developmental Disabilities,4/170,0.5254099945304447,0.5513521130103853,0,0,1.0594213589050079,0.6818185622157537,RET;DLG2;RAD51;SOX10
Thin upper lip vermilion,3/125,0.5287480625442925,0.5547683155831071,0,0,1.0811327052889252,0.6889444786324941,NDN;PAK3;CIT
Corneal Opacity,2/80,0.5342811431804612,0.5603110801998714,0,0,1.1273369219193148,0.7066520898565954,MMP14;BUB1
Depressed nasal ridge,2/80,0.5342811431804612,0.5603110801998714,0,0,1.1273369219193148,0.7066520898565954,RET;PAX3
Microdontia (disorder),2/80,0.5342811431804612,0.5603110801998714,0,0,1.1273369219193148,0.7066520898565954,SIX1;PRKD1
"Parkinson Disease, Familial, Type 1",1/34,0.5349826302017398,0.560434151370283,0,0,1.3323778323778324,0.8334303134550379,UTRN
Anoxemia,1/34,0.5349826302017398,0.560434151370283,0,0,1.3323778323778324,0.8334303134550379,EGR1
Cleft Lip with or without Cleft Palate,1/34,0.5349826302017398,0.560434151370283,0,0,1.3323778323778324,0.8334303134550379,BCL3
Gestational trophoblastic disease,1/34,0.5349826302017398,0.560434151370283,0,0,1.3323778323778324,0.8334303134550379,PPARG
Hypoxia,1/34,0.5349826302017398,0.560434151370283,0,0,1.3323778323778324,0.8334303134550379,EGR1
Underweight,1/34,0.5349826302017398,0.560434151370283,0,0,1.3323778323778324,0.8334303134550379,RPS6KA3
Wolff-Parkinson-White Syndrome,1/34,0.5349826302017398,0.560434151370283,0,0,1.3323778323778324,0.8334303134550379,BMP2
Multicystic Dysplastic Kidney,2/81,0.5409908499553476,0.5666398235028252,0,0,1.113009686544561,0.683780743665752,PAX2;MYLK
"Gait, Drop Foot",1/35,0.5453468590760396,0.5702241173212957,0,0,1.2931240063593006,0.784064078957,EGR2
"Neoplasms, Germ Cell and Embryonal",1/35,0.5453468590760396,0.5702241173212957,0,0,1.2931240063593006,0.784064078957,KIT
Complete trisomy 18 syndrome,1/35,0.5453468590760396,0.5702241173212957,0,0,1.2931240063593006,0.784064078957,PAEP
Limb defects,1/35,0.5453468590760396,0.5702241173212957,0,0,1.2931240063593006,0.784064078957,COL1A1
Neonatal Jaundice,1/35,0.5453468590760396,0.5702241173212957,0,0,1.2931240063593006,0.784064078957,SPTA1
PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA,1/35,0.5453468590760396,0.5702241173212957,0,0,1.2931240063593006,0.784064078957,KIT
Polyuria,1/35,0.5453468590760396,0.5702241173212957,0,0,1.2931240063593006,0.784064078957,PRKCA
Sandal gap,1/35,0.5453468590760396,0.5702241173212957,0,0,1.2931240063593006,0.784064078957,PLK4
Split-Hand/Foot Malformation,1/35,0.5453468590760396,0.5702241173212957,0,0,1.2931240063593006,0.784064078957,RUNX2
Therapy-related myelodysplastic syndrome,1/35,0.5453468590760396,0.5702241173212957,0,0,1.2931240063593006,0.784064078957,CDKN2A
Tooth agenesis,1/35,0.5453468590760396,0.5702241173212957,0,0,1.2931240063593006,0.784064078957,PLK4
Cerebellar Dysmetria,2/82,0.5476333383069559,0.5724366537073177,0,0,1.0990406320541761,0.661786554578112,CAV1;SYNE1
Decreased size of teeth,2/82,0.5476333383069559,0.5724366537073177,0,0,1.0990406320541761,0.661786554578112,SIX1;PRKD1
Gait Ataxia,2/83,0.5542082718822915,0.579219227195996,0,0,1.0854164924894798,0.6406287921288635,CAV1;SYNE1
"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",1/36,0.5554805985133255,0.579556889795789,0,0,1.2561132561132562,0.7384961111462957,CALR
Absence of septum pellucidum,1/36,0.5554805985133255,0.579556889795789,0,0,1.2561132561132562,0.7384961111462957,EZH2
Adrenal gland hypofunction,1/36,0.5554805985133255,0.579556889795789,0,0,1.2561132561132562,0.7384961111462957,MCM4
Dislocation of elbow joint,1/36,0.5554805985133255,0.579556889795789,0,0,1.2561132561132562,0.7384961111462957,PITX1
Hammer Toe,1/36,0.5554805985133255,0.579556889795789,0,0,1.2561132561132562,0.7384961111462957,EGR2
Hepatitis E,1/36,0.5554805985133255,0.579556889795789,0,0,1.2561132561132562,0.7384961111462957,SIRPA
Hereditary Motor and Sensory-Neuropathy Type II,1/36,0.5554805985133255,0.579556889795789,0,0,1.2561132561132562,0.7384961111462957,HOXD10
Low Tension Glaucoma,1/36,0.5554805985133255,0.579556889795789,0,0,1.2561132561132562,0.7384961111462957,SIX1
Radiohumeral dislocation,1/36,0.5554805985133255,0.579556889795789,0,0,1.2561132561132562,0.7384961111462957,PITX1
Thickened nuchal skin fold,1/36,0.5554805985133255,0.579556889795789,0,0,1.2561132561132562,0.7384961111462957,COL2A1
Ulnohumeral dislocation,1/36,0.5554805985133255,0.579556889795789,0,0,1.2561132561132562,0.7384961111462957,PITX1
Late tooth eruption,2/84,0.5607153623326586,0.5848368338913085,0,0,1.072124649011727,0.6202690076095779,TNFSF11;RUNX2
Short philtrum,2/84,0.5607153623326586,0.5848368338913085,0,0,1.072124649011727,0.6202690076095779,MEF2C;RUNX2
Abscess,1/37,0.565388963002432,0.5889797232083657,0,0,1.2211586586586587,0.6963551676977084,IL6
Bone Marrow Diseases,1/37,0.565388963002432,0.5889797232083657,0,0,1.2211586586586587,0.6963551676977084,CCND1
Escherichia coli Infections,1/37,0.565388963002432,0.5889797232083657,0,0,1.2211586586586587,0.6963551676977084,IL6
Hypoxemia,1/37,0.565388963002432,0.5889797232083657,0,0,1.2211586586586587,0.6963551676977084,EGR1
Mitochondrial abnormalities,1/37,0.565388963002432,0.5889797232083657,0,0,1.2211586586586587,0.6963551676977084,PPARGC1A
Renal tubular acidosis,1/37,0.565388963002432,0.5889797232083657,0,0,1.2211586586586587,0.6963551676977084,ERBB2
Sessile Serrated Adenoma/Polyp,1/37,0.565388963002432,0.5889797232083657,0,0,1.2211586586586587,0.6963551676977084,CALR
Vitelliform Macular Dystrophy,1/37,0.565388963002432,0.5889797232083657,0,0,1.2211586586586587,0.6963551676977084,DMD
"Malformations of Cortical Development, Group II",2/85,0.5671543676226083,0.5906355610099918,0,0,1.0591530909189806,0.6006708822847219,PLK4;DMD
Downturned corners of mouth,2/85,0.5671543676226083,0.5906355610099918,0,0,1.0591530909189806,0.6006708822847219,MEF2C;NDN
Postnatal growth retardation,2/86,0.5735250897167194,0.597177442253874,0,0,1.04649037944749,0.5818000885379752,BLM;MCM4
Conductive hearing loss,4/181,0.5749752776250969,0.597311602656394,0,0,0.9930179228000051,0.5495641558854896,COL2A1;SIX1;NEK2;FGFR3
Photodysphoria,4/181,0.5749752776250969,0.597311602656394,0,0,0.9930179228000051,0.5495641558854896,COL17A1;C4A;NEK2;MITF
"Adenoma, Trabecular",1/38,0.5750769539571536,0.597311602656394,0,0,1.1880934989043097,0.6573144084357728,RET
Abnormality of the eye,1/38,0.5750769539571536,0.597311602656394,0,0,1.1880934989043097,0.6573144084357728,PROC
Hypoplasia of the brainstem,1/38,0.5750769539571536,0.597311602656394,0,0,1.1880934989043097,0.6573144084357728,CIT
Monoparesis - leg,1/38,0.5750769539571536,0.597311602656394,0,0,1.1880934989043097,0.6573144084357728,CAV1
Prominent back of the head,1/38,0.5750769539571536,0.597311602656394,0,0,1.1880934989043097,0.6573144084357728,MYCN
Prominent occiput,1/38,0.5750769539571536,0.597311602656394,0,0,1.1880934989043097,0.6573144084357728,MYCN
Radioulnar Synostosis,1/38,0.5750769539571536,0.597311602656394,0,0,1.1880934989043097,0.6573144084357728,MECOM
Sensorimotor neuropathy,1/38,0.5750769539571536,0.597311602656394,0,0,1.1880934989043097,0.6573144084357728,HGF
Subfertility,1/38,0.5750769539571536,0.597311602656394,0,0,1.1880934989043097,0.6573144084357728,LEPR
Takayasu Arteritis,1/38,0.5750769539571536,0.597311602656394,0,0,1.1880934989043097,0.6573144084357728,IL6
Tented mouth,1/38,0.5750769539571536,0.597311602656394,0,0,1.1880934989043097,0.6573144084357728,PAX3
Tented upper lip,1/38,0.5750769539571536,0.597311602656394,0,0,1.1880934989043097,0.6573144084357728,PAX3
Tented upper lip vermilion,1/38,0.5750769539571536,0.597311602656394,0,0,1.1880934989043097,0.6573144084357728,PAX3
Vitamin D Deficiency,1/38,0.5750769539571536,0.597311602656394,0,0,1.1880934989043097,0.6573144084357728,TIMP1
Neurogenic Muscular Atrophy,5/228,0.5753621017698187,0.5975153665511215,0,0,0.9851202609050143,0.5445308336681449,COL2A1;TRIM63;DMD;PPARGC1A;NEFH
Large auricle,3/134,0.5758771435999838,0.597772936076892,0,0,1.006390107422887,0.5553873840443401,PAK3;EZH2;CIT
Large pinnae,3/134,0.5758771435999838,0.597772936076892,0,0,1.006390107422887,0.5553873840443401,PAK3;EZH2;CIT
Macrotia,3/134,0.5758771435999838,0.597772936076892,0,0,1.006390107422887,0.5553873840443401,PAK3;EZH2;CIT
"Acidosis, Lactic",4/183,0.5836696573363288,0.6049983334636818,0,0,0.981821406402412,0.5286323910525126,RPS6KA3;TXNIP;PPARGC1A;MET
"Liver dysfunction, mild",1/39,0.5845494618591173,0.6049983334636818,0,0,1.1567686107159791,0.6210851220432462,FADD
"Obesity, Abdominal",1/39,0.5845494618591173,0.6049983334636818,0,0,1.1567686107159791,0.6210851220432462,NDN
Abnormal cortical bone morphology,1/39,0.5845494618591173,0.6049983334636818,0,0,1.1567686107159791,0.6210851220432462,CIT
Adenocarcinoma of rectum,1/39,0.5845494618591173,0.6049983334636818,0,0,1.1567686107159791,0.6210851220432462,MKI67
Anosmia,1/39,0.5845494618591173,0.6049983334636818,0,0,1.1567686107159791,0.6210851220432462,SOX10
Clonus,1/39,0.5845494618591173,0.6049983334636818,0,0,1.1567686107159791,0.6210851220432462,CAV1
Decreased liver function,1/39,0.5845494618591173,0.6049983334636818,0,0,1.1567686107159791,0.6210851220432462,FADD
Drooling,1/39,0.5845494618591173,0.6049983334636818,0,0,1.1567686107159791,0.6210851220432462,PAK3
Flat occiput,1/39,0.5845494618591173,0.6049983334636818,0,0,1.1567686107159791,0.6210851220432462,COL1A1
Flexion contracture of the knee,1/39,0.5845494618591173,0.6049983334636818,0,0,1.1567686107159791,0.6210851220432462,LIFR
Hyperphosphaturia,1/39,0.5845494618591173,0.6049983334636818,0,0,1.1567686107159791,0.6210851220432462,PER2
Multiple pulmonary infections,1/39,0.5845494618591173,0.6049983334636818,0,0,1.1567686107159791,0.6210851220432462,COL2A1
Orbital separation diminished,1/39,0.5845494618591173,0.6049983334636818,0,0,1.1567686107159791,0.6210851220432462,SIX3
Recurrent pulmonary infections,1/39,0.5845494618591173,0.6049983334636818,0,0,1.1567686107159791,0.6210851220432462,COL2A1
Sense of smell impaired,1/39,0.5845494618591173,0.6049983334636818,0,0,1.1567686107159791,0.6210851220432462,SOX10
Static Tremor,1/39,0.5845494618591173,0.6049983334636818,0,0,1.1567686107159791,0.6210851220432462,ADRB2
Sweet Syndrome,1/39,0.5845494618591173,0.6049983334636818,0,0,1.1567686107159791,0.6210851220432462,TGFBR2
Tropical Spastic Paraparesis,1/39,0.5845494618591173,0.6049983334636818,0,0,1.1567686107159791,0.6210851220432462,ACAN
Atypical scarring of skin,2/88,0.5860611032367069,0.6062825584315656,0,0,1.022048401490892,0.5461123724422107,NEK2;TGFBR2
Blepharophimosis,2/88,0.5860611032367069,0.6062825584315656,0,0,1.022048401490892,0.5461123724422107,MYCN;PAX3
Facial muscle weakness of muscles innervated by CN VII,2/88,0.5860611032367069,0.6062825584315656,0,0,1.022048401490892,0.5461123724422107,TPM3;BIN1
"Xeroderma pigmentosum, group A",1/40,0.593811268947025,0.613638480112051,0,0,1.127050127050127,0.5874114699283974,PTGS2
Adrenal cortical hypofunction,1/40,0.593811268947025,0.613638480112051,0,0,1.127050127050127,0.5874114699283974,MCM4
Decreased motor nerve conduction velocity,1/40,0.593811268947025,0.613638480112051,0,0,1.127050127050127,0.5874114699283974,EGR2
Motor symptoms,1/40,0.593811268947025,0.613638480112051,0,0,1.127050127050127,0.5874114699283974,PPARGC1A
Palpitations,1/40,0.593811268947025,0.613638480112051,0,0,1.127050127050127,0.5874114699283974,RET
Psychiatric symptom,1/40,0.593811268947025,0.613638480112051,0,0,1.127050127050127,0.5874114699283974,TAL1
Spinal Cord Diseases,1/40,0.593811268947025,0.613638480112051,0,0,1.127050127050127,0.5874114699283974,IL6
Vomiting,4/187,0.6007466929234513,0.6207099676421383,0,0,0.9601625714037892,0.48928147636840413,F12;SAA1;SERPING1;MET
"Human immunodeficiency virus, type 2 [HIV-2] infection in conditions classified elsewhere and of unspecified site",1/41,0.6028670517114371,0.6223263325075333,0,0,1.0988175675675675,0.5560660630365292,CXCR4
"Pancreatitis, Alcoholic",1/41,0.6028670517114371,0.6223263325075333,0,0,1.0988175675675675,0.5560660630365292,ALDH2
Arterial Occlusive Diseases,1/41,0.6028670517114371,0.6223263325075333,0,0,1.0988175675675675,0.5560660630365292,APOB
Choreatic disease,1/41,0.6028670517114371,0.6223263325075333,0,0,1.0988175675675675,0.5560660630365292,ADCY5
Recurrent pneumonia,1/41,0.6028670517114371,0.6223263325075333,0,0,1.0988175675675675,0.5560660630365292,COL2A1
Unable to walk,1/41,0.6028670517114371,0.6223263325075333,0,0,1.0988175675675675,0.5560660630365292,MEF2C
Bell Palsy,2/92,0.6103095174758383,0.6299122052201829,0,0,0.9764233759719088,0.48214716614490605,TPM3;BIN1
Anaphylaxis (non medication),1/42,0.6117213828914553,0.6305941377588663,0,0,1.0719622061085476,0.5268462236570121,ESR1
Cerebral Edema,1/42,0.6117213828914553,0.6305941377588663,0,0,1.0719622061085476,0.5268462236570121,MYLK
Choanal Atresia,1/42,0.6117213828914553,0.6305941377588663,0,0,1.0719622061085476,0.5268462236570121,FGFR3
Drug Allergy,1/42,0.6117213828914553,0.6305941377588663,0,0,1.0719622061085476,0.5268462236570121,GZMB
Dyskeratosis Congenita,1/42,0.6117213828914553,0.6305941377588663,0,0,1.0719622061085476,0.5268462236570121,TERT
Late fontanel closure,1/42,0.6117213828914553,0.6305941377588663,0,0,1.0719622061085476,0.5268462236570121,FGFR3
Postnatal microcephaly,1/42,0.6117213828914553,0.6305941377588663,0,0,1.0719622061085476,0.5268462236570121,ARNT2
Ragged-red muscle fibers,1/42,0.6117213828914553,0.6305941377588663,0,0,1.0719622061085476,0.5268462236570121,NEFH
Long philtrum,4/190,0.6132747495239819,0.6320984066609978,0,0,0.9445297832394607,0.46182050672622416,COL2A1;TNNI2;FLI1;EZH2
Dropped beats - heart,1/43,0.6203787340224783,0.638734259956303,0,0,1.0463856713856714,0.4995708111275468,RET
Hyperplasia of nose,1/43,0.6203787340224783,0.638734259956303,0,0,1.0463856713856714,0.4995708111275468,BLM
Hypertrophy of nose,1/43,0.6203787340224783,0.638734259956303,0,0,1.0463856713856714,0.4995708111275468,BLM
Ketotic hypoglycemia,1/43,0.6203787340224783,0.638734259956303,0,0,1.0463856713856714,0.4995708111275468,ALDOA
Large nose,1/43,0.6203787340224783,0.638734259956303,0,0,1.0463856713856714,0.4995708111275468,BLM
Peroxisomal Disorders,1/43,0.6203787340224783,0.638734259956303,0,0,1.0463856713856714,0.4995708111275468,EPAS1
Secondary physiologic amenorrhea,1/43,0.6203787340224783,0.638734259956303,0,0,1.0463856713856714,0.4995708111275468,PPARG
Intermittent migraine headaches,2/95,0.6277758251707043,0.646152098367272,0,0,0.9447802131119687,0.43986334803873267,C4A;TGFBR2
Pachygyria,2/95,0.6277758251707043,0.646152098367272,0,0,0.9447802131119687,0.43986334803873267,CNTNAP2;CIT
"Intellectual disability, progressive",1/44,0.6288434776595022,0.6467554052007989,0,0,1.0219987429289754,0.4740775169964907,NKX2-5
"Multiple Sclerosis, Acute Fulminating",1/44,0.6288434776595022,0.6467554052007989,0,0,1.0219987429289754,0.4740775169964907,SELE
Amelogenesis Imperfecta,1/44,0.6288434776595022,0.6467554052007989,0,0,1.0219987429289754,0.4740775169964907,COL17A1
HELLP Syndrome,1/44,0.6288434776595022,0.6467554052007989,0,0,1.0219987429289754,0.4740775169964907,PAEP
Mitochondrial Encephalomyopathies,1/44,0.6288434776595022,0.6467554052007989,0,0,1.0219987429289754,0.4740775169964907,PPARGC1A
Babinski Reflex,3/145,0.629313014424412,0.6471392137305698,0,0,0.927904531259958,0.42973718519723014,CAV1;GAD1;LMNB1
Undergrowth,11/529,0.6329793573943263,0.6508097618279692,0,0,0.9314760777894419,0.42598028151009826,RET;CA12;CDT1;TERT;TPM3;HMGA2;ASCL1;IL2RG;ANTXR2;GRIN2D;CIT
"Thin, sparse hair",2/96,0.6334613226494689,0.6511059447373481,0,0,0.9346813313481581,0.4267346825835843,TERT;EZH2
Sparse hair,2/96,0.6334613226494689,0.6511059447373481,0,0,0.9346813313481581,0.4267346825835843,TERT;EZH2
"Adenoma, Microcystic",1/45,0.6371198893974103,0.6536659299103281,0,0,0.9987203112203112,0.45022055128879274,CDKN2A
"Granulomatous Disease, Chronic, X-Linked",1/45,0.6371198893974103,0.6536659299103281,0,0,0.9987203112203112,0.45022055128879274,NGFR
Age-related cataract,1/45,0.6371198893974103,0.6536659299103281,0,0,0.9987203112203112,0.45022055128879274,CRYAB
Coarse hair,1/45,0.6371198893974103,0.6536659299103281,0,0,0.9987203112203112,0.45022055128879274,RPS6KA3
Congenital hypoplasia of ovary,1/45,0.6371198893974103,0.6536659299103281,0,0,0.9987203112203112,0.45022055128879274,LEPR
Diminished sweating,1/45,0.6371198893974103,0.6536659299103281,0,0,0.9987203112203112,0.45022055128879274,LIFR
Hypoparathyroidism,1/45,0.6371198893974103,0.6536659299103281,0,0,0.9987203112203112,0.45022055128879274,GATA3
Hypoplastic ovary,1/45,0.6371198893974103,0.6536659299103281,0,0,0.9987203112203112,0.45022055128879274,LEPR
Impulsive character (finding),1/45,0.6371198893974103,0.6536659299103281,0,0,0.9987203112203112,0.45022055128879274,CIT
Panhypopituitarism,1/45,0.6371198893974103,0.6536659299103281,0,0,0.9987203112203112,0.45022055128879274,SIX3
Peripheral axonal neuropathy,1/45,0.6371198893974103,0.6536659299103281,0,0,0.9987203112203112,0.45022055128879274,SERPING1
Rough hair texture,1/45,0.6371198893974103,0.6536659299103281,0,0,0.9987203112203112,0.45022055128879274,RPS6KA3
Dystonic disease,3/148,0.6430546964366833,0.6596540921443051,0,0,0.9085660789514745,0.4011550867675985,PRKN;SNCAIP;ADCY5
Cortical visual impairment,1/46,0.6452121502591643,0.6614631050435884,0,0,0.9764764764764765,0.4278686553140678,GRIN2D
Decreased fertility,1/46,0.6452121502591643,0.6614631050435884,0,0,0.9764764764764765,0.4278686553140678,SOX10
Hypohidrosis,1/46,0.6452121502591643,0.6614631050435884,0,0,0.9764764764764765,0.4278686553140678,LIFR
Telangiectasis,1/46,0.6452121502591643,0.6614631050435884,0,0,0.9764764764764765,0.4278686553140678,ACTA2
Nephrolithiasis,2/99,0.6501105053407688,0.6662814213136888,0,0,0.905634032254311,0.3899777171865873,IL6;PDE1A
Palmoplantar Keratosis,2/99,0.6501105053407688,0.6662814213136888,0,0,0.905634032254311,0.3899777171865873,CTLA4;KRT5
"Blindness, Cortical",1/47,0.653124348544114,0.6687579089529304,0,0,0.9551997649823737,0.40690339035017986,GRIN2D
Abnormality of the cornea,1/47,0.653124348544114,0.6687579089529304,0,0,0.9551997649823737,0.40690339035017986,DCN
FRAGILE X TREMOR/ATAXIA SYNDROME,1/47,0.653124348544114,0.6687579089529304,0,0,0.9551997649823737,0.40690339035017986,PLA2G2A
Hemoglobinopathies,1/47,0.653124348544114,0.6687579089529304,0,0,0.9551997649823737,0.40690339035017986,KLF1
Lower limb muscle weakness,1/47,0.653124348544114,0.6687579089529304,0,0,0.9551997649823737,0.40690339035017986,CAV1
Smell Perception,1/47,0.653124348544114,0.6687579089529304,0,0,0.9551997649823737,0.40690339035017986,FANCA
Abnormal heart beat,2/100,0.6555252278584621,0.6710116491841841,0,0,0.8963468005712443,0.3785438274084049,DMD;NKX2-5
ECG abnormality,2/100,0.6555252278584621,0.6710116491841841,0,0,0.8963468005712443,0.3785438274084049,DMD;NKX2-5
Failure to gain weight,11/539,0.6572240919570514,0.6726481258127944,0,0,0.9133544546850998,0.38336247990770395,RET;CA12;CDT1;TERT;TPM3;HMGA2;ASCL1;IL2RG;ANTXR2;GRIN2D;CIT
Dystonia,5/251,0.6597646970868707,0.675145467870703,0,0,0.8919530672579453,0.37093833015436334,PRKN;RIMS2;DST;SNCAIP;ADCY5
Cone dystrophy,1/48,0.6608604820941782,0.6757519789501372,0,0,0.9348284454667434,0.38721765772919703,ERG
Cytochrome-c Oxidase Deficiency,1/48,0.6608604820941782,0.6757519789501372,0,0,0.9348284454667434,0.38721765772919703,PTGS2
Decreased muscle mass,1/48,0.6608604820941782,0.6757519789501372,0,0,0.9348284454667434,0.38721765772919703,NDN
Delayed myelination,1/48,0.6608604820941782,0.6757519789501372,0,0,0.9348284454667434,0.38721765772919703,ARNT2
Infantile Spasm,1/48,0.6608604820941782,0.6757519789501372,0,0,0.9348284454667434,0.38721765772919703,RIMS2
Cardiac conduction abnormality,2/102,0.6661537823597375,0.6810608619771651,0,0,0.8783295711060948,0.35680797674199366,DMD;NKX2-5
Astigmatism,1/49,0.6684244600076338,0.6826549077571881,0,0,0.9153059309309309,0.36871441631461443,TEAD1
Central nervous system demyelination,1/49,0.6684244600076338,0.6826549077571881,0,0,0.9153059309309309,0.36871441631461443,LMNB1
Congenital absence of germinal epithelium of testes,1/49,0.6684244600076338,0.6826549077571881,0,0,0.9153059309309309,0.36871441631461443,PLK4
Defective or absent horizontal voluntary eye movements,1/49,0.6684244600076338,0.6826549077571881,0,0,0.9153059309309309,0.36871441631461443,LAMA1
Fibrinogen assay,1/49,0.6684244600076338,0.6826549077571881,0,0,0.9153059309309309,0.36871441631461443,CAPN3
Neck webbing,1/49,0.6684244600076338,0.6826549077571881,0,0,0.9153059309309309,0.36871441631461443,TNNI2
Sparse eyelashes,1/49,0.6684244600076338,0.6826549077571881,0,0,0.9153059309309309,0.36871441631461443,SNRPE
Electrocardiogram abnormal,2/103,0.6713682271148127,0.6855570949221654,0,0,0.8695885389893391,0.3464766999284484,DMD;NKX2-5
Hypogonadism,4/205,0.6721570925001955,0.6862582902449549,0,0,0.8733655983122934,0.34695600989005704,LEPR;NMT2;NEK2;SOX10
Active tuberculosis,1/50,0.6758201050546626,0.6892646659904501,0,0,0.8965802537231109,0.3513055660651524,CXCR4
Congenital cerebral hernia,1/50,0.6758201050546626,0.6892646659904501,0,0,0.8965802537231109,0.3513055660651524,LAMC1
Endocardial Cushion Defects,1/50,0.6758201050546626,0.6892646659904501,0,0,0.8965802537231109,0.3513055660651524,GATA4
Hypertrichosis,1/50,0.6758201050546626,0.6892646659904501,0,0,0.8965802537231109,0.3513055660651524,BLM
Opiate Addiction,1/50,0.6758201050546626,0.6892646659904501,0,0,0.8965802537231109,0.3513055660651524,OPRD1
Pointed chin,1/50,0.6758201050546626,0.6892646659904501,0,0,0.8965802537231109,0.3513055660651524,PLK4
Varicella zoster,1/50,0.6758201050546626,0.6892646659904501,0,0,0.8965802537231109,0.3513055660651524,BRCA2
Pick Disease of the Brain,2/105,0.6815991274283865,0.6950531035239969,0,0,0.8526156610927261,0.3268191645288918,RIMS2;NEFH
C-reactive protein measurement,1/51,0.6830511550145831,0.6961110101787465,0,0,0.8786036036036036,0.33491097562862443,LEPR
Hermanski-Pudlak Syndrome,1/51,0.6830511550145831,0.6961110101787465,0,0,0.8786036036036036,0.33491097562862443,VWF
Hypsarrhythmia,1/51,0.6830511550145831,0.6961110101787465,0,0,0.8786036036036036,0.33491097562862443,GRIN2D
NONAKA MYOPATHY,1/51,0.6830511550145831,0.6961110101787465,0,0,0.8786036036036036,0.33491097562862443,ESR1
Narcolepsy,5/258,0.6831926798891323,0.6961496037225631,0,0,0.8669601149838304,0.33029303500072654,CTNND2;SERPING1;TAP1;ANTXR2;VAV2
Central visual impairment,1/52,0.6901212649834398,0.70246353677308,0,0,0.8613319201554496,0.31945763054911464,GRIN2D
Chronic progressive external ophthalmoplegia,1/52,0.6901212649834398,0.70246353677308,0,0,0.8613319201554496,0.31945763054911464,SCN4A
Decreased nerve conduction velocity,1/52,0.6901212649834398,0.70246353677308,0,0,0.8613319201554496,0.31945763054911464,SOX10
Hippocampal sclerosis,1/52,0.6901212649834398,0.70246353677308,0,0,0.8613319201554496,0.31945763054911464,GFAP
Hypocalcemia,1/52,0.6901212649834398,0.70246353677308,0,0,0.8613319201554496,0.31945763054911464,CAV1
Parasitic Diseases,1/52,0.6901212649834398,0.70246353677308,0,0,0.8613319201554496,0.31945763054911464,ADRB2
Progressive visual loss,1/52,0.6901212649834398,0.70246353677308,0,0,0.8613319201554496,0.31945763054911464,DCN
Reduced visual acuity,2/108,0.6964560542173437,0.7088041915629156,0,0,0.8283572554197368,0.2996587200126068,FBN2;MITF
Cone-Rod Dystrophies,1/53,0.6970340091800276,0.709070040238271,0,0,0.8447245322245323,0.3048788868857733,ERG
Hemiplegia/hemiparesis,1/53,0.6970340091800276,0.709070040238271,0,0,0.8447245322245323,0.3048788868857733,ARNT2
Language Disorders,1/53,0.6970340091800276,0.709070040238271,0,0,0.8447245322245323,0.3048788868857733,CNTNAP2
"Xeroderma Pigmentosum, Complementation Group D",1/54,0.7037928824962,0.7156204388863708,0,0,0.8287438381778004,0.29111381527145186,RAD51
Action Tremor,1/54,0.7037928824962,0.7156204388863708,0,0,0.8287438381778004,0.29111381527145186,ADRB2
Cognition,1/54,0.7037928824962,0.7156204388863708,0,0,0.8287438381778004,0.29111381527145186,MEF2C
"Neurogenic muscle atrophy, especially in the lower limbs",4/215,0.7078224829589798,0.7194998933786148,0,0,0.8315439920043847,0.2873499609018664,COL2A1;DMD;PPARGC1A;NEFH
Skeletal muscle atrophy,4/215,0.7078224829589798,0.7194998933786148,0,0,0.8315439920043847,0.2873499609018664,COL2A1;DMD;PPARGC1A;NEFH
"Decreased visual acuity, progressive",1/55,0.7104013023037576,0.7216843361476383,0,0,0.813355021688355,0.27810662247080864,DCN
"Epilepsy, Generalized",1/55,0.7104013023037576,0.7216843361476383,0,0,0.813355021688355,0.27810662247080864,CMA1
Anophthalmos,1/55,0.7104013023037576,0.7216843361476383,0,0,0.813355021688355,0.27810662247080864,RARB
Brugada Syndrome (disorder),1/55,0.7104013023037576,0.7216843361476383,0,0,0.813355021688355,0.27810662247080864,SCN4A
Channelopathies,1/56,0.7168626104602335,0.7278079050417126,0,0,0.7985257985257985,0.26580614013502957,SCN4A
Familial Mediterranean Fever,1/56,0.7168626104602335,0.7278079050417126,0,0,0.7985257985257985,0.26580614013502957,SAA1
Oculomotor apraxia,1/56,0.7168626104602335,0.7278079050417126,0,0,0.7985257985257985,0.26580614013502957,LAMA1
Progressive sensorineural hearing impairment,1/56,0.7168626104602335,0.7278079050417126,0,0,0.7985257985257985,0.26580614013502957,GATA3
"Ataxias, Hereditary",3/167,0.7216628354492609,0.7324599671871296,0,0,0.8025190376338153,0.2617794919729476,PAX2;GFAP;SYNE1
Degenerative brain disorder,3/167,0.7216628354492609,0.7324599671871296,0,0,0.8025190376338153,0.2617794919729476,PLK4;FADD;FGFR3
"Ataxia, Appendicular",1/57,0.7231800745078244,0.7336672780052188,0,0,0.7842261904761905,0.2541653730063829,SYNE1
Bleeding tendency,1/57,0.7231800745078244,0.7336672780052188,0,0,0.7842261904761905,0.2541653730063829,VWF
Ectodermal Dysplasia,1/57,0.7231800745078244,0.7336672780052188,0,0,0.7842261904761905,0.2541653730063829,KIF22
Movement Disorders,3/169,0.7290984967151626,0.7395598102913505,0,0,0.7927683585018809,0.25047234379086003,RAD51;PRKD1;ADCY5
Chlamydia Infections,1/58,0.7293568898171885,0.7395985009832761,0,0,0.770428323059902,0.24314109697919817,IL18
Sparse and thin eyebrow,1/58,0.7293568898171885,0.7395985009832761,0,0,0.770428323059902,0.24314109697919817,SNRPE
"Paraparesis, Spastic",1/59,0.7353961807886813,0.7449352564369206,0,0,0.7571062441752097,0.23269350266757663,SOX10
Angina Pectoris,1/59,0.7353961807886813,0.7449352564369206,0,0,0.7571062441752097,0.23269350266757663,APOB
Conn Syndrome,1/59,0.7353961807886813,0.7449352564369206,0,0,0.7571062441752097,0.23269350266757663,AGT
Drug Resistant Epilepsy,1/59,0.7353961807886813,0.7449352564369206,0,0,0.7571062441752097,0.23269350266757663,SGK1
Moderate mental retardation (I.Q. 35-49),1/59,0.7353961807886813,0.7449352564369206,0,0,0.7571062441752097,0.23269350266757663,RUNX1T1
Skin Abnormalities,1/59,0.7353961807886813,0.7449352564369206,0,0,0.7571062441752097,0.23269350266757663,RET
Tooth problem,1/59,0.7353961807886813,0.7449352564369206,0,0,0.7571062441752097,0.23269350266757663,COL2A1
Hypotrichosis,1/60,0.7413010025347164,0.7505770440258037,0,0,0.7442357611849137,0.22278587730309948,SNRPE
MAJOR AFFECTIVE DISORDER 8,1/60,0.7413010025347164,0.7505770440258037,0,0,0.7442357611849137,0.22278587730309948,GAD1
MAJOR AFFECTIVE DISORDER 9,1/60,0.7413010025347164,0.7505770440258037,0,0,0.7442357611849137,0.22278587730309948,GAD1
"Hemorrhagic Fever, Ebola",1/61,0.7470743425597371,0.7561946171260278,0,0,0.7317942942942943,0.2133843207397855,IL6
MAJOR AFFECTIVE DISORDER 7,1/61,0.7470743425597371,0.7561946171260278,0,0,0.7317942942942943,0.2133843207397855,GAD1
Narrow forehead,1/62,0.7527191221048719,0.7617934936793731,0,0,0.7197607443509083,0.2044574917494203,NDN
Broad cranium shape,2/121,0.7543210372623061,0.7631847071789165,0,0,0.737371246466984,0.2078924013497157,FBN2;FGFR3
Wide skull shape,2/121,0.7543210372623061,0.7631847071789165,0,0,0.737371246466984,0.2078924013497157,FBN2;FGFR3
Dysarthria,5/282,0.7550733650324337,0.763830805777651,0,0,0.7908598621595011,0.22218445614480872,BIN1;SNCAIP;EZH2;ADCY5;SYNE1
Abnormality of the dentition,1/63,0.7582381976297697,0.7668013454722985,0,0,0.708115373437954,0.19597638053669494,COL2A1
Simple ear,1/63,0.7582381976297697,0.7668013454722985,0,0,0.708115373437954,0.19597638053669494,COL1A1
Ciliary Motility Disorders,1/64,0.7636343622900508,0.7717935857246021,0,0,0.6968396968396968,0.1879141045288144,PCSK5
Extrapyramidal sign,1/64,0.7636343622900508,0.7717935857246021,0,0,0.6968396968396968,0.1879141045288144,NEFH
Lissencephaly,1/64,0.7636343622900508,0.7717935857246021,0,0,0.6968396968396968,0.1879141045288144,TUBG1
Unspecified visual loss,1/64,0.7636343622900508,0.7717935857246021,0,0,0.6968396968396968,0.1879141045288144,ANXA1
Familial Nonmedullary Thyroid Cancer,1/65,0.7689103473026596,0.7768921156137598,0,0,0.6859163851351351,0.18024572484213916,RET
Syndactyly of the toes,1/65,0.7689103473026596,0.7768921156137598,0,0,0.6859163851351351,0.18024572484213916,FLI1
"Spastic Paraplegia, Hereditary",2/126,0.7739133998761679,0.7815162683156228,0,0,0.707456491662419,0.18131777243547378,VTN;GAD1
"Bronchitis, Chronic",1/66,0.7740688232334013,0.7815162683156228,0,0,0.6753291753291754,0.1729480810346897,CTLA4
"Hypertrophic disorder of skin, unspecified",1/66,0.7740688232334013,0.7815162683156228,0,0,0.6753291753291754,0.1729480810346897,PRKD1
Pulmonary Stenosis,1/66,0.7740688232334013,0.7815162683156228,0,0,0.6753291753291754,0.1729480810346897,GATA4
Wide spaced nipples,1/66,0.7740688232334013,0.7815162683156228,0,0,0.6753291753291754,0.1729480810346897,GATA4
West Syndrome,1/67,0.7791124016392744,0.7864901381947043,0,0,0.66506279006279,0.16599964171877568,RIMS2
Restless Legs Syndrome,1/68,0.7840436359988355,0.7913491222374781,0,0,0.6551028640580879,0.15938037018093704,PRKN
"Optic Atrophy, Hereditary, Leber",1/69,0.7888650232645682,0.7958566165306954,0,0,0.6454358770535241,0.15307160225746863,ENO2
Bowed and upward slanting eyebrows,1/69,0.7888650232645682,0.7958566165306954,0,0,0.6454358770535241,0.15307160225746863,RPS6KA3
Highly arched eyebrow,1/69,0.7888650232645682,0.7958566165306954,0,0,0.6454358770535241,0.15307160225746863,RPS6KA3
Cerebellar atrophy,3/190,0.7980050914107594,0.8049567728919587,0,0,0.7029786822174365,0.15862032169022292,PLK4;PAEP;SYNE1
"Sensorineural hearing loss, bilateral",1/72,0.8026942481991949,0.8093221094288835,0,0,0.6180687729983505,0.13584001987819333,MITF
MAJOR AFFECTIVE DISORDER 4,1/72,0.8026942481991949,0.8093221094288835,0,0,0.6180687729983505,0.13584001987819333,GAD1
MAJOR AFFECTIVE DISORDER 6,1/72,0.8026942481991949,0.8093221094288835,0,0,0.6180687729983505,0.13584001987819333,GAD1
Cerebellar degeneration,3/193,0.8065480206818294,0.8130856359800609,0,0,0.6917718504405811,0.1487253037587805,PLK4;RUNX1T1;SYNE1
Difficulty speaking,1/73,0.8071001268142919,0.813398026963503,0,0,0.6094532032032032,0.13061042009291676,GATA4
Problems speaking,1/73,0.8071001268142919,0.813398026963503,0,0,0.6094532032032032,0.13061042009291676,GATA4
MAJOR AFFECTIVE DISORDER 1,1/74,0.8114078364155886,0.8176166585697064,0,0,0.6010736764161422,0.12561506391433044,GAD1
Comatose,1/75,0.8156195594571529,0.8217373179289288,0,0,0.5929206233260287,0.1208415269798351,IL6
Poor speech,1/76,0.819737430120138,0.8257621989930775,0,0,0.584984984984985,0.11627816579291349,GATA4
Optic Atrophy,6/363,0.8212539949921548,0.8271658413868193,0,0,0.7349782737696445,0.14473401244057998,PLK4;VCAN;TNFSF11;NEK2;ENO2;SOX5
Congenital anomaly of testis,1/77,0.8237635350746383,0.8294446629027392,0,0,0.5772581792318634,0.11191406048310497,NEK2
Progressive night blindness,1/77,0.8237635350746383,0.8294446629027392,0,0,0.5772581792318634,0.11191406048310497,NEK2
Abnormal vision,1/78,0.8276999148690599,0.8331583675450549,0,0,0.5697320697320697,0.1077389619582807,VCAN
Stereotyped Behavior,1/78,0.8276999148690599,0.8331583675450549,0,0,0.5697320697320697,0.1077389619582807,MEF2C
Supratentorial atrophy,2/143,0.8306527438913004,0.8360053690954554,0,0,0.6216159966700286,0.11533677588180268,PLK4;FADD
Lysosomal Storage Diseases,1/79,0.8315485646487791,0.8366562037724644,0,0,0.5623989373989374,0.10374324391942642,CAV2
Spinocerebellar Ataxia Type 1,1/79,0.8315485646487791,0.8366562037724644,0,0,0.5623989373989374,0.10374324391942642,RIMS2
Ophthalmoplegia,2/144,0.833554153092416,0.8385484859449769,0,0,0.617206625759069,0.1123665448350283,BIN1;NEK2
Non-medullary thyroid carcinoma,1/82,0.8425874276525823,0.847382025174415,0,0,0.5414859303748193,0.09274454620084807,RET
Thalassemia,1/82,0.8425874276525823,0.847382025174415,0,0,0.5414859303748193,0.09274454620084807,KLF1
Abnormality of the retinal vasculature,1/85,0.8529044078667742,0.8576292863053236,0,0,0.5220667095667095,0.08306488747989826,NEK2
Irritation - emotion,1/86,0.8561912152590522,0.8606765756143981,0,0,0.5158982511923689,0.08009915978773542,TGFBR2
Leukoencephalopathies,1/86,0.8561912152590522,0.8606765756143981,0,0,0.5158982511923689,0.08009915978773542,GFAP
Developmental regression,2/154,0.8601898246247138,0.8645667258574645,0,0,0.5763039087560888,0.0867926294867022,CDKN2A;GFAP
"Myoclonic Epilepsies, Progressive",1/88,0.8625466130196304,0.8668057837857007,0,0,0.5039867453660557,0.07452254816707288,PRKN
Speech Disorders,1/93,0.8772357661506388,0.8814355783165306,0,0,0.47647375636506073,0.06240828969477968,RPS6KA3
Macroglossia,1/94,0.879979990829201,0.8840606759026048,0,0,0.471326164874552,0.06026192972873161,NKX2-5
Polyneuropathy,1/95,0.8826630057711742,0.886623503852708,0,0,0.4662880966072455,0.0581982557898353,ALDH2
Abnormality of retinal pigmentation,2/167,0.8889884031719189,0.8925767851252214,0,0,0.5305424447636637,0.062429506893495544,PLK4;NEK2
Infratentorial atrophy,2/167,0.8889884031719189,0.8925767851252214,0,0,0.5305424447636637,0.062429506893495544,PLK4;SYNE1
Retinal pigment epithelial abnormality,2/167,0.8889884031719189,0.8925767851252214,0,0,0.5305424447636637,0.062429506893495544,PLK4;NEK2
Leigh Disease,1/99,0.8928097643273222,0.8962795780601339,0,0,0.44716400073542933,0.050700237239243516,VTN
Sunken eyes,1/103,0.9020808617992263,0.9054513627026759,0,0,0.42953983395159867,0.04426455913062716,ARNT2
Enophthalmos,1/104,0.9042707984309533,0.9073782582193758,0,0,0.42534767777486227,0.04280120882159645,ARNT2
Macrostomia,1/104,0.9042707984309533,0.9073782582193758,0,0,0.42534767777486227,0.04280120882159645,RPS6KA3
Hyperreflexia,4/301,0.9052750696284974,0.9082502789998488,0,0,0.5881337944830008,0.05852897977861043,PRKN;GAD1;CIT;LMNB1
Borderline Personality Disorder,1/110,0.9164213814047322,0.9191586017792982,0,0,0.4018100669476816,0.035069579514669554,GAD1
Lethargy,1/110,0.9164213814047322,0.9191586017792982,0,0,0.4018100669476816,0.035069579514669554,SYNE1
Elevated liver enzymes,1/118,0.9302621480092699,0.9322053992883105,0,0,0.3741818741818742,0.027049178488853003,DMD
Increased liver function tests,1/118,0.9302621480092699,0.9322053992883105,0,0,0.3741818741818742,0.027049178488853003,DMD
Liver enzymes abnormal,1/118,0.9302621480092699,0.9322053992883105,0,0,0.3741818741818742,0.027049178488853003,DMD
Liver function tests abnormal finding,1/118,0.9302621480092699,0.9322053992883105,0,0,0.3741818741818742,0.027049178488853003,DMD
Subclinical abnormal liver function tests,1/118,0.9302621480092699,0.9322053992883105,0,0,0.3741818741818742,0.027049178488853003,DMD
Transaminases increased,1/118,0.9302621480092699,0.9322053992883105,0,0,0.3741818741818742,0.027049178488853003,DMD
Elevated hepatic transaminases,1/119,0.9318229788605942,0.9336301843991871,0,0,0.37099175446633076,0.026196625279326716,DMD
Involuntary jerking movements,1/123,0.9377254037469028,0.9392638048567038,0,0,0.35875424604932804,0.023067223338060383,CTNND2
Spasmodic movement,1/123,0.9377254037469028,0.9392638048567038,0,0,0.35875424604932804,0.023067223338060383,CTNND2
Night Blindness,1/132,0.9492078960931756,0.9506233567196194,0,0,0.3339522728835706,0.017408075655950827,ERG
Electroencephalogram abnormal,1/141,0.958576975119647,0.9597201796218767,0,0,0.31233912483912485,0.013213635304928178,CTNND2
Electroretinogram abnormal,1/141,0.958576975119647,0.9597201796218767,0,0,0.31233912483912485,0.013213635304928178,NEK2
"Psychomotor regression, progressive",1/150,0.9662209113897272,0.9665087341217469,0,0,0.29333696112219604,0.010079874685767617,GFAP
Loss of developmental milestones,1/150,0.9662209113897272,0.9665087341217469,0,0,0.29333696112219604,0.010079874685767617,GFAP
Mental deterioration in childhood,1/150,0.9662209113897272,0.9665087341217469,0,0,0.29333696112219604,0.010079874685767617,GFAP
Neurodevelopmental regression,1/150,0.9662209113897272,0.9665087341217469,0,0,0.29333696112219604,0.010079874685767617,GFAP
Psychomotor regression,1/150,0.9662209113897272,0.9665087341217469,0,0,0.29333696112219604,0.010079874685767617,GFAP
Psychomotor regression beginning in infancy,1/150,0.9662209113897272,0.9665087341217469,0,0,0.29333696112219604,0.010079874685767617,GFAP
Psychomotor regression in infants,1/153,0.9684421142680689,0.9685863349850113,0,0,0.2875029634898056,0.00921923285715787,GFAP
Mitochondrial Diseases,4/384,0.9730785166777949,0.9730785166777949,0,0,0.4576918486692923,0.012490641500005693,C3;ALDH2;FLAD1;PPARGC1A